Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7269047416661465,-2.878944853006951,0.0,0.0,0.0,58/87,15.90%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;SRP19;RPL6;RPL18;RPL36;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;RPL21;RPL34;SEC61A1;RPL10A;RPL35;RPL12;RPL19;RPL14;SRP14;RPS18;RPS13;RPL37;RPS15A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6956586167079879,-2.8093401395368476,0.0,0.0,0.0,58/91,15.90%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;SRP19;RPL6;RPL18;RPL36;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;RPL21;RPL34;SEC61A1;RPL10A;RPL35;RPL12;RPL19;RPL14;SRP14;RPS18;RPS13;RPL37;RPS15A
prerank,protein targeting to ER (GO:0045047),-0.6804821528774363,-2.757341394333784,0.0,0.0,0.0,60/99,15.90%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;CHMP4B;CHMP4A;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;SRP19;RPL6;RPL18;RPL36;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;RPL21;RPL34;SEC61A1;RPL10A;RPL35;RPL12;RPL19;RPL14;SRP14;RPS18;RPS13;RPL37;RPS15A
prerank,cytoplasmic translation (GO:0002181),-0.6746204104865997,-2.7092867289948446,0.0,0.0,0.0,59/91,15.90%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;EIF3M;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;RPL6;RPL18;RPL36;RPS25;RPL28;FTSJ1;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;RPL22L1;TMA7;RPL21;RPL34;RPL10A;RPL35;RPL12;RPL19;RPL14;RPS18;RPS13;RPL37;RPS15A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.602377409756854,-2.4677715915829954,0.0,0.0,0.0,59/110,15.90%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;EIF3E;RPL7;RPL37A;RPS17;RPS16;PABPC1;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;RPL6;RPL18;RPL36;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;NCBP2;RPL21;RPL34;RPL10A;RPL35;RPL12;RPL19;RPL14;NCBP1;RPS18;RPS13;RPL37;RPS15A
prerank,peptide biosynthetic process (GO:0043043),-0.5393083096459879,-2.359564122221181,0.0,0.0,0.0,79/153,22.48%,RPLP1;PCSK5;RPS15;RPL38;RPL18A;RPL41;EEF1A1;RPS12;RPS20;DARS1;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;MRPL52;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;GGTA1;RPL6;RPL18;RPL36;AGO2;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;MRPL23;YARS2;RPS27;RPS9;RPL21;MRPL10;ASMT;RPL34;RPL10A;RPL35;RPL12;RPL19;RPL14;RPS18;RPS13;RPL37;RPS15A;MRPS12;DMD;MRPL43;MRPL55;MRPL36;MRPL35;RPL3;GGT7;RRBP1;RPL15;RPS21;RPL8;GGT1;RPS19
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.7136657145115514,-2.2773449392895664,0.0,0.0,0.0,19/32,14.50%,RHOJ;RHOA;MEOX2;THBS1;NOTCH1;JCAD;KDR;AKT3;STARD13;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;KLF4;FGF2;VEGFA;SRPX2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6513372142887501,-2.1644738349253148,0.0,0.0007881580796064133,0.005,19/39,13.96%,NRP1;COL4A1;SLIT2;LRP6;TIE1;ENG;LRP5;PKD1;BMP4;RASIP1;KDR;SIX1;TGFBR2;MET;NOTCH4;FGF2;SEMA3E;BMP2;VEGFA
prerank,epithelial tube morphogenesis (GO:0060562),-0.6728183119063347,-2.1401697200672833,0.0,0.0012610529273702612,0.009,14/32,7.36%,MEF2C;PODXL;COL4A1;SLIT2;ACVR1;ACVRL1;PKD1;BMP4;RASIP1;MTSS1;SOX17;MET;HES1;PRKX
prerank,regulation of ossification (GO:0030278),-0.6422698016245298,-2.1228120928269116,0.0,0.0026482111474775485,0.018,17/36,12.38%,MEF2C;ZBTB16;BMPR2;PTN;SGMS2;LRP6;ACVR1;TGFB2;NOTCH1;BMP4;S1PR1;WNT5A;MDK;NBR1;TWIST1;BMP2;ECM1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.5416343944899105,-2.121329699862067,0.0,0.0025221058547405225,0.019,29/88,12.38%,PTPRM;NRP1;TEK;CAV1;SPARC;NRP2;BMPR2;TIE1;ACVRL1;THBS1;VEGFC;CDH13;F3;BMP4;KDR;AKT3;PRKD1;XDH;PPP1R16B;WNT5A;FLT4;AGGF1;FGF2;CAV2;PIK3CD;APOE;NRAS;BMP2;ECM1
prerank,negative regulation of vascular permeability (GO:0043116),-0.8265802534887625,-2.0930989272100664,0.0,0.004203509757900871,0.033,11/12,15.01%,PDE3A;CLDN5;SLIT2;RAMP2;PTPRJ;PDE2A;CEACAM1;DDAH1;SH3GL2;VEGFA;FERMT2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.538220163911716,-2.082410937900956,0.0,0.004947207638144871,0.044,27/75,12.38%,NRP1;TEK;NRP2;BMPR2;VEGFC;CDH13;F3;PLCG1;JCAD;BMP4;KDR;AKT3;PRKD1;AGTR1;PPP1R16B;WNT5A;MDK;GATA2;FLT4;IGF2;AGGF1;FGF2;PIK3CD;NRAS;ITGA4;BMP2;ECM1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4771614381919098,-2.076584908926832,0.0,0.005224362127676797,0.051,85/168,24.51%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;AGO1;RPL5;RPL32;TENT2;RPS10;RPS23;RPL10;RPS24;EIF3E;RPL7;RPL37A;CNOT6L;DCP1B;RPS17;RPS16;PABPC1;RPL39;RPS27A;RPL13;CNOT11;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;RPL6;RPL18;RPL36;TENT4B;RPS25;RPL28;RPL27;RPS29;RPL24;RPL23;RPL17;RPS27;RPS9;PAN3;NCBP2;RPL21;RPL34;RPL10A;RPL35;RPL12;RPL19;RPL14;NCBP1;RPS18;NBAS;RPS13;RPL37;RPS15A;TNKS1BP1;PELO;ZC3H12A;MRTO4;RPL3;PPP2CA;MTPAP;EIF4A3;RPL15;RPS21;RPL8;RPS19;RPL13A;EXOSC5;EXOSC4;RPL23A;PNRC2;UPF2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7089937478365858,-2.0765625737819735,0.0,0.004876071319165011,0.051,11/22,12.66%,SLIT2;TMSB4X;GSN;KANK1;KANK3;SSH2;KANK4;PRKCD;TMSB10;HIP1R;PFN1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6252611533774255,-2.0681835179601658,0.0,0.005517106557244893,0.061,8/33,2.97%,PTPRM;PTPRG;DAB2IP;DCN;SLIT2;ACVRL1;THBS1;CORO1C
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6500149646922256,-2.051872021210911,0.0,0.007195419644406785,0.082,17/30,11.97%,ACTB;PECAM1;SLC12A2;LAMA2;CLDN5;TJP1;VCL;ESAM;ACTG1;LSR;F11R;TJP2;ITGB1;OCLN;JAM3;MFSD2A;SLC1A1
prerank,positive regulation of chemotaxis (GO:0050921),-0.6031138796938323,-2.0499650006282555,0.0,0.006935791100536438,0.084,19/43,15.71%,NRP1;NTRK3;PTN;TMSB4X;THBS1;CDH13;F3;KDR;STX3;PRKD1;MET;IL6R;MDK;FGF2;HSPB1;EDN3;VEGFA;RARRES2;SEMA5A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.6255899309365255,-2.047118822811868,0.0,0.007101719117295681,0.09,18/34,11.11%,NRP1;SEMA6A;DAB2IP;GAB1;RAMP2;VEGFC;NOTCH1;KDR;PRKD1;ERN1;FLT1;ANXA1;SPRY2;PIK3CA;FLT4;MT1G;MAPKAPK2;HSPB1
prerank,extracellular matrix organization (GO:0030198),-0.44490070196112885,-2.045977910277804,0.0,0.0069988437469049505,0.093,94/276,14.54%,COL8A1;SH3PXD2A;ELN;COL12A1;ADAMTSL3;VWF;FLRT2;PECAM1;TLL1;SPARC;SPOCK2;LAMA2;LAMA1;COL6A3;DCN;BSG;COL25A1;ITGA6;COL4A1;MFAP5;ADAMTSL1;COL6A2;COL8A2;COL15A1;VIT;GSN;DST;COL6A1;TGFB2;LAMC3;NDNF;THBS1;GAS6;COL4A2;VCAM1;ITGA5;CDH1;CYP1B1;PLOD2;CD44;COL23A1;KDR;FN1;APP;ITGA1;ITGB4;ADAMTS5;F11R;LAMA3;ITGA8;COL5A2;ADAMTS17;FBN1;SLC39A8;COL4A6;ITGB1;P4HA1;ICAM1;CAPN2;CREB3L1;RECK;ADAM10;ADAMTS6;LOX;PLOD3;SH3PXD2B;ITGB5;ADAMTS1;LUM;LAMB2;ADAMTS14;TGFBI;ECM2;ADAM19;SERPINE1;FGF2;VCAN;CRTAP;COL14A1;CAPG;MMP11;COL27A1;ITGA7;JAM3;ITGA4;COMP;ADAMTS20;POSTN;ICAM2;P4HA2;ADAM15;AGRN;HAS1;BGN
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7352807883306777,-2.0397331325710666,0.0,0.0074462172854244,0.102,13/18,14.50%,RHOJ;JCAD;KDR;AKT3;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;VEGFA;SRPX2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8293572040393774,2.0308363182028124,0.0,0.22893453522996945,0.217,5/14,4.23%,ACTN2;ATP1B3;ANK2;LRRC38;ATP1B2
prerank,regulation of endothelial cell migration (GO:0010594),-0.5172273896612789,-2.025951325098132,0.0,0.008827370491591829,0.126,30/85,10.49%,PTPRM;NRP1;FOXP1;TEK;RHOJ;SPARC;NRP2;DAB2IP;BMPR2;DCN;PTN;SLIT2;SCARB1;ETS1;ACVRL1;BMPER;THBS1;BMP4;KDR;PRKD1;WNT5A;PRCP;CEACAM1;EMP2;FLT4;BCAR1;FGF2;EDN1;PIK3CD;APOE
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5807467167648254,-2.025807424761088,0.0,0.00849840016271263,0.127,17/46,12.07%,NRP1;TMEFF2;TEK;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;VAMP3;NTN4;PXN;LAMB2;PARVA;ITGA4;MICALL2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5786044434222399,-2.0255184613537196,0.0,0.008196844027906698,0.128,22/48,14.50%,RHOJ;NOS3;TMSB4X;ETS1;THBS1;PLCG1;JCAD;KDR;AKT3;PTGS2;PIK3C2A;PRKD1;ANXA1;HDAC7;HDAC9;GATA2;ATP5F1B;FGF2;HSPB1;VEGFA;CD40;SRPX2
prerank,translation (GO:0006412),-0.4453007475218261,-2.0142958840158993,0.0,0.009483118013824366,0.153,81/208,17.75%,RPLP1;GATB;RPS15;WARS2;RPL38;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;RPLP0;RPL30;MRPL52;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;RPL6;RPL18;RPL36;LARS2;AGO2;RPS25;RPL28;FTSJ1;RPL27;RPS29;RPL24;RPL23;RPL17;MRPL23;YARS2;RPS27;RPS9;RPL22L1;NDUFA7;TMA7;RPL21;MRPL10;ASMT;RPL34;ABCE1;RPL10A;GARS1;RPL35;EEF1E1;RPL12;RPL19;RPL14;GFM2;RPS18;RPS13;RPL37;RPS15A;PTCD3;EEF1G;MRPS12;MRPL43;MRPL55
prerank,circulatory system development (GO:0072359),-0.4854811990258109,-2.013526460278814,0.0,0.009263888812604612,0.155,36/118,13.50%,TEK;MEF2C;NTRK3;HEG1;PDLIM5;PLCE1;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;RAMP2;NOTCH1;PKD1;FN1;TGFBR2;TBX1;FBN1;SOX17;CRIP1;SH3PXD2B;HDAC9;STRA6;CXADR;PIK3CA;HEY2;FLT4;ZFPM2;NOTCH4;WDR11;LDB3;SOX18;BMP2;NCOA6;FBXW7
prerank,external encapsulating structure organization (GO:0045229),-0.4477025598788541,-1.9995053828779144,0.0,0.010555480058728854,0.177,74/205,14.03%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;SPOCK2;LAMA2;LAMA1;COL6A3;DCN;BSG;ITGA6;COL4A1;MFAP5;ADAMTSL1;COL6A2;COL8A2;COL15A1;VIT;COL6A1;LAMC3;NDNF;THBS1;COL4A2;VCAM1;ITGA5;CDH1;CD44;COL23A1;KDR;FN1;APP;ITGA1;ITGB4;ADAMTS5;F11R;LAMA3;ITGA8;COL5A2;ADAMTS17;FBN1;SLC39A8;COL4A6;ITGB1;ICAM1;RECK;ADAMTS6;LOX;ITGB5;ADAMTS1;LUM;LAMB2;ADAMTS14;TGFBI;ECM2;ADAM19;SERPINE1;FGF2;VCAN;COL14A1;MMP11;HRNR;COL27A1;ITGA7;JAM3;ITGA4;COMP;ADAMTS20;POSTN;ICAM2;ADAM15;AGRN
prerank,endothelial cell migration (GO:0043542),-0.605185887523274,-1.9889226946486165,0.0,0.012475416460055799,0.208,18/37,13.96%,NRP1;NOS3;RHOA;FAP;CDH13;MYH9;CYP1B1;ID1;STARD13;CCN3;ADGRA2;PXN;PRKX;EMP2;PIK3CA;PTP4A3;SOX18;VEGFA
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5620526786455308,-1.9876022185354458,0.0,0.012349621771488076,0.214,22/54,10.63%,NRP1;TEK;LIMS1;VCL;RHOA;ACVRL1;THBS1;ACTG1;LIMCH1;PEAK1;CORO1C;MACF1;PTPRJ;KDR;PHLDB2;MYOC;APOD;EFNA5;SRC;DUSP3;FAM107A;MAP4K4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6009775598098488,-1.9864043900652015,0.0021413276231263384,0.012274248493070544,0.221,13/35,10.49%,PDE4D;PDE3A;PDE7B;RAPGEF2;ADGRG6;GUCY1B1;PDE9A;CAP2;PDE2A;CAP1;ADCY2;AHR;APOE
prerank,regulation of angiogenesis (GO:0045765),-0.4393171700314847,-1.9855506863950563,0.0,0.012366454513566433,0.226,66/192,16.28%,PTPRM;TEK;RHOJ;SEMA6A;SPARC;CLDN5;DAB2IP;GAB1;DCN;NOS3;HIPK1;TIE1;ETS1;TGFB2;RAMP2;BMPER;THBS1;VEGFC;COL4A2;F3;CD34;PTGIS;PLCG1;CYP1B1;BTG1;AGO1;KDR;RUNX1;SERPINF1;ITGB1;PIK3R6;PRKD1;ADGRA2;FLT1;ISM1;PPP1R16B;WNT5A;ADAMTS1;ECSCR;CEACAM1;EMP2;SPRY2;GATA2;AGGF1;SERPINE1;AGO2;KLF4;FGF2;PIK3CD;HGS;HSPB1;SEMA3E;TWIST1;HHEX;TSPAN12;ECM1;STAB1;AMOT;VEGFA;THBS2;CD40;FOXO4;SEMA5A;CEMIP2;ITGB8;APLNR
prerank,heme catabolic process (GO:0042167),-0.7438012872656508,-1.981611990425814,0.0,0.012190178297912526,0.234,3/14,3.09%,ABCG2;ABCC1;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7438012872656508,-1.981611990425814,0.0,0.012190178297912526,0.234,3/14,3.09%,ABCG2;ABCC1;SLCO2B1
prerank,extracellular structure organization (GO:0043062),-0.4440653362704807,-1.9742330167412412,0.0,0.013611953657202525,0.265,73/204,14.03%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;SPOCK2;LAMA2;LAMA1;COL6A3;DCN;BSG;ITGA6;COL4A1;MFAP5;ADAMTSL1;COL6A2;COL8A2;COL15A1;VIT;COL6A1;LAMC3;NDNF;THBS1;COL4A2;VCAM1;ITGA5;CDH1;CD44;COL23A1;KDR;FN1;APP;ITGA1;ITGB4;ADAMTS5;F11R;LAMA3;ITGA8;COL5A2;ADAMTS17;FBN1;SLC39A8;COL4A6;ITGB1;ICAM1;RECK;ADAMTS6;LOX;ITGB5;ADAMTS1;LUM;LAMB2;ADAMTS14;TGFBI;ECM2;ADAM19;SERPINE1;FGF2;VCAN;COL14A1;MMP11;COL27A1;ITGA7;JAM3;ITGA4;COMP;ADAMTS20;POSTN;ICAM2;ADAM15;AGRN
prerank,blood vessel morphogenesis (GO:0048514),-0.5442977100588862,-1.956615339430029,0.0,0.017258410063153005,0.334,29/54,16.28%,NRP1;CAV1;LAMA1;COL4A1;ENG;RAMP2;LRP5;CYP1B1;ID1;RASIP1;KDR;TGFBR2;TBX1;SOX17;FLT1;HES1;LOX;STRA6;HEY2;FLT4;AGGF1;CCBE1;SOX18;SLC1A1;ADM;VEGFA;CDH2;ITGB8;APLNR
prerank,regulation of cell junction assembly (GO:1901888),-0.6309565559078145,-1.952600230411771,0.0,0.017444565495288618,0.349,11/27,7.55%,PRKCH;MEF2C;PDLIM5;RAPGEF2;CLDN5;TJP1;RAP1A;F11R;RUNX1;OCLN;CBFB
prerank,retinoic acid metabolic process (GO:0042573),0.7801999182934969,1.9490516304390872,0.0,0.4404079618407039,0.575,4/14,2.52%,ALDH1A2;ALDH8A1;ADH7;CYP26B1
prerank,regulation of epithelial cell migration (GO:0010632),-0.5497964662249408,-1.9455165691576082,0.0,0.018983958933655013,0.387,15/51,8.89%,PTPRG;RHOJ;DOCK1;DAB2IP;BMPR2;PTN;TGFB2;BMPER;PLCG1;CORO1C;MACF1;PLCG2;CEACAM1;EMP2;SRC
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.7034388747264158,-1.9448905468840485,0.0,0.018650309083739127,0.388,8/18,12.97%,MTUS1;PTN;SLIT2;LYN;IL6R;MDK;PTK2B;EDN3
prerank,regulation of vasculogenesis (GO:2001212),-0.758093455998144,-1.9346818329187532,0.0,0.02092054471816818,0.425,9/14,8.27%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;XDH;CEACAM1;EMP2;HEY2
prerank,positive regulation of cell migration (GO:0030335),-0.42156082653377835,-1.9329075995236766,0.0,0.02083889962479357,0.433,88/253,16.41%,NRP1;LEF1;ACTN4;PODXL;NTRK3;CAV1;PECAM1;GCNT2;SEMA6A;DOCK1;RAPGEF2;DAB2IP;BMPR2;GAB1;SEMA3C;TJP1;ITGA6;SEMA7A;ACVR1;TGFB2;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;PLCG1;STAT3;KDR;FN1;PLCG2;MGAT5;CPNE3;ITGB1;ARHGEF2;FLT1;NUMB;ADAM10;NIPBL;RACK1;TWIST2;CCN1;MYOC;APC;PPP3CA;CXCL12;MDK;SPRY2;PDGFC;TIAM1;SEMA5B;SRC;NEDD9;AGO2;BCAR1;S100A11;FAM107A;EDN1;PIK3CD;NSMF;MAP4K4;RIPOR1;EPHB2;SEMA3E;FBXO5;PDGFD;RET;SEMA3G;BMP2;CCN4;PTK2B;PFN1;HDAC6;SHTN1;SMO;AKT2;PTPRC;VEGFA;FERMT2;CSF1R;SEMA6D;CEMIP;SEMA5A;NCKAP1L;COL1A1;RTN4;RREB1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.5052419954792438,-1.9274361810221223,0.0,0.022452893584885142,0.471,16/67,9.03%,UTRN;NRP1;LIMS1;LIMS2;DOCK1;VIT;NDNF;CDH13;FN1;FLNA;MYOC;MDK;EMP2;ECM2;NEDD9;FBLN2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6569599606673348,-1.9266872276774767,0.0,0.022248576647175323,0.477,12/24,15.01%,NRP1;TEK;LIMS1;PIK3R1;PTPRJ;KDR;MYOC;DUSP3;MAP4K4;VEGFA;S100A10;FERMT2
prerank,smooth muscle cell differentiation (GO:0051145),-0.7860858205377054,-1.9252261838600915,0.0,0.022229723696433907,0.483,9/12,16.89%,MEF2C;MRTFB;TMEM204;BMP4;TBX18;HEY2;MYOCD;APLNR;HEY1
prerank,positive regulation of neuron migration (GO:2001224),-0.8036097026880413,-1.922767155643507,0.0,0.02241234975462601,0.493,8/11,12.90%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;SHTN1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7860864586328542,-1.9225338727246106,0.0,0.021970344334628553,0.493,5/12,7.37%,PDE4D;CAV1;GJD3;CAMK2D;CALM3
prerank,sodium ion transport (GO:0006814),0.5308436579944557,1.9197174276179887,0.0,0.4516606762842109,0.718,11/85,2.78%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC24A3;SLC5A5;ATP1B3;SLC6A9;SLC5A10;SLC23A1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6258355377923747,-1.913704454360456,0.002136752136752137,0.02461794627779336,0.534,9/25,13.88%,SPTBN1;PDE4D;RUNX1;PLCG2;ANXA1;RPS3;MALT1;CD86;PTPRC
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.504736190149501,-1.908857968438247,0.0,0.0258113386410679,0.557,22/70,12.07%,NRP1;TMEFF2;TEK;MEF2C;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;ACTN1;TBCD;VAMP3;NTN4;SIPA1L3;PXN;ARL13B;LAMB2;PARVA;ITGA4;MICALL2
prerank,sodium ion export across plasma membrane (GO:0036376),0.795754717154532,1.907449583879187,0.002012072434607646,0.403933646058302,0.776,3/13,4.23%,ATP1A2;ATP1B3;ATP1B2
prerank,cAMP-mediated signaling (GO:0019933),-0.6382997953021552,-1.9069767465605298,0.00205761316872428,0.026114304370959157,0.563,10/24,10.01%,PDE4D;PDE3A;PDE7B;RAPGEF2;ADGRG6;CAP2;PDE2A;CAP1;ADCY2;AHR
prerank,cardiac myofibril assembly (GO:0055003),0.7360264351416252,1.9044914925656933,0.0019267822736030828,0.3361845446156704,0.787,4/15,4.15%,NEBL;PDGFRA;OBSL1;CSRP3
prerank,cell-cell junction assembly (GO:0007043),-0.5075338471595122,-1.8974054756849883,0.0,0.029081424651599904,0.614,15/63,5.71%,CDH11;ACTB;CLDN5;TJP1;VCL;RHOA;GJC1;GJD3;RAMP2;CD9;ACTG1;WDR1;CTNNA1;TBCD;PAK2
prerank,positive regulation of angiogenesis (GO:0045766),-0.4627269522166651,-1.895519569074175,0.0,0.029382533207727088,0.625,38/108,12.38%,TEK;GAB1;TJP1;NOS3;HIPK1;TIE1;ETS1;RAMP2;BMPER;THBS1;VEGFC;F3;CD34;PTGIS;ITGA5;PLCG1;CYP1B1;BTG1;KDR;RUNX1;ITGB1;PIK3R6;SMAD1;PRKD1;FLT1;WNT5A;MDK;GATA2;AGGF1;SERPINE1;AGO2;KLF4;FGF2;PIK3CD;HSPB1;JAK1;TWIST1;ECM1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4898340878023256,-1.8949714508214168,0.0,0.029053670385491313,0.629,25/79,14.89%,DAB2IP;BMPR2;SLIT2;HTRA3;BMPER;THBS1;NOTCH1;CRIM1;SMURF1;CASK;SMAD1;SMAD5;UBE2D3;CREB3L1;EPN2;SPRY2;PTPN1;FGF2;HGS;LEMD3;HHEX;BMP2;SPRY1;GPC1;SKIL
prerank,endothelial cell development (GO:0001885),-0.6277506911509368,-1.8849246078929203,0.0021321961620469083,0.03249636389761827,0.675,10/25,6.67%,PDE4D;PECAM1;RAPGEF2;COL15A1;RAP1A;ICAM1;MET;PPP1R16B;PDE2A;ROBO4
prerank,negative regulation of angiogenesis (GO:0016525),-0.4744450717707572,-1.8779824650365864,0.0,0.03419118974775595,0.703,28/84,14.08%,PTPRM;TEK;SEMA6A;SPARC;SLC12A2;CLDN5;DAB2IP;DCN;TGFB2;THBS1;COL4A2;AGO1;SERPINF1;CREB3L1;ISM1;ADAMTS1;EPN2;ECSCR;SPRY2;SERPINE1;KLF4;HGS;SEMA3E;HHEX;STAB1;KLF2;AMOT;THBS2
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5622745111420652,-1.877783193207495,0.0,0.03381490071911367,0.706,11/36,10.49%,PTPRM;MEF2C;DAB2IP;DCN;SLIT2;ACVRL1;THBS1;NOTCH1;ANGPT2;FGF2;APOE
prerank,regulation of potassium ion transport (GO:0043266),0.6211051307618846,1.8777701801362692,0.0,0.396173153338642,0.876,11/31,12.80%,CACNA1D;KCNIP3;ACTN2;ANK2;ADRA2A;DLG1;DRD3;KCNH2;VIP;DPP10;KCNIP4
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.6732763919276291,-1.86812314142053,0.0,0.03778573135102165,0.757,8/18,7.35%,HEG1;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC
prerank,artery morphogenesis (GO:0048844),-0.5928215291726833,-1.8678640788727403,0.00211864406779661,0.037268617764246115,0.759,11/30,8.27%,NRP1;BMPR2;JAG1;ENG;TGFB2;NOTCH1;BMP4;TBX1;HES1;STRA6;HEY2
prerank,carboxylic acid transport (GO:0046942),0.5462238642659496,1.8627003557469568,0.0,0.4118604350505261,0.921,11/55,4.11%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC38A1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7275209380686787,-1.861852235075555,0.0,0.0392475068974534,0.781,6/14,9.58%,RHOA;MEOX2;THBS1;NOTCH1;STARD13;KLF4
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.6452678157960451,-1.8604832334423747,0.004228329809725159,0.03939703283439506,0.788,7/21,14.27%,CAV1;LRP6;CSNK1A1;APC;PPP1CA;AMER1;FZD1
prerank,cation transmembrane transport (GO:0098655),0.566517027227535,1.858222228933016,0.0,0.3780330016064368,0.931,4/44,2.24%,TRPM3;ATP1A2;TRPM6;SLC6A9
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6192831067093552,-1.8561750832067976,0.0,0.04127276614833855,0.806,15/26,14.68%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC39A7;SLC30A5;MT3
prerank,regulation of cation transmembrane transport (GO:1904062),0.6170741583988638,1.8553968945037,0.0,0.34844612311273315,0.935,10/29,12.80%,CACNA1D;KCNIP3;WNK3;SNTA1;DLG1;FGF12;KCNH2;PDZK1;DPP10;KCNIP4
prerank,cellular response to copper ion (GO:0071280),-0.6959391932655656,-1.8535242423947458,0.0041753653444676405,0.04174085189595565,0.813,10/16,18.33%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;MT2A
prerank,regulation of T cell migration (GO:2000404),-0.6712484460970072,-1.8530405490843174,0.002053388090349076,0.04132532461988774,0.817,7/18,9.84%,LRCH1;RHOA;CD200;APP;CXCL12;APOD;DOCK8
prerank,endoderm formation (GO:0001706),-0.5731453731725042,-1.8516073371800306,0.0,0.04147236965980585,0.823,12/35,11.98%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;SOX17;ITGB5;SOX7;ITGA7;ITGA4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7357567078552398,-1.8499801070148365,0.0,0.04185494716081296,0.828,8/13,13.96%,NRP1;COL4A1;ENG;KDR;TGFBR2;NOTCH4;SEMA3E;VEGFA
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6658119533061505,-1.848944575666716,0.002066115702479339,0.041713266363169424,0.832,10/19,15.01%,NRP1;TEK;LIMS1;PTPRJ;KDR;MYOC;MAP4K4;VEGFA;S100A10;FERMT2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4931178518177025,-1.843334282113952,0.0,0.044001046758088504,0.856,24/67,11.11%,NRP1;ABI1;NRP2;DOCK1;DAB2IP;RHOA;WASF2;VEGFC;PIK3R1;KDR;CLEC14A;PRKD1;PAK2;FLT1;PXN;NCK1;PIK3CA;FLT4;SRC;MAPKAPK2;BCAR1;NCF2;VAV2;HSPB1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.6680869717169927,-1.8419841283284237,0.0019723865877712033,0.04394578383260001,0.86,9/17,15.66%,PTN;NOTCH1;TNFRSF1B;HES1;MDK;IL34;PTPRZ1;BMP2;ID2
prerank,endothelial cell differentiation (GO:0045446),-0.7356596523369138,-1.8419452414373139,0.00199203187250996,0.04328987661121792,0.86,5/12,3.49%,BMPR2;JAG1;TIE1;ACVRL1;KDR
prerank,sodium ion transmembrane transport (GO:0035725),0.5141232474517692,1.8416693418944123,0.0,0.37227083576208925,0.955,10/84,5.41%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC24A3;ATP1B3;SLC6A9;ATP1B2;NALCN
prerank,lipid translocation (GO:0034204),-0.6387313742930902,-1.8364755191286781,0.0021598272138228943,0.04569462372118123,0.874,8/21,7.43%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;TMEM30A;ATP11B;ATP11C
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6059684739245053,-1.8322047272004545,0.0020876826722338203,0.047280346711693705,0.892,14/25,23.91%,NRP1;ITGA6;THBS1;EGFR;APP;AR;PTGES3;SRC;NCKAP1L;PTH1R;KCTD20;GLMN;BCL10;EGF
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5512560481104956,-1.831671190812027,0.004366812227074236,0.04698322906545203,0.892,16/39,17.23%,TEK;RAMP2;NDNF;THBS1;GAS6;PLCG1;KDR;ICAM1;ECSCR;GATA2;SERPINE1;PDCD4;ITGA4;CD40;SEMA5A;GPER1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.548126179645547,-1.8295749821138425,0.0,0.04760030768101831,0.901,19/39,13.89%,ACTN4;GCNT2;JAG1;RHOA;ACER2;THBS1;NOTCH1;CORO1C;KANK1;TBCD;CASK;AJAP1;MYOC;EFNA5;MAP4K4;SEMA3E;FZD4;AP1AR;ADAM15
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7042700574785512,-1.8237649922547194,0.002028397565922921,0.05056471946274923,0.911,7/14,12.97%,ECE1;NOS3;ENPEP;AGTR1;EDN1;ACE2;EDN3
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6156102575818178,-1.8230384967451823,0.0,0.05032119421136399,0.914,11/23,18.74%,BMP5;SLIT2;THBS1;LYN;MAPK1;MDK;IL34;STK10;RARRES2;CSF1R;MAPK3
prerank,zinc ion homeostasis (GO:0055069),-0.6008456542965787,-1.8228400049531142,0.0,0.049794549375350036,0.915,15/28,14.68%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC39A7;SLC30A5;MT3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6520742575432812,-1.821028106092474,0.006024096385542169,0.0501899065093364,0.918,11/18,13.29%,NOS3;ACVR1;ACVRL1;ENG;TGFB2;NOTCH1;BMP4;TGFBR2;HEYL;BMP2;TBX2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.7063108210792699,-1.8200731280653317,0.0,0.05014344666464381,0.921,8/13,19.13%,LTBP1;GREM2;FBN1;BMP2;CD46;NRROS;CHRDL1;GREM1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5660278595402842,-1.8162988312974924,0.0,0.052243621276767974,0.927,11/33,10.49%,MEF2C;RHOA;MEOX2;ACVRL1;THBS1;NOTCH1;STARD13;ANGPT2;KLF4;FGF2;APOE
prerank,epiboly involved in wound healing (GO:0090505),-0.6747828565009917,-1.808174076206854,0.006289308176100629,0.05677971642210715,0.941,7/16,7.91%,TMEFF2;RHOA;CD44;FLNA;CCN1;ARHGAP35;CEACAM1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6832373140717662,-1.8044582613738884,0.003816793893129771,0.058806569423190416,0.953,8/14,13.96%,NRP1;GAB1;VEGFC;KDR;PIK3CA;FLT4;PIK3CD;VEGFA
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4926080714871904,-1.7995218515702807,0.0,0.06160243550203727,0.959,19/54,14.49%,MEF2C;NOS3;TMSB4X;ETS1;ACVRL1;THBS1;PLCG1;KDR;AKT3;ANGPT2;PRKD1;PRCP;GATA2;ATP5F1B;FGF2;APOE;HSPB1;VEGFA;CD40
prerank,histone lysine demethylation (GO:0070076),0.6255483034072202,1.7988437505634114,0.007766990291262136,0.5564273279996206,0.989,10/25,19.06%,KDM7A;PHF8;PHF2;KDM5B;KDM6B;KDM2A;KDM5C;KDM4A;KDM1A;KDM3B
prerank,actin cytoskeleton reorganization (GO:0031532),-0.48474847158655443,-1.7984297296269427,0.0023584905660377358,0.06176045633182502,0.961,23/63,12.88%,NRP1;GAB1;RHOA;GSN;PARVB;MYH9;THSD7A;MKLN1;TNIK;FLNA;S1PR1;RAP2A;CDC42BPA;ANXA1;CXADR;NEDD9;PTPN1;BCAR1;WHAMM;FGF7;PARVA;MICALL2;TRPV4
prerank,cardiac ventricle development (GO:0003231),-0.6358691240403267,-1.7968540677244103,0.004140786749482402,0.0623913625163555,0.961,12/20,24.66%,ENG;NOTCH1;HES1;PDE2A;HEYL;STRA6;HEY2;HEY1;DLL4;SALL1;MATR3;GJA5
prerank,epithelial cell migration (GO:0010631),-0.5437443949842071,-1.796643224895039,0.002150537634408602,0.0618067868499063,0.961,15/37,14.45%,NRP1;NOS3;RHOA;FAP;CDH13;CYP1B1;KANK1;STARD13;ADGRA2;PXN;PRKX;PIK3CA;PTP4A3;FAT2;PKN3
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.6796099774920816,-1.7952548220102977,0.001949317738791423,0.06224196948663217,0.965,6/15,7.69%,NTRK3;VEGFC;CDH13;F3;KDR;CXCL12
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6325180363539225,-1.7942675872153238,0.0,0.06220699911133536,0.966,9/19,15.34%,LIFR;RUNX1;WNT5A;CBFB;KLF4;TLE5;CD24;IFIH1;IRAK2
prerank,regulation of vasoconstriction (GO:0019229),-0.5793407722388868,-1.7891659587842579,0.006263048016701462,0.06536946453740261,0.973,9/27,12.47%,CAV1;ECE1;BMPR2;ADRA1B;ATP2B1;AGTR1;KCNMB2;ADM;ACE2
prerank,gliogenesis (GO:0042063),-0.6795982437482382,-1.788172609992058,0.004008016032064128,0.06521238069240005,0.973,8/15,26.85%,TGFB2;CD9;ANXA1;CDH2;METTL3;CDK6;METRN;METTL14
prerank,monosaccharide transmembrane transport (GO:0015749),0.6874777554649445,1.7865626546227071,0.005847953216374269,0.5794501230679453,0.995,6/16,8.87%,SLC2A12;SLC5A3;SLC5A10;SLC23A2;SLC23A1;SLC45A3
prerank,regulation of interleukin-1 production (GO:0032652),-0.6750527285378444,-1.7854571305293119,0.0,0.06644889118427161,0.977,5/15,7.91%,FOXP1;GAS6;TMED10;ANXA1;CEACAM1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7664697430440621,-1.7851533715070234,0.004319654427645789,0.0659006423056077,0.977,6/10,7.91%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;CEACAM1
prerank,endothelial cell proliferation (GO:0001935),-0.6584004835136757,-1.7848727123657047,0.008281573498964804,0.06530852993858653,0.978,8/17,7.36%,TEK;BMPR2;ACVRL1;BMPER;CD34;BMP4;ERN1;PRKX
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5378312765785113,-1.7844080934352615,0.0022123893805309734,0.06492343917285355,0.978,13/38,14.29%,BMP5;NOS3;TNFSF10;THBS1;BCL2L1;FAS;ARHGEF2;ICAM1;FEM1B;SERPINE1;GPX1;MADD;TMBIM1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7299382508408635,-1.7825386956590783,0.0038022813688212928,0.06573923738769319,0.981,8/11,16.43%,NDNF;CD34;KDR;ADIPOR2;PRCP;GATA2;VEGFA;MCAM
prerank,phospholipid translocation (GO:0045332),-0.57619377278195,-1.7815805175165316,0.0021691973969631237,0.0657781478567004,0.982,10/28,7.43%,ATP10A;ATP8B1;ATP8A1;ABCC1;PLSCR1;ABCA1;PLSCR4;TMEM30A;ATP11B;ATP11C
prerank,presynapse assembly (GO:0099054),0.6802759347210733,1.7801832908611093,0.001876172607879925,0.5737391963742468,0.998,8/16,11.19%,CEL;IL1RAPL1;NLGN2;WNT7A;NLGN3;LRP4;PTPRD;BSN
prerank,cellular response to drug (GO:0035690),-0.5942018662700235,-1.7776842601818021,0.008350730688935281,0.06828467447143223,0.987,7/25,6.84%,MEF2C;ACER2;GAS6;TFRC;RAP2A;AIM2;KCNQ1
prerank,regulation of dopamine secretion (GO:0014059),0.6197687698250186,1.7735763668178701,0.0018248175182481751,0.5686778200785124,0.998,9/25,10.90%,SYT11;SYT12;SYT9;SYT1;DRD3;SYT13;CHRNB2;SYT10;DTNBP1
prerank,establishment of endothelial barrier (GO:0061028),-0.5625922277221697,-1.7727625553975912,0.0022172949002217295,0.07152161234390493,0.99,12/29,6.78%,PDE4D;PECAM1;RAPGEF2;TJP1;RAP1A;F11R;TJP2;ICAM1;PPP1R16B;PDE2A;ROBO4;RAPGEF6
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5276426019735178,-1.7723250305802503,0.0021413276231263384,0.07111813071648536,0.99,14/42,15.01%,UTRN;NRP1;TEK;LIMS1;CDH13;PTPRJ;KDR;MYOC;EMP2;MAP4K4;PTK2B;VEGFA;S100A10;FERMT2
prerank,positive regulation of cell motility (GO:2000147),-0.39347706476961175,-1.767446075577247,0.0,0.07463613253641928,0.991,68/205,16.08%,LEF1;ACTN4;PODXL;NTRK3;CAV1;PECAM1;GCNT2;SEMA6A;SPOCK2;SEMA3C;TJP1;ITGA6;NTN1;SEMA7A;ACVR1;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;STAT3;KDR;MGAT5;CPNE3;ITGB1;FLT1;NUMB;ADAM10;RACK1;TWIST2;CCN1;MYOC;APC;PPP3CA;CXCL12;MDK;SPRY2;PDGFC;TIAM1;SEMA5B;NEDD9;BCAR1;FAM107A;EDN1;PIK3CD;MAP4K4;RIPOR1;EPHB2;SEMA3E;CCDC25;PDGFD;TWIST1;RET;SEMA3G;BMP2;PTK2B;SMO;AKT2;VEGFA;CAVIN1;FERMT2;CSF1R;SEMA6D;CEMIP;SEMA5A;COL1A1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4677132484363188,-1.7668500260892934,0.0,0.07423484018366365,0.992,24/72,10.96%,NRP1;HEG1;ARHGEF28;NET1;ARHGEF3;STARD8;BCR;KANK1;RASIP1;STMN1;F11R;STARD13;ABCA1;ARHGEF2;EPS8;MET;ARHGDIB;KCTD10;ARHGAP35;MYOC;EPS8L2;LPAR6;APOE;ADGRG1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5602123577870657,-1.766436343311942,0.0,0.07376522729698164,0.992,15/32,11.12%,JAG1;ACER2;ACVRL1;THBS1;CORO1C;PHLDB2;CASK;AJAP1;MYOC;APOD;SRC;SERPINE1;FAM107A;MAP4K4;SEMA3E
prerank,regulation of neuron migration (GO:2001222),-0.5739805544899333,-1.7597224379726466,0.002136752136752137,0.07915629225103131,0.993,10/26,13.91%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;ADGRG1;SHTN1;IGSF10
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.43565848405858854,-1.75860591580756,0.0,0.07944633442432646,0.994,31/100,11.81%,TEK;ROR1;NTRK3;DAB2IP;GAB1;DCN;PIP5K1B;TGFB2;INSR;PIP4K2A;PIK3R1;EGFR;KDR;FN1;PIK3IP1;FLT1;PPP1R16B;LYN;MAPK1;MYOC;CEACAM1;PPP2R5C;PIK3CA;PDGFC;SRC;IER3;FGF2;PIK3CD;PDGFD;TWIST1;UNC5B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6247341527637515,-1.7566716807603984,0.002277904328018223,0.08069502408770289,0.994,13/20,28.58%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA6D;SEMA5A;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6536736369582136,-1.756193399137204,0.004024144869215292,0.08032784715025519,0.994,5/16,7.99%,ST3GAL4;RHOA;ETS1;MDK;NFAT5
prerank,aggrephagy (GO:0035973),-0.5684360470553705,-1.7535117511059741,0.006550218340611353,0.08187143620773081,0.994,13/27,19.47%,DYNC1I2;UBC;RPS27A;UBB;ARL13B;DYNC1I1;SQSTM1;HDAC6;DYNLL1;CFTR;ATG5;ACBD5;DYNC1H1
prerank,phospholipid transport (GO:0015914),-0.4901454694816775,-1.7524661462886817,0.0,0.08186035002814954,0.994,16/52,7.48%,ATP10A;PITPNC1;ATP8B1;ATP8A1;SCARB1;ABCC1;ABCA1;SCARB2;TMEM30A;ATP11B;PLTP;TNFAIP8L3;NPC2;ABCA3;ATP11C;MTTP
prerank,positive regulation of transporter activity (GO:0032411),0.7232988172958166,1.7510674895147615,0.008113590263691683,0.6685405794896419,1.0,7/13,9.83%,WNK3;PON1;KMT2A;STK39;NR1H3;RXRA;PDZK1
prerank,carnitine shuttle (GO:0006853),0.7327517708075606,1.750315117995189,0.019522776572668113,0.6319951258573098,1.0,2/11,1.84%,PRKAG2;PRKAA2
prerank,cell-matrix adhesion (GO:0007160),-0.43904072734751987,-1.7484703130468426,0.0,0.08488313808289447,0.995,27/95,11.98%,ITGBL1;THSD1;VCL;PKD1;CD34;VCAM1;PEAK1;BCR;CD44;FN1;ITGA1;ITGB4;PTPRK;MKLN1;ITGA8;ACTN1;MSLN;ITGB1;ITGB5;EMP2;ECM2;TIAM1;SRC;WHAMM;BCAM;ITGA7;ITGA4
prerank,amide transport (GO:0042886),-0.5659604281301596,-1.7483724353239942,0.008146639511201629,0.08411340880973416,0.995,9/26,6.57%,ABCG2;DISP1;CERT1;SLC5A6;PLEKHA8;PLTP;AQP11;SLC38A5;TAP2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5579240454165412,-1.7461307803040005,0.00211864406779661,0.08550639432530022,0.995,9/30,9.66%,BMP5;NOS3;TNFSF10;BCL2L1;FAS;ARHGEF2;ICAM1;SERPINE1;GPX1
prerank,regulation of fatty acid oxidation (GO:0046320),0.6932347798780174,1.7460059161152104,0.0039603960396039604,0.620611167786926,1.0,7/16,12.01%,PRKAG2;APPL2;PPARA;LONP2;PPARGC1A;ABCD1;SOX9
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.586368964735184,-1.7459272077462729,0.0022935779816513763,0.08488390209280373,0.995,10/24,15.71%,NRP1;SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;VEGFA;SEMA6D;SEMA5A
prerank,sodium-independent organic anion transport (GO:0043252),-0.7397152452502288,-1.745530283786429,0.007407407407407408,0.08445615378124287,0.996,5/10,8.48%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1;SLC16A2
prerank,heart development (GO:0007507),-0.40634466701440836,-1.7450725962251081,0.0,0.0841383601811185,0.996,40/150,13.29%,TEK;MEF2C;FLRT2;NTRK3;BMP5;HEG1;PDLIM5;PLCE1;ECE1;BMPR2;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;INSR;RAMP2;NOTCH1;PKD1;BMP4;FN1;TGFBR2;SGCD;TBX1;FBN1;SOX17;CRIP1;NIPBL;SH3PXD2B;HDAC9;STRA6;CXADR;ZFPM2;WDR11;MYOCD;LDB3;SOX18;BMP2;NCOA6;TBX2
prerank,response to copper ion (GO:0046688),-0.6167680120251763,-1.7448729885748824,0.002109704641350211,0.0835447564382798,0.996,11/20,18.33%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;ATP5F1D;MT2A
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.533361827130142,-1.7447298123649229,0.006521739130434782,0.0829616589563763,0.996,12/35,10.68%,HEG1;DAB2IP;TGFB2;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC;SPRY2;EPHB2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5951618305481144,-1.7432367603608858,0.002004008016032064,0.08371621538893104,0.996,12/21,28.05%,MTUS1;THBS1;MAPK1;MDK;IL34;PTK2B;RARRES2;CSF1R;MAPK3;DDT;CMKLR1;MIF
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4405873167174431,-1.7403193128944041,0.004651162790697674,0.08559807957436748,0.998,31/84,15.71%,NRP1;FOXP1;TEK;SPARC;NRP2;BMPR2;NOS3;TMSB4X;SCARB1;ETS1;THBS1;PLCG1;BMP4;KDR;AKT3;PRKD1;MET;WNT5A;GATA2;FLT4;ATP5F1B;BCAR1;FGF2;EDN1;PIK3CD;HSPB1;PTK2B;VEGFA;CD40;PLPP3;SEMA5A
prerank,positive regulation of vasculature development (GO:1904018),-0.4346355199866918,-1.739553274148924,0.0,0.08550156270488883,0.999,36/94,16.28%,TEK;GAB1;NOS3;HIPK1;TIE1;ETS1;RAMP2;THBS1;VEGFC;F3;CD34;PTGIS;PLCG1;CYP1B1;BTG1;KDR;RUNX1;ITGB1;PIK3R6;PRKD1;FLT1;WNT5A;GATA2;AGGF1;SERPINE1;AGO2;FGF2;PIK3CD;HSPB1;TWIST1;ECM1;VEGFA;CD40;SEMA5A;ITGB8;APLNR
prerank,secretion (GO:0046903),0.680235918980856,1.738389034129994,0.012072434607645875,0.6290741626253266,1.0,6/14,13.20%,SLC22A6;PRKCI;DRD3;RIMS1;VIP;SLC22A2
prerank,xenobiotic transport (GO:0042908),-0.6336027729596296,-1.7380521470296157,0.01020408163265306,0.0862473976480071,1.0,6/17,8.96%,ABCG2;SLC47A1;ABCC1;SLC7A5;ABCA3;SLC22A18
prerank,morphogenesis of an epithelium (GO:0002009),-0.5774449120087308,-1.7375807440014834,0.002061855670103093,0.08592258928861779,1.0,14/25,24.34%,ACTB;VCL;LRP6;ACTG1;TBX18;LAMA3;PRKX;LIN7C;TIMELESS;TRAF3IP1;SOX8;KDM2B;LHX1;ARHGAP12
prerank,lamellipodium assembly (GO:0030032),-0.5630645999508003,-1.7367163588779013,0.004273504273504274,0.08587876406225713,1.0,11/26,13.07%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;GOLPH3;WHAMM;ABLIM2
prerank,microvillus organization (GO:0032528),-0.6890768765612889,-1.7364212538863657,0.00816326530612245,0.08540480950615095,1.0,9/13,18.03%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,endocardial cushion development (GO:0003197),-0.6033750194048302,-1.7325670392120018,0.012244897959183673,0.08853425304140801,1.0,11/21,13.29%,BMPR2;NOS3;ACVR1;ACVRL1;ENG;TGFB2;NOTCH1;BMP4;HEYL;BMP2;TBX2
prerank,protein localization to cell-cell junction (GO:0150105),-0.6518076778806356,-1.7307205347237338,0.002061855670103093,0.08971047833316802,1.0,7/15,5.71%,ACTB;TJP1;ACTG1;LSR;F11R;TJP2;PAK2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5324643785655622,-1.7274875271021828,0.004357298474945534,0.09229267034298448,1.0,14/35,15.86%,NRP1;SEMA6A;NRP2;SEMA3C;SEMA7A;FLNA;MET;SEMA5B;SEMA3E;SEMA3G;ARHGDIA;SEMA6D;SEMA5A;PLXNA4
prerank,regulation of interleukin-2 production (GO:0032663),-0.4935022088431419,-1.7241831539193564,0.004672897196261682,0.09458913933444194,1.0,11/43,13.88%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;ANXA1;HDAC7;RPS3;MALT1;CD86;PTPRC
prerank,membrane repolarization (GO:0086009),0.6843860869651932,1.7233370225317883,0.019120458891013385,0.686395158704663,1.0,5/15,8.26%,ATP1A2;KCND3;ATP1B3;ATP1B2;KCNH2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5839987489837588,-1.7219990023331953,0.008714596949891068,0.09575931509278816,1.0,8/24,9.37%,TEK;RAMP2;NDNF;GAS6;KDR;ICAM1;GATA2;SERPINE1
prerank,positive regulation of cellular component movement (GO:0051272),-0.5762262805353815,-1.7207649109739491,0.0041841004184100415,0.09599014782863631,1.0,11/24,15.53%,ACTN4;SPOCK2;NTN1;ETS1;LYN;CCDC25;TWIST1;AKT2;VEGFA;CAVIN1;CSF1R
prerank,rRNA metabolic process (GO:0016072),-0.3942225175116915,-1.7199175162205083,0.0,0.09608826124537022,1.0,73/160,24.07%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL5;RPL32;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPL29;RPS28;RPL7A;BMS1;RPL6;RPL18;RPL36;RPS25;DDX54;RPL28;PELP1;RPL27;RPL24;RPL23;RPL17;RPS27;RPS9;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL35;RPL12;RPL19;DDX27;TRIR;RPL14;DDX49;ESF1;RPL37;RRP12;PWP2;RCL1;NOP58;MRTO4;EBNA1BP2;RPL3;RPL15;DKC1;RPL8;RPS19;RPL13A;IMP4;UTP14A;EXOSC5;EXOSC4;RPL23A;WDR46
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7300175899117949,-1.7196947943615148,0.01383399209486166,0.09552475924829729,1.0,4/10,7.91%,PRKG1;CD9;PRKCD;CEACAM1
prerank,regulation of striated muscle contraction (GO:0006942),0.5819462530204307,1.7190585507627199,0.007434944237918215,0.6775298168899145,1.0,3/27,1.79%,ATP1A2;SLC8A3;ANK2
prerank,collagen fibril organization (GO:0030199),-0.4340718989370883,-1.7175069409085146,0.0,0.096954441346188,1.0,28/88,9.86%,COL8A1;COL12A1;TLL1;COL6A3;COL25A1;ITGA6;COL4A1;COL6A2;COL8A2;COL15A1;DST;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;COL23A1;ITGB4;LAMA3;COL5A2;COL4A6;P4HA1;LOX;PLOD3;LUM;ADAMTS14;CRTAP;COL14A1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.584232121739852,1.7167085908503856,0.0057361376673040155,0.6599005642617538,1.0,6/26,8.17%,ATP1A2;CRHR1;ADRA2A;GNB5;GSTM2;DRD3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.49546150726589033,-1.7144247877578422,0.0,0.09981718940492298,1.0,16/50,13.53%,LIMS1;ACTN4;RHOA;EGFR;APP;NOD1;NR3C2;IFI35;NFAT5;RPS3;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4638684738149259,-1.7127411430909099,0.0,0.1009708714136387,1.0,21/64,12.44%,UTRN;JAG1;VCL;RHOA;ACER2;THBS1;ACTG1;LIMCH1;CDH13;PEAK1;CORO1C;MACF1;CASK;AJAP1;MYOC;EMP2;EFNA5;DUSP3;MAP4K4;SEMA3E;PTK2B
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6088104188053263,1.7119442923335777,0.00931098696461825,0.6589363818329474,1.0,5/23,4.83%,PRKAG2;BMP7;SPHK1;WNK3;PLK1
prerank,embryonic eye morphogenesis (GO:0048048),-0.7170579399764041,-1.7117406281451102,0.005870841487279843,0.10118039055892755,1.0,8/11,23.05%,MFAP5;LRP6;FBN1;RARG;TBX2;ALDH1A3;EFEMP1;KDM2B
prerank,positive regulation of locomotion (GO:0040017),-0.5548416407986613,-1.7098755650930744,0.0064794816414686825,0.10225906632848322,1.0,10/27,15.53%,SPOCK2;NTN1;THBS1;STX3;CCDC25;TWIST1;AKT2;RARRES2;CAVIN1;CSF1R
prerank,neurotransmitter uptake (GO:0001504),0.6943899767532582,1.708920440710624,0.004201680672268907,0.649114604090516,1.0,6/12,16.43%,ATP1A2;SLC29A2;SLC38A1;SNAP25;SLC22A2;GLUL
prerank,motor neuron axon guidance (GO:0008045),-0.6612910577754115,-1.7085993003442908,0.0,0.10289815453631669,1.0,4/15,2.62%,SLIT2;NTN1;TMEFF1;CHN1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5936752794669016,-1.708280930270162,0.013186813186813187,0.10245354449923723,1.0,6/21,7.55%,FOXP1;PRKCH;SLC39A10;RUNX1;LYN;CBFB
prerank,cellular response to fluid shear stress (GO:0071498),-0.6902361440345205,-1.7073658575014374,0.008,0.1025903646207689,1.0,7/12,22.13%,MEF2C;MTSS1;KLF4;SREBF2;KLF2;ASS1;HAS2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.4127721327304749,-1.705560179105772,0.0,0.10349838770329356,1.0,29/118,10.42%,FMNL2;MEF2C;SHANK3;SPARC;PDLIM5;PID1;NEDD4L;ETS1;BMPER;PHLDB1;CHN1;HECW2;TBX1;TNIK;PHLDB2;RAP2A;PAK2;ADGRA2;ARHGAP35;CEACAM1;EMP2;EFNA5;FLT4;CDK5;ABI3;MYO19;FGF2;CFL1;NSMF
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.3669420643922544,-1.7016965466218497,0.0,0.10701587559734152,1.0,116/306,22.56%,ST3GAL4;RPLP1;PTMA;EXT1;RPA1;KAT7;RPS15;RPL38;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL5;RPL32;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;RPLP0;RPL30;MRPL52;RPS5;RPL35A;RPS8;RPS7;RPL22;TIPIN;RPL29;RPS3;RPS28;RPL7A;RPS26;RPL6;RPL18;RPL36;AGO2;RPS25;RPL28;GOLPH3;RPL27;APOE;RPS29;RPL24;RPL23;RPL17;MRPL23;GCNT1;YARS2;RPS27;B4GALT5;RPS9;BLM;RPL21;MRPL10;KIN;ASMT;RPL34;ORC1;RPL10A;RPL35;NR4A2;RPL12;RPL19;TIMELESS;RPL14;RPS18;RPS13;RPL37;RPS15A;EEF1G;ING4;MRPS12;EPC1;MRPL43;ORC2;RHNO1;NBN;MRPL55;RPA2;BARD1;ST3GAL2;CDC45;ORC5;RMI1;PCLAF;MRPL36;MRPL35;POLA1;DUT;RPL3;SET;POLR3A;RFC4;CHEK1;POLR2I;THAP1;RRBP1;TOP1;RPL15;MCM3;POLA2;RPS21;RPL8;RPS19;POLR2F
prerank,receptor metabolic process (GO:0043112),-0.4724259883852531,-1.700352591498815,0.0,0.10777012751245565,1.0,30/53,31.74%,CAV1;CALCRL;DNM3;RAMP2;CD9;SMURF1;RAB31;TFRC;ITGB1;SNX1;ACKR3;ADM;RAB11B;PIK3R4;LDLRAP1;LRP1;ARRB2;NEDD4;SYK;AP2M1;PHETA1;PHETA2;GRB2;NSG1;DNM2;DNM1;LMTK2;GRK2;CD36;SH3GLB1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7376225791024081,-1.6995828035166765,0.006342494714587738,0.10796414562471394,1.0,4/10,5.56%,FAP;NOTCH1;TNFRSF1B;CST3
prerank,regulation of regulated secretory pathway (GO:1903305),0.5612577704846098,1.6983135461313295,0.007366482504604052,0.6852838425323082,1.0,11/34,10.90%,SYT11;SYT12;UNC13D;SYT9;SYT1;SNAPIN;LRRK2;SYT13;RIMS1;SYT10;DTNBP1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.677675033549564,-1.6980702097795173,0.012048192771084338,0.10867414269841166,1.0,4/13,7.37%,PDE4D;CAV1;CAMK2D;CALM3
prerank,cellular glucan metabolic process (GO:0006073),0.7156476794414792,1.6959623574153069,0.01761252446183953,0.6724001312022194,1.0,5/11,14.00%,PRKAG2;PHKG2;PHKB;PYGL;PYGM
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6620829656980053,-1.6934931656185515,0.01171875,0.11275766914662118,1.0,7/14,9.26%,GHR;PIK3R1;SOCS2;STAT3;LYN;PXN;PTPN1
prerank,lamellipodium organization (GO:0097581),-0.5380726373744226,-1.6930581589548273,0.010964912280701754,0.11239244447086698,1.0,13/29,15.05%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;SNX1;GOLPH3;WHAMM;ABLIM2;SNX2
prerank,microvillus assembly (GO:0030033),-0.658850144476228,-1.692370739396767,0.012024048096192385,0.11245264333584393,1.0,9/14,18.03%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5814398646017481,1.688208053565897,0.011029411764705883,0.6923851908382792,1.0,8/27,9.43%,SYT11;SYT12;SYT9;VAMP7;SYT1;SYT13;RIMS1;SYT10
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.45797668518690277,-1.687796203876159,0.0,0.11671262265730281,1.0,29/67,21.77%,TEK;GHR;ABI1;INSR;EGFR;KDR;BMX;FLT1;LYN;TEC;FLT4;SRC;IL15;ABI3;EPHB2;PIBF1;DYRK1A;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;MAPK3;BTK;JAK3;HCK;SYK;IGF1R;FYN
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.6459949634638806,-1.6872954142969672,0.009940357852882704,0.1165178355494851,1.0,3/14,3.91%,IL6ST;OSMR;PTGS2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6705447447030822,1.6864642119919608,0.01348747591522158,0.6755652625292154,1.0,6/14,20.00%,MOXD1;DAGLA;SLC6A4;SLC22A2;ALDH9A1;ACHE
prerank,heart morphogenesis (GO:0003007),-0.47717193499135724,-1.6863877362881032,0.004338394793926247,0.1166516850774205,1.0,15/50,8.27%,FLRT2;NOS3;ACVR1;ACVRL1;ENG;TGFB2;INSR;NOTCH1;TBX3;TBX1;SOX17;NIPBL;HES1;HEYL;HEY2
prerank,cellular protein metabolic process (GO:0044267),-0.3542936859518163,-1.683608883352626,0.0,0.11920358414804022,1.0,119/396,16.02%,MSRB3;DAB2IP;ST8SIA4;LTBP1;RPLP1;PCSK5;ST3GAL6;GAS6;RPS15;RPL38;RPL18A;RPL41;ATG3;PLOD2;BMP4;EEF1A1;RPS12;RPS20;DARS1;RPL5;RPL32;FN1;APP;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;FBN1;MSLN;PDIA6;IGFBP6;RPS17;RPS16;RPL39;CST3;RPS27A;UBE2D3;ST3GAL1;ADAM10;RPL13;MSRB2;RPLP0;RPL30;PAPPA;MRPL52;RPS5;LOX;RPL35A;RPS8;CSNK1G3;CCN1;RPS7;ABCA3;RPL22;LAMB2;RPL29;RPS3;KTN1;RPS28;MFGE8;RPL7A;SPPL3;RPS26;MGAT4A;RPL6;IGF2;RPL18;RPL36;AGO2;RPS25;RPL28;VCAN;CPE;RPL27;YES1;APOE;RPS29;RPL24;RPL23;RPL17;MRPL23;SFTPA1;SFTPA2;YARS2;RPS27;PNPLA2;RPS9;FBXW2;RPL21;MRPL10;ASMT;RPL34;STK38;AKT2;RPL10A;UBE2L3;LMCD1;EVA1A;UBL5;RPL35;CDH2;ST8SIA2;D2HGDH;RPL12;GOLM1;RPL19;HM13;TNC;RPL14;ICMT;PPP4R2;RPS18;RPS13;RPL37;RPS15A;ZDHHC2;PHKA2
prerank,sprouting angiogenesis (GO:0002040),-0.47799569065527603,-1.6815644544730186,0.0021691973969631237,0.12102722725768279,1.0,22/51,12.44%,NRP1;TEK;RSPO3;SLIT2;ACVRL1;ENG;RAMP2;BMPER;THBS1;VEGFC;CDH13;BMP4;KDR;RECK;ADGRA2;FLT4;CCBE1;FGF2;ESM1;PARVA;SEMA3E;PTK2B
prerank,regulation of platelet aggregation (GO:0090330),-0.611886698457047,-1.6798604884251047,0.014553014553014554,0.12233894799394694,1.0,6/17,7.91%,PRKG1;CD9;F11R;LYN;PRKCD;CEACAM1
prerank,regulation of microtubule-based movement (GO:0060632),0.697995797567797,1.6787093075137351,0.019455252918287938,0.6960607648626456,1.0,4/11,8.60%,MAP2;TTC21B;DYNLT2B;DRC1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.42226826437892245,-1.6772903973765247,0.0,0.12469391561963823,1.0,28/92,12.87%,NRP1;FOXP1;TEK;SPARC;NRP2;DOCK1;BMPR2;SCARB1;ETS1;TGFB2;THBS1;PLCG1;BMP4;KDR;PLCG2;PRKD1;WNT5A;FLT4;SRC;BCAR1;FGF2;EDN1;PIK3CD;FGF7;MAP4K4;PTK2B;PFN1;HDAC6
prerank,limb morphogenesis (GO:0035108),-0.5902670156210004,-1.6767367044916839,0.014957264957264958,0.12444601256943366,1.0,7/20,5.93%,MBNL1;LRP6;PCSK5;TGFB2;TBX3;GLI3;NIPBL
prerank,intestinal lipid absorption (GO:0098856),0.7030808336768415,1.6763014642951564,0.009823182711198428,0.6843148959556725,1.0,3/11,2.16%,CEL;ABCG5;SOAT2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.699337741343041,-1.6762821290813337,0.01338432122370937,0.1242013500819769,1.0,6/11,11.99%,MECOM;CD34;RUNX1;WNT5A;ARIH2;ETV6
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6429304478465214,1.6739709766670852,0.01606425702811245,0.6749559201378941,1.0,3/17,1.28%,ATP1A2;BMP7;TFPI
prerank,sulfation (GO:0051923),0.7031348770345376,1.6712090856253607,0.016771488469601678,0.6677027800605517,1.0,2/11,1.22%,UST;CHST4
prerank,potassium ion transport (GO:0006813),0.4346075002852218,1.6709909459154009,0.006299212598425197,0.6478798843928638,1.0,21/120,12.39%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;KCNJ10;TMEM175;NALCN;KCNC3;KCND2;KCNH2;KCNN4;KCNC2;KCNJ16;KCNH7;SLC9A9;KCNK4
prerank,histone H3-K9 demethylation (GO:0033169),0.6973870188416469,1.6691135440571885,0.030991735537190084,0.6382182179359158,1.0,5/11,19.06%,KDM7A;PHF8;KDM4A;KDM1A;KDM3B
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6748060036775414,1.6687432601917425,0.02074688796680498,0.621181792251607,1.0,3/12,3.84%,IL18;NUPR1;TAFA3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6145885423347445,-1.667907054673059,0.010893246187363835,0.13404009979301176,1.0,7/17,18.84%,PRKG1;MEF2C;TAFA5;TGFB3;PDCD4;GPER1;PTEN
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5720020278674698,1.6675026175685808,0.0176678445229682,0.610262974637719,1.0,9/25,9.83%,ACTN2;ATP1B3;ANK2;SLC6A9;WNK3;STK39;ATP1B2;WNK4;PDZK1
prerank,regulation of cell migration (GO:0030334),-0.3488282864958327,-1.6663270691282448,0.0,0.13498961400598308,1.0,114/382,16.08%,LEF1;TMEFF2;FRMD5;ACTN4;PODXL;NTRK3;CAV1;PECAM1;GCNT2;SEMA6A;DOCK10;CLDN5;SEMA3C;TJP1;JAG1;ITGA6;SLIT2;VCL;SRGAP1;TMSB4X;RHOA;CLIC4;SEMA7A;ACVR1;ACVRL1;ENG;INSR;THBS1;NOTCH1;ACTG1;LIMCH1;CDH13;F3;PRR5L;FOXO3;EGFR;CDH1;CORO1C;CYP1B1;MACF1;SPATA13;KANK1;STAT3;PTPRJ;KDR;ADARB1;PTPRK;DACH1;MGAT5;FLNA;CPNE3;ITGB1;RAP2A;RECK;FLT1;NUMB;ADAM10;RACK1;TWIST2;ROBO4;CCN1;ANXA1;MYOC;PRKX;APC;PPP3CA;CXCL12;MDK;CEACAM1;SPRY2;STK24;PDGFC;TIAM1;SEMA5B;SRC;NEDD9;ABI3;SERPINE1;BCAR1;FGF2;TMSB10;DUSP3;FAM107A;EDN1;PIK3CD;FGF7;MAP4K4;RIPOR1;EPHB2;SEMA3E;PDGFD;CD74;PLXNC1;RET;SEMA3G;BMP2;PTK2B;SST;SMO;AKT2;AMOT;ADAM15;IGSF10;VEGFA;GNA12;FERMT2;CSF1R;SEMA6D;CEMIP;SEMA5A;MCTP1;PLXNA4;RAP2B;COL1A1
prerank,modified amino acid transport (GO:0072337),0.651123432036889,1.6653724539091883,0.0275049115913556,0.6038310043622103,1.0,4/15,8.24%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7122643658697243,-1.6651725723512323,0.016563146997929608,0.1356682774362506,1.0,4/10,7.69%,RAPGEF2;GAS6;LYN;CXCL12
prerank,positive regulation of hemostasis (GO:1900048),-0.6896341147290543,-1.665094994123501,0.01383399209486166,0.1339988455545526,1.0,7/10,25.61%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,positive regulation of coagulation (GO:0050820),-0.6896341147290543,-1.665094994123501,0.01383399209486166,0.1339988455545526,1.0,7/10,25.61%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,mesonephros development (GO:0001823),0.6977363406896628,1.6627730530074736,0.021484375,0.6004104448459098,1.0,3/11,1.12%,BMP7;FGF1;OSR1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.46393204317880454,-1.660576718221361,0.004819277108433735,0.1390647926321394,1.0,11/51,5.78%,BMPR2;HTRA3;GREM2;BMPER;NOTCH1;CRIM1;SMURF1;FBN1;SMAD1;SMAD5;UBE2D3
prerank,myelination in peripheral nervous system (GO:0022011),-0.653318394893608,-1.6600101916545922,0.009398496240601503,0.13890497994983428,1.0,8/13,21.28%,ADGRG6;PARD3;LGI4;MYOC;SOD1;PRX;ARHGEF10;SKI
prerank,heterocycle biosynthetic process (GO:0018130),-0.6418971558892691,-1.659192356535217,0.01002004008016032,0.1391857796234133,1.0,7/14,21.40%,GPHN;GCH1;LIAS;NFS1;MOCS1;NOXRED1;PYCR3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4931213555535286,-1.6581780887125799,0.004405286343612335,0.13964993529026226,1.0,9/35,10.49%,PTPRM;MEF2C;CAV1;SPARC;THBS1;XDH;FLT1;CAV2;APOE
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4522876042228877,-1.657676024839107,0.0,0.13967515061805336,1.0,26/58,19.83%,SGMS1;ST3GAL4;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ST8SIA6;PLPP1;SAMD8;ELOVL6;ELOVL1;VAPB;PLPP3;ELOVL4;SGPP1;ST3GAL2;PPM1L;SPTSSA;ACER3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6857272922290916,-1.6575598626121093,0.018480492813141684,0.1389541917713902,1.0,8/11,20.54%,LIMD1;STAT3;PUM2;PUM1;FMR1;FXR1;XPO5;AJUBA
prerank,positive regulation of heart rate (GO:0010460),-0.6086188636612871,-1.656832865439681,0.012371134020618556,0.13904446004634646,1.0,6/17,12.97%,PDE4D;ADRA1B;KCNQ1;EDN1;ADM;EDN3
prerank,regulation of protein localization to membrane (GO:1905475),-0.5486774454197452,-1.6520031028107076,0.013157894736842105,0.1442006425743512,1.0,15/28,21.77%,SPTBN1;GPC6;ACTB;GSN;AR;CDK5;STX7;ZDHHC7;STX8;GPC1;ZDHHC2;LDLRAP1;CRIPT;GPC4;FYN
prerank,vasoconstriction (GO:0042310),-0.6867336402473317,-1.6506931270665224,0.012269938650306749,0.14510415001405352,1.0,5/11,12.97%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5871380936827675,-1.6506498239599734,0.014028056112224449,0.14430048497479703,1.0,10/20,17.23%,GSN;THBS1;PLCG1;SFRP4;PLA2R1;ECSCR;PDCD4;ITGA4;CD40;GPER1
prerank,endodermal cell differentiation (GO:0035987),-0.5183667980870637,-1.6500674810425313,0.00646551724137931,0.14434951999986806,1.0,12/31,11.98%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;ITGB5;RTF1;PAF1;ITGA7;ITGA4
prerank,B cell receptor signaling pathway (GO:0050853),-0.5037896344304367,-1.6488917646536905,0.013100436681222707,0.14502850460597633,1.0,15/32,20.61%,MEF2C;RFTN1;BMX;PLCG2;TEC;CD38;BCAR1;PIK3CD;NFATC2;SH2B2;PTPRC;NCKAP1L;LAT2;BTK;SYK
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5344416863315984,-1.6472138421361648,0.008869179600886918,0.14644438030244825,1.0,12/29,12.66%,SHANK3;TJP1;SLIT2;KANK1;KANK3;SSH2;KANK4;PRKCD;PIK3CA;HIP1R;LIMA1;PFN1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.42832056951982855,-1.646703752048931,0.005063291139240506,0.1462894712780164,1.0,23/75,14.08%,PTPRM;TEK;SEMA6A;SPARC;CLDN5;DAB2IP;DCN;TGFB2;THBS1;COL4A2;AGO1;SERPINF1;ISM1;ADAMTS1;ECSCR;SPRY2;KLF4;HGS;SEMA3E;HHEX;STAB1;AMOT;THBS2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6532432542454878,-1.6464173882717907,0.014462809917355372,0.14598327732048683,1.0,5/12,17.22%,TMEFF2;AR;EDN1;AP2A1;HDAC2
prerank,regulation of wound healing (GO:0061041),-0.48485123309886735,-1.6453683699903403,0.0064794816414686825,0.14662276881395261,1.0,12/42,10.68%,CAV1;ACTG1;KANK1;CD109;ITGB1;CASK;AJAP1;OCLN;ANXA1;SERPINE1;FGF2;EPHB2
prerank,substantia nigra development (GO:0021762),-0.5018179448271546,-1.6447225592496424,0.016842105263157894,0.1465199381269687,1.0,11/37,14.50%,ACTB;RHOA;YWHAE;GNB4;MAOB;CALM3;YWHAQ;CNP;NDRG2;DYNLL1;GLUD1
prerank,positive regulation of response to wounding (GO:1903036),-0.5526089011525668,-1.643351538645966,0.020964360587002098,0.1475575226492225,1.0,8/24,7.83%,PTN;ACTG1;KANK1;SCARF1;ITGB1;OCLN;ANXA1;MDK
prerank,cGMP-mediated signaling (GO:0019934),-0.6458543565987723,-1.6417058495585222,0.02066115702479339,0.14900373402837086,1.0,5/13,10.49%,PDE3A;GUCY1B1;PDE9A;PDE2A;APOE
prerank,outflow tract septum morphogenesis (GO:0003148),-0.544288356775065,-1.6414479823216237,0.008368200836820083,0.1485208627493829,1.0,10/24,4.23%,NRP1;NRP2;BMPR2;SEMA3C;ACVR1;ENG;TGFB2;BMP4;TGFBR2;TBX1
prerank,clathrin coat assembly (GO:0048268),-0.6295003946710793,-1.6408295410667961,0.010660980810234541,0.1486351657075853,1.0,5/15,5.69%,HIP1;PIK3C2A;FCHO2;SGIP1;CLTB
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4749074395350229,-1.638003475291396,0.00228310502283105,0.15171867886183543,1.0,12/47,8.99%,NRP1;LIMS1;ACTN4;LIMS2;DOCK1;CORO1C;KANK1;FLNA;MYOC;MDK;EFNA5;NEDD9
prerank,receptor internalization (GO:0031623),-0.4707620429968177,-1.637955259322922,0.0047169811320754715,0.15094315840594869,1.0,18/44,20.61%,CAV1;CALCRL;DNM3;RAMP2;CD9;RAB31;TFRC;ITGB1;LMBRD1;SNX1;CEACAM1;ACKR3;ADM;LDLRAP1;LRP1;ARRB2;NEDD4;SYK
prerank,activation of protein kinase B activity (GO:0032148),0.5415532903688591,1.6377383289848342,0.01694915254237288,0.7179068436163352,1.0,8/29,6.81%,FGF1;OSBPL8;IGF1;IL18;RICTOR;ADRA2A;PDPK1;NRG1
prerank,regulation of glucose import (GO:0046324),0.5487079532678445,1.634508459947619,0.012773722627737226,0.717268514289394,1.0,8/30,10.15%,PRKAG2;OSBPL8;IGF1;APPL2;PRKCI;RHOQ;SORBS1;CREBL2
prerank,negative regulation of calcium ion transport (GO:0051926),0.6444527637592848,1.6343760133048653,0.027613412228796843,0.7001322519359243,1.0,2/15,4.52%,ATP1A2;ADRA2A
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.548763758796457,-1.6342730779780024,0.008438818565400843,0.15547673976517193,1.0,10/24,19.09%,NCKAP5;STMN1;MAP7D3;TPPP3;FGF13;TRPV4;NCKAP5L;KATNB1;KIF24;STMN4
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5389381636953997,-1.6320919408637338,0.006382978723404255,0.15764539792048887,1.0,12/27,7.35%,TMEFF2;SHANK3;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5922653082958422,-1.6318975823985666,0.0163265306122449,0.1571518675250005,1.0,9/16,20.28%,THBS1;JCAD;AGTR1;PPP1R16B;GATA2;FGF2;VEGFA;APLNR;DLL4
prerank,cellular response to cadmium ion (GO:0071276),-0.5458732963841078,-1.631749333105694,0.008264462809917356,0.15647962703087415,1.0,14/24,18.74%,EGFR;JUN;MAPK1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;MT2A;MAPK3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5812381829022394,1.6309097201377696,0.019120458891013385,0.7017567501985215,1.0,3/23,1.79%,ATP1A2;CACNB1;ANK2
prerank,regulation of blood coagulation (GO:0030193),-0.5315767581917952,-1.6301449573234668,0.01948051948051948,0.1578892503903153,1.0,10/27,11.46%,ST3GAL4;CAV1;FAP;THBS1;CD34;SERPINE1;EDN1;APOE;EPHB2;ENPP4
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6180189566154273,-1.6301001684126288,0.025390625,0.15709887163645778,1.0,7/14,18.74%,THBS1;MAPK1;MDK;IL34;RARRES2;CSF1R;MAPK3
prerank,monocyte differentiation (GO:0030224),-0.6829575079884919,-1.6293753859512354,0.021956087824351298,0.15716207493768736,1.0,5/10,15.53%,MYH9;BMP4;MT1G;VEGFA;CSF1R
prerank,ribosomal small subunit assembly (GO:0000028),-0.6097543942519066,-1.628830241486807,0.019522776572668113,0.15719792047007067,1.0,8/16,22.48%,RPS15;XRCC5;RPS5;RPS28;RPS27;RRP7A;PWP2;RPS19
prerank,regulation of neuroinflammatory response (GO:0150077),0.5929421534944485,1.6279329410313972,0.0275049115913556,0.7002736037676038,1.0,5/19,3.34%,IGF1;IL18;NUPR1;SPHK1;DAGLA
prerank,organic anion transport (GO:0015711),-0.42199152298950876,-1.627743229204624,0.006787330316742082,0.15790373786876782,1.0,14/76,8.48%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO3A1;LRRC8D;SLCO1C1;SLCO2A1;LRRC8C;SLCO2B1;SLC39A8;CA4;LRRC8A;SLC16A2
prerank,platelet degranulation (GO:0002576),-0.3913553738908696,-1.6263804641054507,0.0025252525252525255,0.15888606647730544,1.0,34/118,14.05%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;THBS1;CD9;VEGFC;GAS6;LHFPL2;FN1;APP;TAGLN2;WDR1;CD109;ACTN1;FLNA;LYN;ALDOA;CHID1;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;ECM1;TMX3;VEGFA;RARRES2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5707954720671534,-1.6248227816103904,0.018711018711018712,0.16025224153597398,1.0,12/19,23.01%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;HEY2;BMP2;HEY1;SLIT3;ZFPM1;SMAD6
prerank,mesenchyme morphogenesis (GO:0072132),-0.5975502946653171,-1.6246434292700467,0.01782178217821782,0.1597224808785805,1.0,9/17,13.29%,NOS3;ACVR1;ACVRL1;ENG;TGFB2;NOTCH1;HEYL;BMP2;TBX2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6256349691127275,1.6237404061123184,0.022988505747126436,0.7074862211706766,1.0,6/18,7.95%,UNC13C;NAPB;GRID2;GRIK5;GRIK2;NAPA
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5236048396547596,-1.6227704639624594,0.014285714285714285,0.16140177415775045,1.0,9/26,10.00%,PDE8A;DAB2IP;PTPN12;IQGAP1;EGFR;PLCG1;EEF1A1;GAREM1;DUSP3
prerank,supramolecular fiber organization (GO:0097435),-0.3403648587161223,-1.622693429314734,0.0,0.16066460988506037,1.0,83/333,14.06%,HIP1;COL8A1;COL12A1;MYO1D;PGM5;TLL1;COL6A3;RHOBTB1;MYO1B;COL25A1;ITGA6;SHROOM4;COL4A1;RHOA;COL6A2;COL8A2;COL15A1;B2M;GSN;DST;COL6A1;TGFB2;COL4A2;CORO1C;CYP1B1;NCKAP5;PLOD2;H3-3A;COL23A1;APP;ITGB4;STMN1;UBC;LAMA3;COL5A2;ACTN1;COL4A6;ARHGEF2;P4HA1;CST3;RPS27A;UBB;ADAM10;TNXB;TPM4;LOX;PLOD3;CLIP4;MAP7D3;ALDOA;LUM;MFAP4;TPM2;IAPP;EMP2;MYH11;ADAMTS14;MFGE8;TGFBI;TMOD3;TPPP3;MYO19;MYO1F;CD2AP;TPM3;BCAR1;CRTAP;COL14A1;FGF13;WHAMM;GFAP;CDC42EP2;COL27A1;CLIP2;HIP1R;ITM2B;TRPV4;P4HA2;MARCKS;AVIL;SHROOM1;NCKAP5L;CLIP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.43406578745941904,-1.6223681735459035,0.004576659038901602,0.16033387219421893,1.0,39/70,28.84%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;MAPK1;NCK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;SYK;ARPC3;CDC42;FYN;FCGR1A;MYO1C;FCGR2B;PRKCE;ACTR3;ARPC1B;GRB2;FCGR3A;ARPC1A;VAV3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5741224723790994,1.6214797468294064,0.021739130434782608,0.7031006404011942,1.0,6/25,2.88%,ERRFI1;SNX6;SLC6A9;CHMP6;GPRC5A;PPARA
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3698180523534897,-1.6212035814836505,0.0,0.1611331182120011,1.0,44/151,10.00%,NRP1;PDE3A;LIMS1;MEF2C;NTRK3;SEMA6A;RAPGEF2;PDE8A;DAB2IP;BMPR2;PTPN12;ACVR1;ACVRL1;RAMP2;NDNF;NOTCH1;RAP1A;IQGAP1;EGFR;RUNX2;PLCG1;BMP4;CD44;EEF1A1;KDR;TGFBR2;TBX1;CPNE3;TMEM100;PRKD1;ERN1;FLT1;RACK1;PDE2A;WNT5A;ANXA1;GAREM1;SPRY2;FLT4;MT1G;MAPKAPK2;KLF4;BCAR1;DUSP3
prerank,positive regulation of vasoconstriction (GO:0045907),-0.6339824672430889,-1.620936896179987,0.023391812865497075,0.16068871392702874,1.0,2/13,1.44%,CAV1;ADRA1B
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6729035062339589,-1.6203502711586188,0.010101010101010102,0.16072404722056247,1.0,3/11,9.67%,NRP1;STMN1;BCAR1
prerank,intraciliary retrograde transport (GO:0035721),0.6673877231493377,1.618998902230449,0.02178217821782178,0.700548300573395,1.0,7/12,10.59%,TTC21B;DYNLT2B;WDR19;WDR35;DYNC2LI1;DYNC2I2;IFT122
prerank,response to progesterone (GO:0032570),-0.5988395156080872,-1.6189824854471058,0.013363028953229399,0.16200746957925746,1.0,6/18,9.79%,CAV1;ABHD2;TGFB2;THBS1;SRC;TGFB3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6184511892360087,-1.6180935811793369,0.026476578411405296,0.1626193625743143,1.0,8/15,20.70%,EGFR;KDR;BMX;TEC;DYRK1A;PTK2B;MAPK3;IGF1R
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.46095761785065964,-1.617746181154949,0.009195402298850575,0.16236368581705818,1.0,16/44,14.68%,YWHAE;THBS1;GAS6;NGF;CD44;CAST;RPS6KA3;CARD16;XIAP;SRC;KLF4;GPX1;USP47;CSNK2A1;VEGFA;MT3
prerank,negative regulation of anoikis (GO:2000811),-0.6328647569762986,-1.617371328615559,0.02012072434607646,0.16212295220940431,1.0,6/14,8.89%,CAV1;NOTCH1;ITGA5;ITGB1;PIK3CA;SRC
prerank,regulation of catecholamine secretion (GO:0050433),0.5493529680782285,1.6159160441840095,0.014787430683918669,0.7023752030382695,1.0,10/29,11.59%,SYT11;SYT12;SYT9;SYT1;DRD3;SYT13;CHRNB2;SYT10;DTNBP1;CHGA
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5033204490752772,-1.6156613317547026,0.013333333333333334,0.16369579691025435,1.0,17/33,15.88%,RHOJ;SEMA6A;TJP1;BMPER;THBS1;ITGA5;SMAD1;CREB3L1;PPP1R16B;EPN2;CEACAM1;KLF4;FGF2;JAK1;KLF2;VEGFA;CEMIP2
prerank,triglyceride homeostasis (GO:0070328),0.5629787192858564,1.6152408674344565,0.029574861367837338,0.6911957143355031,1.0,7/26,9.21%,RORA;IL18;FITM2;ACSM2A;PNPLA8;C1QTNF3;NR1H3
prerank,histone H3-K36 demethylation (GO:0070544),0.6990700431110041,1.615004395786529,0.027139874739039668,0.6777658652101377,1.0,4/10,12.21%,KDM7A;PHF8;KDM2A;KDM4A
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6379193847510235,1.6131636904193423,0.033268101761252444,0.6731356358591601,1.0,4/15,5.20%,OSBPL8;FITM2;PPARA;ABHD5
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5748574762369146,-1.6131087445524726,0.014141414141414142,0.16653895562290286,1.0,9/19,18.74%,THBS1;MPP1;MAPK1;MDK;IL34;JAM3;RARRES2;CSF1R;MAPK3
prerank,cilium-dependent cell motility (GO:0060285),0.5842066187881121,1.6123411290679446,0.015209125475285171,0.6637239003416395,1.0,6/22,13.79%,CFAP44;DNAH1;TEKT2;TEKT5;DRC1;DNAAF2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.43029402078418,-1.6115164998013702,0.0023094688221709007,0.16790368782481324,1.0,39/71,28.84%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;MAPK1;NCK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;SYK;ARPC3;CDC42;FYN;FCGR1A;MYO1C;FCGR2B;PRKCE;ACTR3;ARPC1B;GRB2;FCGR3A;ARPC1A;VAV3
prerank,regulation of osteoblast differentiation (GO:0045667),0.44310148838890506,1.6114314079023226,0.007312614259597806,0.6555181683730046,1.0,15/82,6.87%,RANBP3L;SMOC1;BMP7;WNT4;BMP6;TMEM64;IGF1;DDX5;SUFU;BMPR1A;LRP3;WWTR1;NPNT;CITED1;FGFR2
prerank,filopodium assembly (GO:0046847),-0.5945843683538574,-1.611038488856483,0.018218623481781375,0.16784797224591996,1.0,4/16,3.16%,FGD5;DNM3;FGD6;SPATA13
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5434771760588737,-1.6110169108419086,0.017316017316017316,0.16708345012210113,1.0,12/24,26.78%,PECAM1;VCAM1;F11R;ITGB1;ICAM1;ITGA4;NT5E;SYK;ROCK1;MSN;SEMA4D;SELP
prerank,ncRNA processing (GO:0034470),-0.35805064301715284,-1.610671364815782,0.0,0.16668223501724147,1.0,85/200,24.12%,RPLP1;RPS15;RPL38;RPL18A;RPL41;AGO1;RPL5;RPL32;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;SMAD1;INTS11;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPL29;RPS28;RPL7A;BMS1;RPL6;RPL18;RPL36;AGO2;RPS25;DDX54;RPL28;PELP1;DROSHA;RPL27;RPL24;RPL23;RPL17;RPS27;RPS9;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL35;RPL12;RPL19;DDX27;RPL14;DDX49;ESF1;INTS10;RPL37;RRP12;RPP21;ADAT1;PWP2;AGO4;MRPL44;RCL1;NOP58;INTS9;MRTO4;METTL3;EBNA1BP2;RPL3;RPL15;DKC1;RPL8;RPS19;RPL13A;IMP4;UTP14A;EXOSC5;EXOSC4;RPL23A;WDR46;TARBP2
prerank,response to hydroxyurea (GO:0072710),-0.6594565962444223,-1.6072579539030303,0.02100840336134454,0.17078259644957253,1.0,7/11,21.23%,KAT7;DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,platelet aggregation (GO:0070527),-0.5000015562323995,-1.6068204582611076,0.012875536480686695,0.17055292601120922,1.0,12/33,11.11%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;UBASH3B;PPIA;CLIC1;MYL9;HSPB1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4711960558177226,-1.605758625061659,0.008565310492505354,0.17125336688202747,1.0,14/43,16.28%,MEF2C;MICAL2;ACVR1;ENG;NOTCH1;TBX3;TGFBR2;SOX17;HES1;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6719517269717512,-1.6055519759155938,0.02529182879377432,0.1707217005335627,1.0,6/10,19.13%,FAS;LYN;MAPK1;NBR1;MAPK3;GREM1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6333612227687634,-1.6040603098884307,0.019801980198019802,0.17191569207056076,1.0,6/12,15.87%,CBLB;F3;PTPRJ;APOD;HGS;CBL
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6052076632771807,1.6035379752501273,0.028397565922920892,0.6820129938379644,1.0,5/16,11.74%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.701638906096927,1.6015958908319667,0.026859504132231406,0.6790723978484356,1.0,2/10,4.52%,ATP1A2;ADRA2A
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5807590679986034,-1.600933988979926,0.020964360587002098,0.1756030864769221,1.0,9/18,16.36%,SPTBN1;ACTB;AR;CDK5;STX7;ZDHHC7;STX8;ZDHHC2;LDLRAP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6551066084716848,1.6007993572568777,0.03501945525291829,0.6701185463426393,1.0,4/13,2.50%,ERRFI1;SNX6;CHMP6;GPRC5A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5287008966561988,-1.599759358647198,0.021505376344086023,0.17632555792794735,1.0,10/24,20.49%,DAB2IP;ITGA5;TMEM204;EPN2;PTPN1;HGS;HHEX;MT3;VTN;NEDD4
prerank,triglyceride biosynthetic process (GO:0019432),0.5943531104509047,1.5991966552474561,0.017241379310344827,0.6659490452541674,1.0,5/18,12.95%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2
prerank,metal ion export (GO:0070839),0.5303915666277107,1.5980080455908703,0.02734375,0.6597388873300941,1.0,4/31,4.23%,ATP1A2;KCND3;ATP1B3;ATP1B2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5679546923471863,-1.59617452612102,0.03441295546558704,0.18092332160284952,1.0,9/18,12.04%,PTN;DAAM2;NOTCH1;TNFRSF1B;HES1;TNFRSF21;MDK;IL34;PTPRZ1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5492629827444201,1.5950741411725806,0.0300187617260788,0.6625418547663398,1.0,6/26,11.29%,PRKAG2;LPGAT1;PRKAA2;SLC45A3;NR1H3;WDTC1
prerank,regulation of anoikis (GO:2000209),-0.5726943009472075,-1.595002487105619,0.01417004048582996,0.18191556174284393,1.0,8/19,11.33%,CAV1;NOTCH1;ITGA5;ITGB1;MYBBP1A;PIK3CA;SRC;TLE5
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5832764496154705,-1.5949454097586202,0.02028397565922921,0.1803248365551866,1.0,7/16,10.17%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5832764496154705,-1.5949454097586202,0.02028397565922921,0.1803248365551866,1.0,7/16,10.17%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5716614624865841,-1.5949273775041748,0.029106029106029108,0.17953741767772807,1.0,6/18,3.91%,LTBP1;CD200;TGFB2;CD34;FN1;PTGS2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4895757711435637,-1.5948865625361783,0.021367521367521368,0.17877981433839746,1.0,11/34,16.41%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;MYOC;MDK;NEDD9;S100A10;FERMT2;RREB1
prerank,cyclooxygenase pathway (GO:0019371),0.6742471428774912,1.594539042189566,0.03909465020576132,0.6534067266756474,1.0,2/10,0.32%,PTGDS;PTGS1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4228617896022093,-1.594313844343446,0.002304147465437788,0.1787811134475821,1.0,31/73,22.27%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;MAPK1;NCK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;SYK;ARPC3;CDC42;FYN;FCGR1A;MYO1C
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6052409273083996,1.591091011659499,0.046065259117082535,0.6592078197138971,1.0,6/19,16.08%,DDO;ALDH7A1;ASPA;GCDH;GOT1;GOT2
prerank,cell-substrate junction assembly (GO:0007044),-0.5013138809457225,-1.5906745709479015,0.011037527593818985,0.1834775712318044,1.0,12/33,10.43%,THSD1;ITGA6;DST;PEAK1;BCR;FN1;ITGB4;PTPRK;LAMA3;ACTN1;SRC;WHAMM
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5815236856712469,-1.5903220581861959,0.019880715705765408,0.18321137396802878,1.0,6/17,9.43%,MAML2;PBX1;NOTCH3;NOTCH1;HEYL;NOTCH4
prerank,mesenchymal cell differentiation (GO:0048762),0.47548928917655153,1.590115742513831,0.012302284710017574,0.6532524088319116,1.0,11/51,6.87%,RANBP3L;BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;DDX17;FGFR2
prerank,acylglycerol homeostasis (GO:0055090),0.5867837308536135,1.5899260315872445,0.04271844660194175,0.6434084570558752,1.0,5/20,9.21%,RORA;IL18;ACSM2A;PNPLA8;NR1H3
prerank,maturation of 5.8S rRNA (GO:0000460),0.6061676644148326,1.5899001017178531,0.034764826175869123,0.6331310366868406,1.0,2/17,0.31%,NSA2;MPHOSPH6
prerank,histone H3-K4 trimethylation (GO:0080182),0.672053225451808,1.589371360401122,0.028169014084507043,0.6256804868407769,1.0,5/11,20.09%,CTR9;KMT2A;BEND3;TET2;SETD1B
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6076636185686939,1.5887696914938658,0.03389830508474576,0.618935671702507,1.0,3/17,1.79%,ATP1A2;CACNA1D;ANK2
prerank,protein localization to synapse (GO:0035418),0.6789848204531748,1.5873384325457445,0.01984126984126984,0.6155981001821357,1.0,5/12,11.19%,NLGN2;ZDHHC12;SHANK1;DLG4;BSN
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5589643123820384,-1.5873357543888238,0.02386117136659436,0.18693156690190763,1.0,7/19,7.55%,PRKCH;CLDN5;TJP1;F11R;RUNX1;OCLN;CBFB
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6741205240044578,-1.5872272033098238,0.036016949152542374,0.18633584709186476,1.0,5/10,17.43%,PDE4D;PDE3A;PDE2A;APLNR;RNF157
prerank,positive regulation of wound healing (GO:0090303),-0.4799623984307029,-1.5862022791665005,0.01702127659574468,0.187222112243348,1.0,18/36,25.61%,ST3GAL4;THBS1;ACTG1;KANK1;ITGB1;OCLN;ANXA1;SERPINE1;ENPP4;FERMT2;PLPP3;RREB1;VTN;MYLK;HPSE;PRKCE;F2R;DMTN
prerank,inorganic cation transmembrane transport (GO:0098662),0.3749318731929459,1.5858372502875417,0.0,0.6131024414977434,1.0,23/268,5.41%,TRPM3;ATP1A2;KCNK2;SLC6A13;SLC6A1;CACNA1D;SLC6A12;SLC8A3;SLC41A1;SLC24A3;TRPM6;KCND3;ATP1B3;TRPV1;KCNA3;SLC30A6;LRRC38;SLC6A9;KCNJ10;TMEM175;ATP6V1H;SLC30A10;NALCN
prerank,vasculogenesis (GO:0001570),-0.4927572552338698,-1.5852108564021359,0.031914893617021274,0.18796296755427566,1.0,15/32,16.28%,CAV1;ENG;RAMP2;NOTCH1;RASIP1;KDR;TGFBR2;SOX17;HEY2;AGGF1;SOX18;ADM;VEGFA;ITGB8;APLNR
prerank,neuron cell-cell adhesion (GO:0007158),0.6445513192111716,1.5846293168702708,0.03941908713692946,0.6094071693424934,1.0,4/14,6.98%,CEL;NLGN2;NRXN3;NLGN3
prerank,positive regulation of GTPase activity (GO:0043547),-0.36103141895866886,-1.5836845499992223,0.0,0.18942659820745722,1.0,54/188,15.76%,DOCK9;LIMS1;TBC1D4;NTRK3;RABGAP1L;RAPGEF2;DOCK10;ARHGAP42;ITGA6;NET1;BCAR3;SIPA1L2;RAP1A;TBC1D8;CORO1C;BCR;F11R;TBC1D12;SNX13;SNX18;TIAM2;TBC1D5;USP6NL;ARAP1;ITGB1;TBC1D2B;ARHGEF15;RACK1;SIPA1L3;TBC1D1;RAPGEF6;RGS6;TGM2;CCL13;EVI5L;ABR;TIAM1;TBC1D13;DOCK8;CAV2;MAP4K4;RGS10;RALGAPA1;SIPA1;TBC1D10A;TAX1BP3;TBC1D7;ARHGAP27;AGRN;CD40;S100A10;FERMT2;TBC1D25;RAP1GAP
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6267955495152727,-1.5825718864139837,0.033663366336633666,0.19021154609680524,1.0,5/13,11.85%,DAB2IP;EPN2;PTPN1;HGS;HHEX
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6203316141282103,-1.5815269753183403,0.033264033264033266,0.19087558016178488,1.0,7/13,11.77%,SEMA7A;TGFB2;IRAK3;PLCG2;WNT5A;TGFB3;CD74
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6683457263531636,-1.5798833706692301,0.029166666666666667,0.1926704856714761,1.0,5/10,8.07%,SEMA6A;DAB2IP;DCN;XDH;SPRY2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.37338355908721227,-1.5770399475495678,0.0,0.1963739641899357,1.0,41/151,15.53%,NRP1;TEK;ROR1;NTRK3;GCNT2;RAPGEF2;PDE8A;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;MFHAS1;TNFRSF11A;TNFAIP8L3;ICAM1;CCL13;GAREM1;SPRY2;PDGFC;FLT4;FGF2;ACKR3;APOE;PDGFD;PHB2;CD74;BMP2;PTK2B;HTR2A;FBXW7;PTPRC;P2RY6;MTURN;MT3;FERMT2;CSF1R
prerank,hemopoiesis (GO:0030097),-0.3988421991999336,-1.5753995366829388,0.004842615012106538,0.19796921104912205,1.0,30/87,16.00%,MECOM;KITLG;TEK;SNRK;ZBTB16;JAG1;MFAP5;HIPK1;TGFB2;CD34;RUNX2;BMP4;KDR;TGFBR2;RUNX1;KAT6A;FLT1;WNT5A;PRKX;ARIH2;FLT4;NOTCH4;TAL1;ETV6;NCOA6;PTPRC;CSF1R;KIRREL3;MKNK2;ATF4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.40505623610650654,-1.5745575597661163,0.004705882352941176,0.1984288154995536,1.0,17/73,12.31%,BMPR2;HTRA3;ACVRL1;ENG;BMPER;NOTCH1;CRIM1;BMP4;SMURF1;SFRP4;SMAD1;SMAD5;UBE2D3;CCN1;XIAP;LEMD3;BMP2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5819018563463445,-1.5735329185789202,0.03359683794466403,0.19917719084494087,1.0,8/15,15.71%,TMSB4X;KDR;PRKD1;MET;FGF2;HSPB1;VEGFA;SEMA5A
prerank,sterol biosynthetic process (GO:0016126),0.513662211138486,1.5725416833476347,0.03867403314917127,0.6548828731356598,1.0,10/33,18.84%,PRKAG2;ACAT2;INSIG2;DHCR24;SC5D;CYP51A1;SQLE;MSMO1;GGPS1;HMGCR
prerank,negative regulation of cell adhesion (GO:0007162),-0.4112557366586076,-1.572513742341689,0.0,0.20001994961440067,1.0,26/72,15.86%,PODXL;GCNT2;SEMA6A;JAG1;RHOA;ACER2;ACVRL1;NOTCH1;CDH13;CDH1;CYP1B1;TBCD;ADAM10;ARHGDIB;MDK;TGFBI;SERPINE1;EPHB2;FZD4;JAM3;PLXNC1;SIPA1;ARHGDIA;PTPRC;SEMA5A;PLXNA4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5452816090057769,1.572230793366842,0.03888888888888889,0.6468539388200065,1.0,10/26,18.18%,EYA1;HSPA1A;EYA4;EYA2;HTRA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of wound healing (GO:0061045),-0.49814375986385495,-1.5714204495114794,0.024336283185840708,0.20099284168332787,1.0,10/28,10.49%,SLC12A2;CD34;CD109;PHLDB2;CASK;AJAP1;SERPINE1;FGF2;EDN1;APOE
prerank,positive regulation of protein modification process (GO:0031401),-0.3545908677740771,-1.5702017815522478,0.0,0.20209424038547913,1.0,63/203,17.58%,TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;NIBAN1;ENG;INSR;VEGFC;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;NOS1AP;CARD14;TBX1;TNIK;FAS;RALB;FAM161A;TFRC;RAP2A;RACK1;PPP1R16B;PPIA;AXIN2;LYN;NPTN;PRKCD;NNMT;CCN1;CALM3;RB1CC1;SPPL3;EFNA5;FLT4;IL34;IGF2;TMEM119;FGF2;NSMF;FGF7;TERF2IP;KRAS;DYRK1A;CD74;BMP2;AKT2;VEGFA;RARRES2;CD40;MT3;PLAUR;CSF1R;ALG10B;FMR1;FXR1;RAB3GAP2;GPER1;CEP295
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.36598331633493775,-1.5694680087469262,0.002617801047120419,0.20242777405911175,1.0,43/138,21.77%,PTPRG;TEK;ROR1;NTRK3;ABI1;BMPR2;IL6ST;PTN;LIFR;TIE1;INSR;MERTK;EGFR;NGF;MTSS1;KDR;FLT1;MET;LYN;FLT4;SRC;NEDD9;BCAR1;YES1;EPHB2;MPZL1;RET;PTK2B;ALK;POLR1G;CSF1R;SHC4;FGFR3;NPPC;JAK3;HCK;SYK;EPHB6;IGF1R;TRIO;ROR2;PTPRF;FYN
prerank,cellular sodium ion homeostasis (GO:0006883),0.6207009794839956,1.5694067201383974,0.049800796812749,0.6503847219983612,1.0,3/15,4.23%,ATP1A2;ATP1B3;ATP1B2
prerank,heart looping (GO:0001947),-0.4727949293853627,-1.5685738628123398,0.019438444924406047,0.20298262264402392,1.0,12/39,16.28%,MEF2C;MICAL2;ENG;NOTCH1;TBX3;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,substrate-dependent cell migration (GO:0006929),-0.5899873378009206,-1.568305234468796,0.03054989816700611,0.2025987912943827,1.0,7/14,13.88%,NRP1;NTN1;VEGFC;ANKS1A;CD2AP;SHTN1;PTPRC
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.4388146885527306,-1.568172056192782,0.015217391304347827,0.20202688086435866,1.0,25/51,32.89%,PTN;THBS1;VEGFC;GAS6;IL6R;MAPK1;CXCL12;MDK;IL34;SERPINE1;EDN3;VEGFA;RARRES2;CSF1R;MAPK3;HMGB1;CCR2;ANO6;PLA2G7;AIF1;CMKLR1;PGF;VEGFD;LGALS9;CXCL17
prerank,regulation of muscle contraction (GO:0006937),0.5474816657353295,1.5665677744402264,0.03195488721804511,0.6537723254098908,1.0,5/26,7.17%,ATP1A2;ANXA6;ENO1;CHRM2;TNNI1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5303537898068171,-1.56616141682257,0.022821576763485476,0.2044346945685389,1.0,11/24,7.35%,TMEFF2;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,atrioventricular valve development (GO:0003171),-0.5986256374631134,-1.566002826798494,0.03373015873015873,0.20382921340689564,1.0,11/14,24.66%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;BMP2;APLNR;SLIT3;ZFPM1;GJA5
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.367917348654673,-1.5633921056871372,0.0,0.20740491547161738,1.0,31/140,10.44%,ARHGAP31;ARHGAP10;RHOJ;CHN2;PLCE1;ARAP2;SLIT2;SRGAP1;RHOA;NET1;ARHGEF3;MCF2L;STARD8;CHN1;BCR;RASGRF2;ARAP3;STARD13;TIAM2;ARAP1;ARHGEF2;ARHGDIB;ARHGAP32;ARHGAP35;TGM2;ABR;TIAM1;SRC;CD2AP;ARHGEF12;VAV2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5510777129106517,1.5632350708855265,0.040152963671128104,0.6606011642989452,1.0,6/23,4.05%,ERRFI1;SNX6;SH3BP5L;CHMP6;GPRC5A;SH3BP5
prerank,regulation of glycolytic process (GO:0006110),0.4444299756040323,1.5628981421876982,0.015332197614991482,0.6529976237056361,1.0,8/68,3.92%,PRKAG2;IGF1;NUPR1;GCK;PRKAA2;PPARA;POM121;NUP155
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6071543638469505,-1.5625508490410351,0.019417475728155338,0.20796186541769734,1.0,9/14,24.83%,THBS1;PLCG1;ECSCR;PDCD4;ITGA4;CD40;GPER1;RGCC;ANO6
prerank,cell junction assembly (GO:0034329),-0.3888129812485372,-1.5595652702358243,0.00477326968973747,0.21180624710232557,1.0,17/100,4.62%,CDH11;ACTB;LIMS1;SHANK3;FARP1;LIMS2;DNM3;SPOCK2;CLDN5;TJP1;ITGA6;RHOA;GJC1;ACTG1;CDH1;FN1;FLNA
prerank,sterol metabolic process (GO:0016125),0.4559901750869032,1.558327012599635,0.01721170395869191,0.6654412764061957,1.0,22/60,18.84%,PRKAG2;LIPA;SOAT2;CYP26B1;CYP11B1;INSIG2;APOF;SOAT1;OSBPL5;SC5D;CLN8;CYP27A1;RXRA;FDX1;CYP51A1;SQLE;TSKU;GBA2;FDX2;MSMO1;ABCA5;HMGCR
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6032340769855864,1.55768298063315,0.040152963671128104,0.6596936177892295,1.0,7/16,18.96%,NUPR1;PPIF;COX7A1;COX7A2L;ABCD1;ATP7A;MLXIPL
prerank,cellular potassium ion homeostasis (GO:0030007),0.6505338112156898,1.5571462444078576,0.03636363636363636,0.6532905305505345,1.0,3/13,4.23%,ATP1A2;ATP1B3;ATP1B2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5080813176099117,-1.5565779921123606,0.02510460251046025,0.215695536909119,1.0,10/25,18.00%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;PLAUR;CBL;RTN4;GPER1;PDE6H
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4551439749736053,-1.555487772719546,0.01910828025477707,0.2167604282807273,1.0,12/42,11.32%,LIMS1;GCNT2;RHOA;VIT;NDNF;NOTCH1;CORO1C;TBCD;EMP2;ECM2;FBLN2;FZD4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4318896604087615,-1.5549157625113228,0.0069767441860465115,0.21680602412030386,1.0,17/50,15.31%,YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;CARD16;PAK2;XIAP;SRC;KLF4;GPX1;USP47;CSNK2A1;VEGFA;MT3;PLAUR
prerank,peptidyl-tyrosine modification (GO:0018212),-0.43434079317597096,-1.5543110765969061,0.01818181818181818,0.21696091629475386,1.0,24/56,21.77%,TEK;ABI1;INSR;EGFR;KDR;FLT1;LYN;TEC;FLT4;SRC;ABI3;EPHB2;DYRK1A;TPST2;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;BTK;JAK3;HCK;SYK;FYN
prerank,ceramide biosynthetic process (GO:0046513),-0.4615493612690745,-1.553941318303886,0.008791208791208791,0.2166181113153223,1.0,11/40,9.48%,SGMS1;ST6GALNAC3;ST8SIA4;SGMS2;DEGS2;AGK;ST6GALNAC5;CERS5;CERS6;ST8SIA6;SAMD8
prerank,autophagy of peroxisome (GO:0030242),-0.626740427908361,-1.5532920677464084,0.029411764705882353,0.2168912128964899,1.0,7/12,16.35%,MAP1LC3B;RB1CC1;NBR1;PIK3C3;SQSTM1;PIK3R4;ACBD5
prerank,apical junction assembly (GO:0043297),-0.4284356095578843,-1.5516765395818488,0.01327433628318584,0.21872371906677476,1.0,15/53,7.38%,PECAM1;CLDN5;VCL;ESAM;PARD3;RHOA;RAMP2;WDR1;F11R;CTNNA1;TBCD;PAK2;CLDN14;OCLN;APC
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6059298348463752,1.5513127113159502,0.047058823529411764,0.6692366721699506,1.0,2/15,4.10%,MOXD1;SAT1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6471051798348035,1.5506139975719626,0.04380952380952381,0.6635221275309283,1.0,4/12,7.03%,ATP1B3;WNK3;ATP1B2;WNK4
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.5241416380994622,-1.5502302226904903,0.024691358024691357,0.22033097119730288,1.0,11/22,31.13%,RUNX1;CBFB;MDK;NFATC2;SOX12;CD46;LAG3;SOCS1;IL2RA;IL4I1;VSIR
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5599580450468173,1.5495604903450055,0.04725897920604915,0.6517649810606434,1.0,9/21,18.18%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5599580450468173,1.5495604903450055,0.04725897920604915,0.6517649810606434,1.0,9/21,18.18%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,regulation of macrophage migration (GO:1905521),-0.6473180726298634,-1.5489101458474128,0.03992015968063872,0.221808456759932,1.0,3/10,12.44%,MTUS1;CD200;PTK2B
prerank,regulation of cellular component organization (GO:0051128),-0.3674199988693578,-1.5486338566167563,0.0024449877750611247,0.22151684935767338,1.0,31/135,12.16%,HIP1;LTBP4;PLCE1;RAPGEF2;DAB2IP;TJP1;MLLT3;NET1;HJURP;STON2;STK38L;RAP1A;CDH13;SOCS2;IRAK3;TFRC;AGTR1;CAMK2D;WNT5A;ANKRA2;CEACAM1;ZFYVE16;PTPN1;BCAR1;FAM107A;RPTOR;APOE;GFAP;BAG5;HIP1R;DCUN1D5
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6004336812332234,-1.54856850367739,0.04930966469428008,0.2207182137147634,1.0,4/13,7.99%,RHOA;ETS1;MDK;NFAT5
prerank,response to cadmium ion (GO:0046686),-0.5025911141535433,-1.5480611904767057,0.037267080745341616,0.22076156821637782,1.0,14/26,18.74%,EGFR;JUN;MAPK1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;MT3;MT2A;MAPK3
prerank,regulation of protein phosphorylation (GO:0001932),-0.3379904250859125,-1.5470976534097802,0.0,0.22175760123179405,1.0,74/256,16.67%,TEK;NTRK3;PECAM1;SLCO3A1;PLCE1;PDE8A;DAB2IP;PID1;SLIT2;NIBAN1;LRP6;ENG;INSR;BMPER;VEGFC;GAS6;LIMCH1;PRR5L;EGFR;LIMK2;CORO1C;BMP4;KDR;FN1;APP;CARD14;FNIP2;TBX1;TNIK;FAS;RALB;TFRC;BRD4;RAP2A;XDH;RACK1;PPIA;AXIN2;LYN;NPTN;OCLN;CCN1;RB1CC1;PPP2R5C;SOD1;EFNA5;FLT4;IL34;IGF2;TMEM119;FGF2;EIF2AK3;FGF7;EPHB2;TERF2IP;HSPB1;KRAS;SH3GL2;CD74;BMP2;AKT2;VEGFA;RARRES2;CD40;PAQR3;MT3;PLAUR;PLPP3;CSF1R;ATF4;FKBP8;TRAF3IP1;FMR1;FXR1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.6469269604141314,-1.5456372628595514,0.0425531914893617,0.22323993229089212,1.0,3/10,1.49%,BMP5;SLIT2;CD200
prerank,positive regulation of hydrolase activity (GO:0051345),-0.36968248289498395,-1.5453941519480145,0.0,0.22282900760945193,1.0,36/137,15.01%,DOCK9;LIMS1;RAPGEF2;DOCK10;ITGA6;RHOA;CD200;NET1;BCAR3;RAP1A;F11R;SNX13;SNX18;USP6NL;ARAP1;ITGB1;RACK1;RAPGEF6;RGS6;CALM3;TGM2;CCL13;EVI5L;RPS3;DOCK8;CAV2;MAP4K4;PSAP;RGS10;BMP2;TBC1D7;ARHGAP27;AGRN;CD40;S100A10;FERMT2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6597453324231534,-1.5449479318871342,0.03937007874015748,0.22269718828329618,1.0,6/10,23.56%,RUNX1;CBFB;NCKAP1L;SH3RF1;HMGB1;SOCS1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6723005156719873,1.5447288141001911,0.03740157480314961,0.6646526684456443,1.0,5/10,15.38%,USH1C;WHRN;ADGRV1;PDZD7;TSKU
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5076793802631204,-1.5445792948219452,0.036511156186612576,0.22241939526504956,1.0,6/25,7.07%,BMPR2;ACVRL1;ENG;NOTCH1;BMP4;CCN1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4214790381169259,-1.5432581391453484,0.014527845036319613,0.22383453308588547,1.0,22/65,18.00%,HIP1;DAB2IP;BCAR3;PTPN12;CDH13;EGFR;AFAP1L2;PTPRJ;ITGA1;ARAP1;CEACAM1;SPRY2;MVB12B;DUSP3;HGS;SH3GL2;HIP1R;SPRY1;PLAUR;CBL;GPER1;PDE6H
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6308610249294593,1.543241085769053,0.0392156862745098,0.6629258945536862,1.0,5/13,11.26%,IGF1;SOAT1;GOLGA2;PLCB1;ABCA2
prerank,organic hydroxy compound transport (GO:0015850),-0.46924000573567237,-1.5431729005725752,0.02242152466367713,0.22313578682397447,1.0,9/36,7.91%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;NPC2;OSBP;STRA6;CEACAM1
prerank,energy reserve metabolic process (GO:0006112),0.5774360236832878,1.5425102998752398,0.044145873320537425,0.6579775827324243,1.0,7/19,14.00%,PRKAG2;LEPR;PHKG2;MRAP2;PHKB;PYGL;PYGM
prerank,positive regulation of leukocyte migration (GO:0002687),-0.5037812350435272,-1.542460133264267,0.03862660944206009,0.22354858696869245,1.0,8/27,15.74%,PTN;ICAM1;IL6R;MDK;JAM3;EDN3;VEGFA;NCKAP1L
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6085661975901688,-1.540386381486848,0.028199566160520606,0.22606475477990884,1.0,5/13,10.78%,CD9;CDH13;ABCA1;ITGB1;SREBF2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6778616546464676,1.540064963951295,0.0392156862745098,0.6613602759875946,1.0,7/10,26.18%,KMT5A;SETD4;SETD7;SMYD2;METTL18;SETD2;EHMT1
prerank,cardiac muscle cell action potential (GO:0086001),0.5159455008869239,1.5398989974717874,0.037037037037037035,0.6543008361816853,1.0,4/30,1.79%,ATP1A2;CACNA1D;KCND3;ANK2
prerank,regulation of cardiac conduction (GO:1903779),0.45330007026284747,1.5379320892887238,0.019572953736654804,0.6560413735023259,1.0,11/54,11.28%,ATP1A2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2;CORIN;FXYD4;ITPR2;RYR2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6126276893730285,-1.5379205838966847,0.05496828752642706,0.22959539275442323,1.0,5/12,8.07%,SEMA6A;DAB2IP;DCN;XDH;SPRY2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5263781819606534,1.5379106938467342,0.023008849557522124,0.6485809490189394,1.0,7/26,4.69%,CACNA1D;ACTN2;ATP1B3;ANK2;STK39;ATP1B2;DLG1
prerank,transepithelial transport (GO:0070633),-0.5749008010594724,-1.5374112483121871,0.04073319755600815,0.22962753838132965,1.0,7/15,12.50%,ABCG2;SLC12A2;ABCC1;SLC1A3;CXADR;SLC1A1;SLC26A6
prerank,cellular response to zinc ion (GO:0071294),-0.5890495466603034,-1.53736755375096,0.031683168316831684,0.22882336579904994,1.0,11/15,18.33%,MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;GLRA2;MT3;MT2A
prerank,carbohydrate homeostasis (GO:0033500),0.4316701553447557,1.5361932459868284,0.005226480836236934,0.6487683726218475,1.0,19/67,16.88%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;USF1;PYGL;HECTD4;TCF7L2;IL6;BACE2;RBP4
prerank,amino sugar metabolic process (GO:0006040),-0.648040837676332,-1.5349273947030868,0.03024193548387097,0.23229607446408465,1.0,3/10,11.35%,CSGALNACT1;ST3GAL1;GFPT2
prerank,regulation of integrin activation (GO:0033623),-0.5881870656353518,-1.5340083906388637,0.045714285714285714,0.23310219438913635,1.0,12/15,32.77%,PIEZO1;RASIP1;SRC;JAM3;FERMT2;KIF14;SELP;PTGER4;FBLIM1;SKAP1;RAP1B;FARP2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.5951463022645438,1.5334237831169986,0.05220883534136546,0.652962625639346,1.0,7/16,15.51%,UPB1;DPYD;CRMP1;NT5C3A;UPP2;DPYSL2;TET2
prerank,rRNA processing (GO:0006364),-0.34924415010538956,-1.5316090285980077,0.0,0.23638345742908634,1.0,77/172,24.07%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL5;RPL32;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPL29;RPS28;RPL7A;BMS1;THUMPD1;RPL6;RPL18;RPL36;RPS25;DDX54;RPL28;PELP1;RPL27;RPL24;RPL23;RPL17;RPS27;RPS9;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL35;RPL12;RRP15;RPL19;DDX27;RPL14;DDX49;ESF1;RPL37;RRP12;PWP2;MRPL1;RCL1;NOP58;MRTO4;EBNA1BP2;RPL3;RPL15;NHP2;DKC1;RPL8;RPS19;RPL13A;IMP4;UTP14A;EXOSC5;EXOSC4;RPL23A;RIOK1;WDR46
prerank,regulation of membrane repolarization (GO:0060306),-0.6168231835535034,-1.5312571120308403,0.05470459518599562,0.23618565296739769,1.0,6/13,6.84%,CAV1;NEDD4L;YWHAE;KCNJ2;CACNA2D1;KCNQ1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.40667536668751536,-1.53084367785992,0.011990407673860911,0.23601195236743644,1.0,28/73,16.12%,NRP1;ITGBL1;DOCK1;PTN;SEMA7A;DST;MYH9;ITGA5;FN1;ITGB4;LAMA3;ITGB1;PRKD1;ADAM10;TEC;ITGB5;ADAMTS1;CEACAM1;SRC;NEDD9;BCAR1;ISG15;PTK2B;NME2;ADAM15;FERMT2;PLPP3;ITGB8
prerank,bile acid and bile salt transport (GO:0015721),-0.5149877930339982,-1.5300440974895528,0.02914798206278027,0.23658528092237124,1.0,5/24,7.91%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3201779804344519,-1.5299061004017267,0.0,0.23600605535734442,1.0,103/390,16.16%,NRP1;PTPRG;ACTB;TEK;GHR;ROR1;FLRT2;NTRK3;ABI1;ARHGEF28;NRP2;DOCK1;RAPGEF2;GAB1;RHOA;BCAR3;TIE1;WASF2;INSR;RAB14;MERTK;VEGFC;FOXO1;ACTG1;ANKS1A;COL4A2;CHN1;PIK3R1;GRB14;EGFR;NGF;SOCS2;ATP6V0A4;STAT3;PTPRJ;MTSS1;KDR;STMN1;AP2B1;PIK3C2A;COL4A6;ANGPT2;SPRED2;PRKD1;PAK2;UBASH3B;FLT1;MET;LYN;PXN;MAPK1;NCK1;APC;SHOC2;GRIN2B;ATP6V0D1;PIK3CA;PDGFC;EFNA5;ATP6V0A1;FLT4;TIAM1;SRC;IGF2;NEDD9;SORT1;MAPKAPK2;BCAR1;FGF2;EIF2AK3;NCF2;CAV2;GTF2F1;VAV2;YES1;FGF7;EPHB2;PDGFD;MPZL1;RET;NCBP2;PTK2B;SH2B2;AKT2;FGFRL1;ATP6V1D;AP2A1;ALK;VEGFA;RARRES2;POLR1G;RBFOX2;NCBP1;IRS1;GIT1;FOXO4;ARPC2;CSF1R;NCKAP1L;DDIT4;CBL;COL1A1;SHC4
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3240892092748387,-1.5298769098484444,0.0,0.23521554121799823,1.0,71/348,9.00%,NRP1;TEK;GHR;NTRK3;CAV1;PECAM1;BMP5;SLCO3A1;RAPGEF2;PDE8A;BMPR2;NIBAN1;BCAR3;ACVR1;ACVRL1;ENG;TGFB2;INSR;RPS6KA5;VEGFC;GAS6;LIMCH1;RBPMS;RAP1A;RASSF2;IQGAP1;ITGA5;EGFR;LIMK2;NGF;BMP4;CD44;PTPRJ;CSPG4;KDR;APP;CARD14;FNIP2;TBX1;PLCG2;TNIK;FAS;RALB;CACUL1;CAB39;TFRC;ARHGEF2;RAP2A;PRKD1;PAK2;RACK1;XRCC5;PPIA;AXIN2;LYN;NPTN;IL6R;TEC;CCN1;MAPK1;CALM3;RB1CC1;SPRY2;PDGFC;EFNA5;FLT4;SRC;IL15;IL34;IGF2;TMEM119
prerank,regulation of MAPK cascade (GO:0043408),-0.35121868972372366,-1.5293981554117722,0.005649717514124294,0.23531605370240385,1.0,44/157,13.96%,TEK;ROR1;NTRK3;CAV1;DAB2IP;ADRA1B;BCAR3;INSR;STK3;IQGAP1;EGFR;JCAD;PTPRJ;KDR;FN1;TBX1;PLCG2;TNIK;FAS;DHX33;PAK2;FLT1;LYN;CCN1;MAPK1;MYOC;CEACAM1;IAPP;NBR1;FLT4;IGF2;FGF2;DUSP3;ATP6AP2;CAV2;YWHAZ;MAP4K4;PHLPP1;CD74;RET;BMP2;PEBP1;PTPRC;CD24
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4400596842952372,1.528875352696972,0.0137221269296741,0.6653846457836468,1.0,10/65,7.48%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;LMNA;PGK1;CPEB4;KCND2
prerank,mesoderm formation (GO:0001707),-0.5515858505029906,-1.5282377257600797,0.04375,0.23669918886565694,1.0,4/17,5.18%,BMPR2;ITGB4;ITGA8;ITGB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5546572327314965,1.5269756386913234,0.05918367346938776,0.6660634756962676,1.0,5/20,11.74%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,potassium ion transmembrane transport (GO:0071805),0.3882362534536535,1.5260704614112117,0.00933125972006221,0.6628473020770449,1.0,24/135,12.39%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;ATP1B2;KCNJ10;TMEM175;NALCN;KCNC3;KCND2;KCNH2;KCNN4;KCNC2;KCNJ16;SLC12A5;KCNH7;SLC12A1;SLC9A9;KCNK4
prerank,protein depolymerization (GO:0051261),-0.49291138215008673,-1.525971240935692,0.027253668763102725,0.2397465869982483,1.0,9/27,15.53%,MICAL2;GSN;NCKAP5;WDR1;STMN1;CFL1;NCKAP5L;KATNB1;KIF24
prerank,skeletal system morphogenesis (GO:0048705),0.4695193098965648,1.5258127215161967,0.0297951582867784,0.6568881579479932,1.0,11/42,9.81%,WWOX;PDGFRA;RFLNA;CYP26B1;HOXB9;HOXB3;FGFR2;HOXA3;TGFBR1;HOXB4;MEGF8
prerank,SNARE complex assembly (GO:0035493),-0.6418926298876284,-1.5252002680222132,0.03592814371257485,0.24030359099140883,1.0,2/10,5.51%,STXBP6;VAMP3
prerank,entry into host (GO:0044409),-0.6029188169200784,-1.5250558071147335,0.05719921104536489,0.23968824171974612,1.0,10/13,33.00%,CDH1;MET;PPIA;SRC;CBL;CXCR4;CBLL1;GRB2;ITGAV;CTNNB1
prerank,glycerolipid catabolic process (GO:0046503),-0.5449649546831621,-1.5227061757829847,0.041928721174004195,0.24311518631148626,1.0,6/19,11.84%,PLA2G4A;GPCPD1;ABHD2;MGLL;PRDX6;ABHD6
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6504750242300742,1.522542203705256,0.04500978473581213,0.6638936404802738,1.0,4/10,16.56%,IL18;PRKCZ;SPHK2;RARA
prerank,response to laminar fluid shear stress (GO:0034616),-0.6493973098054113,-1.521530000509673,0.04242424242424243,0.24424143155803185,1.0,7/10,28.89%,ABCA1;KLF4;SREBF2;KLF2;ASS1;SMAD6;SMAD7
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6086910965791845,-1.5212422420367016,0.02610441767068273,0.2438675640306891,1.0,8/13,23.25%,ARID1B;ARID1A;SERTAD1;ZMIZ2;CDCA4;SPI1;CHEK1;ZMIZ1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3895934125553194,-1.5195967003103161,0.007075471698113208,0.24607925917201065,1.0,25/86,13.96%,NRP1;GHR;PECAM1;ACVR1;ITGA5;EGFR;CD44;PTPRJ;CSPG4;APP;PLCG2;ARHGEF2;PAK2;IL6R;TEC;PRKCD;EFNA5;SRC;IL15;IGF2;FGF7;CD74;PTK2B;PTPRC;VEGFA
prerank,anion transmembrane transport (GO:0098656),0.4288497556775727,1.5192704181735963,0.022608695652173914,0.6708006528079989,1.0,11/67,6.12%,SLC6A13;SLC13A4;SLC13A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC25A42;SLC25A5;SFXN2;SLC25A11
prerank,cardiac cell development (GO:0055006),-0.6279720152561441,-1.5190775445794273,0.057539682539682536,0.24625200205434739,1.0,5/11,13.96%,JAG1;NOTCH1;CXADR;MYH11;VEGFA
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6172828038538866,1.5187661217379438,0.05927342256214149,0.6658341076536605,1.0,7/13,16.43%,DDO;ASPA;GAD1;MTHFS;GOT1;GOT2;GLUL
prerank,striated muscle tissue development (GO:0014706),-0.4835139076180063,-1.5187118105631188,0.029850746268656716,0.24606943046473545,1.0,9/29,5.58%,MEF2C;PGM5;CAV1;BMP5;BMPR2;SVIL;SIX1;SGCD;MYL6
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5391259958520505,-1.5184499945482135,0.04242424242424243,0.24570303589663303,1.0,8/18,11.98%,MEF2C;PLCG1;AKT3;FLT1;MDK;IGF2;FGF2;ITGA4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6208999293892355,-1.516176598091874,0.0437375745526839,0.24913087118203917,1.0,7/11,17.91%,MAP3K5;CYP1B1;PRKCD;STK24;GSKIP;DIABLO;PRODH
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5273620853524529,-1.5156909524554136,0.026915113871635612,0.24922253124953767,1.0,9/21,10.00%,VCL;RHOA;ACTG1;LIMCH1;PEAK1;CORO1C;MACF1;EFNA5;DUSP3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6365427404781799,-1.515473601820929,0.0430327868852459,0.24877677243533458,1.0,6/11,15.64%,CD200;THBS1;CD34;PTGS2;ATP6AP2;CD46
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.6105517819879805,-1.5147419545398064,0.05112474437627812,0.2491280116515916,1.0,4/12,12.55%,WAPL;CTCF;AXIN2;RAD21
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.647293911842423,1.5128892241073386,0.059322033898305086,0.6838274167293789,1.0,3/10,4.19%,ATP1A2;OSR1;STK39
prerank,ribosome biogenesis (GO:0042254),-0.3416631443883225,-1.5123951314459887,0.0,0.2526591479247276,1.0,82/187,24.07%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL5;RPL32;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPL29;RPS28;RPL7A;BMS1;SURF6;RPL6;RPL18;RPL36;RPS25;DDX54;RPL28;PELP1;RPL27;RPL24;RPL23;RPL17;RPS27;RPS9;RRP7A;DCAF13;RPL21;RPL34;ABCE1;RPL10A;RPL35;RPL12;RPL19;DDX27;RPL14;DDX49;ESF1;RPL37;RRP12;GTF3A;PWP2;URB2;RCL1;LTV1;NOP58;MRTO4;MRPL36;EBNA1BP2;RPL3;SDAD1;RPL15;RRS1;DKC1;RPL8;RPS19;RPL13A;IMP4;UTP14A;NOP16;EXOSC5;EXOSC4;RPL23A;RIOK1;WDR46
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4221629485504916,-1.5123015085842804,0.013888888888888888,0.25197440164819024,1.0,18/56,15.82%,NRP1;TEK;LIMS1;CAV1;CLDN5;PTPRJ;KDR;CLSTN2;MYOC;IL1RAP;MAP4K4;EPHB2;ACE2;VEGFA;SRPX2;S100A10;FERMT2;NPHP1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6486054340174818,1.511771765326899,0.06805293005671077,0.6818305552532282,1.0,5/11,16.82%,DAB2;RAB21;MTMR2;EIPR1;PTPN23
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5663632939076932,-1.5111972816199923,0.046511627906976744,0.25315217165982207,1.0,8/15,31.57%,LEF1;JUN;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1;HPN
prerank,regulation of water loss via skin (GO:0033561),-0.5748365269851367,-1.5101300201728771,0.050880626223091974,0.25339230063446877,1.0,5/15,13.08%,LSR;STMN1;MET;HRNR;UGCG
prerank,establishment of skin barrier (GO:0061436),-0.5748365269851367,-1.5101300201728771,0.050880626223091974,0.25339230063446877,1.0,5/15,13.08%,LSR;STMN1;MET;HRNR;UGCG
prerank,determination of heart left/right asymmetry (GO:0061371),-0.44508730062742585,-1.509518836219093,0.02575107296137339,0.25356320000010946,1.0,12/42,16.28%,MEF2C;MICAL2;ENG;NOTCH1;TBX3;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35531411559560505,-1.5082886597851217,0.002824858757062147,0.25495669415141775,1.0,32/149,8.39%,PRKCH;ROR1;CAV1;SLCO3A1;TRAF5;RPS6KA5;NFKBIA;STAT3;APP;UBC;IRAK3;CARD14;NOD1;MID2;DHX33;TNFRSF11A;TFRC;CARD16;TRIM37;ARHGEF2;PRKD1;RPS27A;UBB;AIM2;PPIA;TRIM14;WNT5A;AR;TRIM25;PSMA6;RPS3;IL1RAP
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3619145844087804,-1.5075690066829726,0.005037783375314861,0.2553983618904538,1.0,37/121,17.36%,NRP1;GHR;PECAM1;IL6ST;ACVR1;GAS6;ITGA5;CD44;STAT3;PTPRJ;CSPG4;PLCG2;ARHGEF2;PAK2;HES1;LYN;IL6R;TEC;EFNA5;SRC;IL15;IL34;IGF2;NEDD9;PTPN1;FGF7;PIBF1;CD74;ARL2BP;PTK2B;PTPRC;VEGFA;CD40;CSF1R;SOCS3;VTN;FGFR3
prerank,protein localization to vacuole (GO:0072665),-0.5903092617650447,-1.5069351288249329,0.04609218436873747,0.2556558150403318,1.0,6/13,17.17%,SH3BP4;LMBRD1;KPTN;MFSD1;RTN4;RNF128
prerank,sodium ion homeostasis (GO:0055078),0.5572186770927312,1.5068030060121962,0.05714285714285714,0.6972293181314717,1.0,3/21,4.23%,ATP1A2;ATP1B3;ATP1B2
prerank,membrane depolarization during action potential (GO:0086010),0.5254011906726751,1.5057953865681257,0.03189493433395872,0.6945873798877272,1.0,2/26,0.44%,ATP1A2;CACNA1D
prerank,response to lipid (GO:0033993),-0.37393151522333185,-1.5056170939176825,0.004901960784313725,0.2571685362341041,1.0,19/105,9.47%,FOXP1;NOS3;ACER2;PPARD;FOXO1;FOXO3;SOCS2;ALPL;STAT3;IRAK3;ESR1;RPS6KA3;TNFRSF11A;GCH1;STRN3;SRR;ANXA1;TRIM16;MAPKAPK2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.5387020893205853,-1.504926052597675,0.052083333333333336,0.25664263556830497,1.0,12/17,34.31%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;JAK3;SMARCA4;SOCS1;IL2RG;IL7R;TSLP
prerank,cellular response to interleukin-7 (GO:0098761),-0.5387020893205853,-1.504926052597675,0.052083333333333336,0.25664263556830497,1.0,12/17,34.31%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;JAK3;SMARCA4;SOCS1;IL2RG;IL7R;TSLP
prerank,regulation of microglial cell activation (GO:1903978),0.5857838211792359,1.5044809610587697,0.05521472392638037,0.693073469114901,1.0,3/15,3.84%,SYT11;SPHK1;TAFA3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6584146583888411,1.5036123297453083,0.06557377049180328,0.6901664858684277,1.0,5/10,13.17%,KMT2A;CAMK1;PIH1D1;SPHK2;RAPGEF3
prerank,genitalia development (GO:0048806),-0.5995677720006087,-1.5029042279079212,0.060362173038229376,0.2592602781293189,1.0,5/12,12.00%,TBX3;PKD1;WNT5A;STRA6;FOXF2
prerank,negative regulation of ion transport (GO:0043271),0.531335999329538,1.501784932278007,0.05576923076923077,0.6914071601090465,1.0,6/24,10.45%,SYT11;ACTN2;WNK3;ADRA2A;WNK4;VIP
prerank,purine ribonucleotide transport (GO:0015868),-0.5520253822141972,-1.5009755286889288,0.04781704781704782,0.2619827319530308,1.0,4/16,7.04%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.538947366459771,1.5008623695547036,0.04046242774566474,0.6885571785640623,1.0,7/21,10.04%,BMP6;DAB2;OVOL2;BMPR1A;WWTR1;TGFBR1;VEPH1
prerank,long-chain fatty acid transport (GO:0015909),0.49076452929535563,1.5008239856814203,0.058935361216730035,0.6821768738399016,1.0,3/30,1.84%,PRKAG2;ACSL1;PRKAA2
prerank,positive regulation of developmental growth (GO:0048639),-0.42643671601585603,-1.5004506706075063,0.03002309468822171,0.2620564987146739,1.0,9/49,3.18%,GHR;NEDD4L;NTN1;SEMA7A;INSR;NGF;MACF1;SMURF1;ITSN2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.39804517843487497,-1.4992098719792117,0.027972027972027972,0.2635802064358378,1.0,20/72,11.81%,TEK;ROR1;NTRK3;GAB1;DCN;TGFB2;INSR;PIK3R1;KDR;FN1;FLT1;LYN;MYOC;PIK3CA;PDGFC;SRC;FGF2;PIK3CD;PDGFD;UNC5B
prerank,vascular transport (GO:0010232),0.41632848478075285,1.4990309829636517,0.015332197614991482,0.6833845961615298,1.0,16/81,4.71%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC24A3;SLC5A5;SLC38A3;SLC5A3;SLC6A9;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,positive regulation of telomerase activity (GO:0051973),-0.45712149121611606,-1.4970247919968849,0.041666666666666664,0.26689743437657787,1.0,14/33,21.94%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;HMBOX1;KLF4;CCT2;PARM1;MAPK3;GREM1;MAP2K7;MAP3K4;DKC1
prerank,lymphocyte chemotaxis (GO:0048247),-0.4566184484348904,-1.4966290453416626,0.031315240083507306,0.26677874929214873,1.0,5/34,10.31%,CYP7B1;SLC12A2;GAS6;CCL13;PIK3CD
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5131856478243391,1.4953331298595185,0.046875,0.6938025547314708,1.0,10/26,12.31%,SLC8A3;PRKCZ;NLGN2;WNT7A;NLGN3;LRRK2;SHANK1;RIMS1;DLG4;MTMR2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.49953992046660717,-1.495307222368083,0.045064377682403435,0.2684645999461379,1.0,9/24,7.91%,TMEFF2;RHOA;ACVRL1;ITGA5;CD44;FLNA;CCN1;ARHGAP35;CEACAM1
prerank,transport across blood-brain barrier (GO:0150104),0.4129326829348029,1.4944195817568628,0.011945392491467578,0.6913161884935624,1.0,16/83,4.71%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC24A3;SLC5A5;SLC38A3;SLC5A3;SLC6A9;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.4930612410985092,-1.4929197639211458,0.04564315352697095,0.2722044404045347,1.0,12/24,27.08%,SLIT2;CCN3;LYN;CXCL12;SERPINE1;GREM1;HMGB1;DUSP1;CCR2;ANO6;PLA2G7;AIF1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5379327999301386,-1.4926938853352156,0.046908315565031986,0.27182035505218416,1.0,6/19,9.95%,CYTH3;PARD3;RHOA;RAP2A;SIPA1L3;GOLPH3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.46351555743903594,1.492595752494019,0.04878048780487805,0.6926844928334304,1.0,5/41,5.76%,PRKAG2;GCK;POM121;NUP155;LACC1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5032920623956172,1.4924668928789329,0.05892857142857143,0.6870575854516425,1.0,12/26,24.85%,CTR9;EEF2KMT;KMT2A;ANTKMT;SETD4;KMT5C;BEND3;TET2;SETD1B;VCPKMT;SETD2;SETD5
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6279915835036314,-1.4912632335997211,0.05523809523809524,0.2737315012627786,1.0,5/10,16.99%,IRAK3;KLF4;TLE5;PTPRC;SIGIRR
prerank,aortic valve development (GO:0003176),-0.46089737258090585,-1.4910038163993493,0.030837004405286344,0.273439623348251,1.0,14/34,12.31%,ELN;BMPR2;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;HEY2;TWIST1;BMP2
prerank,nuclear migration (GO:0007097),0.6087515491019171,1.4908543683750397,0.06529850746268656,0.6871951260433325,1.0,5/13,11.00%,SYNE3;SYNE2;CLMN;PCM1;DOCK7
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.6100610626329472,-1.4901903732424666,0.06534653465346535,0.2740020514806654,1.0,5/11,9.40%,JAG1;TGFB2;BMP4;HEY2;ZFPM2
prerank,T cell mediated immunity (GO:0002456),-0.5742109970115132,-1.4898510571777843,0.05443548387096774,0.27388346404568903,1.0,6/13,19.33%,JAG1;CD55;EMP2;CD46;GNL1;CADM1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.543860847517788,-1.4898440430133975,0.06707317073170732,0.27304724019038384,1.0,7/17,20.93%,PODXL;TGFB2;PIEZO1;RET;NCKAP1L;SYK;RAC3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5532988773274994,1.4883148364443821,0.07485604606525911,0.6855742887015728,1.0,8/20,10.73%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5532988773274994,1.4883148364443821,0.07485604606525911,0.6855742887015728,1.0,8/20,10.73%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,ganglion development (GO:0061548),-0.6218975655376356,-1.48793152516998,0.07495069033530571,0.2756918580383263,1.0,2/11,0.78%,NRP1;NRP2
prerank,positive chemotaxis (GO:0050918),-0.5461004473153485,-1.4863975954059243,0.060665362035225046,0.2778972635638711,1.0,6/17,15.71%,NRP1;PTPRJ;MET;FGF7;VEGFA;SEMA5A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.45107671908431424,1.4859300827442536,0.03900709219858156,0.6896423122373628,1.0,5/48,3.92%,PRKAG2;GCGR;GCK;POM121;NUP155
prerank,negative regulation of heart contraction (GO:0045822),0.6176249863132484,1.4857262185995328,0.07633587786259542,0.6845901782011705,1.0,1/11,0.03%,ATP1A2
prerank,meiosis I (GO:0007127),0.5221343162803052,1.4850236813083146,0.0661625708884688,0.681638863983376,1.0,5/23,12.71%,MEI1;DNMT3L;TDRD9;MEIOB;MYBL1
prerank,positive regulation of cell development (GO:0010720),-0.4682442473674554,-1.484816382226351,0.02526315789473684,0.2801316898598146,1.0,12/31,24.21%,PDE3A;BMP4;SERPINF1;NUMB;TGM2;SPEN;GPER1;LIG4;NKX6-1;SNW1;SOX11;NUMBL
prerank,UV protection (GO:0009650),-0.6267400730820313,-1.48472038066214,0.047244094488188976,0.27942541883323246,1.0,6/10,20.35%,MFAP4;CAT;GPX1;ERCC2;SCARA3;XPA
prerank,lipid transport (GO:0006869),-0.3673179090038236,-1.483433730344555,0.007537688442211055,0.2810879285761194,1.0,22/97,8.46%,ABCC4;PITPNC1;ATP8B1;SLCO3A1;SLCO1C1;ATP8A1;SCARB1;PPARD;SLCO2A1;CERT1;SLCO2B1;ABCA1;PLEKHA8;PLTP;TNFAIP8L3;SPNS2;NPC2;OSBP;ABCA3;MTTP;CEACAM1;ABCD2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5517128634558564,1.4815810725140088,0.07528957528957529,0.6900669923720217,1.0,4/20,5.76%,ATP1A2;ATP1B3;ATP1B2;LACC1
prerank,positive regulation of neuron projection development (GO:0010976),-0.3783218422961076,-1.4814871589412253,0.009259259259259259,0.284070378581352,1.0,25/85,14.27%,ROR1;NTRK3;BMP5;RAPGEF2;DAB2IP;PTN;ITGA6;NDNF;RAP1A;SCARF1;SCARB2;PRKD1;LYN;WNT5A;NPTN;ARHGAP35;MDK;RETREG3;APOE;VLDLR;RET;PTK2B;AVIL;ALK;FZD1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5710976838523202,-1.481286620515696,0.058091286307053944,0.2835840537580215,1.0,6/15,8.84%,RSPO3;DAAM2;SFRP4;CSNK1E;ZNRF3;TIAM1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.567039579251062,1.4812559200127955,0.08835341365461848,0.6857710655568687,1.0,4/17,6.71%,PRKAG2;PRKAA2;PPARA;PANK2
prerank,regulation of stress fiber assembly (GO:0051492),-0.38843168263343447,-1.481141805901317,0.019184652278177457,0.2830130414190328,1.0,17/74,7.35%,NRP1;TMEFF2;TJP1;RHOA;WASF2;ACTG1;LIMCH1;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;ARHGEF15;PAK2;MET;PXN;MYOC
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6104232659642709,-1.4799212078570503,0.058823529411764705,0.28446239392676576,1.0,8/11,33.00%,LRP6;WNT5A;NR4A2;FZD1;RYK;LMX1A;WNT2;CTNNB1
prerank,regulation of monooxygenase activity (GO:0032768),-0.5014930900553976,-1.4795325588776718,0.05465587044534413,0.2842405724401113,1.0,7/23,13.18%,CAV1;NOS3;NOSTRIN;EGFR;NOS1AP;DDAH1;CYGB
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.36945592466141014,-1.4791298236862493,0.004842615012106538,0.28420508399661387,1.0,27/93,18.84%,PDE4D;NTRK3;CAV1;BCAR3;GAS6;RASSF2;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;RACK1;NCK1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;PAQR3;MAD2L2;DDIT4;DMD;LATS1;TNKS1BP1;PTEN
prerank,protein export from nucleus (GO:0006611),0.5123405126883663,1.478614412051947,0.058287795992714025,0.6912968657603669,1.0,1/27,0.01%,RANBP3L
prerank,negative regulation of ATPase activity (GO:0032780),0.5790280336370872,1.4780713691146907,0.07939508506616257,0.6879288771342591,1.0,9/16,21.18%,PPIF;IFIT1;PAM16;TSC1;SIRT1;OXA1L;VCPKMT;ATP5IF1;TNNI3
prerank,skeletal muscle organ development (GO:0060538),-0.4856412494260134,-1.4777319366972392,0.030434782608695653,0.2862477215017594,1.0,7/26,7.77%,MEF2C;CAV1;DISP1;SVIL;SIX1;MYL6;STRA6
prerank,T cell migration (GO:0072678),-0.5703686043251818,-1.4773719774500733,0.04684317718940937,0.2861239016994025,1.0,9/13,35.46%,SLC12A2;S1PR1;PIK3CD;MSN;PIK3CG;CXCL16;MYO1G;GPR183;ZAP70
prerank,macrophage activation (GO:0042116),-0.4513394181643837,-1.4767047726088012,0.03854389721627409,0.2864872763188938,1.0,16/34,31.70%,FOXP1;CD93;APP;PLCG2;IFI35;DYSF;CRTC3;NMI;SYK;TLR4;SBNO2;AIF1;MAPT;TREM2;TLR1;TMEM106A
prerank,sensory perception (GO:0007600),0.45451935554783496,1.4765441075581183,0.050359712230215826,0.6884968041014705,1.0,15/45,20.58%,USH1C;RETREG1;WHRN;PCDH15;PTGES;ADGRV1;NTSR2;CHRNB2;TTC8;KCNK4;OPRM1;PENK;P2RX4;OPRL1;SCN9A
prerank,hippo signaling (GO:0035329),-0.4782840178210945,-1.4759854087854343,0.05434782608695652,0.287229055226411,1.0,12/26,24.76%,TJP1;YWHAE;TEAD4;STK3;YWHAB;TJP2;TEAD1;AMOT;LATS1;AMOTL1;TEAD3;LATS2
prerank,negative regulation of blood pressure (GO:0045776),-0.5826356685138736,-1.4747563938499781,0.052845528455284556,0.2886881223642964,1.0,3/13,6.77%,BMPR2;NOS3;PRCP
prerank,axon guidance (GO:0007411),-0.3281442561821633,-1.472408274473729,0.008108108108108109,0.2924344648779654,1.0,48/201,13.02%,PTPRM;NRP1;SPTBN1;SHANK3;SEMA6A;NRP2;LAMA2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;NTN1;SEMA7A;NOTCH3;RPS6KA5;TMEFF1;NOTCH1;CHN1;PIK3R1;PLCG1;PALLD;LAMA3;KLF7;NTN4;WNT5A;NPTN;ROBO4;SPTAN1;MAPK1;ARHGAP35;CXCL12;PIK3CA;EFNA5;SEMA5B;SRC;PIK3CD;DSCAML1;EPHB2;SEMA3E;VLDLR;UNC5B;PLXNC1;RET;SEMA3G;RANBP9;SMO;EMB
prerank,ERBB signaling pathway (GO:0038127),-0.39994023400612455,-1.4711070796166763,0.024774774774774775,0.2940139353010125,1.0,15/64,9.67%,PLCE1;GAB1;PTPN12;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;CPNE3;MAPK1;GAREM1;PIK3CA;SRC;BCAR1
prerank,cellular response to hydroxyurea (GO:0072711),-0.6169212515390646,-1.470474714549836,0.06339468302658487,0.29447429498726263,1.0,6/10,21.23%,DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,regulation of ATP metabolic process (GO:1903578),0.4406171948122279,1.4699763407960025,0.04013961605584642,0.7090482311330648,1.0,17/54,20.91%,PRKAG2;GCK;POM121;NUP155;COX7A1;COX7A2L;ABCD1;SPHK2;NUP98;BEND3;NUP37;ATP7A;NUP88;NDC1;EIF6;RAE1;ATP5IF1
prerank,negative regulation of platelet activation (GO:0010544),-0.5467360892087861,-1.4698536304546286,0.06790123456790123,0.2949246172821796,1.0,6/16,10.49%,PRKG1;NOS3;CD9;PRKCD;CEACAM1;APOE
prerank,regulation of biomineral tissue development (GO:0070167),-0.48603222829675674,-1.4693592806119036,0.035789473684210524,0.29503872893471145,1.0,10/26,12.38%,SGMS2;NOS3;NOTCH1;GAS6;S1PR1;NBR1;HEY2;FBXO5;TWIST1;ECM1
prerank,regulation of multicellular organismal development (GO:2000026),-0.48171909348106273,-1.4677654442592527,0.0420353982300885,0.2974147638879306,1.0,9/25,18.05%,PTN;INSR;RAB14;SOX17;NIPBL;SPAAR;CD24;TDG;DUSP6
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5580141083395074,-1.4670026300502006,0.07010309278350516,0.2981661240902708,1.0,7/16,21.45%,ATP5MF;ATP5F1B;ATP5F1E;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,arachidonic acid metabolic process (GO:0019369),0.4863777002105837,1.4666725162596006,0.044444444444444446,0.717454397260728,1.0,6/35,6.37%,PTGDS;PTGS1;DAGLA;PLA2G4C;PNPLA8;PTGES
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6041888063816572,1.4665589734377302,0.08249496981891348,0.7121628931899585,1.0,2/12,3.87%,IL18;IL17D
prerank,glycogen metabolic process (GO:0005977),0.5063224056136724,1.4663939168822033,0.0675422138836773,0.707260264498932,1.0,8/27,15.46%,PRKAG2;PHKG2;PGM1;PHKB;PYGL;GYG1;PYGM;PER2
prerank,positive regulation of developmental process (GO:0051094),-0.33664514083383484,-1.4660490059305231,0.005115089514066497,0.29926566704059443,1.0,41/164,16.41%,SLC6A6;SHANK3;BMP5;ZBTB16;DAB2IP;BMPR2;DCN;PTN;ACVR1;INSR;PHLDB1;CORO1C;BMP4;KDR;MFF;RPS6KA3;PHLDB2;TFRC;WNT5A;AR;SHLD1;MDK;SRC;TMEM119;VHL;AGO2;CFL1;APOE;FBXO5;FZD4;B4GALT5;VLDLR;BMP2;EDN3;ALK;VEGFA;MAD2L2;PA2G4;RTN4;FMR1;RREB1
prerank,cation transport (GO:0006812),0.36048292846479857,1.4654295795084529,0.004594180704441042,0.7056074027320687,1.0,14/167,3.25%,TRPM3;ATP1A2;SLC8A3;SLC41A1;SLC5A5;TRPM6;KCND3;KCNA3;KCNJ13;NDFIP1;SLC6A9;SLC5A10;SLC23A1;KCNJ5
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5499389908944101,-1.4648068730146824,0.084,0.3009604275197767,1.0,5/15,9.62%,PTPN12;CDH13;EGFR;CEACAM1;MVB12B
prerank,regulation of GTPase activity (GO:0043087),-0.33518411897754313,-1.4620622255940707,0.005263157894736842,0.30555059496929526,1.0,45/177,15.86%,PRKG1;DOCK9;LIMS1;LRCH1;CHN2;FGD5;RAPGEF2;DOCK10;DAB2IP;ITGA6;NET1;FGD6;BCAR3;RAP1A;SH3BP4;CHN1;RASIP1;F11R;SNX13;SNX18;USP6NL;ARAP1;ITGB1;RACK1;RAPGEF6;RGS6;TGM2;CCL13;EVI5L;SOD1;EFNA5;DOCK8;CAV2;VAV2;MAP4K4;RGS10;PLXNC1;TBC1D7;ARHGAP27;AGRN;CD40;S100A10;FERMT2;RAP1GAP;PLXNA4
prerank,ethanol metabolic process (GO:0006067),0.6093619028957786,1.4616843219119167,0.0658682634730539,0.7162201505343517,1.0,5/12,10.86%,ADH7;ADH4;ALDH1A1;ACSS2;ALDH2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.5638275289696993,-1.460225617753328,0.07195571955719557,0.30839950090930723,1.0,5/14,8.04%,LIMS1;LIMS2;FLNA;PRKD1;EMP2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6020185348437815,-1.4601444481725108,0.08829174664107485,0.3076502086143671,1.0,7/10,33.00%,LRP6;WNT5A;FZD1;RYK;WNT2;WNT3;CTNNB1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3768045898354495,-1.4599209776986675,0.028277634961439587,0.30724193211420736,1.0,29/74,21.35%,LEF1;GCNT2;BMP5;DAB2IP;TGFB2;PHLDB1;SDHAF2;TGFBR2;IL17RD;PHLDB2;SPRED2;AXIN2;MDK;SPRY2;VASN;TIAM1;TGFB3;TWIST1;BMP2;SPRY1;FERMT2;MAD2L2;COL1A1;PTEN;GREM1;PPP2CA;MCRIP1;TGFB1I1;BCL9L
prerank,muscle organ development (GO:0007517),-0.4043988315724556,-1.4598750036284025,0.03837471783295711,0.3064715852299358,1.0,10/54,4.23%,UTRN;MEF2C;LAMA2;COL6A3;TCF12;SMTN;TEAD4;FHL1;SGCD;TBX1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5704137659684914,1.4597138912019605,0.08113590263691683,0.7191733483698025,1.0,6/15,19.53%,DAB2;PIK3CB;TNK2;WASL;DGKD;AAK1
prerank,negative regulation of cell motility (GO:2000146),-0.3602244750613841,-1.4593862544771443,0.002564102564102564,0.3067172827669686,1.0,21/108,5.84%,TMEFF2;FRMD5;CLDN5;JAG1;SLIT2;VCL;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;FOXO3;CDH1;CYP1B1;KANK1;PTPRJ;ADARB1;PTPRK;DACH1;RAP2A;RECK
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.4159561931568698,-1.4587818828973147,0.037694013303769404,0.3070361935896371,1.0,21/47,21.89%,DAB2IP;TGFB2;FOXO1;EGFR;MID1;FAS;RAP2A;PPIA;MAPK1;NBR1;PER1;MAP4K4;PHLPP1;KLHDC10;TAOK3;NOD2;MAPK3;GREM1;IGF1R;TAOK1;SEMA4C
prerank,thyroid hormone generation (GO:0006590),0.6494300777784598,1.458379651318802,0.07056451612903226,0.7192954050533839,1.0,2/10,2.28%,SLC5A5;CPQ
prerank,response to zinc ion (GO:0010043),-0.4870843058749759,-1.4582012011607335,0.053497942386831275,0.30739936246402044,1.0,13/25,14.68%,CRIP1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC30A5;D2HGDH;GLRA2;MT3
prerank,hexose biosynthetic process (GO:0019319),0.44965026129189095,1.457198689916151,0.047706422018348627,0.7188484710123196,1.0,19/42,21.84%,CHST15;SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,regulation of glycogen metabolic process (GO:0070873),0.6033357329986507,1.4571703432294294,0.08641975308641975,0.7135269512306611,1.0,6/12,21.55%,GCGR;PPP1R3F;RUBCNL;AKT1;KHK;INPP5K
prerank,regulation of defense response (GO:0031347),-0.3772989836314433,-1.4570845759530597,0.022271714922048998,0.30888378762175106,1.0,40/76,30.18%,FOXP1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;AGTR1;WNT5A;PSMA6;ANXA1;XIAP;SPATA2;APOE;IL1RL2;ACE2;BIRC3;BCL6B;N4BP1;NOD2;ADAMTS12;HCK;MYD88;GGT1;CYLD;ERAP1;FCGR2B;CCR2;CASP1;ZBP1;LRP8;SBNO2;CASP8;AREL1;AKNA;TREM2;CASP4;AHSG;GRN;PARK7
prerank,selective autophagy (GO:0061912),-0.40603729994957194,-1.4568378789489336,0.0514018691588785,0.30862333025571353,1.0,29/56,30.25%,DYNC1I2;UBC;RPS27A;UBB;MAP1LC3B;ARL13B;RB1CC1;UFC1;NBR1;DYNC1I1;PHB2;SQSTM1;HDAC6;DYNLL1;KLHL3;AUP1;CFTR;ATG5;ACBD5;DYNC1H1;ULK2;TEX264;ULK1;UBQLN1;WDFY3;STBD1;ATG14;PARK7;USP30
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5922091040114896,-1.4566025272415795,0.06614785992217899,0.30821327856893826,1.0,6/11,28.05%,SLIT2;CCN3;GREM1;DUSP1;DDT;MIF
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.45890236912521304,1.4566014979713884,0.06126126126126126,0.7104966251294762,1.0,6/37,6.81%,PRKAG2;BMP7;SPHK1;WNK3;PLK1;PPEF2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5402470146195697,-1.456344885239284,0.0430327868852459,0.30791759854063355,1.0,3/17,0.51%,NRP1;TEK;NTRK3
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3792753094383664,-1.4560969462002735,0.028985507246376812,0.3076584888428837,1.0,25/76,24.80%,NRP1;TEK;NTRK3;WDR1;CDC42EP3;CDC42EP5;NCK1;SYNPO2;CDK5;EDN1;CDC42EP2;PTK2B;PFN1;LIMK1;SEMA5A;NCKAP1L;FCHSD1;DYNC1H1;HCK;CDC42;HCLS1;GPSM2;NUP62;PRKCE;FES
prerank,regulated exocytosis (GO:0045055),-0.3307582275592436,-1.4555461154525975,0.005571030640668524,0.3078780600027174,1.0,45/173,14.05%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;THBS1;CD9;VEGFC;GAS6;MYH9;LHFPL2;FN1;APP;TAGLN2;WDR1;STX1A;CD109;RAB31;ACTN1;TMED10;RAB11FIP5;FLNA;LYN;RAB11FIP1;ALDOA;CHID1;SOD1;SYT4;CDK5;IGF2;SERPINE1;TGFB3;ISLR;PSAP;RAB3A;ECM1;STEAP2;TMX3;VEGFA;RAB11B;RARRES2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4056946108994922,1.4555138498707318,0.04060913705583756,0.7096591319928467,1.0,15/75,12.36%,ATP1A2;SLC6A1;SLC8A3;ATP1B3;TRPV1;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;TRPM2;SLC12A1;SLC9A9
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5334858249550687,-1.4554516282981875,0.05091649694501019,0.3072036098274165,1.0,5/17,9.69%,BMP4;BTG1;SFRP4;TMEM100;FGF2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.4824585595883444,-1.4552476392380882,0.04487179487179487,0.3067545890139352,1.0,13/25,21.16%,CD200;VCAM1;ITGA5;ITGB1;CXADR;CTNNA3;PARVA;ITGA7;JAM3;ITGA4;DSG2;DSP;JUP
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4783551247764902,-1.455239945397507,0.07317073170731707,0.30592453030097133,1.0,8/27,12.31%,PPP1R16B;PPIA;PRKCD;CALM3;SPPL3;SRC;NSMF;BMP2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4640989430201624,1.454245227923247,0.05436893203883495,0.7095696481384034,1.0,3/31,1.71%,RANBP3L;TMEM64;SUFU
prerank,hemidesmosome assembly (GO:0031581),-0.5951251650206406,-1.453712395786267,0.07028112449799197,0.3080931467555229,1.0,4/11,4.07%,ITGA6;DST;ITGB4;LAMA3
prerank,prostanoid biosynthetic process (GO:0046457),0.5783314335073811,1.4526128160807357,0.08464566929133858,0.7106829292139583,1.0,4/15,6.37%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3667800802703598,-1.451528530881992,0.02072538860103627,0.3118614814390325,1.0,33/98,19.91%,ECE1;SLCO1C1;PID1;PPARD;INSR;THBS1;NFKBIA;TGFBR2;SFRP4;TBC1D5;VAMP3;XDH;AGTR1;ACACB;KLF4;GHITM;APOE;FASN;STARD4;ACE2;AGPAT1;VEGFA;ROMO1;MT3;RAB1B;FMR1;IFNAR1;CBR1;ZC3H12A;GREM1;DHRS4;ARRB2;RIPK1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5724238442680086,-1.4513975737438873,0.07272727272727272,0.3112573327336092,1.0,8/13,23.33%,PLCG1;AKT3;MDK;IGF2;FGF2;ITGA4;HMGB1;SIRT6
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5165213828875246,1.4504727470941425,0.05725190839694656,0.7146215483431012,1.0,7/22,15.53%,AEBP1;MAP2;PRUNE1;ARL2;EFEMP2;ABL1;GBA2
prerank,neutrophil migration (GO:1990266),-0.39699241747673314,-1.450312062702733,0.03036876355748373,0.31263176638436724,1.0,42/58,50.43%,PECAM1;BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;PRTN3;S100A9;IRAK4;CCL5;CCL4;PF4;FCER1G;PPBP;CCL8;CCL19;CXCL5;CCL14;CXCL1;PDE4B;CCL7;CXCR2;S100A8;CCL1;CCL3;CCL11;CD177;LGALS3;CXCL13;CXCL2;CKLF;PIP5K1C;ITGB2;XCL1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5830373093279075,-1.4502720551985444,0.08523908523908524,0.31189247145021615,1.0,3/12,7.27%,PRKG1;MEF2C;ADAMTS1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.624235935902282,1.449711170251798,0.0861344537815126,0.7125831694615671,1.0,4/10,11.18%,UPB1;DPYD;NT5C3A;UPP2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5438062216562682,-1.44839294728547,0.08560311284046693,0.3148213534583116,1.0,5/15,13.67%,PRKCH;BMP4;SFRP4;TRIM16;NME2
prerank,regulation of acrosome reaction (GO:0060046),0.6392811354936804,1.4477940336727138,0.088659793814433,0.7153543459346284,1.0,3/10,10.51%,SERPINA10;GLRA1;PLCB1
prerank,sympathetic nervous system development (GO:0048485),-0.5511350814009304,-1.4477102890308027,0.061855670103092786,0.3152361124247724,1.0,2/15,0.78%,NRP1;NRP2
prerank,microtubule depolymerization (GO:0007019),-0.5231349653786529,-1.4476720192450439,0.08023483365949119,0.3144788772067747,1.0,8/17,26.18%,NCKAP5;STMN1;NCKAP5L;KATNB1;KIF24;STMN4;KIF14;CCSAP
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.611522410276737,-1.4474847424736872,0.06903353057199212,0.313998807115924,1.0,7/11,23.25%,ARID1B;ARID1A;SERTAD1;ZMIZ2;CDCA4;CHEK1;ZMIZ1
prerank,basement membrane organization (GO:0071711),-0.5550564673976995,-1.4473316296017193,0.0846774193548387,0.3134574040505711,1.0,5/14,7.90%,FLRT2;COL4A1;RAMP2;NTN4;LAMB2
prerank,endothelial tube morphogenesis (GO:0061154),-0.6130509831896606,-1.4471846436615585,0.07952286282306163,0.3129490655662741,1.0,4/10,3.83%,RHOA;ACVRL1;BMP4;STARD13
prerank,vesicle organization (GO:0016050),-0.4102114901908947,-1.4468580348832372,0.033707865168539325,0.31274112598782483,1.0,14/46,16.33%,CAV1;CD34;WASHC4;CHMP2B;ALS2CL;RAB22A;ZFYVE16;SORT1;CAV2;FNBP1L;SQSTM1;SNX10;SAR1A;USP50
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5388504328738192,1.4457150408422046,0.0720164609053498,0.7191464361395417,1.0,7/18,9.11%,PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;DLG4
prerank,potassium ion import across plasma membrane (GO:1990573),0.4451003034357271,1.4439663004545082,0.05745062836624776,0.7214431192650191,1.0,10/41,11.60%,ATP1A2;ATP1B3;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1
prerank,macrophage activation involved in immune response (GO:0002281),-0.5764609408353294,-1.4438557957078566,0.08139534883720931,0.3181723274845411,1.0,9/13,32.55%,PLCG2;IFI35;DYSF;NMI;SYK;SBNO2;TREM2;GRN;TYROBP
prerank,intracellular cholesterol transport (GO:0032367),-0.5497653616505302,-1.4430881537994473,0.06719367588932806,0.31881015115807115,1.0,6/15,16.36%,LRP6;ABCA1;NPC2;OSBP;STARD4;LDLRAP1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.40191348400700466,-1.442252802860456,0.04072398190045249,0.3195839973989761,1.0,29/56,36.87%,ALPK1;UBC;RPS6KA3;NOD1;PLCG2;RPS27A;UBB;MAPKAPK2;SFTPA1;SFTPA2;CTSB;TAB1;IRAK2;NOD2;CTSS;HMGB1;MYD88;BCL10;TLR4;TLR6;MAPKAPK3;CD36;TLR1;S100A9;CD14;TLR3;IRAK4;TAB3;TLR2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6100752534755962,-1.4417715046418766,0.06732673267326733,0.3197116705154935,1.0,4/10,15.78%,ABCA1;ZDHHC8;APOE;PRKACA
prerank,prostaglandin biosynthetic process (GO:0001516),0.5468780471239478,1.4403723166968403,0.080078125,0.731627331015377,1.0,4/18,6.37%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,cytoskeleton organization (GO:0007010),-0.3554665555799332,-1.4402019195768816,0.010282776349614395,0.32205377077345704,1.0,27/114,12.75%,FMNL2;ARHGAP10;FGD5;SEMA6A;PLCE1;RHOBTB1;MICAL2;MARK1;RHOA;FGD6;DST;LIMD1;ARAP3;PALLD;TNIK;SIPA1L3;MAST4;CCL13;MDK;CNN2;BRWD1;NEDD9;CFL1;APOE;NECTIN2;RANBP9;SIPA1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.37973733405427906,-1.4398682711302575,0.019851116625310174,0.3218681200209067,1.0,27/78,17.23%,SPTBN1;PRKCH;ACTB;PID1;PIK3R1;BCL2L1;EGFR;STX3;ITGB1;NKD2;TMEM59;NUMB;ZDHHC8;AR;CDK5;ABI3;STAC;EPHB2;SQSTM1;STX7;ZDHHC7;TMBIM1;STX8;ZDHHC2;LDLRAP1;LRP1;GPER1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4808483768452287,1.4388214658859804,0.07366482504604052,0.7330933052219647,1.0,9/31,11.22%,SYT11;SYT12;SYT9;RAB3GAP1;ADRA2A;SYT1;SYT13;SYT10;SCAMP5
prerank,regulation of axon guidance (GO:1902667),-0.609747334365933,-1.4386718682608268,0.07524752475247524,0.3233090122385474,1.0,1/10,0.07%,NRP1
prerank,regulation of T cell differentiation (GO:0045580),-0.4413677362214097,-1.4378152578133754,0.03333333333333333,0.32422817174441576,1.0,26/33,47.85%,RUNX1;CBFB;ZBTB1;MDK;SOD1;NFATC2;METTL3;PRDM1;ZMIZ1;CCR2;TCF7;IL2RA;ZAP70;FANCA;GATA3;CLPTM1;CRTAM;PRELID1;IL4;CTLA4;TNFRSF18;XBP1;FOXP3;RHOH;TBX21;IL2
prerank,ERBB2 signaling pathway (GO:0038128),-0.45989752361209274,-1.4376059581447098,0.04583333333333333,0.32375737073158783,1.0,8/31,8.89%,GAB1;PTPN12;PIK3R1;EGFR;CPNE3;MYOC;PIK3CA;SRC
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4653967837052198,1.4365554448178641,0.06954887218045112,0.7377677924943327,1.0,9/31,9.81%,PDGFRA;OSR1;HOXB9;HOXB3;FGFR2;HOXA3;TGFBR1;HOXB4;MEGF8
prerank,cellular response to inorganic substance (GO:0071241),-0.48419761363764324,-1.4360371042455686,0.057494866529774126,0.32616628893553923,1.0,11/21,27.02%,FOXO1;GUCY1B1;DDI2;BLM;MT3;TIMELESS;FMR1;SPIDR;NSMCE3;ADCY10;CDK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.38957180274837233,-1.435916391645975,0.032407407407407406,0.32555316371899373,1.0,17/63,15.74%,MEF2C;IL6ST;VCAM1;TFRC;SLC7A1;NCK1;ANXA1;CD38;IL15;EPHB2;NFATC2;CD74;CD86;PTPRC;CD40;CD46;NCKAP1L
prerank,negative regulation of viral life cycle (GO:1903901),-0.5391438100733694,-1.4357366550092818,0.0872210953346856,0.3251636319458784,1.0,5/15,6.18%,GSN;LY6E;MID2;IFITM3;PPIA
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.38091356082316347,-1.435699183837807,0.026829268292682926,0.324407482300522,1.0,24/71,18.02%,FAP;UBC;RPS27A;UBB;CAPN2;ZYG11B;PSMA6;OTUD7B;CHMP4B;DDI2;CTSO;MALT1;CTSB;ISG15;RNF123;FBXO44;HDAC6;HM13;RHBDD1;CTSF;RSPRY1;CTSS;ADAMTS12;ATE1
prerank,regulation of hydrolase activity (GO:0051336),-0.382000770738167,-1.4347968007180982,0.02608695652173913,0.32540648364967395,1.0,20/71,17.34%,PRKG1;CAV1;CHN2;FGD5;DAB2IP;FGD6;CHN1;RASIP1;SCARB2;RAPGEF6;SOD1;EFNA5;VAV2;PLXNC1;ARHGAP27;RAP1GAP;PLXNA4;PAFAH1B1;RAB3GAP2;TDG
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4176800370215284,-1.4336887943670447,0.038876889848812095,0.32684111318339587,1.0,12/45,9.67%,PLCE1;GAB1;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;GAREM1;PIK3CA;SRC;BCAR1
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.41091534944005115,-1.4334709252669766,0.03811659192825112,0.3265324885370293,1.0,20/49,25.06%,MEF2C;THBS1;KMT2E;H3-3A;AGO1;RUNX1;DPY30;CBFB;MYL9;PITHD1;KMT2C;MTURN;PRMT6;AGO4;L3MBTL1;ZFPM1;TESC;PRMT1;ASH2L;KMT2B
prerank,endochondral bone morphogenesis (GO:0060350),-0.5948010466614186,-1.4334224244730434,0.08187134502923976,0.32579654449224943,1.0,6/11,17.36%,MEF2C;BMPR2;BMP4;TMEM119;TRPV4;FGFR3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4371076747482754,-1.4332202497682829,0.05043859649122807,0.3254091209645468,1.0,10/33,12.46%,ETS1;TGFB2;FOXO3;STAT3;JUN;GNL3;GATA2;KLF4;FGF2;TEAD1
prerank,wound healing (GO:0042060),0.41219561252686143,1.4329464547203796,0.048214285714285716,0.7478097012361242,1.0,13/62,9.64%,FGF1;SYT11;ANXA6;IGF1;PDGFRA;SMAD3;WNT7A;NRG1;MYOF;CORO1B;CFLAR;FZD7;TGFBR1
prerank,pulmonary valve development (GO:0003177),-0.511867338729532,-1.4323866529634424,0.08316430020283976,0.32637705688428803,1.0,12/18,8.27%,BMPR2;JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;STRA6;HEY2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4470459820147617,-1.4322856172109946,0.04241071428571429,0.32580906488757605,1.0,10/33,9.37%,TEK;RAMP2;NDNF;GAS6;KDR;CAST;ICAM1;MDK;GATA2;SERPINE1
prerank,plasma membrane invagination (GO:0099024),-0.45430120276125047,-1.4312310928994334,0.052742616033755275,0.32722422380443145,1.0,17/29,31.20%,DOCK1;RHOA;GSN;MYH9;SNX18;GULP1;CDC42;ALKBH4;FCGR1A;FCGR2B;ARHGAP12;BIN2;AIF1;ARHGAP25;MSR1;CD36;SPIRE2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5742374623062401,-1.4308062272126851,0.078125,0.3274218048039523,1.0,5/12,16.28%,PRKD1;NIPBL;SAP30BP;VEGFA;APLNR
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5356919347868201,1.4307165225309264,0.07393715341959335,0.7528266665104086,1.0,7/18,17.09%,ROCK2;PICALM;CASP3;ABCA2;CLU;EPHA4;RELA
prerank,response to molecule of bacterial origin (GO:0002237),-0.37779170027404163,-1.4298295421298532,0.029748283752860413,0.32864930866660064,1.0,30/69,33.76%,FOXP1;NOS3;IRAK3;RPS6KA3;TNFRSF11A;GCH1;C4B;SRR;MAPKAPK2;LIAS;CD24;IFNAR1;IRF5;ERBIN;GGT7;GGT1;SMAD6;FCGR2B;TLR4;F2R;PELI1;SELP;NOCT;MAPKAPK3;TRIB1;NOS2;NOS1;LGALS9;S100A9;CD14
prerank,negative regulation of protein polymerization (GO:0032272),-0.46509379037484444,-1.4298069508538267,0.046255506607929514,0.3278863401978377,1.0,11/27,12.66%,SLIT2;KANK1;STMN1;KANK3;SSH2;TBCD;KANK4;PRKCD;DYRK1A;HIP1R;PFN1
prerank,striated muscle contraction (GO:0006941),0.42754898229341687,1.4294758365264149,0.041970802919708027,0.7528634711145208,1.0,8/53,11.28%,ATP1A2;DTNA;CSRP3;TNNI1;ARHGEF11;KCNH2;MYH14;RYR2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4854406683305909,-1.4291581650819087,0.04842105263157895,0.3283160707251217,1.0,11/24,20.92%,PKD1;UBB;GPX1;APOE;TMF1;PTK2B;PRKACA;LATS1;PSMD14;UCHL5;PSME1
prerank,metanephric mesenchyme development (GO:0072075),0.6128396039355609,1.4281557008625538,0.10973084886128365,0.753221809027352,1.0,3/10,9.76%,WNT4;OSR1;STAT1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5582054154956944,-1.428070356916282,0.08080808080808081,0.32977316341630203,1.0,6/14,14.88%,THBS1;CREB3L1;SPRY2;FGF2;SPRY1;GPC1
prerank,fatty acid transmembrane transport (GO:1902001),0.5165584254187032,1.4278578359880933,0.1,0.7493175206924667,1.0,2/19,1.84%,PRKAG2;PRKAA2
prerank,dicarboxylic acid transport (GO:0006835),0.47638645524630335,1.4272403277502164,0.06529850746268656,0.746923986537583,1.0,6/28,9.98%,SLC22A6;SLC13A3;SLC26A1;PDPN;SLC19A1;SLC25A12
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3600532975630937,-1.4267482507662634,0.023752969121140142,0.3317349553518051,1.0,22/87,7.25%,GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;ENG;TGFB2;ID1;SMURF1;TGFBR2;UBC;PTPRK;F11R;JUN;ITGB1;SMAD1;RPS27A;UBB;SMAD5;PXN;ITGB5
prerank,neurotransmitter transport (GO:0006836),0.3957665135208465,1.4263626272477725,0.0351493848857645,0.7455401882541083,1.0,17/73,16.43%,ATP1A2;SLC29A2;SLC38A1;SYT1;SYN2;SNAPIN;RIMS1;SLC6A4;SNAP25;GLS2;GAD1;SYN3;CPLX1;SLC22A2;SYN1;NAAA;GLUL
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4316049342715507,-1.4259422328206182,0.05066079295154185,0.3327031267714563,1.0,11/39,10.95%,RAPGEF2;DAB2IP;TJP1;HJURP;TIE1;NOTCH1;RAP1A;ANKRA2;APOE;GFAP;BAG5
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4885903556194987,1.4255464076268682,0.0825515947467167,0.7438714938747457,1.0,5/26,4.52%,ERRFI1;SNX6;CHMP6;GPRC5A;ADRA2A
prerank,regulation of inclusion body assembly (GO:0090083),0.611956055355541,1.4253108404557235,0.10114503816793893,0.7400038255181037,1.0,3/11,2.99%,HSPA1A;SNCAIP;DNAJB8
prerank,regulation of spindle organization (GO:0090224),-0.5179054576455857,-1.4246177154064212,0.0684326710816777,0.33457659908982706,1.0,9/18,28.13%,SENP6;MAP9;DYNC1H1;DCTN1;TPX2;GPSM2;NUP62;FSD1;PARP3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.596304954201564,-1.424214086135796,0.10365853658536585,0.33465927932496786,1.0,2/10,2.87%,PODXL;PIEZO1
prerank,blood vessel diameter maintenance (GO:0097746),-0.44848545912613463,-1.4240196163195742,0.05790645879732739,0.3342037522811069,1.0,11/34,13.24%,EDNRA;ECE1;NOS3;AGTR1;KCNMB2;GCLC;EDN1;GCLM;ACE2;EDN3;KLF2
prerank,muscle tissue development (GO:0060537),-0.5648576877142718,-1.4237657459993092,0.07429718875502007,0.33390153244391796,1.0,7/13,12.98%,PGM5;ENG;BMP4;STRA6;CSRP2;PTCH1;SMO
prerank,ribosomal large subunit assembly (GO:0000027),-0.4740456319517181,-1.4234899185349519,0.08403361344537816,0.3336499986713932,1.0,12/24,28.60%,RPL5;RPL10;MRPL20;RPLP0;RPL6;RPL24;RPL3;RRS1;RPL23A;PPAN;MDN1;RSL24D1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.48436230784848444,1.4233626969235589,0.07861060329067641,0.7433385415417579,1.0,4/32,2.88%,PRKAG2;PRKAA2;FITM2;PPARA
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.5684422360467121,-1.4232739996673691,0.096579476861167,0.3333015047379662,1.0,5/12,17.75%,KAT7;TIPIN;WRNIP1;BLM;NBN
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.31676802596101045,-1.423273592648468,0.0,0.3324925205031653,1.0,62/214,19.04%,NRP1;TEK;ROR1;NTRK3;GCNT2;SEMA6A;RAPGEF2;PDE8A;DAB2IP;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;FN1;APP;MFHAS1;TNFAIP8L3;SPRED2;ICAM1;LYN;CCN1;CCL13;GAREM1;CEACAM1;SPRY2;PDGFC;FLT4;PTPN1;FGF2;DUSP3;YWHAZ;ACKR3;APOE;EPHB2;PDGFD;PHB2;CD74;BMP2;PTK2B;RANBP9;HTR2A;FBXW7;PTPRC;P2RY6;SPRY1;MTURN;MT3;FERMT2;CSF1R;GPER1;FGFR3;NOD2;DUSP6;CCL25;PTPN6;MAPK3;PTEN;ARHGEF5
prerank,thymus development (GO:0048538),-0.5557623028384914,-1.4226407165518515,0.08932038834951456,0.3331072834347005,1.0,5/13,8.69%,SIX1;TBX1;HES1;ZBTB1;SOD1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4834433970732452,1.4223932781939408,0.09315589353612168,0.7422961679164639,1.0,3/28,2.69%,PRKAG2;PRKAA2;FITM2
prerank,cellular response to misfolded protein (GO:0071218),0.5157738910598542,1.4222560184822255,0.065439672801636,0.7379978237921814,1.0,8/20,18.34%,DERL1;DNAJC18;DNAJB14;RNF126;UBE2W;BAG6;RNF5;UGGT2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.44650275929156474,-1.4219116076098082,0.05785123966942149,0.3337343066048196,1.0,15/30,29.27%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;POLR1A;UBTF;POLR1H;POLR2F;CCNH;POLR1E;POLR2H;POLR1C;POLR2E
prerank,lipid catabolic process (GO:0016042),0.5350108956773993,1.421401643687492,0.098,0.7366498473892628,1.0,6/18,23.30%,CEL;PLA1A;PLAAT3;HSD11B1;LIPC;LIPH
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3715752650852558,-1.4213002038555347,0.02481389578163772,0.3342549927969367,1.0,19/73,18.01%,NTRK3;CAV1;BCAR3;GAS6;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;MAD2L2;LATS1;TNKS1BP1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5437968612105895,1.4209570976201302,0.0940959409594096,0.7336532553694862,1.0,2/16,1.91%,RANBP3L;IGFBP3
prerank,positive regulation of behavior (GO:0048520),-0.599009565119424,-1.4207834131957537,0.09019607843137255,0.3344882262305033,1.0,3/10,7.77%,MEF2C;SGIP1;STRA6
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.47881981606691226,-1.420508452066848,0.06352459016393443,0.3342999900626991,1.0,5/22,6.03%,GHR;NOTCH1;CYP1B1;MGAT5;HES1
prerank,positive regulation of phosphorylation (GO:0042327),-0.31342982795550567,-1.4201519687858422,0.009259259259259259,0.3342453969598229,1.0,61/240,15.74%,NRP1;TEK;ROR1;NTRK3;PECAM1;SLCO3A1;PDE8A;ITGA6;NIBAN1;TIE1;ENG;INSR;THBS1;MERTK;VEGFC;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;CARD14;TBX1;TNIK;FAS;RALB;TFRC;RAP2A;FLT1;MET;RACK1;PPIA;AXIN2;LYN;NPTN;AR;CCN1;RB1CC1;PTGES3;EFNA5;FLT4;IL34;IGF2;TMEM119;FGF2;FGF7;EPHB2;KRAS;CD74;RET;BMP2;AKT2;ALK;VEGFA;RARRES2;CD40;MT3;PLAUR;CSF1R;NCKAP1L
prerank,protein homotrimerization (GO:0070207),-0.548531056610874,-1.4177277780085782,0.07966457023060797,0.33787210932613215,1.0,3/14,2.93%,SCARA5;DISP1;SLC1A5
prerank,protein trimerization (GO:0070206),-0.548531056610874,-1.4177277780085782,0.07966457023060797,0.33787210932613215,1.0,3/14,2.93%,SCARA5;DISP1;SLC1A5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.579342085578527,-1.417265920461659,0.10020449897750511,0.33807900416508135,1.0,5/11,22.95%,MERTK;GAS6;CXCL12;NOD2;HCLS1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5575224107804884,1.416874143628759,0.09284332688588008,0.7464316953207134,1.0,4/15,7.14%,CHST4;RENBP;LARGE1;GNPDA1
prerank,ceramide metabolic process (GO:0006672),-0.40800311933300126,-1.4167221172612285,0.03836930455635491,0.33854489856564995,1.0,11/49,9.48%,SGMS1;ST6GALNAC3;SGMS2;ACER2;DEGS2;AGK;CERS5;CERS6;ORMDL3;PLPP1;SAMD8
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3461385151236453,-1.415958690325827,0.011904761904761904,0.3393395047537763,1.0,38/113,21.78%,DAB2IP;RPA1;PIEZO1;ICE1;RASIP1;UNC13B;ABCA1;ESR1;FNIP2;DHX33;TFRC;GBP5;RACK1;RPS3;CHD1L;SRC;TPPP3;GTF2H5;TAL1;CAPG;CDC42EP2;GTF2H1;ISG15;ERCC2;VEGFA;PSMC4;FERMT2;BAK1;USP50;RPA2;SLF2;SPIDR;XPA;MYD88;AJUBA;SYK;FAF1;BIK
prerank,ATP transport (GO:0015867),0.6099010676036631,1.4156485292596457,0.10916179337231968,0.7466130885746336,1.0,2/10,4.94%,SLC25A42;SLC25A5
prerank,embryonic organ development (GO:0048568),-0.38476674397374977,-1.415287948193775,0.033112582781456956,0.33993704100639477,1.0,24/61,17.78%,KITLG;PBX1;RARB;PCSK5;TGFB2;TEAD4;PBX3;KDR;TGFBR2;RPL10;GLI3;SOX17;STRA6;HEY2;TAL1;MFSD2A;SOX18;TEAD1;TBX2;RARRES2;STIL;ATF4;HEY1;ALDH1A3
prerank,regulation of ruffle assembly (GO:1900027),-0.4761043633569728,-1.4147439308924754,0.08405172413793104,0.34036263587227134,1.0,6/23,12.66%,CAV1;KANK1;EPS8;EPS8L2;ABI3;PFN1
prerank,smooth muscle tissue development (GO:0048745),-0.6025430609851926,-1.414222271209469,0.08764940239043825,0.34065302282391446,1.0,5/10,12.98%,ENG;BMP4;STRA6;PTCH1;SMO
prerank,neuron migration (GO:0001764),-0.40026622265632456,-1.413978626365315,0.060674157303370786,0.34027756040187707,1.0,14/48,15.99%,NRP1;MEF2C;RAPGEF2;MARK1;NDNF;DISC1;CEP85L;CDK5;FGF13;VEGFA;NR4A2;MAP1B;DDIT4;PAFAH1B1
prerank,regulation of transport (GO:0051049),-0.4315415560732709,-1.4139741316524463,0.058315334773218146,0.33949135852893364,1.0,15/36,24.80%,NRP1;ACTB;ACTG1;ICA1;DNAJA1;CDK5;GAPVD1;REEP5;EPB41;RAB11A;CLDN10;DISP3;POFUT2;MUL1;FES
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5984192058428196,1.4139088885423816,0.11530815109343936,0.7493386260865184,1.0,1/11,0.52%,TAS1R2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5002769394587283,-1.4138436252273718,0.08024691358024691,0.3390057131814222,1.0,8/20,16.00%,NOTCH1;RUNX2;SMAD1;SMAD5;BMP2;VEGFA;MT3;ATF4
prerank,negative regulation of cell migration (GO:0030336),-0.3385444150938486,-1.4131460998513028,0.008152173913043478,0.3395898226159056,1.0,25/137,5.95%,PTPRG;TMEFF2;CLDN5;DAB2IP;JAG1;SLIT2;VCL;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;FOXO3;CDH1;CORO1C;CYP1B1;KANK1;PTPRJ;ADARB1;PTPRK;DACH1;PHLDB2;RAP2A;RECK;ARHGDIB
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5941242673947261,-1.4123810119473272,0.08782435129740519,0.3402765531327935,1.0,3/10,6.48%,SHANK3;APP;NPTN
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.4399609088874745,1.4110124593283884,0.07420494699646643,0.7570336547119244,1.0,4/41,3.92%,PRKAG2;GCK;POM121;NUP155
prerank,positive regulation of immune system process (GO:0002684),-0.5305339030838826,-1.4108774001271347,0.08677685950413223,0.3426415082448933,1.0,7/16,15.74%,TGFB2;ANXA1;IL15;PIK3CD;RSAD2;VEGFA;NCKAP1L
prerank,response to metal ion (GO:0010038),-0.37693821734378224,-1.4108262122000144,0.03917050691244239,0.34193755923698615,1.0,19/67,15.24%,CAV1;NEDD4L;TRPC3;THBS1;PLSCR1;GPHN;CRIP1;CALM3;PPP3CA;MT1A;MT1X;PPP1CA;TRPC1;SLC30A5;ITPR3;SEC31A;D2HGDH;MT3;ATP5F1D
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4611833322596039,-1.4107272752620055,0.053811659192825115,0.34138794813285567,1.0,6/27,9.33%,UTRN;NEDD4L;FXYD5;CAMK2D;SLMAP;FXYD6
prerank,cellular response to glucose starvation (GO:0042149),0.44050250204855695,1.4106025973972158,0.0586145648312611,0.754128275246761,1.0,7/41,8.36%,PRKAG2;PRKAA2;PRKAG3;NIM1K;CPEB4;IMPACT;SESN1
prerank,purine nucleotide catabolic process (GO:0006195),-0.5674990600661101,-1.4104557402372342,0.09072978303747535,0.3411075694230386,1.0,7/13,22.76%,XDH;GPX1;NT5C1A;NT5E;NT5C;HINT1;GDA
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5176751511477781,1.4099257511614989,0.10775047258979206,0.7520869653046186,1.0,6/19,11.36%,IGF1;PICALM;RTN1;FLOT2;NTRK2;CLU
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.34453568157931275,-1.4098874501053928,0.01832460732984293,0.3415544499842985,1.0,21/104,5.78%,CAV1;BMPR2;HTRA3;ACVR1;BMPER;NOTCH1;CRIM1;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CCN3;CD109;ASPN;SPRED2;SMAD1;RPS27A;UBB;SMAD5;UBE2D3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.39772744758033046,-1.409636548938621,0.04047619047619048,0.34128363057505423,1.0,21/53,21.50%,DAB2IP;PKD1;GABARAPL2;UBB;ECSCR;PRKCG;GPX1;APOE;TMF1;FOXF2;RAD23B;FBXW7;GNA12;PRKACA;FMR1;PSMD14;PSME3IP1;UCHL5;GLMN;PSME1;TMTC3
prerank,response to interleukin-6 (GO:0070741),-0.6025948844359661,-1.4090738542168102,0.0835030549898167,0.3417654971312485,1.0,3/10,2.68%,PID1;ST3GAL6;PTGIS
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.43394224658583336,1.409066090689288,0.05536332179930796,0.7510595390071418,1.0,13/44,10.67%,ACTN2;ATP1B3;ANK2;WNK3;KCNJ5;ATP1B2;KCNJ10;WNK4;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5348294762730676,1.408455530247057,0.10458715596330276,0.7490286473148183,1.0,4/18,10.44%,MCM3AP;PABPN1;PCID2;DDX19B
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5987062652581442,-1.4076732052789698,0.10371819960861056,0.3440491347700765,1.0,5/10,28.76%,KDR;NOD2;IL33;TLR4;NAMPT
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6106602386466968,-1.4076020540423115,0.09787234042553192,0.34342197050486717,1.0,5/10,17.09%,PTPN12;PTPRJ;APOD;HGS;LRP1
prerank,regulation of peptide hormone secretion (GO:0090276),0.39389049141535043,1.4071522439453008,0.05026929982046679,0.749752421635825,1.0,21/67,17.41%,CACNA1D;GCK;CACNA2D2;ITPR1;PASK;ADRA2A;SNAP25;CLOCK;KCNC2;ITPR2;GRP;RAPGEF3;KCNS3;ENSA;PRKCA;EIPR1;PER2;IL6;GIPR;PICK1;HFE
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5619020446391447,1.4065806541689514,0.1144578313253012,0.7476328570074827,1.0,2/14,3.87%,IL18;IL17D
prerank,retina homeostasis (GO:0001895),-0.47052322106803074,-1.4065604704494437,0.07112970711297072,0.3448908268096476,1.0,6/23,11.11%,ACTB;POTEF;B2M;ACTG1;SOD1;HSPB1
prerank,adherens junction organization (GO:0034332),-0.40056198738379295,-1.4065353502232727,0.04740406320541761,0.3441618859179802,1.0,11/48,5.97%,CDH11;ACTB;TJP1;VCL;RAMP2;CDH13;CDH1;CTNNA1;TBCD;PAK2;NECTIN3
prerank,prostaglandin metabolic process (GO:0006693),0.4935255033274424,1.4058463114409103,0.09784735812133072,0.7463838646769169,1.0,5/26,7.89%,PTGDS;PTGS1;PNPLA8;PTGES;PTGR1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4186301934831966,1.405436366544029,0.06593406593406594,0.7436480668595361,1.0,12/50,12.26%,RORA;DCDC2;SUFU;INTU;TULP3;FGFR2;EVC;ARMC9;MEGF8;IFT122;TEDC2;GAS1
prerank,positive regulation of protein binding (GO:0032092),-0.3895232589317685,-1.4047181501329224,0.04895104895104895,0.34711122315502235,1.0,22/56,22.06%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;BMP4;APP;RALB;SPPL3;TIAM1;APOE;HIP1R;BMP2;NMD3;EPB41;LRP1;VTN;MARK3;PPP2CA;RIPK2;DTX3L
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4835738750880648,-1.404198035709103,0.08803611738148984,0.3473377154209265,1.0,6/21,13.88%,FOXP1;PRKCH;SLC39A10;RPS3;NECTIN2;PTPRC
prerank,regulation of B cell apoptotic process (GO:0002902),-0.556132470589335,-1.4009558712282004,0.08296943231441048,0.35352556133774127,1.0,3/12,8.51%,FOXP1;LYN;ORMDL3
prerank,nitrogen compound transport (GO:0071705),-0.3269966882545265,-1.3986407318847347,0.01272264631043257,0.35767249833948583,1.0,27/141,9.01%,ABCG2;SLC6A6;CALCRL;SLC12A2;LRRC8D;RAMP2;CERT1;SEC14L1;MYH9;SLC1A5;ABCC1;SLC7A5;LMAN2L;SCARB2;TMEM30A;ATP11B;CHMP2B;SLC38A5;SLC43A2;SLC44A2;SLC7A7;SLC7A1;CMTM6;CUBN;SLC7A14;TXNIP;SLC43A1
prerank,activation of GTPase activity (GO:0090630),-0.3549658828950343,-1.3986084335753803,0.022332506203473945,0.356937222543043,1.0,27/89,15.76%,TBC1D4;NTRK3;RABGAP1L;ARHGAP42;SIPA1L2;TBC1D8;CORO1C;BCR;TBC1D12;TIAM2;TBC1D5;USP6NL;TBC1D2B;ARHGEF15;SIPA1L3;TBC1D1;EVI5L;ABR;TIAM1;TBC1D13;RALGAPA1;SIPA1;TBC1D10A;TAX1BP3;TBC1D7;TBC1D25;RAP1GAP
prerank,positive regulation of cell adhesion (GO:0045785),-0.3680997949657382,-1.3985849767764145,0.03218390804597701,0.35619396982669693,1.0,16/74,12.15%,FRMD5;LIMS1;ZFHX3;VIT;TGFB2;NDNF;PTPRJ;STX3;PPP3CA;TGM2;CXCL12;MDK;ECM2;FBLN2;ADGRG1;RET
prerank,L-serine metabolic process (GO:0006563),-0.5793968027964753,-1.398127742988008,0.09859154929577464,0.3563864767480338,1.0,6/10,28.16%,SERINC5;SRR;SERINC3;SHMT2;CBS;SHMT1
prerank,neutrophil activation (GO:0042119),-0.5603765382345685,-1.397742913651696,0.10317460317460317,0.35645482513015525,1.0,5/12,20.61%,KMT2E;PRKCD;IL15;PREX1;SYK
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.48287296393971435,1.3973038411259546,0.09288537549407115,0.7725296602678464,1.0,8/26,15.45%,LGR4;APPL2;NLRP2B;FLOT2;OTUD4;CACTIN;TYRO3;TLR5
prerank,hepaticobiliary system development (GO:0061008),0.5164854216319078,1.3971780986374427,0.11434108527131782,0.7684975410387967,1.0,4/20,7.68%,TGFBR3;WNT4;CEBPA;PHF2
prerank,manganese ion transport (GO:0006828),-0.5387665216722717,-1.3964530038992018,0.09248554913294797,0.3583962749858328,1.0,5/14,9.58%,TRPC3;SLC39A8;TRPC6;TRPC4;TRPC1
prerank,regulation of cell population proliferation (GO:0042127),-0.279371064374696,-1.3958406839601982,0.0,0.3589453240634418,1.0,142/691,13.96%,LEF1;ELN;KITLG;LIMS1;NTRK3;ABI1;GCNT2;BMP5;ZBTB7C;RAPGEF2;CLDN5;DAB2IP;BMPR2;IL6ST;PTN;TJP1;JAG1;OSMR;NOS3;LIFR;RHOA;CD200;ACER2;ETS1;ACVRL1;ENG;TGFB2;INSR;THBS1;VEGFC;NOTCH1;TBX3;LRP5;CDH13;TBC1D8;SH3BP4;EGFR;NGF;CTCF;CYP1B1;BMP4;BTG1;STAT3;PTPRJ;KDR;FN1;SIX1;TGFBR2;APP;SFRP4;ADARB1;ITGA1;PTPRK;RUNX1;JUN;TBX1;CACUL1;CBFA2T3;GNL3;TNFRSF11A;TFRC;IGFBP6;STX3;CNOT6L;NUAK1;ARHGEF2;JAG2;AQP11;DNAJA2;FLT1;AGTR1;ADAM10;HES1;S100A13;XRCC5;AXIN2;LYN;IL6R;AR;KLF11;ADAMTS1;APC;NACC2;RPS6KA2;TIPIN;GAREM1;IFI35;PPP2R5C;EMP2;CDC123;PDGFC;PLPP1;RBBP4;FLT4;XIAP;TIAM1;IL15;IL34;IGF2;VHL;TSPAN31;KLF4;FGF2;TGFB3;S100A11;EDN1;BTG3;S1PR3;ESM1;FGF7;TES;RPL23;SERTAD1;ADGRG1;HGS;PBRM1;MYOCD;SOX7;GRK5;FBXO5;DDAH1;PDGFD;KRAS;HHEX;RPS9;BMP2;PTK2B;ACE2;RARG;SST;WNT9A;NACC1;EDN3;AKT2;TBX2;CD86;CSNK2A1;RERG;EEF1E1;ALK;COPS9;VEGFA
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3265551795912569,-1.3937156426932178,0.014450867052023121,0.3627211353873958,1.0,48/151,19.83%,SGMS1;ST3GAL4;PLA2G4A;SGMS2;ELOVL7;ACER2;PCSK5;CERT1;CEPT1;DEGS2;GPHN;PRKD3;GCH1;PRKD1;SPNS2;ELOVL5;SLC44A2;CERS5;CERS6;AKR1A1;PLPP1;SAMD8;GOLPH3;APOE;GCNT1;ELOVL6;B4GALT5;MFSD2A;SLC44A1;LPIN3;NFS1;CSNK2A1;ESD;ELOVL1;VAPB;PLPP3;GSTT1;ELOVL4;MOCS1;DMD;STARD10;SGPP1;ST3GAL2;PPM1L;ASS1;LCMT2;SPTSSA;ACER3
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.2866891534224688,-1.3937051676759311,0.0,0.36195274430108226,1.0,108/509,13.96%,HIP1;VWF;KITLG;TEK;LIMS1;ROR1;ACTN4;NTRK3;CAV1;GCNT2;RAPGEF2;DAB2IP;GAB1;DCN;RHOA;ADRA1B;TRAF5;BCAR3;TNFSF10;ENG;TGFB2;INSR;THBS1;GAS6;CDH13;RPS15;F3;PIK3R1;IQGAP1;BCL2L1;EGFR;JCAD;RPS20;PTPRJ;KDR;FN1;APP;ALPK1;MIER1;MFHAS1;REL;NOS1AP;ESR1;TBX1;NOD1;MID2;PLCG2;FLNA;DHX33;TFRC;BRD4;TNFAIP8L3;CARD16;ITGB1;NR3C2;PRKD1;FLT1;MET;RACK1;S100A13;SLC44A2;TRIM14;LYN;WNT5A;PLK2;TRIM25;PUM2;MYOC;TGM2;BCAP31;SCHIP1;IFI35;IAPP;NFAT5;RPS3;SPRY2;PIK3CA;PDGFC;FLT4;SRC;IGF2;FGF2;GOLPH3;CAV2;MALT1;PIK3CD;RPTOR;FGF7;RPL23;TERF2IP;PTP4A3;PDCD4;PDGFD;PHB2;CD74;UNC5B;RET;EDA2R;BMP2;ECM1;TNFRSF19;RRAGA;TCIM;AKT2;CD86;BIRC3;PTPRC;VEGFA
prerank,carboxylic acid transmembrane transport (GO:1905039),0.432098323537699,1.393549644911622,0.08994708994708994,0.7790767665095399,1.0,10/40,9.48%,SLC13A3;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC38A1;SLC7A13;SLC25A11;SLC19A1;SLC38A9
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5219648735390221,-1.3930741702693168,0.09127789046653144,0.3625707316607697,1.0,7/16,11.50%,NRP1;PTPRJ;PIK3C2A;PDGFC;PTPN1;BCAR1;PDGFD
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5519999063427736,1.3930362055022076,0.10905349794238683,0.7765741145372121,1.0,3/13,3.46%,BMP6;DAB2;BMPR1A
prerank,actin filament organization (GO:0007015),-0.3233533578006723,-1.3928973633326165,0.0113314447592068,0.36217384764734983,1.0,37/151,14.63%,HIP1;MYO1D;ABI1;RHOBTB1;MYO1B;SHROOM4;RHOA;SVIL;GSN;CORO1C;PLS3;ACTN1;FLNA;ARHGEF2;EPS8;TPM4;ALDOA;TPM2;EMP2;TMOD3;NEDD9;MYO19;MYO1F;CD2AP;TPM3;BCAR1;WHAMM;CAPG;CDC42EP2;HIP1R;TRPV4;GAS2L1;MARCKS;AVIL;SHROOM1;VILL;RND3
prerank,neural crest cell migration (GO:0001755),-0.42344543275881014,-1.3927710310827301,0.06818181818181818,0.3616572862580493,1.0,12/36,15.71%,NRP1;SEMA6A;SEMA3C;SEMA7A;CORO1C;FN1;TBX1;SEMA5B;SEMA3E;SEMA3G;SEMA6D;SEMA5A
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5172439804911241,-1.39240308810436,0.09109311740890688,0.36164960447882466,1.0,4/16,12.14%,BMPR2;PRCP;DDAH1;ADM
prerank,alpha-amino acid catabolic process (GO:1901606),0.47118762593856683,1.3918518325686793,0.08743169398907104,0.7769769630497276,1.0,6/29,9.17%,DDO;IDO1;ACAT1;ACADSB;HAAO;KMO
prerank,regulation of stem cell proliferation (GO:0072091),0.5201909252589062,1.391486356475993,0.10700389105058365,0.7741468426078643,1.0,6/17,17.25%,FBLN1;HNRNPU;EIF2AK2;TERT;AGO3;KDM1A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5477555837946906,-1.390988600389757,0.09730848861283643,0.36397723937023874,1.0,6/13,28.76%,KDR;EDN1;NOD2;IL33;TLR4;NAMPT
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3066071795258785,-1.3907625250130873,0.005952380952380952,0.363726044125286,1.0,63/245,15.01%,NRP1;TEK;ROR1;NTRK3;GCNT2;RAPGEF2;PDE8A;DAB2IP;ADRA1B;SEMA7A;BCAR3;TGFB2;INSR;BMPER;NOTCH1;GAS6;RAP1A;IQGAP1;EGFR;JCAD;CD44;PTPRJ;KDR;APP;MID1;MFHAS1;TBX1;PLCG2;DHX33;TNFAIP8L3;PIK3R6;ICAM1;FLT1;CCL13;GAREM1;IAPP;SPRY2;PDGFC;FLT4;IL34;IGF2;FGF2;CAV2;EDN1;ACKR3;APOE;PDGFD;PHB2;CD74;RET;BMP2;PTK2B;EDN3;HTR2A;FBXW7;PTPRC;P2RY6;CD24;VEGFA;MTURN;CD40;MT3;FERMT2
prerank,regulation of activated T cell proliferation (GO:0046006),0.4703501450086014,1.3888758649968138,0.10246679316888045,0.7805644677301639,1.0,3/30,1.24%,IGF1;IL18;IDO1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41618780122654664,-1.3881835256169994,0.0668103448275862,0.3686487175921489,1.0,10/37,8.69%,CAV1;BCL2L1;UBB;RACK1;NCK1;RPS7;NACC2;BCAP31;RPS3;SOD1
prerank,lipid droplet formation (GO:0140042),0.6111462391504124,1.3877253535937992,0.11727078891257996,0.781069477708377,1.0,4/10,14.61%,FITM2;PLA2G4C;CDS1;SQLE
prerank,response to X-ray (GO:0010165),-0.5428448545425675,-1.3877049038178848,0.09126984126984126,0.36884706304863807,1.0,10/14,33.42%,NIPBL;XRCC5;ANXA1;BLM;LIG4;NUCKS1;IKBIP;XRCC4;BRCC3;XRRA1
prerank,positive regulation of DNA replication (GO:0045740),-0.5087105563857874,-1.3872261857486043,0.09090909090909091,0.3691534979785221,1.0,7/16,25.15%,BCAR3;KAT7;EGFR;BRPF3;FAF1;EGF;CTC1
prerank,mitochondrion disassembly (GO:0061726),-0.4285128914786989,-1.3866678621896098,0.06858407079646017,0.3695754768868914,1.0,12/34,20.04%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;GABARAP;ATG12;ATG5;WDR45B;ULK2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5070355668424411,-1.3866434589147905,0.10953346855983773,0.36884306557601537,1.0,6/16,13.12%,NOS3;NDNF;GUCY1B1;APOE;DDAH1;GUCY1A1
prerank,T-helper cell differentiation (GO:0042093),-0.5381997012840438,-1.3864412979137744,0.07855626326963906,0.3685034792526136,1.0,2/14,0.18%,LEF1;FOXP1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.49344551896502953,-1.386055525640497,0.09635974304068523,0.3686082009650482,1.0,9/19,32.20%,SLCO1C1;APP;KLF4;KLF2;EGF;WFS1;HPN;TMEM106A;MAPK8
prerank,protein homotetramerization (GO:0051289),0.41138804030297293,1.3854888919804338,0.07179487179487179,0.7861902304300031,1.0,4/49,1.13%,ALDH1A2;UPB1;APPL2;TRPV1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5483063241406123,-1.3854759069418385,0.10444874274661509,0.36915168802734705,1.0,7/13,20.47%,DCN;CSPG4;VCAN;HEXA;BGN;NCAN;BCAN
prerank,cardiac conduction system development (GO:0003161),0.4880056286874578,1.3852847801292596,0.09615384615384616,0.7827215615165883,1.0,4/24,3.46%,NOTCH2;GJB6;MSX2;BMPR1A
prerank,histone H2A acetylation (GO:0043968),0.5419900622296668,1.3851555685401127,0.09867172675521822,0.7789249656571164,1.0,7/16,13.40%,BRD8;RUVBL2;MEAF6;DMAP1;EP400;SPHK2;YEATS4
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.48895932624141497,1.3851131011399385,0.12573673870333987,0.7748058781048371,1.0,2/22,2.44%,ALDH1A2;RBP1
prerank,calcium ion transmembrane transport (GO:0070588),0.38301687988349853,1.3849438856619654,0.051457975986277875,0.7712138880406715,1.0,10/86,5.41%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;TRPV1;CACNB3;AFG3L2;GRIN2D;NALCN
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5902129787236017,-1.3844204797041466,0.08118811881188119,0.3700922032698234,1.0,4/10,11.01%,CDC42EP3;CDC42EP5;APC;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5902129787236017,-1.3844204797041466,0.08118811881188119,0.3700922032698234,1.0,4/10,11.01%,CDC42EP3;CDC42EP5;APC;CDC42EP2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3589647238378499,-1.3843252274436508,0.04481132075471698,0.369483152929986,1.0,32/76,23.91%,MAML2;IL6ST;JAG1;NOS3;NOTCH3;TGFB2;NOTCH1;EGFR;STAT3;CCN3;JAG2;EPN2;GATA2;SRC;NOTCH4;MFNG;SREBF2;TCIM;FBXW7;CD46;LFNG;HEY1;NOD2;PRAG1;YJEFN3;METTL3;DLL4;MAML3;DLL1;SNW1;ZMIZ1;EGF
prerank,positive regulation of heart contraction (GO:0045823),0.5155046352025877,1.384196720817536,0.09423076923076923,0.7700359502848626,1.0,1/19,0.03%,ATP1A2
prerank,regulation of neuron projection development (GO:0010975),-0.32572282367459554,-1.3839727280422294,0.013623978201634877,0.3694030126057666,1.0,40/163,14.68%,ROR1;NTRK3;SHANK3;PDLIM5;RAPGEF2;DAB2IP;PTN;ITGA6;MARK1;NDNF;MBOAT1;RAP1A;CHN1;DISC1;KANK1;SCARF1;SCARB2;PRKD1;PAK2;LYN;WNT5A;NPTN;ARHGAP35;NCS1;MDK;RETREG3;CDK5;ABI3;CFL1;APOE;BAG5;MFSD2A;RET;PTK2B;TRPV4;AVIL;CDH2;FZD1;PAQR3;MT3
prerank,regulation of centriole replication (GO:0046599),-0.515910088337173,-1.3839699717819571,0.10950413223140495,0.3686326980161338,1.0,7/17,23.49%,TRIM37;PLK2;CEP76;STIL;CEP295;CDK5RAP2;NUP62
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4680174531984434,-1.383936622805305,0.08384458077709611,0.3679348053785916,1.0,7/21,13.96%,MEF2C;ACVR1;CXADR;MYH11;MYOCD;BMP2;VEGFA
prerank,tryptophan metabolic process (GO:0006568),0.5769176954337024,1.3836601385873821,0.127134724857685,0.7680947669283467,1.0,5/11,18.83%,IDO1;HAAO;KMO;ATP7A;KYAT1
prerank,positive regulation of T cell activation (GO:0050870),-0.37770468082981057,-1.3817729517123294,0.052873563218390804,0.37202123296729966,1.0,16/62,19.60%,IL6ST;VCAM1;TFRC;SLC7A1;NCK1;ANXA1;ZBTB1;MDK;IL15;DOCK8;CD86;PTPRC;CD46;NCKAP1L;NOD2;JAK3
prerank,regulation of leukocyte activation (GO:0002694),-0.5330744190202014,-1.3801907185374207,0.09574468085106383,0.37463604099234454,1.0,6/14,17.23%,CD200;PLSCR1;MFHAS1;LYN;CD74;GPER1
prerank,positive regulation of axon extension (GO:0045773),-0.46886829039649053,-1.3796270021440213,0.09544468546637744,0.37503238190962374,1.0,8/22,15.71%,NRP1;NTN1;SEMA7A;MACF1;SHTN1;VEGFA;LIMK1;SEMA5A
prerank,tight junction assembly (GO:0120192),-0.38816126993958283,-1.3794660201210023,0.04956896551724138,0.37462769412642644,1.0,13/49,7.38%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;ACTG1;LSR;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,negative regulation of cell cycle (GO:0045786),0.39462280380495035,1.3790698052635013,0.06701030927835051,0.7832937967913238,1.0,15/73,8.00%,BMP7;NUPR1;SMAD3;CDKN2A;GMNC;ANGEL2;PLK1;TSPYL2;NLRP2B;NR2F2;CEBPA;TRIM35;HTRA2;INHA;MAD2L1
prerank,carbohydrate derivative transport (GO:1901264),-0.4884188441127416,-1.3788788435921377,0.10429447852760736,0.37507241848974193,1.0,6/18,11.89%,SCARB1;SLC10A7;PLTP;NPC2;VLDLR;MFSD2A
prerank,Golgi to endosome transport (GO:0006895),-0.5051378398909494,-1.3788098717047743,0.10887096774193548,0.37444076765301354,1.0,8/16,13.77%,RAB14;VPS13C;WIPI1;SORT1;VPS13A;AP1AR;SYS1;AP2A1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.33467298615248436,-1.3781321199375045,0.028368794326241134,0.3751252307836156,1.0,27/112,7.25%,PDE3A;LIMS1;MEF2C;GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;ENG;TGFB2;ID1;SMURF1;TGFBR2;UBC;PTPRK;F11R;JUN;ITGB1;SMAD1;RPS27A;UBB;SMAD5;PDE2A;WNT5A;PXN;ITGB5
prerank,response to alcohol (GO:0097305),0.47221853674558045,1.3781125325388732,0.10114503816793893,0.783033715413692,1.0,8/27,11.26%,TGFBR3;ADH7;GRIN3A;GLRA1;DRD3;CHRNB2;TGFBR1;ABCA2
prerank,glucose homeostasis (GO:0042593),0.3754177845560179,1.377947714964234,0.033783783783783786,0.7794315187930156,1.0,23/83,16.88%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;HKDC1;CEBPA;PDK2;PPARGC1A;USF1;PYGL;HECTD4;TCF7L2;IL6;SIRT1;HK1;BACE2;RBP4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5348126876133303,1.3770366838911907,0.13157894736842105,0.7788686424593638,1.0,5/16,7.73%,LEPROT;CHMP6;STAM;VTA1;SNF8
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5261274226811081,-1.3766033773744881,0.1193058568329718,0.3778266315359368,1.0,7/14,13.98%,CAV1;ZEB1;SPRED2;XDH;SPRY2;NOTCH4;SPRY1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.582393171946752,-1.3762662465839135,0.12371134020618557,0.3777858704589952,1.0,3/10,2.84%,RAPGEF2;RAP1A;NGF
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5279795185119539,1.3762235404820484,0.10663983903420524,0.7780366150751596,1.0,2/17,4.23%,ATP1A2;ATP1B2
prerank,regulation of cell killing (GO:0031341),-0.49918872282071863,-1.3760612940537404,0.12366737739872068,0.3774534639157074,1.0,6/16,11.64%,TGFB2;CR1L;ICAM1;WNT5A;CD55;CFH
prerank,regulation of T cell proliferation (GO:0042129),-0.36657264378959264,-1.3757324573200302,0.052873563218390804,0.3774526419803837,1.0,16/61,20.60%,IL6ST;VCAM1;TNFRSF1B;TFRC;SLC7A1;NCK1;ANXA1;TNFRSF21;IL15;CD86;PTPRC;CD46;NCKAP1L;JAK3;TNFSF8;GLMN
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4632977568594736,-1.374956716921586,0.1127348643006263,0.3783781524297139,1.0,9/22,12.98%,UBC;XPC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.43098028358262946,-1.3747795778138008,0.0668103448275862,0.3779947887593455,1.0,16/33,29.28%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;FBXW7;PLAUR;CBL;GPER1;PDE6H;NUP62;EGF;SHKBP1;AGT;BTC;NEU3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5547684790658572,1.3745880632080145,0.13663366336633664,0.7805626111529582,1.0,3/13,5.68%,CHST4;RENBP;LARGE1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5157688250137882,-1.3741465126259598,0.11741682974559686,0.37854586532283235,1.0,9/15,31.73%,BMP4;SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,actin filament depolymerization (GO:0030042),-0.5685064581844099,-1.3726036663192456,0.11594202898550725,0.3809901356460128,1.0,4/11,10.40%,MICAL2;GSN;WDR1;CFL1
prerank,negative regulation of hydrolase activity (GO:0051346),0.40950021440735923,1.3725590508836591,0.07829181494661921,0.7849149238583008,1.0,9/49,7.82%,CPEB2;MAP2;GCHFR;SH3RF2;SH2D4A;GMIP;ARL2;LRRK2;GPSM1
prerank,mesoderm development (GO:0007498),-0.5012184747526292,-1.3722263943100586,0.09574468085106383,0.38106188529986224,1.0,8/18,20.15%,TIE1;TBX3;TBX1;BMX;VEGFA;BTK;HCK;MEST
prerank,positive regulation of cellular process (GO:0048522),-0.27950919859255374,-1.3721257950114576,0.0,0.38046557536018,1.0,169/565,23.38%,LEF1;SLC6A6;KITLG;FRMD5;ACTN4;NTRK3;CAV1;GCNT2;BMP5;CLDN5;IL6ST;ZFHX3;PTN;TJP1;OSMR;PARD3;LIFR;LRP6;ACER2;ETS1;TGFB2;INSR;TRPC3;THBS1;MERTK;VEGFC;NOTCH1;TBX3;LRP5;GAS6;TBC1D8;EGFR;BMP4;H3-3A;PTPRJ;KDR;FN1;TGFBR2;TNFRSF1B;RPS6KA3;TBX1;CACUL1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;FLT1;ADAM10;HES1;S100A13;AXIN2;LYN;WNT5A;IL6R;PRKCD;AR;APC;PPP3CA;TGM2;CXCL12;TIPIN;DOCK2;MDK;GAREM1;EMP2;CDC123;PDGFC;GATA2;SMC5;FLT4;TIAM1;IL15;IL34;IGF2;VHL;ACACB;TSPAN31;FGF2;TAL1;TGFB3;CDKN2AIP;EDN1;RPTOR;S1PR3;ESM1;FASN;FGF7;RPL23;SERTAD1;ADGRG1;GRK5;FBXO5;PABIR1;PDGFD;KRAS;MFSD2A;RPS9;RAB27A;PTK2B;NACC1;EDN3;AGPAT1;AKT2;USP47;TBX2;CD86;CSNK2A1;COPS9;VEGFA;ROMO1;MT3;NCBP1;IRS1;DDX49;PTGFR;CSF1R;PA2G4;RPS15A;UBE2A;FMR1;KLHL22;TBRG4;FXR1;LRP1;HDAC2;GPER1;TCIRG1;FGFR3;PRODH;CCND1;PTPN6;GRIN1;KIF20B;PTEN;CRLF1;ZC3H12A;GREM1;PRC1;DYNC1H1;HCK;ACER3;PSMD10;CCPG1;PTHLH;NSMCE4A;NOXO1;CHEK1;CCND2;POU3F3;IGF1R;RIPK2;FAF1;CDC42;POFUT2;RPRD1B;HAS2;CEP131;DLL1;CTF1;MYRF;RPS19;CDKN1B;HCLS1;SOX11;PRMT1;CDCA7L;FCGR2B;EXOSC4
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6093731444059821,1.3720714346419713,0.1326923076923077,0.7828720384820326,1.0,5/10,20.62%,HSPA1A;DNAJB8;HSPA1B;DNAJB2;DNAJB1
prerank,limb development (GO:0060173),0.47603843450446537,1.3720135997003247,0.10980392156862745,0.7790247976719817,1.0,7/28,10.59%,SMOC1;RSPO2;INTU;LRP4;IQCE;MEGF8;IFT122
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5760217936308452,-1.3716008768315082,0.13438735177865613,0.38013711489320334,1.0,5/10,22.97%,AP2B1;VLDLR;AP2A1;AP2M1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5760217936308452,-1.3716008768315082,0.13438735177865613,0.38013711489320334,1.0,5/10,22.97%,AP2B1;VLDLR;AP2A1;AP2M1;MYLIP
prerank,neutrophil mediated immunity (GO:0002446),-0.28332883607346276,-1.3714419085777463,0.0,0.3797556228488047,1.0,113/432,18.82%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;RAP1A;APAF1;KMT2E;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;STOM;RAB6A;RAB31;TMEM30A;ATP11B;CAB39;PLEKHO2;CPNE3;ADGRE5;UBR4;CST3;NPC2;ADAM10;EEF2;XRCC5;SLC44A2;PPIA;VAT1;SLC2A3;PRKCD;PRCP;PSMB7;SPTAN1;MAPK1;OSTF1;ALDOA;DOCK2;CD55;CMTM6;CEACAM1;CNN2;CTSD;ORMDL3;CAP1;PYGB;ATP6V0A1;CAT;AGA;PFKL;CAND1;S100A11;ATP6AP2;FTL;GAA;PRDX6;PSAP;CTSB;HRNR;PGM2;CRACR2A;ENPP4;STK10;NRAS;RAB3A;RAB27A;CYSTM1;SCAMP1;ARSA;ATP6V1D;DYNLL1;LRG1;IST1;DERA;NME2;PTPRC;CYB5R3;PGAM1;CCT2;TMBIM1;SURF4;RAB5C;SRP14;PLAUR;PA2G4;NCKAP1L;PPIE;RAP2B;SNAP23;CDA;PSMD11;PDAP1;SYNGR1;CREG1;IMPDH1;PDXK;TCIRG1;CTSS;PTPN6;TMEM179B;NFASC;DSP;PSMD14;RAB3D;CD53
prerank,positive regulation of B cell proliferation (GO:0030890),-0.43857323207732274,-1.3713521271278715,0.09544468546637744,0.3791846035610446,1.0,9/29,15.74%,MEF2C;TFRC;CD38;EPHB2;NFATC2;CD74;PTPRC;CD40;NCKAP1L
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.49110135910896635,1.3706120344613852,0.10597302504816955,0.7804935541368961,1.0,7/23,10.26%,BMP7;UACA;CPNE1;C1QTNF3;NLRC3;NLRP3;ADGRG3
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2873375569470441,-1.370268988733219,0.0,0.38083035672956467,1.0,121/423,20.70%,LEF1;FOXP1;PRKCH;KITLG;MEF2C;NTRK3;GCNT2;BMP5;CLDN5;IL6ST;PID1;PTN;TJP1;OSMR;LIFR;ACER2;TGFB2;INSR;THBS1;VEGFC;NOTCH1;TBX3;LRP5;GAS6;CDH13;TBC1D8;EGFR;BMP4;KDR;FN1;TGFBR2;TBX1;CACUL1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;FLT1;ADAM10;HES1;S100A13;LYN;WNT5A;IL6R;AR;CCN1;TIPIN;MDK;GAREM1;EMP2;CDC123;PDGFC;FLT4;TIAM1;IL15;IL34;IGF2;TMEM119;ZFPM2;TSPAN31;FGF2;TGFB3;S100A6;EDN1;S1PR3;ESM1;FGF7;RPL23;SERTAD1;GRK5;FBXO5;PDGFD;KRAS;CD74;RPS9;BMP2;CCN4;PTK2B;NACC1;EDN3;AKT2;TBX2;CD86;CSNK2A1;NME2;PTPRC;COPS9;VEGFA;SAAL1;ROMO1;IRS1;PTGFR;CSF1R;ID2;RPS15A;UBE2A;TBRG4;HDAC2;GPER1;TCIRG1;FGFR3;NOD2;PTPN6;KIF20B;PTEN;CRLF1;GREM1;LIG4;SOX8;PRC1;HCK;ACER3;CCPG1;CDK6;DISP3;PTHLH;DLL4;CCND2;POU3F3;IGF1R
prerank,mucosal immune response (GO:0002385),-0.5174992317001078,-1.3698472944762776,0.11133200795228629,0.3810384331226846,1.0,3/15,7.40%,DEFA6;RPL39;OTUD7B
prerank,neutrophil degranulation (GO:0043312),-0.2826893051760556,-1.3691478678128044,0.0,0.38181795893106446,1.0,112/425,18.82%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;RAP1A;APAF1;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;STOM;RAB6A;RAB31;TMEM30A;ATP11B;CAB39;PLEKHO2;CPNE3;ADGRE5;UBR4;CST3;NPC2;ADAM10;EEF2;XRCC5;SLC44A2;PPIA;VAT1;SLC2A3;PRKCD;PRCP;PSMB7;SPTAN1;MAPK1;OSTF1;ALDOA;DOCK2;CD55;CMTM6;CEACAM1;CNN2;CTSD;ORMDL3;CAP1;PYGB;ATP6V0A1;CAT;AGA;PFKL;CAND1;S100A11;ATP6AP2;FTL;GAA;PRDX6;PSAP;CTSB;HRNR;PGM2;CRACR2A;ENPP4;STK10;NRAS;RAB3A;RAB27A;CYSTM1;SCAMP1;ARSA;ATP6V1D;DYNLL1;LRG1;IST1;DERA;NME2;PTPRC;CYB5R3;PGAM1;CCT2;TMBIM1;SURF4;RAB5C;SRP14;PLAUR;PA2G4;NCKAP1L;PPIE;RAP2B;SNAP23;CDA;PSMD11;PDAP1;SYNGR1;CREG1;IMPDH1;PDXK;TCIRG1;CTSS;PTPN6;TMEM179B;NFASC;DSP;PSMD14;RAB3D;CD53
prerank,cellular response to oxygen levels (GO:0071453),0.6030953619881647,1.3688237166144248,0.11730769230769231,0.7837659875472395,1.0,4/10,7.40%,ATP6V0A2;CCDC115;TMEM199;CPEB4
prerank,bone morphogenesis (GO:0060349),-0.5185745698598848,-1.368777093857392,0.11984282907662082,0.38188928269865663,1.0,4/14,3.61%,BMPR2;LRP6;LRP5;SFRP4
prerank,adenine nucleotide transport (GO:0051503),-0.49342986290389657,-1.368389249075747,0.11666666666666667,0.3819577990653237,1.0,4/17,7.04%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,neutrophil chemotaxis (GO:0030593),-0.3798263091746335,-1.368233247696909,0.06263498920086392,0.38149493978247284,1.0,38/53,50.43%,BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CCL4;PF4;FCER1G;PPBP;CCL8;CCL19;CXCL5;CCL14;CXCL1;PDE4B;CCL7;CXCR2;S100A8;CCL1;CCL3;CCL11;LGALS3;CXCL13;CXCL2;CKLF;PIP5K1C;ITGB2;XCL1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.5538554704391638,-1.3680425336204227,0.11181434599156118,0.3811369189231039,1.0,3/12,1.99%,MBNL1;LRP6;TGFB2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.38804478348228116,-1.36785969741664,0.0670995670995671,0.3808154204945538,1.0,25/46,34.41%,PIEZO2;PIEZO1;F11R;FAS;CRADD;PDE2A;CASP8AP2;CNN2;CD40;BAK1;MAPK3;MYD88;CHEK1;BCL10;CASP1;TLR4;CASP8;FADD;PTGER4;HABP4;AQP1;MAPK8;TMEM150C;TLR3;MAP3K14
prerank,cellular response to superoxide (GO:0071451),-0.5826113011943136,-1.3675942412138382,0.09504132231404959,0.38065032738019833,1.0,3/10,14.68%,NOS3;SOD1;MT3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5738206851777659,-1.3666939072114617,0.13333333333333333,0.381931728981043,1.0,4/10,16.53%,ETFBKMT;HDAC6;MT3;AOC3
prerank,retinoid metabolic process (GO:0001523),0.3853191383586959,1.3666369465762513,0.06770833333333333,0.7887511396418497,1.0,7/71,2.52%,ALDH1A2;ALDH8A1;ADH7;ADH4;RBP1;ABCA4;CYP26B1
prerank,sensory perception of sound (GO:0007605),0.3804966626679425,1.3664348908329378,0.054187192118226604,0.7855942840775393,1.0,16/88,9.05%,EYA1;CACNA1D;DCDC2;USH1C;COL4A3;ALDH7A1;KIT;WHRN;GSDME;EML2;CCDC50;PCDH15;MYO3A;ADGRV1;CHRNB2;MYH14
prerank,in utero embryonic development (GO:0001701),-0.4501655542423271,-1.3662723904205938,0.08333333333333333,0.3820342398071978,1.0,12/25,19.92%,MBNL1;PKD1;FUT8;ADAM10;IGF2;TGFB3;BMP2;VEGFA;STIL;LIG4;SOX8;LMX1B
prerank,actin polymerization or depolymerization (GO:0008154),-0.38818090131940863,-1.3656637018057345,0.07918552036199095,0.3825940064853917,1.0,16/50,17.55%,ABI1;MICAL2;SVIL;GSN;WDR1;MSRB2;WASHC3;FAM107A;CFL1;CAPG;MICALL2;PSTPIP2;AVIL;VILL;PREX1;DIAPH3
prerank,primary alcohol metabolic process (GO:0034308),0.4664534869174901,1.3654954193463078,0.09961685823754789,0.7854833658933827,1.0,4/25,2.67%,IGF1;ADH7;ADH4;CYP11B1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4329262612978358,-1.365396160571234,0.07415254237288135,0.3824366417139024,1.0,10/29,12.98%,RPA1;UBC;XPC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,T cell activation involved in immune response (GO:0002286),-0.5445541666979821,-1.3653278219688503,0.1277056277056277,0.3818562409482338,1.0,3/12,11.77%,ICAM1;MDK;CD74
prerank,superoxide metabolic process (GO:0006801),-0.4270995984286987,-1.3646078212003752,0.08278867102396514,0.3826850557064966,1.0,9/29,20.49%,SH3PXD2A;NOS3;SH3PXD2B;SOD1;NCF2;MT3;NRROS;PREX1;NOXO1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5369011115570991,-1.3644230409167097,0.1120162932790224,0.382298929922968,1.0,5/14,16.28%,NIPBL;NNMT;SAP30BP;DYRK1A;APLNR
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.40274737907908087,-1.364213474696083,0.08624708624708624,0.3819955912452408,1.0,17/37,22.74%,PRKG1;MEF2C;JUN;ERN1;ADAMTS1;TAFA5;FGF2;TGFB3;PDCD4;P2RY6;HTR1B;LDLRAP1;GPER1;PTEN;DNMT1;MMP2;CDKN1B
prerank,linoleic acid metabolic process (GO:0043651),0.5220804420500829,1.3638205873459082,0.13051823416506717,0.7883724664354079,1.0,4/17,9.38%,ACSL1;PNPLA8;GSTM2;ABCD1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3562794824420649,1.3636237666905147,0.033707865168539325,0.7852570965778747,1.0,32/117,17.91%,ALDH1A2;IGF1;ALDH8A1;ADH7;CYP26B1;PPARA;ME2;PCCA;AASDH;PNPLA8;ACADSB;PANK2;GLYAT;PTGR1;ECHDC3;CPT1C;FA2H;AMACR;MTHFS;CROT;SLC27A4;VDAC1;LDHB;NAAA;PER2;GBA2;GGT5;GOT2;ACOT1;MSMO1;ACOT6;AASDHPPT
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4178051677845302,1.3634807218764777,0.09454545454545454,0.7818406844433562,1.0,8/46,8.17%,ATP1A2;CACNG7;NLGN2;SYT1;NLGN3;LRRK2;ATAD1;DRD3
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.42556786667029034,-1.363426743705176,0.08958333333333333,0.38301348472999563,1.0,10/32,16.41%,PLCE1;WASF2;PIK3R1;CORO1C;OCLN;PIK3CA;SRC;AVIL;ARPC2;RREB1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2813453051264233,-1.3632810566977673,0.0,0.38264369409411564,1.0,112/428,18.82%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;RAP1A;APAF1;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;STOM;RAB6A;RAB31;TMEM30A;ATP11B;CAB39;PLEKHO2;CPNE3;ADGRE5;UBR4;CST3;NPC2;ADAM10;EEF2;XRCC5;SLC44A2;PPIA;VAT1;SLC2A3;PRKCD;PRCP;PSMB7;SPTAN1;MAPK1;OSTF1;ALDOA;DOCK2;CD55;CMTM6;CEACAM1;CNN2;CTSD;ORMDL3;CAP1;PYGB;ATP6V0A1;CAT;AGA;PFKL;CAND1;S100A11;ATP6AP2;FTL;GAA;PRDX6;PSAP;CTSB;HRNR;PGM2;CRACR2A;ENPP4;STK10;NRAS;RAB3A;RAB27A;CYSTM1;SCAMP1;ARSA;ATP6V1D;DYNLL1;LRG1;IST1;DERA;NME2;PTPRC;CYB5R3;PGAM1;CCT2;TMBIM1;SURF4;RAB5C;SRP14;PLAUR;PA2G4;NCKAP1L;PPIE;RAP2B;SNAP23;CDA;PSMD11;PDAP1;SYNGR1;CREG1;IMPDH1;PDXK;TCIRG1;CTSS;PTPN6;TMEM179B;NFASC;DSP;PSMD14;RAB3D;CD53
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.44449052329106886,-1.3631639814017174,0.08247422680412371,0.3821529072153293,1.0,5/27,7.99%,RHOA;ETS1;CD44;MDK;NFAT5
prerank,nucleoside catabolic process (GO:0009164),0.5781775860161701,1.3628734229977946,0.11506276150627615,0.7804827415692098,1.0,4/11,11.18%,UPB1;DPYD;NT5C3A;UPP2
prerank,negative regulation of response to stimulus (GO:0048585),-0.37337396370205894,-1.3623697829581363,0.05909090909090909,0.3831132559173338,1.0,18/60,11.80%,SLIT2;ACVR1;CD34;VPS13C;AKT3;KLF7;CASK;AQP11;UBASH3B;HHIP;LYN;PTPN1;KLF4;SOCS5;FBXO5;TLE5;DDAH1;TWIST1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4148113169930915,-1.3620352979711736,0.07032967032967033,0.38316007765741755,1.0,11/36,15.39%,CAV1;NOS3;NOSTRIN;SCARB1;EGFR;NOS1AP;GCH1;APOE;DDAH1;CYGB;DHFR
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.4668127348332635,-1.3619962288107001,0.1038135593220339,0.38250072373646343,1.0,7/21,13.98%,DAB2IP;SLIT2;TGFB2;SPRY2;CD2AP;EPHB2;SPRY1
prerank,axonogenesis (GO:0007409),-0.29866285056845976,-1.361217274147578,0.008902077151335312,0.38347671909303294,1.0,50/237,13.02%,NRP1;SPTBN1;ACTB;SHANK3;SEMA6A;NRP2;LAMA2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;PARD3;SEMA7A;NOTCH3;RPS6KA5;NOTCH1;PIK3R1;PLCG1;APP;PALLD;LAMA3;KLF7;NTN4;WNT5A;NPTN;ROBO4;SPTAN1;MAPK1;ARHGAP35;CXCL12;PIK3CA;EFNA5;SEMA5B;SRC;CDK5;S100A6;PIK3CD;DSCAML1;EPHB2;SEMA3E;B4GALT5;VLDLR;UNC5B;RAB3A;RET;SEMA3G;RANBP9;SHTN1;EMB
prerank,artery development (GO:0060840),-0.45278803241326815,-1.361106064078537,0.11958762886597939,0.3829429724138139,1.0,8/23,7.77%,NRP1;BMPR2;ACVRL1;ENG;TBX1;HES1;PDE2A;STRA6
prerank,carboxylic acid catabolic process (GO:0046395),0.5679331899962891,1.3608101095333307,0.11650485436893204,0.7847960736125902,1.0,4/12,11.63%,RENBP;PON1;GNPDA1;NPL
prerank,ribosome assembly (GO:0042255),-0.3885296262735594,-1.3607577622048672,0.06976744186046512,0.38291714810537947,1.0,19/47,26.31%,RPS15;RPL5;RPL10;MRPL20;RPLP0;RPS5;RPS28;RPL6;RPL24;RPS27;RRP7A;MTERF3;PWP2;RPL3;RRS1;RPS19;RPL23A;PPAN;MDN1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.47433100605267076,-1.3602876068738234,0.1069182389937107,0.3832030622571896,1.0,11/20,13.98%,ACVRL1;ENG;TGFB2;NOTCH1;TBX3;BMP4;HEYL;HEY2;PDCD4;BMP2;SPRY1
prerank,regulation of developmental growth (GO:0048638),-0.4378540569450983,-1.360244614164456,0.091324200913242,0.38256921925100407,1.0,12/29,17.46%,GHR;INSR;SIX1;APP;NIPBL;SPAAR;SOD1;APOE;MFSD2A;SIX4;FGFR3;LATS1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5115622288461761,1.360115484566677,0.12280701754385964,0.7835054316378284,1.0,2/18,4.06%,PRKAG2;CLIP3
prerank,positive regulation of tissue remodeling (GO:0034105),0.6027825335087993,1.3598652273850431,0.15169660678642716,0.7806904251729753,1.0,2/10,0.87%,ROCK2;IL18
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5463957683614074,-1.3593984881644423,0.11900191938579655,0.3836103752343886,1.0,4/12,9.84%,RHOA;APP;CXCL12;DOCK8
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4905404739934751,-1.3593357083734234,0.0995850622406639,0.38301420111762363,1.0,3/20,1.44%,PDE4D;RAPGEF2;ADRA1B
prerank,protein phosphorylation (GO:0006468),-0.276881964331719,-1.3591326785525373,0.0,0.3827247685788234,1.0,145/478,21.77%,PRKG1;PRKCH;TEK;ABI1;ERG;SNRK;DAB2IP;BMPR2;MARK1;NEK7;HIPK1;ACVR1;CDK17;ACVRL1;TGFB2;MAP3K5;INSR;RPS6KA5;MERTK;STK38L;GAS6;PKD1;STK3;EGFR;PEAK1;LIMK2;BCR;EEF2K;BMP4;KDR;AKT3;TGFBR2;APP;CRY1;IRAK3;CDK14;RPS6KA3;FNIP2;BMX;TNIK;CAB39;CSNK1E;MAP3K20;NUAK1;PRKD1;CSNK1G1;PAK2;CIT;ERN1;FLT1;TNKS;ADAM10;CAMK2D;LYN;MAST4;CDC42BPA;TEC;PRKCD;CDKL2;DCLK1;PLK2;CSNK1G3;MAPK1;CSNK1A1;PRKX;RPS6KA2;PRKCG;STK24;FLT4;SRC;CDK5;STK33;ABI3;MAPKAPK2;GTF2H5;EIF2AK3;BCKDK;NEK3;PIK3CD;YWHAZ;MAP4K4;EPHB2;GRK5;JAK1;VRK3;STK10;GTF2H1;DYRK1A;PRKG2;RET;MORC3;BMP2;PTK2B;INCENP;STK16;STK32A;STK38;AKT2;CSNK2A1;ALK;LIMK1;PKN3;ACVR1C;PIK3R4;CSF1R;MKNK2;PRKACA;CAD;TAOK3;FGFR3;COQ8A;STRADA;LATS1;MASTL;MAST2;MAPK12;STK26;PTPN6;PRAG1;EFEMP1;HUNK;MAPK3;MARK3;CDK16;BTK;JAK3;HCK;STK17B;CAMK1G;RIPK1;TRIB2;CDK6;ULK2;DYRK2;CHEK1;SYK;IGF1R;CDKL4;MAP3K6;ROCK1;TOP1;TAOK1;CSNK1D;SLK;FYN
prerank,mononuclear cell differentiation (GO:1903131),-0.45198311101164856,-1.3590995293859218,0.08921161825726141,0.38210621566260494,1.0,8/24,15.53%,GAS6;MYH9;BMP4;LYN;RELB;MT1G;VEGFA;CSF1R
prerank,stabilization of membrane potential (GO:0030322),0.5260908436281136,1.3590099260641155,0.12022900763358779,0.7802911723554822,1.0,3/16,12.39%,KCNK2;KCNN4;KCNK4
prerank,regulation of histone methylation (GO:0031060),0.5563017105820932,1.3589395475172399,0.12781954887218044,0.7768215722076647,1.0,6/13,14.31%,CTR9;TET1;JARID2;NSD1;PIH1D1;MTHFR
prerank,regulation of T cell cytokine production (GO:0002724),-0.5055208444415442,-1.358577886510168,0.11992263056092843,0.382569543483136,1.0,4/15,10.19%,B2M;TNFRSF1B;CD55;MALT1
prerank,regulation of macroautophagy (GO:0016241),0.36012858062540776,1.358367861789705,0.051457975986277875,0.7753478428163365,1.0,30/105,18.64%,PRKAG2;SNX6;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;ATP6V0B;QSOX1;ATP6V1H;CASP3;IKBKG;LRRK2;GPSM1;SESN1;ATP6V1B2;SLC38A9;ATP6V1E1;PAFAH1B2;ATG13;LAMTOR2;ATP6V0E2;ATP6V1C1;TSC1;ATP6V0D2;LAMTOR3;SIRT1;RRAGB;CDK5R1;AKT1;TRIM13
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.41403799628225296,-1.358079750925363,0.09429824561403509,0.38283564446872304,1.0,10/36,11.32%,LEF1;FZD6;NFATC1;AGO1;GNB1;WNT5A;GNG2;PPP3CA;AGO2;FZD4
prerank,positive regulation of chromatin organization (GO:1905269),-0.5423112115836167,-1.3578601250844888,0.12190082644628099,0.38255587126121765,1.0,4/12,10.80%,H3-3A;MIER1;TAL1;TERF2IP
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5469026932523805,-1.3577082736489552,0.12138728323699421,0.3821441594143192,1.0,5/11,17.67%,WIPI1;APOE;PIK3C3;UGCG;WDR45B
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.41804330010521895,-1.3573106576345568,0.09205020920502092,0.3822957802130608,1.0,13/35,13.61%,NRP1;TEK;NTRK3;TJP1;ESAM;F11R;ARHGDIB;MDK;CDK5;ABI3;SEMA3E;PTK2B;ARHGDIA
prerank,regulation of myelination (GO:0031641),-0.44721662576888244,-1.3572042307866226,0.08786610878661087,0.3818506119324501,1.0,7/25,12.04%,PTN;PARD3;TNFRSF1B;LGI4;TNFRSF21;EIF2AK3;PTPRZ1
prerank,cellular metal ion homeostasis (GO:0006875),0.36383474729201026,1.3571590264446032,0.050761421319796954,0.7764948504953566,1.0,11/102,4.23%,ATP1A2;SLC8A3;SLC41A1;SLC24A3;ATP1B3;ATP13A5;ANK2;DMPK;CSRP3;ATP13A3;ATP1B2
prerank,dendrite self-avoidance (GO:0070593),-0.4986620647255281,-1.3563817776910256,0.1157684630738523,0.38284055500666153,1.0,6/16,13.02%,BSG;PALLD;NPTN;ROBO4;DSCAML1;EMB
prerank,regulation of exocytosis (GO:0017157),0.41648303766253264,1.3561138953199718,0.09363957597173145,0.7769177080560553,1.0,16/46,16.48%,IL1RAPL1;UNC13D;CHMP6;RAB21;SYT1;CLASP1;RAB3C;STXBP5L;NSF;CPLANE2;RAB2B;RAB13;CPLX1;CADPS2;STX4;CPLX2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5266488405092891,-1.3560767313415842,0.12475633528265107,0.3828038123675513,1.0,8/13,36.24%,RACK1;NCK1;PTPN1;ATF6B;WFS1;HSPA5;ABCA7;DDRGK1
prerank,granulocyte chemotaxis (GO:0071621),-0.3710297205023221,-1.355625150280268,0.06609808102345416,0.3831083498772225,1.0,13/55,21.79%,BSG;TGFB2;PPIA;ANXA1;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB
prerank,protein maturation (GO:0051604),0.37009578690001677,1.3549072602887766,0.05218855218855219,0.777932386787072,1.0,10/95,4.57%,AEBP1;NNAT;METAP2;ADAMTS13;PCSK4;TSPAN5;CPN1;FURIN;PITRM1;AFG3L2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.46842248752721893,-1.3548412120560733,0.1083844580777096,0.38407163375108677,1.0,11/22,26.26%,RASSF2;RAP2A;CALM3;PDGFC;PDGFD;VEGFA;NBN;TNKS1BP1;GREM1;TOM1L1;CALM1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5721232390726756,-1.3543933904691223,0.13114754098360656,0.3843961222512242,1.0,3/10,8.32%,LRCH1;CD200;APOD
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4972747537162482,-1.3542257783097633,0.1337448559670782,0.3840666538984181,1.0,7/16,20.70%,INSR;IRAK3;MTRF1;HDAC6;TBC1D25;CLEC16A;IGF1R
prerank,cellular component disassembly (GO:0022411),-0.3851295484038021,-1.3526058069975644,0.06444444444444444,0.3869424143475705,1.0,10/53,11.12%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;ADAM10;SH3PXD2B;CAPG;MMP11
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.29130216505512246,-1.3520622670898288,0.0,0.38736702149569713,1.0,62/259,15.53%,NRP1;ABCC4;FGD5;DNM3;RAPGEF2;ABLIM1;VCL;FXYD5;NTN1;FGD6;GSN;PARVB;NOTCH1;PKD1;RAP1A;CDH13;DISC1;SPATA13;EMP1;EXOC6;MTSS1;TNIK;EXOC4;FLNA;FAM161A;IFT140;ITGB1;S1PR1;RAP2A;ABLIM3;RAPGEF6;BBS9;ARL13B;EMP2;ATP6V0D1;PDE6D;CD2AP;RP2;GOLPH3;WHAMM;MAP4K4;WDR11;PARVA;EXOC1;EHD2;TCTN3;FNBP1L;EHD4;PIBF1;SNX10;HDAC6;SHTN1;ABLIM2;ATP6V1D;DYNLL1;AVIL;CYS1;DZIP1L;BBIP1;CFAP43;TMEM216;KIF24
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5512680307858939,-1.350858223737045,0.12323232323232323,0.3894466479611509,1.0,4/12,2.65%,PODXL;JAG1;PROM1;IQGAP1
prerank,positive regulation of histone methylation (GO:0031062),0.47821829150852624,1.3508131140203554,0.11487758945386065,0.7907283171574303,1.0,6/24,7.68%,CTR9;KMT2A;TET1;AUTS2;JARID2;PHF1
prerank,innate immune response in mucosa (GO:0002227),-0.5793068161269869,-1.3506309672928012,0.12871287128712872,0.3892055231032315,1.0,2/10,5.53%,DEFA6;RPL39
prerank,extracellular matrix disassembly (GO:0022617),-0.38427470743317177,-1.3504955098628333,0.06444444444444444,0.38873347353387605,1.0,10/53,11.12%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;ADAM10;SH3PXD2B;CAPG;MMP11
prerank,sphingolipid metabolic process (GO:0006665),-0.33036400457057713,-1.3497427523487084,0.03291139240506329,0.3897208871633867,1.0,37/108,21.25%,SGMS1;ST6GALNAC3;ESYT2;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ORMDL3;PLPP1;ESYT3;SAMD8;HEXA;ELOVL6;PSAP;UGCG;ARSA;ELOVL1;VAPB;PLPP3;ELOVL4;SGPP1;PPM1L;ASAH2;SPTSSA;ACER3;ARV1;PPP2CA;CERS4;GLTP
prerank,calcium ion transport (GO:0006816),0.3515033466436491,1.3496895332899332,0.05392156862745098,0.7913480085527832,1.0,11/113,3.90%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;CACNG7;TRPV1;ANK2;CACNB3;ITPR1;GRIN3A
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5778404426637306,-1.3492926128802243,0.12476007677543186,0.38998639184111855,1.0,4/10,9.26%,GHR;STAT3;LYN;PTPN1
prerank,aortic valve morphogenesis (GO:0003180),-0.4290887987211571,-1.3491027806584437,0.07709251101321586,0.3896699653542201,1.0,10/30,8.27%,ELN;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;HEYL;HEY2
prerank,cellular amide metabolic process (GO:0043603),0.36040310210739673,1.3490612034367653,0.056218057921635436,0.7903336555280264,1.0,29/102,18.49%,AEBP1;ALDH1L1;CPN1;ACSM2A;ACSM2B;PLAAT5;PM20D1;PCCA;SMPD3;PANK2;GLYAT;SLC19A1;ORMDL2;CLN8;SMPD2;ABCA2;MTHFS;PLA2G15;MTHFR;NAAA;MTHFD1;CERK;FPGS;ACOT1;PLAAT3;ACOT6;MTHFD2;AASDHPPT;ACOT13
prerank,positive regulation of binding (GO:0051099),-0.34687693636868755,-1.3489506594084884,0.05236907730673317,0.38929256153873554,1.0,31/84,22.06%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;NGF;BMP4;APP;STMN1;RALB;MET;HES1;SPPL3;TIAM1;HMBOX1;APOE;HIP1R;BMP2;NMD3;NCBP1;PLAUR;EPB41;LRP1;VTN;DPH3;MARK3;HMGB1;RIPK2;SKI;DTX3L
prerank,regulation of kinase activity (GO:0043549),-0.33774615386467877,-1.3481999928644361,0.052109181141439205,0.39033378151891296,1.0,20/89,12.15%,TEK;ROR1;NTRK3;PLCE1;TIE1;INSR;MERTK;EGFR;EEF1A1;KDR;FLT1;MET;NLRC5;EMP2;CDKN1C;SOD1;FLT4;EPHB2;CD74;RET
prerank,positive regulation of synapse assembly (GO:0051965),0.46012758907715234,1.3480170991159093,0.10956175298804781,0.7908086462593421,1.0,11/27,19.52%,IL1RAPL1;NLGN2;WNT7A;VSTM5;GRID2;NLGN3;PTPRD;BDNF;EPHB1;SYNDIG1;DLG5
prerank,potassium ion homeostasis (GO:0055075),0.4748770974054645,1.3479651633561869,0.1233644859813084,0.7873630643614652,1.0,6/23,11.60%,ATP1A2;ATP1B3;ATP1B2;KCNH2;SLC12A5;SLC12A1
prerank,ncRNA transcription (GO:0098781),-0.5375327364452903,-1.347734256173164,0.11475409836065574,0.39073381031041904,1.0,6/13,20.16%,SPIN1;USPL1;POLR1G;CAVIN1;GTF3A;SIRT7
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4020301101854028,-1.347530410429445,0.08050847457627118,0.3904801183362561,1.0,12/39,9.43%,MAML2;IL6ST;JAG1;NOS3;TGFB2;NOTCH1;STAT3;CCN3;JAG2;EPN2;SRC;NOTCH4
prerank,sphingolipid biosynthetic process (GO:0030148),-0.35576891926047327,-1.3470246003391513,0.0673076923076923,0.3908304578055245,1.0,26/71,19.83%,SGMS1;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;ST6GALNAC5;CERS5;CERS6;PLPP1;SAMD8;ELOVL6;ELOVL1;VAPB;PLPP3;ELOVL4;SGPP1;PPM1L;ASAH2;SPTSSA;ACER3
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5552306305350703,1.3468895094912954,0.1328125,0.7878294853386063,1.0,2/12,0.41%,NOTCH2;DOCK11
prerank,lung development (GO:0030324),0.437918297913919,1.3464644233426812,0.0940959409594096,0.7859314406769045,1.0,7/33,6.87%,FGF1;ERRFI1;FGF9;LOXL3;PDPN;CEBPA;FGFR2
prerank,negative regulation of cell development (GO:0010721),0.4666670440824044,1.3456503778183042,0.11235955056179775,0.785624089924227,1.0,5/25,5.41%,IGF1;APPL2;RFLNA;WNT7A;PAX6
prerank,tryptophan catabolic process (GO:0006569),0.5701336055399097,1.3455947778050583,0.14864864864864866,0.7822400286582722,1.0,3/11,9.17%,IDO1;HAAO;KMO
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4667270792622544,-1.345353036495926,0.1134020618556701,0.393929674583057,1.0,9/21,18.84%,PDE4D;CAV1;RASSF2;RACK1;NCK1;PAQR3;DDIT4;DMD;PTEN
prerank,negative regulation of axon extension (GO:0030517),-0.4279189261504958,-1.3447341556925365,0.11060948081264109,0.3945843714816835,1.0,13/30,21.89%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;MT3;SEMA6D;SEMA5A;RTN4;SEMA3F;RTN4R;SEMA4C
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5259645479679644,-1.343282727027114,0.11064718162839249,0.39708625340568326,1.0,4/13,14.40%,TMEM30A;SEC16B;INSIG1;SAR1A
prerank,cGMP metabolic process (GO:0046068),-0.5357241096636502,-1.343124534975349,0.14031620553359683,0.3967326943446153,1.0,5/12,18.98%,GUCY1B1;PDE9A;PDE2A;GUCY1A1;NPPC
prerank,amyloid fibril formation (GO:1990000),-0.36898945258306803,-1.3420126061284927,0.04719101123595506,0.39834103645630276,1.0,12/51,8.15%,B2M;GSN;H3-3A;APP;UBC;CST3;RPS27A;UBB;ADAM10;IAPP;MFGE8;TGFBI
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5528827359387577,-1.3414210583876118,0.13995943204868155,0.3989650549088957,1.0,4/11,6.13%,CACNB2;CACNA2D1;NOS1AP;CAMK2D
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.48793626958096603,1.3406750309129207,0.1297709923664122,0.7981649204494454,1.0,2/23,1.35%,METAP2;NMT2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.53297314690182,-1.3397300839343629,0.14345114345114346,0.4005000695483638,1.0,8/12,33.30%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.53297314690182,-1.3397300839343629,0.14345114345114346,0.4005000695483638,1.0,8/12,33.30%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.53297314690182,-1.3397300839343629,0.14345114345114346,0.4005000695483638,1.0,8/12,33.30%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,oogenesis (GO:0048477),-0.5018401009948866,-1.3381704189858425,0.12355212355212356,0.4031509917344485,1.0,12/15,46.64%,PTN;MDK;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;IHO1;MARF1;NANOS2;FMN2;HORMAD1
prerank,positive regulation of synaptic transmission (GO:0050806),0.37610923976050337,1.3379090923094743,0.07719298245614035,0.8058362802832155,1.0,16/72,12.47%,SLC8A3;CACNG7;PRKCZ;NLGN2;ZDHHC12;ADCY1;GRIN2D;SYT1;ADCY8;NLGN3;GRIK2;SHISA7;RIMS1;DLG4;DTNBP1;ZDHHC3
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.39751702644756937,-1.3378334311923523,0.08423326133909287,0.403205434390365,1.0,10/41,9.94%,MEF2C;JAG1;ENG;TGFB2;NOTCH1;BMP4;TGFBR2;HEYL;HEY2;CPE
prerank,acidic amino acid transport (GO:0015800),0.49823627592243486,1.3376308997626398,0.137546468401487,0.8032945174826878,1.0,2/17,0.21%,SLC6A13;SLC6A1
prerank,negative regulation of chemotaxis (GO:0050922),-0.42163521395749193,-1.3374596553253792,0.10071942446043165,0.4034005462822964,1.0,13/31,15.71%,SEMA6A;SEMA3C;SLIT2;SEMA7A;THBS1;NOTCH1;ANGPT2;SEMA5B;DUSP3;SEMA3E;SEMA3G;SEMA6D;SEMA5A
prerank,heart contraction (GO:0060047),0.4196317986191599,1.3374202186724815,0.1089866156787763,0.8005502561237816,1.0,7/41,11.28%,ATP1A2;CSRP3;SGCZ;TNNI1;KCNH2;SGCG;RYR2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.34397827195401254,-1.3372851988709582,0.05,0.40304367534795466,1.0,22/80,16.38%,NRP1;PLCE1;WASF2;PIK3R1;CDC42EP3;CDC42EP5;ARAP1;EPS8;OCLN;ARHGAP35;APC;PIK3CA;EPS8L2;TGFB3;CDC42EP2;FNBP1L;PFN1;AVIL;AGRN;CCP110;ARPC2;FMR1
prerank,negative regulation of response to wounding (GO:1903035),-0.4713449476356495,-1.3366651882631215,0.11623246492985972,0.40373077351587094,1.0,9/19,21.33%,CD109;CASK;AJAP1;MDK;SERPINE1;FGF2;GIT1;RTN4RL1;RTN4R
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5166566436364164,-1.3362653538812048,0.12863070539419086,0.40391947838724496,1.0,5/13,14.18%,GAS6;WNT5A;CD74;AGPAT1;IFIH1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5173225349113635,1.335867580392968,0.142578125,0.8032075473769326,1.0,4/15,11.74%,CPEB2;PPIF;GSTO2;GSTO1
prerank,indolalkylamine catabolic process (GO:0046218),0.580319516913946,1.3357562393671496,0.14922480620155038,0.8000861963189272,1.0,3/10,9.17%,IDO1;HAAO;KMO
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.45329825208261126,-1.3355757886403885,0.1411042944785276,0.40480243001306293,1.0,11/22,35.32%,PSMB7;PSMA6;PSMB6;PSMB5;PSMB8;PSMB4;PSMB3;PSMB9;PSMA5;PSMA3;ENC1
prerank,regulation of viral entry into host cell (GO:0046596),-0.42163505828996684,-1.3352660001612424,0.09565217391304348,0.40478025959197167,1.0,8/30,11.96%,GSN;LY6E;MID2;IFITM3;TRIM14;TRIM25;CD74;NECTIN2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.31973718458820793,-1.3351800652349533,0.03674540682414698,0.4042559581644403,1.0,28/128,7.25%,GCNT2;BMP5;CLDN5;BMPR2;PARD3;RHOA;ACVR1;ACVRL1;ENG;TGFB2;RUNX2;ID1;BMP4;SMURF1;TGFBR2;UBC;PTPRK;F11R;RNF111;JUN;ITGB1;TMEM100;SMAD1;RPS27A;UBB;SMAD5;PXN;ITGB5
prerank,aorta morphogenesis (GO:0035909),-0.4770272681122303,-1.3351002701063117,0.124,0.40372686767223814,1.0,10/17,21.84%,JAG1;ACVRL1;ENG;TBX1;HEY2;TBX2;HEY1;LRP1;DLL4;MYLK
prerank,gluconeogenesis (GO:0006094),0.41617420630128454,1.3339088632363019,0.10681399631675875,0.8039426024063971,1.0,17/39,21.84%,ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.4379806231864718,-1.3332741024719474,0.10891089108910891,0.407051129706435,1.0,7/24,15.35%,PLCE1;WASF2;PIK3R1;OCLN;PIK3CA;AVIL;ARPC2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.32677198454913425,-1.332722497755329,0.03864734299516908,0.4075225682619174,1.0,29/114,20.92%,LIMS1;ACTN4;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;AIM2;TNFRSF11B;PSMB7;PSMA6;PSMB6;PSMB5;EDA2R;PTK2B;BIRC3;CD40;PSMC4;PSMB8;PSMD11;PSMB4;EDAR;PSMD14;PSMD10;RIPK1;TNFSF8;PSME1
prerank,negative regulation of complement activation (GO:0045916),-0.5588512091283592,-1.33267150303834,0.13836477987421383,0.40694880992260557,1.0,4/10,15.64%,CR1L;CD55;SUSD4;CD46
prerank,regulation of cartilage development (GO:0061035),-0.4850832168586656,-1.332463377917136,0.13347022587268995,0.4066489960696808,1.0,6/18,12.31%,ZBTB16;BMPR2;TRPS1;BMP4;MDK;BMP2
prerank,organic cation transport (GO:0015695),-0.4739173478074855,-1.3317019752836567,0.11198428290766209,0.40764849474043047,1.0,5/20,12.41%,SLC47A1;SEC14L1;SLC44A2;SLC22A18;SLC44A1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.38745298676263057,-1.3313415284693075,0.08842105263157894,0.40774627460617013,1.0,22/48,29.27%,ACTB;ARID1B;MYBBP1A;ARID1A;SERTAD1;ATAD2;POLR1F;POLR1G;ZMIZ2;POLR1A;CDCA4;CHEK1;POLR1H;MYO1C;POLR2F;ZMIZ1;POLR1E;POLR2H;POLR1C;SMARCA5;DDX21;POLR2E
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4846829348501377,1.3306800152307272,0.14227642276422764,0.8132383699725791,1.0,5/21,11.74%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3396969878777528,-1.3305128458049194,0.0593607305936073,0.40882768649701795,1.0,24/91,10.06%,ABCG2;SLC39A10;SCARA5;SLC40A1;APP;SLC30A1;SLC39A8;TFRC;SLC30A9;SLC31A1;ATOX1;ATP6V0D1;SOD1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC39A7;CAND1;FTL
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5482741013103178,-1.3301495518165953,0.14147286821705427,0.40902763525572094,1.0,5/11,13.24%,SEMA6A;THBS1;CREB3L1;EPN2;KLF2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3872486426577092,-1.3300206799891852,0.091324200913242,0.40857897423877954,1.0,15/44,14.52%,DAB2IP;BMP4;PTPRJ;IRAK3;DNAJA1;LYN;PRKCD;SPRY2;PTPN1;APOE;AIDA;PDCD4;STK38;SPRY1;PAQR3
prerank,macrophage differentiation (GO:0030225),-0.5153313497369341,-1.3294502053446742,0.1527777777777778,0.4091042358268222,1.0,7/13,29.20%,BMP4;IL15;VEGFA;CSF1R;CDC42;CASP8;PARP1
prerank,presynapse organization (GO:0099172),0.5731426929386609,1.3293598131718698,0.1402805611222445,0.8150618449741753,1.0,3/10,6.98%,NLGN2;WNT7A;NLGN3
prerank,histone H2B ubiquitination (GO:0033523),0.5805604015672758,1.32913385281137,0.16535433070866143,0.8124122415485092,1.0,4/10,11.57%,CTR9;LEO1;RNF20;CDC73
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3771507687474153,-1.3290687443145557,0.07606263982102908,0.40927017738704324,1.0,26/47,32.89%,PID1;THBS1;TGFBR2;PLCG2;XDH;AGTR1;PRKCD;SOD1;RAB27A;ACE2;ROMO1;GRIN1;CBR1;ZC3H12A;DHRS4;RIPK1;SYK;TLR4;MAPT;GRB2;DCXR;AGT;TLR6;CD36;TYROBP;TP53
prerank,mismatch repair (GO:0006298),0.450804423323891,1.3290378425949378,0.1180952380952381,0.8093656383300102,1.0,10/27,14.92%,RNASEH2A;ERCC1;PMS2;POLD2;MSH4;MSH6;MLH3;MSH3;ABL1;RPA3
prerank,myofibril assembly (GO:0030239),0.4192853893190032,1.3286983392694234,0.09876543209876543,0.807281910122664,1.0,8/42,9.37%,PDGFRA;ACTN2;OBSL1;CAPN3;CSRP3;CSRP1;TMOD2;CFLAR
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.572025316976291,1.3278067929738573,0.1796875,0.8074076577838517,1.0,3/11,3.72%,LEPROT;ACTN2;PICALM
prerank,regulation of JUN kinase activity (GO:0043506),-0.4110510417595595,-1.3276983089650665,0.09375,0.4115423516541909,1.0,8/33,11.39%,DAB2IP;MAP3K5;DNAJA1;TNFRSF11A;RPS3;EDN1;AIDA;PDCD4
prerank,response to ketone (GO:1901654),-0.4469329047484588,-1.327499392328244,0.12445414847161572,0.4112716826246484,1.0,5/24,2.21%,CAV1;SLIT2;ABHD2;TGFB2;THBS1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.42635688426998086,1.3274502897110967,0.10873440285204991,0.8053633724570556,1.0,11/37,11.70%,TTC21B;WDR19;IFT74;WDR35;DYNC2LI1;KIF3C;DYNC2I2;IFT122;PCM1;KIF3A;IFT80
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4949191441603681,-1.3271397819480464,0.1524008350730689,0.41137271007641674,1.0,3/15,10.49%,SCARB1;PLTP;APOE
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4283347066302886,-1.3270086235973495,0.12688172043010754,0.41098274414534564,1.0,10/26,12.98%,UBC;RNF111;XPC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,regulation of B cell proliferation (GO:0030888),-0.3919146126421289,-1.3261880864183684,0.09456264775413711,0.4120227273259667,1.0,12/44,15.74%,MEF2C;TFRC;LYN;CD38;TNFRSF21;AHR;EPHB2;NFATC2;CD74;PTPRC;CD40;NCKAP1L
prerank,regulation of amyloid-beta formation (GO:1902003),0.4330048225796163,1.325811685005325,0.11970534069981584,0.8084154801129714,1.0,9/34,12.61%,IGF1;ROCK2;PICALM;RTN1;CASP3;NTRK2;ABCA2;CLU;EPHA4
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.338533061741818,-1.3255672275852972,0.05,0.41264525611654734,1.0,25/85,13.98%,ARHGEF28;PLCE1;DAB2IP;TGFB2;NOTCH1;STARD8;NGF;BCR;KANK1;STARD13;ARHGEF2;EPS8;ARHGDIB;LYN;SHOC2;SPRY2;EPS8L2;LRRC59;EPHB2;SQSTM1;GABARAP;MADD;ARHGDIA;DENND4B;SPRY1
prerank,iron ion transmembrane transport (GO:0034755),-0.5623322858583343,-1.3254314635183253,0.14942528735632185,0.4122701029566895,1.0,3/10,4.77%,SCARA5;SLC40A1;SLC39A8
prerank,aspartate family amino acid metabolic process (GO:0009066),0.48513080907986694,1.325348068528776,0.15728155339805824,0.8067722734404824,1.0,8/18,16.08%,ASPG;ADI1;ASPA;SLC25A12;MTHFR;GOT1;MTHFD1;GOT2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4299252604322208,-1.3250017599518136,0.11949685534591195,0.4125801824122185,1.0,15/27,23.30%,VPS13C;RAB6A;TMED10;GBP5;GOLPH3;RIPOR1;VPS13A;VPS13D;ARL5A;SYS1;PAQR3;BICD2;COG7;CSNK1D;GAK
prerank,metal ion homeostasis (GO:0055065),-0.39655037640993557,-1.3243884721106804,0.08843537414965986,0.4132860921309958,1.0,18/40,30.18%,TMTC2;CAV1;SLC12A7;SLC12A2;SLC12A6;JPH2;CNNM2;MT3;SLC7A8;GRIN1;SLC12A8;LETM1;SLC8A1;WFS1;SELENON;TESMIN;SLC12A4;SLC12A3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5048877412595448,-1.3240611460702523,0.13211382113821138,0.4132461922364458,1.0,5/15,20.40%,TGFB2;IRAK3;TGFB3;JAK3;CUEDC2
prerank,positive regulation of protein kinase activity (GO:0045860),-0.3125935193128863,-1.3233778183028793,0.041666666666666664,0.4140400403137648,1.0,32/148,13.96%,RAPGEF2;DAB2IP;RHOA;TGFB2;INSR;GAS6;RAP1A;STK3;RASSF2;IQGAP1;TGFBR2;TNIK;RALB;CACUL1;CAB39;PAK2;XRCC5;IL6R;PRKCD;CCN1;CALM3;EMP2;SRC;IL34;NEDD9;PTPN1;RPTOR;MAP4K4;PTK2B;INCENP;PTPRC;VEGFA
prerank,negative regulation of protein transport (GO:0051224),0.46551123832526786,1.3233405790425463,0.1450980392156863,0.8112236233561193,1.0,11/25,21.11%,NDFIP1;DRD3;PKDCC;SERGEF;CYP51A1;SNX3;NDFIP2;RHBDF1;IL12A;HMGCR;ERP29
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.5466812063111814,-1.3232753870983482,0.11895161290322581,0.4135829004829214,1.0,6/11,28.87%,AGK;TIMM22;ROMO1;TIMM29;TIMM10;TIMM8B
prerank,regulation of establishment of protein localization (GO:0070201),-0.5056457853465133,-1.3231097186752399,0.14989733059548255,0.4132417457575229,1.0,10/13,36.07%,DNAJA1;CTSD;GAPVD1;PTP4A3;CEP295;SPIDR;TREM2;SCFD1;CORO2B;CEP135
prerank,glucose import (GO:0046323),-0.5212540633706017,-1.3226226943108992,0.12092130518234165,0.41358939054696703,1.0,4/13,13.20%,SLC2A1;SLC2A3;SORT1;ZDHHC7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33660728225511577,-1.3225559001782066,0.0488997555012225,0.4130212376695263,1.0,34/93,23.35%,DAB2IP;SH3RF3;TRAF5;TGFB2;MAP3K5;RASSF2;APP;MID1;MFHAS1;XDH;FLT4;EDA2R;BMP2;PTK2B;TNFRSF19;ANKRD6;VEGFA;MTURN;KLHDC10;TAOK3;NOD2;EDAR;RELL1;ZC3H12A;RIPK1;SH3RF1;SPI1;HMGB1;TRAF4;MAP3K4;TAOK1;SEMA4C;PRMT1;FCGR2B
prerank,positive regulation of apoptotic process (GO:0043065),-0.28449370055303597,-1.3225074080115116,0.012345679012345678,0.41243178834317884,1.0,83/293,20.13%,DAB2IP;ITGA6;SLIT2;NET1;TNFSF10;ARHGEF3;TGFB2;MAP3K5;FAP;FOXO1;DCUN1D3;MCF2L;STK3;APAF1;RASSF2;PTGIS;FOXO3;NGF;CYP1B1;BMP4;BTG1;RASGRF2;UNC13B;SFRP4;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;CRADD;MAP3K20;ARHGEF2;RPS27A;UBB;RACK1;KLF11;APC;TGM2;MYBBP1A;RPS6KA2;IAPP;RPS3;CTSD;ABR;SOD1;TIAM1;CDK5;ARHGEF12;TGFB3;VAV2;TCTN3;TNFAIP8;TLE5;HIP1R;SQSTM1;BMP2;RARG;PLEKHG2;SAP18;EEF1E1;JMY;ACVR1C;BAK1;ATF4;DIABLO;ING4;GPER1;TOP2A;PREX1;LATS1;DUSP6;BARD1;IRF5;ARHGEF5;ZC3H12A;PSEN2;RHOB;RYBP;FOXL2;STK17B;RIPK1;HMGB1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.27010711051853725,-1.3221394961644632,0.0,0.4125664125606389,1.0,157/532,22.74%,LIMS1;GHR;ACTN4;IL6ST;IL1R1;OSMR;LIFR;TMSB4X;ZEB1;TRAF5;B2M;GREM2;RPS6KA5;FOXO1;F3;PIK3R1;VCAM1;BCL2L1;FOXO3;NFKBIA;SOCS2;CD44;STAT3;PTPRJ;FN1;TNFRSF1B;UBC;IRAK3;MID1;PTGS2;ADIPOR2;STX1A;CARD14;NOD1;IFITM3;MTAP;TNFRSF11A;STX3;ITGB1;S1PR1;ICAM1;RPS27A;IRF9;UBB;PAK2;AIM2;CAMK2D;RPLP0;PPIA;TNFRSF11B;INPP5D;IL6R;TEC;PRKCD;PSMB7;TRIM25;PSMA6;ANXA1;IL20RB;XAF1;CXCL12;CCL13;CEACAM1;IFI35;PIK3CA;CNN2;IL1RAP;SOD1;CNTFR;BRWD1;SRC;IL15;IL34;IRF2;FGF2;SOCS5;MAOA;PSMB6;PIK3CD;YWHAZ;ACKR3;CFL1;IL4R;PSMB5;PDCD4;JAK1;CEBPD;ISG15;TWIST1;PTPRZ1;EDA2R;SQSTM1;IL1RL2;PTK2B;UGCG;RSAD2;CD86;POU2F1;BIRC3;VEGFA;IL17RE;CD40;MT3;PSMC4;PSMB8;IRS1;TAB1;IRAK2;CSF1R;PRKACA;CBL;BOLA2;PSMD11;IFITM1;CISH;SOCS3;SP100;IFNAR1;MAP3K8;NOD2;PSMB4;CCL25;EDAR;JUNB;CCND1;MT2A;PTPN6;PSMD14;MAPK3;MCL1;CRLF1;IRF5;IL33;JAK3;HCK;PSMD10;RIPK1;SPI1;SMARCA4;MYD88;TNFSF8;SYK;PSME1;CAPZA1;RIPK2;IFITM2;CDC42;HNRNPF;MMP2;FYN;F13A1;MSN;FCGR1A;CTF1;CSF2RB;PSMB3;CDKN1B
prerank,cellular response to calcium ion (GO:0071277),0.37706147221264397,1.3220678479798542,0.08680555555555555,0.8128790052721155,1.0,16/67,12.28%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SYT10;TRPM2;CPNE6
prerank,prostanoid metabolic process (GO:0006692),0.5392614131105363,1.3216537671910453,0.1532258064516129,0.8112215134469005,1.0,3/13,7.89%,PTGS1;PTGES;PTGR1
prerank,negative chemotaxis (GO:0050919),-0.4062587053203542,-1.3216321531611366,0.08200455580865604,0.4130116477527922,1.0,6/33,1.62%,SEMA6A;SEMA3C;SLIT2;RHOA;NTN1;SEMA7A
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5284249285913639,-1.3216073972584608,0.15109343936381708,0.4123810933123366,1.0,3/12,4.15%,BMP5;SLIT2;CCN3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4864129157213381,1.3209736513296066,0.15294117647058825,0.8106384347252493,1.0,4/18,8.26%,ATP1A2;STK39;PPIF;KCNH2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4141669198027262,-1.320711986643253,0.12472160356347439,0.4137070562973251,1.0,11/29,20.81%,BMP5;DAB2IP;SDHAF2;IL17RD;SPRED2;SPRY2;VASN;SPRY1;MAD2L2;PTEN;PPP2CA
prerank,intestinal absorption (GO:0050892),-0.5061807151702009,-1.3193141123044085,0.15520628683693516,0.41616001382250833,1.0,5/13,13.08%,F11R;TJP2;KCNQ1;SLC26A6;UGCG
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4312223177855051,-1.3188787205101502,0.09829059829059829,0.4164773441158361,1.0,7/27,9.26%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1
prerank,carbohydrate catabolic process (GO:0016052),0.42421750143137743,1.3186023346418958,0.11423550087873462,0.81677092795472,1.0,9/38,7.09%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;NAGA;HKDC1;MAN2C1
prerank,melanocyte differentiation (GO:0030318),0.560652148354883,1.3182723360153246,0.15129151291512916,0.8147875992608297,1.0,3/11,6.74%,LRMDA;KIT;CITED1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4879704356238838,1.3178671940564206,0.13438735177865613,0.8130601156401295,1.0,3/20,7.07%,WNT4;GCK;C1QTNF3
prerank,nucleotide catabolic process (GO:0009166),-0.500354651083782,-1.3177380260035558,0.15217391304347827,0.41814013809593165,1.0,6/16,15.44%,XDH;GPX1;DERA;NT5C1A;NT5E;NT5C
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.49155726691968127,1.3171560836194076,0.12810707456978968,0.8125712956954471,1.0,8/18,20.61%,SMAD3;CLASP1;PDPN;IER3IP1;EFEMP2;IL6;CARMIL2;EMILIN1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.47590995422384363,-1.3166282955438384,0.14344262295081966,0.41993270575972175,1.0,5/17,8.83%,SLIT2;TMEM204;SFRP4;CASK;XIAP
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.43722088623362043,1.3165476862598655,0.12075471698113208,0.8084950718122189,1.0,9/29,21.24%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13;ACOT9
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.43722088623362043,1.3165476862598655,0.12075471698113208,0.8084950718122189,1.0,9/29,21.24%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13;ACOT9
prerank,positive regulation of macrophage migration (GO:1905523),-0.4648065005605267,-1.3161884203849665,0.14285714285714285,0.42018823694443524,1.0,7/19,18.74%,THBS1;MAPK1;MDK;IL34;RARRES2;CSF1R;MAPK3
prerank,cellular response to interleukin-6 (GO:0071354),-0.4307338199020644,-1.3148714467404008,0.10851063829787234,0.42261451048537774,1.0,10/26,16.82%,IL6ST;PID1;ST3GAL6;PTGIS;STAT3;IL6R;SRC;JAK1;CBL;SOCS3
prerank,gene expression (GO:0010467),-0.2767811340431515,-1.3134274687851433,0.0034602076124567475,0.42502039180194245,1.0,115/348,22.56%,RPLP1;PTMA;RBPMS;RPS15;RPL38;RPL18A;RPL41;RBM3;EEF1A1;RPS12;RPS20;DARS1;RPL5;RPL32;ADARB1;RPS10;RPS23;RPL10;RPS24;RPL7;RPL37A;ANGPT2;RPS17;RPS16;RPL39;RPS27A;RPL13;CDC40;RPLP0;RPL30;MRPL52;RPS5;RPL35A;RPS8;RPS7;RPL22;RPL29;RPS3;RPS28;RPL7A;RPS26;NUP107;RPL6;RPL18;RPL36;EIF4E;AGO2;RPS25;DDX54;RPL28;DROSHA;GOLPH3;RPL27;WDR33;CPSF4;RPS29;RPL24;RPL23;RPL17;MRPL23;YARS2;RPS27;HHEX;RPS9;NCBP2;RPL21;TPR;MRPL10;ASMT;RPL34;CLP1;RPL10A;THOC3;SYNCRIP;ATXN1;RPL35;NR4A2;RBM6;RPL12;RPL19;RPL14;NCBP1;DHX38;SRSF3;RPS18;RPS13;RPL37;RPS15A;DDX25;SEC13;MRPS12;EPC1;MRPL43;MRPL55;MRPL44;NUP50;NUFIP1;MRPL36;MRPL35;NUP85;RPL3;POLR3A;POLR2I;THAP1;RRBP1;HNRNPF;EIF4A3;RPL15;DKC1;AAAS;RPS21;RPL8;RPS19;TESC;POLR2F
prerank,heterochromatin organization (GO:0070828),-0.4982014661688776,-1.3132390192531715,0.14613778705636743,0.42473502973758964,1.0,4/14,12.32%,MECOM;PRDM16;EZH1;SMCHD1
prerank,keratinocyte differentiation (GO:0030216),-0.4188743378389125,-1.3132024025583293,0.11228813559322035,0.42412243904586655,1.0,10/29,18.72%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG;DSP;EXPH5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3551374127273204,-1.3130833063272933,0.0867579908675799,0.4237014203324139,1.0,12/67,6.56%,MYO10;PODXL;CAV1;ATP8B1;TBC1D8;ATG3;TBC1D5;USP6NL;IFT140;TBC1D2B;PPP1R16B;TBC1D1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.45430772122587104,1.3129844587533153,0.1266294227188082,0.8192315440060817,1.0,7/26,10.15%,OSBPL8;IGF1;CLIP3;PRKCI;RHOQ;SORBS1;CREBL2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.48508887277312124,1.3129609987218092,0.13909774436090225,0.8160032925485057,1.0,7/20,19.24%,EPAS1;HSPA1A;TGFBR1;HSPA1B;DNAJB2;WASHC1;HSP90AA1
prerank,lipid homeostasis (GO:0055088),0.38824053713081536,1.3118781430511728,0.09632224168126094,0.8168651003421695,1.0,21/57,20.49%,PRKAA2;RBP1;FITM2;ABHD5;PNPLA8;CEBPA;ADCK1;ORMDL2;CLN8;USF1;NR1H3;ABCD1;ABCA2;DGAT2;ABCB4;SIRT1;TM6SF2;TLCD3A;MLXIPL;DDX3X;RCN3
prerank,catecholamine metabolic process (GO:0006584),0.5293455121897102,1.31108290678668,0.15204678362573099,0.8167111496199286,1.0,5/14,19.22%,SNCAIP;DRD3;COMT;ATP7A;RNF180
prerank,mitochondrial fission (GO:0000266),-0.4951643455640271,-1.311018067170618,0.1503267973856209,0.4275360288477193,1.0,8/16,28.90%,DNM3;MFF;MTFR2;GDAP1;MIEF1;MUL1;DNM2;DNM1
prerank,vasodilation (GO:0042311),-0.5200505181828945,-1.3106882010824437,0.16633266533066132,0.4275832033279478,1.0,4/13,17.23%,NOS3;SOD1;KLF2;GPER1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5221285369754051,-1.3106799554919302,0.15767634854771784,0.42622360646808954,1.0,5/12,13.54%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5221285369754051,-1.3106799554919302,0.15767634854771784,0.42622360646808954,1.0,5/12,13.54%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.43935343228892415,-1.3106603734320335,0.12072434607645875,0.4255675518381012,1.0,12/23,24.10%,BMP4;SIX1;MDK;FGF2;PIK3CD;SMO;VEGFA;SIX4;SOX8;SIRT6;EGF;LHX1
prerank,erythrocyte differentiation (GO:0030218),0.4072617883602654,1.3105788104660576,0.11342155009451796,0.8154855606668996,1.0,9/44,8.37%,TGFBR3;KIT;FLVCR1;SLC25A5;IKZF1;ABCB10;CASP3;INHA;MED1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5331236839681854,-1.3100938456606888,0.16455696202531644,0.42616038951860347,1.0,4/12,4.60%,GSN;LY6E;MID2;IFITM3
prerank,bicarbonate transport (GO:0015701),-0.43448706873795107,-1.3100589011773183,0.12304250559284116,0.4255432271000887,1.0,7/25,15.91%,SLC4A10;SLC26A7;SLC39A8;CA4;SLC26A6;CA2;CFTR
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5480907434856063,-1.31004039693691,0.1375770020533881,0.42490568200840617,1.0,4/10,11.76%,ACER2;CYP1B1;SERPINE1;JAM3
prerank,regulation of embryonic development (GO:0045995),-0.3960096456801296,-1.310035194915691,0.09006928406466513,0.4242255152191088,1.0,8/34,11.55%,INSR;RAB14;PHLDB1;PHLDB2;SOX17;NIPBL;CFL1;B4GALT5
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5363706647123183,1.3099084333480149,0.15637065637065636,0.8149287245793742,1.0,2/12,1.79%,ANXA6;ANK2
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5557088213122457,-1.309763182953839,0.14553014553014554,0.42410710235510524,1.0,6/10,22.58%,ACTN4;RARB;TBX1;RARG;SNW1;RXRG
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.46205192049693466,-1.3093681936784851,0.13107822410147993,0.42435139462710064,1.0,8/21,22.49%,MYH9;ADAM10;SPPL3;ADAM19;HM13;PSEN2;PSENEN;ERAP1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5332051724919542,-1.3092884864677043,0.15476190476190477,0.4238754570486348,1.0,4/11,6.47%,LRP5;TGFBR2;TBX1;WNT5A
prerank,regulation of acute inflammatory response (GO:0002673),-0.4678168268123374,-1.3086247270768725,0.14285714285714285,0.4245531404248654,1.0,2/18,1.15%,IL6ST;OSMR
prerank,inorganic anion transport (GO:0015698),0.3899087582257681,1.3081461454219545,0.10221465076660988,0.8187105102051407,1.0,11/53,9.55%,SLC13A4;SLC5A5;ENPP3;SLC26A1;GLRA1;CLCN6;SLC25A11;CLCN2;NMUR1;SLC34A3;CLCN4
prerank,chloride transport (GO:0006821),-0.3378146571364986,-1.306772275990945,0.06338028169014084,0.4279723553032141,1.0,20/74,15.91%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;ANO1;CLIC5;SLC12A6;CLIC1;LRRC8A;SLC1A3;GABRA3;GLRB;SLC1A1;SLC26A6;ANO4;GABRE;GLRA2;ANO2;CFTR
prerank,response to muramyl dipeptide (GO:0032495),-0.534517709420408,-1.3065511305695587,0.1513859275053305,0.42777851719483734,1.0,6/12,21.17%,NOD1;ARHGEF2;NOD2;IRF5;ERBIN;RIPK2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.43892602235628375,-1.306481919628861,0.1350210970464135,0.42728609754193597,1.0,4/22,2.84%,NTRK3;RAPGEF2;RAP1A;NGF
prerank,peptidyl-lysine methylation (GO:0018022),0.4475661190699397,1.3061367241262092,0.141804788213628,0.8233180053777539,1.0,8/26,13.46%,KMT5A;EEF2KMT;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2
prerank,cholesterol metabolic process (GO:0008203),0.3745642757891713,1.305945557132334,0.08506944444444445,0.8207801433360224,1.0,21/68,18.84%,CEL;SOAT2;ACAT2;CYP11B1;INSIG2;DHCR24;APOF;SOAT1;OSBPL5;CLN8;CYP27A1;RXRA;FDX1;CYP51A1;SQLE;TSKU;GBA2;MSMO1;GGPS1;ABCA5;HMGCR
prerank,regulation of ion transport (GO:0043269),0.3674917628833323,1.3048010099352942,0.11764705882352941,0.8221241660465107,1.0,16/76,11.25%,SYT11;SYT12;SNX6;KCNJ13;KCNJ5;SYT9;KCNJ10;SYT1;DRD3;SYT13;CHRNB2;SYT10;PDZK1;KCNJ16;DTNBP1;CHRM1
prerank,receptor-mediated endocytosis (GO:0006898),-0.30691432812035324,-1.3046261995872355,0.0395778364116095,0.43073277612219996,1.0,32/132,13.98%,CAV1;CALCRL;DNM3;SPARC;LRP6;SCARB1;INSR;RAMP2;CD9;SCARF1;AP2B1;RAB31;SCARB2;FCHO2;SGIP1;TFRC;ITGB1;CLTB;LMBRD1;SNX1;CUBN;CAV2;GPR107;ACKR3;APOE;FNBP1L;VLDLR;HIP1R;ADM;STAB1;AP2A1;ARHGAP27
prerank,neuromuscular junction development (GO:0007528),0.4625407442678311,1.3042082937240713,0.13043478260869565,0.8212533871462743,1.0,6/24,8.07%,UNC13C;CACNB1;CACNB3;PDZRN3;LRRK2;LRP4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4702636915798827,-1.3038912664502154,0.15,0.431690443779853,1.0,8/17,21.89%,TGFB2;MID1;LYN;KLHDC10;TAOK3;NOD2;TAOK1;SEMA4C
prerank,liver development (GO:0001889),0.4318835093354293,1.3032277248248654,0.15601503759398497,0.8217820360395292,1.0,5/32,8.39%,TGFBR3;WNT4;CEBPA;PHF2;E2F8
prerank,cellular amino acid catabolic process (GO:0009063),0.3578346585984775,1.3030539249172455,0.09847198641765705,0.819247350552615,1.0,18/87,12.05%,DDO;IDO1;ALDH7A1;IVD;SLC25A44;DBT;ACAT1;GLDC;ACADSB;HAAO;ECHS1;BCAT2;KMO;ASPA;GLS2;BCKDHB;GAD1;GCDH
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.335787125254069,-1.3027951138606568,0.06,0.43347245466510664,1.0,35/80,25.35%,TNFSF10;MAP3K5;YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;NOD1;CARD16;BCAP31;CTSD;XIAP;SRC;KLF4;GPX1;MALT1;SOX7;USP47;CSNK2A1;VEGFA;ACVR1C;MT3;GPER1;FOXL2;SH3RF1;HMGB1;SYK;BEX3;BCL10;CASP1;TRIAP1;ARL6IP1;DAPK1;F2R
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.38919593570920014,1.3027462327027124,0.10338680926916222,0.8172724123318534,1.0,18/57,19.00%,CACNG7;ACTN2;NLGN2;NPTX1;DLG1;SHANK1;SHISA7;DLG4;GSG1L;NPTXR;CNIH3;OPRM1;SHISA8;GRIA2;LRRC7;NEFL;MINK1;MAPK8IP2
prerank,sensory perception of taste (GO:0050909),0.5665297504255714,1.3021370770158762,0.17777777777777778,0.8165435824445609,1.0,1/10,0.52%,TAS1R2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.39930967956804597,-1.301825297768413,0.1108695652173913,0.43492757703283325,1.0,9/34,15.35%,PLCE1;SLIT2;WASF2;PIK3R1;OCLN;PIK3CA;ABI3;AVIL;ARPC2
prerank,regulation of JNK cascade (GO:0046328),-0.3222507421275859,-1.3015496368630093,0.04854368932038835,0.4347863462667458,1.0,31/101,22.20%,MECOM;DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;EGFR;APP;MFHAS1;RAP2A;FLT4;DUSP3;PER1;MAP4K4;AIDA;PHLPP1;EDA2R;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;NOD2;EDAR;RIPK1;SH3RF1;HMGB1;TRAF4;IGF1R;TAOK1;CYLD
prerank,regulation of trans-synaptic signaling (GO:0099177),0.420952283334698,1.3012785359776906,0.12121212121212122,0.8166763399594545,1.0,10/33,13.84%,CEL;NLGN2;IQSEC2;GRID2;NLGN3;GRIK5;GRIK2;LRRC4C;BDNF;PSMC5
prerank,intracellular lipid transport (GO:0032365),0.46736512274904185,1.3008395336741825,0.15768463073852296,0.8152471370945013,1.0,2/21,1.84%,PRKAG2;PRKAA2
prerank,homeostasis of number of cells (GO:0048872),-0.5236177924693738,-1.300542679474747,0.1599229287090559,0.43638597318674843,1.0,3/12,4.15%,NOS3;NOTCH1;CCN3
prerank,mRNA splice site selection (GO:0006376),0.4343378713820919,1.3004877710519607,0.14311926605504588,0.8135877159167776,1.0,11/30,21.74%,CELF2;SRSF5;SRSF10;PSIP1;YTHDC1;NOL3;SRSF6;PUF60;CELF6;CELF1;LUC7L
prerank,myoblast differentiation (GO:0045445),0.534621973209235,1.2999081228249758,0.16025641025641027,0.8127930086277241,1.0,6/14,8.73%,EPAS1;IGF1;DDX5;DDX17;NRG1;HINFP
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5071375264593493,-1.299785967543251,0.1483050847457627,0.43743443662822057,1.0,3/14,1.23%,PRKG1;MEF2C;SLIT2
prerank,embryonic limb morphogenesis (GO:0030326),-0.39772189565073524,-1.2989699080360788,0.12331838565022421,0.4385529661568466,1.0,12/34,13.29%,MBNL1;ECE1;LRP6;TGFB2;TBX3;GLI3;MAP3K20;NIPBL;TWIST1;PTCH1;RARG;TBX2
prerank,regulation of actin filament polymerization (GO:0030833),-0.3466143286375266,-1.2983879812835817,0.08793969849246232,0.43913149191408374,1.0,15/69,12.78%,SLIT2;ESAM;KANK1;KANK3;SSH2;CDC42EP3;CDC42EP5;KANK4;PRKCD;NCK1;CDC42EP2;HIP1R;PTK2B;PFN1;PLEKHG2
prerank,regulation of cell growth (GO:0001558),-0.2922216644953364,-1.29814676047574,0.025787965616045846,0.4390223336316471,1.0,65/204,23.65%,APBB2;LTBP4;PLCE1;BMPR2;SLIT2;NET1;ACVRL1;TGFB2;DCUN1D3;SH3BP4;EGFR;SOCS2;BTG1;H3-3A;PTPRJ;FHL1;CCN3;RPS6KA3;SOX17;TFRC;CCDC85B;AGTR1;ADAM10;RACK1;CAMK2D;CEACAM1;BCAR1;CDKN2AIP;FAM107A;RPTOR;NME6;PABIR1;MFSD2A;DCUN1D5;SIPA1;USP47;CSNK2A1;RERG;ADAM15;PTCH2;MT3;NCBP1;DDX49;MAD2L2;RTN4;CDA;CISH;KLHL22;OSGIN1;NUBP1;ENPP1;RASGRP2;PSMD10;SMARCA4;SLIT3;PPP2CA;CDC42;ESR2;PRDM11;CDKN1B;EXOSC4;CDK11B;WFDC1;JADE1;FXN
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.4035151460767804,-1.2966597982491166,0.12,0.4417987429491794,1.0,16/32,29.27%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;POLR1H;POLR2F;CCNH;POLR1E;POLR2H;POLR1C;POLR2E
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3455331474717133,1.296496414366242,0.08768971332209106,0.823242403632622,1.0,23/107,13.84%,ATP1A2;SLC8A3;CEL;SNCAIP;NLGN2;NPTX1;IQSEC2;GRID2;SYT1;NLGN3;GRIK5;GRIK2;LRRK2;RIMS1;CHRNB2;DLG4;NPTXR;DGKI;LRRC4C;BDNF;SYN3;CPLX1;PSMC5
prerank,cell projection assembly (GO:0030031),-0.45107308394797657,-1.2960999711696304,0.14163090128755365,0.44242465640626405,1.0,8/22,21.41%,RHOJ;GSN;PARVB;PARVA;CAPG;NCKAP1L;RAC3;CDC42
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.520114574546902,-1.2955035054570885,0.14910536779324055,0.4429679567636039,1.0,5/12,18.74%,LYN;MAPK1;IL34;CSF1R;MAPK3
prerank,regulation of vasculature development (GO:1901342),-0.41283500322671424,-1.2950451337673237,0.11788617886178862,0.44326599674133543,1.0,13/26,33.80%,ETS1;BMPER;ADGRA2;EMP2;FGF2;TSPAN12;SP100;PLXND1;HMOX1;GPNMB;VASH2;CTNNB1;PROK2
prerank,positive regulation of embryonic development (GO:0040019),0.4772272404452044,1.294465087276243,0.15264187866927592,0.8282422186951869,1.0,2/19,1.12%,WNT4;OSR1
prerank,Notch signaling pathway (GO:0007219),-0.35332072394207564,-1.2944450304828996,0.0898876404494382,0.4440043801540637,1.0,24/59,22.29%,SORBS2;MAML2;PBX1;JAG1;NOTCH3;NOTCH1;JAG2;ADAM10;HES1;HEYL;MDK;HEY2;NOTCH4;BMP2;HEY1;PSEN2;DLL4;PSENEN;PLXND1;MAML3;DTX3L;SUSD5;DLL1;SNW1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3413824313978758,-1.2943537343244162,0.07673267326732673,0.44353228775466,1.0,20/72,12.66%,SHANK3;SLIT2;KANK1;STMN1;KANK3;SSH2;TBCD;KANK4;ARHGEF2;ATXN7;PRKCD;APC;IAPP;PIK3CA;FGF13;APOE;DYRK1A;HIP1R;LIMA1;PFN1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.34174744253810896,-1.294177020369693,0.0894854586129754,0.4432356649604265,1.0,14/65,15.53%,LEF1;FOXP1;MYH9;BMP4;TGFBR2;RUNX1;CBFA2T3;TNFRSF11A;IL15;MT1G;PIK3CD;SNX10;VEGFA;CSF1R
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5191232424265161,-1.2940952998476607,0.1588235294117647,0.4427623199203692,1.0,4/13,7.55%,TGFBR2;RUNX1;GLI3;CBFB
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5029462468069104,-1.2938895397603083,0.1529175050301811,0.44253797088008934,1.0,11/14,47.64%,TYROBP;POU4F1;ATP6AP1;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;IL12B;CSF1;IL23R
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5481198485567267,-1.2938519380509774,0.1728395061728395,0.44191731613131735,1.0,4/10,23.56%,TGFBR2;CD55;NCKAP1L;SOCS1
prerank,DNA damage checkpoint signaling (GO:0000077),0.4463736335246481,1.2936543715460322,0.14568345323741008,0.8282617511556207,1.0,10/28,17.93%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47399040267141024,1.2933031746644812,0.17008196721311475,0.8265703680651378,1.0,8/19,21.53%,OBSL1;IL1RAPL1;PTPRD;CDKL3;CDKL5;CAPRIN2;DBNL;CUL7
prerank,natural killer cell activation (GO:0030101),-0.4378077164234534,-1.2932982664419574,0.14864864864864866,0.44245275806722256,1.0,7/23,17.76%,PBX1;KAT7;ELF4;PIK3CD;NFIL3;PTPRC;ULBP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.38173918133819296,-1.293106156942377,0.12559241706161137,0.4422163401630696,1.0,14/40,16.08%,LEF1;GCNT2;JAG1;TGFB2;NOTCH1;TGFBR2;AXIN2;MDK;TIAM1;TGFB3;TWIST1;BMP2;FERMT2;COL1A1
prerank,positive regulation of cell projection organization (GO:0031346),-0.3183510832831446,-1.293092653349969,0.05555555555555555,0.4415661089092255,1.0,31/115,14.27%,ROR1;NTRK3;RAPGEF2;DAB2IP;PTN;ITGA6;SLIT2;RHOA;NDNF;RAP1A;NGF;SCARF1;TIAM2;SCARB2;PRKD1;LYN;FBXW8;WNT5A;NPTN;ARHGAP35;MDK;RETREG3;TIAM1;APOE;FZD4;PLXNC1;RET;PTK2B;AVIL;ARHGDIA;FZD1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.45252454603827585,-1.2927725353968929,0.15051546391752577,0.44162963216424633,1.0,11/21,21.30%,NOS3;NOTCH1;GAS6;ASPN;HEY2;ECM1;PTK2B;HEY1;ENPP1;GREM1;ROCK1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4484341963572455,-1.2926363975315052,0.14052953156822812,0.4412352739639888,1.0,7/21,18.32%,YWHAE;MFHAS1;YWHAB;PPP1R16B;MASTL;BOD1L1;PPP1R11
prerank,protein K63-linked ubiquitination (GO:0070534),0.401374056554743,1.2924195615694354,0.1358695652173913,0.8271391823704263,1.0,7/41,11.44%,RNF152;UBE2E2;TRIM5;RNF126;PELI3;RNF135;PRPF19
prerank,cellular response to glucagon stimulus (GO:0071377),0.47826006798894377,1.291134576505014,0.16538461538461538,0.8292873974830456,1.0,4/17,6.40%,ADCY5;GCGR;ADCY1;ADCY8
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.520673961002773,-1.2905184581706344,0.1673228346456693,0.44537728457347947,1.0,5/12,17.52%,CSGALNACT1;FUT8;PARG;GFPT2;UGP2
prerank,skeletal system development (GO:0001501),-0.30155756514137466,-1.2900342042860748,0.05555555555555555,0.4457658450164062,1.0,32/148,10.22%,CDH11;BMP5;TLL1;ZBTB16;TRPS1;EXT1;PCSK5;TGFB2;TBX3;SLC10A7;PKD1;TEAD4;PLS3;BPNT2;CD44;ALPL;KIAA1217;RPS6KA3;PAPSS2;FBN1;RPL13;HHIP;WNT5A;TNFRSF11B;SH3PXD2B;MYOC;TGM2;IGF2;XYLT1;EIF2AK3;VCAN;ETS2
prerank,ganglioside biosynthetic process (GO:0001574),-0.49316432620065026,-1.2896575794212617,0.16334661354581673,0.445995589207915,1.0,8/15,18.27%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2;ST3GAL2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.553611008946181,1.2896425786824741,0.18,0.832215838024537,1.0,3/11,7.14%,RENBP;GNPNAT1;GNPDA1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4320319585097995,-1.2888100143987995,0.16024340770791076,0.4472611158840461,1.0,8/23,21.29%,DAB2IP;MAP3K5;TNFRSF11A;RPS3;EDN1;TAOK3;ARHGEF5;MAP3K4
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3104749247138643,1.2883985953050956,0.056716417910447764,0.8339999696154444,1.0,52/224,18.33%,SLC6A1;UNC13C;DTNA;CEL;CACNB1;APBA3;CACNB3;NOVA1;NLGN2;PCDHB11;GABRG1;NPTX1;GLRA1;CHRM2;DLG1;CAMK1;SYT1;SYN2;NLGN3;GRIK2;HRH2;HTR7;KCND2;CHRNB2;DLG4;SNAP25;SYT10;SLC12A5;GABBR2;HTR1F;BSN;CHRM1;GAD1;PCDHB3;CPNE6;CPLX1;SPG11;GABRG3;SCN2B;GABRB2;SYN1;AMPH;RIT2;GRIA2;HRH1;HTR1A;KCNQ3;PENK;PTCHD1;MINK1;RAPSN;GABRB3
prerank,positive regulation of cartilage development (GO:0061036),-0.4681513262994062,-1.288370940717114,0.16075156576200417,0.44760862842688254,1.0,6/17,12.31%,ZBTB16;BMPR2;ACVRL1;BMP4;MDK;BMP2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5179019460116201,1.2883550494002183,0.17580340264650285,0.8311062858263887,1.0,8/15,22.33%,FANCD2;EME2;MDC1;MRE11;CHEK2;RAD17;ATF2;RAD9B
prerank,regulation of exosomal secretion (GO:1903541),0.47904828505480973,1.2882135200465794,0.17120622568093385,0.8285976846688303,1.0,4/19,7.73%,CHMP6;STAM;SMPD3;SNF8
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.52490721476326,1.2877739007337163,0.17829457364341086,0.8272516532794069,1.0,3/13,7.14%,RENBP;GNPNAT1;GNPDA1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.4976194676704554,-1.2874106826217537,0.15717092337917485,0.449273546799571,1.0,8/13,41.90%,CBLB;IPO5;KPNA2;KPNA1;NUP54;NUP35;KPNB1;KPNA7
prerank,protein tetramerization (GO:0051262),0.36805645144600985,1.287048517965202,0.12116040955631399,0.8270499974059585,1.0,11/67,11.37%,ALDH1A2;UPB1;APPL2;TRPV1;CPSF6;KCNC3;CPSF7;GOLGA2;SSBP1;CUTC;TRPM2
prerank,protein localization to lysosome (GO:0061462),-0.4165439129339836,-1.286987759876144,0.15022421524663676,0.44958638615628765,1.0,16/28,32.76%,SH3BP4;SCARB2;LMBRD1;ZFYVE16;KPTN;MFSD1;HGS;RTN4;RNF128;NEDD4;GGA3;NCOA4;M6PR;LAPTM5;LAMTOR5;NAGPA
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2988153068943818,-1.2864390142646462,0.04639175257731959,0.45012530663198097,1.0,55/161,24.04%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;SFRP4;TBX18;TLE4;GLI3;SOX17;IGFBP6;NKD2;AXIN2;WNT5A;TLE3;PSMB7;ZNRF3;PSMA6;INVS;CSNK1A1;APC;MDK;PSMB6;AMER1;APOE;PSMB5;FZD4;TLE5;BMP2;DKK2;ANKRD6;PSMC4;PSMB8;AMER2;MAD2L2;PSMD11;LATS1;PSMB4;PSMD14;GREM1;IGFBP4;PSMD10;RBMS3;PSME1;CHD8;SOX13;CYLD;FRMD8;PSMB3;TLE6;JADE1;CUL3
prerank,positive regulation of signal transduction (GO:0009967),-0.28368312956983255,-1.2862092105783796,0.025936599423631124,0.44996159067531233,1.0,56/238,13.93%,NRP1;VWF;TEK;LIMS1;NTRK3;SHANK3;MAML2;LIMS2;DAB2IP;IL6ST;RSPO3;JAG1;NOS3;TGFB2;NOTCH1;GAS6;F3;DISC1;PIK3R1;PTGIS;ITGA5;JCAD;MACF1;KANK1;STAT3;CCN3;FAS;MGAT5;FLNA;CRADD;JAG2;ERN1;NPTN;EPN2;RPS3;EMP2;SPIN1;SRC;IGF2;TRIM16;NOTCH4;CCBE1;ATP6AP2;CAV2;CDKN2AIP;ESM1;CD74;HHEX;BMP2;PTK2B;SMO;AGPAT1;KLF2;CSNK2A1;PTPRC;P2RY6
prerank,glycolytic process (GO:0006096),0.44208126165893114,1.2860853703630921,0.16573556797020483,0.8279412860544008,1.0,7/28,6.76%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,regulation of cholesterol storage (GO:0010885),-0.4791799317034062,-1.285910664171934,0.1522633744855967,0.44991629510086134,1.0,5/15,10.78%,SCARB1;PPARD;ABCA1;TTC39B;SREBF2
prerank,organic substance transport (GO:0071702),-0.3119643151560071,-1.2856845367038332,0.04522613065326633,0.4497875722106643,1.0,22/121,8.96%,ABCG2;SLC47A1;CALCRL;ATP8A1;DISP1;SLCO2A1;RAMP2;MYH9;SLCO2B1;ABCA1;LMAN2L;PLEKHA8;PLTP;CHMP2B;SPNS2;TAP2;ABCA3;CMTM6;CUBN;ABCD2;TXNIP;SLC22A18
prerank,regulation of cytoplasmic translation (GO:2000765),0.5133216676583935,1.2839616509330818,0.16122840690978887,0.833209890384999,1.0,3/14,7.46%,CPEB2;CPEB4;UNK
prerank,regulation of mast cell activation (GO:0033003),-0.5368445391863613,-1.2838012914956332,0.16602316602316602,0.45340636515545074,1.0,7/10,34.31%,PLSCR1;LYN;NECTIN2;CD300LF;MILR1;CD84;TSLP
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.507876961230579,1.2834046286376,0.17670682730923695,0.8325706034060073,1.0,3/14,3.84%,SYT11;IGF1;TAFA3
prerank,negative regulation of growth (GO:0045926),-0.3114027250987673,-1.2823998689594769,0.049738219895287955,0.4560296849649186,1.0,36/121,18.38%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;DCUN1D3;NOTCH1;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;CDKN2AIP;NME6;SIPA1;RERG;ADAM15;MT3;RTN4;CDA;ING4;OSGIN1;FGFR3;MT2A;ENPP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3940811087864559,1.2821978521661297,0.13799621928166353,0.8341397359750117,1.0,10/45,9.64%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,regulation of cell size (GO:0008361),-0.4284257638760067,-1.282193065117674,0.15384615384615385,0.4557846093939816,1.0,9/23,22.03%,RHOA;EDN1;RPTOR;VAV2;RARG;PTEN;AKT1S1;PRR16;MSN
prerank,blood circulation (GO:0008015),-0.36447167513931955,-1.2820815642477823,0.0962800875273523,0.45534959940010666,1.0,17/49,13.94%,ELN;NOS3;MEOX2;ACVRL1;GUCY1B1;TBC1D8;SGCD;AGTR1;CXCL12;SOD1;GPX1;GCLC;GCLM;ACE2;EDN3;GUCY1A1;CYB5R3
prerank,Wnt signaling pathway (GO:0016055),-0.32614022440760604,-1.2814561579214865,0.06930693069306931,0.4561090834615577,1.0,33/92,21.35%,LEF1;LRP6;FZD6;LRP5;SFRP4;UBC;PLCG2;CSNK1E;RPS27A;UBB;CSNK1G1;WNT5A;CSNK1G3;CSNK1A1;APC;VPS26A;CPE;AMER1;FZD4;RARG;WNT9A;CD24;NR4A2;FZD1;FERMT2;PLPP3;CELSR2;PTEN;GPC4;DIXDC1;RAC3;BCL9;BCL9L
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.4118910523117595,-1.2804056666810508,0.11894273127753303,0.45782620636604754,1.0,8/28,20.08%,DAB2IP;NGF;CRADD;CASP8AP2;SORT1;GABARAP;DIABLO;SPI1
prerank,negative regulation of apoptotic process (GO:0043066),-0.26329403896494774,-1.28025191268736,0.0,0.4575160160132208,1.0,149/444,24.22%,LEF1;ARHGAP10;PRKCH;TEK;MEF2C;CAV1;IL6ST;TJP1;PTMA;NDNF;YWHAE;THBS1;MERTK;FOXO1;NOTCH1;TBX3;GAS6;PIK3R1;BCL2L1;ITGA5;EGFR;NGF;NFKBIA;SOCS2;BMP4;CD44;KDR;SIX1;UBC;RPL10;RPS6KA3;CARD14;TBX1;NAA16;DNAJA1;FAS;FLNA;TFRC;CARD16;ITGB1;RNF144B;RPS27A;UBB;PAK2;ADAM10;WNT5A;PRKCD;TPT1;PLK2;MAPK1;ANXA1;CD38;PRKCG;FOXQ1;MDK;SPRY2;PIK3CA;SOD1;FLT4;XIAP;SRC;CAT;VHL;KLF4;GPX1;GCLC;TGFB3;GOLPH3;MALT1;YWHAZ;CFL1;APOE;MAP4K4;GRK5;HSPB1;BABAM2;TNFAIP8;PHB2;CD74;UNC5B;PTPRZ1;COMP;SERPINB9;SQSTM1;PTK2B;TCIM;AKT2;USP47;CSNK2A1;ARHGDIA;NME2;BIRC3;HIGD2A;VEGFA;NR4A2;MT3;RHBDD1;PLAUR;PA2G4;NCKAP1L;BAG1;STIL;CBL;SIX4;HDAC2;RNF157;BARD1;MAPK3;MCL1;ASAH2;CRLF1;ZC3H12A;PSEN2;GREM1;LIG4;SOX8;NR1H4;HCK;HYPK;PSMD10;RIPK1;AGAP2;SH3RF1;SET;MYD88;CCND2;POU3F3;IGF1R;BEX3;RIPK2;UBE2Z;DLL1;DDAH2;RASA1;NFATC4;HCLS1;SMAD6;KDM2B;TAF9;TMBIM6;PTRH2;NUP62;TAX1BP1;FANK1;FXN;PLK3;TRIAP1;NAA15;AATF
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.39428324608339244,1.2801106185194204,0.14067796610169492,0.8392670162057247,1.0,11/45,13.54%,BMP7;SMAD3;ZWINT;ANGEL2;FZD3;TOM1L2;TRIM35;MAD2L1;GAS1;PRCC;FOXC1
prerank,anion transport (GO:0006820),0.4172289635681934,1.2798852389682696,0.14314115308151093,0.8372227954960951,1.0,3/33,0.35%,SLC13A4;SLC22A6;SLC13A3
prerank,focal adhesion assembly (GO:0048041),-0.4509508484944464,-1.2798247104083231,0.1540084388185654,0.4578485347107903,1.0,7/21,10.43%,THSD1;PEAK1;BCR;PTPRK;ACTN1;SRC;WHAMM
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5102223343632842,1.279025259645039,0.20204081632653062,0.8374254786477878,1.0,4/14,11.18%,UPB1;DPYD;NT5C3A;UPP2
prerank,epithelial to mesenchymal transition (GO:0001837),0.3935841062897232,1.2788950099398149,0.13309352517985612,0.8350017868363975,1.0,9/47,6.45%,BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;DDX17
prerank,neuromuscular process controlling balance (GO:0050885),0.5350286873604503,1.278647502784125,0.18687872763419483,0.8330590454065772,1.0,3/12,7.85%,USH1C;PCDH15;SHANK1
prerank,histone H3-K4 methylation (GO:0051568),0.44006912028025424,1.2785556241921128,0.172147001934236,0.8305187372429426,1.0,7/26,15.51%,CTR9;KMT2A;DYDC2;SETD4;BEND3;MEN1;TET2
prerank,histone monoubiquitination (GO:0010390),0.4521704834032877,1.2785068056760946,0.16600790513833993,0.8277993631747029,1.0,6/24,12.40%,DDB2;CTR9;LEO1;RNF20;CDC73;RING1
prerank,positive regulation of programmed cell death (GO:0043068),-0.2783015672210031,-1.2782974574029042,0.018518518518518517,0.46071341376558045,1.0,80/272,21.37%,DAB2IP;ITGA6;SLIT2;NET1;TNFSF10;ARHGEF3;MAP3K5;FOXO1;DCUN1D3;MCF2L;STK3;APAF1;RASSF2;FOXO3;NGF;CYP1B1;BMP4;RASGRF2;UNC13B;SFRP4;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;CRADD;MAP3K20;ARHGEF2;RPS27A;UBB;RACK1;KLF11;APC;TGM2;RPS6KA2;IAPP;CTSD;ABR;SOD1;TIAM1;ARHGEF12;TGFB3;VAV2;TCTN3;TNFAIP8;HIP1R;SQSTM1;BMP2;RARG;PLEKHG2;SAP18;HDAC6;EEF1E1;JMY;ACVR1C;BAK1;ATF4;DIABLO;ING4;GPER1;TOP2A;PREX1;LATS1;DUSP6;BARD1;IRF5;ARHGEF5;PSEN2;RHOB;RYBP;FOXL2;STK17B;RIPK1;HMGB1;PSENEN;SYK;FAF1;TRIO;UBE2Z
prerank,aminoglycan catabolic process (GO:0006026),-0.41471249610329647,-1.2782592457228985,0.13559322033898305,0.4601402516126861,1.0,7/28,14.97%,GPC6;GNS;SDC3;NAGLU;AGRN;GPC1;SGSH
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4191909487403988,-1.2778615050706643,0.15822784810126583,0.46032541947444483,1.0,11/26,22.20%,ALPK1;UBC;NOD1;RPS27A;UBB;IFIH1;TAB1;IRAK2;NOD2;RIPK2;CYLD
prerank,Rap protein signal transduction (GO:0032486),-0.5465633187691509,-1.2776353227355444,0.17296222664015903,0.4601798525671679,1.0,4/10,6.86%,RAPGEF2;RAP1A;RAP2A;PLK2
prerank,vesicle transport along actin filament (GO:0030050),-0.45579822811717136,-1.276892558102261,0.15353535353535352,0.46122126032539984,1.0,6/19,11.29%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,regulation of inflammatory response (GO:0050727),-0.28929442064283134,-1.2768051621851524,0.03735632183908046,0.4607362887871232,1.0,37/190,12.47%,FOXP1;TEK;IL1R1;TMSB4X;CD200;SEMA7A;ETS1;PPARD;PTGIS;NFKBIA;ABCC1;APP;TNFRSF1B;MFHAS1;PTGS2;CCN3;BRD4;MGLL;VAMP3;AGTR1;PDE2A;WNT5A;PRKCD;PSMA6;ANXA1;MDK;IFI35;XIAP;IL15;SERPINE1;KLF4;SPATA2;APOE;PDCD4;IL1RL2;CCN4;ACE2
prerank,regulation of cellular localization (GO:0060341),0.38842238709018373,1.2763788318090379,0.14904679376083188,0.8329935656037522,1.0,4/46,2.29%,PARD6G;ADCY5;MAP2;UNC13D
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.3426254667538213,-1.276332972632282,0.08373205741626795,0.46117764169789954,1.0,16/65,8.81%,CAV1;LTBP1;HTRA3;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;ASPN;FBN1;SPRED2;RPS27A;UBB;SPRY2;VASN
prerank,steroid biosynthetic process (GO:0006694),0.3826949953434325,1.2762429988166621,0.11896551724137931,0.8306563803926814,1.0,18/56,21.62%,PRKAG2;CYP11B1;INSIG2;PRLR;SC5D;CYP27A1;DHRS11;AMACR;OSBPL9;CYP51A1;SQLE;STAR;MSMO1;HMGCR;HSD17B4;FDXR;HSD11B1;LBR
prerank,chemical synaptic transmission (GO:0007268),0.29996971992485816,1.275950399758111,0.054285714285714284,0.8290606376984383,1.0,63/284,18.33%,SLC6A1;UNC13C;DTNA;CEL;CACNB1;APBA3;NQO1;CACNB3;NOVA1;NLGN2;PCDHB11;NAPB;GABRG1;NPTX1;GLRA1;CHRM2;DLG1;CAMK1;GRID2;GRIN2D;SYT1;SYN2;SNAPIN;NLGN3;GRIK5;GRIK2;HRH2;HTR7;KCND2;NAPA;RIMS1;CHRNB2;DLG4;SNAP25;SYT10;SLC12A5;GABBR2;HTR1F;BSN;CHRM1;GAD1;PCDHB3;CPNE6;SYN3;CPLX1;SPG11;GABRG3;SCN2B;GABRB2;SYN1;AMPH;RIT2;NAAA;GRIA2;HRH1;HTR1A;KCNQ3;PENK;KIF1B;PTCHD1;MINK1;RAPSN;GABRB3
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.4563967421924572,-1.2756558217760277,0.18322295805739514,0.46204979258846374,1.0,10/18,30.18%,AGTR1;RFK;EDN1;EDN3;POR;NOD2;FXN;PDP1;AGT;PARK7
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.44118349629104986,1.2755476009729023,0.1660377358490566,0.827669837066668,1.0,3/25,2.76%,IGF1;MSX2;DOT1L
prerank,positive regulation of cell differentiation (GO:0045597),-0.28087780272232554,-1.2753587617557192,0.009287925696594427,0.46202497891852723,1.0,45/237,9.18%,LEF1;PRKCH;SLC6A6;KITLG;MEF2C;GCNT2;RAPGEF2;ZBTB16;BMPR2;IL6ST;PTN;ZEB1;RHOA;ACVR1;ACVRL1;TGFB2;PPARD;BOC;LRP5;RAP1A;CD34;ZHX3;NGF;RUNX2;BMP4;BTG1;KDR;TGFBR2;CTNNA1;RPS6KA3;ARHGEF2;TMEM100;PRKD1;AGTR1;AXIN2;IL6R;AR;LRRC8A;CCN1;HEYL;MDK;CEACAM1;TIAM1;TMEM119;VHL
prerank,positive regulation of secretion (GO:0051047),-0.5198890680187889,-1.274636068081846,0.16996047430830039,0.46303200859289045,1.0,7/11,47.87%,ACSL3;AQP1;SCIN;GPLD1;TRH;XBP1;ABCB11
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3981962898269129,1.2744793519464497,0.13464991023339318,0.8288153251950309,1.0,13/41,20.25%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,"phagocytosis, engulfment (GO:0006911)",-0.39062704721994335,-1.2738583684428113,0.1303370786516854,0.4641487164066695,1.0,6/36,7.13%,DOCK1;RHOBTB1;GSN;THBS1;MYH9;GULP1
prerank,gas transport (GO:0015669),-0.5372539789804741,-1.2737203026680626,0.17995910020449898,0.46380383609007203,1.0,8/10,41.95%,IPCEF1;CYGB;CA2;MYC;AQP1;MB;NGB;RHAG
prerank,regulation of intracellular transport (GO:0032386),0.40662632070005283,1.2735196592362052,0.13427561837455831,0.8297154547834835,1.0,18/38,26.94%,MAP2;TTC21B;DYNLT2B;ANTKMT;LRRK2;GRIPAP1;RINT1;GAS1;SPAG5;RNF139;CAPN10;ATP13A2;WWC1;LAMP1;MLC1;ATP9A;HAP1;RBM4
prerank,response to histamine (GO:0034776),0.5704975910372331,1.2734700983272471,0.1949317738791423,0.8271238367633534,1.0,4/10,18.33%,DRD3;GABRB2;HRH1;GABRB3
prerank,regulation of heart contraction (GO:0008016),0.34756479503590676,1.2731269990136558,0.0979381443298969,0.825564361663126,1.0,8/90,4.23%,ATP1A2;CELF2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.41563170812301625,-1.2729666631490881,0.1515837104072398,0.4648885423899307,1.0,7/27,7.11%,MAP3K5;KAT7;UBC;MAP3K20;RPS27A;UBB;MAPK1
prerank,magnesium ion transport (GO:0015693),0.5240337416791496,1.2728546822274625,0.19642857142857142,0.8239082566977463,1.0,5/12,20.21%,SLC41A1;TUSC3;MAGT1;MMGT1;MRS2
prerank,proton transmembrane transport (GO:1902600),0.41757611864541255,1.2727621171227208,0.15722120658135283,0.8214950298353895,1.0,2/36,5.17%,ATP1A2;ATP6V1H
prerank,gland development (GO:0048732),-0.3462532504583051,-1.2725903237783236,0.10407239819004525,0.4651079378508153,1.0,16/59,9.79%,CAV1;IGSF3;TBX3;LSR;SIX1;TBX1;MET;HES1;ANXA1;ARHGAP35;ZBTB1;STRA6;MDK;SOD1;NOTCH4;TGFB3
prerank,negative regulation of viral release from host cell (GO:1902187),0.5194913400534471,1.2723945586379302,0.2239089184060721,0.8200115548039917,1.0,9/13,28.15%,TRIM5;TRIM35;PML;TRIM13;CHMP3;TRIM32;TRIM8;TRIM11;TRIM28
prerank,sensory perception of pain (GO:0019233),0.4529532506010786,1.2718751617098187,0.1694915254237288,0.8192571085981584,1.0,8/21,20.58%,RETREG1;PTGES;CHRNB2;KCNK4;OPRM1;P2RX4;OPRL1;SCN9A
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5410267319384865,-1.271828716362382,0.1913214990138067,0.4660774524621695,1.0,4/10,8.66%,PARD3;DGKH;PRKD3;PLPP1
prerank,male meiosis I (GO:0007141),0.4931237522996209,1.271395143689123,0.1889763779527559,0.8183581375904566,1.0,3/16,12.71%,DNMT3L;TDRD9;MYBL1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3934020040714355,1.2713937555287687,0.14025500910746813,0.8156483424328724,1.0,13/43,20.25%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,steroid hormone biosynthetic process (GO:0120178),0.43351269154155286,1.2713475488152035,0.14864864864864866,0.813135719022327,1.0,8/29,20.34%,HSD17B2;CYP11B1;MED1;FDX1;STAR;FDX2;HSD17B11;FDXR
prerank,acute inflammatory response (GO:0002526),-0.4304498946051173,-1.2709792732355456,0.14130434782608695,0.467339249765506,1.0,11/23,38.16%,F3;PLSCR1;IL6R;SIGIRR;ANO6;CEBPB;AHSG;VNN1;HPR;HP;CRP
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.47332546576376033,-1.270655141936544,0.1925343811394892,0.46740771180411494,1.0,4/15,11.62%,STOX2;TGFB2;RAI2;SCEL
prerank,transition metal ion transport (GO:0000041),-0.3971986636491925,-1.270634486076515,0.14699792960662525,0.4667723444208185,1.0,12/35,14.68%,TRPC3;SLC30A1;SLC39A8;TFRC;SLC30A9;TRPC6;TRPC4;SLC31A1;ATOX1;TRPC1;SLC30A5;MT3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3719075785282159,-1.269612435221198,0.13592233009708737,0.4684601753853968,1.0,11/39,12.08%,RPS15;RPS24;RPS17;RPS16;RPS5;RPS7;RPS28;SURF6;RPS25;RPS27;RRP7A
prerank,regulation of fibroblast migration (GO:0010762),-0.4427650106063605,-1.2693087967626848,0.1696969696969697,0.4685103198111704,1.0,7/20,14.60%,THBS1;PRR5L;CORO1C;ITGB1;FGF2;HAS1;GNA12
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4739889404363454,-1.2692992399259055,0.17729083665338646,0.46784699665197915,1.0,5/14,17.65%,ENTPD1;ENTPD6;ENTPD2;ADPRM;NUDT16
prerank,autonomic nervous system development (GO:0048483),-0.45859650279859066,-1.2692165531246542,0.1646090534979424,0.46737637839724355,1.0,2/17,3.54%,NRP1;FN1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.47495178904031166,-1.2688858353857915,0.17269076305220885,0.46751677455992646,1.0,12/16,47.64%,TNFRSF21;JAK3;TRIB2;DLL1;FCGR2B;VSIR;TYROBP;PDCD1LG2;IL23A;FOXP3;IL12B;IL23R
prerank,myelination (GO:0042552),-0.3607172556827402,-1.2686528488453122,0.14096916299559473,0.4673415040535177,1.0,20/46,25.24%,ADGRG6;PARD3;CMTM8;LGI4;MYOC;TNFRSF21;EIF2B2;ABCD2;B4GALT5;GPC1;PMP22;ARHGEF10;NFASC;ACER3;SKI;MYRF;PLLP;MPZ;MARVELD1;CXCR4
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4453182636665797,1.2674237816061962,0.16425992779783394,0.8256832390542708,1.0,6/22,10.67%,CACNA1D;CRHR1;DRD3;ADGRV1;LTB4R2;GABBR2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4433505184784492,1.2673614499943193,0.16475095785440613,0.8232559675161134,1.0,4/23,5.82%,TGFBR3;SMAD3;DKK3;NREP
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3156715429702616,-1.2673079021157214,0.06682027649769585,0.4697666404303858,1.0,28/94,21.17%,IL1R1;RPS6KA5;NFKBIA;UBC;IRAK3;NOD1;RPS27A;UBB;PSMB7;PSMA6;IL1RAP;PSMB6;PSMB5;SQSTM1;PSMC4;PSMB8;TAB1;IRAK2;PSMD11;MAP3K8;NOD2;PSMB4;PSMD14;MAPK3;PSMD10;MYD88;PSME1;RIPK2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.39026120874235815,-1.2668265921518007,0.13675213675213677,0.47027337527442925,1.0,14/32,22.96%,FOXO3;RBM3;APP;RPL10;TMED10;PRKCD;EIF4E;SAMD8;PGAM1;DDX25;TIGAR;NR1H4;ROCK1;NANOS3
prerank,insulin receptor signaling pathway (GO:0008286),-0.3343347171211293,-1.2667262795716188,0.08728179551122195,0.46983151747675966,1.0,21/69,15.21%,GAB1;BCAR3;INSR;FOXO1;PIK3R1;GRB14;ATP6V0A4;PIK3C2A;APC;ATP6V0D1;PIK3CA;ATP6V0A1;IGF2;BCAR1;CAV2;SH2B2;AKT2;ATP6V1D;RARRES2;IRS1;FOXO4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4567931443839114,-1.2665768297687248,0.1762208067940552,0.46951882892685964,1.0,6/18,11.98%,VCAM1;SLC39A8;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,protein catabolic process (GO:0030163),0.37512801058661854,1.2664395753477582,0.14285714285714285,0.824250554524775,1.0,18/59,15.00%,MAGEA2;SIAH2;CAPN3;RNF41;SOCS6;HTRA2;CTRL;CLN8;LAMP2;FBXO6;PRPF19;CHEK2;BAG6;FBXO17;CLN5;ADAMTS9;RNF5;UCHL3
prerank,organic acid transport (GO:0015849),0.34126853124310613,1.2657619434830698,0.11480865224625623,0.8241188255676445,1.0,14/94,6.42%,SLC6A13;SLC22A6;SLC13A3;SLC6A12;ACSL1;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC38A1;SLC26A1;STARD5;SLC25A11;PDPN
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.47660081362809004,-1.2657202152871982,0.1814595660749507,0.4707649095812426,1.0,7/15,15.57%,RPL5;RPS7;RPL23;BAG5;FBXO5;LIMK1;MAD2L2
prerank,reverse cholesterol transport (GO:0043691),-0.49153673866440617,-1.2655876024294295,0.1875,0.4704266330598497,1.0,3/13,10.49%,SCARB1;ABCA1;APOE
prerank,rRNA methylation (GO:0031167),0.45038026959737426,1.2654763429995095,0.17208413001912046,0.8225315997881693,1.0,5/22,14.93%,FDXACB1;MRM3;NSUN3;MTERF4;METTL5
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2620316194551592,-1.2652521022771608,0.014652014652014652,0.4705288039356811,1.0,104/416,19.61%,LEF1;GHR;LRCH1;SLC12A2;DAB2IP;IL6ST;PID1;IL1R1;OSMR;LIFR;ZEB1;RHOA;PTPN12;ST3GAL6;GREM2;FOXO1;GAS6;F3;PIK3R1;PTGIS;VCAM1;BCL2L1;FOXO3;SOCS2;STAT3;PTPRJ;FN1;TNFRSF1B;UBC;IRAK3;PTGS2;STX1A;GBP4;STX3;ITGB1;S1PR1;ARHGEF2;ICAM1;GBP5;RPS27A;UBB;AIM2;PDE2A;YBX3;WNT5A;INPP5D;IL6R;TEC;ANXA1;IL20RB;CXCL12;TNFRSF21;CCL13;NFAT5;RPS3;PIK3CA;IL1RAP;CNTFR;IL34;MT1X;FGF2;SOCS5;DOCK8;MAOA;PIK3CD;YWHAZ;IL4R;JAK1;CEBPD;TWIST1;PTPRZ1;IL1RL2;TPR;SLC26A6;CD86;SYNCRIP;POU2F1;VEGFA;CD40;IRAK2;CSF1R;PRKACA;CBL;LDLRAP1;SOCS3;SIGIRR;IFNAR1;GPER1;ADAMTS12;CCL25;JUNB;CCND1;MT2A;PTPN6;GAPDH;MCL1;ASAH2;CRLF1;IRF5;ZC3H12A;USP10;ERBIN;JAK3;HCK
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.34316297471539836,1.2648576882225386,0.12,0.8222505742543038,1.0,7/90,1.06%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,anterograde axonal transport (GO:0008089),0.41025043077747625,1.2635794960805378,0.17228464419475656,0.8245473446943763,1.0,17/37,25.17%,TRAK1;KIF5C;RAB21;AP3S2;SNAPIN;DTNBP1;KIF3A;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1;SPAST;MAP1A;DLG2;KIF5A
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5042037088458465,-1.2635456556520281,0.17892644135188868,0.4739158707306108,1.0,5/13,24.99%,PLA2G4A;MGLL;ABHD6;AWAT2;MOGAT3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5192757978689142,-1.2632901990977463,0.18972332015810275,0.47387328173728277,1.0,4/11,14.79%,TIPIN;FBXO5;BLM;TIMELESS
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.2905597173606551,-1.2632467920727393,0.049479166666666664,0.4733056723719148,1.0,41/175,20.92%,LIMS1;ACTN4;DAB2IP;PID1;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;ARHGEF2;AIM2;YBX3;TNFRSF11B;PSMB7;PSMA6;TNFRSF21;CCL13;RPS3;PSMB6;PSMB5;EDA2R;PTK2B;BIRC3;CD40;PSMC4;PSMB8;PSMD11;GPER1;PSMB4;ADAMTS12;CCL25;EDAR;PSMD14;ZC3H12A;ERBIN;PSMD10;RIPK1;TNFSF8;PSME1
prerank,cardiac muscle cell contraction (GO:0086003),-0.44466103066972107,-1.2630541842014507,0.17634854771784234,0.47309996952714023,1.0,8/19,14.55%,GSN;KCNJ2;CACNA2D1;CACNA1G;CAMK2D;PIK3CA;SCN4B;ATP1A1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.32622804624229873,-1.2628502746555952,0.08232445520581114,0.472983905173973,1.0,29/88,22.69%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMB7;PSMA6;TIAM1;PSMB6;PSMB5;FZD4;PFN1;DAAM1;AP2A1;FZD1;PSMC4;PSMB8;PSMD11;PSMB4;CELSR2;PSMD14;ARRB2;PSMD10;PSME1;ROR2;CDC42;AP2M1;PSMB3
prerank,positive regulation of defense response (GO:0031349),-0.3151263557242683,-1.261994935493681,0.07579462102689487,0.474308863387627,1.0,17/89,12.43%,MEF2C;ETS1;NFKBIA;POLR3F;ABCC1;PLSCR1;APP;GBP5;AGTR1;PDE2A;WNT5A;MDK;IFI35;IL15;SERPINE1;PDCD4;CCN4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.39345140315782806,-1.2618272774837782,0.145748987854251,0.4740546612308519,1.0,17/32,27.66%,CDK17;CDK14;BRD4;KLF11;CDK5;FBXO5;ORC1;DHFR;ID2;CDC45;CDK16;POLA1;E2F7;CDK18;TYMS;NPAT;TFDP1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5335161305627879,1.2614153384375217,0.19681908548707752,0.8298287379126578,1.0,3/12,8.22%,UNC13C;SYT1;RIMS1
prerank,Rho protein signal transduction (GO:0007266),-0.3488008935567499,-1.2606537569305218,0.12045454545454545,0.4761476903359957,1.0,21/53,14.60%,RHOJ;RHOA;NTN1;ARHGEF3;CDH13;CDC42EP3;CDC42EP5;AGTR1;EPS8;ARHGDIB;EPS8L2;CFL1;RIPOR1;ADGRG1;CDC42EP2;ARHGAP1;SHTN1;ARHGDIA;TAX1BP3;LIMK1;GNA12
prerank,cellular response to interleukin-4 (GO:0071353),-0.5281147738910708,-1.2604081770857025,0.1803921568627451,0.4760882163425679,1.0,1/10,0.16%,LEF1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3534792175157232,-1.2602849144884942,0.12272727272727273,0.4757105507938248,1.0,13/52,12.18%,SPTBN1;PRKCH;PIK3R1;EGFR;STX3;ITGB1;NKD2;RACK1;ZDHHC8;STAC;ACSL3;EPHB2;SQSTM1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.374275747834094,-1.259982662606394,0.13987473903966596,0.47569954250987595,1.0,14/36,23.83%,EIF3H;GABARAPL2;AQP11;PRKCG;UBXN1;USP7;BAG5;N4BP1;RYBP;PSME3IP1;UCHL5;FHIT;TAF9;GIPC1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5248876892330532,-1.2588538374400953,0.1910569105691057,0.47763041015544117,1.0,8/11,32.89%,CREB3L1;ATF6B;ATF4;ATF3;MBTPS2;CEBPB;HSPA5;TP53
prerank,glucose transmembrane transport (GO:1904659),-0.4464122136273112,-1.257611434575609,0.1693227091633466,0.4798359226057002,1.0,5/18,12.83%,SLC2A1;PPARD;SLC2A3;SORT1;SLC2A9
prerank,peptidyl-serine modification (GO:0018209),-0.28998328546333835,-1.257604374798225,0.06182795698924731,0.4791825244937625,1.0,56/166,21.67%,PRKCH;MARK1;HIPK1;RPS6KA5;NDNF;STK38L;GAS6;PKD1;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;PRKD1;CSNK1G1;PAK2;TNKS;CAMK2D;MAST4;GALNT13;PRKCD;PLK2;CSNK1G3;MAPK1;CSNK1A1;PRKX;RPS6KA2;PRKCG;HPF1;CDK5;MAPKAPK2;EIF2AK3;VRK3;DYRK1A;POGLUT3;MORC3;STK32A;STK38;AKT2;CSNK2A1;PKN3;MKNK2;PRKACA;NAA10;LATS1;MASTL;MAST2;MAPK12;MARK3;CAMK1G;ULK2;DYRK2;GALNT4;ROCK1;TOP1;CSNK1D
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5087088003644156,-1.2570991090529124,0.2029598308668076,0.4797779486306502,1.0,3/11,2.70%,FAP;PTGIS;BCL2L1
prerank,modulation by symbiont of host process (GO:0044003),-0.5220087980242536,-1.2570967951294045,0.19427402862985685,0.47911592527898333,1.0,5/10,11.00%,B2M;UBC;RPS27A;UBB;HGS
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.34851104419087453,-1.2569882818393416,0.12037037037037036,0.47871670877854067,1.0,18/55,17.11%,GPC6;DCN;GNS;CD44;CSPG4;LUM;SDC3;FGF2;VCAN;HEXA;NAGLU;AGRN;BGN;GPC1;SGSH;CEMIP;CEMIP2;NCAN
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4922425694451088,-1.2568031048735473,0.18326693227091634,0.4785004991261527,1.0,7/13,31.01%,TMEM30A;BCAP31;SEC16B;SAR1A;EDEM2;EDEM1;TMEM30B
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.32719206105954324,-1.2567693069778476,0.0810126582278481,0.4772640560391765,1.0,35/78,29.26%,DYNC1I2;AP2B1;SEC24D;CTSD;CAPZA2;SEC23A;DYNC1I1;KIF23;SH3GL2;CD74;DCTN3;SEC31A;SEC24B;DYNLL1;DCTN5;AP2A1;DCTN6;CTSF;SEC13;CTSS;DYNC1H1;LAG3;AP1S2;DCTN1;CAPZA1;AP2M1;SEC24A;FCGR2B;KIF4A;KIF22;KIFAP3;CTSE;ACTR1A;DNM2;ACTR1B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.32719206105954324,-1.2567693069778476,0.0810126582278481,0.4772640560391765,1.0,35/78,29.26%,DYNC1I2;AP2B1;SEC24D;CTSD;CAPZA2;SEC23A;DYNC1I1;KIF23;SH3GL2;CD74;DCTN3;SEC31A;SEC24B;DYNLL1;DCTN5;AP2A1;DCTN6;CTSF;SEC13;CTSS;DYNC1H1;LAG3;AP1S2;DCTN1;CAPZA1;AP2M1;SEC24A;FCGR2B;KIF4A;KIF22;KIFAP3;CTSE;ACTR1A;DNM2;ACTR1B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5200972899793148,-1.2563602038033224,0.20081135902636918,0.47753148159348835,1.0,5/11,10.31%,MEF2C;RAPGEF2;LYN;ANXA1;PIK3CD
prerank,lipid biosynthetic process (GO:0008610),0.34902200491216784,1.2563358646500966,0.11980033277870217,0.8464060979494282,1.0,23/77,23.57%,ACSL1;PRKAA2;FITM2;ACSM2A;ACSM2B;AGPAT4;PCYT2;PRLR;CLN8;DHRS11;ACSS2;CYP51A1;ACACA;STAR;GGPS1;HMGCR;PAM;FDXR;ALOX5;DOLPP1;LIPC;LIPH;CBR4
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4913326291458447,-1.2562319441179297,0.20039292730844793,0.47715633696668536,1.0,4/13,4.62%,PKD1;NFKBIA;YWHAB;FLNA
prerank,B cell activation (GO:0042113),-0.3319969717715258,-1.2560370987711487,0.10551558752997602,0.4769368176839452,1.0,17/68,14.49%,MEF2C;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;MALT1;PIK3CD;EPHB2;PHB2;HHEX;ITGA4;CTPS1;CD86;PTPRC;CD40
prerank,response to ethanol (GO:0045471),0.49968070810070864,1.2560123257606628,0.2047713717693837,0.8450184815451616,1.0,5/14,8.95%,ADH7;GRIN3A;GLRA1;DRD3;CHRNB2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5501692331725064,1.255719195031278,0.21428571428571427,0.8433999684957605,1.0,7/10,28.81%,E2F8;SSBP1;DBF4;CDC7;ATRX;STOML2;WIZ
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4976206230279584,-1.2548343808051234,0.19573643410852712,0.4791949086059509,1.0,8/12,31.73%,SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,regulation of receptor binding (GO:1900120),-0.5472036593618801,-1.2547161218097143,0.20553359683794467,0.4788415437798674,1.0,4/10,13.89%,B2M;GREM2;ATP2A3;ADAM15
prerank,lymphocyte migration (GO:0072676),-0.3891154417558691,-1.2542389254886037,0.14192139737991266,0.4793125519621245,1.0,23/32,50.43%,S1PR1;CCL13;RET;CCL25;MSN;MYO1G;ZAP70;CCL5;CCL4;GATA3;CRTAM;CCL8;CCL19;CCL14;MSMP;CCL7;CCR6;CCL1;CCL3;CCL11;TBX21;CKLF;XCL1
prerank,DNA methylation (GO:0006306),0.44218563538669936,1.2540313339331548,0.18968692449355432,0.8473669682354321,1.0,12/23,22.07%,DNMT3L;DNMT3A;N6AMT1;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3;PICK1;BAZ2A;ATRX;HELLS
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.43240783236094876,-1.2537751088400984,0.177319587628866,0.4797339005576272,1.0,5/22,13.03%,B2M;ZBTB1;CD55;MALT1;STX7
prerank,regulation of glucose metabolic process (GO:0010906),0.4162586946066016,1.2533479110476302,0.18063314711359404,0.8473475709018109,1.0,9/34,18.59%,RORA;GCGR;PDK2;SLC45A3;PDK1;RUBCNL;SIRT1;AKT1;KHK
prerank,cellular response to organonitrogen compound (GO:0071417),-0.31514104196108317,-1.2531299974168655,0.10194174757281553,0.48061987513561816,1.0,24/99,15.91%,ACTB;PDE3A;MEF2C;RAPGEF2;SLIT2;RAP1A;SH3BP4;CDH1;CTNNA1;CAPN2;PDE2A;KCNQ1;SPAAR;GOLPH3;AHR;RPTOR;NSMF;IPO5;SLC26A6;RRAGA;P2RY6;GLRA2;HTR1B;CFTR
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4157702994378887,-1.2530312536983013,0.15932914046121593,0.48021308934235735,1.0,16/27,36.87%,UBC;IRAK3;RPS27A;UBB;TAB1;IRAK2;BTK;MYD88;TLR4;TLR6;CD36;TLR1;CD14;IRAK4;TAB3;TLR2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.25981182384652873,-1.2527489909994787,0.020134228187919462,0.4802426745753055,1.0,100/417,17.22%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;ZBTB16;DAB2IP;ELK3;ZEB1;FOXP2;WWP1;PPARD;MDFIC;RPS6KA5;KAT7;FOXO1;NOTCH1;TBX3;GAS6;LIMD1;ZHX3;CTCF;RUNX2;ID1;BMP4;PRDM16;CRY1;PTPRK;DACH1;L3MBTL3;JUN;KAT6A;CBFA2T3;GLI3;KCTD1;CCDC85B;BHLHE40;PSPC1;CREB3L1;NIPBL;HES1;XRCC5;TWIST2;WNT5A;SP3;FOXN3;MYBBP1A;NACC2;CD38;HEYL;HDAC9;DAP;YWHAQ;PRDM5;HEY2;CDKN1C;NAB1;SPEN;CDK5;HMBOX1;ZFPM2;CIR1;KLF4;GCLC;AHR;PER1;SOX7;TLE5;PDCD4;PHB2;TWIST1;HHEX;SOX18;BMP2;SAP18;HDAC6;NACC1;USP47;TBX2;NFIL3;POU2F1;SUV39H1;ATXN1;ZNF318;MTERF3;MT3;RBFOX2;TIMELESS;SPINDOC;PA2G4;YAF2;ID2;ARID5A;SIX4;ZBTB33;ING4;HEY1;PEX14;EPC1;HDAC2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5396323261119512,-1.2518044928561276,0.2109375,0.48180124882037034,1.0,3/10,21.42%,CAV1;KCNE4;KCNAB1
prerank,positive regulation of vascular permeability (GO:0043117),-0.5013045557248657,-1.2517500966404287,0.18487394957983194,0.4812812786604273,1.0,7/12,13.96%,PDE3A;TJP1;TJP2;PDE2A;OCLN;TRPV4;VEGFA
prerank,neutral amino acid transport (GO:0015804),-0.399324826222198,-1.2515979979900556,0.1822125813449024,0.48098203501546155,1.0,9/28,14.15%,SLC6A6;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.47790636617005483,1.2514022784228138,0.19678714859437751,0.8519356294814618,1.0,8/17,17.66%,EMC2;EMC4;BAG6;MMGT1;GET1;UBL4A;EMC1;EMC10
prerank,positive regulation of glucose import (GO:0046326),0.456589066888599,1.2512751277028995,0.19274809160305342,0.8497641911767054,1.0,6/21,10.15%,OSBPL8;IGF1;PRKCI;RHOQ;SORBS1;CREBL2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.39090741964335196,1.2511570816568187,0.15636363636363637,0.8475747410728078,1.0,9/40,8.45%,BMP7;WNT4;BMP6;OSR1;BMPR1A;FZD9;WNT6;ADGRV1;PKDCC
prerank,secondary alcohol metabolic process (GO:1902652),0.3982138982896457,1.2507702939575809,0.15942028985507245,0.8464345157793391,1.0,13/42,15.53%,SOAT2;CYP11B1;APOF;SOAT1;OSBPL5;CLN8;CYP27A1;RXRA;FDX1;SQLE;IDH2;TSKU;GBA2
prerank,regulation of myoblast differentiation (GO:0045661),0.41324733614182013,1.2501002048767098,0.16051660516605165,0.8463989846293581,1.0,8/32,12.01%,RANBP3L;IGFBP3;FLOT2;SOSTDC1;PLCB1;MAPK14;SRA1;SOX9
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4845967916832605,1.2489257111245753,0.2152917505030181,0.8481447313498207,1.0,6/15,18.39%,SH3D19;FURIN;ADRA2A;NRDC;SNX33;SNX9
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.40448556713633543,-1.2489233968372462,0.15778251599147122,0.48662612285495566,1.0,11/27,20.54%,LIMD1;EGFR;BMP4;STAT3;PUM2;AGO2;PUM1;FMR1;FXR1;RIPK1;AJUBA
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.38483708000046,-1.2486950876918377,0.15673289183222958,0.48652207960094535,1.0,16/33,27.48%,ACER2;TGFB2;CYP1B1;LYN;SERPINE1;JAM3;RET;NCKAP1L;SYK;RAC3;TESC;ADA;PIK3CG;PTPN11;CIB1;SNAI2
prerank,acylglycerol metabolic process (GO:0006639),-0.3674469544239518,-1.2481802683761343,0.16778523489932887,0.48704628474176614,1.0,8/37,11.88%,CAV1;ABHD2;DGKH;DGKZ;MGLL;APOE;ABHD6;PNPLA2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.49445307927776116,1.248088576559056,0.20428015564202334,0.848558222364332,1.0,5/15,9.21%,LPGAT1;PPARA;SLC45A3;PPARGC1A;NR1H3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.307939390237298,-1.2476277030705236,0.08695652173913043,0.48761508450252955,1.0,31/107,14.90%,CAV1;SLC39A10;STIM2;ATP2B1;SLC10A7;SLC30A1;SLC39A8;SLC30A9;NPTN;TPT1;CXCL12;CCL13;ATP2A3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC39A7;TMCO1;EDN1;SLC30A5;TRPV4;EDN3;HTR2A;CD40;MT3;VAPB
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.45438065195981336,-1.2471634562299343,0.20123203285420946,0.48820106912520844,1.0,6/17,13.96%,CLDN5;VCL;PPP1R12A;F11R;S1PR3;VEGFA
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3243892955994513,-1.2468370103452056,0.08974358974358974,0.4883164033743031,1.0,35/79,29.26%,DYNC1I2;AP2B1;SEC24D;CTSD;CAPZA2;SEC23A;DYNC1I1;KIF23;SH3GL2;CD74;DCTN3;SEC31A;SEC24B;DYNLL1;DCTN5;AP2A1;DCTN6;CTSF;SEC13;CTSS;DYNC1H1;LAG3;AP1S2;DCTN1;CAPZA1;AP2M1;SEC24A;FCGR2B;KIF4A;KIF22;KIFAP3;CTSE;ACTR1A;DNM2;ACTR1B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.45042120584231315,1.2467129663887448,0.176,0.8510817395388587,1.0,4/22,4.52%,TIMP3;SH3D19;FURIN;ADRA2A
prerank,ketone body metabolic process (GO:1902224),0.5361191395782112,1.2459893453242006,0.2123015873015873,0.851168453648393,1.0,3/10,10.51%,OXCT1;ACAT1;BDH1
prerank,cardiac muscle tissue development (GO:0048738),0.3717408729290305,1.2459548294685587,0.1634446397188049,0.8486717723950371,1.0,9/50,8.02%,NOTCH2;BMP7;GJB6;MSX2;BMPR1A;CSRP3;SGCZ;NRG1;KDM6B
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5076515097691945,-1.245763031119636,0.1968503937007874,0.49009981886041915,1.0,5/12,15.24%,DAB2IP;PIK3R1;ERN1;PTPN1;BAK1
prerank,positive regulation of blood coagulation (GO:0030194),-0.4477127078810707,-1.2452922087932516,0.16149068322981366,0.4906258621095742,1.0,5/17,11.46%,ST3GAL4;THBS1;F3;SERPINE1;ENPP4
prerank,organelle fission (GO:0048285),-0.4170391198330914,-1.2447156214623585,0.17932489451476794,0.4912537471601673,1.0,10/24,28.90%,DNM3;CORO1C;MFF;SEC16B;MTFR2;GDAP1;MIEF1;MUL1;DNM2;DNM1
prerank,phosphorylation (GO:0016310),-0.26155038404751974,-1.2445071246624184,0.010344827586206896,0.49105164333071655,1.0,74/384,12.44%,PRKG1;PRKCH;ERG;SNRK;BMPR2;MARK1;NEK7;HIPK1;ACVR1;CDK17;ACVRL1;TGFB2;MAP3K5;INSR;RPS6KA5;MERTK;DGKH;STK38L;GAS6;STK3;LIMD1;PEAK1;LIMK2;BCR;DGKZ;STAT3;AKT3;TGFBR2;APP;IRAK3;AGK;CDK14;FNIP2;BMX;TNIK;PANK3;CSNK1E;MAP3K20;NUAK1;PRKD1;PAK2;ERN1;ADAM10;CAMK2D;LYN;CDC42BPA;TEC;PRKCD;CDKL2;DCLK1;PLK2;MAPK1;CSNK1A1;PRKCG;PIK3CA;STK24;CDK5;MAPKAPK2;EIF2AK3;BCKDK;NEK3;PIK3CD;YWHAZ;MAP4K4;EPHB2;GRK5;JAK1;STK10;DYRK1A;PRKG2;RET;MORC3;BMP2;PTK2B
prerank,cilium movement (GO:0003341),0.3778614082075334,1.2440957437536149,0.1783783783783784,0.8532080301622016,1.0,15/47,22.78%,DNAH1;TEKT2;RSPH4A;TEKT5;CFAP61;CFAP251;ROPN1L;DNAH9;DNHD1;DNAAF2;DNAAF5;SPA17;CFAP54;CFAP91;DNAH5
prerank,electron transport chain (GO:0022900),-0.46580824024694795,-1.2434752019697086,0.20784313725490197,0.492826911905027,1.0,6/15,17.07%,ENOX2;PDIA5;NDUFA5;ETFA;UQCRFS1;POR
prerank,positive regulation of kinase activity (GO:0033674),-0.3083274155316898,-1.2425569714155016,0.09359605911330049,0.4943748950200305,1.0,36/107,21.59%,TEK;ROR1;NTRK3;RAPGEF2;TIE1;INSR;MERTK;GAS6;RAP1A;RASSF2;IQGAP1;EGFR;KDR;CACUL1;FLT1;MET;XRCC5;CCN1;FLT4;EPHB2;CD74;RET;PTK2B;PTPRC;ALK;CSF1R;FGFR3;NBN;TIGAR;AGAP2;TRAF4;MMD2;EPHB6;IGF1R;ROR2;MMD
prerank,amino sugar biosynthetic process (GO:0046349),0.5205129969817772,1.2421589687644274,0.1956521739130435,0.8578254639994151,1.0,3/12,7.14%,RENBP;GNPNAT1;GNPDA1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3836288181668328,-1.2420297067145145,0.16556291390728478,0.4949725340610525,1.0,10/33,25.74%,LEF1;RUNX1;IL34;CD74;ID2;RIPK1;TESC;HCLS1;FES;CASP8
prerank,response to cytokine (GO:0034097),-0.29872666221944216,-1.2413595408396172,0.07627118644067797,0.49587963912004995,1.0,58/141,26.16%,LEF1;IL6ST;PID1;IL1R1;OSMR;LIFR;RHOA;PTPN12;BCL2L1;STAT3;PLSCR1;APP;IRAK3;REL;IFITM3;TNFRSF11A;GCH1;ADAM10;IL6R;TRIM56;ANXA1;RELB;XAF1;NFAT5;SRC;MAPKAPK2;TLE5;ISG15;CD74;IL1RL2;CD40;IRAK2;CSF1R;LDLRAP1;IFITM1;SP100;SIGIRR;PTPN6;MCL1;ASAH2;KYNU;JAK3;RIPK1;MYD88;GGT7;MAP2K7;IFITM2;MAP4K3;GGT1;HCLS1;TAF9;CASP1;SHMT2;PTPN11;CXCR4;CASP8;TIMP1;SMPD1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2896838729384006,-1.2410510624203874,0.07853403141361257,0.49590780431459286,1.0,52/153,21.67%,PRKCH;MARK1;HIPK1;RPS6KA5;STK38L;GAS6;PKD1;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;PRKD1;CSNK1G1;PAK2;ERN1;TNKS;CAMK2D;MAST4;PRKCD;PLK2;CSNK1G3;MAPK1;CSNK1A1;PRKX;RPS6KA2;PRKCG;CDK5;MAPKAPK2;EIF2AK3;VRK3;DYRK1A;MORC3;STK32A;STK38;AKT2;CSNK2A1;PKN3;MKNK2;PRKACA;LATS1;MASTL;MAST2;MAPK12;MARK3;CAMK1G;RIPK1;ULK2;DYRK2;ROCK1;TOP1;CSNK1D
prerank,positive regulation of JNK cascade (GO:0046330),-0.3304592599964717,-1.2408740560270666,0.11845102505694761,0.495652493079462,1.0,21/70,21.65%,DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;APP;MFHAS1;FLT4;EDA2R;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;NOD2;EDAR;RIPK1;SH3RF1;HMGB1;TRAF4;TAOK1
prerank,positive regulation of innate immune response (GO:0045089),-0.38246746083718464,-1.2406920467624474,0.1643835616438356,0.4954112576024844,1.0,15/30,31.61%,POLR3F;PLSCR1;GBP5;NLRC5;WNT5A;IFI35;POLR3B;SPI1;NMI;POLR3D;RPS19;ZBP1;FADD;PLA2G5;UBE2K
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3473413221043512,1.2404349924236946,0.12071778140293637,0.8617921018625452,1.0,15/85,9.05%,EYA1;CACNA1D;DCDC2;USH1C;COL4A3;ALDH7A1;WHRN;GSDME;EML2;CCDC50;PCDH15;MYO3A;ADGRV1;CHRNB2;MYH14
prerank,mitotic spindle assembly (GO:0090307),-0.36305937592330173,-1.2397421550075152,0.14161220043572983,0.4970438440745896,1.0,17/42,24.71%,RHOA;FLNA;SMC1A;STAG1;MAP9;KIF23;PIBF1;MZT1;TOGARAM1;STAG2;ARHGEF10;RAB11A;PRC1;AAAS;TPX2;KIFC1;KIF4A
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.3639080927151358,-1.2396107997161472,0.1489841986455982,0.49670619946264327,1.0,12/45,16.23%,GCNT2;FOXO3;RBM3;APP;ZC3H7A;RPL10;PUM2;EIF4E;PER1;TDRD7;PUM1;DDX25
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4707968744118,1.2392240995373511,0.20194174757281552,0.8637028614023273,1.0,5/16,6.87%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4397978874589083,-1.2386343267327795,0.1983640081799591,0.49836277910655846,1.0,9/18,27.67%,SEC14L1;RNF125;PUM2;BIRC3;PUM1;ZCCHC3;USP15;UFD1;OASL
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3262695143341,-1.2384787471796204,0.14320388349514562,0.49810591117576547,1.0,18/73,11.99%,HIP1;ACER2;TNFSF10;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;ATP2A3;EIF2AK3;IFT57;HIP1R
prerank,neuron apoptotic process (GO:0051402),-0.43385481966019457,-1.238203884817527,0.20040485829959515,0.4980942787544514,1.0,8/19,19.22%,APP;FAS;CIT;TNFRSF21;CDK5;DIABLO;GAPDH;LIG4
prerank,epithelial cell development (GO:0002064),0.456846068403572,1.2380731503796836,0.20112781954887218,0.8655504952530977,1.0,6/20,12.60%,WNT5B;WNT7A;RILPL2;RILPL1;DACT2;PDZD7
prerank,alcohol catabolic process (GO:0046164),0.530625785305175,1.2377326819709338,0.2189922480620155,0.8642103392595812,1.0,3/10,9.24%,CEL;ADH4;CYP27A1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.32611250615298853,-1.237242809212616,0.12561576354679804,0.4997923258154911,1.0,21/76,13.53%,LIMS1;ACTN4;TMSB4X;RHOA;RASSF2;EGFR;NFKBIA;APP;CCN3;NOD1;NR3C2;HDAC7;IFI35;NFAT5;RPS3;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,bicellular tight junction assembly (GO:0070830),-0.3507069432166372,-1.2370429068351847,0.14838709677419354,0.4995727542983994,1.0,11/46,7.38%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,regulation of adaptive immune response (GO:0002819),-0.4453245748836849,-1.2359459255974865,0.1987179487179487,0.5015792448371452,1.0,9/18,35.26%,IL6ST;ADCY7;AHR;FCGR2B;SAMSN1;FADD;IL4I1;SKAP1;SASH3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.48199943664866474,1.235679371254196,0.21346153846153845,0.8695993316514609,1.0,3/16,6.45%,DDX5;PQBP1;DDX17
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3398545757383371,1.2352971028354272,0.1464226289517471,0.8685106633690367,1.0,30/77,19.82%,IGF1;HSPA1A;SIAH2;SLC25A5;PPIF;FZD9;PELI3;HTT;PHIP;CFLAR;TGFBR1;BCL2;CSNK2A2;CAAP1;PIH1D1;CLU;QARS1;NOC2L;BDNF;TMEM14A;SCG2;TCF7L2;NDUFA13;HGF;RELA;NOL3;CX3CL1;AKT1;MAPK8IP2;DDX3X
prerank,positive regulation of catabolic process (GO:0009896),-0.3324813161826605,-1.2351832873488944,0.11421319796954314,0.5026553658647658,1.0,9/65,7.38%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;WNT5A;PLK2;APC
prerank,regulation of dendrite development (GO:0050773),-0.37453376209269795,-1.2344745468546399,0.1794871794871795,0.5037286661295356,1.0,12/37,13.94%,BMP5;DAB2IP;PTN;NEDD4L;MARK1;HECW2;TNIK;RAP2A;NSMF;VLDLR;MFSD2A;ALK
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4472754848387339,-1.2344000017061993,0.18924731182795698,0.5032657559622941,1.0,8/17,13.96%,CAV1;KLF7;AJAP1;PRKX;CEACAM1;APOLD1;MAFF;CD24
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.43245497613374484,-1.2341910032084855,0.2127659574468085,0.5031123133999581,1.0,10/20,23.93%,TTC39B;APOE;SREBF2;ACADVL;LDLRAP1;NR1H4;ARV1;SREBF1;LPCAT3;MBTPS2
prerank,muscle contraction (GO:0006936),-0.29349921492771963,-1.2332211629191248,0.07122507122507123,0.5047784144014196,1.0,22/126,10.67%,UTRN;EDNRA;CALD1;VCL;GJC1;SMTN;SNTB1;MYL12B;ITGA1;MYL6;TPM4;PXN;ITGB5;ALDOA;ACTA2;TPM2;MYH11;MYL9;TMOD3;TPM3;CHRNB1;DYSF
prerank,signal release from synapse (GO:0099643),0.38126268809091735,1.2325363389191948,0.16824196597353497,0.8764190833285974,1.0,18/43,24.95%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;SYN1;NAAA;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3588644005366709,-1.232504027384879,0.1373873873873874,0.5058252637772757,1.0,11/43,9.69%,ETS1;TGFB2;PPARD;FOXO3;BMP4;STAT3;JUN;GNL3;GATA2;KLF4;FGF2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.47945175446680094,1.2319028617173744,0.1984732824427481,0.8762820405835826,1.0,5/16,9.35%,IGF1;IGFBP3;CDH3;MYORG;PHIP
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31795856028673575,-1.2317361023003748,0.10874704491725769,0.5069662647468336,1.0,30/85,22.81%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMB7;PSMA6;TIAM1;PSMB6;PSMB5;FZD4;PFN1;DAAM1;AP2A1;FZD1;PSMC4;PSMB8;PSMD11;PSMB4;CELSR2;PSMD14;ARRB2;PSMD10;PSME1;ROR2;CDC42;AP2M1;PSMB3;RYK
prerank,positive regulation of bone mineralization (GO:0030501),0.3948335825535375,1.2315406697283502,0.19669117647058823,0.8750473675203548,1.0,8/35,8.45%,BMP7;WNT4;BMP6;OSR1;BMPR1A;FZD9;ADGRV1;PKDCC
prerank,mitochondrion organization (GO:0007005),0.30341748079971104,1.231510894917525,0.09404388714733543,0.8725755661752362,1.0,37/165,14.16%,IFIT2;TRAK1;MIGA2;ESRRA;SPATA18;PITRM1;NIPSNAP2;POLRMT;AFG3L2;AIFM1;COX7A1;TOMM40;SUPV3L1;MIEF2;CHCHD3;TIMM17A;LRRK2;ADCK1;MTX2;FMC1;NDUFS1;COX7A2L;WASF1;TOMM22;MYH14;PPARGC1A;CYCS;AFG1L;MPV17;SSBP1;MFN2;GABPA;TERT;AIFM2;ATAD3A;TMEM11;GABPB1
prerank,response to iron ion (GO:0010039),0.5155121676696377,1.2315010955533565,0.20920502092050208,0.8700382246477325,1.0,3/12,9.67%,BMP6;ACO1;BCL2
prerank,intracellular sterol transport (GO:0032366),-0.49071033262860425,-1.2313619511244882,0.21881390593047034,0.5072499307656776,1.0,4/13,11.02%,ABCA1;NPC2;OSBP;STARD4
prerank,osteoclast differentiation (GO:0030316),-0.42502825836948877,-1.2309371808863026,0.19222903885480572,0.5076278483919889,1.0,13/22,36.63%,FOXP1;TNFRSF11A;SRC;SNX10;CSF1R;OSTM1;SBNO2;EFNA2;TREM2;TYROBP;FARP2;GPR183;OSCAR
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.35112667832448247,-1.2302949401267291,0.15677966101694915,0.5084791116910431,1.0,9/48,8.99%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;FBXW8;MYOC;MDK;NEDD9
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5450747029136289,1.2301073033451435,0.2440944881889764,0.8726514288407538,1.0,6/10,18.96%,LPGAT1;SLC45A3;NR1H3;ABCD1;MID1IP1;MLXIPL
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4047434537025657,-1.229995209411926,0.1645021645021645,0.508488556685348,1.0,7/28,12.18%,SHANK3;PTN;APP;FAM107A;APOE;EPHB2;SQSTM1
prerank,positive regulation of response to stimulus (GO:0048584),-0.36086375747974087,-1.2297841799286133,0.16818181818181818,0.5082940553589415,1.0,17/40,24.18%,B2M;TGFB2;WNT5A;PRKCD;IL15;ABI3;CDKN2AIP;RSAD2;EEF1E1;IFIH1;FMR1;FXR1;YPEL3;NSMCE4A;TAF9;FCGR2B;IER5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4909459811406951,-1.2297688860128306,0.21497120921305182,0.5076715593074116,1.0,6/13,29.21%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,protein localization to cell surface (GO:0034394),-0.39508006715697597,-1.22941015868653,0.16444444444444445,0.5078821510468355,1.0,9/26,16.94%,VCL;SMURF1;PTPRK;FLNA;EMP2;FGF7;JAM3;UNC50;PIGK
prerank,positive regulation of transferase activity (GO:0051347),-0.2939536387250709,-1.229162406514081,0.07629427792915532,0.5078029378834878,1.0,47/142,22.94%,TEK;ROR1;NTRK3;NEK7;CD200;TIE1;INSR;MERTK;DCUN1D3;EGFR;EPM2AIP1;KDR;SERINC5;FLT1;TNKS;MET;XRCC5;MAPK1;PTGES3;FLT4;IGF2;HMBOX1;KLF4;EPHB2;CD74;RET;DCUN1D5;UBE2L3;FBXW7;ALK;CCT2;CSF1R;FGFR3;NBN;PARM1;MAPK3;GREM1;RFC4;EPHB6;IGF1R;MAP2K7;MAP3K4;ROR2;DKC1;DTX3L;RYK;POLG2
prerank,neurotransmitter secretion (GO:0007269),0.376845903980579,1.2291448318041684,0.1704119850187266,0.8737541028869489,1.0,18/44,24.95%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;SYN1;NAAA;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.46047180908011004,-1.2288608121013582,0.21008403361344538,0.5078846033123363,1.0,7/17,21.45%,ATP5MF;ATP5F1B;ATP5F1E;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,response to estrogen (GO:0043627),-0.39405602501611914,-1.228774263899862,0.18775510204081633,0.5074522364676192,1.0,8/31,15.72%,CAV1;ESR1;AR;TRIM25;PELP1;SERPINB9;CD24;ARID5A
prerank,pulmonary valve morphogenesis (GO:0003184),-0.449910985869114,-1.2282301257273394,0.20618556701030927,0.5081654782921448,1.0,10/17,8.27%,JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;HEYL;STRA6;HEY2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.39536523789816425,1.2281072576087415,0.17325800376647835,0.8750636286392037,1.0,8/32,12.89%,IGF1;NUPR1;PRKAA2;PPARA;ENO1;PPARGC1A;BEND3;ARNT
prerank,apoptotic cell clearance (GO:0043277),-0.39217228539994425,-1.2276690370134247,0.16989247311827957,0.5088397063974672,1.0,6/30,7.50%,RHOBTB1;SCARB1;THBS1;GAS6;ANXA1;TGM2
prerank,amino acid import across plasma membrane (GO:0089718),-0.40837187613458725,-1.227529413914447,0.1759656652360515,0.5084868960071548,1.0,7/24,8.48%,SLC47A1;SLC6A6;SLC1A5;SLC7A5;SLC7A1;SLC1A3;SLC16A2
prerank,regulation of apoptotic process (GO:0042981),-0.24395982356771873,-1.2272876276167282,0.018691588785046728,0.5083349503019762,1.0,183/676,20.70%,HIP1;LEF1;ARHGAP10;TEK;MEF2C;ACTN4;DAB2IP;IL6ST;TJP1;ITGA6;SLIT2;PTMA;STEAP3;NET1;ACER2;TNFSF10;ARHGEF3;MAP3K5;THBS1;FOXO1;DCUN1D3;TBX3;MCF2L;GAS6;STK3;APAF1;RASSF2;PIK3R1;BCL2L1;FOXO3;EGFR;NGF;NFKBIA;SOCS2;CYP1B1;BMP4;CD44;RASGRF2;UNC13B;KDR;SFRP4;UBC;RPL10;JUN;RPS6KA3;CARD14;NAA16;DNAJA1;TIAM2;ACTN1;FAS;FLNA;TFRC;ITGB1;RNF144B;CRADD;MAP3K20;ARHGEF2;RPS27A;UBB;PAK2;ADAM10;RACK1;PERP;PPIA;WNT5A;TPT1;PLK2;KLF11;ANXA1;APC;TGM2;CD38;RPS6KA2;IAPP;RPS3;SPRY2;CTSD;ABR;SOD1;FLT4;XIAP;TIAM1;SRC;CDK5;CAT;VHL;BCAR1;ARHGEF12;GCLC;TGFB3;GOLPH3;MALT1;YWHAZ;CFL1;NSMF;VAV2;MAP4K4;IFT57;TCTN3;PHLPP1;GRK5;CTSB;HSPB1;BABAM2;TNFAIP8;PHB2;CD74;HIP1R;COMP;SERPINB9;SQSTM1;BMP2;PTK2B;RARG;PLEKHG2;SAP18;TCIM;AKT2;MADD;USP47;ARHGDIA;NME2;BIRC3;EEF1E1;HIGD2A;ALK;VEGFA;JMY;LANCL1;ACVR1C;MT3;BAK1;RHBDD1;PLAUR;PA2G4;NCKAP1L;BAG1;STIL;CBL;SIX4;ATF4;RTN4;DIABLO;RBM25;ING4;HDAC2;GPER1;TOP2A;OSGIN1;TMEM219;RNF157;PREX1;LATS1;STK26;DUSP6;BARD1;PTPN6;MCL1;IRF5;ARHGEF5;PSEN2;GREM1;SOX8;NR1H4;AKT1S1;RHOB;RYBP;JAK3;HCK;HYPK;FOXL2;STK17B;PSMD10;RIPK1;SH3RF1;HMGB1;MYD88;LCMT1;PSENEN;CCND2;POU3F3;IGF1R
prerank,positive regulation of protein secretion (GO:0050714),0.3519292062955708,1.2272778811237794,0.15789473684210525,0.8756663955677209,1.0,7/69,2.86%,BMP6;IGF1;NNAT;FRMD4A;WLS;GCK;NLGN2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.47824329326435694,1.2266127516171974,0.2229038854805726,0.8757309961842817,1.0,4/16,7.96%,TOP2B;EME2;MEIOB;MSH4
prerank,bile acid biosynthetic process (GO:0006699),-0.4150090363923643,-1.2259296512342477,0.18161925601750548,0.5109422479633308,1.0,4/24,6.14%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,negative regulation of protein modification process (GO:0031400),-0.3186070291391769,-1.2256723934895275,0.11920529801324503,0.5109130199466586,1.0,19/79,11.72%,NTRK3;DAB2IP;PID1;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;MFHAS1;YWHAB;XDH;PPP1R16B;PPIA;LYN;OCLN;CRTAP;EPHB2;TERF2IP;SH3GL2
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3778850054873335,-1.2256007897288304,0.17922606924643583,0.5104260318939772,1.0,13/36,25.53%,NRP1;SHANK3;ITGB1;EDN1;EPHB2;HDAC6;FBXW7;HDAC2;GREM1;NCOA3;CCR2;EGF;BUD31
prerank,transcription by RNA polymerase I (GO:0006360),-0.37617480257411384,-1.2255889663713333,0.17708333333333334,0.5097910744441709,1.0,16/34,29.27%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;POLR1H;POLR2F;CCNH;POLR1E;POLR2H;POLR1C;POLR2E
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.36563895857482803,-1.2254436637718462,0.1703056768558952,0.5094798038473521,1.0,10/38,13.24%,CAV1;INSR;CD34;PTGIS;PTGS2;NOS1AP;KLF4;EDN1;DDAH1;KLF2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.37297939685100556,-1.225139530787475,0.1452991452991453,0.5096094115452293,1.0,10/36,14.09%,SGMS1;DAB2IP;FAS;CRADD;PPIA;RPS3;PTPMT1;MADD;CSNK2A1;NR4A2
prerank,response to estradiol (GO:0032355),-0.3842514368841504,-1.224597520322332,0.17832957110609482,0.5102581358286573,1.0,12/31,22.19%,EGFR;SOCS2;STAT3;ESR1;STRN3;ANXA1;NRIP1;GPER1;GGT7;NCOA3;CCDC62;GGT1
prerank,calcium ion import across plasma membrane (GO:0098703),0.49282867592706675,1.223821986532415,0.21923076923076923,0.8836276964059222,1.0,2/14,1.13%,SLC8A3;TRPV1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4094032962086782,-1.2233305422603247,0.2013274336283186,0.5127856232764846,1.0,9/25,26.69%,TMTC2;CAV1;JPH2;CNNM2;MT3;GRIN1;SLC8A1;WFS1;SELENON
prerank,translesion synthesis (GO:0019985),-0.3652593307659495,-1.222439916408725,0.15973741794310722,0.5142545141289133,1.0,22/42,28.89%,RPA1;UBC;RPS27A;UBB;REV3L;TRIM25;ZBTB1;ISG15;MAD2L2;USP43;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4;DTL;UFD1;RFC2;RCHY1;VCP;FAAP20
prerank,mRNA metabolic process (GO:0016071),0.3303131929765842,1.2223137394773806,0.12903225806451613,0.8868605849182528,1.0,20/90,17.01%,HSPA1A;DDX5;CPSF3;SRSF5;CPSF6;HNRNPA2B1;SON;PRMT9;PTBP1;LSM5;PPARGC1A;SRRM4;SLBP;AGO3;LSM11;USP39;SRSF11;HSPA1B;AKAP8L;PRPF3
prerank,regulation of cholesterol efflux (GO:0010874),-0.3929454241199896,-1.2220417206299663,0.1702127659574468,0.5144602349721822,1.0,12/30,18.94%,CAV1;NFKBIA;PLTP;ZDHHC8;TTC39B;ABCA3;APOE;SREBF2;PTCH1;LRP1;NAXE;YJEFN3
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.47127237760167034,1.22200008824679,0.22540983606557377,0.8854878744858371,1.0,2/18,0.87%,IGF1;IL18
prerank,cardiac muscle contraction (GO:0060048),0.39643700296932094,1.2219927104501547,0.18726591760299627,0.8829745894723937,1.0,4/34,8.26%,ATP1A2;CSRP3;TNNI1;KCNH2
prerank,postreplication repair (GO:0006301),-0.35738730996608453,-1.2217892355565654,0.15384615384615385,0.5144094098343752,1.0,21/45,28.89%,RPA1;UBC;UBE2V2;RPS27A;UBB;TRIM25;ZBTB1;WDR33;ISG15;UBE2A;USP43;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4;DTL;RFC2;VCP;FAAP20
prerank,antibacterial humoral response (GO:0019731),-0.4529798093554449,-1.2209931553633395,0.23060344827586207,0.5156292950141649,1.0,3/16,13.92%,DEFA6;RPL39;PLA2G6
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4062426900454411,-1.2202496709044985,0.1905829596412556,0.5168968706635348,1.0,4/24,6.15%,PDE4D;PDE3A;RAPGEF2;PDE2A
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4187532862199895,-1.2201318813790178,0.1983640081799591,0.5165801925782134,1.0,6/22,17.23%,ASXL3;CEACAM1;APOD;CCDC3;ALK;GPER1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4192913011564622,-1.2197270974910945,0.20606060606060606,0.5168386657711933,1.0,7/21,12.43%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1
prerank,regulation of interleukin-12 production (GO:0032655),-0.35282206771233976,-1.219210606712041,0.16546762589928057,0.5174172853274192,1.0,15/47,24.53%,FOXP1;THBS1;IRAK3;PLCG2;MDK;PIBF1;CD40;MAST2;IRF5;JAK3;HMGB1;SYK;RIPK2;MAPK11;TLR4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4447036037156988,1.2186234943464784,0.21755725190839695,0.8935818230234044,1.0,2/20,5.41%,IGF1;PAX6
prerank,inositol lipid-mediated signaling (GO:0048017),-0.342568113438838,-1.2182720002470069,0.18764302059496568,0.5190487535899914,1.0,15/50,16.32%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;TNFAIP8L3;PIK3CA;PIK3CD;EXOC1;PIK3C3;IRS1;CSF1R;PI4KB
prerank,regulation of lipid metabolic process (GO:0019216),0.33206558721528134,1.217633203005998,0.15559157212317667,0.8949067611766761,1.0,24/88,19.94%,PRKAG2;RORA;PPARA;NFYB;SMARCD3;NFYC;PANK2;CHD9;MED1;SC5D;RXRA;CYP51A1;SQLE;TBL1XR1;RUBCNL;NCOR2;ACACA;TM6SF2;GGPS1;MID1IP1;HMGCR;NCOR1;OPA3;SIN3A
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2843418864130922,-1.2169308349825618,0.10136986301369863,0.5216644934137337,1.0,48/150,20.00%,PDE4D;NTRK3;CAV1;DAB2IP;PID1;SLIT2;PARD3;NIBAN1;LRP6;ENG;RASSF2;PRR5L;CORO1C;SPRED2;PAK2;UBASH3B;XDH;RACK1;PPIA;LYN;PRKCD;OCLN;NCK1;CALM3;CEACAM1;SPRY2;EPHB2;TERF2IP;HSPB1;SH3GL2;TWIST1;DBNDD2;GSKIP;PTPRC;PAQR3;TAB1;PLPP3;DDIT4;FKBP8;TRAF3IP1;DMD;PTPN6;ENPP1;PTEN;ZC3H12A;GREM1;AKT1S1;TRIB2
prerank,protein autoubiquitination (GO:0051865),0.35527538349606946,1.2169299728136964,0.17235494880546076,0.8949926414359548,1.0,16/61,21.47%,RNF220;DDB2;SH3RF2;RNF41;TRIM71;RNF10;RNFT1;OBI1;RNF213;MDM2;TRIM13;RNF13;BFAR;NFX1;RNF146;RNF11
prerank,UV-damage excision repair (GO:0070914),0.495259155970162,1.2168546831025338,0.2524084778420039,0.8927079969001139,1.0,2/12,3.40%,DDB2;ERCC1
prerank,arachidonic acid secretion (GO:0050482),0.5328794716447927,1.2167350801974905,0.2535211267605634,0.8881270093367937,1.0,3/10,8.17%,BDKRB2;PNPLA8;DRD3
prerank,arachidonate transport (GO:1903963),0.5328794716447927,1.2167350801974905,0.2535211267605634,0.8881270093367937,1.0,3/10,8.17%,BDKRB2;PNPLA8;DRD3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2671096456855884,-1.2167238702703025,0.06567164179104477,0.5215201670082399,1.0,53/234,15.36%,PRKCH;ROR1;CAV1;SLCO3A1;CD200;LRP6;TRAF5;RPS6KA5;STK3;NFKBIA;STAT3;APP;UBC;IRAK3;ESR1;CARD14;NOD1;MID2;PLCG2;DHX33;TNFRSF11A;TFRC;CARD16;TRIM37;ARHGEF2;PRKD1;RPS27A;UBB;AIM2;PPIA;TRIM14;WNT5A;AR;TRIM25;PSMA6;RPS3;IL1RAP;MALT1;EDN1;TERF2IP;MYOCD;FZD4;PHB2;EDA2R;SMO;ALK;VEGFA;JMY;FZD1;CD40;TAB1;IRAK2;PLPP3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4505841232462025,-1.2166631125010687,0.23045267489711935,0.521006689997857,1.0,6/16,10.38%,BCL2L1;TPT1;NACC2;CXCL12;RPS3;ACKR3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.2503463552253827,-1.2163454918643126,0.011363636363636364,0.5211399374048714,1.0,109/476,17.22%,MECOM;LEF1;MEF2C;ZBTB16;ZFHX3;MLLT3;LRP6;ACVR1;ETS1;ACVRL1;MAP3K5;PPARD;MDFIC;FLI1;FOXO1;NOTCH1;LRP5;KMT2E;FOXO3;EGFR;AFAP1L2;CTCF;RUNX2;CDH1;BMP4;NFATC1;PRDM16;STAT3;SIX1;RNF111;RUNX1;JUN;ESR1;TBX1;NAA16;KAT6A;GLI3;TFEB;SOX17;BRD4;ARID1B;ZXDC;SMARCC1;NFYA;XPC;SMAD5;HES1;WNT5A;AR;SP3;TRIM56;ELF4;CD38;ACTA2;HEY2;ARID1A;CDKN1C;SPIN1;TRIM16;VHL;NOTCH4;KLF4;ELK1;FGF2;TAL1;TGFB3;AHR;ETS2;APOE;PITHD1;FGF7;NFATC2;MYOCD;FZD4;ATAD2;GTF2H1;DYRK1A;CD74;HHEX;SOX18;FOXF2;RET;BLM;BMP2;TEAD1;NCOA6;HNRNPAB;KLF2;NFIL3;CD86;NME2;FZD1;ZNF318;MRPL12;MT3;BRCA2;ENY2;MAD2L2;YAF2;ID2;SIX4;ATF4;COL1A1;DNAJC2;RREB1;HEY1;SP100;EPC1;HDAC2
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4591596463917007,1.2161505852156032,0.220675944333996,0.8877566460433572,1.0,6/18,16.82%,DAB2;RAB21;MTMR2;DENND10;SNX3;PTPN23
prerank,regulation of lipid kinase activity (GO:0043550),0.5147007833377559,1.216077890377385,0.22661122661122662,0.8855485162921891,1.0,2/11,3.08%,PIK3R3;WDR91
prerank,synapse organization (GO:0050808),0.31329940197739786,1.2153658511531773,0.11219512195121951,0.8858222023182081,1.0,24/125,13.53%,SDK1;SLC6A1;UNC13C;SLC8A3;CACNB1;OBSL1;CACNB3;PDZRN3;SDK2;NLGN2;PCDHB11;FLRT3;NLGN3;LRRK2;LRP4;PTPRD;GPM6A;LRRC4C;FZD5;CYFIP1;PCDHB3;BDNF;L1CAM;ELFN1
prerank,glycerol metabolic process (GO:0006071),0.5311888923551719,1.2153009427257044,0.23279352226720648,0.8836014636659784,1.0,5/10,20.92%,GK;TKFC;GOT1;COQ3;TPI1
prerank,cellular protein modification process (GO:0006464),-0.23772620134126443,-1.2152944368924978,0.0,0.5230781666832652,1.0,269/982,21.92%,PRKG1;PTPRM;PTPRB;PTPRG;PRKCH;ST3GAL4;ERG;FBXL7;GCNT2;SNRK;ZBTB16;BMPR2;ST8SIA4;LTBP1;MARK1;NEK7;PTPN12;HIPK1;ACVR1;ST3GAL6;CDK17;ACVRL1;PTP4A2;TGFB2;MAP3K5;INSR;RPS6KA5;THBS1;MERTK;DCUN1D3;STK38L;GAS6;B3GNT2;STK3;SDHAF2;PEAK1;LIMK2;SOCS2;BCR;ATG3;PLOD2;BMP4;PTPRJ;PPP1R12A;FN1;AKT3;WIPI1;TGFBR2;APP;PTPRK;IRAK3;BTBD1;DCAF6;SSH2;CDK14;LMO7;FNIP2;BMX;TNIK;FBN1;MSLN;PDIA6;CSNK1E;COP1;MAP3K20;NUAK1;CST3;PRKD1;PAK2;UBE2D3;ERN1;ST3GAL1;TNKS;ADAM10;ART3;CAMK2D;KLHL2;LYN;LOX;FBXW8;CDC42BPA;TEC;PRKCD;DCAF10;CDKL2;DCLK1;PSMB7;PLK2;CSNK1G3;PSMA6;COG3;CCN1;MAPK1;ANXA1;CSNK1A1;PPP3CA;TGM2;FEM1B;PRKCG;FBXO31;ST8SIA6;LAMB2;PPP2R5C;STT3B;KTN1;FBXO30;MFGE8;STK24;PPM1H;MGAT4A;CDK5;PPP1CA;VHL;AGA;FBXO4;PTPN1;PTAR1;MAPKAPK2;CAND1;SOCS5;EIF2AK3;VCAN;CPE;BCKDK;PSMB6;NEK3;FBXO32;PIK3CD;YWHAZ;MTMR7;YES1;APOE;MAP4K4;SIRT5;OARD1;PSMB5;UBE2F;GRK5;METAP1D;JAK1;STK10;B4GALT5;DYRK1A;ISG15;RAB3A;PNPLA2;PIK3C3;ILKAP;PTPRZ1;PRKG2;RET;MORC3;DCAF13;BMP2;FBXW2;PPP2R3A;PTK2B;FBXO44;DCAF5;STK38;UGCG;AKT2;UBE2L3;FBXW7;EVA1A;CSNK2A1;UBL5;PTPRC;RAB11B;CDH2;PPP1CC;ST8SIA2;FBXL18;GOLM1;LIMK1;PKN3;ACVR1C;MT3;RAB1B;KLHL3;PSMC4;TNC;PSMB8;PIK3R4;ICMT;KBTBD7;PPP4R2;TAB1;RHBDD1;ASB13;ALG10B;MKNK2;PRKACA;PHKA2;ST6GALNAC2;ATG5;GPS1;CTTNBP2NL;PSMD11;CHRDL1;CISH;KLHL22;PHEX;SOCS3;PIGK;TAOK3;COQ8A;STRADA;LATS1;WDR45B;MAST2;KCTD6;PSMB4;CCNF;ATE1;STK26;DUSP6;FBXL4;CTDNEP1;ST3GAL2;PTPN6;PRAG1;PPM1L;DSP;PSMD14;HUNK;MAPK3;MARK3;PTEN;RAB11A;CDK16;IGFBP4;MATN3;BTK;JAK3;HCK;STK17B;PSMD10;TRIB2;CDK6;FBXW5;SIRT7;C3;PPP2R5B;DYRK2;ENGASE;CKAP4;LCMT1;KLHL11;CHEK1;SYK;PPP2CA;PSME1;CDKL4;COPS6;RCE1;MAP3K6;COG7;ROCK1;DUSP1;CHM;PTPRF;ASB1;TAOK1;CSNK1D;FYN;CCDC22;JMJD4;F13A1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.49577701467975976,-1.2150366038415237,0.24293785310734464,0.5230565568164233,1.0,6/12,29.21%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,response to prostaglandin E (GO:0034695),0.5274048984204591,1.2148764808959096,0.24425887265135698,0.8828954763266204,1.0,1/10,0.29%,TGFBR3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.40935759354057066,-1.214720976964525,0.2088607594936709,0.5231945879152455,1.0,6/23,12.44%,GHR;NOTCH1;CYP1B1;HES1;PIBF1;PTK2B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3210750461500656,-1.2143426345506956,0.1382488479262673,0.5235338578807758,1.0,16/66,10.49%,PTPRM;CAV1;SPARC;DAB2IP;B2M;TGFB2;THBS1;MTSS1;PTPRK;CASK;AQP11;XDH;CEACAM1;CDKN1C;CAV2;APOE
prerank,positive regulation of protein processing (GO:0010954),-0.4178834476492638,-1.2138882171385696,0.19742489270386265,0.5239706127404806,1.0,5/19,15.26%,GSN;MYH9;NKD2;CCBE1;RHBDD1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4940159202266347,-1.21380595222521,0.22700587084148727,0.523556752822514,1.0,3/12,6.03%,JAG1;NOTCH1;HES1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.49614121317234927,-1.213767456432472,0.23493975903614459,0.5230006840780264,1.0,5/11,19.13%,MEF2C;TGFB2;MYOCD;GPER1;GREM1
prerank,pore complex assembly (GO:0046931),0.4580416214765284,1.2135460457501293,0.2127659574468085,0.8854937762374251,1.0,3/19,5.56%,AFDN;PLEKHA7;GSDMD
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.33284711882923096,-1.2133845233765115,0.18599562363238512,0.5232809871701438,1.0,15/55,20.49%,PID1;THBS1;CYP1B1;TGFBR2;XDH;AGTR1;SIRT5;ACE2;ROMO1;MT3;CBR1;ZC3H12A;DHRS4;RIPK1;NOXO1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.47965787231066825,-1.2132538663488615,0.21782178217821782,0.5229378385011041,1.0,3/13,1.39%,PID1;NOS3;TMSB4X
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4575276979890928,1.2126431887459557,0.258130081300813,0.886493336776317,1.0,5/17,12.59%,CTR9;CPSF6;CPSF7;RNF20;ZC3H3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.40780646358806943,-1.212621540199577,0.2064516129032258,0.5237790313830134,1.0,4/23,5.43%,SLC12A7;SLC12A2;ATP6V0A4;SLC12A6
prerank,DNA methylation or demethylation (GO:0044728),0.45539904494098976,1.2125568731636032,0.2339622641509434,0.8819019650868039,1.0,7/19,12.41%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,DNA alkylation (GO:0006305),0.45539904494098976,1.2125568731636032,0.2339622641509434,0.8819019650868039,1.0,7/19,12.41%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.32083150908015107,-1.2122997143440246,0.14460784313725492,0.5238822850434672,1.0,29/72,25.74%,LIFR;HIPK1;GAS6;IRAK3;RUNX1;RACK1;CBFB;PTPN1;SPATA2;JAK1;CD74;ABCE1;AGPAT1;MADD;BIRC3;PTPRC;CD24;IRAK2;SOCS3;SIGIRR;PTPN6;RIPK1;SYK;CYLD;TAX1BP1;SOCS1;ZBP1;PTPN11;CASP8
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4870207665906754,-1.2122486570188893,0.2179732313575526,0.5233570798133281,1.0,4/12,13.88%,RUNX1;LYN;CBFB;PTPRC
prerank,regulation of interleukin-10 production (GO:0032653),-0.3504797030865018,-1.211995174217942,0.17286652078774617,0.5233462373066537,1.0,15/44,24.53%,CD34;STAT3;PLCG2;TNFRSF21;PIBF1;ISG15;CD46;NOD2;JAK3;TRIB2;HMGB1;SYK;DLL1;FCGR2B;TLR4
prerank,regulation of small molecule metabolic process (GO:0062012),0.4233010232278049,1.21173275616622,0.2169811320754717,0.8825897505887587,1.0,8/28,16.00%,RORA;PPARA;PANK2;PDK2;PDK1;EPHX2;NCOR2;SIRT1
prerank,cellular response to hormone stimulus (GO:0032870),0.3424415845740334,1.2109059488493954,0.1759581881533101,0.8833694447105344,1.0,8/69,4.52%,ATP1A2;SLC5A5;TFPI;GCK;THRB;CYP11B1;BRD8;ADRA2A
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.27059928596696664,-1.2107336628221395,0.05714285714285714,0.5257633726944309,1.0,33/199,8.93%,PTPRG;MEF2C;BMP5;DAB2IP;BMPR2;NOS3;ATP2B1;PLCL1;RPS6KA5;NOTCH1;GAS6;EGFR;SDHAF2;CORO1C;ID1;BMP4;IL17RD;ADAMTS5;TBX18;KLF7;RAB11FIP5;SPRED2;ARHGDIB;NPTN;TLE3;NOVA2;RAB11FIP1;HDAC9;MDK;SPRY2;HEY2;VASN;IL15
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.43510768021017593,-1.2098902188743594,0.2084130019120459,0.527187955338574,1.0,3/18,4.10%,DCN;KDR;MFF
prerank,regulation of cell-cell adhesion (GO:0022407),-0.36516811795540915,-1.2098608136907762,0.18550106609808104,0.5266166263181195,1.0,7/39,8.89%,PTPRG;PODXL;JAG1;CDH1;CEACAM1;EFNA5;SRC
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.4523521197551307,1.2097269122990184,0.2263779527559055,0.8854870617856184,1.0,3/19,8.23%,IGF1;NLRP2B;NLRP3
prerank,autophagy of mitochondrion (GO:0000422),-0.36069484246211553,-1.2096891170798183,0.17467248908296942,0.5264004007505141,1.0,13/38,20.04%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;PHB2;SQSTM1;GABARAP;ATG12;ATG5;WDR45B;ULK2
prerank,autophagosome assembly (GO:0000045),-0.3365553219865653,-1.209638102080951,0.16705336426914152,0.5259051506011226,1.0,16/52,20.04%,ATG3;SMURF1;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;GABARAP;UBXN2A;RAB1B;ATG12;ATG5;WDR45B;EMC6;ULK2
prerank,activation of adenylate cyclase activity (GO:0007190),0.3897410279156729,1.2093835484526003,0.2196078431372549,0.8844191606280838,1.0,5/35,6.40%,ADCY5;LGR4;ADCY1;CRHR1;ADCY8
prerank,positive regulation of myelination (GO:0031643),-0.4983936475563463,-1.2086870731962527,0.2092130518234165,0.5275696230418878,1.0,2/11,3.66%,PARD3;TNFRSF1B
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25327402705357654,-1.2082759382307464,0.02888086642599278,0.5279322233388327,1.0,69/351,12.91%,ABI1;BMP5;ZBTB7C;RAPGEF2;DAB2IP;BMPR2;NOS3;CD200;B2M;ETS1;ACVRL1;TGFB2;FAP;NOTCH1;TBX3;CDH13;SH3BP4;NGF;CTCF;CYP1B1;BMP4;BTG1;PTPRJ;MTSS1;APP;SFRP4;ADARB1;ITGA1;PTPRK;CCN3;CBFA2T3;IGFBP6;AQP11;HES1;AXIN2;LYN;WNT5A;AR;KLF11;ADAMTS1;APC;NACC2;RPS6KA2;IFI35;PPP2R5C;APOD;CDKN1C;SLC16A2;GATA2;PLPP1;RBBP4;VHL;KLF4;TGFB3;S100A11;BTG3;TES;ADGRG1;HGS;PBRM1;MYOCD;SOX7;DDAH1;MORC3;BMP2;PTK2B;RARG;SST;WNT9A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2946586310373389,-1.208231378766095,0.12285012285012285,0.5274109004080026,1.0,28/113,13.96%,NRP1;TEK;BMP5;NRP2;BMPR2;PTN;VEGFC;CDH13;F3;EGFR;BMP4;KDR;AKT3;TBX1;PRKD1;PPP1R16B;WNT5A;MDK;FLT4;AGGF1;FGF2;PIK3CD;FGF7;NRAS;BMP2;ECM1;NME2;VEGFA
prerank,import into cell (GO:0098657),0.3744513647681263,1.208136300594152,0.19649805447470817,0.8867058845960846,1.0,8/41,9.33%,ATP1A2;SLC6A13;SLC5A3;SLC29A2;SLC38A1;SLC19A1;SNAP25;IL10RA
prerank,regulation of plasminogen activation (GO:0010755),-0.4781531266368194,-1.207537016021968,0.2268041237113402,0.5285141603313894,1.0,3/12,9.37%,THBS1;RUNX1;SERPINE1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.43309199809291565,1.2072440894625787,0.20925553319919518,0.8877141394322168,1.0,2/23,6.87%,TGFBR3;FGFR2
prerank,negative regulation of cell differentiation (GO:0045596),0.29568882786261075,1.2069935001507355,0.1119751166407465,0.8862503660156346,1.0,26/181,9.64%,RANBP3L;BMP7;RORA;COL5A1;TMEM64;SMAD3;OSR1;OVOL2;SUFU;CTR9;DTX1;PPARA;MEIS1;LRP3;LEO1;E2F1;HNRNPU;WWTR1;CITED1;USF3;PTBP1;ADGRV1;MED1;NR1H3;SPRED3;TGFBR1
prerank,mitochondrial transport (GO:0006839),0.36031309547818163,1.2059715579078314,0.18525179856115107,0.8875765469886696,1.0,13/53,13.15%,PITRM1;FLVCR1;COX18;SLC25A5;PPIF;ABCB10;TOMM40;TIMM17A;MTX2;TOMM22;BCL2;MFN2;TMEM14A
prerank,pentose-phosphate shunt (GO:0006098),-0.4866903980169643,-1.2058847297351576,0.2450199203187251,0.531805561212318,1.0,5/11,26.68%,PGM2;RPE;DERA;RBKS;H6PD
prerank,negative regulation of hormone secretion (GO:0046888),-0.5169894792857108,-1.205288294692425,0.2677165354330709,0.5325501230051773,1.0,6/10,37.55%,RAB11FIP5;RAB11FIP1;RAB11FIP3;IL11;LIF;GJA1
prerank,negative regulation of cellular component organization (GO:0051129),0.33751415229163345,1.2052064916906147,0.1672473867595819,0.8880048102168777,1.0,18/74,16.14%,BMP6;SYT11;HSPA1A;PRKCZ;PON1;DNAJB8;OPRD1;TFIP11;IMPACT;SCAMP5;CLU;WASL;MTMR2;RTEL1;RAPGEF3;HSPA1B;SNX33;DNAJB2
prerank,organonitrogen compound catabolic process (GO:1901565),0.359004036195091,1.2051902018555376,0.18998272884283246,0.8856948393456444,1.0,15/57,17.07%,ADAMTS13;CPQ;RENBP;CAPN3;PNPLA8;GNPDA1;CTRL;CLN8;SMPD2;PLA2G15;NPL;CLN5;UCHL3;TRHDE;CTH
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5150451687865518,-1.2050873529642268,0.24903474903474904,0.5324232471831645,1.0,4/10,11.75%,UBC;RPS27A;UBB;ISG15
prerank,response to steroid hormone (GO:0048545),0.3958967011210854,1.2050458609429884,0.21978021978021978,0.8838454208393499,1.0,6/31,11.26%,ATP1A2;TFPI;MED1;NR1H3;PAQR7;ABCA2
prerank,error-prone translesion synthesis (GO:0042276),-0.42388109888915704,-1.203706932980393,0.23517382413087934,0.535097158081215,1.0,9/21,20.50%,RPA1;UBC;RPS27A;UBB;REV3L;MAD2L2;RPA2;PRIMPOL;RFC4
prerank,positive regulation of potassium ion transport (GO:0043268),0.37922329668439064,1.2032063635565342,0.1967799642218247,0.8885929721188699,1.0,11/38,10.67%,ACTN2;ANK2;KCNJ5;ADRA2A;DLG1;KCNJ10;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,calcium ion import into cytosol (GO:1902656),0.4793139553698584,1.2030502015586444,0.22770398481973433,0.8868034740483582,1.0,2/15,1.13%,SLC8A3;TRPV1
prerank,detection of mechanical stimulus (GO:0050982),-0.4354276346292706,-1.202776094664408,0.21413276231263384,0.5367800929326006,1.0,3/19,2.87%,PIEZO2;PKD1;PIEZO1
prerank,nucleic acid-templated transcription (GO:0097659),0.38371859278344045,1.202523348078368,0.21641791044776118,0.8864438247677607,1.0,16/42,22.81%,THRB;RRAGC;DTX1;E2F1;DRG1;CREBL2;TOPORS;TERT;XAB2;POLR2D;RNPS1;MEF2A;POLR2A;BAZ2A;MMS19;POLR2B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3997413588430618,1.201415029779961,0.2339622641509434,0.8881124292702098,1.0,5/30,5.82%,TGFBR3;SMAD3;TWSG1;DKK3;NREP
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4235749236569145,1.2011147152272004,0.256,0.8869137461930562,1.0,6/22,11.32%,NOTCH2;CDH3;FGFR2;MED1;CRNN;STXBP4
prerank,organelle fusion (GO:0048284),0.43567547684901986,1.2008313570766205,0.24719101123595505,0.8856070068183347,1.0,8/22,19.72%,MIGA2;AFG3L2;MIEF2;CHCHD3;MFN2;STX4;MIGA1;BAX
prerank,cellular response to increased oxygen levels (GO:0036295),-0.49493753468054963,-1.2007171346042027,0.2400793650793651,0.5413361811902333,1.0,4/11,8.08%,CAV1;FOXO1;FAS;ATP6V0D1
prerank,relaxation of muscle (GO:0090075),0.4851036171369513,1.2005131534543694,0.2446601941747573,0.8845128513155766,1.0,1/13,0.03%,ATP1A2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3727646628768159,-1.1997179647415688,0.20842572062084258,0.5430697149324967,1.0,10/30,11.80%,BCL2L1;CD44;TPT1;CXCL12;RPS3;ACKR3;FBXO5;DYRK1A;CD74;TWIST1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3254332878305477,-1.1993979779703934,0.15348837209302327,0.54318227437234,1.0,24/62,25.06%,MEF2C;ZBTB16;THBS1;KMT2E;H3-3A;AGO1;RUNX1;LYN;DPY30;CBFB;MYL9;PAF1;PTK2B;KMT2C;PRMT6;AGO4;CDK6;SPI1;L3MBTL1;ZFPM1;PRMT1;ASH2L;FES;KMT2B
prerank,regulation of histone modification (GO:0031056),-0.47175201243747145,-1.1993015144601142,0.23715415019762845,0.5427411521691411,1.0,5/13,11.03%,NNMT;HPF1;IGF2;PARG;MYOCD
prerank,cellular response to organic substance (GO:0071310),-0.2856152150978067,-1.1992168696569028,0.12368421052631579,0.5422965558169893,1.0,16/116,6.00%,LEF1;GHR;BMPR2;PID1;SLIT2;RHOA;PTPN12;ACVR1;ACVRL1;RAMP2;SOCS2;CYP1B1;STAT3;TGFBR2;CPNE3;RACK1
prerank,modulation by host of symbiont process (GO:0051851),-0.371732928211431,-1.1989360922321635,0.19088937093275488,0.54232516372198,1.0,15/31,37.91%,LEF1;JUN;SAP30BP;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1;POU2F3;AQP1;HPN;SAP30;CCL5;CCL4;HDAC1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4492641987535747,-1.198374757729305,0.24390243902439024,0.5430256621763103,1.0,8/15,13.96%,TJP1;BMPER;ITGA5;SMAD1;KLF4;FGF2;JAK1;VEGFA
prerank,myotube differentiation (GO:0014902),0.44846173412195345,1.1981077978315813,0.21188118811881188,0.8911300654452072,1.0,4/17,5.18%,IGF1;ADAM12;ADAMTS15;ADGRB3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4093430755151337,-1.1978547123424041,0.22058823529411764,0.543577014826594,1.0,10/24,23.10%,B2M;TAP2;SEC24D;BCAP31;SEC23A;SEC31A;SEC24B;SEC13;ERAP1;SEC24A
prerank,pharyngeal system development (GO:0060037),-0.45234968716941304,-1.1976139136110384,0.22736842105263158,0.5434897630114361,1.0,6/15,6.03%,BMP5;BMPR2;TGFB2;BMP4;TBX1;HES1
prerank,stem cell differentiation (GO:0048863),0.3786695924659272,1.19749659836881,0.222007722007722,0.8911740539119305,1.0,10/39,9.85%,OSR1;DNMT3L;KIT;LMBR1L;WNT7A;FGFR2;JARID2;HOXB4;GPM6A;BATF
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.34718496648115915,1.197299913759165,0.16058394160583941,0.8895586037608998,1.0,18/69,16.14%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;DNAJC10;USP19;ECPAS;SGTB;FBXO6;RNF121;TMEM67;BAG6;FBXO17;RNF5;UBXN4;DNAJB2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4249536252864199,-1.1972099418175035,0.24183006535947713,0.5438515937306997,1.0,5/21,7.88%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,negative regulation of neurogenesis (GO:0050768),-0.36050845006481513,-1.1966512831331433,0.1963882618510158,0.5446444108728457,1.0,5/34,2.26%,RAPGEF2;PTN;RHOA;B2M;NOTCH1
prerank,bone development (GO:0060348),0.38326736061467986,1.1965620872190414,0.21032504780114722,0.8900902164095001,1.0,3/39,2.52%,RANBP3L;DYM;CYP26B1
prerank,peptide metabolic process (GO:0006518),0.33519495014705464,1.196287073376226,0.1657848324514991,0.888825717203461,1.0,6/75,3.24%,AEBP1;ADAMTS13;CPQ;CPN1;ETHE1;FURIN
prerank,cAMP biosynthetic process (GO:0006171),0.5112431815726002,1.1959964871374853,0.24203821656050956,0.887549705219552,1.0,3/10,6.40%,ADCY5;ADCY1;ADCY8
prerank,regulation of microtubule nucleation (GO:0010968),0.5203036658002254,1.1958814602513395,0.2476007677543186,0.8856822326471121,1.0,2/10,5.40%,HSPA1A;EML2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4937269768919327,-1.1957471654908844,0.2535211267605634,0.5462740498737125,1.0,3/11,6.34%,PID1;TFRC;VAT1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4957108347821179,1.1957076558581452,0.2533081285444234,0.8840098951066457,1.0,5/13,18.12%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,regulation of transmembrane transport (GO:0034762),-0.37520098403975055,-1.195608716645492,0.21193415637860083,0.5459536424493002,1.0,10/31,16.22%,ACTB;SLC2A1;NEDD4L;KCNJ2;OCLN;KCNJ12;ACE2;KCNJ8;KCNJ15;CTTNBP2NL
prerank,cobalamin metabolic process (GO:0009235),-0.4359417620617082,-1.194432503388626,0.22645290581162325,0.5482412660356816,1.0,4/17,8.29%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.37507643914146405,1.194400714426175,0.2036036036036036,0.8865686376435968,1.0,8/41,9.38%,PTGS1;ACSL1;DAGLA;PLA2G4C;PNPLA8;GSTM2;PTGR1;ABCD1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.29031062802290164,-1.194139183367902,0.11928934010152284,0.5482968585986201,1.0,24/119,12.10%,PIP5K1B;RAB14;PIP4K2A;INPP4A;TTC7A;PIK3R1;SOCS2;PIK3C2A;BMX;PLCG2;PLEKHA8;PIK3R6;EFR3B;INPP5D;PLEKHA4;PIK3CA;FGF2;PIGC;SOCS5;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12
prerank,mitotic chromosome condensation (GO:0007076),0.4146413124341361,1.193853882954412,0.23722627737226276,0.8862919337615975,1.0,6/26,9.72%,KMT5A;NCAPD2;PLK1;PHF8;TENT4A;CSNK2A2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5097002013093285,-1.1930916044884103,0.2490842490842491,0.5500739700102427,1.0,3/10,7.83%,BMP4;GLI3;MDK
prerank,regulation of autophagy (GO:0010506),0.2915811386064853,1.1926336695614765,0.11455108359133127,0.88854672063811,1.0,44/216,15.11%,PRKAG2;RNF152;SNX6;LEPR;NUPR1;CTSA;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;PLEKHF1;ITPR1;OPTN;PIK3CB;TRIM5;ATP6V0B;ATP6V1H;ZKSCAN3;CASP3;RMC1;LRRK2;MTMR4;HTRA2;KAT5;ATP6V1B2;GOLGA2;IL10RA;SLC38A9;BCL2;CSNK2A2;ATP6V1E1;FZD5;ATG13;KDM4A;LAMTOR2;ATP6V0E2;ATP6V1C1;TBC1D14;NPRL2;VDAC1;ABL1;ATP6V0D2;ATM;LAMTOR3
prerank,protein localization to chromosome (GO:0034502),-0.3650578910448719,-1.192462192693498,0.2021505376344086,0.5509759100106083,1.0,10/34,18.04%,RPA1;WAPL;CTCF;ESR1;TNKS;XRCC5;TERF2IP;RAD21;RPA2;SLF2
prerank,cellular response to alcohol (GO:0097306),-0.35607201867372973,-1.1920022183609167,0.18494623655913978,0.5514846179356211,1.0,17/42,15.91%,LRP6;CDH1;CTNNA1;GNB1;GNG2;ADCY7;ADCY2;GOLPH3;AHR;BLM;GRAMD1A;PTCH1;SMO;ADAM15;GLRA2;PTGFR;CFTR
prerank,negative regulation of cellular process (GO:0048523),-0.24495685738173487,-1.1917438194575671,0.0371900826446281,0.5514321546362891,1.0,105/521,13.89%,APBB2;PODXL;ABI1;BMP5;ZBTB7C;RAPGEF2;PDE8A;DAB2IP;BMPR2;SLIT2;NOS3;CD200;ETS1;ACVRL1;TGFB2;CD9;DCUN1D3;NOTCH1;CDH13;SH3BP4;MYH9;CD34;NGF;CTCF;VPS13C;CYP1B1;BMP4;BTG1;PTPRJ;PLSCR1;APP;SFRP4;TNFRSF1B;ADARB1;ITGA1;FHL1;PTPRK;CCN3;TBX1;ACTN1;CBFA2T3;SOX17;IGFBP6;CCDC85B;CASK;VAMP3;AQP11;PRKD1;ADAM10;ARHGDIB;RACK1;AXIN2;LYN;AR;KLF11;CCN1;NCK1;ADAMTS1;APC;CHMP4B;NACC2;TNFRSF21;RPS6KA2;MDK;IFI35;PPP2R5C;TGFBI;PLPP1;RBBP4;TXNIP;VHL;NOTCH4;KLF4;FGF2;EIF2AK3;TGFB3;S100A11;CDKN2AIP;BTG3;TES;DYSF;EPHB2;ADGRG1;HGS;PBRM1;MYOCD;SOX7;FBXO5;NME6;DDAH1;PDCD4;PLXNC1;BLM;BMP2;CCN4;PTK2B;RARG;SST;SIPA1;WNT9A;SUZ12;ARHGDIA;RERG;EEF1E1;ADAM15
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.44848290747857555,1.1913033911757043,0.2490272373540856,0.8912837027925827,1.0,7/17,20.23%,BMP6;TRIM5;CACTIN;SASH1;PRKCA;CX3CL1;NFKBIL1
prerank,regulation of DNA metabolic process (GO:0051052),-0.34812352245596667,-1.190984411950104,0.18502202643171806,0.5526675723576114,1.0,23/44,33.75%,KAT7;UBE2V2;XRCC5;PARG;TERF2IP;YLPM1;WRNIP1;KPNA2;NBN;SIRT7;NUCKS1;TOM1L1;USP1;HNRNPD;WDR18;TERF2;STOX1;KPNA1;HELB;MYC;PIF1;TICRR;IL7R
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.4992586609246174,-1.190938683245322,0.25984251968503935,0.5521233504839166,1.0,9/11,47.43%,ANXA1;SOCS5;ZC3H12A;JAK3;SMAD7;IL4;RC3H2;FOXP3;TBX21
prerank,regulation of smooth muscle contraction (GO:0006940),-0.42052191940711947,-1.1903855632849343,0.22016460905349794,0.5527467320732677,1.0,3/20,1.56%,CAV1;PLCE1;ATP2B1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.34804912189908416,1.1903854234243572,0.21929824561403508,0.8924783291111302,1.0,13/61,16.38%,EYA1;DNMT3L;EYA4;EYA2;SMOC2;OTUD4;ABRAXAS1;MRE11;PML;RTEL1;HGF;SIRT1;USP9X
prerank,regulation of cell differentiation (GO:0045595),-0.27856045476733876,-1.1901425891260473,0.09230769230769231,0.5527373863904432,1.0,35/148,16.89%,SLC6A6;LTBP4;SPOCK2;ZFHX3;TRPS1;PHLDB1;NGF;RUNX2;SIX1;RUNX1;RPS6KA3;TBX1;PHLDB2;AR;APC;CBFB;MDK;EMP2;HEY2;TIAM1;IGF2;VHL;NOTCH4;KLF4;CEBPD;EDN3;SUZ12;ALK;CD24;PA2G4;ID2;PRKACA;ATF4;BCL6B;HEY1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.493551225783182,-1.1899020628837678,0.2572533849129594,0.5526926231679334,1.0,2/11,4.35%,CDH13;PLCG2
prerank,regulation of protein binding (GO:0043393),-0.29483969872002413,-1.1895411473904967,0.12878787878787878,0.5529621216997801,1.0,39/114,22.15%,ACTB;CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;DISC1;BMP4;APP;BTBD1;RALB;CSNK1E;CARD16;RACK1;PRKCD;SPPL3;TIAM1;PPP1CA;GTF2F1;PRMT7;TLE5;HIP1R;BMP2;NMD3;EPB41;PRKACA;LDLRAP1;LRP1;PEX14;VTN;MARK3;PSME3IP1;PPP2CA;RIPK2;ROCK1;EFHB;DTX3L;ZFPM1
prerank,mitochondrial membrane organization (GO:0007006),0.3957551996861008,1.1893181678937776,0.213768115942029,0.8943604393293411,1.0,10/32,14.23%,SLC25A5;PPIF;CHCHD3;MTX2;APOO;BCL2;MICOS10;MFN2;TMEM11;APOOL
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3034855442916752,-1.1892864956550315,0.16350710900473933,0.5529717086518595,1.0,29/82,22.62%,ACTB;ARHGEF28;RHOA;ACTG1;ANKS1A;CHN1;AP2B1;LYN;GRIN2B;EFNA5;TIAM1;SRC;VAV2;YES1;EPHB2;AP2A1;GIT1;ARPC2;GRIN1;PSEN2;PSENEN;EPHB6;ARPC3;ROCK1;CDC42;MMP2;FYN;AP2M1;RASA1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.41703486317509564,-1.1891840020813917,0.22736418511066397,0.5526089903944538,1.0,9/19,33.00%,LRP6;VEGFA;NR4A2;MANF;LMX1B;RYK;LMX1A;WNT2;CTNNB1
prerank,regulation of insulin secretion (GO:0050796),0.3142708549649469,1.1888975390386634,0.1733102253032929,0.8937050046453482,1.0,26/101,17.28%,CACNA1D;ADCY5;NNAT;GCK;NLGN2;CACNA2D2;ITPR1;ADRA2A;BMP8A;SNAP25;CLOCK;KCNC2;ITPR2;STXBP4;CHGA;RAPGEF3;KCNS3;ENSA;PRKCA;EIPR1;PER2;TCF7L2;IL6;GIPR;RBP4;PICK1
prerank,respiratory tube development (GO:0030323),0.40040234225006643,1.188252644157575,0.21428571428571427,0.8938621525003022,1.0,6/28,6.87%,FGF1;FGF9;LOXL3;PDPN;CEBPA;FGFR2
prerank,cellular response to interleukin-1 (GO:0071347),-0.27731885785386634,-1.1876151931117205,0.09725685785536159,0.5558318589976201,1.0,36/143,21.17%,DAB2IP;IL1R1;RPS6KA5;PTGIS;NFKBIA;UBC;IRAK3;NOD1;RPS27A;UBB;PSMB7;PSMA6;CCL13;IL1RAP;PSMB6;PSMB5;SQSTM1;CD40;PSMC4;PSMB8;TAB1;IRAK2;PSMD11;MAP3K8;NOD2;PSMB4;ADAMTS12;CCL25;PSMD14;MAPK3;ZC3H12A;USP10;PSMD10;MYD88;PSME1;RIPK2
prerank,lipid oxidation (GO:0034440),-0.48014852009591,-1.1874916203209052,0.27459016393442626,0.5554989526733588,1.0,2/12,5.30%,ADIPOR2;ACOX1
prerank,negative regulation of cation channel activity (GO:2001258),0.40650973959358677,1.1873381710011317,0.21553398058252426,0.8949096024195239,1.0,6/26,11.74%,SLC6A9;CRHR1;GNB5;GSTM2;DRD3;GSTO1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3608801268937221,-1.1870241011864886,0.2153846153846154,0.5560334278522655,1.0,13/39,16.82%,PIP4K2A;TTC7A;PIK3R1;SOCS2;PIK3C2A;EFR3B;PIK3CA;SOCS5;PIK3CD;PIK3C3;PI4KB;CISH;SOCS3
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42832470846814885,1.1868515449762849,0.24765478424015008,0.8943277389504498,1.0,6/22,12.61%,ROCK2;PICALM;CASP3;ABCA2;CLU;EPHA4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24301078813559496,-1.1868363617028581,0.028169014084507043,0.5559178270762559,1.0,111/497,17.22%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;ZBTB16;DAB2IP;BMPR2;ELK3;ZEB1;FOXP2;WWP1;ACVRL1;PPARD;MDFIC;RPS6KA5;KAT7;FOXO1;NOTCH1;TBX3;WAPL;GAS6;LIMD1;ZHX3;CTCF;RUNX2;ID1;BMP4;PRDM16;CRY1;PTPRK;DACH1;L3MBTL3;JUN;KAT6A;CBFA2T3;GLI3;KCTD1;CCDC85B;BHLHE40;PSPC1;CREB3L1;NIPBL;RACK1;HES1;XRCC5;TWIST2;WNT5A;SP3;FOXN3;MYBBP1A;NACC2;CD38;HEYL;HDAC9;DAP;RPS3;YWHAQ;PRDM5;HEY2;CDKN1C;NAB1;SPEN;CDK5;HMBOX1;ZFPM2;CIR1;KLF4;GCLC;EIF2AK3;S100A11;AHR;PER1;SOX7;TLE5;PDCD4;PHB2;TWIST1;HHEX;SOX18;BMP2;SAP18;HDAC6;NACC1;USP47;TBX2;NFIL3;SYNCRIP;POU2F1;SUV39H1;ATXN1;ZNF318;MTERF3;MT3;RBFOX2;TIMELESS;SPINDOC;DHFR;PA2G4;YAF2;ID2;ARID5A;SIX4;ZBTB33;FMR1;FXR1;ING4;HEY1;PEX14;EPC1;HDAC2
prerank,melanosome organization (GO:0032438),0.4091311891754488,1.1867720048144823,0.23277467411545624,0.8923674170946218,1.0,8/26,19.09%,GPR143;SNAPIN;DTNBP1;AP1M1;SHROOM2;HPS1;HPS4;RAB38
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3663245925867481,-1.1867069583180958,0.21413721413721415,0.5555991460736194,1.0,5/30,9.38%,BMPR2;ACVRL1;DACH1;SRC;TENT4B
prerank,plasma membrane repair (GO:0001778),0.4828298461055878,1.186696522042939,0.26996197718631176,0.8904110665502543,1.0,3/13,6.95%,SYT11;ANXA6;MYOF
prerank,sulfate transport (GO:0008272),0.46869884201254786,1.1866408314411405,0.2547892720306513,0.8883910912017923,1.0,3/14,6.12%,SLC13A4;SLC26A1;SLC25A11
prerank,neural tube development (GO:0021915),0.4702714552238637,1.1866250814886286,0.27547169811320754,0.8862386401822917,1.0,2/15,5.79%,ALDH1A2;TRIM71
prerank,synapse assembly (GO:0007416),0.3398083724409972,1.1866023214126924,0.20033670033670034,0.8841429467978562,1.0,14/67,12.87%,SDK1;OBSL1;SDK2;NLGN2;PCDHB11;FLRT3;WNT7A;CBLN4;GRID2;NLGN3;GPM6A;FZD5;PCDHB3;BDNF
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3602698542208834,-1.1864965220656862,0.2219730941704036,0.5554813939389494,1.0,12/39,8.38%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;TJP2;UBASH3B;PPIA;CLIC1;MYL9
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3621231115599786,1.185795671066929,0.2115732368896926,0.8849644339871026,1.0,19/52,20.12%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;HNRNPL;PTBP1;SRRM4;YTHDC1;FXR2;RBM5;MBNL3;RNPS1;RBFOX1;SRSF6;PUF60;CELF6;REST
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3498848442906845,-1.1854587674820918,0.19661733615221988,0.5574160444896402,1.0,6/40,7.63%,MEF2C;ZEB1;RHOA;NGF;ARHGEF2;HEYL
prerank,eye morphogenesis (GO:0048592),-0.4182371281508751,-1.18490516136855,0.24369747899159663,0.5580764217445612,1.0,11/19,21.28%,MFAP5;STAT3;COL5A2;FBN1;NIPBL;RARG;VEGFA;ALDH1A3;AGTPBP1;EFEMP1;SKI
prerank,organophosphate ester transport (GO:0015748),-0.39272712421336764,-1.184699060329139,0.24,0.5579110753142613,1.0,7/24,7.48%,PITPNC1;SCARB1;PLTP;TNFAIP8L3;NPC2;ABCA3;MTTP
prerank,regulation of proteolysis (GO:0030162),-0.3441166115807841,-1.1846543974604213,0.20956719817767655,0.5573752123861312,1.0,14/48,17.22%,CAV1;LTBP4;DNAJC1;SPOPL;CST3;PERP;CDK5;HDAC6;GSAP;IST1;TBC1D10A;BAK1;PLAUR;HDAC2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.43738380074667166,1.1844259416974918,0.27079303675048355,0.8878290389002335,1.0,7/19,17.87%,ALDH1L1;SLC19A1;MTHFS;MTHFR;MTHFD1;FPGS;MTHFD2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3729337506880693,-1.1838609599098913,0.22629310344827586,0.5587742955089066,1.0,9/30,17.11%,DCN;CSGALNACT1;NDNF;CSPG4;VCAN;HEXA;CHSY3;BGN;NCAN
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3006893528589809,1.1838078469800426,0.15275590551181104,0.8878594765331089,1.0,18/142,9.82%,ATP1A2;ADCY5;CCR9;ACKR2;PDGFRA;SMAD3;TAC1;C5AR2;BDKRB1;LPAR2;BDKRB2;FZD9;ADCY8;DRD3;LPAR1;DLG4;PTGER1;C3AR1
prerank,skeletal muscle tissue development (GO:0007519),-0.37432023679251714,-1.183616256777448,0.20444444444444446,0.5587190045308583,1.0,5/32,5.58%,MEF2C;CAV1;SVIL;SIX1;MYL6
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3642401413313315,-1.1832686058987862,0.21978021978021978,0.5589276471329682,1.0,13/34,25.24%,PTPRB;PTPN12;PTPRJ;UBASH3B;PTPN1;DUSP3;PTPRZ1;DUSP6;PTPN6;DUSP1;PTPRF;DUSP7;PTPN11
prerank,negative regulation of neuron differentiation (GO:0045665),0.4203131495948728,1.1830263782259467,0.2509727626459144,0.8885916330534593,1.0,4/22,12.01%,BMP7;DTX1;MED1;SOX9
prerank,epidermis development (GO:0008544),0.34341257188267726,1.1829329569630667,0.19708029197080293,0.8868042158631307,1.0,7/56,6.87%,OVOL2;LAMB3;CRABP2;CCN2;SPRR1A;FLOT2;FGFR2
prerank,ameboidal-type cell migration (GO:0001667),-0.3307772051126154,-1.1826196990632079,0.19212962962962962,0.5599147388621972,1.0,19/51,21.89%,SEMA6A;SEMA3C;SEMA7A;CORO1C;CCN3;TBX1;SEMA5B;SEMA3E;ITGA4;SEMA3G;FAT2;AMOT;PKN3;SEMA6D;SEMA5A;SOX8;AMOTL1;SEMA3F;SEMA4C
prerank,acyl-CoA metabolic process (GO:0006637),0.37615211894387385,1.1822687738603623,0.22021660649819494,0.8869959258106004,1.0,10/35,21.24%,ACSM2A;ACSM2B;SUCLA2;GLYAT;ACACA;ACOT1;ACOT6;ACOT13;SUCLG2;ACOT9
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.46881929103483444,-1.1822638695749856,0.261758691206544,0.5601200855096476,1.0,3/13,3.07%,NOTCH1;TBX3;BMP4
prerank,actomyosin structure organization (GO:0031032),-0.31258247081748564,-1.1822543938670547,0.18341708542713567,0.5595073718476061,1.0,14/75,8.89%,FRMD5;PGM5;TJP1;RHOA;MYH9;WDR1;F11R;ITGB1;CIT;CDC42BPA;ITGB5;TMOD3;CSRP2;SRC
prerank,positive regulation of ion transport (GO:0043270),0.3612368701948544,1.1819220241947126,0.20588235294117646,0.8861349767206492,1.0,7/48,5.44%,CACNA1D;ACTN2;ANK2;WNK3;ADRA2A;DLG1;VAMP7
prerank,ERAD pathway (GO:0036503),0.32822258399114806,1.181742101895185,0.18006993006993008,0.8846057565338243,1.0,25/83,20.71%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;DNAJC10;USP19;ECPAS;SGTB;FBXO6;RNF121;TMEM67;CCDC47;UBXN6;BAG6;FBXO17;RNF5;UBXN4;DNAJB2;UGGT2;RNF139;TRIM13;RCN3;RNF103-CHMP3
prerank,central nervous system development (GO:0007417),-0.2564633840051961,-1.1815214239803775,0.0712166172106825,0.5606707686294885,1.0,47/250,14.09%,ADGRL2;SLC2A1;ZBTB16;PBX1;ZFHX3;SHROOM4;COL4A1;VIT;GSN;WWP1;TBX3;PKD1;PBX3;STAT3;LSR;TGFBR2;EML1;RPS6KA3;BPTF;CHST8;ADGRA2;NIPBL;DCLK1;UFC1;EIF2B2;GRIN2B;APOD;PDGFC;CDK5;VCAN;ATP6AP2;DSCAML1;BTD;CAPG;ADGRG1;SH3GL2;MFSD2A;PTPRZ1;SNTG2;PTCH1;SMO;NCOA6;SOX12;MARCKS;ATXN1;CDH2;NR4A2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.44944243644215803,1.1812426513474543,0.25,0.8842621085840365,1.0,3/18,5.92%,HSPA1A;SLC25A5;FZD9
prerank,cellular copper ion homeostasis (GO:0006878),-0.4536025451568271,-1.180738714344583,0.2484725050916497,0.5619280668428795,1.0,8/14,28.65%,APP;SLC31A1;ATOX1;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,canonical glycolysis (GO:0061621),0.4175601346292214,1.1804189543929773,0.23703703703703705,0.8830131716201066,1.0,9/24,20.92%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4175601346292214,1.1804189543929773,0.23703703703703705,0.8830131716201066,1.0,9/24,20.92%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,regulation of histone deacetylation (GO:0031063),-0.4669188858430977,-1.1802586142653542,0.26785714285714285,0.5624612758861344,1.0,5/13,17.68%,NIPBL;CAMK2D;SAP30BP;APLNR;PRMT6
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.37659568890520645,1.180086713462315,0.2264808362369338,0.8820956587789287,1.0,8/36,9.39%,AFDN;VAMP5;OPTN;RILPL2;RILPL1;GGA2;NSF;AMN
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.421133864445491,1.1793705685971716,0.2587548638132296,0.8826546207574328,1.0,4/24,4.20%,IGF1;GCK;PPP1R3F;PASK
prerank,relaxation of cardiac muscle (GO:0055119),0.47833484968251866,1.1789115326977304,0.2581888246628131,0.8822844762510851,1.0,1/13,0.03%,ATP1A2
prerank,Ras protein signal transduction (GO:0007265),-0.2762272925810066,-1.178581405883945,0.12303664921465969,0.5661149860550841,1.0,43/137,16.83%,PLCE1;RAPGEF2;RHOA;NTN1;ARHGEF3;RASGRP3;RAP1A;CDH13;JUN;CDC42EP3;CDC42EP5;RALB;RAP2A;PRKD1;AGTR1;EPS8;ARHGDIB;GNB1;RAPGEF6;PLK2;SHOC2;G3BP1;TIAM1;EPS8L2;FGF2;CFL1;GRAP;RIPOR1;ADGRG1;CDC42EP2;KRAS;NRAS;ARHGAP1;SHTN1;ARHGDIA;RERG;TAX1BP3;LIMK1;GNA12;RAP2B;USP50;RREB1;MRAS
prerank,cellular response to organic cyclic compound (GO:0071407),0.30119087096351516,1.1785093599654548,0.18226600985221675,0.8815493735899962,1.0,16/141,8.37%,ATP1A2;RORA;ADCY5;SLC5A5;ROCK2;IL18;TRPV1;TFPI;ADCY1;RUVBL2;ADCY8;CASP3;LRRK2;KAT5;IMPACT;MED1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4718104276509059,-1.1785089373110564,0.27380952380952384,0.5656597969894323,1.0,5/12,16.35%,ACTB;ACTG1;LAMA3;ZDHHC7;TRAF3IP1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.37780159630212273,-1.1780743324558132,0.21956521739130436,0.5660979927917619,1.0,8/31,15.57%,TFRC;VAMP3;SHLD1;EPHB2;PHB2;CD86;PTPRC;MAD2L2
prerank,positive regulation of type 2 immune response (GO:0002830),0.46456327125989166,1.1775348590158246,0.283203125,0.8830516846792147,1.0,5/14,16.56%,IL18;PRKCZ;NLRP3;IL6;RARA
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.48942896332405494,1.1774648242331536,0.25609756097560976,0.8811901232115957,1.0,4/12,11.26%,ROCK2;PICALM;FLOT2;ABCA2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3787501496962702,-1.1756056092137297,0.23060344827586207,0.571735603005253,1.0,10/27,17.11%,DCN;CSGALNACT1;CSPG4;XYLT1;VCAN;CHSY3;BGN;B3GAT1;B3GAT3;NCAN
prerank,response to peptide (GO:1901652),-0.3608009076832017,-1.1755167752927194,0.22559652928416485,0.5713328396687064,1.0,12/33,21.77%,KAT7;STAT3;ANXA1;EIF2B2;CACNA1B;IRS1;EIF2B1;NOD2;IRF5;ERBIN;MMP2;FYN
prerank,sulfur compound transport (GO:0072348),0.39571680571598455,1.1748866054315963,0.22242647058823528,0.8884550437661158,1.0,4/27,6.12%,SLC6A13;SLC13A4;SLC26A1;SLC25A11
prerank,regulation of synapse maturation (GO:0090128),-0.50465644944927,-1.1748697545506006,0.25595238095238093,0.5723021344773085,1.0,3/10,10.31%,DAB2IP;ARHGEF15;YWHAZ
prerank,toll-like receptor signaling pathway (GO:0002224),-0.303739444997036,-1.174671784856079,0.17349397590361446,0.5721866991516366,1.0,28/84,21.17%,RFTN1;UBC;IRAK3;RPS6KA3;PLCG2;RPS27A;UBB;UBE2D3;MAPKAPK2;TRIL;SFTPA1;SFTPA2;CTSB;PIK3C3;BIRC3;SCARA3;PIK3R4;TAB1;IRAK2;CTSS;BTK;NR1H4;RIPK1;HMGB1;MYD88;NMI;TICAM1;RIPK2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.33661293617139065,-1.1745723113043438,0.2076749435665914,0.5717890719606165,1.0,23/51,32.55%,STAT3;APP;TMED10;GBP5;AIM2;S100A13;WNT5A;TRIM16;MALT1;HSPB1;USP50;NOD2;HMGB1;MYD88;RIPK2;CASP1;TLR4;CASP8;TLR6;CD36;TMEM106A;LGALS9;TYROBP
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3029507677050878,-1.1744762310441126,0.17718446601941748,0.5714008928734904,1.0,23/75,15.21%,HEG1;DAB2IP;LRP6;LRP5;BMP4;PTPRJ;RASIP1;IRAK3;LYN;PRKCD;APC;SPRY2;IPO7;CDKN1C;PTPN1;APOE;MYOCD;IPO5;HHEX;STK38;SPRY1;PAQR3;PRKAR2B
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.42485029325685525,-1.1743303321672172,0.2520833333333333,0.5710975653449298,1.0,8/18,19.24%,MDFIC;MFHAS1;CTNNA1;OTUD7B;APOD;LATS1;POLR1A;CABP1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4168292954202719,1.1736267970082914,0.240234375,0.8906935815543745,1.0,4/23,7.07%,NUPR1;GCK;PPARA;C1QTNF3
prerank,mitochondrion distribution (GO:0048311),0.490481304588846,1.1736026897012173,0.281437125748503,0.8886679316454034,1.0,7/12,26.73%,TRAK1;LRRK2;ARMC1;MEF2A;DNM1L;MTM1;HAP1
prerank,ureteric bud development (GO:0001657),0.45193528589331283,1.173362433777892,0.2669404517453799,0.8874461234614279,1.0,4/17,6.87%,BMP7;OSR1;NPNT;FGFR2
prerank,rRNA transcription (GO:0009303),-0.4266332735135117,-1.1732912876956445,0.26156941649899396,0.5731051934669148,1.0,10/17,33.29%,GTF3C5;SPIN1;POLR1G;CAVIN1;GTF3A;GTF3C3;SIRT7;POLR1E;GTF3C6;GTF3C2
prerank,regulation of protein secretion (GO:0050708),0.3033963149192513,1.173193507729344,0.15619694397283532,0.8859549729683,1.0,37/119,20.37%,BMP6;CACNA1D;IGF1;FRMD4A;GCK;CACNA2D2;ITPR1;ADRA2A;LLGL2;STXBP5L;DRD3;SERGEF;LLGL1;SNAP25;CLOCK;KCNC2;MYO18A;ITPR2;IER3IP1;RAPGEF3;KCNS3;ENSA;CYP51A1;PRKCA;EIPR1;PER2;IL6;GIPR;PICK1;IL1A;RHBDF1;APBB1;IL12A;HMGCR;DPP4;ACHE;DNM1L
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4011512384877833,-1.1731160363737145,0.23779193205944799,0.5729383800018887,1.0,9/22,15.73%,RPS15;RPS20;PLA2R1;SPRED2;UBB;RPS7;RPL23;EEF1E1;RPL37
prerank,response to lipopolysaccharide (GO:0032496),-0.2767588821213553,-1.1721092573370775,0.11764705882352941,0.574953605939816,1.0,20/138,11.69%,FOXP1;MEF2C;DAB2IP;NOS3;RHOA;SCARB1;TNFRSF1B;IRAK3;RPS6KA3;DEFA6;TNFRSF11A;GCH1;CARD16;WNT5A;SRR;SERPINE1;MAPKAPK2;PDCD4;LIAS;PAF1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.34674078390420343,1.171733480239762,0.22105263157894736,0.8892325142633153,1.0,11/57,11.25%,ADCY5;ADCY1;ADRA2A;CHRM2;ADCY8;DRD3;LPAR1;GABBR1;GPR37;HTR1F;CHRM1
prerank,regulation of RNA metabolic process (GO:0051252),0.34183897609084773,1.170832178153771,0.20437956204379562,0.8901756581250725,1.0,23/59,17.40%,OAS2;NOVA1;HNRNPH3;PQBP1;FASTK;PTBP2;SON;HNRNPL;PTBP1;MED1;OAS3;SRRM4;CLK3;AFF2;PCBP4;GRSF1;MBNL3;FAM50A;CLK2;HNRNPH2;METTL18;MITF;PTBP3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3668165321867785,-1.1707752196458086,0.21518987341772153,0.5777393549107721,1.0,9/32,19.77%,CAV1;TRPC3;PLCG1;TRPC1;CEMIP;APLNR;GPER1;GRIN1;NPSR1
prerank,catecholamine biosynthetic process (GO:0042423),0.5020720410864634,1.1707271607667165,0.2865384615384615,0.8884534062600569,1.0,1/11,0.24%,MOXD1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4287222889539588,-1.1701270678043738,0.24572649572649571,0.57871855974979,1.0,8/17,25.50%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.38427425199131504,-1.17008705408875,0.25054945054945055,0.5781701474158142,1.0,6/27,9.69%,BMPR2;ACVRL1;DACH1;TNKS;HMBOX1;FGF2
prerank,cell projection organization (GO:0030030),-0.37384587833499217,-1.1700425379563402,0.23160173160173161,0.5776187268689444,1.0,10/30,21.41%,RHOJ;GSN;PARVB;ITGB1;PARVA;CAPG;NCKAP1L;NPHP1;RAC3;CDC42
prerank,negative regulation of secretion by cell (GO:1903531),-0.35141787421243187,-1.1694849181594529,0.22077922077922077,0.5782604747389894,1.0,11/38,14.92%,STXBP6;NOTCH1;TNFRSF1B;SLC30A1;VAMP3;GRM7;ANXA1;SYT4;APOE;RSAD2;HTR1B
prerank,regulation of nervous system process (GO:0031644),0.44537779979540215,1.1694785298025006,0.24124513618677043,0.8909045642169657,1.0,3/18,4.18%,SLC8A3;ROCK2;NPTX1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.4345700014964631,-1.1692263733244652,0.258,0.578254058598528,1.0,5/15,18.47%,ENTPD1;ENTPD6;ENTPD2;NME2;AK4
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3404978515771186,1.1686856807533732,0.21691176470588236,0.891785047033651,1.0,12/61,16.00%,PRKAG2;NQO1;PPARA;PSMD3;PANK2;PDK2;PSMD1;PSMC5;PSMA1;NCOR2;PSMD12;SIRT1
prerank,positive regulation of protein maturation (GO:1903319),-0.4790443738570993,-1.1686798764829438,0.29411764705882354,0.5790498891108367,1.0,3/11,15.26%,NKD2;CCBE1;RHBDD1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3703674633465538,1.1686656578207724,0.23134328358208955,0.8898069574920323,1.0,11/40,16.48%,UNC13C;SYT1;SNAP29;SNAP47;SNAPIN;RIMS1;SNAP25;SYT10;CPLX1;STX4;CPLX2
prerank,response to chemokine (GO:1990868),-0.45391291497777153,-1.1684359623468286,0.27049180327868855,0.5790257369422602,1.0,5/13,9.84%,LRCH1;SLC12A2;RHOA;CXCL12;DOCK8
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3951054404641025,1.1683118855039107,0.24593128390596744,0.8890836264333227,1.0,4/27,5.76%,IGF1;PDGFRA;SPHK1;E2F1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4167813980831183,-1.1683110965751569,0.2549800796812749,0.5786744388630599,1.0,5/19,11.87%,SLC26A2;BPNT2;PAPSS2;SLC35B3;TPST2
prerank,RNA processing (GO:0006396),0.28801981960101947,1.1679100799550974,0.16326530612244897,0.8884083319965407,1.0,55/176,23.39%,CELF2;PABPN1;RRAGC;NOVA1;SRSF5;CCAR2;TFIP11;CPSF6;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;TENT4A;DDX17;SON;PRMT9;HNRNPL;PTBP1;LSM5;ZMAT5;PPARGC1A;SRRM4;BICD1;LSM4;TUT4;MPHOSPH10;DICER1;USP39;SRSF11;USB1;RBM5;DHX8;AKAP8L;RNPS1;PRPF3;PRPF6;NOL3;DDX39B;THOC1;DDX47;SF3B2;SF3B1;FASTKD5;ADAR;SUPT4H1;SNRPB;CDK12;CELF1;HNRNPH1;SF3B3;SCNM1;SRPK1;TSEN34;SRSF2
prerank,negative regulation of receptor binding (GO:1900121),-0.5020275165671737,-1.1677268330474642,0.2771317829457364,0.5794783678754992,1.0,4/10,21.54%,B2M;ATP2A3;ADAM15;PTPRF
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4410030666849529,1.1674614967112469,0.2554890219560878,0.8879234645998274,1.0,7/18,26.18%,KMT2A;SETD4;SETD7;SMYD2;SETD1B;SETD2;EHMT1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5047423806518283,-1.1673983062528777,0.3101391650099404,0.5796611932746916,1.0,4/10,23.75%,TNFRSF1B;ZBTB1;HMGB1;CCR2
prerank,negative regulation of programmed cell death (GO:0043069),-0.24477398973301884,-1.1673187151643072,0.054313099041533544,0.5792403788708926,1.0,79/355,15.95%,MECOM;LEF1;ARHGAP10;TEK;IL6ST;TJP1;PTMA;THBS1;FOXO1;TBX3;GAS6;PIK3R1;BCL2L1;EGFR;NGF;NFKBIA;SOCS2;BMP4;CD44;KDR;UBC;RPL10;RPS6KA3;CARD14;NAA16;DNAJA1;FAS;FLNA;TFRC;RNF144B;RPS27A;UBB;PAK2;MET;ADAM10;WNT5A;TPT1;PLK2;ANXA1;CD38;SPRY2;FLT4;XIAP;SRC;CAT;VHL;GCLC;GOLPH3;MALT1;YWHAZ;CFL1;MAP4K4;GRK5;HSPB1;BABAM2;TNFAIP8;PHB2;CD74;COMP;SERPINB9;SQSTM1;PTK2B;TCIM;AKT2;USP47;ARHGDIA;NME2;BIRC3;HIGD2A;VEGFA;MT3;RHBDD1;PLAUR;PA2G4;NCKAP1L;BAG1;STIL;CBL;SIX4
prerank,autophagosome organization (GO:1905037),-0.32805370135291206,-1.1665550738041084,0.21315192743764172,0.5805750667427669,1.0,15/50,20.04%,ATG3;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;GABARAP;UBXN2A;RAB1B;ATG12;ATG5;WDR45B;EMC6;ULK2
prerank,regulation of cell morphogenesis (GO:0022604),-0.3647226113729289,-1.1661331933053949,0.2572614107883817,0.5810842512370501,1.0,7/30,11.89%,FMNL2;SPARC;MACF1;CD44;EFNA5;CFL1;MFSD2A
prerank,cellular glucose homeostasis (GO:0001678),-0.34695646156699345,-1.166065647800043,0.2149321266968326,0.5805879307792369,1.0,8/41,7.04%,LRRC8D;FOXO1;GAS6;PIK3R1;UNC13B;ERN1;RACK1;LRRC8A
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.444833150471695,1.1659956551768047,0.26425855513307983,0.891226731460603,1.0,6/16,20.52%,CTR9;KMT2A;AUTS2;PIH1D1;KDM1A;SMAD4
prerank,regulation of telomerase activity (GO:0051972),-0.3330015395481335,-1.1657943636851942,0.23390557939914164,0.5806305706207391,1.0,15/45,21.94%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;SRC;HMBOX1;KLF4;CCT2;PARM1;MAPK3;GREM1;MAP2K7;MAP3K4;DKC1
prerank,amide biosynthetic process (GO:0043604),-0.3281381725226578,-1.1656582447108428,0.23863636363636365,0.580347413922851,1.0,22/47,30.81%,SGMS1;SGMS2;PCSK5;DEGS2;AGK;CERS5;CERS6;SAMD8;ASMT;DMD;ASAH2;ASS1;SPTSSA;CERS4;SMPD1;NANP;CERS3;SPTLC3;TLCD3B;SPTSSB;NMRAL1;ALOXE3
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.48726626381078086,-1.165547960495421,0.3004201680672269,0.5799814602434344,1.0,3/10,11.39%,DNAJA1;AIDA;PDCD4
prerank,dopamine metabolic process (GO:0042417),0.45057788892816664,1.1651601289461047,0.266260162601626,0.892115698321041,1.0,4/18,10.87%,MOXD1;SNCAIP;DRD3;COMT
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2793194686184011,1.1649598354210544,0.1515601783060921,0.8908159741174263,1.0,92/241,26.94%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;SF3B5;HNRNPH3;CCAR1;HNRNPA2B1;PQBP1;HNRNPU;HNRNPA3;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;DHX8;SNIP1;RNPS1;HNRNPH2;ALYREF;PRPF3;SNU13;PRPF6;MTREX;ELAVL2;SRRT;DDX39B;SNRPB2;SRSF6;SUGP1;PUF60;SF3B2;SF3B1;CWF19L1;POLR2A;PRPF40A;SNRPB;GCFC2;PPIL1;HNRNPH1;SART3;DDX39A;SF3B3;EFTUD2;POLR2B;PRPF38A;PPIL3;SRSF2;DDX41;SNRPN;RBM15B;WDR83;HNRNPC;SNRPC;CSTF2;U2SURP;PRPF8;PNN;U2AF2;SF3B6;NONO;POLR2C;SNRNP40;GEMIN7;DHX16;FIP1L1;RBM4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.339902151058631,1.164680652064517,0.22486288848263253,0.8897661229159496,1.0,10/56,9.64%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,visual system development (GO:0150063),0.37733132437502603,1.1643312321925916,0.23529411764705882,0.8889503310502878,1.0,16/37,20.04%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;CPAMD8;ZDHHC16;FOXC1;ADAMTS18;ITGAM;RBP4;HIPK2;SOX2;C1QA;MEIS3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.48231569045550793,1.1641516823224844,0.275390625,0.8875399242895305,1.0,3/13,6.07%,BMP7;METRNL;HNRNPU
prerank,extracellular matrix assembly (GO:0085029),-0.3966156742304421,-1.1640189254430642,0.25,0.583155038244963,1.0,7/23,8.04%,RAMP2;GAS6;NTN4;TNXB;MFAP4;LAMB2;MYH11
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4115919665264436,-1.1640157220269298,0.2808080808080808,0.5825204400341729,1.0,5/19,9.66%,ACOX1;MAOB;SOD1;CAT;GPX1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.4393893518350888,-1.1637622248339416,0.2800829875518672,0.5825371638226777,1.0,7/16,24.70%,RBM3;PRDX6;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,cellular component assembly (GO:0022607),-0.25630624407569236,-1.163640396183243,0.09567901234567901,0.5821911770573427,1.0,48/253,14.55%,SPTBN1;ACTB;LIMS1;SLC2A1;RHOJ;LIMS2;CALD1;MYO1B;PARD3;RHOA;GSN;PARVB;ACTG1;GAS6;PLS3;DARS1;FAS;FLNA;WIPF1;VAMP3;EPS8;HES1;WNT5A;CLDN14;OCLN;ABCA3;APC;IL1RAP;CAPZA2;RBBP4;NEDD9;CD2AP;FAM107A;YWHAZ;PARVA;CAPG;CD74;LIMA1;PTK2B;TEAD1;RANBP9;RAD21;STX7;SHROOM1;FZD1;HAS1;CD40;ZW10
prerank,regulation of keratinocyte migration (GO:0051547),-0.4774338686634829,-1.1632327117410302,0.265748031496063,0.5825124265688971,1.0,5/12,25.17%,FGF7;MAP4K4;PTEN;MAPRE2;EPB41L4B
prerank,autophagy of nucleus (GO:0044804),-0.4351968476970719,-1.1631040273712874,0.27647058823529413,0.5822307608829087,1.0,7/16,20.04%,ATG3;WIPI1;RB1CC1;ATG12;ATG5;WDR45B;ULK2
prerank,mRNA export from nucleus (GO:0006406),0.30846703564944855,1.163057301450616,0.21187800963081863,0.8893594887433683,1.0,28/102,20.79%,MCM3AP;PABPN1;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;PCID2;SMG5;NXT1;DDX19B;SLBP;YTHDC1;NUP98;UPF3B;SRSF11;SMG6;NUP37;POLR2D;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;RAE1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4029818236952411,-1.16271279153744,0.24404761904761904,0.5826354263088187,1.0,7/20,14.88%,THBS1;CREB3L1;NPTN;SPRY2;FGF2;SPRY1;GPC1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.28879046329057756,-1.162685746630957,0.1596009975062344,0.5820648198762558,1.0,32/109,21.07%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;LYN;TEC;PSMB7;PSMA6;MAPK1;PPP3CA;PIK3CA;PSMB6;MALT1;VAV2;NFATC2;PSMB5;PSMC4;PSMB8;TAB1;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;SYK;PSME1;MAP2K7
prerank,icosanoid biosynthetic process (GO:0046456),-0.5009519350953654,-1.1626239326728143,0.2787524366471735,0.5815587872947018,1.0,1/10,0.89%,PLA2G4A
prerank,cellular response to lipid (GO:0071396),0.287229656022677,1.1625500368726154,0.1578125,0.8891580154039859,1.0,28/191,12.39%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;PABPN1;CTR9;WNT5B;PTK7;ADCY1;RUVBL2;TNIP3;ADCY8;WNT6;HTRA2;KAT5;NLRP3;TNIP2;MED1;CACTIN;NR1H3;FZD7;LCOR;MAPK14;CDC73;SPHK2;SOX9;KCNK4
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3843662894248344,-1.1624432877684219,0.27472527472527475,0.5813811545625233,1.0,7/25,10.17%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.30649738778253016,-1.1623578285061134,0.1875,0.5809387855018935,1.0,20/73,20.92%,KITLG;TCF12;LMO2;RUNX1;PSMB7;PSMA6;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;METTL3;PSMD10;SPI1;PSME1
prerank,regulation of hippo signaling (GO:0035330),-0.4208401112605978,-1.1616012701305687,0.28716904276985744,0.5821014823936219,1.0,7/17,22.99%,LIMD1;MOB3B;CIT;SCHIP1;MARK3;AJUBA;SOX11
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.48873336422754976,1.160660628792082,0.2836734693877551,0.8938182447042795,1.0,4/11,13.25%,ARR3;ARRB1;DRD3;GRK3
prerank,histone H2A monoubiquitination (GO:0035518),0.4330294343014731,1.1605637145080703,0.2754491017964072,0.8921514748449563,1.0,5/17,12.40%,DDB2;PCGF2;PCGF5;PCGF6;RING1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3782417880045175,1.1602885727145344,0.24955752212389382,0.8910803063166711,1.0,5/34,4.96%,LEPROT;ROCK2;ACTN2;PICALM;TTBK2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.32103205360240894,-1.1600591890496101,0.255125284738041,0.5853684324979423,1.0,12/54,7.00%,CAV1;NEDD4L;YWHAE;KCNJ2;FHL1;NOS1AP;FLNA;CAB39;GNB1;KCNMB2;KCNQ1;GNG2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3458229442846179,-1.1595649727072666,0.23433874709976799,0.5859815832441571,1.0,8/39,10.33%,UTRN;NEDD4L;FXYD5;HECW2;CAMK2D;SLMAP;FXYD6;FGF13
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3099370944408143,-1.158976246976431,0.20286396181384247,0.5868177127090227,1.0,18/68,15.36%,LEF1;CAV1;LRP6;FZD6;LRP5;SFRP4;CSNK1E;WNT5A;CSNK1A1;APC;PPP1CA;AMER1;FZD4;RARG;WNT9A;NR4A2;FZD1;PLPP3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.28565755641983276,-1.1588024441516294,0.17782909930715934,0.5866423683144558,1.0,28/101,15.63%,RAPGEF2;DAB2IP;RHOA;PKD1;EGFR;RALB;CAB39;PIK3R6;FLT1;CCNY;WNT5A;CALM3;PDGFC;SRC;IL34;FGF2;EDN1;RPTOR;PDGFD;INCENP;EDN3;TCIM;CD24;VEGFA;CD40;FERMT2;CSF1R;CEMIP
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2962477260976256,-1.1585740659445194,0.2,0.5866066105945437,1.0,26/84,24.04%,CDC27;UBC;ANAPC5;RPS27A;UBB;PSMB7;PSMA6;CDC16;FBXO31;PSMB6;PSMB5;FBXO5;PTTG1;PSMC4;FZR1;PSMB8;PSMD11;ECRG4;PSMB4;PSMD14;CDC26;PSMD10;PSME1;PSMB3;CDC23;CUL3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2848353224398861,-1.1585310943794873,0.18829516539440203,0.5860855952241406,1.0,25/108,11.99%,HIP1;ACER2;GSN;TNFSF10;MAP3K5;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;BCAP31;DAP;RPS3;CASP8AP2;ATP2A3;CTSD;EIF2AK3;MALT1;IFT57;SOX7;HIP1R
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.30715389286234607,-1.1583327526351836,0.1925601750547046,0.5859892337318725,1.0,17/65,22.69%,FBXL7;FHL1;PSMB7;PSMA6;PSMB6;PSMB5;PABIR1;USP47;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PSMD10;CHEK1;PSME1;PSMB3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4383120131065905,1.1577680334811236,0.2934131736526946,0.8982119274959477,1.0,3/17,2.49%,ROBO1;EFNB2;PIK3R3
prerank,cellular protein localization (GO:0034613),-0.24864994897008896,-1.1576543416496485,0.10526315789473684,0.5870480250533281,1.0,75/285,17.67%,TBC1D4;RABGAP1L;VCL;ESAM;RAB14;TBC1D8;EGFR;ID1;SMURF1;SCFD2;WIPI1;PTPRK;TBC1D12;STX1A;SNX13;RAB6A;HERC2;RAB31;TBC1D5;TMED10;USP6NL;FLNA;STX3;ARHGEF2;TBC1D2B;RAP2A;NIPBL;AXIN2;SNX1;WNT5A;TBC1D1;SH3PXD2B;OCLN;COG3;EVI5L;EMP2;HEY2;RAB22A;VPS26A;TBC1D13;CPE;DNAJC27;FGF7;WDR11;HGS;JAM3;CD74;HHEX;RRAGA;HDAC6;STX7;SEC31A;ARL5A;TBC1D10A;AMOT;AP2A1;CNTLN;STX8;SAR1A;RAB5C;RAB1B;FERMT2;TBC1D25;BICD2;ARF5;UNC50;NPHP1;SEC13;IFT27;PIGK;RAB3GAP2;DMD;KIF13A;COPB2;WDR45B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3753638002234141,-1.1576214126025102,0.24166666666666667,0.586501040472909,1.0,9/25,15.76%,SLIT2;LIMK2;KANK1;PRKCD;EVI5L;ABI3;TBC1D7;CCP110;RAP1GAP
prerank,protein oxidation (GO:0018158),0.4940900025870303,1.1576112722220453,0.30093457943925234,0.8967803658475655,1.0,3/11,6.70%,LOXL3;SUMF1;LOXL1
prerank,cellular response to metal ion (GO:0071248),0.29823318070828425,1.1574951580889603,0.20364238410596028,0.8952099957013028,1.0,21/123,9.43%,BMP6;SYT11;SYT12;SLC41A1;PRKAA2;CPNE1;CYP11B1;CAPN3;SYT9;ADCY1;CHUK;GLRA1;CPNE4;PPIF;SYT1;ADCY8;LRRK2;SYT13;ADGRV1;DLG4;SYT10
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.30300745465137546,-1.1574679149053062,0.18632075471698112,0.5862592978999083,1.0,34/73,29.27%,ACTB;CTCF;H3-3A;MYBBP1A;RBBP4;IGF2;GPX1;PRMT7;MTA1;DNMT3B;HDAC6;SUZ12;POLR1F;TASOR;POLR1G;ZFP57;EPC1;TDG;POLR1A;SPI1;AEBP2;GLMN;DNMT1;POLR1H;MYO1C;POLR2F;BMI1;POLR1E;POLR2H;PHF19;POLR1C;SMARCA5;DDX21;POLR2E
prerank,cortical actin cytoskeleton organization (GO:0030866),0.42346828411180804,1.1573736288983658,0.26895306859205775,0.8936293594385353,1.0,7/20,12.85%,ROCK2;DLG1;LLGL2;LLGL1;RHOQ;FHOD1;RAB13
prerank,positive regulation of cytokine production (GO:0001819),-0.2500319538241387,-1.157184035710077,0.0880281690140845,0.5863584238967097,1.0,87/292,25.50%,SPTBN1;FOXP1;PDE4D;IL6ST;IL1R1;LRRFIP1;CD200;RFTN1;F3;CD34;AFAP1L2;POLR3F;CYP1B1;SLC7A5;STAT3;APP;RUNX1;PTGS2;NOD1;PLCG2;PLA2R1;TMED10;DHX33;ARHGEF2;GBP5;S100A13;XRCC5;WNT5A;IL6R;ANXA1;MDK;RPS3;G3BP1;SOD1;FLT4;IL15;SERPINE1;CCBE1;EIF2AK3;MALT1;PIK3CD;POLR3H;PIBF1;ISG15;CD74;TWIST1;AGPAT1;CD86;PTPRC;IFIH1;CD40;CSF1R;CD46;ATF4;POLR3B;NFKB2;NOD2;GAPDH;IRF5;IL33;NR1H4;CADM1;RIPK1;HMGB1;C3;POLR3A;MYD88;GLMN;SYK;TICAM1;RIPK2;POLR3D;ZFPM1;POLR2F;PAEP;BCL10;HPSE;MAPK11;CCR2;RGCC;TLR4;ZBP1;PIK3CG;CD276;PTPN11;F2R;POLR2H
prerank,digestive tract development (GO:0048565),-0.35939513575767984,-1.1571676580879628,0.23198198198198197,0.5857827887658805,1.0,9/32,14.05%,RARB;PCSK5;TGFB2;PKD1;GLI3;NIPBL;STRA6;SMO;RARRES2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.35901374026557215,1.1571556923051531,0.2554347826086957,0.8924360139997811,1.0,8/43,6.59%,BMP7;WNT4;BMP6;IGF1;BMPR1A;LRP3;WWTR1;NPNT
prerank,response to glucagon (GO:0033762),0.4234156214672458,1.1569337378367168,0.28007889546351084,0.8912634011590916,1.0,4/19,6.40%,ADCY5;GCGR;ADCY1;ADCY8
prerank,regulation of intracellular signal transduction (GO:1902531),-0.23970158390400434,-1.1565815922826057,0.0784313725490196,0.5866101601833532,1.0,58/420,8.92%,ARHGAP31;SGMS1;ARHGAP10;VWF;TEK;NTRK3;RHOJ;CHN2;DAB2IP;PIP5K1B;ARAP2;SRGAP1;TMSB4X;RHOA;NET1;TRAF5;HIPK1;ARHGEF3;RPA1;PIP4K2A;MCF2L;STK3;STARD8;RASSF2;CHN1;EGFR;NFKBIA;BCR;MOB3B;RASGRF2;ARAP3;RPL5;STARD13;PLCG2;TIAM2;KAT6A;TNIK;ARAP1;NUAK1;ARHGEF2;PAK2;ARHGDIB;PPP1R16B;PDE2A;LYN;WNT5A;ARHGAP32;MAPK1;ARHGAP35;MYOC;CEACAM1;PPP2R5C;USP7;RBBP4;ABR;XIAP;TIAM1;CDK5
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.37270736558160655,-1.156561810684636,0.23160173160173161,0.5860287311289851,1.0,7/29,22.07%,RUNX1;ESR1;STRN3;CBFB;LATS1;KCTD6;SRARP
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.32422638120367936,-1.155361448728421,0.20794392523364486,0.5884648128860238,1.0,14/52,17.23%,SPTBN1;PRKCH;PIK3R1;EGFR;STX3;ITGB1;NKD2;ZDHHC8;STAC;EPHB2;SQSTM1;EPB41;LRP1;GPER1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.4496939537046759,-1.1551634450504924,0.26641651031894936,0.588339859925543,1.0,5/14,20.59%,ADAM10;ADAM19;DYRK1A;PSEN2;PSENEN
prerank,nuclear export (GO:0051168),0.31989326270495294,1.1549384371766722,0.1983739837398374,0.8963934425114007,1.0,16/80,18.57%,RANBP3L;SRSF5;POM121;NUP155;NUP62CL;STRADB;NEMF;RITA1;UPF3B;SRSF11;DESI1;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4525562352665493,-1.1546432134998244,0.284,0.5889561772812745,1.0,5/13,22.03%,RHOA;RAP2A;ZDHHC7;CDC42;MSN
prerank,neuron projection morphogenesis (GO:0048812),0.2979765609056054,1.1545987382358969,0.20701168614357263,0.8956189780761779,1.0,29/137,13.37%,ALCAM;BMP7;MAP2;DCDC2;BAIAP2;CPNE1;GAS7;FLRT3;ATL1;WNT7A;AFG3L2;FGFR2;LRRK2;FLRT1;SHANK1;CNTNAP2;LRP4;IMPACT;LLGL1;DLG4;KLK8;GPM6A;SLITRK4;DTNBP1;DOCK7;WASL;NYAP2;BDNF;DICER1
prerank,organelle organization (GO:0006996),-0.24380368792319715,-1.1536427031705552,0.11267605633802817,0.590895486574915,1.0,93/388,19.22%,FMNL2;ARHGAP10;SYNE1;CAV1;ATP8B1;FGD5;SEMA6A;PLCE1;MICAL2;NOS3;MARK1;FGD6;DST;RAB14;ATL3;TMEM135;LIMD1;VPS13C;ARAP3;FAF2;PALLD;LMAN2L;RAB31;TMED10;USP6NL;TNIK;FAM161A;CHMP2B;PRKD1;ATXN7;SIPA1L3;PPIA;MAST4;NRF1;FBXW8;COG3;CSNK1A1;ABCA3;CHMP4B;CHMP4A;CCL13;MDK;CXADR;SEC16B;CNN2;ABCD2;PEX7;BRWD1;ATP5F1B;NEDD9;ZFYVE16;SORT1;EIF2AK3;GOLPH3;CAV2;CFL1;APOE;SIRT5;BAG5;FNBP1L;PHB2;NECTIN2;RANBP9;VPS13D;SIPA1;ODF2;STX7;SEC61A1;SEC31A;UBXN2A;REEP5;SAR1A;ZW10;SURF4;VAPB;AUP1;PITPNB;SLC25A36;LYSMD3;RANBP10;FANCG;PEX14;DIAPH3;MAST2;HACE1;CHMP1B;TOR1AIP2;AGTPBP1;PEX2;FAM161B;MNS1;MTFR2;LIG4
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.34487773288852314,1.1535628764677102,0.24253731343283583,0.8973466259756813,1.0,10/48,11.44%,ROBO1;NLRP2B;OTUD4;USP18;PELI3;CACTIN;PARP14;NR1H3;OAS3;STAT2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.484667415871257,1.1533319739877557,0.2953156822810591,0.8962211824749083,1.0,4/12,14.60%,LPIN1;PLK1;PRKCB;PRKCA
prerank,spindle assembly (GO:0051225),-0.30542838890851504,-1.153164954822396,0.22544642857142858,0.5914875991808901,1.0,19/67,22.60%,RHOA;NEK7;STARD9;FLNA;SMC1A;TNKS;RPS3;STAG1;MAP9;PIBF1;MZT1;TOGARAM1;STAG2;ARHGEF10;RAB11A;MAPRE2;CSNK1D;AAAS;TPX2
prerank,monocyte chemotaxis (GO:0002548),-0.36043933545278606,-1.153020986776126,0.2398286937901499,0.5912014883717589,1.0,5/32,7.81%,TNFRSF11A;FLT1;IL6R;ANXA1;CCL13
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4544961458671777,1.1527188490845035,0.29423076923076924,0.8963318147053757,1.0,8/16,21.97%,HNRNPA2B1;TNKS2;SMG5;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3615970128869497,-1.1524313195852178,0.25308641975308643,0.5920334938499872,1.0,7/32,10.42%,ITGA1;PPP1R16B;PPIA;PRKCD;CALM3;SPPL3;NSMF
prerank,2-oxoglutarate metabolic process (GO:0006103),0.478661441156619,1.151695231906075,0.3029126213592233,0.8980567563064168,1.0,5/13,21.75%,ADHFE1;IDH2;GOT1;GOT2;L2HGDH
prerank,negative regulation of endocytosis (GO:0045806),0.400318124321985,1.1513510272134775,0.25572519083969464,0.8973733322225037,1.0,7/24,15.81%,SYT11;PICALM;NR1H3;SCAMP5;CD300A;MTMR2;SNX33
prerank,mesonephric tubule development (GO:0072164),0.45086137208898547,1.1513063763096183,0.2926356589147287,0.8955423021487798,1.0,4/15,6.87%,BMP7;OSR1;NPNT;FGFR2
prerank,B cell proliferation (GO:0042100),-0.42004105259813773,-1.151229078642943,0.28775510204081634,0.5945308402747531,1.0,4/17,14.49%,MEF2C;CTPS1;PTPRC;CD40
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.47701947662604166,1.1509223402417936,0.3020833333333333,0.8949598845991047,1.0,4/11,12.84%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.38328668441515773,1.1504952191121185,0.2739463601532567,0.8946134750232451,1.0,7/31,11.28%,TGFBR3;BMPR1A;RBPJ;NRG1;FGFR2;TGFBR1;RYR2
prerank,ventricular septum development (GO:0003281),-0.3489545271559056,-1.1502160097065888,0.24364406779661016,0.5963896806193751,1.0,12/37,9.40%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;TGFBR2;HES1;PDE2A;HEYL;STRA6;HEY2;ZFPM2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.33382469269050424,-1.1498451804023713,0.23873873873873874,0.5967240937539131,1.0,8/43,9.26%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;IGF2;PTPN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.32078870611863264,-1.1497828056967967,0.21975308641975308,0.5962589534172261,1.0,21/52,29.95%,PDIA5;WIPI1;PDIA6;ERN1;TATDN2;ATP6V0D1;SEC31A;KDELR3;ACADVL;VAPB;SRPRA;PPP2R5B;EXTL3;DCTN1;WFS1;DNAJB11;YIF1A;GOSR2;ADD1;PLA2G4B;EDEM1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.367045776257461,-1.1497576049895435,0.26899383983572894,0.5956813694634456,1.0,9/29,17.04%,SLC4A10;APP;NSMF;APOE;EPHB2;RAB3A;MCTP1;ZDHHC2;SYNGR1
prerank,regulation of lipase activity (GO:0060191),-0.44735478483144725,-1.149616871871712,0.292,0.5954422649584309,1.0,2/13,1.81%,RHOA;PCSK5
prerank,positive regulation of T cell differentiation (GO:0045582),-0.34894167218846267,-1.1493621423502387,0.22270742358078602,0.5954327056619881,1.0,7/36,15.74%,LEF1;GLI3;ZBTB1;MDK;SOX12;CD46;NCKAP1L
prerank,mesenchyme development (GO:0060485),0.4417863734179036,1.1491654995922256,0.29504950495049503,0.8973928724929493,1.0,4/15,10.18%,BMP7;FGFR2;TGFBR1;CRELD1
prerank,regulation of bone mineralization (GO:0030500),-0.31837513453389055,-1.1490600435971934,0.2511520737327189,0.5956173793254494,1.0,17/55,12.44%,MEF2C;BMPR2;PTN;SGMS2;ATP2B1;ACVR1;BMP4;S1PR1;CCN1;NBR1;TMEM119;TGFB3;ISG15;TWIST1;BMP2;ECM1;PTK2B
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2807030465028473,-1.1487787526312772,0.19241192411924118,0.595763127928615,1.0,39/124,22.81%,LEF1;RHOA;FZD6;PRICKLE2;SMURF1;NFATC1;AGO1;SFRP4;AP2B1;GNB1;WNT5A;PSMB7;PSMA6;GNG2;PPP3CA;TIAM1;AGO2;PSMB6;PSMB5;FZD4;PFN1;DAAM1;AP2A1;FZD1;PSMC4;PSMB8;PSMD11;AGO4;PSMB4;CELSR2;PSMD14;ARRB2;PSMD10;PSME1;ROR2;CDC42;AP2M1;PSMB3;RYK
prerank,negative regulation of developmental process (GO:0051093),-0.30423243378828435,-1.148565749867779,0.21462264150943397,0.595713438344907,1.0,23/69,22.25%,NOS3;NOTCH1;GAS6;BMP4;KANK1;TBX1;KLF7;TFRC;CST3;ARHGEF15;VAT1;HEY2;NOTCH4;BMP2;TBX2;SUZ12;HEY1;FGFR3;GREM1;CDK6;SPI1;ROCK1;DLL1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2966179187817265,-1.1485568948983098,0.1724137931034483,0.5951095734252648,1.0,24/86,19.61%,APP;WDR1;CDC42EP3;CDC42EP5;MET;OCLN;NCK1;RPS3;SYNPO2;GPX1;EDN1;APOE;CDC42EP2;PTK2B;PFN1;TRPV4;CLIP1;LIMK1;KATNB1;SEMA5A;NCKAP1L;TOGARAM1;FCHSD1;HCK
prerank,actin filament-based transport (GO:0099515),-0.3994085993521583,-1.1481295332869519,0.25971370143149286,0.5956077491699967,1.0,6/21,11.29%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,muscle cell differentiation (GO:0042692),0.38309602069297893,1.1474448347646977,0.2766798418972332,0.9014598378276929,1.0,6/32,4.97%,RORA;NEBL;DUSP29;SPEG;WNT5B;SGCZ
prerank,regulation of chromosome organization (GO:0033044),-0.3980148001136517,-1.1474375545296924,0.2655038759689923,0.5966672587475124,1.0,12/22,33.90%,WAPL;XRCC5;TERF2IP;YLPM1;SHCBP1L;LIG4;HNRNPD;TERF2;MAPT;MYC;PIF1;BUB1
prerank,kinetochore organization (GO:0051383),0.45906921225575137,1.147306365955463,0.29434697855750486,0.9000335739323506,1.0,6/13,22.22%,NDC80;CENPC;POGZ;NUF2;CENPA;CENPH
prerank,negative regulation of cholesterol transport (GO:0032375),0.5034757634452407,1.146723702777464,0.30196078431372547,0.9001488764673592,1.0,4/10,22.02%,ABCG5;ABCA2;NFKB1;SHH
prerank,negative regulation of TOR signaling (GO:0032007),0.36908777623916794,1.1462327114582251,0.28703703703703703,0.8998748296775064,1.0,11/36,18.47%,RNF152;PRKAA2;NPRL3;DEPTOR;SESN1;NPRL2;TSC1;ATM;SIRT1;FNIP1;CASTOR2
prerank,action potential (GO:0001508),-0.3335020816771028,-1.1462223661369533,0.22321428571428573,0.599161407227435,1.0,13/44,18.83%,KCNJ2;CACNA1G;GNA11;KCNMB2;KCNQ1;CACNA1I;KCNB1;KCNE4;SCN3A;GPER1;DMD;GNA14;CACNA1H
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2851237532543069,-1.14618326024773,0.18501170960187355,0.5986185234369893,1.0,35/110,21.78%,DAB2IP;HJURP;GSN;ICE1;ABCA1;FNIP2;RALB;TFRC;RACK1;ANKRA2;IAPP;RPS3;SRC;TAL1;APOE;AIDA;GFAP;CDC42EP2;HDAC6;VEGFA;SAR1A;BAK1;TRAF3IP1;NCLN;LATS1;SLF2;ATF7IP;HCK;SPIDR;LCMT1;AJUBA;SYK;FAF1;CDC42;BIK
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2721513701307466,1.1456132981549698,0.17113095238095238,0.9002088643558572,1.0,99/264,26.94%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;STRAP;SRSF5;TFIP11;SF3B5;HNRNPH3;CCAR1;HNRNPA2B1;PQBP1;HNRNPU;DDX17;HNRNPA3;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;PRCC;SRSF11;SNUPN;RBM5;LSM8;POLR2D;DHX8;SNIP1;RNPS1;HNRNPH2;ALYREF;PRPF3;SNU13;PRPF6;MTREX;ELAVL2;SRRT;DDX39B;SNRPB2;SRSF6;SUGP1;PUF60;SF3B2;SF3B1;CWF19L1;POLR2A;PRPF40A;SNRPB;GCFC2;PRMT5;PPIL1;HNRNPH1;SART3;DCPS;DDX39A;SF3B3;EFTUD2;SCNM1;POLR2B;SRPK1;PRPF38A;PPIL3;SRSF2;DDX41;SNRPN;RBM15B;WDR83;HNRNPC;SNRPC;CSTF2;U2SURP;PRPF8;PNN;U2AF2;SF3B6;NONO;POLR2C;SNRNP40;GEMIN7;DHX16;FIP1L1;RBM4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.36800098539288306,-1.1454752975007758,0.2505263157894737,0.5997480662433625,1.0,7/28,9.26%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4084029328260858,1.1452598553850024,0.2898832684824903,0.8995254953618331,1.0,12/27,23.03%,PLAAT5;LPIN1;ETNK2;PNPLA8;PCYT2;CHKB;PLA2G15;NAAA;PLAAT3;NAPEPLD;SLC27A1;PISD
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.4536390411819582,-1.1450592527104781,0.2971887550200803,0.6001584116849478,1.0,3/12,11.77%,FOXP1;KLF4;CD74
prerank,regulation of steroid metabolic process (GO:0019218),0.40647150889419004,1.1448871085638406,0.2892249527410208,0.898907778730198,1.0,5/23,16.16%,RORA;PANK2;ABCA2;EPHX2;STAR
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4470048795703516,-1.1444812169699243,0.313953488372093,0.6009680675639415,1.0,4/13,9.94%,NOTCH1;TGFBR2;HEY2;CPE
prerank,bile acid metabolic process (GO:0008206),-0.37524007606040943,-1.1444298341027594,0.2616407982261641,0.6004676431775635,1.0,4/27,6.14%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4234529171841331,-1.1440705884231976,0.32091097308488614,0.6007275202920115,1.0,6/16,12.31%,BMPR2;ENG;TGFB2;NOTCH1;HEY2;BMP2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.34127670608283434,-1.1439793511445426,0.24511930585683298,0.6003281171527978,1.0,10/39,15.57%,PODXL;JAG1;FXYD5;NOTCH1;CDH1;NOTCH4;KLF4;BMP2;VEGFA;MAD2L2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.43454955161810743,-1.1438731393527264,0.28402366863905326,0.5999950876649842,1.0,3/14,2.87%,TMSB4X;PKD1;NFKBIA
prerank,folic acid metabolic process (GO:0046655),0.4291187679032595,1.1437646941744108,0.3055028462998102,0.9009800234485414,1.0,7/18,17.87%,ALDH1L1;SLC19A1;MTHFS;MTHFR;MTHFD1;FPGS;MTHFD2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3962063433573665,1.1437065917634845,0.299625468164794,0.8992766889899548,1.0,4/25,4.40%,HSPA1A;DNAJC18;DNAJB14;DNAJB4
prerank,dephosphorylation (GO:0016311),-0.26929066346092917,-1.1432787473617205,0.15240641711229946,0.6009251122591651,1.0,47/147,24.51%,PTPRM;PTPRB;PTPRG;PTPN12;SDHAF2;ALPL;PTPRJ;PPP1R12A;PTPRK;SSH2;PPP3CA;PPP2R5C;PPM1H;PLPP1;PPP1CA;PTPN1;DUSP3;MTMR7;DUSP23;ILKAP;PTPRZ1;PPP2R3A;PTPRC;PPP1CC;PPP4R2;TAB1;PLPP3;NT5C;THNSL2;CTTNBP2NL;SGPP1;DUSP6;CTDNEP1;PTPN6;PPM1L;PTEN;PPP2R5B;PPP2CA;DUSP1;PTPRF;ACP3;PLPP2;CTDSP1;TIMM50;PDP1;PLPP6;DUSP7
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4668146114825395,1.1431099602241204,0.3192771084337349,0.8994230585511042,1.0,5/12,15.78%,MAP2;CLIP3;EML2;TUBB4A;MAPRE1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4825588100968399,-1.1428885122413461,0.2918287937743191,0.6013639606665983,1.0,4/10,23.52%,UBE2J1;INSIG1;OS9;SVIP
prerank,oligosaccharide metabolic process (GO:0009311),-0.3250734744006537,-1.141950400261036,0.23076923076923078,0.6030590320992285,1.0,7/46,7.88%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,ventricular septum morphogenesis (GO:0060412),-0.37346596004652904,-1.1417526561718248,0.2803347280334728,0.6029569225121155,1.0,11/27,9.40%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;BMP4;TGFBR2;HES1;HEYL;HEY2;ZFPM2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4045319701340841,-1.1414379840543263,0.2757936507936508,0.6031249702932961,1.0,9/21,21.77%,NGF;AIM2;GRIN2B;BIRC3;MT3;USP50;GRIN1;BEX3;FYN
prerank,regulation of MAP kinase activity (GO:0043405),0.30462931330360415,1.1413972447961453,0.22857142857142856,0.9036193292931005,1.0,11/92,8.11%,ROBO1;BMP7;FGF1;TENM1;KIT;PIK3CB;ADRA2A;PPEF2;LRRK2;SNF8;KSR1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3406482026801281,-1.1412237228763678,0.24242424242424243,0.6029995542271414,1.0,14/40,21.82%,SMURF1;RPL5;RPS7;RPL23;FOXF2;RAD23B;PTK2B;FBXW7;CSNK2A1;GNA12;LATS1;PTEN;GLMN;CCDC22
prerank,embryonic digestive tract development (GO:0048566),-0.4133219873892433,-1.1410726163399605,0.28661087866108786,0.6027494629815281,1.0,8/18,15.66%,RARB;PCSK5;TGFB2;GLI3;NIPBL;STRA6;RARRES2;ID2
prerank,cellular response to sterol (GO:0036315),0.46427307109855565,1.1408606840280904,0.30364372469635625,0.9036448425807361,1.0,3/13,5.62%,RORA;INSIG2;GRAMD1B
prerank,regulation of metal ion transport (GO:0010959),0.4333569193903625,1.140583658585702,0.2835249042145594,0.9027719227267147,1.0,5/16,15.08%,ANK2;DLG1;SLC30A10;BCL2;ORAI1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.41742810235492356,1.140533561808379,0.3001841620626151,0.9010257435060652,1.0,2/19,0.43%,AFDN;BMP6
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3749155176449023,-1.1405221432720698,0.2851153039832285,0.6034944291296566,1.0,6/25,10.19%,B2M;SLC7A5;PLCG2;WNT5A;CD55;MALT1
prerank,negative regulation of JNK cascade (GO:0046329),-0.35235899920348857,-1.1404953135379143,0.2681818181818182,0.6029443400275718,1.0,6/31,11.39%,MECOM;DNAJA1;DUSP3;PER1;AIDA;PDCD4
prerank,regulation of signal transduction (GO:0009966),-0.25564361126792845,-1.140454767976763,0.14325068870523416,0.6024330068031597,1.0,47/190,15.88%,PLCE1;RSPO3;RGS3;LIFR;RGS12;ACVR1;RGS5;MDFIC;TMEM204;SOCS2;PLSCR1;APP;RUNX1;ESR1;IGFBP6;MGLL;PRKD1;UBASH3B;HHIP;PPIA;PXN;NCK1;RGS6;CBFB;CD55;SRC;PTPN1;SOCS5;CDKN2AIP;MFNG;SREBF2;WDR11;GRK5;CDC42SE2;TSPAN12;PTCH1;UGCG;ZDHHC7;GSKIP;RGS4;CD24;GIT1;IRAK2;CD46;SEMA5A;LFNG;GIT2
prerank,epidermal cell differentiation (GO:0009913),-0.33340618014348544,-1.140112543516754,0.25054466230936817,0.6026653590811444,1.0,9/41,13.08%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;ERCC2;UGCG
prerank,protein complex oligomerization (GO:0051259),0.3141828905276365,1.140018954936942,0.23039215686274508,0.9009526164014795,1.0,32/85,24.85%,UPB1;WDCP;TMEM120B;ATL1;CPSF6;VSTM5;GSDMD;ADCY8;KCNC3;CPSF7;ELAVL1;RNF135;KCNC2;CUTC;BEND3;MICU1;RNF213;TRMT61B;NOL3;ALAD;OXA1L;HGSNAT;NLRC4;PYCARD;DNM1L;MAT2A;ALS2;IKZF4;SLC9A1;SPAST;MPP2;JMJD6
prerank,cellular response to virus (GO:0098586),0.3785963893429043,1.1396483457608784,0.2781954887218045,0.9004553167393866,1.0,11/30,20.49%,CHUK;GSDME;VWCE;MAPK14;IL6;GBF1;IL12A;HSP90AA1;BAX;DDX3X;POU2F2
prerank,mRNA processing (GO:0006397),0.26776667421681305,1.1396131510459717,0.17271407837445574,0.8987070929388573,1.0,106/287,26.75%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;CPSF6;SF3B5;HNRNPH3;CCAR1;HNRNPA2B1;PQBP1;HNRNPU;HNRNPA3;SON;PRMT9;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;PPARGC1A;CACTIN;IK;SRRM4;RNMT;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;RPRD2;ZMAT2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;DHX8;SNIP1;AKAP8L;RNPS1;HNRNPH2;ALYREF;PRPF3;SNU13;PRPF6;MTREX;ELAVL2;SRRT;DDX39B;SNRPB2;THOC1;SRSF6;SUGP1;PUF60;SF3B2;SF3B1;CWF19L1;POLR2A;SARNP;PRPF40A;SUPT4H1;SNRPB;GCFC2;CELF1;PPIL1;HNRNPH1;SART3;DDX39A;SF3B3;EFTUD2;POLR2B;PRPF38A;PPIL3;SRSF2;DDX41;SNRPN;RBM15B;WDR83;HNRNPC;SNRPC;CSTF2;U2SURP;PRPF8;PNN;U2AF2;SF3B6;NONO;RAMAC;POLR2C;SNRNP40;THOC2;GEMIN7;ZC3H11A;DHX16;FIP1L1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.40889085809168324,-1.1392528041430334,0.27637130801687765,0.6042709274283118,1.0,4/20,6.31%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5
prerank,tetrapyrrole metabolic process (GO:0033013),-0.4129073916837336,-1.1389045927194583,0.2813765182186235,0.6045397196679786,1.0,4/18,8.29%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,atrial septum development (GO:0003283),0.46194069334056387,1.13878301831683,0.30434782608695654,0.8996411688067701,1.0,2/13,1.79%,NOTCH2;ANK2
prerank,positive regulation of metabolic process (GO:0009893),0.3011903022022172,1.138760908926781,0.22842639593908629,0.8978487561464042,1.0,7/103,1.06%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,synaptic vesicle endocytosis (GO:0048488),0.37902385514053494,1.137876629617705,0.29097605893186,0.8991036934816502,1.0,8/33,11.20%,DNAJC6;CEL;NLGN2;PICALM;SYT1;NLGN3;SYNJ2;CANX
prerank,regulation of protein localization (GO:0032880),0.33030138746521154,1.1376001053041194,0.25609756097560976,0.8982337402958017,1.0,9/58,10.45%,AFDN;MAP2;PICALM;TRIM5;DLG1;CAMK1;CEP290;WDPCP;VIP
prerank,nervous system development (GO:0007399),0.25640810186337176,1.137084945871834,0.15555555555555556,0.898109821684312,1.0,88/429,16.65%,SDK1;ROBO1;ALDH1A2;NOTCH2;TRAK1;NR2E1;ESS2;OBSL1;SDK2;INTU;VXN;RAPGEF5;ARNT2;TENM1;NLGN2;ADAM22;LRCH4;PCDHB11;CELSR1;DAGLA;FLRT3;NPTX1;IL1RAPL2;GFRAL;CRMP1;CHRM2;NRTN;ADGRB2;PAX6;MARCKSL1;MAB21L2;TRIM71;FZD9;WWTR1;FGF12;IGSF8;ATN1;NRG1;DPF1;NLGN3;JARID2;SCRG1;LPAR1;ADGRV1;WDR62;LSAMP;CLN8;WDPCP;DLG4;TMOD2;ZIC2;TGFBR1;GPM6A;SRRM4;APC2;LDB2;LDB1;NES;RITA1;CHRM1;FZD5;FKTN;CHERP;PCDHB3;CPNE6;DPYSL2;ARHGAP26;BDNF;L1CAM;ZIC5;TYRO3;HDAC4;CLN5;HPCAL4;CYP51A1;GPM6B;FUT10;GFRA4;CSPG5;NAV3;GBA2;SCN8A;KALRN;NRSN2;DPF3;AXL;EPHB1;TRIM3
prerank,negative regulation of transposition (GO:0010529),0.4400540460712469,1.1368618590562163,0.2891089108910891,0.897036311551018,1.0,4/16,12.71%,TDRD9;SPOCD1;TUT4;MYBL1
prerank,positive regulation of ossification (GO:0045778),-0.33839340004773133,-1.1366583880294943,0.27586206896551724,0.6095226968948325,1.0,14/39,12.31%,MEF2C;ZBTB16;BMPR2;PTN;ATP2B1;ACVR1;TGFB2;BMP4;WNT5A;CCN1;TMEM119;TGFB3;ISG15;BMP2
prerank,heart trabecula morphogenesis (GO:0061384),-0.40628940909676614,-1.1364812691943122,0.29591836734693877,0.6093867248473925,1.0,7/18,5.34%,TEK;BMP5;ADGRG6;ENG;TGFB2;NOTCH1;S1PR1
prerank,regulation of chromatin organization (GO:1902275),-0.44241140897523723,-1.1364543092721342,0.3181818181818182,0.6088268116250957,1.0,4/14,10.11%,MLLT3;HPF1;IGF2;PARG
prerank,response to interleukin-4 (GO:0070670),-0.47941287732658233,-1.1363601929536937,0.3081510934393638,0.6084226146211125,1.0,1/10,0.16%,LEF1
prerank,negative regulation of signal transduction (GO:0009968),-0.24802288998496838,-1.1359301711401717,0.1452513966480447,0.6088530815874804,1.0,66/249,18.95%,BMP5;SEMA6A;DAB2IP;PID1;DCN;NTN1;PTPN12;NOTCH3;ACVR1;PIP4K2A;THBS1;GRB14;EGFR;NFATC1;KANK1;PTPRJ;SFRP4;CRY1;IRAK3;YWHAB;GLI3;CARD16;NKD2;UBASH3B;CREB3L1;XDH;RACK1;HHIP;LYN;PRKCD;NCK1;EPN2;SPRY2;APOD;GATA2;PTPN1;FGF2;SOCS5;HGS;HERC4;HHEX;BMP2;PTCH1;TCIM;FBXW7;CSNK2A1;TAX1BP3;PTPRC;SPRY1;NR4A2;PTCH2;TMBIM1;GPC1;IRS1;DDIT4;CILP;HEY1;SIGIRR;LRP1;RNF157;KCTD6;ADAMTS12;ENPP1;LRRC14;PTEN;ASAH2
prerank,regulation of phospholipase C activity (GO:1900274),-0.42484441469478484,-1.1359247627102196,0.3112449799196787,0.6082504329222365,1.0,5/15,9.69%,NTRK3;PLCG1;ESR1;FLT1;FGF2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.29333097119676305,-1.1356777522352437,0.23486682808716708,0.6082024880340058,1.0,14/79,11.55%,ST3GAL4;GCNT2;BMPR2;ST8SIA4;CSGALNACT1;ST3GAL6;B3GNT2;CHST8;COG3;ST8SIA6;XYLT1;GOLPH3;GCNT1;B4GALT5
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3366523765799918,-1.1356637379981005,0.2422907488986784,0.6076273845869015,1.0,15/40,20.41%,CRY1;UBE2V2;PRKCD;FEM1B;IER3;WDR76;PARG;FBXO5;WRNIP1;FMR1;FXR1;RPA2;MCL1;SIRT7;NSMCE4A
prerank,peptidyl-amino acid modification (GO:0018193),0.4880460121501526,1.1355381573761696,0.3393574297188755,0.899887294701714,1.0,4/10,24.03%,METAP2;ATP7A;TTLL4;METAP1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2836207299342613,-1.1352528176772734,0.22139303482587064,0.6080146184390066,1.0,22/109,12.10%,PLA2G4A;PIP5K1B;RAB14;PIP4K2A;INPP4A;PIK3R1;PLCG1;PIK3C2A;BMX;PLCG2;PLEKHA8;PIK3R6;INPP5D;PLEKHA4;PIK3CA;FGF2;MTMR11;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12
prerank,regulation of cell cycle (GO:0051726),-0.24222428435063775,-1.1352184651793529,0.12202380952380952,0.6074920837163532,1.0,84/271,23.43%,APBB2;MECOM;TTC28;DAB2IP;NEK7;LRP6;PLAGL1;TGFB2;FAP;THBS1;DCUN1D3;NOTCH1;TBX3;PKD1;IQGAP1;AFAP1L2;BMP4;STAT3;ADARB1;PTPRK;JUN;MAP3K20;ERN1;ADAM10;RACK1;APC;MYBBP1A;RPS6KA2;CDC123;RBBP4;XIAP;CDK5;WHAMM;RPL23;GRK5;FBXO5;PDCD4;BMP2;SIPA1;LIN54;AKT2;MADD;GAS2L1;CSNK2A1;BIRC3;PTPRC;JMY;PUM1;FOXO4;ID2;PRKACA;RPS15A;TBRG4;ING4;GPER1;MASTL;NBN;MAPK12;BARD1;JUNB;CCND1;KIF20B;CDC26;ASAH2;PCLAF;RHOB;METTL3;CCPG1;CDK6;JUND;CHEK1;L3MBTL1;THAP1;TTLL12;DUSP1;RPRD1B;FBXL6;CYLD;PRDM11;CDKN1B;NANOS3;CCNB2;RNF40;CDK11B
prerank,regulation of neuron projection arborization (GO:0150011),-0.4326688916804356,-1.1350016263896432,0.27920792079207923,0.6074169653639813,1.0,4/15,11.89%,MACF1;WNT5A;FZD4;MFSD2A
prerank,postsynaptic membrane organization (GO:0001941),0.42820624885133446,1.1349195023034289,0.32437619961612285,0.9002187457454593,1.0,6/17,9.11%,CEL;NLGN2;NLGN3;SHISA7;LRP4;DLG4
prerank,positive regulation of cell growth (GO:0030307),-0.2847597777115622,-1.1347489417106569,0.22921914357682618,0.6074633771684532,1.0,27/96,18.14%,NEDD4L;NTN1;SEMA7A;TGFB2;EGFR;NGF;MACF1;SMURF1;ITSN2;H3-3A;RPS6KA3;ADAM10;SYT4;CDKN2AIP;EDN1;RPTOR;PABIR1;MFSD2A;SHTN1;USP47;CSNK2A1;LIMK1;NCBP1;DDX49;KLHL22;RNF157;UNC13A
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2665147383591321,-1.1347127307887788,0.2,0.6069417106568435,1.0,27/150,10.61%,HIP1;KITLG;TEK;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;F3;PIK3R1;EGFR;PTPRJ;MFHAS1;ESR1;TNFAIP8L3;ITGB1;MET;MYOC;IAPP;SPRY2;PIK3CA;SRC;IGF2;FGF2;PIK3CD;FGF7
prerank,positive regulation of ATPase activity (GO:0032781),0.3598618201714864,1.1346790000885452,0.2894736842105263,0.8992268594770674,1.0,14/41,20.74%,ATP1B3;ATP1B2;ALDOB;HNRNPU;MSH6;DNAJC10;SSBP1;RYR2;MSH3;DNAJB2;ATP2A1;FGF10;DNAJB1;VMP1
prerank,chloride transmembrane transport (GO:1902476),-0.3163956354418076,-1.1345770924669023,0.23157894736842105,0.606691415786918,1.0,14/48,15.91%,SLC12A7;SLC12A2;ANO1;SLC12A6;LRRC8A;SLC1A3;GABRA3;GLRB;SLC1A1;ANO4;GABRE;GLRA2;ANO2;CFTR
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4240021918660499,-1.1339852353057212,0.2813141683778234,0.6076759298830144,1.0,10/17,20.96%,CACNA1G;STX1A;SYT4;RAB3A;RAB27A;CACNA1I;KCNB1;RAB3D;CACNA1H;SLC4A8
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2834032740458404,1.1338195347307936,0.18641390205371247,0.900489564612758,1.0,17/159,6.00%,SDK1;ROBO1;ALCAM;CLDN20;OBSL1;SDK2;IL1RAPL1;TENM1;CDH3;CDH15;PCDHB11;CDH17;FLRT3;MPZL2;GRID2;IGSF9;CDH10
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.26648278734991016,-1.1332324748354698,0.1842818428184282,0.608924410713347,1.0,39/136,20.08%,DAB2IP;TMSB4X;CD200;FZD6;GAS6;PKD1;PTGIS;NFKBIA;CYP1B1;ID1;SFRP4;IRAK3;ESR1;FLNA;BHLHE40;TRIM37;AIM2;HES1;NLRC5;HEYL;DAP;USP7;KLF4;PHB2;PTCH1;MTURN;IRAK2;MAD2L2;ID2;SP100;SIGIRR;PEX14;HDAC2;LRRC14;ZC3H12A;ERBIN;ARRB2;PSMD10;SPI1
prerank,skin development (GO:0043588),-0.3075798472998751,-1.1330216666767858,0.21271393643031786,0.6088254208190643,1.0,16/65,13.08%,JAG1;ITGA6;CLIC4;PKD1;BCR;LSR;ITGB4;STMN1;COL5A2;MET;WNT5A;ANXA1;TXNIP;HRNR;SCEL;UGCG
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4121429981571067,1.1327729931520667,0.30739299610894943,0.9022845128079132,1.0,4/21,8.26%,CACNA1D;ANK2;SNTA1;KCNH2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2756291838013335,-1.1326191816716793,0.21195652173913043,0.609224447770016,1.0,20/110,10.96%,ADGRL4;ADGRL2;CALCRL;RAPGEF2;ADGRG6;ADRA1B;RAMP2;ABCA1;ADCY4;ADGRE5;S1PR1;GNB1;GNG2;ADGRD1;ADCY7;IAPP;ADCY2;S1PR3;ADGRG2;ADGRG1
prerank,establishment of vesicle localization (GO:0051650),0.42467594750610926,1.1325826645394619,0.3092979127134725,0.9011351649852004,1.0,4/18,6.84%,SYT11;KIF5C;IKBKG;SNAPIN
prerank,regulation of cell adhesion (GO:0030155),-0.26964441848540305,-1.1323020774590675,0.19592875318066158,0.6093841628454673,1.0,50/129,25.67%,FRMD5;PODXL;ZFHX3;ACVRL1;CDH13;PTPRJ;PPP1R12A;STX3;NUAK1;ADAM10;ARHGDIB;LYN;PRKX;PPP3CA;TGM2;CXCL12;MDK;TGFBI;EFNA5;SRC;EPHB2;ADGRG1;PLXNC1;RET;PTK2B;SIPA1;ARHGDIA;VEGFA;SEMA5A;PLXNA4;ZDHHC2;CELSR2;GPR4;PPP2CA;ROCK1;DUSP1;PLXND1;DLL1;ATXN3;TESC;RASA1;LPXN;FES;PIK3CG;EPB41L4B;PTPN11;CXCR4;RND1;KIF14;SEMA4D
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.30042753451443516,-1.1321133388233335,0.23821339950372208,0.6092900789102401,1.0,11/70,9.26%,DAB2IP;HIPK1;TGFB2;BCL2L1;NGF;TNFRSF1B;FAS;CRADD;IL6R;CASP8AP2;SORT1
prerank,positive regulation of macroautophagy (GO:0016239),0.3340678005668344,1.1319431060687715,0.24548736462093862,0.901555171466706,1.0,10/48,10.32%,PRKAA2;RAB3GAP1;OPTN;FYCO1;SLC25A5;IKBKG;GPSM1;SESN1;HTT;PAFAH1B2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4374958270615258,-1.1317213228025338,0.31,0.6096494539266886,1.0,3/13,6.00%,PDE8A;MET;RACK1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.43793077285134097,-1.1317091581774126,0.3226452905811623,0.6090645318179104,1.0,4/13,12.31%,BMP5;SOD1;APOE;BMP2
prerank,chordate embryonic development (GO:0043009),-0.3136127696231821,-1.1314382433521624,0.22811059907834103,0.6091340528029878,1.0,18/55,16.08%,MBNL1;BMP5;PCSK5;PKD1;FUT8;KIAA1217;TBX1;ADAM10;WNT5A;IGF2;XYLT1;TGFB3;BMP2;PTCH1;VEGFA;STIL;SIX4;COL1A1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.386737565188406,1.1313638555485288,0.2828828828828829,0.9017095579266461,1.0,5/26,4.52%,GCHFR;SPHK1;NQO1;PM20D1;ARG2
prerank,microtubule nucleation (GO:0007020),0.4241579007043609,1.131350891374863,0.291015625,0.8999286846400693,1.0,5/19,9.15%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,glial cell development (GO:0021782),-0.374966984753176,-1.1312186713289838,0.2978723404255319,0.6090582683540134,1.0,14/25,32.96%,APP;MDK;EIF2B2;MT3;NRROS;EIF2B1;CDK6;DLL1;MYRF;SOX11;MXRA8;NSUN5;PRDM8;S100A9
prerank,membrane organization (GO:0061024),-0.24915463629598356,-1.131213108835402,0.16272189349112426,0.6084567764032237,1.0,57/227,18.55%,HIP1;SPTBN1;ACTB;DNM3;STON2;ACTG1;CERT1;EGFR;CORO1C;UBC;AP2B1;PIK3C2A;SCARB2;FCHO2;PLEKHA8;SGIP1;CHMP2B;TFRC;VAMP3;RPS27A;UBB;CLTB;WNT5A;FNBP1;EPN2;CHMP4B;CHMP4A;NEMP1;GAPVD1;CHRNB1;RABIF;DYSF;HGS;FNBP1L;LEMD3;FZD4;SUN1;SH3GL2;HIP1R;UBXN2A;AP2A1;REEP3;SAR1A;VAPB;ARPC2;CBL;CFTR;SYNGR2;SNAP23;LDLRAP1;TLCD1;SYNGR1;CTDNEP1;HACE1;REEP1;CHMP1B;TOR1AIP2
prerank,regulation of type I interferon production (GO:0032479),-0.290869282719602,-1.1312127864997736,0.20854271356783918,0.6078489274757479,1.0,28/84,25.50%,LRRFIP1;POLR3F;DHX33;RNF125;XRCC5;NLRC5;TRIM56;TRIM25;G3BP1;POLR3H;ISG15;IFIH1;POLR3B;TRAF3IP1;PCBP2;NFKB2;GAPDH;IRF5;POLA1;POLR3A;MYD88;POLR3D;CYLD;POLR2F;TAX1BP1;UFD1;ZBP1;POLR2H
prerank,response to sterol (GO:0036314),0.48471808204829697,1.1309067519551992,0.30443548387096775,0.8996883154524843,1.0,3/11,11.26%,RORA;TGFBR1;ABCA2
prerank,regulation of cellular respiration (GO:0043457),-0.41331709589975896,-1.1309050879468723,0.3033932135728543,0.6079508475063206,1.0,9/17,38.42%,PRDM16;CBFA2T3;IFNAR1;SHMT2;IFNLR1;VCP;NOS2;PRELID1;IL4
prerank,macroautophagy (GO:0016236),0.29462739754797607,1.1307950248612046,0.23102866779089376,0.898287181838405,1.0,21/118,12.48%,PRKAG2;PRKAA2;PRKAG3;CHMP6;STAM;SNX14;VAMP7;VTA1;SNAP29;TOMM40;SNF8;AMBRA1;VPS16;TOMM22;CSNK2A2;LAMP2;LIX1L;MFN2;ATG13;VPS39;UBXN6
prerank,cellular response to glucose stimulus (GO:0071333),-0.3555787516095009,-1.130591664388964,0.2736625514403292,0.6081028555498877,1.0,14/30,28.74%,GAS6;UNC13B;RAB11FIP5;ERN1;RACK1;RAB11B;KCNB1;PRKACA;GPER1;IGF1R;RAB11FIP2;TRA2B;SELENOT;PDK3
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4292324846330444,1.1305410834051837,0.30754352030947774,0.897401249788906,1.0,4/17,11.36%,IGF1;RTN1;NTRK2;CLU
prerank,leukocyte tethering or rolling (GO:0050901),-0.4141707827776172,-1.1304085258407255,0.29637526652452023,0.6079305053550599,1.0,7/17,21.75%,VCAM1;ITGB1;GOLPH3;GCNT1;ITGA4;ROCK1;JAM2
prerank,mitochondrial fusion (GO:0008053),0.4281787035581234,1.130059505296849,0.31721470019342357,0.8972544824082226,1.0,5/18,11.46%,MIGA2;AFG3L2;MIEF2;CHCHD3;MFN2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3817505336674781,1.1294627064477805,0.27798507462686567,0.8974854620432375,1.0,7/26,14.03%,SLC5A3;PPARA;SLC30A10;ABCD1;SPHK2;TRAP1;CYBA
prerank,regulation of AMPA receptor activity (GO:2000311),0.3968830748282911,1.1293228631839038,0.3029126213592233,0.896192852070243,1.0,13/25,24.30%,CACNG7;NLGN2;NLGN3;SHANK1;SHISA7;GSG1L;CNIH3;SHISA8;MINK1;MAPK8IP2;CACNG5;CACNG4;CACNG8
prerank,negative regulation of autophagy (GO:0010507),0.3369319529738801,1.1292971899124344,0.2703180212014134,0.8944802653445701,1.0,12/54,13.96%,LEPR;NUPR1;CTSA;QSOX1;ZKSCAN3;LRRK2;GOLGA2;IL10RA;BCL2;KDM4A;TBC1D14;TSC1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3616770210773656,-1.129283213316365,0.2542372881355932,0.6101225018423766,1.0,7/27,14.15%,SLC47A1;SLC7A5;SLC38A5;SLC7A1;SLC1A3;SLC1A1;SLC36A4
prerank,eye development (GO:0001654),0.3372780765914541,1.1291113973946054,0.26666666666666666,0.8933391680960161,1.0,15/54,15.38%,SMOC1;COL5A1;PBX2;RAB3GAP1;MEIS1;PAX6;MAB21L2;PBX4;CEP290;CPAMD8;ZDHHC16;SHROOM2;FOXC1;ADAMTS18;TSKU
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4615375058135153,-1.1290607040752338,0.3136456211812627,0.6100826145872363,1.0,4/12,15.66%,NOTCH1;HES1;BMP2;ID2
prerank,fatty acid metabolic process (GO:0006631),0.29673537936101685,1.1289385213682508,0.25245901639344265,0.8921317691172771,1.0,25/115,17.52%,ACSL1;CEL;PON1;ACSM2A;ACSM2B;PPARA;LPIN1;AASDH;PNPLA8;ACADSB;SLC27A6;ECHDC3;CPT1C;PPARGC1A;FA2H;PLA2G15;CROT;SLC27A4;NAAA;PER2;GGT5;ACACA;ACOT1;MSMO1;ACOT6
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3333909247070905,-1.1286595201413896,0.2545454545454545,0.6105286938766146,1.0,11/41,15.36%,PODXL;GCNT2;TJP1;PIEZO1;CD44;DENND6A;MDK;ADAM19;JAK1;PLAUR;PLPP3
prerank,neural crest cell differentiation (GO:0014033),-0.4062763407764124,-1.1283837382431374,0.29065040650406504,0.6105810600928051,1.0,2/18,1.52%,MEF2C;LRP6
prerank,secondary palate development (GO:0062009),-0.42455523317922733,-1.1281970089592448,0.29979035639413,0.610395859620559,1.0,5/14,9.79%,LEF1;TGFB2;TGFBR2;WNT5A;TGFB3
prerank,glycoprotein metabolic process (GO:0009100),-0.3135128131204359,-1.128112895505563,0.25783132530120484,0.6100150008229143,1.0,14/53,14.13%,ST3GAL4;ST6GALNAC3;ST8SIA4;FUT8;ST8SIA6;STT3B;MGAT4A;AGA;GOLPH3;GCNT1;B4GALT5;FBXO44;MGAT4B;ST8SIA2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.43811329451377823,1.1276573436638324,0.31237721021611004,0.8947924942329538,1.0,4/17,16.47%,LPGAT1;PLA2G4C;LCLAT1;PLAAT3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4573621225867004,-1.1274201491953069,0.3319587628865979,0.6111865768019695,1.0,3/12,9.00%,NOTCH1;CCN3;TMEM119
prerank,cartilage development (GO:0051216),-0.31590054099722265,-1.1268226210713,0.26096997690531176,0.6120630039767857,1.0,9/49,6.49%,MEF2C;ZBTB16;PKD1;RUNX2;BMP4;CD44;RUNX1;CCN3;SNX19
prerank,copper ion transport (GO:0006825),-0.4775235597441266,-1.1268016044323022,0.33539094650205764,0.6115123250744164,1.0,9/11,34.05%,STEAP3;SLC31A1;ATOX1;STEAP2;SLC31A2;ATP7B;COX17;STEAP4;SLC11A2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4328852638600972,1.1267880668310337,0.29693486590038315,0.8959933616169325,1.0,3/16,6.74%,FGF1;NPNT;CITED1
prerank,fat cell differentiation (GO:0045444),0.32508690376063437,1.1267770658438458,0.26666666666666666,0.8942567297112567,1.0,16/57,17.30%,OSBPL8;WNT5B;TMEM120B;METRNL;CLIP3;CEBPA;C1QTNF3;MED1;PPARGC1A;ADIG;CTBP2;FAM120B;PER2;TCF7L2;SIRT1;OSBPL11
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3771885653810406,1.1266008981245739,0.2962962962962963,0.8931120272051368,1.0,8/28,15.78%,MAP2;PRUNE1;CLASP1;ARL2;SKA2;ABL1;GBA2;MAPRE1
prerank,cellular response to chemokine (GO:1990869),-0.32312160477716556,-1.1263917343752805,0.2636363636363636,0.6119763005049976,1.0,8/46,12.44%,LRCH1;SLC12A2;RHOA;CXCL12;CCL13;DOCK8;ACKR3;PTK2B
prerank,regulation of cytokine production (GO:0001817),-0.2711112655243952,-1.1262930263546185,0.1967654986522911,0.6116330332747666,1.0,50/126,28.50%,FOXP1;ATP2B1;RPS6KA5;AFAP1L2;TNFRSF1B;PLA2R1;S100A13;LYN;NPTN;TRIM56;ANXA1;HDAC9;SOD1;IL15;MAPKAPK2;PER1;PIK3CD;TRIL;ISG15;CCN4;ACE2;AGPAT1;PTPRC;IFIH1;BCL6B;N4BP1;MAST2;PPP1R11;GAPDH;IL33;CADM1;PLD3;POLA1;GLMN;ASB1;ACKR1;FCGR2B;CCR2;RGCC;ZBP1;PIK3CG;CD276;CASP8;HILPDA;PLD4;NFAM1;SNAI2;MIF;AGT;TREM2
prerank,protein alkylation (GO:0008213),0.40174652731815347,1.1261676649040933,0.30685920577617326,0.8928378264504686,1.0,8/22,20.89%,EEF2KMT;PRMT2;FAM98B;PCMT1;PRMT3;ETF1;SNRPB;VCPKMT
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3872013645313106,-1.1260669009704867,0.2875,0.6116094285807505,1.0,8/21,20.47%,DCN;CSGALNACT1;CSPG4;VCAN;CHSY3;BGN;NCAN;BCAN
prerank,negative regulation of phosphatase activity (GO:0010923),0.3962712745540863,1.1258422899468767,0.31047619047619046,0.8921949363397641,1.0,3/25,5.04%,SH3RF2;SH2D4A;PPP4R4
prerank,amino acid transmembrane transport (GO:0003333),-0.3290421985461769,-1.125813526974123,0.23529411764705882,0.6116453890292143,1.0,10/45,8.48%,SLC47A1;SLC6A6;LRRC8D;SLC38A11;SLC7A5;SFXN1;SLC38A5;SLC7A7;SLC7A1;SLC16A2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.35078818005931917,-1.1253125633568335,0.27876106194690264,0.61233658039878,1.0,7/36,7.69%,CAV1;STIM2;ATP2B1;TRPC3;CACNB2;TRPC6;CXCL12
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3057818116975765,1.1252212655908684,0.25041736227045075,0.8926161249400688,1.0,11/85,7.29%,FGF1;TGFBR3;BMP6;IGF1;NUPR1;OSR1;FGF9;MCC;FUT2;FGFR2;NLRC3
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4769496019874364,-1.1252181803358312,0.3306930693069307,0.6119732688989333,1.0,3/10,4.23%,LRP5;TGFBR2;TBX1
prerank,regulation of protein import into nucleus (GO:0042306),-0.3411971246379609,-1.125200789583777,0.2647702407002188,0.6114066759186787,1.0,9/36,12.48%,MDFIC;PIK3R1;CDH1;BMP4;FLNA;PRKCD;APOD;IPO5;TPR
prerank,cellular response to hexose stimulus (GO:0071331),-0.3767911007121987,-1.1240419095581062,0.27422680412371137,0.613723952398211,1.0,9/23,20.70%,GAS6;UNC13B;ERN1;RACK1;SLC26A6;KCNB1;PRKACA;GPER1;IGF1R
prerank,regulation of TORC1 signaling (GO:1903432),0.3615170149229202,1.123480471514467,0.30570902394106814,0.8967992040971919,1.0,9/33,18.47%,RNF152;RRAGC;GPR137C;SESN1;PIH1D1;ATM;TELO2;RRAGB;CASTOR2
prerank,protein localization to membrane (GO:0072657),-0.2518131831976731,-1.1233297535331501,0.18575851393188855,0.6149644289297551,1.0,44/187,15.01%,SPTBN1;CAV1;SHANK3;RAPGEF2;BSG;PTN;RFTN1;LRP6;RAMP2;GAS6;RAP1A;CACNB2;TTC7A;PACS1;CDH1;SMURF1;F11R;TNIK;FLNA;FCHO2;RAP2A;NKD2;EFR3B;RAPGEF6;SH3PXD2B;SLMAP;EMP2;CPE;FGF13;EHD2;HGS;EHD4;RAB3A;ITGA4;PTCH1;KCNB2;LIN7C;ARL5A;PPIL2;RAB11B;AGRN;S100A10;KCNB1;FERMT2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.41065337850936207,1.1229614074583785,0.2963709677419355,0.8968618391350985,1.0,7/21,22.02%,DCDC2;EVC;ARMC9;TEDC2;DLG5;TXNDC15;SHH
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4419474197772749,1.122864188460936,0.3175542406311637,0.8954415837933429,1.0,3/14,8.23%,IL18;PRKCZ;NLRP3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.32358744290963276,1.1225758154219165,0.2851985559566787,0.8947652209835227,1.0,7/61,8.27%,ROBO1;NOTCH2;IGF1;PIK3CB;AUTS2;ARRB1;LPAR1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4207923337029146,1.1225001805928096,0.3191489361702128,0.893304902662814,1.0,9/19,16.31%,HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST5;HS6ST2;HS2ST1;NDST2
prerank,amino acid transport (GO:0006865),-0.3205848471284973,-1.1224776368764806,0.2528216704288939,0.6164946303789178,1.0,11/49,9.01%,SLC6A6;SLC38A11;SH3BP4;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC7A14;SLC43A1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2848607360790588,1.1224213923265711,0.2350230414746544,0.891851734604994,1.0,28/148,16.22%,PRKAG2;KMT5A;PRKAA2;RICTOR;PRKAG3;CHD4;TTC5;MEAF6;PDPK1;MAP2K6;KAT5;CHD3;TAF10;RFC5;CSNK2A2;MRE11;BRD7;MAPK14;TAF1;PML;CHEK2;NOC2L;SMYD2;RPA3;ATM;BANP;CHD5;MDM2
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36577621562303414,1.1223621049129135,0.29714285714285715,0.8903112910283585,1.0,9/32,16.48%,SYT11;SNCAIP;SNAPIN;LRRK2;RIMS1;DTNBP1;CPLX1;SYN1;CPLX2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.40296497858372593,1.1220828775677316,0.3019230769230769,0.8895558234784045,1.0,6/22,15.91%,KRI1;EXOSC8;NOP9;PES1;EXOSC2;WDR12
prerank,protein modification process (GO:0036211),-0.2950046965868401,-1.1217672927831865,0.21515892420537897,0.6176930334545394,1.0,20/76,16.60%,ST8SIA4;ST3GAL6;ATG3;PLOD2;UBE2D3;ST3GAL1;LOX;CSNK1G3;CPE;YES1;FBXW2;STK38;AKT2;UBE2L3;UBL5;ST8SIA2;ICMT;PPP4R2;PHKA2;PHEX
prerank,negative regulation of synaptic transmission (GO:0050805),0.39209418181811706,1.1217555270408415,0.3049907578558225,0.8889584714272663,1.0,5/23,12.31%,SYT11;LRRK2;ATAD1;DRD3;MTMR2
prerank,positive regulation of cellular respiration (GO:1901857),0.4703172701442753,1.121153679735554,0.332657200811359,0.8893316121417335,1.0,1/11,0.90%,NUPR1
prerank,positive regulation of exosomal secretion (GO:1903543),0.43406136816068086,1.121126552567415,0.3005893909626719,0.8877111660633585,1.0,3/15,7.73%,STAM;SMPD3;SNF8
prerank,response to hydrogen peroxide (GO:0042542),-0.32268875789447465,-1.1210771645411346,0.27539503386004516,0.6189014011380852,1.0,10/45,9.66%,NET1;MAP3K5;CYP1B1;PRKCD;ANXA1;RPS3;STK24;SOD1;CAT;GPX1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.27998367322321926,-1.120837162130467,0.24873096446700507,0.6189139607048243,1.0,25/103,13.73%,ARHGAP31;PLCE1;RAPGEF2;NTN1;RASGRP3;BCR;JUN;TIAM2;RALB;PRKD1;GNB1;ARHGAP32;RAPGEF6;PLK2;SHOC2;G3BP1;ABR;TIAM1;FGF2;GRAP;KRAS;NRAS;ARHGAP1;SHTN1;RERG
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4199941000316431,1.120494815677228,0.2985685071574642,0.8879813958311664,1.0,6/18,15.04%,RAB3GAP1;SNAPIN;LRRK2;RIMS1;DTNBP1;SYN1
prerank,sarcomere organization (GO:0045214),0.3886849800940118,1.1201513002289918,0.3018181818181818,0.887498241076657,1.0,4/27,8.77%,ACTN2;CAPN3;CSRP3;CSRP1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.31154394337655206,-1.120133316517518,0.23927765237020315,0.6200782656724787,1.0,12/51,15.01%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;SYNPO2;TGFB3;PFN1;LIMK1;S100A10;FERMT2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4507532305269728,-1.1201078840179075,0.33073929961089493,0.6195327318416556,1.0,6/12,31.70%,CHMP4B;CHMP4A;SEC61A1;SEC62;HSPA5;GET3
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4822086589117729,-1.1191115962920708,0.3320079522862823,0.621493207001315,1.0,3/10,10.49%,TMEM30A;ABCA3;APOE
prerank,regulation of phosphatase activity (GO:0010921),0.3925718684788059,1.1189278185997689,0.3185328185328185,0.88990974295976,1.0,4/24,13.96%,SH3RF2;SH2D4A;HTT;TSC1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3626724945000812,-1.1188396895084538,0.3054945054945055,0.6215693149311105,1.0,17/26,37.84%,CDC27;HECW2;ANAPC5;CDC16;FBXO5;LCMT1;DUSP1;CDK5RAP2;CDC23;CUL3;ANAPC11;NSMCE2;CDC6;ESPL1;UBE2C;CENPE;CCNB1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4755344974141478,-1.1179079671119234,0.33131313131313134,0.6233038472582428,1.0,5/10,8.89%,DCN;KDR;RACK1;MYOC;SRC
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.44090854026809045,-1.117502850659587,0.31746031746031744,0.6236725432688324,1.0,6/13,29.95%,UBE2J1;BCAP31;OS9;SVIP;EDEM2;EDEM1
prerank,response to interleukin-1 (GO:0070555),-0.29546954080456195,-1.1172843321618613,0.22911694510739858,0.6235973868063759,1.0,20/73,23.69%,DAB2IP;IL1R1;PTGIS;APP;IRAK3;TNFRSF11A;ANXA1;CCL13;SRC;TLE5;CD40;IRAK2;ADAMTS12;CCL25;ZC3H12A;USP10;MYD88;HAS2;TAF9;MAPK11
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41485023336741067,-1.1172439594019135,0.312625250501002,0.6230906419267395,1.0,2/17,1.44%,RAPGEF2;ADRA1B
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3366892725373559,-1.117202052048022,0.30736842105263157,0.6225946235332656,1.0,11/40,13.93%,NTRK3;EDNRA;EGFR;PLCG1;ESR1;FLT1;FGF2;PHB2;HTR2A;CD86;P2RY6
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.46010612759897235,1.1171352898996383,0.32091097308488614,0.8941430207796376,1.0,4/12,17.04%,UCKL1;DCK;UPP2;UMPS
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3301576028934688,-1.116848213890504,0.2635135135135135,0.6228956327954741,1.0,11/43,15.01%,KAT7;LIMK2;BMP4;MFHAS1;CTNNA1;TFRC;OTUD7B;ORMDL3;EIF2AK3;TPR;FERMT2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.34862064635063256,-1.1166120212443438,0.2894168466522678,0.6228798862431787,1.0,9/30,20.61%,CD34;STAT3;PLCG2;PIBF1;ISG15;CD46;NOD2;HMGB1;SYK
prerank,cellular response to hypoxia (GO:0071456),0.2878501118742477,1.1162619205017457,0.2628099173553719,0.8954504164039848,1.0,21/126,16.22%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;PSMD3;LMNA;PGK1;KCND2;HIF3A;NDRG1;ANGPT4;TERT;ARNT;PSMD1;PSMC5;PSMA1;PSMD12;SIRT1;MDM2
prerank,response to fatty acid (GO:0070542),-0.4100934769702318,-1.116201234039598,0.31379962192816635,0.6232869507812777,1.0,3/17,2.77%,PID1;FOXO1;FOXO3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.30846772041953785,-1.116120818036568,0.26869158878504673,0.6228594075328707,1.0,21/59,16.92%,PTPRM;HMCN1;PECAM1;BSG;PKD1;CDH13;CDH1;PALLD;ITGB1;NECTIN3;NPTN;ROBO4;CEACAM1;DSCAML1;NECTIN2;FAT2;EMB;CDH2;KIRREL3;PVR;DSG2
prerank,lipid modification (GO:0030258),-0.33655661426417527,-1.1160749249484603,0.2743764172335601,0.6223805467946755,1.0,14/37,26.92%,MBOAT1;DGKH;DGKZ;PLPP1;PLPP3;DGKB;SGPP1;PLPP2;LPCAT3;PLPP6;DGKG;PLA2G7;PLPP5;DGKA
prerank,positive regulation of inflammatory response (GO:0050729),-0.2829796496086232,-1.116032662142089,0.22409638554216868,0.6219074516022878,1.0,15/86,12.43%,IL6ST;OSMR;ETS1;NFKBIA;ABCC1;APP;AGTR1;PDE2A;WNT5A;MDK;IFI35;IL15;SERPINE1;PDCD4;CCN4
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3662411035952094,-1.1157046218385842,0.3049040511727079,0.6221311429968701,1.0,4/25,3.33%,GHR;PKD1;SOCS2;STAT3
prerank,protein monoubiquitination (GO:0006513),0.3600287400107528,1.1156682869359726,0.3212996389891697,0.8958445293743099,1.0,9/36,14.38%,CTR9;RNF126;LEO1;TOPORS;RNF20;UBE2W;CDC73;OBI1;UBE2R2
prerank,positive regulation of phagocytosis (GO:0050766),-0.32413666638565525,-1.1151715785959693,0.25957446808510637,0.6229311286038842,1.0,21/47,31.47%,MERTK;GAS6;PTPRJ;RAB31;C4B;DOCK2;GATA2;IL15;RAB27A;PTPRC;NCKAP1L;C3;FCGR2B;ANO6;CD300LF;IL2RG;LYAR;TREM2;AHSG;PLA2G5;CD47
prerank,neuron projection extension (GO:1990138),0.3715826014739755,1.1148515347125953,0.3173996175908222,0.8969310489225165,1.0,8/32,8.28%,ALCAM;CPNE1;FLRT3;AUTS2;NLGN3;LLPH;FLRT1;IMPACT
prerank,pre-replicative complex assembly (GO:0036388),-0.3010919264461954,-1.1147960079126906,0.24,0.6232778251629574,1.0,19/64,22.69%,UBC;RPS27A;UBB;PSMB7;PSMA6;PSMB6;PSMB5;ORC1;PSMC4;PSMB8;PSMD11;ORC2;PSMB4;PSMD14;ORC5;PSMD10;PSME1;MCM3;PSMB3
prerank,regulation of organelle organization (GO:0033043),-0.28764958764015114,-1.114516964432748,0.24708624708624707,0.6233873353422382,1.0,35/80,31.36%,TJP1;CLIC4;F11R;MFF;USP6NL;SCARB2;PAK2;CAPN2;PDE2A;ARMH3;MAPK1;GOLPH3;SQSTM1;SAR1A;SURF4;TBC1D25;CLEC16A;PRMT6;MAPK3;ARHGEF5;SIRT7;TAOK1;MSN;RHOT2;STX5;MUL1;ARL6IP1;AKAP9;MAPT;STOX1;CAMSAP2;CAMSAP3;VPS35;LMAN1;CLN3
prerank,regulation of protein localization to cell surface (GO:2000008),0.361390696495806,1.1144166261970607,0.2961608775137112,0.8967263980006202,1.0,11/33,18.46%,LEPROT;ACTN2;PICALM;ABCA2;BDNF;GPM6B;SNX33;STX4;GBF1;HFE;GPD1L
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.387957083268201,1.1143115312536485,0.3238434163701068,0.8953913274277673,1.0,6/25,7.38%,GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4224572872478828,-1.1143047353184699,0.3258655804480652,0.623327852758431,1.0,8/15,33.43%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;ARPC5
prerank,acylglycerol biosynthetic process (GO:0046463),0.3869757358879877,1.1142327678099206,0.31608133086876156,0.8939795865201694,1.0,6/23,12.95%,LPGAT1;GK;LPIN1;MOGAT1;PLA2G15;DGAT2
prerank,regulation of hemopoiesis (GO:1903706),-0.4672495244693623,-1.1141172849817131,0.3515151515151515,0.6231673104986624,1.0,3/10,7.55%,PTN;RUNX1;CBFB
prerank,negative regulation of nuclear division (GO:0051784),0.4754294218412034,1.113919697506022,0.34004024144869216,0.8933739442643474,1.0,2/11,6.94%,BMP7;TOM1L2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2792676721896344,1.1137191811610883,0.23993808049535603,0.8924072513840311,1.0,24/152,10.78%,CACNA1D;ADCY5;LGR4;GCGR;PTH2R;ADGRG4;ADCY1;LPAR2;CRHR1;ADRA2A;CHRM2;ADGRB2;ADGRB3;ADCY8;GPR12;LPAR1;GPR26;GABBR1;PTGER1;ADGRL1;GPR37;ADGRG3;VIP;HTR1F
prerank,cell junction organization (GO:0034330),0.31343803165700185,1.113584479014525,0.2681660899653979,0.8912106322475916,1.0,7/71,2.86%,SDK1;SLC6A1;SLC8A3;SMAD3;SDK2;FLNC;NLGN2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3170300556789989,-1.1135139381315937,0.2511520737327189,0.6241116992234791,1.0,11/45,11.40%,B2M;VCAM1;CD44;MID1;ICAM1;IRF9;CAMK2D;PRKCD;TRIM25;IRF2;JAK1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3996942926940417,1.113333226755261,0.3104125736738703,0.8904108463032709,1.0,6/22,10.61%,APPL2;TAFA3;TRIM71;FZD9;LRRK2;NES
prerank,chondrocyte differentiation (GO:0002062),-0.3498289365783192,-1.1125818292050162,0.27896995708154504,0.6258440984305004,1.0,9/32,12.31%,MEF2C;BMPR2;RUNX2;BMP4;RUNX1;CCN3;SNX19;EIF2AK3;BMP2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.34217147362640243,1.1117452097447418,0.2957983193277311,0.8941099222900023,1.0,15/47,19.70%,BMP7;TMEM64;LMO3;METRNL;HNRNPU;CREBL2;AAMDC;ADIG;CDS1;TFE3;CREB1;AKT1;ASXL2;FNDC5;PIM1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.44412364370433566,1.1115613970008411,0.3468208092485549,0.8930798101316958,1.0,4/16,16.00%,RORA;PDK2;PDK1;SIRT1
prerank,nuclear membrane disassembly (GO:0051081),0.45276718188314996,1.1115430642146222,0.32989690721649484,0.8914848014277307,1.0,5/14,16.22%,LPIN1;PLK1;PRKCB;PRKCA;AKAP8L
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.45564530926387903,1.111453232831561,0.311787072243346,0.8901112694056227,1.0,5/12,15.71%,PCM1;BICD1;KIF3A;CCDC120;NINL
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4507782407928157,1.1107165749413435,0.3313840155945419,0.8909059986888177,1.0,6/14,18.57%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3253026000737129,1.1105641829228377,0.2859560067681895,0.8897390584837918,1.0,12/53,17.26%,EYA1;DDX5;EYA4;EYA2;CCAR2;ABRAXAS1;SPRED3;FXR2;ATM;MSX1;SIRT1;SPRED1
prerank,Fc receptor signaling pathway (GO:0038093),-0.27639147764265315,-1.110329424568087,0.26356589147286824,0.6308699504824906,1.0,32/110,21.07%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;LYN;TEC;PSMB7;PSMA6;MAPK1;PPP3CA;PIK3CA;PSMB6;MALT1;VAV2;NFATC2;PSMB5;PSMC4;PSMB8;TAB1;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;SYK;PSME1;MAP2K7
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.33366191647046267,1.1100905767517006,0.3120689655172414,0.8896497368490356,1.0,12/54,14.65%,HSPA1A;SPHK1;CPNE1;CLIP3;CHUK;NLRP2B;IKBKG;PELI3;CFLAR;RNF31;RBCK1;HSPA1B
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.35759535478685434,-1.1099005608759132,0.2794759825327511,0.6314047612520527,1.0,11/29,17.80%,TEK;DGKZ;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;PIK3R4;IRS1;FGFR3;NOD2
prerank,positive regulation of B cell activation (GO:0050871),-0.31222988171584554,-1.1098380340029725,0.24489795918367346,0.6309687911853205,1.0,14/50,20.61%,MEF2C;TFRC;SHLD1;CD38;EPHB2;NFATC2;CD74;PTPRC;CD40;MAD2L2;NCKAP1L;NOD2;BTK;SYK
prerank,embryonic skeletal system development (GO:0048706),0.35494858477269736,1.1096443859932072,0.30093457943925234,0.8895122405231445,1.0,8/35,11.49%,PDGFRA;OSR1;HOXB9;HOXB3;HOXA3;HOXB4;MEGF8;UCMA
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3053808267873765,-1.109641324728038,0.2958963282937365,0.6309048993214544,1.0,15/55,22.69%,FBXL7;FHL1;PSMB7;PSMA6;PSMB6;PSMB5;USP47;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4090365219125203,1.1094818172507612,0.3365200764818356,0.8883827600689808,1.0,6/20,23.66%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,protein localization to cell periphery (GO:1990778),-0.2642931431775145,-1.1093035882827038,0.23410404624277456,0.6311713474876474,1.0,30/133,12.87%,SPTBN1;CAV1;RAPGEF2;BSG;LRP6;RAMP2;GAS6;RAP1A;CACNB2;TTC7A;PACS1;CDH1;SMURF1;F11R;TNIK;FLNA;FCHO2;RAP2A;NKD2;EFR3B;RAPGEF6;SLMAP;EMP2;FGF13;EHD2;EHD4;RAB3A;PTCH1;KCNB2;LIN7C
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4056798862676416,1.1092500799740634,0.30785123966942146,0.8875843241083348,1.0,5/20,10.40%,PRKAA2;RUVBL2;ARRB1;PPARGC1A;BRD7
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4826807528532104,1.109191836948171,0.3434343434343434,0.8861574694016124,1.0,3/10,6.88%,DNMT3L;DNMT3A;PCGF5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4729020349995921,1.1083488549544298,0.35852713178294576,0.8875497088788501,1.0,5/12,16.90%,PLK1;GOLGA2;CDC14B;RAB1A;UBE2S
prerank,regulation of gene expression (GO:0010468),0.23738335993207332,1.1082601100919296,0.149812734082397,0.8862496821539712,1.0,133/903,12.83%,PRDM6;ROBO1;DENND4A;NOTCH2;BMP7;RORA;AFDN;FGF1;WNT4;BMP6;PPARGC1B;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;PABPN1;OVOL2;SUFU;CTR9;ANK2;PRKAA2;ZBTB38;NDFIP1;SCRT1;MYBL2;PIK3R3;NOVA1;CRABP2;CPNE1;ARNT2;ZNF431;OPRD1;NFYB;CDH3;ESRRA;TULP3;POU1F1;FGF9;BMPR1A;PICALM;CCAR2;HNRNPH3;TNRC6A;PIK3CB;TRIM5;CCAR1;ASCC2;LRP3;PEG3;RBPJ;PQBP1;PAX6;ACTR8;MZF1;E2F1;TRIM71;RNF14;ZNF462;FLOT2;PDCD5;WWTR1;NFYC;CITED1;CIAO3;WNT6;CEBPA;FASTK;PTBP2;SON;SRSF10;PHF1;SNF8;CHD3;AFF3;FAM98B;NTRK2;KDM6B;HNRNPL;PTBP1;RIMS1;MED1;HES6;CRNN;MAFA;HINFP;ZNF711;PPARGC1A;CACTIN;PARP14;GON4L;PRDM2;SSBP2;CLOCK;FZD7;NKAP;TGFBR1;NSD1;MEGF8;SRRM4;CREBL2;FUBP1;LDB1;HRG;RNF20;MAGED1;DTNBP1;CLK3;RNF6;CTSH;MAPK14;TAF1;ZFPL1;CLU;YTHDC1;ATRAID;AFF2;MAPK9;SOX9;DMTF1;KDM4A;PML;CHEK2;RBAK;RLIM;GABPA;TERT;MYBL1;ZC3H7B;TGFBRAP1
prerank,regulation of monocyte differentiation (GO:0045655),-0.4253330881727697,-1.1082397805743174,0.3288201160541586,0.6333282722744727,1.0,3/14,11.77%,FOXP1;IL34;CD74
prerank,regulation of multicellular organism growth (GO:0040014),-0.42492766739699495,-1.1080024370171466,0.3473895582329317,0.6333124830786484,1.0,5/15,12.43%,GHR;APP;SOD1;MFSD2A;PTCH1
prerank,Golgi ribbon formation (GO:0090161),0.45802543813513086,1.1078018381019394,0.358148893360161,0.8861015247228345,1.0,4/13,10.42%,OPTN;STX16;GOLGA2;MYO18A
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3833135173096022,-1.1077650793712075,0.32548179871520344,0.6333480248707793,1.0,6/22,9.69%,NTRK3;PLCG1;ESR1;FLT1;AGTR1;FGF2
prerank,protein processing (GO:0016485),0.2966896977547884,1.1074086051115137,0.2776831345826235,0.8857778503331977,1.0,11/102,8.74%,AEBP1;METAP2;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2;SPRTN;HTRA2;LONP2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3542177482109278,1.1074066242735259,0.2998204667863555,0.8841816156326517,1.0,5/38,3.25%,CACNA1D;DSC2;KCND3;ANK2;KCNJ5
prerank,retinol metabolic process (GO:0042572),0.43131475572022737,1.1073456627594322,0.33976833976833976,0.8827777986944428,1.0,2/14,1.22%,ADH7;ADH4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3813910763921037,1.107050608381377,0.3140655105973025,0.882110273008658,1.0,5/27,7.32%,SYT11;C5AR2;C1QTNF3;NLRC3;ARRB1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4491293810849234,-1.1069742915988234,0.3326530612244898,0.6347685122375982,1.0,5/11,6.78%,RAPGEF2;TJP1;F11R;TJP2;RAPGEF6
prerank,metal ion transport (GO:0030001),0.30532660191169914,1.1069264686931204,0.2854609929078014,0.8809669386748715,1.0,15/86,11.37%,CACNA1D;SLC8A3;SLC41A1;CACNG7;CACNB3;NDFIP1;ITPR1;GRIN3A;TUSC3;NMUR1;CHRNB2;KCNN4;MAGT1;RYR2;TRPM2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.36042761442848104,1.1067001250405386,0.31386861313868614,0.8801571192634797,1.0,5/34,6.22%,RORA;SMAD3;LRP3;E2F1;WWTR1
prerank,respiratory system development (GO:0060541),0.3618417291724331,1.1066503955689013,0.3301707779886148,0.8787427435796386,1.0,6/32,6.87%,FGF1;FGF9;LOXL3;PDPN;CEBPA;FGFR2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3932974465363083,1.105700858238895,0.31835205992509363,0.8803277636554938,1.0,3/22,7.53%,BMP7;CDKN2A;INHA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.38762443256966006,1.1056419652285874,0.3125,0.8789736743363293,1.0,9/25,20.92%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,positive regulation of T cell migration (GO:2000406),-0.393213399784879,-1.1055411430682627,0.3066132264529058,0.6377950822579994,1.0,6/20,9.84%,RHOA;APP;ADAM10;WNT5A;CXCL12;DOCK8
prerank,vasculature development (GO:0001944),-0.41584646447117335,-1.1052321855192104,0.31496062992125984,0.6380011764612319,1.0,9/16,16.28%,BMPR2;ACVRL1;STRA6;PIK3CA;FLT4;NOTCH4;SOX18;FBXW7;APLNR
prerank,regulation of microtubule-based process (GO:0032886),-0.3342066805094446,-1.1044343576583648,0.30385487528344673,0.6395725276155878,1.0,14/36,23.24%,PHLDB1;MACF1;PHLDB2;APC;EFNA5;FAM107A;HDAC6;BICD2;TRAF3IP1;MEMO1;ROCK1;TAOK1;CYLD;MAP6D1
prerank,cellular response to light stimulus (GO:0071482),-0.29876642858734576,-1.1043291622273852,0.2707317073170732,0.6392434029881674,1.0,30/66,36.28%,PTPRK;GNB1;PRKCD;ZBTB1;USP47;COPS9;BAK1;RHBDD1;ATF4;FMR1;N4BP1;RHNO1;METTL3;GPR88;NEDD4;NSMCE3;TRIAP1;SMPD1;GPR52;PARP1;SDE2;BMF;MYC;AQP1;RRH;TP53;OPN1MW3;OPN1MW;PDE6B;PDE6A
prerank,alpha-amino acid metabolic process (GO:1901605),0.3360961328509574,1.1039328886419573,0.30353817504655495,0.8830387505246818,1.0,14/45,16.43%,ASPG;RIMKLA;MMUT;KMO;ASPA;GLS2;SLC25A12;MTHFR;KYAT3;GOT1;MTHFD1;GOT2;ATP7A;GLUL
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2712375477493966,-1.103899444519068,0.24444444444444444,0.6397726033990758,1.0,27/108,13.85%,RSPO3;DAAM2;MDFIC;DISC1;MACF1;NFATC1;KANK1;APP;SFRP4;RUNX1;CDK14;ESR1;NKD2;RACK1;CCNY;CBFB;SPIN1;TIAM1;PPP1CA;ATP6AP2;AMER1;SOX7;HHEX;BMP2;CSNK2A1;GSKIP;TAX1BP3
prerank,regulation of dephosphorylation (GO:0035303),0.4205344926469591,1.1036429209442133,0.32231404958677684,0.8823887722058736,1.0,5/15,15.04%,PPP1R16A;MTMR4;SMG5;MTMR2;SMG6
prerank,cell-cell junction organization (GO:0045216),0.31021074666317394,1.1035865019356048,0.2857142857142857,0.8810037220817414,1.0,12/79,8.14%,SDK1;AFDN;SMAD3;SDK2;NLGN2;CDH3;CDH15;CDH17;CDH10;PKP4;PRKCI;CDH18
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.46962021247098495,-1.1033957045286065,0.352,0.6404359218860167,1.0,4/10,7.37%,CACNB2;CACNA2D1;NOS1AP;CALM3
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3266626694751483,-1.1033631414168854,0.3013392857142857,0.6399281164957596,1.0,20/42,28.89%,RPA1;UBC;RPS27A;UBB;TRIM25;ZBTB1;ISG15;WRNIP1;USP43;RPA2;PRIMPOL;USP10;PCLAF;POLA1;RFC4;POLD4;DTL;RFC2;VCP;FAAP20
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.31387621860720727,-1.103319458557775,0.28868360277136257,0.6394354595538224,1.0,15/49,18.99%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;VEGFA;CD40;CSF1R;SOCS3;FGFR3;CRLF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.4430839229861287,-1.1032710753665507,0.35129740518962077,0.6389638178074327,1.0,4/11,17.02%,H3-3A;RBBP4;NASP;UBN1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.30509158364713684,-1.1031276154202294,0.26741573033707866,0.6387233077130373,1.0,12/56,11.76%,CDC27;KMT2E;RAD51B;EGFR;ANAPC5;BRD4;ANXA1;CDC16;ADAMTS1;RPTOR;FBXO5;PHB2
prerank,response to organonitrogen compound (GO:0010243),0.3552259096876142,1.1030864622031047,0.2877959927140255,0.8810819583341423,1.0,10/38,15.88%,TRPV1;RRAGC;DERL1;GLRA1;DRD3;TRPM2;CCDC47;UBXN6;RNF5;IL6
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.25291583854748045,-1.1015579656540493,0.2153392330383481,0.6421519796806722,1.0,45/163,22.88%,PDE4D;MEF2C;RFTN1;PIK3R1;PLCG1;PTPRJ;BMX;PLCG2;PAK2;INPP5D;TEC;PSMB7;PSMA6;NCK1;CD38;TNFRSF21;EIF2B2;PIK3CA;SPPL3;BCAR1;PSMB6;MALT1;PIK3CD;NFATC2;PSMB5;SH2B2;PTPRC;PSMC4;PSMB8;NCKAP1L;PSMD11;DENND1B;EIF2B1;LAT2;PSMB4;PSMD14;ZC3H12A;BTK;PSMD10;SYK;PSME1;RIPK2;FYN;PSMB3;BCL10
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.47591410620242064,1.1015154683968873,0.34845360824742266,0.8847759765266527,1.0,3/10,16.00%,KLF15;NOC2L;SIRT1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4582712521526992,1.1009857677333017,0.33725490196078434,0.8849035743599402,1.0,4/12,13.97%,CCDC115;TMEM199;LRRK2;CLN5
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.27221201083697166,-1.100760941224885,0.2668269230769231,0.6435235587160085,1.0,23/107,16.00%,DAB2IP;NIBAN1;MAP3K5;THBS1;PIK3R1;RASGRF2;JUN;ERN1;CREB3L1;NCK1;BCAP31;UFC1;ATP2A3;EIF2AK3;TMCO1;PDIA4;ATF6B;BAK1;RHBDD1;BBC3;CFTR;OS9;ATF4
prerank,protein transport (GO:0015031),-0.23297698257833696,-1.1007170153445724,0.1625441696113074,0.6430310221246005,1.0,81/332,18.71%,SPTBN1;TBC1D4;CALCRL;RABGAP1L;STEAP3;RAB14;RAMP2;SLC10A7;TBC1D8;MYH9;MACF1;SCFD2;ATP6V0A4;ABCA1;TBC1D12;STX1A;SNX13;RAB6A;HERC2;MIA2;LMAN2L;RAB31;TBC1D5;TMED10;USP6NL;CHMP2B;TFRC;STX3;MON1A;ARHGEF2;TBC1D2B;SNX1;TBC1D1;MTTP;CMTM6;EVI5L;ATP6V0D1;ATP6V0A1;RAB22A;TXNIP;VPS26A;TBC1D13;GOLPH3;APOE;DNAJC27;WDR11;VLDLR;CD74;RAB3A;PDIA4;SCAMP1;ARHGAP1;HDAC6;STX7;SEC31A;ATP6V1D;ARL5A;TBC1D10A;SYS1;AP2A1;RAB11B;STX8;SAR1A;RAB5C;RAB1B;HIKESHI;TBC1D25;LRP1B;ARF5;SEC13;IFT27;RAB3GAP2;LRP1;TCIRG1;KIF13A;COPB2;FAM91A1;SCAMP2;CHMP1B;RAB3D;COPA
prerank,regulation of T cell chemotaxis (GO:0010819),0.4609348288616786,1.100613511828518,0.3312883435582822,0.8846152744457502,1.0,2/11,4.19%,OXSR1;STK39
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.25169846214179653,-1.100526734091158,0.23404255319148937,0.6429581869467434,1.0,42/172,17.63%,PLA2G4A;PIP5K1B;RAB14;PIP4K2A;INPP4A;DGKH;PIK3R1;CEPT1;DGKZ;PLSCR1;AGK;PIK3C2A;BMX;PLCG2;PLEKHA8;CPNE3;PIK3R6;SLC44A2;INPP5D;PLEKHA4;PIK3CA;FGF2;PIK3CD;MTMR7;FIG4;MFSD2A;PIK3C3;MTMR12;SLC44A1;AGPAT1;LPIN3;ABHD4;CSNK2A1;ETNK1;ABHD8;PIK3R4;AGPAT5;PI4KB;MTMR1;DGKB;TAMM41;STARD10
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4714780115364493,1.1003170666388562,0.3312883435582822,0.8840939448566434,1.0,2/10,4.19%,OXSR1;STK39
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.43681566499311436,1.0997381061428588,0.3553398058252427,0.8844092504160392,1.0,1/14,0.12%,PPP2R2B
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3138495038965931,-1.099004816744116,0.31666666666666665,0.646175037522908,1.0,10/47,10.49%,FOXO3;NFKBIA;RBM3;APP;RPL10;AGTR1;EIF4E;KLF4;EDN1;APOE
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3646199932440536,1.0988383329569773,0.31907308377896615,0.885813189995087,1.0,8/31,13.20%,MAGEA2;PLK1;ARRDC3;DCUN1D4;GOLGA2;TOPORS;CDC14B;RAB1A
prerank,L-amino acid transport (GO:0015807),-0.3535784104412083,-1.0981975234401045,0.3120728929384966,0.6476915779730505,1.0,8/28,17.60%,SLC7A5;SFXN1;SLC38A5;SLC7A1;SLC1A3;SLC1A1;SLC36A4;SLC7A8
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.357325770211112,1.0980413058856209,0.3286219081272085,0.8868827229022507,1.0,7/34,7.38%,GABRG1;GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4788417789593903,-1.0980313641333557,0.33268101761252444,0.6469623431028263,1.0,6/10,22.93%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.4788417789593903,-1.0980313641333557,0.33268101761252444,0.6469623431028263,1.0,6/10,22.93%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3172117731994143,-1.0974681021887753,0.29321663019693656,0.6477374358108646,1.0,15/43,16.36%,FOXP1;THBS1;CDH13;BMP4;JUN;ERN1;IL6R;ADAMTS1;FGF2;EDN1;CCN4;P2RY6;HTR1B;ID2;LDLRAP1
prerank,DNA modification (GO:0006304),-0.3770934609095035,-1.0974245977883135,0.3313253012048193,0.6472476979558455,1.0,17/22,41.31%,TERF2IP;TDG;NEIL3;MUTYH;SMUG1;EXOSC5;EXOSC4;TINF2;TERF2;EXOSC3;PARP3;PARP1;OGG1;UNG;PARP2;NTHL1;TERF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2573525593890335,-1.0967652846024893,0.25,0.6483097642809285,1.0,53/145,29.68%,FBXL7;YWHAE;RAD51B;FHL1;DYNC1I2;BRD4;CSNK1E;PSMB7;PSMA6;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;ODF2;USP47;DYNLL1;PSMC4;PSMB8;CCP110;PRKAR2B;PRKACA;PAFAH1B1;PSMD11;PSMB4;CCND1;PSMD14;RAB11A;DYNC1H1;PSMD10;DCTN1;PSME1;CSNK1D;TUBA4A;CEP131;TPX2;PSMB3;CEP41;CDK5RAP2;CEP152;DTL;HMMR;KIF14;AKAP9;CDK2;AVEN;ACTR1A;STOX1;CUL1;PPP2R1A;CNTRL;PSMB9
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.47211716361900874,-1.0961935338107998,0.3359683794466403,0.6491620236118245,1.0,3/10,13.67%,PRKCH;TRIM16;NME2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4739852326117912,-1.0959124933759326,0.34765625,0.6492392759033975,1.0,4/10,25.17%,FGF7;MAP4K4;MAPRE2;EPB41L4B
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.43727762030777323,1.0956397606177968,0.35699797160243407,0.893299308205064,1.0,4/15,12.93%,NLGN2;ZDHHC12;ZDHHC3;SYN3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33928099728013583,-1.0955715588625663,0.3168103448275862,0.6495413236759308,1.0,13/34,17.80%,TEK;DAB2IP;PIK3R1;TNFAIP8L3;PRKD1;PIK3IP1;FLT1;FGF2;PTK2B;PIK3R4;IRS1;FGFR3;NOD2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.33966961142147317,-1.0952129959034953,0.32166301969365424,0.6498672662000152,1.0,9/37,12.42%,MFHAS1;YWHAB;PPP1R16B;PPIA;PRKCD;CALM3;SPPL3;NSMF;PPP1R2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.35917010996822885,-1.0951787844788654,0.3325892857142857,0.649351517624896,1.0,4/27,7.30%,MARK1;MBOAT1;DISC1;NCS1
prerank,lymphocyte mediated immunity (GO:0002449),-0.4379546864016236,-1.0950711940582614,0.34439834024896265,0.64901687015659,1.0,4/12,17.41%,JAG1;CD55;CD46;GNL1
prerank,positive regulation of immune response (GO:0050778),-0.29670435066090417,-1.0948743707260558,0.27577937649880097,0.6489127547090539,1.0,13/64,17.80%,IL6ST;TGFB2;POLR3F;PLSCR1;GBP5;IFI35;IL15;CD74;RSAD2;PTPRC;CD46;POLR3B;NOD2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.45556116726039436,-1.0947746712707047,0.34024896265560167,0.6485547640451435,1.0,3/11,4.84%,CAV1;NEDD4L;CAB39
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4562434555328493,1.0947057121712425,0.32341269841269843,0.8917468615975142,1.0,3/11,6.71%,PANK1;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4562434555328493,1.0947057121712425,0.32341269841269843,0.8917468615975142,1.0,3/11,6.71%,PANK1;ACAT1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.4562434555328493,1.0947057121712425,0.32341269841269843,0.8917468615975142,1.0,3/11,6.71%,PANK1;ACAT1;PANK2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4179357381232718,1.0941011813859678,0.3511450381679389,0.8922569144265483,1.0,3/16,6.45%,PPARGC1B;DDX5;DDX17
prerank,microtubule anchoring at centrosome (GO:0034454),0.4736541211426195,1.0938331779521728,0.3561643835616438,0.8915863019454637,1.0,4/10,15.71%,PCM1;KIF3A;CCDC120;NINL
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3945033950243951,-1.0938318437682186,0.35881104033970274,0.650296481867258,1.0,8/19,15.78%,VCAM1;PTPRJ;KDR;STIMATE;BCAP31;PTPRC;PTGFR;PRKACA
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3308041751205835,-1.0936722035612876,0.2938689217758985,0.650118524730289,1.0,14/34,24.36%,INSR;LRP5;CDC27;ANAPC5;CDC16;IGF2;EDN1;EDN3;NUSAP1;NUP62;CDC23;EGF;CUL3;RGCC
prerank,cellular response to leucine (GO:0071233),-0.46114063251271253,-1.0934514218338969,0.36270491803278687,0.6494931158255693,1.0,5/10,19.67%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,response to leucine (GO:0043201),-0.46114063251271253,-1.0934514218338969,0.36270491803278687,0.6494931158255693,1.0,5/10,19.67%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,positive regulation of DNA repair (GO:0045739),0.3327836004197577,1.093090606612099,0.3139745916515426,0.8924364881697721,1.0,5/46,6.87%,EYA1;EYA4;EYA2;XRCC1;ABRAXAS1
prerank,axonal transport of mitochondrion (GO:0019896),0.4732732388084999,1.092835946475263,0.35542168674698793,0.8917705707574813,1.0,3/11,16.32%,TRAK1;ACTR10;NEFL
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3053155347430021,-1.0924467453072324,0.31194690265486724,0.6514389247306874,1.0,17/55,20.61%,IL6ST;VCAM1;TFRC;SLC7A1;NCK1;ANXA1;RPS3;IL15;IGF2;CD86;PTPRC;CD24;CD46;NCKAP1L;JAK3;HMGB1;SYK
prerank,negative regulation of protein processing (GO:0010955),-0.43624112744998966,-1.0918203353458291,0.36363636363636365,0.6524454787941703,1.0,3/12,9.37%,THBS1;TMEM59;SERPINE1
prerank,response to organophosphorus (GO:0046683),-0.40364741185016595,-1.0916560713915757,0.33463796477495106,0.6522721341374523,1.0,3/16,9.06%,TRPC3;ABCC9;TRIM16
prerank,ganglioside metabolic process (GO:0001573),-0.3921989593703805,-1.091438919159809,0.35523613963039014,0.6522350003800433,1.0,6/20,14.13%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6;HEXA;ST8SIA2
prerank,regulation of cell projection organization (GO:0031344),-0.4288924011875238,-1.091281458588551,0.3428030303030303,0.6520633146837771,1.0,3/13,11.89%,MACF1;SPRY2;MFSD2A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3698848175448803,-1.0911926294842167,0.3392857142857143,0.6516919208398628,1.0,13/25,30.62%,CSGALNACT1;EXT1;B3GNT2;HAS1;HAS2;B3GNT3;B3GALT5;B3GNT8;EXT2;B3GALT1;CSGALNACT2;B3GNT6;NDST3
prerank,protein localization to nucleus (GO:0034504),0.28884268558894427,1.090801895534271,0.27980132450331124,0.8969427368770813,1.0,23/102,17.14%,BMP7;APPL2;IPO13;FAM53A;POM121;NUP155;LMNA;PLK1;NUP62CL;HNRNPU;TNPO3;ARL2;TOR1B;TOPORS;NXT1;PML;IPO8;BANP;MSX1;MDM2;TNPO2;IPO4;NUP88
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4359319445379401,1.0907213264116384,0.3359375,0.8956464928718753,1.0,3/14,5.30%,CTR9;KMT2A;AUTS2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4614010238039524,1.0906296506434048,0.3561368209255533,0.8944108109276555,1.0,6/11,21.32%,NECAB1;SOAT1;ABCA2;BACE2;NECAB3;ITM2C
prerank,long-term synaptic potentiation (GO:0060291),0.3998783774196808,1.090549456954924,0.3474903474903475,0.893122038339439,1.0,3/21,5.22%,SLC8A3;PRKCZ;GRIN2D
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.2681991514204284,1.0902704389071534,0.25606060606060604,0.892473967461645,1.0,17/182,4.72%,ROBO1;NOTCH2;WNT4;IGF1;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;CPNE1;OPRD1;BMPR1A;PICALM;OPTN;TNRC6A;LRP3;TET1
prerank,iron ion homeostasis (GO:0055072),0.32340702417886363,1.090234166386102,0.31273408239700373,0.8910613686931508,1.0,10/58,7.09%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;PICALM;FLVCR1;ACO1;CCDC115;CP;TMEM199
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4615734904007236,1.090147282825401,0.35496957403651114,0.889776971257699,1.0,4/11,12.28%,ENPP3;NT5C3A;DCK;THTPA
prerank,positive regulation of dendrite development (GO:1900006),-0.459575186703941,-1.0901030136430638,0.3395061728395062,0.6539156648380408,1.0,3/10,1.11%,BMP5;DAB2IP;PTN
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4514965187076253,-1.0900397135119424,0.3509803921568627,0.6534767089993551,1.0,4/11,8.89%,CORO1C;CD44;KANK1;SRC
prerank,copper ion homeostasis (GO:0055070),-0.39666326454121437,-1.0899951099051495,0.33880903490759756,0.6529892555568515,1.0,9/17,28.65%,APP;SLC31A1;ATOX1;XIAP;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.43776766835701597,1.089852043033206,0.3757115749525617,0.8892451960637687,1.0,6/14,17.32%,ANGEL2;ELAVL4;ELAVL1;MAPK14;BOLL;TIRAP
prerank,membrane assembly (GO:0071709),0.3594785437850532,1.089783222499244,0.3295668549905838,0.8879378613783087,1.0,8/34,8.72%,CEL;IL1RAPL1;NLGN2;PICALM;FLOT2;NLGN3;LRP4;PTPRD
prerank,Golgi inheritance (GO:0048313),0.4614626736769028,1.0892076379684543,0.37623762376237624,0.8882504229143747,1.0,4/11,16.34%,PLK5;GOLGA2;STK25;GBF1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3767393316653512,-1.0892044141429658,0.33739837398373984,0.6544017118877039,1.0,11/20,31.73%,ACVR1;ACVRL1;DSCAML1;AIDA;PTCH1;GREM1;LMX1B;LHX1;BMPR1B;TBX20;NOG
prerank,negative regulation of ossification (GO:0030279),-0.3728448280629677,-1.0891079878744396,0.3380281690140845,0.6540424688189408,1.0,7/23,19.13%,MEF2C;NOTCH1;MDK;ECM1;PTK2B;ENPP1;GREM1
prerank,regulation of translational initiation (GO:0006446),-0.29372193104868094,-1.0889446800218685,0.2857142857142857,0.6538770937745325,1.0,20/63,22.54%,EIF3E;ALKBH1;EIF3H;NCK1;EIF2B2;CDC123;AGO2;EIF2AK3;HSPB1;NCBP2;TPR;EIF1B;NCBP1;ATF4;FMR1;EIF4G3;ATF3;EIF4H;EIF3B;KLHL25
prerank,neuron development (GO:0048666),-0.2572482199785782,-1.0887614892489041,0.2558746736292428,0.6537200141292004,1.0,24/141,12.07%,PTPRM;FRY;MEF2C;RAPGEF2;PBX1;TGFB2;PBX3;APP;STMN1;RUNX1;TBCD;STX3;VSX1;MAP4;ETV1;LYN;LGI4;MYOC;CDK5;FRYL;APOE;B4GALT5;SH3GL2;MICALL2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.21568840532281522,-1.0881703152853188,0.09433962264150944,0.654639393370566,1.0,117/834,10.26%,LEF1;MEF2C;ERG;MAML2;BMP5;MRTFB;DAB2IP;BMPR2;PID1;PBX1;ELK3;ZFHX3;DCN;JAG1;ITGA6;MICAL2;LRP6;RARB;NOTCH3;ACVR1;PLAGL1;MEOX2;ETS1;ACVRL1;ENG;TGFB2;PPARD;TCF12;RPS6KA5;KAT7;FOXO1;NOTCH1;TBX3;LRP5;PKD1;CDH13;PIK3R1;FOXO3;EGFR;NFKBIA;LMO2;RUNX2;ASXL3;BMP4;NFATC1;STAT3;AGO1;PLSCR1;PPP1R12A;SIX1;NFIA;APP;UBC;RNF111;RUNX1;DCAF6;REL;JUN;ESR1;RPS6KA3;LMO7;TBX1;KLF7;KAT6A;GLYR1;BPTF;GLI3;NFIX;TFEB;SOX17;GNL3;BRD4;ARHGEF2;SMAD1;PRKD1;RPS27A;UBB;SMAD5;TNKS;MET;HES1;ETV1;SLC30A9;NLRC5;NRF1;WNT5A;AR;SP3;CCN1;NCK1;ELF4;ETV5;PPP3CA;HEYL;NFAT5;HEY2;GATA2;NRIP1;IGF2;SERPINE1;ZFPM2;NOTCH4;AGO2;IRF2;KLF4;ELK1;FGF2;PELP1;TAL1;TGFB3;SS18;AHR;RFXAP;TCF20;GTF2F1;EDN1;PER1
prerank,nucleoside salvage (GO:0043174),0.46372981468657415,1.0879796148228331,0.3649789029535865,0.890706928578944,1.0,3/10,11.18%,UCKL1;DCK;UPP2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.381059073932621,-1.0879747170416894,0.3576017130620985,0.6545674229741018,1.0,9/20,28.28%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3;STOX1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3607455690503948,1.0877506308745117,0.3443830570902394,0.8899167455673954,1.0,4/30,4.40%,HSPA1A;DNAJC18;DNAJB14;DNAJB4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4555674895834789,1.087702975974599,0.3667334669338677,0.8885790426253384,1.0,1/12,0.24%,BMP7
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2893027590829213,-1.0876418904578737,0.2986425339366516,0.6548304963910426,1.0,17/63,15.91%,SLC12A7;SLC12A2;ANO1;SLC26A2;SLC5A6;SLC12A6;LRRC8A;SLC1A3;GABRA3;GLRB;SLC37A3;SLC1A1;ANO4;GABRE;GLRA2;ANO2;CFTR
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4489530398764625,1.08701657144714,0.3762575452716298,0.8893432894147505,1.0,5/13,16.00%,PRKCZ;ECHDC3;GKAP1;SORBS1;SIRT1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.35706579372935937,1.0868319608695294,0.3339253996447602,0.8884534001589687,1.0,11/33,18.18%,IGF1;HSPA1A;SLC25A5;PPIF;FZD9;ADCK1;CLU;TMEM14A;HGF;NOL3;AKT1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3386944805938802,-1.0865485362673453,0.3231441048034934,0.6568799659714649,1.0,10/32,21.29%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,regulation of protein acetylation (GO:1901983),0.44898408232490306,1.0854056607644933,0.3533980582524272,0.8915225293779757,1.0,6/12,19.82%,MAGEA2;CAMK1;KAT5;RAPGEF3;SIRT1;DDX3X
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3478167740461651,-1.0853720378372151,0.34347826086956523,0.6593078078191871,1.0,12/28,25.42%,NOTCH3;EGFR;GATA2;TCIM;FBXW7;LFNG;HEY1;METTL3;DLL4;DLL1;EGF;ZBTB7A
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.43199436172888767,-1.0850642034797655,0.3717171717171717,0.6594704685775741,1.0,2/13,0.78%,NRP1;NRP2
prerank,regulation of chromosome segregation (GO:0051983),-0.40397814260186804,-1.084183984519898,0.3407258064516129,0.6612605141931455,1.0,10/16,37.23%,PUM2;SMC5;CSNK2A1;PUM1;MKI67;CDC6;SMC6;BUB1;IHO1;KIF2C
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3236678815707265,-1.0840962087907737,0.31346578366445915,0.6608881273762134,1.0,11/39,15.87%,DAB2IP;PTPN12;EGFR;PTPRJ;ITGA1;SPRY2;DUSP3;HGS;SH3GL2;SPRY1;CBL
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4208814039562032,-1.0830318735864404,0.37764932562620424,0.6629954607557952,1.0,5/13,18.38%,ENTPD1;ENTPD6;ENTPD2;SMPDL3A;ENPP1
prerank,myeloid cell differentiation (GO:0030099),-0.30518082547284286,-1.0829747810518582,0.3107822410147992,0.6625214367005643,1.0,9/47,9.75%,SNRK;ZBTB16;KMT2E;RUNX1;MFHAS1;KAT6A;LYN;PRKX;TAL1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.37768122389302283,1.0820012912088173,0.33586337760910817,0.9009305990969702,1.0,6/24,11.99%,ANXA6;ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.44318978001732867,1.0817505192761958,0.3592436974789916,0.9002640309399382,1.0,4/12,11.08%,THRB;BRD8;MED1;CTSH
prerank,cytosolic calcium ion transport (GO:0060401),-0.34790409491145535,-1.0814632871673593,0.3224400871459695,0.6658653513699837,1.0,10/28,14.09%,ATP2B1;MICU3;CACNA2D1;SLC35G1;ATP2A3;MCUB;JPH2;ITPR3;SMDT1;MICU2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3040786949315704,1.0813691911315577,0.3205828779599271,0.9000390671216644,1.0,13/72,10.21%,FGF1;FGF4;FGF9;FLRT3;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;GALNT3;FRS2
prerank,RNA interference (GO:0016246),-0.38644688577161923,-1.0811874329642313,0.34592445328031807,0.6659828424978761,1.0,6/17,18.40%,AGO1;AGO2;DROSHA;CLP1;AGO4;MRPL44
prerank,organophosphate catabolic process (GO:0046434),0.4632444060431914,1.0808692801068818,0.38703339882121807,0.900248301270737,1.0,4/11,26.82%,PON1;PLBD2;ABHD12;ANGPTL3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2987260460615432,-1.0808590480341493,0.30180180180180183,0.6662085038126726,1.0,10/55,8.00%,CAV1;DAB2IP;TNFSF10;BCL2L1;FAS;CRADD;PAK2;RACK1;BCAP31;RPS3
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.38234806384158637,1.0806832207271158,0.3815789473684211,0.8993530071259646,1.0,7/24,12.95%,LEPR;COQ10A;NDUFS1;PPARGC1A;CYCS;MRAP2;COX10
prerank,transcription by RNA polymerase II (GO:0006366),0.251406872687165,1.0798786888689775,0.27089337175792505,0.9004370361076149,1.0,39/305,11.69%,MAF;NOTCH2;RORA;DDX5;NR2E1;PABPN1;SOX5;CTR9;THRB;DTX1;NR6A1;CCN2;PPARA;CPSF3;GLIS3;ESRRA;CCNT2;GTF2I;TCEA1;RBPJ;PCID2;LEO1;WWTR1;INTS4;CPSF7;ZC3H8;MED1;TAF10;PPARGC1A;NR1H3;EAF2;RXRA;RNMT;MBD1;SLBP;TAF1;TSC22D1;CDC73;MLLT1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4204090198866281,-1.0796150657416272,0.372,0.668910749121991,1.0,5/13,18.26%,PTGIS;PTGS2;NNMT;NUDT12;NAXE
prerank,regulation of dendrite extension (GO:1903859),-0.38608329958567145,-1.0795130850059131,0.37945492662473795,0.6685654096283441,1.0,6/18,18.14%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,regulation of nervous system development (GO:0051960),-0.32774093258980475,-1.0790388176207675,0.34934497816593885,0.6692013806514174,1.0,7/37,8.27%,PTN;TNFRSF1B;BHLHE40;HES1;LGI4;HEYL;HEY2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.41782406495310476,-1.0786534055055395,0.3628865979381443,0.6695898561052308,1.0,4/14,19.60%,THBS1;IRAK3;PIBF1;JAK3
prerank,mammary gland epithelium development (GO:0061180),0.4265498491272615,1.0784778181152392,0.3403041825095057,0.9035511974443119,1.0,1/14,0.42%,WNT4
prerank,positive regulation of cell division (GO:0051781),0.3405153869478181,1.078448468184334,0.3116883116883117,0.9021340745294173,1.0,5/38,8.17%,FGF1;TAS1R2;PKP4;FGFR2;DRD3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3784626763997256,-1.0784140054998628,0.36075949367088606,0.6696303437645122,1.0,6/20,12.45%,PLOD2;PLSCR1;GATM;GSS;GCLC;GCLM
prerank,mitotic nuclear division (GO:0140014),-0.28595108981599815,-1.0782737080413953,0.29453681710213775,0.6694147307623874,1.0,30/71,26.78%,RHOA;SMC4;FLNA;PPP2R2D;SMC1A;EPS8;CHMP4B;STAG1;NCAPG2;MAP9;PIBF1;MZT1;ZW10;KLHL22;NUSAP1;TOGARAM1;STAG2;ARHGEF10;RAB11A;KNSTRN;AAAS;TPX2;NUP62;KIFC1;NSL1;CENPK;NDEL1;MIS12;CDCA8;SGO1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.46683244827947934,1.0781639600979105,0.3677685950413223,0.9015543282725522,1.0,5/10,17.66%,EMC2;EMC4;MMGT1;EMC1;EMC10
prerank,regulation of mitotic spindle assembly (GO:1901673),0.398592223016713,1.0778561880511812,0.360146252285192,0.9010163320487082,1.0,7/19,16.65%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,regulation of microtubule polymerization (GO:0031113),0.3344548628986042,1.0778310948869643,0.3481349911190053,0.8996052951454705,1.0,12/40,15.78%,MAP2;CLIP3;EML2;PRUNE1;CLASP1;ARL2;DRG1;TUBB4A;ABL1;NAV3;GBA2;MAPRE1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.27904364777181406,1.0778079082702732,0.28938906752411575,0.8981937926922635,1.0,17/132,7.57%,RNF152;IGF1;PRKAA2;GTPBP1;SH3D19;PPARA;FURIN;PLEKHF1;PHKG2;OPTN;PIK3CB;ADRA2A;TRIM5;ABHD5;SUPV3L1;LRRK2;KAT5
prerank,DNA dealkylation (GO:0035510),-0.4565281722775331,-1.0774083284016063,0.38247011952191234,0.670409364268094,1.0,2/10,4.56%,FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.4565281722775331,-1.0774083284016063,0.38247011952191234,0.670409364268094,1.0,2/10,4.56%,FTO;ALKBH1
prerank,chromosome condensation (GO:0030261),0.3505972293260469,1.0770394634463585,0.33707865168539325,0.8992979142506672,1.0,10/36,16.65%,KMT5A;NCAPD2;AIFM1;PLK1;PHF8;TENT4A;CSNK2A2;ACIN1;AKAP8L;CHMP1A
prerank,regulation of postsynapse organization (GO:0099175),-0.34537813047274374,-1.0761824581703627,0.3463203463203463,0.6729923650173025,1.0,6/28,10.40%,SHANK3;PDLIM5;WNT5A;CDK5;ABI3;CFL1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.33540608920410764,1.0760113348701603,0.356140350877193,0.90127401205488,1.0,6/43,4.61%,ERRFI1;SNX6;CHMP6;GPRC5A;STAM;RNF126
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.43299767198287115,1.0759245599318228,0.3699186991869919,0.9000591421640983,1.0,4/13,6.87%,TGFBR3;BMPR1A;RBPJ;FGFR2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4348264682458983,1.075751124584713,0.35969868173258,0.8991217810163566,1.0,4/13,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,COPII-coated vesicle budding (GO:0090114),0.3075499155011811,1.0756074827287871,0.34210526315789475,0.8981087401099137,1.0,21/68,17.95%,F5;BET1;SEC23B;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;MIA3;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC31B;F8;TFG;SEC22B
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.3957744776443929,-1.0756066645940212,0.35856573705179284,0.6739695691910317,1.0,8/16,32.17%,SMC1A;NIPBL;RAD21;MAU2;REC8;SGO1;DSCC1;NAA50
prerank,positive regulation of dendrite extension (GO:1903861),-0.3919576699700267,-1.0755921605063687,0.38784067085953877,0.6734044991251652,1.0,6/17,18.14%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,monocarboxylic acid transport (GO:0015718),0.3296941768870196,1.075319552527462,0.34137291280148424,0.8975631176926087,1.0,5/51,2.87%,SLC16A6;SLC6A13;SLC6A12;SLC16A11;SLC16A12
prerank,negative regulation of cytokine production (GO:0001818),-0.24974626326178329,-1.07497196827098,0.27146814404432135,0.6743449812588554,1.0,52/163,24.61%,LEF1;TMSB4X;CD200;ATP2B1;RPS6KA5;THBS1;GAS6;CD34;FN1;IRAK3;RNF125;NLRC5;NPTN;TRIM25;ANXA1;OTUD7B;ADCY7;HDAC7;HDAC9;TNFRSF21;CEACAM1;APOD;ABCD2;CHID1;KLF4;PDCD4;PIBF1;ISG15;PTPRC;IFIH1;NCKAP1L;TRAF3IP1;N4BP1;SIGIRR;PCBP2;PPP1R11;PTPN6;ZC3H12A;NR1H4;JAK3;TRIB2;HMGB1;CUEDC2;ASB1;ZFPM1;CYLD;DLL1;FCGR2B;TAX1BP1;RGCC;TLR4;UFD1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3724908984194238,-1.0747997708014163,0.35912698412698413,0.6741588949721417,1.0,4/21,12.31%,MEF2C;ITGA1;CALM3;BMP2
prerank,cholesterol biosynthetic process (GO:0006695),0.3578535818085781,1.074540524484,0.3296296296296296,0.8986055556058226,1.0,9/31,18.84%,ACAT2;INSIG2;DHCR24;SC5D;CYP51A1;SQLE;MSMO1;GGPS1;HMGCR
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4196551980102471,1.0743550301191331,0.3645224171539961,0.8977360728732788,1.0,3/16,7.83%,PIK3CB;AUTS2;ARHGAP24
prerank,positive regulation of growth (GO:0045927),-0.2820566345315718,-1.0738736291064663,0.3287981859410431,0.6760180281738191,1.0,16/64,16.57%,RFTN1;TGFB2;INSR;EGFR;H3-3A;RPS6KA3;ADAM10;CDKN2AIP;RPTOR;PABIR1;MFSD2A;USP47;CSNK2A1;NCBP1;DDX49;KLHL22
prerank,signal transduction in response to DNA damage (GO:0042770),0.3312238629308564,1.0737714809227317,0.3409490333919156,0.8981363339367009,1.0,19/49,23.08%,DOT1L;E2F1;HINFP;CLOCK;NDRG1;BATF;FBXO6;MAPK14;PRPF19;CHEK2;ABL1;ATM;GADD45A;CLSPN;RAD17;MYO6;CASP9;ATRX;MDM4
prerank,cellular response to dsRNA (GO:0071359),0.42195704182908933,1.07373834992544,0.37890625,0.8968005229715127,1.0,3/15,7.81%,COLEC12;PQBP1;IFIT1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.25218742762033075,-1.0735677862289446,0.27225130890052357,0.6761772480585458,1.0,19/128,9.37%,PTN;ETS1;THBS1;NFKBIA;POLR3F;ABCC1;PLSCR1;SCARF1;APP;STX3;GBP5;AGTR1;PDE2A;WNT5A;PUM2;MDK;IFI35;IL15;SERPINE1
prerank,acute-phase response (GO:0006953),-0.4254191914308285,-1.0731338682353928,0.3816046966731898,0.6767301963603242,1.0,5/12,28.93%,PLSCR1;IL6R;SIGIRR;CEBPB;AHSG
prerank,carnitine metabolic process (GO:0009437),0.4459908173568897,1.0730307540470583,0.35330578512396693,0.8977795809439774,1.0,5/12,19.77%,BBOX1;CPT1C;CROT;CPT2;ALDH9A1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.415623002502293,1.072992708481897,0.366,0.8964398800597265,1.0,10/17,26.65%,CORO1B;WASF1;CYFIP1;WASF3;PICK1;BRK1;CTNNA2;ARF1;GMFB;ARFIP1
prerank,camera-type eye morphogenesis (GO:0048593),-0.45131830934323747,-1.0715846962716828,0.384180790960452,0.6800177869061302,1.0,5/10,23.05%,LRP6;TBX2;VEGFA;SKI;KDM2B
prerank,negative regulation of cyclase activity (GO:0031280),0.42525553809695915,1.071461542327947,0.37093690248565964,0.8998259965583391,1.0,4/14,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3390105181825392,1.0712427663516182,0.36065573770491804,0.8990906323438329,1.0,6/37,10.06%,ALCAM;IL1RAPL1;TENM1;GRID2;PTPRD;ADGRL1
prerank,negative regulation of glycolytic process (GO:0045820),0.4701720789348621,1.0711248903502015,0.40652173913043477,0.8966338540190042,1.0,2/10,2.88%,NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4701720789348621,1.0711248903502015,0.40652173913043477,0.8966338540190042,1.0,2/10,2.88%,NUPR1;PPARA
prerank,keratan sulfate catabolic process (GO:0042340),0.46855365278503347,1.0708363392717712,0.3858267716535433,0.8961052154376048,1.0,3/11,6.29%,OGN;OMD;GALNS
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.33406360649808564,1.0706402694848305,0.3541284403669725,0.8952735723778897,1.0,13/44,22.46%,PRKAG2;INSIG2;SC5D;CYP27A1;AMACR;OSBPL9;SQLE;PER2;MSMO1;HMGCR;HSD17B4;LBR;PSAT1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4261196338649245,-1.0705073245340115,0.36327345309381237,0.6822196341686803,1.0,5/13,15.93%,SHANK3;APP;EPHB2;SQSTM1;ZDHHC2
prerank,BMP signaling pathway (GO:0030509),0.31725179371609913,1.0701428366609504,0.34954954954954953,0.8954789090456422,1.0,7/62,5.35%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,negative regulation of TORC1 signaling (GO:1904262),0.4359526805043755,1.0696868348026813,0.3705179282868526,0.895533586551664,1.0,4/13,18.47%,RNF152;SESN1;ATM;CASTOR2
prerank,inorganic ion transmembrane transport (GO:0098660),-0.43421590700536883,-1.0696219618548615,0.36585365853658536,0.6840013242637224,1.0,7/12,41.95%,ABCC9;KCNJ8;CACNA1H;ABCC8;P2RX3;KCNJ11;RHAG
prerank,RNA polyadenylation (GO:0043631),-0.34972246003202323,-1.0691037432399741,0.3319327731092437,0.6841267537527048,1.0,8/26,13.11%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,mRNA polyadenylation (GO:0006378),-0.34972246003202323,-1.0691037432399741,0.3319327731092437,0.6841267537527048,1.0,8/26,13.11%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,neuron projection organization (GO:0106027),-0.4093147637592351,-1.0682816711617835,0.3796680497925311,0.6856706806768169,1.0,3/15,8.46%,INSR;APP;ABCD2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.34131703536935953,-1.0681998644159554,0.34051724137931033,0.685298195830579,1.0,17/29,33.91%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;TLR4;CASP8;CD300LF;FADD;TLR6;IRF3;IKBKB;CD14;TLR3
prerank,lymphocyte differentiation (GO:0030098),-0.28124925390560407,-1.0681171648976249,0.31009615384615385,0.6849020491134299,1.0,15/68,13.88%,PBX1;KAT7;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;JAG2;RELB;HDAC9;PIK3CD;HHEX;ITGA4;NFIL3;PTPRC
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.23592326231488947,-1.0679090120733552,0.2719033232628399,0.6848544347654192,1.0,59/248,16.44%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;DAAM2;STK3;LIMD1;EGFR;SDHAF2;KANK1;SFRP4;CDK14;TLE4;GLI3;SOX17;IGFBP6;CSNK1E;NKD2;CSNK1G1;ADGRA2;TNKS;AXIN2;CCNY;WNT5A;TLE3;PLEKHA4;PSMB7;ZNRF3;CSNK1G3;PSMA6;INVS;CSNK1A1;APC;MDK;XIAP;PPP1CA;ATP6AP2;PSMB6;AMER1;APOE;PSMB5;SOX7;FZD4;TLE5;SCEL;HHEX;BMP2;DKK2;ANKRD6;USP47;GSKIP;PSMC4;PSMB8;AMER2;MAD2L2;SEMA5A;COL1A1;PSMD11
prerank,regulation of epidermal cell differentiation (GO:0045604),0.39091590783210356,1.0674658780590136,0.34593572778827975,0.9013038720049376,1.0,3/21,4.42%,ERRFI1;ROCK2;MAFG
prerank,pancreas development (GO:0031016),-0.4197685914725032,-1.0670454123498014,0.38330170777988615,0.6865710538903401,1.0,9/12,42.83%,MET;NKX6-1;FOXF1;ZIC3;SELENOT;NPHP3;CCDC40;ISL1;DNAAF1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.22855114736239573,-1.0668991900844693,0.25766871165644173,0.6863258510832798,1.0,60/308,16.41%,LEF1;PRKCH;GHR;CAV1;GCNT2;ZBTB16;BMPR2;PTN;ADRA1B;ACVR1;TGFB2;GAS6;BMP4;EBF2;PRDM16;SIX1;TGFBR2;GATM;ABCA1;ADIPOR2;PLA2R1;TFRC;S100A13;AXIN2;WNT5A;APC;SHLD1;MDK;PDGFC;SOD1;TIAM1;IL15;TMEM119;TRIM16;SERPINE1;AGO2;FGF2;TGFB3;PIK3CD;CFL1;APOE;IL4R;ELOVL6;FBXO5;HADH;B4GALT5;TWIST1;BMP2;SMO;AGPAT1;NME2;VEGFA;SCD;FERMT2;UCP2;MAD2L2;SIX4;COL1A1;RTN4;RREB1
prerank,activation of protein kinase activity (GO:0032147),0.2803803531108124,1.066449720309617,0.3107890499194847,0.9031495837009006,1.0,13/106,7.87%,FGF1;OSBPL8;ADCY5;IGF1;IL18;RICTOR;ADCY1;ADRA2A;ADCY8;PDPK1;STRADB;NRG1;PRLR
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2631782533966657,-1.0663388303421435,0.3333333333333333,0.6872044599718803,1.0,26/104,15.40%,ST3GAL4;DCN;CSGALNACT1;SLC26A2;ST3GAL6;SLC10A7;B3GNT2;CSPG4;B4GALT4;PAPSS2;GSS;ST3GAL1;AKR1A1;LUM;GGTA1;GCLC;VCAN;SLC35B3;B4GALT5;LIAS;GCLM;CHSY3;ESD;CHST1;BGN;GSTT1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.37688839625768894,-1.0663302736772278,0.3747412008281574,0.6866213110486157,1.0,7/19,23.25%,GAS6;ZBTB1;MDK;NCKAP1L;BTK;SYK;ZMIZ1
prerank,peptide cross-linking (GO:0018149),-0.35405513047200676,-1.0658231413747543,0.34615384615384615,0.6873189222869077,1.0,5/25,7.50%,NDNF;THBS1;FN1;ANXA1;TGM2
prerank,sulfur amino acid metabolic process (GO:0000096),0.37186679083090063,1.06572869037183,0.3784786641929499,0.9040566870137187,1.0,7/24,17.07%,ADI1;MMUT;CDO1;MTHFR;AHCY;MTHFD1;CTH
prerank,cellular response to starvation (GO:0009267),0.2694202060168826,1.0654160486789732,0.3001531393568147,0.9036453223438615,1.0,20/147,10.25%,PRKAG2;RNF152;GCGR;PRKAA2;NPRL3;RRAGC;PRKAG3;PPARA;ATP6V0B;ATP6V1H;NIM1K;LRRK2;CPEB4;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMP2
prerank,regulation of cellular component movement (GO:0051270),-0.2992552492891129,-1.065154035551028,0.33636363636363636,0.6884975500867317,1.0,8/49,6.32%,ACTN4;RHOA;ETS1;CD9;EGFR;ACTN1;ARAP1;LYN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.4201816452854027,-1.0648740731767175,0.39869281045751637,0.6886512356899427,1.0,8/13,28.39%,CD44;DYRK1A;CD74;TWIST1;PSMD10;SNAI2;MIF;PTTG1IP
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4171493239821885,-1.0646391846953267,0.386,0.6886313963073005,1.0,6/13,8.66%,ABHD2;BMP4;ESR1;NR3C2;AR;PLPP1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.30036620418025706,1.0646276002921646,0.343804537521815,0.9048513134152136,1.0,8/66,9.94%,ROBO1;FGF1;TENM1;KIT;ADRA2A;LRRK2;MAP3K10;SASH1
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.2499656289360243,-1.0645344559902075,0.2918918918918919,0.6883004367225664,1.0,34/144,15.93%,YWHAE;GAS6;PIK3R1;PRR5L;CDH1;ICE1;MFF;YWHAB;FLNA;TMEM30A;UBE2D3;ABLIM3;SAE1;PRKCD;YWHAQ;SEC16B;ARIH2;YWHAZ;RIPOR1;SREBF2;IPO5;MICALL2;TPR;AKT2;UBE2L3;FBXW7;UBL5;SAR1A;UBE2J2;KCNB1;ZFAND1;BBC3;CEMIP;ZDHHC2
prerank,regulation of tube diameter (GO:0035296),-0.42306444097028706,-1.0644899095022011,0.37782340862423,0.6872257219746377,1.0,5/13,12.47%,NOS3;AGTR1;GCLC;GCLM;ACE2
prerank,vascular process in circulatory system (GO:0003018),-0.42306444097028706,-1.0644899095022011,0.37782340862423,0.6872257219746377,1.0,5/13,12.47%,NOS3;AGTR1;GCLC;GCLM;ACE2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3782346595427547,1.0644423949475088,0.3669201520912547,0.9040016236074553,1.0,3/21,4.57%,ANXA6;SLC8A3;AFG3L2
prerank,aorta development (GO:0035904),0.4204104792436759,1.0641144646462048,0.38742393509127787,0.9036180412316378,1.0,1/14,0.08%,ROBO1
prerank,protein-containing complex disassembly (GO:0032984),-0.299640647129947,-1.0639266181104052,0.3544600938967136,0.6881207397137699,1.0,11/54,14.27%,CAV1;LRP6;GABARAPL2;CSNK1A1;APC;MAP1LC3B;PPP1CA;AMER1;RPL23;GABARAP;FZD1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.28241934860511303,1.063835469665797,0.33993399339933994,0.9030814382824511,1.0,16/102,9.84%,CPEB2;ADCY5;GCGR;GCK;CYP11B1;ADCY1;INSIG2;CRHR1;LPIN1;SLC30A10;ADCY8;PDPK1;PRKCI;USF1;RHOQ;SORBS1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4240286729388117,1.063405390756857,0.3861003861003861,0.9029926009870691,1.0,5/15,18.83%,IDO1;HAAO;KMO;GSTZ1;KYAT1
prerank,cellular response to interferon-gamma (GO:0071346),-0.26957628010713575,-1.0633782156123934,0.33687002652519893,0.6889869121207265,1.0,23/88,19.61%,B2M;VCAM1;CD44;MID1;GBP4;ICAM1;GBP5;IRF9;CAMK2D;WNT5A;PRKCD;TRIM25;CCL13;IRF2;JAK1;SLC26A6;SYNCRIP;SP100;CCL25;MT2A;GAPDH;IRF5;HCK
prerank,protein localization to mitochondrion (GO:0070585),0.4399068467769308,1.0631986147582442,0.3824091778202677,0.9022329312624568,1.0,6/11,20.17%,COX18;LRRK2;HK1;MTCH2;AKT1;MAIP1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.39607109216909053,-1.062562962184009,0.3745019920318725,0.6904482952599129,1.0,10/16,38.44%,SHLD1;SMCHD1;FANCB;MAD2L2;SHLD3;CGAS;HELB;POLQ;RADX;SHLD2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3593073281271887,-1.0624425557397166,0.35787321063394684,0.6901534494220752,1.0,4/22,7.92%,DAB2IP;MFHAS1;LYN;IFI35
prerank,regulation of protein kinase B signaling (GO:0051896),-0.2414797241942849,-1.062021640412713,0.2541899441340782,0.6906333862466172,1.0,32/193,11.04%,HIP1;KITLG;TEK;NTRK3;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;F3;PIK3R1;EGFR;PTPRJ;MFHAS1;ESR1;TNFAIP8L3;ITGB1;XDH;MET;RACK1;MYOC;PPP2R5C;IAPP;SPRY2;PIK3CA;SRC;IGF2;FGF2;PIK3CD;FGF7;PHLPP1
prerank,mitochondrion morphogenesis (GO:0070584),-0.433639893491667,-1.0619125924503932,0.38976377952755903,0.6903247448200247,1.0,3/11,7.75%,PID1;MFF;NUBPL
prerank,cellular iron ion homeostasis (GO:0006879),0.31664398402285054,1.0616451311325075,0.3596330275229358,0.9059516357366707,1.0,9/55,7.09%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;FLVCR1;ACO1;CCDC115;CP;TMEM199
prerank,regulation of filopodium assembly (GO:0051489),-0.31605709872210064,-1.061413350466884,0.34782608695652173,0.6911015758971982,1.0,11/38,16.67%,NRP1;MYO10;PIK3R1;ARAP1;PPP1R16B;PRKCD;TGFB3;FNBP1L;AGRN;FMR1;FXR1
prerank,response to thyroid hormone (GO:0097066),0.42404480328856425,1.0611533316131403,0.38589211618257263,0.9061287533829948,1.0,4/13,11.08%,THRB;BRD8;MED1;CTSH
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2725448189924812,-1.060528314650255,0.3290155440414508,0.6928644047769773,1.0,22/87,14.52%,CAV1;SEMA6A;DAB2IP;FOXO1;BMP4;PTPRJ;IRAK3;SPRED2;PPIA;LYN;PRKCD;SPRY2;PTPN1;DUSP3;APOE;EPHB2;RANBP9;STK38;PEBP1;PTPRC;SPRY1;PAQR3
prerank,DNA replication initiation (GO:0006270),-0.3306719933898409,-1.060456178525766,0.35476718403547675,0.6924406896398645,1.0,16/37,27.02%,RPA1;ORC1;ORC2;RPA2;CDC45;ORC5;POLA1;PURA;MCM3;POLA2;CDC34;PRIM2;MCM5;MCM6;POLE3;CDK2
prerank,B cell homeostasis (GO:0001782),-0.4511371743339694,-1.0602054295987993,0.38446969696969696,0.6924991369533334,1.0,3/10,6.32%,MEF2C;DOCK10;LYN
prerank,regulation of histone acetylation (GO:0035065),0.34218201896929834,1.0601203695986008,0.35645472061657035,0.9080104390145262,1.0,8/33,13.17%,KMT2A;CAMK1;RUVBL2;ARRB1;PPARGC1A;BRD7;NOC2L;RAPGEF3
prerank,DNA-dependent DNA replication (GO:0006261),-0.2584825411062146,-1.0600862491663217,0.3283582089552239,0.6921967187002722,1.0,54/128,32.07%,RPA1;UBC;RPS27A;UBB;REV3L;PSMB7;PSMA6;RPAIN;PSMB6;PSMB5;WRNIP1;BLM;ORC1;DDX23;PSMC4;PSMB8;PSMD11;ORC2;RPA2;PSMB4;PRIMPOL;CDC45;PSMD14;ORC5;PSMD10;POLA1;SIRT7;RFC4;PSME1;PURA;MCMBP;MCM3;POLA2;POLD4;PSMB3;WDHD1;POLG2;POLB;CDC34;GINS3;PRIM2;MCM5;MCM6;RFC2;POLE3;CDK2;RECQL5;DDX21;PSMB9;HELB;PSMD5;ORC3;GINS2;RECQL
prerank,regulation of platelet activation (GO:0010543),-0.35854068932566807,-1.0599693699381003,0.3684210526315789,0.6919110563531478,1.0,5/21,10.49%,PLA2G4A;NOS3;LYN;TEC;APOE
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.34859367307140615,-1.0599664677097098,0.3757828810020877,0.6913273843291284,1.0,7/25,13.24%,INSR;PTGS2;NOS1AP;KLF4;EDN1;DDAH1;KLF2
prerank,positive regulation of glycolytic process (GO:0045821),0.3877350447491069,1.0597534937526896,0.37209302325581395,0.9063807543004937,1.0,2/20,1.84%,IGF1;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3877350447491069,1.0597534937526896,0.37209302325581395,0.9063807543004937,1.0,2/20,1.84%,IGF1;PRKAA2
prerank,hexose metabolic process (GO:0019318),0.33123998157399764,1.0595279967817677,0.3629764065335753,0.9056978523638816,1.0,12/39,18.59%,CHST15;SORD;PGM1;ALDOB;GALT;FUCA1;PMM2;BRAT1;HECTD4;HK1;ALDOC;KHK
prerank,Notch signaling involved in heart development (GO:0061314),0.4513274718907184,1.059192694280417,0.38414634146341464,0.9054057026348064,1.0,3/11,5.14%,NOTCH2;GALNT11;RBPJ
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.24393825305188965,1.058883591864299,0.30575035063113604,0.9050132363849439,1.0,46/348,11.36%,ROBO1;BMP7;AFDN;FGF1;BMP6;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;OVOL2;MAGI2;ANK2;PIK3R3;CDH3;FGF9;TNRC6A;PIK3CB;LRP3;RBPJ;PAX6;E2F1;PDCD5;CITED1;WNT6;ARRB1;ATAD1;SNF8;FAM98B;NTRK2;PPHLN1;RIMS1;MED1;HINFP;PPARGC1A;NSF;TGFBR1;MPHOSPH8;FUBP1;DTNBP1;CTSH;MAPK14;CLU
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3448711370478681,1.0588737368466261,0.36684303350970016,0.903647413580364,1.0,10/36,17.93%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.41897199080603054,1.0588046927620964,0.3867735470941884,0.9011083527125063,1.0,5/15,19.63%,AP3S2;SNAPIN;DTNBP1;AP3B2;AP3S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.41897199080603054,1.0588046927620964,0.3867735470941884,0.9011083527125063,1.0,5/15,19.63%,AP3S2;SNAPIN;DTNBP1;AP3B2;AP3S1
prerank,response to interferon-alpha (GO:0035455),-0.38971744161243166,-1.0579561318362125,0.3670103092783505,0.696021251969545,1.0,6/16,21.26%,GAS6;IFITM3;TPR;IFITM1;IFNAR1;IFITM2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3363865821481247,-1.0569643396191502,0.39082969432314413,0.6979992733110528,1.0,4/29,3.33%,GHR;PKD1;SOCS2;STAT3
prerank,cellular response to peptide (GO:1901653),-0.2929487213022715,-1.0569272139505945,0.33710407239819007,0.6975186868635291,1.0,20/56,21.77%,CAV1;VCAM1;CACNA2D1;ABCC1;APP;NOD1;ARHGEF2;ICAM1;SRC;CDK5;RPL23;ITGA4;TIMELESS;LRP1;GPER1;NOD2;GRIN1;IGF1R;RIPK2;FYN
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3359060170659827,-1.0568664410485895,0.3927038626609442,0.6964910546442578,1.0,12/29,30.16%,HJURP;RBBP4;NASP;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;SMARCA5;RSF1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3359060170659827,-1.0568664410485895,0.3927038626609442,0.6964910546442578,1.0,12/29,30.16%,HJURP;RBBP4;NASP;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;SMARCA5;RSF1
prerank,camera-type eye development (GO:0043010),-0.34681881525300234,-1.0568657493737725,0.39957716701902746,0.6958989309678164,1.0,9/25,21.28%,LAMA1;CYP1B1;FBN1;STRA6;VEGFA;ALDH1A3;EFEMP1;FOXL2;SKI
prerank,barbed-end actin filament capping (GO:0051016),-0.37848797698633957,-1.0568499835082563,0.3885480572597137,0.6947424152668822,1.0,7/18,14.06%,SVIL;GSN;EPS8;CAPZA2;CAPG;AVIL;VILL
prerank,actin filament capping (GO:0051693),-0.37848797698633957,-1.0568499835082563,0.3885480572597137,0.6947424152668822,1.0,7/18,14.06%,SVIL;GSN;EPS8;CAPZA2;CAPG;AVIL;VILL
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.3389565736011005,-1.056750881686648,0.3860369609856263,0.6944194542597126,1.0,10/28,22.95%,ESAM;WDR1;ARHGAP35;CXCL12;PFN1;PLEKHG2;LATS1;FCHSD1;RASA1;HCLS1
prerank,negative regulation of cell growth (GO:0030308),-0.2556014314336205,-1.0566955994307359,0.3384615384615385,0.6939576403966383,1.0,37/121,24.16%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;CDKN2AIP;FGF13;NME6;SEMA3G;SIPA1;RERG;ADAM15;MT3;RTN4;CDA;OSGIN1;ENPP1;ULK2;SMARCA4;SLIT3;PPP2CA;RTN4R;ESR2;PRDM11;CDKN1B;WFDC1;JADE1;MUL1
prerank,steroid metabolic process (GO:0008202),0.2977745329180046,1.0566602955891302,0.3614457831325301,0.9064914180358508,1.0,20/72,22.02%,LIPA;CYP26B1;CYP11B1;DHCR24;PRLR;CYP27A1;DHRS11;AMACR;FDX1;PIAS4;CYP51A1;GBA2;STAR;FDX2;MSMO1;HSD17B4;FDXR;HSD11B1;NPC1;SHH
prerank,positive regulation of transmembrane transport (GO:0034764),0.42149326100001017,1.0563317869601339,0.37109375,0.9061230219739939,1.0,3/13,10.68%,ACSL1;CLIP3;AZIN2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3110602891527954,-1.0562835739836784,0.3574561403508772,0.6943398131789051,1.0,15/40,20.17%,HIP1;B2M;INSR;SFRP4;TBC1D5;SGIP1;SERPINE1;VEGFA;CBL;LDLRAP1;FMR1;VTN;GREM1;ARRB2;C3
prerank,plasma membrane organization (GO:0007009),0.31144008389625494,1.0559459607462907,0.35060449050086356,0.9059826046102868,1.0,10/61,10.01%,COL5A1;SYT11;ANXA6;ANK2;MICALL1;PLSCR2;MYOF;NSF;ABCD1;FA2H
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22800553993940673,-1.0559332819711809,0.3069908814589666,0.6946196392942241,1.0,57/291,15.16%,ACTB;PDE3A;MEF2C;RAPGEF2;DAB2IP;PID1;SLIT2;RHOA;FOXO1;GUCY1B1;RAP1A;SH3BP4;EGFR;TNFRSF1B;PTPRK;JUN;ESR1;TBX1;DEFA6;CARD16;PRKD1;CAPN2;GNB1;PDE2A;LYN;WNT5A;PXN;PRKCD;KCNQ1;GNG2;MAPK1;TGM2;RPS3;SPAAR;NRIP1;SERPINE1;INSIG1;AHR;RPTOR;NSMF;FZD4;IPO5;PDCD4;PAF1;RET;PTK2B;SLC26A6;RRAGA;WNT9A;CD86;P2RY6;ROMO1;GLRA2;MT3;ZFAND1;IRS1;GIT1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3571983131512803,-1.0558447179544037,0.3796095444685466,0.6942786254179356,1.0,9/24,22.20%,UBC;NOD1;RPS27A;UBB;TAB1;IRAK2;NOD2;RIPK2;CYLD
prerank,mitochondrial translation (GO:0032543),-0.2602138847700264,-1.0555374172256748,0.3333333333333333,0.6945323805716219,1.0,29/104,19.87%,GATB;DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MTIF3;GFM1;LARS2;MRPL23;MRPS31;NDUFA7;MRPL10;EARS2;MRPL12;GFM2;PTCD3;MRPS12;MRPL43;MRPL1;MRPS22;MRPL55;MRPL45;MRPL44;MRPL33;CHCHD1;MRPL36;MRPL35
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4453359728234427,1.0553917225250975,0.3941176470588235,0.9062956120669704,1.0,2/11,3.76%,STX18;ATL1
prerank,myoblast fusion (GO:0007520),0.435977083623516,1.0551938010540165,0.3840155945419103,0.9055042887107311,1.0,3/12,5.18%,ADAM12;ADAMTS15;ADGRB3
prerank,protein glycosylation (GO:0006486),-0.25138072816162477,-1.0546273589847635,0.31313131313131315,0.6963809753215688,1.0,32/125,19.75%,ST3GAL4;GCNT2;ST8SIA4;ST3GAL6;B3GNT2;FUT8;EOGT;PLOD2;MGAT5;SLC39A8;AQP11;ST3GAL1;PLOD3;COG3;ST8SIA6;STT3B;MGAT4A;GFPT2;B4GALT5;PMM1;MGAT4B;GALNT10;ST8SIA2;GALNT6;ALG10B;ST6GALNAC2;KRTCAP2;ST3GAL2;ALG6;GALNT9;TMEM258;POMT2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.29485356815848285,1.0545135022665177,0.35701906412478335,0.9062876909801019,1.0,27/84,21.64%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;SON;SRSF10;HNRNPL;PTBP1;TIA1;C1QBP;SRRM4;YTHDC1;NUP98;FXR2;PCBP4;RBM5;MBNL3;RNPS1;RBFOX1;SRSF6;PUF60;CELF6;REST;LARP7;CELF1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.31426279968488635,-1.0544683158707082,0.34475374732334046,0.696254846721871,1.0,17/37,27.79%,PHLDB1;STMN1;PHLDB2;EFNA5;FAM107A;GAS2L1;BICD2;TRAF3IP1;MAPRE2;STMN4;ROCK1;TAOK1;CYLD;MAP6D1;MAPRE3;SKA3;MAPT
prerank,base conversion or substitution editing (GO:0016553),-0.438351507447713,-1.0544527181871546,0.40529531568228105,0.6957217274534866,1.0,3/11,19.80%,ADARB1;NUDT16;METTL3
prerank,phagolysosome assembly (GO:0001845),-0.4235648117716065,-1.0542985110514682,0.4017467248908297,0.6954824053080445,1.0,7/12,34.90%,RAB14;ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.44042110867584083,-1.0540330845742365,0.40681362725450904,0.6956042439952349,1.0,4/11,6.59%,RSPO3;MLLT3;CSNK1E;PLEKHA4
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4599892772720493,1.0540007204743724,0.42448979591836733,0.9065014933159278,1.0,3/10,8.17%,CRHR1;GNB5;DRD3
prerank,O-glycan processing (GO:0016266),0.31594088670465476,1.0539019623517873,0.3486238532110092,0.9054397893596816,1.0,6/54,4.13%,GXYLT2;CHST4;MUC19;ST3GAL3;GALNT11;GALNT14
prerank,histone ubiquitination (GO:0016574),0.3798013116728427,1.0533776020690442,0.39285714285714285,0.9056956374599396,1.0,10/21,28.38%,CTR9;LEO1;RNF20;CDC73;PHC1;RNF8;UBR2;UBE2B;UBE2N;UHRF1
prerank,androgen receptor signaling pathway (GO:0030521),0.4408507465022342,1.0533073114348017,0.3803339517625232,0.9045391711367581,1.0,4/11,11.94%,DDX5;RNF14;DDX17;PMEPA1
prerank,regulation of immune response (GO:0050776),-0.24989628356046664,-1.0530239577575442,0.3238341968911917,0.6976770004263967,1.0,28/135,17.76%,FOXP1;CLEC2D;CD200;B2M;TGFB2;CD34;VCAM1;PLSCR1;ITGB1;ICAM1;LYN;ADCY7;CXADR;XIAP;IL15;AHR;NECTIN2;ITGA4;RSAD2;ICAM2;BIRC3;CD40;COL1A1;IFITM1;PVR;N4BP1;DENND1B;ULBP1
prerank,amino acid import (GO:0043090),0.38113949673338765,1.0529347623154175,0.384765625,0.9042861068305315,1.0,2/21,0.21%,SLC6A13;SLC6A1
prerank,leukotriene metabolic process (GO:0006691),-0.3794654213892892,-1.0523549623150739,0.42028985507246375,0.6988421734084813,1.0,4/19,14.48%,PLA2G4A;ABCC1;MAPKAPK2;ABCC10
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.20565932365219916,-1.0522145516672043,0.18823529411764706,0.6986020919158626,1.0,287/1082,23.28%,MECOM;LEF1;MEF2C;ERG;MAML2;BMP5;MRTFB;ZBTB16;DAB2IP;BMPR2;PID1;PBX1;ELK3;ZFHX3;DCN;JAG1;ITGA6;MLLT3;LRP6;RARB;ACVR1;PLAGL1;MEOX2;ETS1;ACVRL1;ENG;MAP3K5;PPARD;MDFIC;FLI1;TCF12;RPS6KA5;KAT7;FOXO1;NOTCH1;TBX3;LRP5;PKD1;CDH13;KMT2E;PIK3R1;FOXO3;EGFR;AFAP1L2;CTCF;NFKBIA;LMO2;RUNX2;ASXL3;CDH1;BMP4;NFATC1;PRDM16;ICE1;STAT3;AGO1;PLSCR1;PPP1R12A;SIX1;NFIA;APP;UBC;RNF111;RUNX1;DCAF6;REL;JUN;ESR1;RPS6KA3;LMO7;TBX1;KLF7;NAA16;KAT6A;GLYR1;BPTF;GLI3;DHX33;NFIX;TFEB;SOX17;BRD4;ARID1B;ZXDC;SMARCC1;ARHGEF2;NFYA;XPC;SMAD1;PRKD1;RPS27A;UBB;SMAD5;TNKS;MET;HES1;ETV1;SLC30A9;NLRC5;NRF1;WNT5A;AR;SP3;TRIM56;CCN1;NCK1;ELF4;ETV5;PPP3CA;CD38;HEYL;ACTA2;NFAT5;HEY2;ARID1A;CDKN1C;SPIN1;GATA2;NRIP1;IGF2;TRIM16;VHL;SERPINE1;ZFPM2;NOTCH4;AGO2;IRF2;KLF4;ELK1;FGF2;PELP1;TAL1;EIF2AK3;TGFB3;SS18;AHR;RFXAP;TCF20;GTF2F1;EDN1;ETS2;PER1;RPTOR;APOE;PITHD1;FGF7;SREBF2;NFATC2;SERTAD1;MYOCD;TMF1;FZD4;ATAD2;GTF2H1;DYRK1A;CD74;TWIST1;HHEX;SOX18;FOXF2;FOSL2;RET;SQSTM1;BLM;BMP2;TEAD1;RARG;NCOA6;HNRNPAB;KLF2;LPIN3;NFIL3;SOX12;CD86;POU2F1;NME2;KMT2C;MAFF;VEGFA;AGRN;NR4A2;FZD1;ZNF318;CD40;MRPL12;MT3;TFCP2;E2F5;ATF6B;FOXO4;BRCA2;ENY2;MAD2L2;YAF2;ID2;SIX4;ATF4;COL1A1;CRTC3;RGMA;DNAJC2;RREB1;CSRNP2;FOXD2;HEY1;SP100;ELL;EPC1;HDAC2;GPER1;NFKB2;IER2;SP7;NOD2;JUNB;PCBP1;GRIN1;MED14;ZMIZ2;ZBTB48;ATF7IP;ZNF496;MAPK3;UBTF;IRF5;NR2F1;ZC3H12A;IL33;NUFIP1;GREM1;HIVEP1;SOX8;NR1H4;PAX3;SSBP4;FOXE1;RYBP;FOXL2;NFATC3;CDCA4;RIPK1;LMX1B;NUP85;SPI1;ATF3;HMGB1;SIRT7;SMARCA4;JUND;CHEK1;NKX6-1;POU3F3;NCOA3;TGFB1I1;MAP2K7;JUP;RIPK2;BCL9;SKI;BCL9L;CHD8;ESR2;RPRD1B;CCDC62;MED13;MAML3;DTX3L;ZFPM1;DLL1;SNW1;MYRF;TESC;RXRG;NAT14;PRDM11;CAMKK2;BCL10;HCLS1;CDK5RAP2;SOX11;SS18L2;E2F7;SREBF1;TAF9;GALR1;ZMIZ1;RORB
prerank,leukotriene biosynthetic process (GO:0019370),-0.4054780005809011,-1.0521559058391898,0.40524193548387094,0.6981736275316655,1.0,6/14,31.56%,PLA2G4A;GGTA1;GGT7;GGT1;PLA2G5;ALOX5AP
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4047280149224956,-1.0521450811884998,0.412,0.6976208376712825,1.0,6/15,28.50%,APP;IAPP;APOE;PFDN6;LDLR;TREM2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.27946048640899807,-1.0520810295811174,0.35279805352798055,0.697203446048932,1.0,33/73,33.91%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;CD86;PTPRC;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;BCL10;CCR2;TLR4;PTPN11;DDT;MIF;RASGRP1;FADD;TLR1;TMEM106A;LGALS9;TYROBP;CD14;TLR3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3726196462526148,-1.052057621526907,0.38762886597938145,0.6966724982748104,1.0,8/20,18.40%,AGO1;ZC3H7A;PUM2;AGO2;DROSHA;PUM1;AGO4;MRPL44
prerank,mRNA transport (GO:0051028),0.27948167790230055,1.051740620609032,0.35973597359735976,0.906669316271304,1.0,39/101,27.84%,MCM3AP;CPSF3;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;SMG5;NXT1;DDX19B;SLBP;YTHDC1;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;RAE1;DDX39A;SRSF2;RBM15B;ZFP36;ZFP36L1;U2AF2;NUP160;THOC2;ZC3H11A;FIP1L1;NUP133;POLDIP3;GLE1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3224504695744269,-1.0513630537081835,0.3554083885209713,0.6978347672921958,1.0,9/35,17.26%,HIP1;B2M;MKLN1;SGIP1;SERPINE1;HIP1R;CBL;LDLRAP1;VTN
prerank,cellular response to heat (GO:0034605),0.33608898768123413,1.0511948043700217,0.3857404021937843,0.907029927422635,1.0,3/35,1.13%,FGF1;HSPA1A;TRPV1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.27035356620128614,-1.0509536137464568,0.33480176211453744,0.6982705649140949,1.0,33/83,27.66%,ACVR1;CDK17;CDK14;CACUL1;BRD4;PLK2;KLF11;CDK5;EIF4E;FBXO5;NASP;ORC1;DHFR;LATS1;CCND1;CDC45;CDK16;POLA1;CDK6;CDKN1B;CCNH;CDK18;PLK3;CUL3;CDC34;LATS2;PIM2;CDKN3;CUL4A;TYMS;NPAT;CDK2;TFDP1
prerank,embryonic organ morphogenesis (GO:0048562),-0.307499706848806,-1.050577187020021,0.3816631130063966,0.698689804051346,1.0,15/42,19.58%,MFAP5;ACVR1;SIX1;TBX1;FBN1;SOX17;NIPBL;HES1;DSCAML1;RARG;ID2;ALDH1A3;EFEMP1;HOXA4;FOXE1
prerank,miRNA metabolic process (GO:0010586),0.38291111076899104,1.0505011695471775,0.38593155893536124,0.9078449801703657,1.0,6/20,14.29%,TRIM71;DDX17;BCDIN3D;TUT4;DICER1;SND1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3239608694296977,-1.0504357655101466,0.3777292576419214,0.6985020666739545,1.0,6/33,11.39%,PRKG1;MEF2C;APOD;TAFA5;TGFB3;PDCD4
prerank,lipid droplet organization (GO:0034389),0.3774634493339364,1.0503712290135663,0.38877755511022044,0.9068757051252206,1.0,5/22,14.61%,FITM2;RAB3GAP1;PLA2G4C;CDS1;SQLE
prerank,regulation of tissue remodeling (GO:0034103),0.4010834866746297,1.0501531093728051,0.40625,0.9061539909366837,1.0,2/18,0.87%,LEPR;IL18
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4451556061702699,1.0499441549928934,0.4148296593186373,0.9054519818196176,1.0,2/11,8.31%,COLEC12;TNIP2
prerank,regulation of protein catabolic process (GO:0042176),-0.25908436191338696,-1.0496330379843715,0.337696335078534,0.7000150100814673,1.0,30/99,23.26%,DAB2IP;NEDD4L;WWP1;FOXO1;EGFR;SMURF1;EEF1A1;HECW2;IRAK3;FLNA;WNT5A;PLK2;APC;PRKCG;GFAP;HGS;CSNK2A1;FZR1;MAD2L2;ZDHHC2;BARD1;HACE1;AGAP2;NEDD4;FAF1;AZIN1;ODC1;CDKN1B;OAZ1;STX5
prerank,protein-DNA complex assembly (GO:0065004),-0.2562627077515086,-1.0492381141054554,0.33827160493827163,0.7005349011588713,1.0,32/116,22.79%,RPA1;H3-3A;UBC;XPC;RPS27A;UBB;PSMB7;PSMA6;CHD1L;GTF2H5;PSMB6;PSMB5;GTF2H1;RAD23B;DMC1;ORC1;ERCC2;PSMC4;PSMB8;PSMD11;ORC2;RPA2;PSMB4;PSMD14;ORC5;CHAF1A;PSMD10;XPA;PSME1;MCM3;PSMB3;CCNH
prerank,cardiac muscle cell development (GO:0055013),-0.37350857104891155,-1.0492153153490067,0.4036885245901639,0.7000053263891169,1.0,5/20,8.27%,SORBS2;PDLIM5;CXADR;MYH11;HEY2
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.33114582874257015,-1.0491232927516647,0.38247863247863245,0.6996731483251605,1.0,10/31,22.66%,GPHN;GCH1;LIAS;NFS1;MOCS1;NOXRED1;LSS;SRD5A1;PYCR3;SCP2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2584814346092551,1.0487654513190094,0.3134087237479806,0.9078726189754404,1.0,31/170,15.57%,PRDM6;IGF1;ROCK2;NOVA1;TRIM5;PEG3;ZNF462;KIF16B;CIAO3;MTMR4;AFF3;KDM6B;CRNN;HINFP;ZNF711;CACTIN;PRDM2;NKAP;MEGF8;RSPO1;FUBP1;HRG;ATRAID;AFF2;MTMR2;ZFP64;TBC1D16;ZNF507;PCBP4;TSKU;TAPBP
prerank,regulation of response to external stimulus (GO:0032101),-0.2510738390868773,-1.0487367025226342,0.3625,0.7000933251755463,1.0,44/121,26.28%,FOXP1;CAV1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;ADGRA2;AGTR1;WNT5A;PSMA6;ANXA1;CD55;SPAAR;STK24;XIAP;SPATA2;EPHB2;IL1RL2;ACE2;BIRC3;BCL6B;N4BP1;NOD2;ADAMTS12;HCK;MYD88;GGT1;CYLD;ERAP1;FCGR2B;CCR2;CASP1;GUCA1B;ZBP1;LRP8;CXCR4;F2R;SBNO2;CASP8;AREL1;CALM1;AKNA
prerank,positive regulation of exocytosis (GO:0045921),0.3363614242685012,1.0483551236476991,0.36524822695035464,0.9078250018719481,1.0,7/35,14.03%,UNC13D;STAM;CLASP1;SMPD3;SNF8;RAB2B;CADPS2
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.3012740463763565,-1.04804981463461,0.37142857142857144,0.7012304070580625,1.0,10/44,15.01%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;TGFB3;LIMK1;S100A10;FERMT2
prerank,fatty acid catabolic process (GO:0009062),0.29950872468859574,1.0478870342170086,0.3777372262773723,0.9079171466078007,1.0,15/67,13.05%,CEL;ACAT2;LPIN1;PCCA;ACAT1;ACAD10;ECHS1;MMUT;ABCD1;ACAD11;ECHDC2;PLA2G15;CROT;ABHD3;SLC27A4
prerank,regulation of cell communication (GO:0010646),-0.32199650637207516,-1.0478046321786127,0.3587962962962963,0.7013079074214749,1.0,10/35,13.08%,SOCS2;TBX18;MGLL;CAMK2D;ANXA1;CXADR;PTPN1;GRK5;CDC42SE2;UGCG
prerank,regulation of axonogenesis (GO:0050770),0.31281602333140784,1.0477777922109417,0.3853989813242784,0.9069309110833893,1.0,11/51,12.61%,ROBO1;PLXNA2;RUFY3;PLXNA1;KIF13B;NTRK2;LRP4;PLXNA3;SIPA1L1;LRRC4C;EPHA4
prerank,steroid catabolic process (GO:0006706),0.4497238262616118,1.0474190922424997,0.4157782515991471,0.906676112649925,1.0,10/10,55.06%,HSD17B11;HSD11B1;SPP1;HSD17B14;HSD17B6;CYP19A1;CYP27B1;FGF23;YWHAH;CYP24A1
prerank,central nervous system neuron differentiation (GO:0021953),0.33972145901594286,1.0473912711114528,0.36654135338345867,0.9054016279302888,1.0,11/33,19.94%,MAP2;GRID2;NTRK2;MDGA2;GBA2;CHD5;ATP7A;FAIM2;KNDC1;SPOCK1;SIN3A
prerank,positive regulation of actin nucleation (GO:0051127),-0.42657288486815426,-1.0462925190354675,0.40556660039761433,0.7044834472852481,1.0,3/11,10.43%,GSN;WASF2;WHAMM
prerank,response to interferon-gamma (GO:0034341),-0.2772517087391653,-1.0462399542387582,0.35604395604395606,0.7040275353041537,1.0,20/67,25.00%,IFITM3;GBP4;GCH1;GBP5;WNT5A;CCL13;CD74;SLC26A6;SYNCRIP;CD40;IFITM1;SP100;CCL25;GAPDH;KYNU;IFITM2;RPL13A;CASP1;TLR4;DAPK1
prerank,positive regulation of cellular component organization (GO:0051130),-0.2578713338158641,-1.0458966941485668,0.3502415458937198,0.7043398859040313,1.0,19/107,11.01%,ATP10A;SHANK3;DAB2IP;NEDD4L;TGFB2;INSR;ICE1;RUNX1;FNIP2;TMEM30A;TFRC;RACK1;AR;RPS3;GPX1;TAL1;TGFB3;APOE;CDC42EP2
prerank,cellular response to BMP stimulus (GO:0071773),0.30492328371779026,1.0457118619746193,0.3868092691622103,0.9092440773400133,1.0,7/66,5.35%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.37728596392339125,-1.0456027797491505,0.3870967741935484,0.704592166314961,1.0,8/17,28.39%,CD44;DYRK1A;CD74;TWIST1;PSMD10;SNAI2;MIF;PTTG1IP
prerank,chemical homeostasis (GO:0048878),0.3075799628370936,1.0451457729705897,0.38047138047138046,0.9097537847780209,1.0,12/61,9.21%,WNK3;RBP1;FITM2;SLC4A9;ABHD5;PNPLA8;CEBPA;WNK4;ADCK1;CLN8;USF1;NR1H3
prerank,neuron projection fasciculation (GO:0106030),-0.4465246902053333,-1.0450070032291474,0.3949416342412451,0.705513180472267,1.0,4/10,16.13%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,positive regulation of DNA recombination (GO:0045911),-0.341831662746861,-1.0448216578152292,0.39186295503211993,0.7054219511929009,1.0,7/27,15.57%,TFRC;SHLD1;FUS;ERCC2;FANCB;TIMELESS;MAD2L2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2773698128929175,-1.0445130744966933,0.34823529411764703,0.7055903786387199,1.0,16/69,16.32%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;PIK3CA;EDN1;PIK3CD;EXOC1;PIK3C3;HTR2A;IRS1;CSF1R;PI4KB
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3801329956573676,-1.0443821748582909,0.39462809917355374,0.7053742764519285,1.0,7/19,12.97%,PLCE1;NFATC1;PPP3CA;NFAT5;EDN1;NFATC2;EDN3
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.35889729492366523,-1.0442139327177138,0.37553648068669526,0.7052448901045311,1.0,10/21,19.52%,PDE4D;PDE9A;XDH;PDE2A;HPRT1;NT5C1A;NT5E;NUDT16;HINT1;MLYCD
prerank,phagosome acidification (GO:0090383),0.36719638553579914,1.044112981158604,0.41088180112570355,0.9115926771268349,1.0,8/26,14.91%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2774296733930085,-1.0438847954230916,0.34521158129175944,0.7055284442228059,1.0,30/68,29.91%,PAPOLA;GTF2H5;WDR33;CPSF4;GTF2H1;NCBP2;ERCC2;CLP1;POLR1F;SNRPE;POLR1G;CAVIN1;NCBP1;POLR1A;UBTF;CSTF1;SMN1;MED18;POLR1H;POLR2F;CCNH;SSU72;POLR1E;POLR2H;SCAF8;PCF11;POLR1C;POLR2E;CSTF3;SETX
prerank,synaptic vesicle cycle (GO:0099504),0.34082405137068367,1.04383066366175,0.3874538745387454,0.9111716551444813,1.0,10/30,23.17%,WNT7A;SNAPIN;RIMS1;SNAP25;SYT10;CPLX1;CPLX2;SYNDIG1;SLC32A1;SYT7
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.35231839147666355,-1.0435612522089908,0.39878542510121456,0.7057564769956219,1.0,8/23,18.74%,GNB1;KCNQ1;GNG2;MAPK1;TGM2;PRKACA;ATF4;MAPK3
prerank,epithelial cell differentiation (GO:0030855),0.2851522774330169,1.0433633031654224,0.39655172413793105,0.9113301810551109,1.0,12/88,11.22%,MAF;DAB2;OVOL2;HNRNPH3;PGK1;CITED1;FGFR2;KDM6B;E2F8;FZD7;E2F4;PIH1D1
prerank,response to light stimulus (GO:0009416),0.3057680457172071,1.0431655543938512,0.3631484794275492,0.9106088685128598,1.0,9/55,10.80%,DDB2;CCAR2;UBE4B;SPRTN;MSH6;REV1;USF1;CLOCK;MAPK10
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2841029621744618,1.0431602115690795,0.37719298245614036,0.9092787056945772,1.0,12/86,9.64%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;RBPJ;BMP8A;CITED1;INHA;GDF9;TGFBR1
prerank,regulation of membrane depolarization (GO:0003254),-0.371821972650886,-1.043073753720956,0.4147368421052632,0.7064418499128203,1.0,3/18,6.13%,NEDD4L;FHL1;CAMK2D
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4428819328661743,-1.0430412027461538,0.41947565543071164,0.7059386732019979,1.0,4/11,15.71%,WDR1;TRPV4;KATNB1;SEMA5A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3495457533079034,-1.0430041663297558,0.39271255060728744,0.7054456491861368,1.0,10/23,25.19%,UBC;XPC;RPS27A;UBB;RAD23B;GPS1;XPA;COPS6;COPS4;CUL4A
prerank,AMP metabolic process (GO:0046033),-0.4121997568356411,-1.042940559871752,0.42073170731707316,0.705040403900925,1.0,7/13,26.28%,XDH;NT5C1A;NT5E;ADSS1;AK4;AMPD2;ADSS2
prerank,GTP metabolic process (GO:0046039),0.41885988384757644,1.0429158783109338,0.39883268482490275,0.9087628543957467,1.0,5/15,18.12%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,synaptic vesicle recycling (GO:0036465),0.3562863201078659,1.0424515816942317,0.4197292069632495,0.9089034212639769,1.0,7/31,11.20%,CEL;NLGN2;WNT7A;SYT1;NLGN3;SYNJ2;CANX
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.36275593551835594,1.0419779629976869,0.4058252427184466,0.9090469984470297,1.0,11/25,24.85%,CCAR2;CCNT2;EAF2;LDB1;ALYREF;DDX39B;THOC1;SUPT4H1;HTATSF1;WDR43;SETD5
prerank,adipose tissue development (GO:0060612),-0.4388531242213909,-1.0418559005385672,0.43339960238568587,0.7072437926768051,1.0,6/11,28.76%,LRP5;SH3PXD2B;PGRMC2;SOX8;RORC;NAMPT
prerank,clathrin-dependent endocytosis (GO:0072583),-0.34739255336502906,-1.041800137730453,0.4109014675052411,0.7068274013406147,1.0,9/26,13.77%,ITSN2;AP2B1;FCHO2;SGIP1;CLTB;LMBRD1;GPR107;FNBP1L;AP2A1
prerank,post-translational protein modification (GO:0043687),-0.22115645711304677,-1.0410357379428947,0.33650793650793653,0.7082438852508021,1.0,89/332,21.82%,FBXL7;ZBTB16;LTBP1;PTP4A2;DCUN1D3;GAS6;SOCS2;BMP4;FN1;APP;BTBD1;DCAF6;LMO7;FBN1;MSLN;PDIA6;COP1;CST3;ADAM10;KLHL2;FBXW8;DCAF10;PSMB7;PSMA6;CCN1;FEM1B;FBXO31;LAMB2;STT3B;KTN1;FBXO30;MFGE8;MGAT4A;VHL;FBXO4;CAND1;SOCS5;VCAN;PSMB6;FBXO32;APOE;PSMB5;UBE2F;RAB3A;PNPLA2;DCAF13;FBXW2;FBXO44;DCAF5;FBXW7;EVA1A;RAB11B;CDH2;FBXL18;GOLM1;RAB1B;KLHL3;PSMC4;TNC;PSMB8;ICMT;KBTBD7;RHBDD1;ASB13;ATG5;GPS1;PSMD11;CHRDL1;CISH;KLHL22;SOCS3;KCTD6;PSMB4;CCNF;FBXL4;PSMD14;RAB11A;IGFBP4;MATN3;PSMD10;FBXW5;C3;CKAP4;KLHL11;PSME1;COPS6;CHM;ASB1;CCDC22
prerank,cellular response to ATP (GO:0071318),0.4160589227049093,1.0409878769658722,0.40119760479041916,0.9107878354317422,1.0,4/14,23.92%,TRPV1;TAF1;P2RX4;P2RY12
prerank,establishment of spindle orientation (GO:0051294),0.3522153705147958,1.040939914595648,0.40337711069418386,0.9095820902434318,1.0,7/28,9.58%,PLK1;CLASP1;LLGL2;MAD2L1;HTT;LLGL1;NDC80
prerank,glucose metabolic process (GO:0006006),0.3049250323662753,1.040403287278932,0.39779005524861877,0.9099297018594236,1.0,21/58,21.84%,SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;BRAT1;HECTD4;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;OMA1;SLC25A13
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.32309559229253654,1.0399289001534695,0.3888888888888889,0.9100550549501735,1.0,10/41,10.67%,ACTN2;ANK2;KCNJ5;KCNJ10;KCNH2;GABBR1;KCNN4;PDZK1;KCNJ16;GABBR2
prerank,positive regulation of cation channel activity (GO:2001259),0.3304101101412243,1.0398321740067045,0.37657657657657656,0.9090131358419359,1.0,7/40,8.85%,ACTN2;ANK2;LRRC38;ANTKMT;GSTM2;NLGN3;HTT
prerank,positive regulation of nervous system process (GO:0031646),-0.3734974047248258,-1.039712714316752,0.41,0.7111296232580512,1.0,3/18,3.66%,PARD3;UNC13B;TNFRSF1B
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4495499089773736,-1.0394872719358068,0.441351888667992,0.7111152728793069,1.0,4/10,20.13%,ESR1;PSMC4;ATF7IP;HMGB1
prerank,protein localization to plasma membrane (GO:0072659),0.27433362048373944,1.0391654671443171,0.37990580847723704,0.9097107494897978,1.0,16/129,6.24%,AFDN;ROCK2;KCNIP3;ANK1;ACTN2;ATP1B3;FYB1;TSPAN5;ANK2;CACNB3;WNK3;PLEKHF1;DLG1;FYB2;FLOT2;RAB3C
prerank,positive regulation of cell communication (GO:0010647),0.35779669506866024,1.0390789993864311,0.39811320754716983,0.9086689759359429,1.0,5/28,9.11%,WLS;SYT1;GRIK2;RIMS1;DLG4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.2354892915135165,-1.0388005112591707,0.33509234828496043,0.7122723652123087,1.0,53/186,21.38%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;NFATC1;SFRP4;TLE4;GLI3;SOX17;IGFBP6;NKD2;RACK1;AXIN2;WNT5A;TLE3;PSMB7;ZNRF3;PSMA6;INVS;CSNK1A1;APC;MDK;PSMB6;AMER1;APOE;PSMB5;FZD4;TLE5;BMP2;DKK2;ANKRD6;TAX1BP3;PSMC4;PSMB8;AMER2;MAD2L2;PSMD11;LRP1;LATS1;PSMB4;PSMD14;GREM1;IGFBP4;PSMD10;RBMS3;PSME1;WIF1;CHD8;SOX13
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40505362726825234,-1.038609288451067,0.4233128834355828,0.7121901923997065,1.0,2/13,7.59%,CAV1;BCAP31
prerank,regulation of extracellular matrix organization (GO:1903053),0.40928125542534743,1.0383770041549945,0.40828402366863903,0.9096098332242509,1.0,1/15,0.06%,AEBP1
prerank,intracellular pH reduction (GO:0051452),0.3435256652584702,1.0382011626225847,0.41621621621621624,0.9087762243015587,1.0,9/33,14.91%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;CLCN3;ATP6V0D2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.31233399847863363,-1.0379493537068867,0.39732142857142855,0.7132776619395066,1.0,15/38,30.22%,HJURP;H3-3A;RBBP4;NASP;UBN1;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;SMARCA5;RSF1;ASF1B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43724395666842886,1.0379020361651576,0.4308617234468938,0.9083994141088949,1.0,3/12,7.81%,COLEC12;PQBP1;IFIT1
prerank,regulation of coagulation (GO:0050818),-0.42837145788440256,-1.0379013790750646,0.41916167664670656,0.7128063131223014,1.0,2/11,10.68%,CAV1;EPHB2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4408592354152973,-1.0377802299973322,0.39375,0.7125575458441403,1.0,4/10,22.03%,RHOA;RAP2A;CDC42;MSN
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4290419085800615,1.0374871285854463,0.40388349514563104,0.9070659024515063,1.0,1/12,1.59%,FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4290419085800615,1.0374871285854463,0.40388349514563104,0.9070659024515063,1.0,1/12,1.59%,FHL2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3578060923460072,1.0373918922181464,0.4157088122605364,0.9060515230230439,1.0,10/29,18.96%,LPGAT1;PPARA;SLC45A3;NR1H3;SORBS1;CREBL2;CREB1;AKT1;MID1IP1;MLXIPL
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2500907609030299,-1.0373846405298548,0.3549222797927461,0.7130099963722855,1.0,43/122,27.04%,NIBAN1;BCAR3;TGFB2;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;KDR;RPL5;EIF3E;EEF2;NLRC5;AR;IGF2;KLF4;FGF2;NMD3;AKT2;IRS1;FMR1;FXR1;BRPF3;NOD2;IL33;METTL3;DYRK2;PIWIL2;FAF1;EIF4A3;PRR16;PRMT1;EGF;RGCC;TLR4;PPP1R3E;CTC1;BCL3;HNRNPD;RPS4X;METTL14;SLC25A37
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.387646727458015,-1.0371417890157664,0.42231075697211157,0.7131069759947993,1.0,4/16,7.88%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.34485405760250376,-1.0369316833266464,0.3786848072562358,0.7130921369915386,1.0,8/25,10.33%,CAV1;TBX18;NOS1AP;CAMK2D;CALM3;CXADR;CTNNA3;FGF13
prerank,hexose transmembrane transport (GO:0008645),0.374096492365237,1.0367312434238007,0.41379310344827586,0.9067520718283522,1.0,3/21,2.73%,SLC2A12;SLC5A3;SLC5A10
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.36722834770558144,-1.0366683581912957,0.4192872117400419,0.7131459020663141,1.0,8/19,12.12%,SEMA6A;DAB2IP;DCN;JCAD;XDH;SPRY2;CCBE1;TSPAN12
prerank,protein destabilization (GO:0031648),0.33598934184928964,1.0365944081302365,0.38475177304964536,0.9058672408275331,1.0,10/32,19.21%,DERL1;CAPN3;PLK1;HTT;CTSH;CDC73;SIRT1;MDM2;RNF139;PRNP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3363602253518258,1.0363484096722264,0.38301886792452833,0.9053495618007582,1.0,10/38,16.57%,RORA;TNIP3;NLRC3;NLRX1;CACTIN;STAT1;OTUD7A;MAPKBP1;SIRT1;PPM1B
prerank,proteolysis (GO:0006508),0.24685667537999967,1.0359826355865178,0.3776435045317221,0.9051774130223204,1.0,44/252,16.60%,AEBP1;METAP2;ADAMTS13;PCSK4;CTSA;SUFU;CPQ;CPNE1;CPN1;PGPEP1;FURIN;PITRM1;CAPN3;AFG3L2;PLAT;DPP8;CASP3;SPRTN;HTRA2;NAPSA;PLG;ADGRV1;CTRL;LONP2;ATG4D;CPA2;FBXO6;CTSH;ENDOU;NEDD8;APH1A;CNDP2;ADAMTS9;DESI2;DESI1;ATG4C;TRHDE;VASH1;GGT5;PAPPA2;HGF;ADAMTS7;MDM2;BACE2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3255776562546701,-1.0359526993536563,0.40350877192982454,0.7144146090288156,1.0,5/31,10.40%,SHANK3;PDLIM5;CDK5;ABI3;CFL1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.42216917658583486,1.035767163090063,0.4339250493096647,0.9045532474012847,1.0,4/13,9.84%,IGF1;GCK;PHKG2;SORBS1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.40905136890593563,-1.0354857131586621,0.4134419551934827,0.7150088344352923,1.0,5/13,17.91%,NOS3;GLS;DDAH1;GLUD1;PRODH
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3110637955781662,-1.035414083206521,0.40552016985138006,0.7146340990110321,1.0,14/37,23.83%,RPL5;EIF3H;RPS7;UBXN1;USP7;RPL23;BAG5;CSNK2A1;N4BP1;RYBP;UCHL5;FHIT;TAF9;GIPC1
prerank,RNA export from nucleus (GO:0006405),0.27577577527571084,1.0349389674320002,0.39603960396039606,0.9058016016007137,1.0,26/100,20.79%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;NUP62CL;SMG5;NXT1;DDX19B;SLBP;YTHDC1;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;RAE1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3780793602094351,1.034877330124272,0.3937007874015748,0.9046949597798015,1.0,4/20,4.52%,ACTN2;OSR1;STK39;ADRA2A
prerank,anterior/posterior pattern specification (GO:0009952),-0.2929461591343508,-1.0347099435689036,0.41134751773049644,0.7158393469220614,1.0,12/53,12.31%,BMPR2;PCSK5;LRP5;TBX1;BHLHE40;HES1;HEYL;HEY2;HOXA6;ATP6AP2;HHEX;BMP2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4451679164900849,1.0346395450134083,0.4087136929460581,0.904118435986133,1.0,2/10,3.24%,CDH3;FURIN
prerank,cellular macromolecule catabolic process (GO:0044265),0.31710301774044924,1.0345377617335614,0.3896797153024911,0.9031676903906393,1.0,11/49,14.58%,MAGEA2;RNASEH2A;SIAH2;SUPV3L1;HTRA2;FBXO6;CHEK2;FBXO17;SND1;ADAMTS9;RNF5
prerank,JNK cascade (GO:0007254),-0.30445372603569304,-1.0343921900253237,0.4110854503464203,0.716062959943014,1.0,13/40,22.04%,MAP3K5;UBC;NOD1;RPS27A;UBB;TNFRSF19;TAB1;IRAK2;GPS1;NOD2;MAP2K7;RIPK2;MAP4K3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3028904625020443,-1.0343778798024754,0.38666666666666666,0.7155283576133968,1.0,20/45,32.55%,STAT3;APP;GBP5;AIM2;WNT5A;TRIM16;MALT1;HSPB1;USP50;NOD2;MYD88;RIPK2;CASP1;TLR4;CASP8;TLR6;CD36;TMEM106A;LGALS9;TYROBP
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3379781709295346,-1.0343658203612207,0.39915966386554624,0.7149783334579696,1.0,7/26,13.24%,INSR;PTGS2;NOS1AP;KLF4;EDN1;DDAH1;KLF2
prerank,embryonic heart tube development (GO:0035050),-0.4068707843179503,-1.0343351076294314,0.4137254901960784,0.7144922490846454,1.0,5/14,13.29%,ACVR1;SOX17;HES1;SOX18;TBX2
prerank,spliceosomal complex assembly (GO:0000245),0.3200511556950234,1.0337604708370927,0.3805970149253731,0.9042784432068208,1.0,18/46,23.01%,CELF2;SRSF5;SRSF10;YTHDC1;PRPF19;USP39;RBM5;PRPF6;NOL3;DDX39B;SRSF6;PUF60;SF3B1;CELF6;GCFC2;CELF1;LUC7L;SRPK1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3803316062289225,1.0337503457710397,0.43566176470588236,0.9030204130069918,1.0,3/20,5.88%,PPIL6;PPIF;NKTR
prerank,calcium ion import (GO:0070509),-0.3308182522462685,-1.0332100643864146,0.4079822616407982,0.7168369500227417,1.0,10/28,14.96%,CACNB2;MICU3;CACNA1G;TRPC4;MCUB;CACNA1B;TRPV4;SMDT1;MICU2;CACNA1I
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3431034577078521,1.0331560594228624,0.4091778202676864,0.9035954465666055,1.0,10/30,18.87%,DAB2;DDX5;PRMT2;RNF14;RNF6;SAFB2;NCOR2;SIRT1;KDM1A;NCOR1
prerank,negative regulation of GTPase activity (GO:0034260),-0.3441866486528898,-1.0331149209713653,0.42116630669546434,0.716516667768798,1.0,4/22,3.80%,LRCH1;DAB2IP;SH3BP4;F11R
prerank,positive regulation of gene expression (GO:0010628),-0.2139770106078254,-1.032986272491536,0.3118279569892473,0.7162526996544465,1.0,75/442,12.31%,LEF1;ACTB;LIMS1;MEF2C;NTRK3;CLDN5;PID1;NOS3;NIBAN1;GSN;ETS1;RAMP2;THBS1;NOTCH1;ACTG1;GAS6;F3;PIK3R1;CD34;EGFR;NGF;CTCF;BMP4;RBM3;STAT3;AGO1;PLSCR1;RPL5;FN1;APP;SFRP4;NOS1AP;EIF3E;PLCG2;PLA2R1;TFRC;SMAD1;ERN1;S100A13;EEF2;PDE2A;WNT5A;AR;OCLN;MAPK1;RPS7;MYBBP1A;ACTA2;RPS3;SPRY2;SEC16B;HEY2;GATA2;SOD1;IL15;TMEM119;ADAM19;TENT4B;AGO2;KLF4;FGF2;EIF2AK3;PIK3CD;FGF7;RPL23;EPHB2;HGS;KRAS;DYRK1A;CD74;TWIST1;RAB27A;SERPINB9;DNMT3B;BMP2
prerank,regulation of protein kinase activity (GO:0045859),-0.253391749115668,-1.0327348607935372,0.3643031784841076,0.716364227938291,1.0,32/106,24.12%,PLCE1;RAPGEF2;LRP6;GAS6;RAP1A;RASSF2;IQGAP1;CACUL1;PAK2;UBASH3B;XRCC5;PPIA;CCN1;CEACAM1;SOD1;HSPB1;PTK2B;DBNDD2;GSKIP;PTPRC;TAB1;RAP2B;AKT1S1;AGAP2;TRIB2;TRAF4;MMD2;MMD;PRKRIP1;CAMKK2;TRIB3;TARBP2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3200829176748764,1.032705787506767,0.39750445632798576,0.9036676068469901,1.0,11/46,13.41%,LGR4;NPR3;NOVA1;ARRDC3;RBPJ;MAP2K6;ALDH1A1;NR1H3;DOCK7;LAMA4;NRDC
prerank,peptidyl-threonine modification (GO:0018210),0.2951273306798095,1.0326373349183195,0.3958333333333333,0.902593600563735,1.0,22/66,18.70%,ROCK2;OXSR1;WNK3;GALNT11;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;GALNT3;TAF1;GALNT2;MAP3K12;PRKDC;PRKCA;GALNT1;DYRK4;CDK5R1;AKT1;NLK;HIPK2
prerank,translational elongation (GO:0006414),-0.2534643611212648,-1.0316181480875466,0.3844221105527638,0.7187049565727976,1.0,28/101,19.87%,EEF2K;EEF1A1;DAP3;MRPS10;MRPL20;RACK1;EEF2;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;EEF1G;MRPS12;MRPL43;MRPL1;MRPS22;MRPL55;MRPL45;MRPL44;MRPL33;CHCHD1;MRPL36;MRPL35
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.42845062535069567,-1.0313342824606675,0.4330543933054393,0.7188720263521271,1.0,2/11,2.26%,FOXO1;NOTCH1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3254838008505007,1.031168232972566,0.4065934065934066,0.9057788419296474,1.0,8/41,11.99%,SLC8A3;TRPV1;ITPR1;GRIN2D;ITPR2;RYR2;TRPM2;CHERP
prerank,establishment of protein localization to organelle (GO:0072594),0.28636201295752134,1.0311017593501184,0.4064625850340136,0.9047016038123556,1.0,17/72,18.18%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;IL10RA;LAMP2;NXT1;RYR2;IPO8;HK1;TNPO2;IPO4;NUP88;AKT1
prerank,MAPK cascade (GO:0000165),-0.22221820706726253,-1.031086010570948,0.3573667711598746,0.71895388154809,1.0,82/295,22.73%,SPTBN1;KITLG;TEK;MEF2C;SHANK3;RAPGEF2;DAB2IP;RASAL2;MAP3K5;RASGRP3;YWHAE;PIK3R1;BCL2L1;EGFR;RASGRF2;KDR;IL17RD;UBC;YWHAB;TNIK;MAP3K20;RPS27A;UBB;MET;PSMB7;SPTAN1;PSMA6;MAPK1;SHOC2;GRIN2B;PIK3CA;MAPKAPK2;PDE6D;FGF2;PSMB6;FGF13;FGF7;MAP4K4;PSMB5;JAK1;KRAS;NRAS;PRKG2;RET;RANBP9;PEBP1;PPP1CC;ABHD17C;PAQR3;RASA3;MT3;PSMC4;PSMB8;ICMT;IRS1;KBTBD7;PSMD11;MRAS;TAOK3;MAP3K8;FGFR3;PSMB4;MAPK12;DUSP6;GRIN1;PSMD14;MAPK3;MARK3;GOLGA7;JAK3;PSMD10;ABHD17B;PSME1;MAP2K7;RCE1;TAOK1;FYN;NRG2;CSF2RB;RASA1;PSMB3;CAMKK2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.42989085382842857,1.0310197230000997,0.4268041237113402,0.9036754933629527,1.0,6/12,23.66%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,activation of protein kinase A activity (GO:0034199),0.3944917855226508,1.0307176735549146,0.39960629921259844,0.9033104376700818,1.0,3/16,6.40%,ADCY5;ADCY1;ADCY8
prerank,receptor clustering (GO:0043113),0.3490875899007465,1.0302250218986062,0.4350282485875706,0.903597111649612,1.0,8/27,17.42%,MAGI2;DLG1;LRP4;DLG4;ITGB7;LRRC7;PICK1;DNAJA3
prerank,regulation of programmed cell death (GO:0043067),-0.23700660813852986,-1.0292746280655987,0.3888888888888889,0.7231542367613362,1.0,62/161,31.04%,HIP1;MECOM;ACTN4;STEAP3;ACER2;APAF1;ACTN1;FAS;CRADD;PERP;TPT1;TGM2;RPS3;CDK5;BCAR1;MALT1;IFT57;PHLPP1;CTSB;RARG;MADD;NME2;BIRC3;ALK;RTN4;RBM25;OSGIN1;TMEM219;STK26;PTPN6;TIGAR;AKT1S1;JAK3;ACER3;RIPK1;LCMT1;CHM;SLK;NUP62;FANK1;CASP1;TRIAP1;DAPK1;BCL3;LRP8;WFS1;ZBTB7A;DAPK2;DDX42;BIRC5;AGT;RTKN;VCP;MARK4;FLT3;FBXO10;PMAIP1;IRF3;ANP32E;TNFRSF25;USP36;PIDD1
prerank,acylglycerol catabolic process (GO:0046464),-0.3287668244123506,-1.0290009050202915,0.42410714285714285,0.7232981596270173,1.0,4/30,11.88%,ABHD2;MGLL;ABHD6;PNPLA2
prerank,fatty acid oxidation (GO:0019395),0.2993311483289921,1.0289685897409544,0.3663716814159292,0.9061577963310352,1.0,11/57,11.93%,ADH7;ADH4;ACAT2;ACAT1;ACAD10;ECHS1;PPARGC1A;ABCD1;ACAD11;ECHDC2;CROT
prerank,lipoprotein catabolic process (GO:0042159),-0.4367441923538032,-1.0289384989813346,0.4348697394789579,0.7228627767118649,1.0,4/11,20.26%,CTSD;APOE;ABHD17C;ABHD17B
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.282650474045528,-1.0288830354182545,0.3862559241706161,0.7224290978884453,1.0,24/57,24.03%,RPS15;RPL38;RPL5;RPS24;RPL7;RPS17;RPS16;RPL35A;RPS7;RPS28;SURF6;RPS25;RPL14;GTF3A;URB2;LTV1;MRTO4;MRPL36;EBNA1BP2;SDAD1;RRS1;RPS19;NOP16;RIOK1
prerank,female gonad development (GO:0008585),0.3752910579488662,1.0284932988315332,0.4086629001883239,0.9063549009130395,1.0,5/19,10.52%,KIT;NR2F2;INHA;EIF2B4;COL9A3
prerank,negative regulation of blood coagulation (GO:0030195),0.33082155925089013,1.0277596205020008,0.39433962264150946,0.9072276481345835,1.0,7/38,10.54%,PDGFRA;TFPI;F10;PLAT;PLG;THBD;HRG
prerank,negative regulation of neuron death (GO:1901215),-0.26047427296842995,-1.0272593560573138,0.38461538461538464,0.7260854687796985,1.0,23/93,16.00%,MEF2C;CD200;NDNF;CD34;NGF;SIX1;TNFRSF1B;CHMP4B;CHMP4A;PRKCG;FOXQ1;MDK;SOD1;CDK5;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;NENF;SIX4;ATF4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3805093572942864,-1.0269842774003857,0.4248496993987976,0.726207470712338,1.0,4/17,8.07%,PARD3;SPRED2;CALM3;SPRY2
prerank,DNA geometric change (GO:0032392),0.36249100066297807,1.0268070730638985,0.4003831417624521,0.9089195292300201,1.0,5/24,12.35%,RECQL4;HNRNPA2B1;SUPV3L1;MRE11;RTEL1
prerank,regulation of chromatin binding (GO:0035561),-0.43773519754802026,-1.026137889084852,0.42052313883299797,0.7278035233528399,1.0,2/10,9.29%,WAPL;HMBOX1
prerank,negative regulation of phosphorylation (GO:0042326),-0.2649292428491853,-1.0257752531372353,0.39429928741092635,0.728224403984161,1.0,24/85,16.35%,NTRK3;DAB2IP;PID1;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;BMP4;CBFA2T3;XDH;PPIA;LYN;OCLN;CDKN1C;EPHB2;TERF2IP;SH3GL2;DYNLL1;PAQR3;GIT1;PLPP3;FKBP8;TRAF3IP1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.43604430650549686,-1.0253830801274002,0.4158004158004158,0.7287590730489675,1.0,8/10,47.43%,MALT1;ZC3H12A;SMAD7;NFKBID;IL4;RC3H2;FOXP3;TBX21
prerank,engulfment of apoptotic cell (GO:0043652),-0.3953506907355048,-1.0249747402784233,0.43254817987152033,0.7292337011743589,1.0,2/15,2.21%,RHOBTB1;THBS1
prerank,response to nitric oxide (GO:0071731),-0.3974716372478769,-1.0247740863738355,0.44025157232704404,0.7291712763805185,1.0,2/13,2.31%,FOXO1;GUCY1B1
prerank,negative regulation of lyase activity (GO:0051350),0.3920848679983739,1.0247716325908387,0.4143126177024482,0.9139739005944879,1.0,4/16,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35121889170839893,1.0246133974910567,0.41527001862197394,0.913176529813249,1.0,5/27,7.57%,BRD8;ATAT1;SGF29;RUVBL2;KAT5
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.39167979073169984,-1.0244520640179293,0.4198782961460446,0.7294324774366608,1.0,4/14,15.57%,TFRC;SHLD1;NECTIN2;MAD2L2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.22045471417166457,1.0243496219597379,0.385286783042394,0.9126868317518001,1.0,123/807,12.78%,PRDM6;AEBP1;BMP7;WWOX;WNT4;BMP6;DAB2;SNX6;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;DNMT3L;SCML4;CXXC5;MSX2;FHL2;SUFU;CTR9;THRB;ZBTB38;CDKN2A;SCRT1;ARID4A;NR6A1;PCGF2;PPARA;ZNF431;GLIS3;CAPN3;TFDP2;CCAR2;ENO1;DKK3;LOXL3;ZHX1;IFI27;DLG1;PLK1;PEG3;RBPJ;PRMT2;PAX6;IKZF1;MZF1;DNMT3A;E2F1;HNRNPU;HOXA7;RCOR3;ZKSCAN3;MOSPD1;NR2F2;CITED1;CEBPA;ATN1;NRG1;DPF1;FGFR2;PBXIP1;JARID2;LBH;BCL7A;PRDX5;BEND5;KAT5;ZC3H8;CHD3;MIER3;IMPACT;MED1;E2F8;KDM2A;HINFP;MAX;MAP3K10;NR1H3;PRDM2;ZIC2;CLOCK;DMAP1;NKAP;COMMD7;CBX6;MPHOSPH8;NSD1;ZFP90;FOXP4;STAT1;RXRA;MED25;C1QBP;LCOR;BRD7;LDB2;LDB1;PLCB1;MBD1;MXI1;RITA1;FST;TAF1;GATAD2A;CDC73;KDM5C;PCGF6;QARS1;SOX9;RCOR2;CIPC;KDM4A;PML;RBAK;RLIM;RING1;BEND3;NOC2L;CBFA2T2;BHLHE41
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.28280481766885274,1.0242552710246449,0.4007029876977153,0.9117339422457754,1.0,22/74,18.18%,EYA1;IGF1;HSPA1A;EYA4;EYA2;SIAH2;PELI3;HTT;PHIP;CFLAR;TGFBR1;BCL2;FAIM;TERT;SCG2;HSPA1B;TCF7L2;FAIM2;RELA;IL1A;NOL3;AKT1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.2823012391804399,-1.024018265347333,0.4033018867924528,0.7299674928578722,1.0,19/57,23.56%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;VEGFA;CD40;CSF1R;SOCS3;FGFR3;CRLF1;PPP2CA;CTF1;HCLS1;SOCS1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2771816290272646,1.023946712662392,0.43847487001733104,0.9113993689153078,1.0,15/95,10.04%,TGFBR3;DAB2;SNX6;HSPA1A;SMAD3;PPARA;STRAP;DKK3;NREP;PDPK1;CITED1;MTMR4;SPRED3;TGFBR1;VEPH1
prerank,coenzyme A metabolic process (GO:0015936),0.40208559324272186,1.023676748342349,0.41749502982107356,0.9109636106344581,1.0,4/14,11.93%,PANK1;ACAT1;PANK2;CROT
prerank,regulation of cellular pH (GO:0030641),-0.32698566833244075,-1.0236644603995395,0.4057649667405765,0.7303396529221634,1.0,6/29,14.35%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2
prerank,muscle cell development (GO:0055001),0.34512718494553807,1.023626164851999,0.41353383458646614,0.9098420985258123,1.0,5/30,6.95%,IGF1;NEBL;ANK2;SGCZ;MYOF
prerank,protein homooligomerization (GO:0051260),0.2677208633420124,1.0234779986393017,0.4037854889589905,0.9090741929588105,1.0,27/114,20.04%,ALDH1A2;UPB1;APPL2;TRPV1;ATL1;VSTM5;GSDMD;CLYBL;ADCY8;GOLGA2;ELAVL1;RNF135;KCNC2;SSBP1;TRPM2;BEND3;MICU1;RNF213;TRMT61B;ACACA;CTH;ALAD;ACOT13;NLRC4;USP16;ALDH9A1;PYCARD
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.35211904065015665,1.0233898116255016,0.42570281124497994,0.9080771965895873,1.0,2/29,0.69%,NOTCH2;IGF1
prerank,eye photoreceptor cell development (GO:0042462),0.39823524099500535,1.0233240493410798,0.40824742268041236,0.9070049142642824,1.0,3/15,10.17%,USH1C;CEP290;TOPORS
prerank,vesicle coating (GO:0006901),0.29863062040007377,1.023286254350089,0.40398550724637683,0.9033926767127588,1.0,20/61,20.36%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;F8;TFG;SEC22B;PEF1;PDCD6
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.29863062040007377,1.023286254350089,0.40398550724637683,0.9033926767127588,1.0,20/61,20.36%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;F8;TFG;SEC22B;PEF1;PDCD6
prerank,COPII vesicle coating (GO:0048208),0.29863062040007377,1.023286254350089,0.40398550724637683,0.9033926767127588,1.0,20/61,20.36%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;F8;TFG;SEC22B;PEF1;PDCD6
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.267375306632113,-1.0231394638610578,0.40229885057471265,0.7311219147558846,1.0,31/76,28.89%,CAV1;DCUN1D3;CRY1;GNL3;UBB;SAE1;XIAP;FBXO4;FAM107A;MALT1;AMER1;DCUN1D5;UBE2L3;FBXW7;BIRC3;TBC1D7;PHF23;ZC3H12A;PSMD10;CENPX;RIPK2;NSMCE3;BCL10;PIAS3;CUL3;MUL1;WFS1;RCHY1;UBQLN1;PTTG1IP;SMAD7
prerank,peripheral nervous system development (GO:0007422),-0.33858991900869434,-1.0226755618147763,0.4222689075630252,0.7317671475145545,1.0,6/23,19.26%,ADGRG6;NGF;GPC1;PMP22;NFASC;SOX8
prerank,early endosome to Golgi transport (GO:0034498),-0.4156880026845514,-1.022562231301931,0.42323651452282157,0.7314945020249881,1.0,4/11,15.05%,RAB6A;SNX1;SURF4;SNX2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4227237943564437,-1.022494210231311,0.4329268292682927,0.7310946869830706,1.0,7/11,22.61%,VCL;CCN3;ITGB5;SERPINB8;DSP;JUP;THBS4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3518964465036715,-1.0221605724270888,0.4451219512195122,0.7313947603969966,1.0,4/20,5.92%,CRY1;STMN1;YWHAB;MET
prerank,histone lysine methylation (GO:0034968),0.33733957905286666,1.0219600754890548,0.4294117647058823,0.906212933417391,1.0,7/33,14.33%,DOT1L;KMT2A;N6AMT1;DYDC2;SMYD3;SMYD2;MEN1
prerank,ubiquinone metabolic process (GO:0006743),0.3955521402557926,1.0219409309810255,0.4489795918367347,0.905034818402831,1.0,6/15,20.34%,COQ10A;COQ8B;AIFM2;COQ3;COQ7;FDXR
prerank,early endosome to late endosome transport (GO:0045022),0.37457401543293734,1.021187222332046,0.41509433962264153,0.9060894736737539,1.0,6/20,16.82%,WDR91;SNX16;KIF16B;SNF8;HOOK1;PTPN23
prerank,endodermal cell fate commitment (GO:0001711),0.4355851256564901,1.0209715522821767,0.4461538461538462,0.9054991606890684,1.0,3/10,11.57%,CTR9;LEO1;CDC73
prerank,glycine transport (GO:0015816),0.44076646427611244,1.0207219593594161,0.44294003868471954,0.9050648202107542,1.0,1/10,2.24%,SLC6A9
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3018648569360086,1.0204017802651866,0.42579505300353354,0.9048248820422715,1.0,9/48,8.86%,ADCY5;PANK1;ADCY1;SLC26A1;ACAT1;ADCY8;PANK2;AK5;AMPD3
prerank,ether lipid biosynthetic process (GO:0008611),-0.4325332947534933,-1.019922457669505,0.44468085106382976,0.7366410318394957,1.0,3/10,8.59%,PLA2G4A;DHRS7B;PEX7
prerank,DNA strand elongation (GO:0022616),0.38577489798978953,1.019820415850264,0.4297029702970297,0.9053025979244328,1.0,6/18,17.08%,GINS1;POLD2;MRE11;TERT;MCM7;MCMDC2
prerank,histone modification (GO:0016570),0.2701477666499719,1.0197555064744594,0.4016,0.9042679852624481,1.0,28/109,20.86%,EYA1;EYA4;EYA2;BRD8;SGF29;RUVBL2;PRMT2;RCOR3;KAT5;MIER3;TAF10;NSD1;RCOR2;KDM4A;MAP3K12;HDAC4;NTMT1;TBL1XR1;SIRT1;NSD3;KAT6B;BRMS1L;USP21;USP16;SIN3A;KAT8;BAZ2A;PHC1
prerank,DNA replication (GO:0006260),-0.2565509516590181,-1.0195985224200763,0.4020356234096692,0.7369084112678925,1.0,49/105,33.06%,RPA1;KAT7;REV3L;TIPIN;RPAIN;WRNIP1;BLM;KIN;ORC1;TIMELESS;ING4;ORC2;RHNO1;NBN;RPA2;BARD1;CDC45;ORC5;RMI1;PCLAF;POLA1;DUT;SET;RFC4;CHEK1;TOP1;MCMBP;MCM3;POLA2;POLD4;WDHD1;POLG2;POLB;MCM5;MCM6;RFC2;POLE3;CDK2;RECQL5;FAM111A;HELB;RBMS1;ORC3;CDK1;PIF1;FEN1;CDC6;TICRR;GRWD1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2818327220436977,-1.0195435849186667,0.4185022026431718,0.7364638532220154,1.0,26/57,25.74%,TNFSF10;MAP3K5;NOD1;AIM2;PERP;BCAP31;GRIN2B;CTSD;MALT1;SOX7;TBC1D10A;ACVR1C;BAK1;USP50;GPER1;GRIN1;FOXL2;HMGB1;SYK;RIPK2;FYN;BCL10;CASP1;DAPK1;F2R;CASP8
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4314065948811924,1.0195135652455063,0.45109780439121755,0.903786140885778,1.0,2/11,7.07%,GCK;C1QTNF3
prerank,keratan sulfate metabolic process (GO:0042339),-0.31886545610857586,-1.0194896882386408,0.4418103448275862,0.7360408473238284,1.0,9/31,11.55%,ST3GAL4;ST3GAL6;B3GNT2;GNS;B4GALT4;ST3GAL1;LUM;HEXA;B4GALT5
prerank,regulation of chemokine production (GO:0032642),-0.3140060771773751,-1.0192291969365592,0.40301724137931033,0.7361413826565779,1.0,14/36,28.50%,FOXP1;APP;WNT5A;IL6R;CD74;CSF1R;SIGIRR;IL33;ACKR1;TLR4;HMOX1;AIF1;SNAI2;TREM2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2889167253934158,-1.0189849144655654,0.43243243243243246,0.7362239148263102,1.0,14/54,13.95%,CAV1;DCUN1D3;RPL5;CRY1;SPOPL;DNAJA1;PRKCG;RPS3;SPRY2;UBXN1;BAG5;ISG15;SQSTM1;COPS9
prerank,negative regulation of binding (GO:0051100),-0.26615940927134435,-1.0189709110386054,0.4107981220657277,0.7356822298643986,1.0,12/81,6.70%,LEF1;ACTB;CAV1;WAPL;DISC1;NFKBIA;JUN;RALB;CSNK1E;CARD16;RACK1;PRKCD
prerank,neural crest cell development (GO:0014032),-0.2954275871170897,-1.0184746385329975,0.42417582417582417,0.7363757225872235,1.0,20/44,28.58%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;SEMA5B;SEMA3E;SEMA3G;CDH2;SEMA6D;SEMA5A;SOX8;SEMA3F;SEMA4C;SOX11;TAPT1;SEMA4D;SEMA4F;SNAI2;SEMA6B
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.36468202231243974,1.018469389313297,0.43137254901960786,0.9057020071009616,1.0,2/22,6.16%,BMP7;FLOT2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.27268265392659047,1.0177926493634832,0.423841059602649,0.9064737905569755,1.0,25/96,20.79%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;SMG5;NXT1;DDX19B;SLBP;YTHDC1;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;RAE1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2587029356073586,1.0176709853680954,0.39781591263650545,0.9056044664859465,1.0,17/140,9.82%,ADCY5;CCR9;ACKR2;PDGFRA;TAC1;CACNB3;C5AR2;BDKRB1;JPH1;LPAR2;BDKRB2;ADCY8;DRD3;LPAR1;DLG4;PTGER1;C3AR1
prerank,renal system development (GO:0072001),-0.2864612839424212,-1.0175639758204735,0.42032332563510394,0.7382213727436705,1.0,10/52,7.77%,PCSK5;TGFB2;PKD1;BMP4;SIX1;TBX18;ITGA8;SOX17;AGTR1;STRA6
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.31986545942330247,-1.0162429567055136,0.44537815126050423,0.7410988654664526,1.0,11/30,23.83%,EIF3H;UBXN1;USP7;BAG5;N4BP1;RYBP;UCHL5;FHIT;TAF9;SVIP;GIPC1
prerank,negative regulation of RNA splicing (GO:0033119),0.3834328571582872,1.015993424032776,0.43190661478599224,0.9094994159774556,1.0,8/19,18.57%,PTBP2;SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;PTBP3;SRSF6
prerank,regulation of cellular component size (GO:0032535),-0.31988132138023345,-1.0154765809047095,0.4264069264069264,0.7425893346310799,1.0,13/30,31.32%,EPS8;RAB22A;PPP1CA;RPTOR;VAV2;RARG;PTEN;MSN;AP2M1;RAB3B;NEB;VAV3;LAMTOR5
prerank,epithelium development (GO:0060429),0.2683608263583153,1.0153610219902187,0.43448275862068964,0.9101783693523474,1.0,10/107,6.87%,ALDH1A2;WNT4;ERRFI1;OSR1;LOXL3;HNRNPH3;TRIM71;PGK1;NDRG4;FGFR2
prerank,mitotic spindle organization (GO:0007052),-0.23568828709733158,-1.0150119171762724,0.416,0.7432890665286507,1.0,54/153,26.78%,RHOA;EML1;STMN1;DYNC1I2;FLNA;SMC1A;TNKS;MAP4;PLK2;STAG1;NUP107;MAP9;DYNC1I1;RPS27;KIF23;PIBF1;RMDN1;MZT1;INCENP;DYNLL1;ZWILCH;CLIP1;PPP1CC;ZW10;DCTN6;STIL;PAFAH1B1;SEC13;PMF1;CENPL;TOGARAM1;CENPQ;STAG2;ARHGEF10;RAB11A;PRC1;DYNC1H1;NUP85;TAOK1;B9D2;AAAS;TPX2;GPSM2;KIFC1;NSL1;KIF4A;CENPN;CENPK;NDEL1;SPDL1;MIS12;CDCA8;SPC25;SGO1
prerank,negative regulation of mRNA processing (GO:0050686),0.40219747010011797,1.0143193787035045,0.4416826003824092,0.9121113622658108,1.0,6/15,18.57%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,regulation of protein sumoylation (GO:0033233),0.39683923991909203,1.0141207998960062,0.43711340206185567,0.9114370571024984,1.0,5/17,13.91%,MAGEA2;CAPN3;GNL3L;PIAS4;HDAC4
prerank,DNA duplex unwinding (GO:0032508),-0.28915857409247797,-1.013884458606483,0.41814159292035397,0.7457003304598785,1.0,12/50,12.98%,RPA1;UBC;XPC;RPS27A;UBB;ANXA1;CHD1L;GTF2H5;GTF2H1;BLM;RAD23B;ERCC2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.30414271815523597,-1.0138131850838616,0.43427230046948356,0.7452852356686229,1.0,9/42,13.52%,ACTB;ARID1B;SMARCC1;ARID1A;GATAD2B;RBBP4;PBRM1;NASP;ACTR6
prerank,cellular response to osmotic stress (GO:0071470),0.3678250635924021,1.01358870594861,0.4415841584158416,0.9117195372501664,1.0,4/21,4.19%,OXSR1;WNK3;CAPN3;STK39
prerank,apoptotic process (GO:0006915),-0.229124352354408,-1.0135702401854845,0.42450142450142453,0.7453698942136355,1.0,64/203,24.14%,HIP1;SEMA6A;MAGI3;ZBTB16;PLAGL1;PPARD;FAP;FOXO1;STK3;APAF1;BCL2L1;NFKBIA;PLSCR1;TGFBR2;APP;TBX1;FAS;CIT;PPIA;PRKCD;FEM1B;CASP7;TNFRSF21;DAP;IAPP;PIK3CA;RFK;EFNA5;CDK5;IER3;AHR;IFT57;PDCD4;PTK2B;TNFRSF19;ERCC2;ADAM15;BAK1;BBC3;DDIT4;RTN4;DIABLO;FXR1;ING4;ATCAY;GAPDH;LIG4;PAX3;RHOB;RIPK1;MYD88;CHEK1;PPP2CA;BIK;EGLN3;PAEP;CDK11B;JADE1;BOK;PLK3;CASP1;PRKCE;TRAIP;MRPS30
prerank,regulation of immunoglobulin production (GO:0002637),-0.3462517388979346,-1.0135620507164051,0.42915811088295686,0.7448160249373116,1.0,5/23,13.88%,VAMP3;EPHB2;PHB2;CD86;PTPRC
prerank,actin nucleation (GO:0045010),-0.34772969680019605,-1.0134503911985469,0.44841269841269843,0.7445264346345557,1.0,10/21,33.43%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;SPIRE2;SCIN;ARPC5
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3761812271865642,-1.013399669749231,0.42887931034482757,0.7440880118829254,1.0,5/16,17.38%,CAV1;TRIM14;TRIM25;NECTIN2;EXOC7
prerank,cochlea morphogenesis (GO:0090103),-0.4261877403691656,-1.0132864115653173,0.45267489711934156,0.7437817742968755,1.0,2/10,4.23%,TBX18;TBX1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3247332201133299,-1.0130901826556016,0.43655913978494626,0.7437211632326103,1.0,11/29,25.69%,LEF1;TLE4;AXIN2;TLE3;RUVBL1;SMARCA4;BCL9;BCL9L;TRRAP;ASH2L;TCF7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.30467159851618497,-1.0128171714518015,0.42403628117913833,0.7438869891911506,1.0,6/39,6.51%,UTRN;NEDD4L;FXYD5;YWHAE;FHL1;TRPC6
prerank,membrane lipid metabolic process (GO:0006643),-0.3434958217009313,-1.0127551585123848,0.44924406047516197,0.7434739223453486,1.0,4/22,3.98%,ST3GAL6;CYP1B1;AGK;B4GALT4
prerank,regulation of centrosome duplication (GO:0010824),-0.32394983506281466,-1.0126437268419801,0.4245689655172414,0.7431857428971165,1.0,11/29,25.18%,CHMP2B;PLK2;CHMP4B;CEP76;STIL;CEP295;CCNF;CHMP1B;FBXW5;CEP131;XRCC3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.36311212742330146,-1.0126188376068859,0.4480651731160896,0.742685879630014,1.0,8/18,20.08%,IL6ST;STAT3;IL6R;SRC;JAK1;CBL;SOCS3;SPI1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2887586801151686,-1.0122867747298325,0.4247787610619469,0.7430033982171452,1.0,12/50,12.18%,CAV1;CRY1;SPOPL;DNAJA1;PRKCG;RPS3;SPRY2;UBXN1;BAG5;FBXO5;ISG15;SQSTM1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.21026171876367586,1.0121934052946235,0.4104903078677309,0.9147813251508273,1.0,289/1668,16.56%,PRDM6;AEBP1;ZKSCAN2;MAF;RORA;FGF1;WWOX;HLF;EPAS1;BMP6;DAB2;CREB5;PPARGC1B;IGF1;DDX5;CBX7;IL18;TRAK1;SMAD3;KCNIP3;KMT5A;VGLL3;KDM7A;OSR1;NR2E1;MAGEA2;HMX2;NPAS3;SOX5;CXXC5;MSX2;BEX1;OVOL2;FHL2;SUFU;CTR9;THRB;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;FBXL19;MYBL2;ARID4A;NR6A1;CREBRF;ARNT2;DOT1L;ZNF23;PCGF2;PPARA;ZNF431;PBX2;KIT;SALL4;ZFP3;NFYB;GLIS3;UBP1;SLTM;ESRRA;POU1F1;KMT2A;HOXB9;BMPR1A;BRD8;SIM1;TFDP2;ENO1;WNT7A;SMARCD3;CCNT2;HOXB3;CHUK;CSRP3;ZHX1;TNRC6A;MEIS1;MAFG;IFI27;LPIN1;DLG1;TET1;TIAL1;PLK1;MLXIP;CAMK1;TCEA1;PEG3;RUVBL2;RBPJ;AUTS2;PAX6;IKZF1;PHF8;MZF1;IKZF2;DNMT3A;E2F1;ARID3A;ZBTB26;ZFHX2;TNIP3;HNRNPU;RNF14;ZNF462;WWTR1;HOXA7;RCOR3;ZKSCAN3;RFX8;DRGX;PBX4;DDX17;IKBKG;NFYC;MOSPD1;NR2F2;CITED1;CEBPA;ATN1;DPF1;FGFR2;PCGF5;BCL11B;ARRB1;ZSCAN22;HOXB6;KAT5;TEF;PHF2;SNF8;CHD3;KLF15;KDM5B;ZNF569;KDM6B;ZNF467;NFATC2IP;MIER3;NLRP3;HOXA3;IMPACT;TNIP2;MED1;E2F8;KDM2A;HES6;ZFX;MAFA;HINFP;MAX;PPARGC1A;USF1;NR1H3;HIF3A;PRDM2;ZBTB22;SSBP2;PHIP;HDX;RHOQ;ZIC2;CLOCK;DMAP1;EAF2;NKAP;CBX6;HOXB4;NSD1;ZFP90;FOXP4;PSIP1;STAT1;RXRA;BATF;MED25;SALL3;C1QBP;PPM1D;LCOR;ZNF260;BRD7;LDB2;LDB1;CSRNP3;PRKCB;MXI1;RNF10;BCLAF3;RITA1;E2F4;CSRNP1;MAPK14;FST;TAF1;ABCA2;STAT2;GATAD2A;CDC73;PCGF6;FZD5;WASL;ZBTB49;SRA1;SOX9;RCOR2;DMTF1;RBAK;BEND3;ZNF367;MED12L;PURB;GABPA;HBP1;FHOD1;MYBL1;NOC2L;BHLHE41;ARNT;PIAS4;AGO3;ZIC5;JAZF1;BRD2;DICER1;YEATS4;ABHD14B;SMYD2;FOXC1;ZSCAN20;EN2;PSMC5;HDAC4;ZNF483;CTBP2;GABPB1;SAFB2;PRKDC;CREB3L4;MEN1;ZKSCAN4;ZFP64;WBP2;BAZ1A;PLAGL2;PTOV1;MED15;ABL1;ZNF507;ATM;GADD45A;ZNF276;MLLT10;TBL1XR1;BCL11A;NCOR2;WAS;PER2;HEXIM2;TET2;TCF7L2;TCF4;PPP3R1;ZBTB43;MUC1;TADA1;HNF4G;MSX1;IL6;HGF;TFE3;ERF;SIRT1;HIC2;MDFI;CHD5;CAMTA2;AKAP8L;MDM2;TADA3;HDGFL2;USP9X;DPF3;SAFB;MCRS1;RARA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3657570314802376,-1.0118787867240042,0.4205020920502092,0.7435146586737598,1.0,6/17,17.41%,JAG1;STAT3;CD55;BACH2;CD46;GNL1
prerank,cellular response to amino acid starvation (GO:0034198),0.2862550709736358,1.0108820604652298,0.45017182130584193,0.9175631017078298,1.0,17/71,15.11%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;NPRL2;ATP6V0D2;LAMTOR3
prerank,protein-containing complex assembly (GO:0065003),0.23922304999441088,1.0107394065747517,0.43870014771048743,0.9167566408322176,1.0,67/259,19.56%,AFDN;F5;USH1C;CD247;WDCP;BET1;KMT2A;WDR19;CAPN3;PICALM;PLEKHA7;RSPH4A;DNAJB14;ADD2;AFG3L2;LEO1;GSDMD;ADCY8;IKBKG;LRRK2;KAT5;SHANK1;NAPA;RIMS1;WASF1;GOLGA2;PPARGC1A;TUBGCP4;LLGL1;DLG4;NSF;SEC23IP;CAND2;CDC73;WASL;EPRS1;SOX9;CNIH3;PML;TERT;TRAPPC1;USO1;WASF3;RAB1A;PPP6C;TRAPPC4;MEN1;TRAPPC3;WAS;TCF7L2;TAPBP;SKAP2;MDM2;TMED2;MCFD2;MITF;HFE;NOL3;F8;TFG;SEC22B;CX3CL1;SNX9;HGSNAT;PEF1;TFAP4;PYGO1
prerank,phospholipid catabolic process (GO:0009395),-0.3379762737069266,-1.0107239945229824,0.4326086956521739,0.746106402058522,1.0,4/24,14.26%,PLA2G4A;GPCPD1;PRDX6;SMPDL3A
prerank,protein deacetylation (GO:0006476),-0.2968477423079837,-1.0106593691821895,0.43908045977011495,0.7456964589739175,1.0,14/41,23.33%,MIER1;FLNA;HDAC7;HDAC9;PRDM5;SIRT5;MTA1;HDAC6;HDAC2;MTA3;MIER2;SIRT7;MSL3;SIRT6
prerank,atrial septum morphogenesis (GO:0060413),-0.4242370632214426,-1.0105262394876287,0.46285714285714286,0.7454546402056658,1.0,4/10,8.27%,BMPR2;ACVR1;TGFB2;HEY2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.44641085944753384,1.0103988514797622,0.4451345755693582,0.9165307459096457,1.0,5/10,24.85%,PRKAA2;KLF15;SIRT1;DIP2A;SETD5
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.33603874212461765,-1.0102690133060415,0.4444444444444444,0.7455547297823549,1.0,7/24,12.24%,BMPR2;ACVRL1;DACH1;XRCC5;RPS3;TERF2IP;BLM
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3809547598966956,1.0102466591597374,0.4576612903225806,0.9157887752931485,1.0,3/18,6.98%,CACNG7;NLGN2;NLGN3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.29081911263802773,-1.0101329215537176,0.43897216274089934,0.7453240883070326,1.0,19/48,26.69%,PDE4D;PLCG1;UBASH3B;CAMK2D;CALM3;TRPC1;JPH2;PTK2B;CEMIP;PRKACA;APLNR;GPER1;DMD;NPSR1;JPH3;F2R;CASQ1;CALM1;SELENON
prerank,regulation of axon regeneration (GO:0048679),-0.40898437991117653,-1.0098971410454214,0.46502057613168724,0.7453532021587966,1.0,7/12,30.12%,PTN;SCARF1;STK24;RTN4RL1;RTN4R;INPP5F;GRN
prerank,carbohydrate transport (GO:0008643),0.4269663440585951,1.0098692010276302,0.4538152610441767,0.9157216292332402,1.0,2/11,2.78%,SLC23A2;SLC23A1
prerank,positive regulation of integrin activation (GO:0033625),-0.42251705134831563,-1.009843005646554,0.45098039215686275,0.7449357089479791,1.0,4/11,15.01%,PIEZO1;RASIP1;SRC;FERMT2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4036252995159362,1.009795723539026,0.4596153846153846,0.9147116534366397,1.0,2/15,0.77%,IGF1;ROCK2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3634007213416942,-1.0097021286333683,0.43070362473347545,0.7447429374391953,1.0,9/18,28.19%,FLNA;DHX33;EIF2AK3;MAF1;ATF4;UBTF;SIRT7;RASL11A;LYAR
prerank,striated muscle cell differentiation (GO:0051146),-0.3786114411234158,-1.0092206674862743,0.44421906693711966,0.7454199199802722,1.0,10/16,34.26%,MEF2C;SORT1;MYOCD;BMP2;PLD3;SKI;CBY1;SIK1;POPDC3;POPDC2
prerank,glycolipid metabolic process (GO:0006664),-0.288878145996035,-1.0091819557294335,0.425764192139738,0.7449490986572258,1.0,10/47,13.25%,ST3GAL4;ST6GALNAC3;ESYT2;ST3GAL6;ST8SIA6;ESYT3;HEXA;PSAP;UGCG;ARSA
prerank,cognition (GO:0050890),-0.29216747449630426,-1.0090903104091475,0.43870967741935485,0.7446309457549339,1.0,8/42,11.89%,ST3GAL4;SHROOM4;APP;CHMP2B;NIPBL;STRA6;FAM107A;MFSD2A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2891287285511655,-1.0088545057090048,0.42596810933940776,0.7446672266541928,1.0,9/46,12.48%,YWHAE;GAS6;PIK3R1;CDH1;FLNA;PRKCD;IPO5;NCBP2;TPR
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.32847474221214323,-1.0086108553435609,0.45114345114345117,0.7447508018305725,1.0,10/27,17.44%,PDE4D;AHNAK;YWHAE;CACNB2;CAMK2D;JPH2;CACNB4;PRKACA;PLN;DMD
prerank,embryonic hemopoiesis (GO:0035162),-0.40486873589159333,-1.0081556609296787,0.44081632653061226,0.745323800195179,1.0,4/12,9.75%,KITLG;KDR;TGFBR2;TAL1
prerank,histone H3 acetylation (GO:0043966),-0.29384036998096985,-1.0078122337037936,0.47019867549668876,0.7456141868906794,1.0,13/40,23.64%,LEF1;KAT7;KAT6A;TRIM16;PER1;JADE2;TAF5L;BRCA2;ING4;BRPF3;SPI1;TAF9;JADE1
prerank,brain development (GO:0007420),-0.23738203423170207,-1.0077898616300982,0.4219948849104859,0.7451039201434364,1.0,22/136,14.08%,ADGRL2;SHANK3;RAPGEF2;PBX1;ZFHX3;SHROOM4;COL4A1;PBX3;TGFBR2;EML1;BPTF;NIPBL;UFC1;GRIN2B;APOD;DSCAML1;ADGRG1;MFSD2A;PTCH1;NCOA6;ATXN1;CDH2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.41875114813562386,-1.0077717360290983,0.451417004048583,0.7445713121152443,1.0,5/11,15.39%,NOS3;GCH1;QDPR;PRKG2;DHFR
prerank,positive regulation of protein catabolic process (GO:0045732),-0.25554448874548646,-1.007736185726433,0.38875305623471884,0.744089574291846,1.0,24/84,24.55%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;TNFRSF1B;WNT5A;PLK2;APC;AMER1;APOE;CSNK2A1;FZR1;BARD1;HACE1;NEDD4;FAF1;MSN;CDKN1B;OAZ1;STX5;PLK3;DTL
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3697481752845012,-1.007548880910893,0.4495798319327731,0.7440116081329898,1.0,7/17,17.26%,NRP1;ADAMTS1;MDK;S100A11;CCN4;DOCK4;VTN
prerank,maturation of LSU-rRNA (GO:0000470),0.342577434444041,1.0073676537970517,0.4319852941176471,0.9207937828613856,1.0,1/26,0.08%,NSA2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3977620099323402,1.0072961026917535,0.4637964774951076,0.9198095729281656,1.0,3/16,6.07%,BMP7;METRNL;HNRNPU
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.44155298091442796,1.0072217677340514,0.4613861386138614,0.9187745876744748,1.0,3/10,11.63%,RENBP;GNPDA1;NPL
prerank,actin filament bundle organization (GO:0061572),0.33464073894879964,1.0069243832538035,0.43884892086330934,0.9184538007896769,1.0,6/33,6.98%,USH1C;RFLNA;BAIAP2;PAWR;ADD2;CORO1B
prerank,protein ubiquitination (GO:0016567),0.22493532203957223,1.0068809125805525,0.43724137931034485,0.9173649777182338,1.0,116/471,21.78%,RNF220;RNF152;RNF43;EPAS1;UBE2E2;DDB2;SH3RF2;CTR9;PDZRN3;ASB2;DTX1;DERL1;FBXL19;TRIM62;SIAH2;PSMD3;RNF41;TRIM5;RNF126;FBXL12;PLK1;KLHL13;LEO1;DZIP3;TRIM71;SHPRH;RNF14;TNKS2;UBE4B;UBA1;TRIM35;ARRB1;FBXO11;DTX2;PELI3;DTX3;BRAP;HIF3A;RNF135;BCL2;TRAF7;SASH1;TOPORS;RNF20;RNF10;FBXO6;UBE2W;RNF6;CAND2;HLTF;TAF1;RNFT1;PRPF19;CDC73;FBXO9;OBI1;RLIM;NEDD8;FBXO17;RNF31;RNF138;PSMD1;PSMC5;FBXO41;SPSB2;PRKDC;UBE2R2;RBCK1;RNF7;EIPR1;PSMA1;UCHL3;RNF213;PSMD12;SIRT1;MDM2;KLHL20;USP9X;TRIM3;FBXL16;UBE2S;RBBP6;ANKIB1;ANAPC7;SPSB1;FBXL22;FBXO22;RNF139;TRIM13;RNF13;PSMD7;MYCBP2;RNF26;KCTD13;TRIM63;TRIM2;FBXL5;BFAR;ZSWIM8;KLHL7;NFX1;TRIM41;RNF103-CHMP3;PSME2;PHC1;RMND5A;KLHL42;RNF146;FBXL15;KLHL21;RNF11;CUL7;TRIM33;HECW1;UBOX5;TRIM32
prerank,cytosolic transport (GO:0016482),-0.24669588272154988,-1.0068166998015797,0.4314214463840399,0.7452793965706552,1.0,39/108,25.01%,MYO1D;RAB14;VPS53;VPS13C;RAB6A;ANKFY1;TBC1D5;VAMP3;SNX1;EMP2;VPS26A;SORT1;TMEM87B;PIK3C3;VPS13A;GOSR1;TBC1D10A;SYS1;AP2A1;STX8;SNX2;ANKRD27;RHOBTB3;STX6;PREPL;DCTN1;EPS15;EVI5;VPS52;RIC1;VPS26B;STX5;DOP1B;GAK;RAB9B;SNX5;VPS50;BET1L;PHETA1
prerank,blood vessel endothelial cell migration (GO:0043534),0.3564468070783268,1.006712677550784,0.44031311154598823,0.9166951661090216,1.0,3/22,2.49%,ROBO1;EFNB2;PIK3R3
prerank,regulation of transposition (GO:0010528),0.4076662058362962,1.0066522921941345,0.4384920634920635,0.9156727894022385,1.0,3/13,12.71%,TDRD9;SPOCD1;MYBL1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.35709561476947094,-1.0065731826114546,0.4267515923566879,0.7453850467652597,1.0,4/17,10.00%,DGKZ;PTPRJ;CEACAM1;DUSP3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.360828814712379,-1.0064631099034143,0.4369747899159664,0.7450769031150503,1.0,7/18,23.72%,PIK3R1;ERN1;NCK1;BAK1;ATXN3;FCGR2B;BOK
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3340110040516008,-1.0063686449522964,0.4485776805251641,0.7447615563195035,1.0,9/24,20.25%,ZBTB16;TRPS1;ACVRL1;MDK;WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3068158132626616,-1.0061592963567552,0.42951541850220265,0.7447935741541232,1.0,14/35,23.29%,DAB2IP;MFHAS1;XDH;PER1;PHLPP1;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;DUSP1;CYLD;PRMT1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.2655218350918569,-1.0060096150711486,0.43601895734597157,0.7446311669470379,1.0,20/66,22.95%,KAT7;PIK3R1;LIMK2;CDH1;FLNA;TFRC;PRKCD;ORMDL3;EIF2AK3;IPO5;TPR;NMD3;CCT2;FERMT2;ZC3H12A;MEPCE;JUP;DKC1;DTX3L;HCLS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3368168886449736,-1.0059470743144532,0.4357894736842105,0.7442432030810413,1.0,13/24,34.87%,NOTCH1;CREB3L1;KLF2;VEGFA;MT3;ATF6B;ATF4;ATF3;MBTPS2;CEBPB;HSPA5;TP53;GCN1
prerank,regulation of actomyosin structure organization (GO:0110020),0.4156907984643561,1.005687878072254,0.4530612244897959,0.9173708017404002,1.0,4/13,15.37%,ROCK2;FHOD1;TSC1;WAS
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.33169244293000694,-1.0056652685937035,0.46709129511677283,0.7444074783862538,1.0,5/26,10.26%,FOXP1;CRY1;STRN3;HEYL;PER1
prerank,regulation of vacuole organization (GO:0044088),0.37030393946546536,1.0056185343133164,0.44510978043912175,0.9163512402134781,1.0,11/20,26.40%,NPRL3;ENO1;ENO4;TBC1D14;NPRL2;ANXA2;ADPRH;IFT20;PIKFYVE;MTM1;ENO3
prerank,apoptotic mitochondrial changes (GO:0008637),0.33341287966282196,1.0054791687357854,0.4344569288389513,0.9155357375055642,1.0,7/32,13.02%,IFIT2;CCAR2;FZD9;NDUFS1;BCL2;CLU;AIFM2
prerank,cellular protein catabolic process (GO:0044257),-0.2723150115459334,-1.0053663643493906,0.4423076923076923,0.7446192719458283,1.0,17/59,17.98%,DAB2IP;FAP;AP2B1;CAPN2;PSMA6;CTSO;MALT1;CTSB;VLDLR;RNF123;AP2A1;CTSF;RSPRY1;UBE2G1;TCIRG1;CTSS;ADAMTS12
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2617041766585312,-1.0051110086796995,0.41284403669724773,0.7446751418004214,1.0,24/76,22.20%,DAB2IP;TMSB4X;CD200;PTGIS;NFKBIA;CYP1B1;IRAK3;TRIM37;AIM2;NLRC5;DAP;USP7;KLF4;MTURN;IRAK2;LRRC14;ZC3H12A;ERBIN;ARRB2;PSMD10;SPI1;FAF1;CCDC22;CYLD
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3898063820743688,-1.004842845703864,0.45546558704453444,0.7447948382861979,1.0,6/14,29.98%,RHOA;RAP2A;CDC42;MSN;FOXJ1;CAMSAP3
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3043576625786851,-1.0046739217743414,0.4403470715835141,0.7446350730178619,1.0,18/34,31.88%,PDE4D;KCNQ1;CALM3;PRKACA;PLN;ZC3H12A;GJA5;PIK3CG;SLC8A1;STC1;CALM1;RGS2;HCN4;SMAD7;RNF207;ATP1B1;ADRA1A;NOS1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.38628261056922214,-1.0044119166203085,0.4423076923076923,0.7447708107238622,1.0,4/14,14.62%,ARHGDIB;AGO2;VEGFA;ACVR1C
prerank,icosanoid metabolic process (GO:0006690),-0.29819682909557377,-1.0041801630167475,0.4444444444444444,0.744775003690701,1.0,9/40,9.66%,PLA2G4A;PTGIS;CYP1B1;ABCC1;PTGS2;MGLL;PON2;MAPKAPK2;GPX1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.39643108548320977,-1.0038483052008789,0.4215885947046843,0.7450939780549953,1.0,6/13,18.83%,CACNA1G;STX1A;SYT4;CACNA1I;KCNB1;CACNA1H
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3991382712224994,1.0038238830391821,0.4457593688362919,0.9192801354373455,1.0,5/15,11.76%,SPHK1;SMPD3;ORMDL2;SMPD2;SPHK2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3405096098392401,-1.003218273149031,0.44536082474226807,0.7461869691390169,1.0,6/22,19.23%,SLC7A5;TNFRSF1B;WNT5A;TRIL;NOD2;BTK
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.26983547794257357,-1.003198624582836,0.4650602409638554,0.7456763591156277,1.0,31/69,33.91%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;CCR2;TLR4;PTPN11;DDT;MIF;RASGRP1;FADD;TLR1;TMEM106A;LGALS9;TYROBP;CD14;TLR3
prerank,nitric oxide metabolic process (GO:0046209),0.39562855873088193,1.0031817415587134,0.45294117647058824,0.9199551825193061,1.0,3/14,4.52%,GCHFR;NQO1;ARG2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.314829907986195,-1.0023041257640422,0.434878587196468,0.7468732927165216,1.0,11/31,25.50%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CMTR2;POLR2F;CCNH;POLR2H
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.314829907986195,-1.0023041257640422,0.434878587196468,0.7468732927165216,1.0,11/31,25.50%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CMTR2;POLR2F;CCNH;POLR2H
prerank,negative regulation of cell death (GO:0060548),-0.2571278604822732,-1.0022288546438012,0.4433249370277078,0.7465300687349878,1.0,14/88,9.69%,MECOM;PDE8A;CD200;CD34;BMP4;TNFRSF1B;CCN3;PRKD1;CCN1;NCK1;CHMP4B;CHMP4A;CDK5;FGF2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4211460867439075,-1.0020469287879679,0.4797687861271676,0.7464335115770873,1.0,4/11,22.61%,P4HA1;CRTAP;P4HA2;EGLN3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.27007083409529353,-1.0019905562879816,0.4650602409638554,0.7460097742252226,1.0,21/59,25.20%,DAB2IP;NFKBIA;UBC;REL;RPS27A;UBB;RELB;NKIRAS1;TBKBP1;BIRC3;TAB1;IRAK2;RIPK1;TICAM1;RIPK2;ROCK1;IRAK1BP1;BCL10;AZI2;TLR4;BCL3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.39050985018392265,1.0019881565201738,0.4491017964071856,0.9222666807482705,1.0,2/14,4.19%,OXSR1;STK39
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35532989465925047,1.0019854658021854,0.45351043643263755,0.9198689865237801,1.0,8/22,17.81%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35532989465925047,1.0019854658021854,0.45351043643263755,0.9198689865237801,1.0,8/22,17.81%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,regulation of mRNA processing (GO:0050684),0.32472375618383476,1.0019170954614376,0.4165103189493433,0.9188837138466892,1.0,8/32,16.50%,PABPN1;SLTM;SON;SRSF10;TIA1;YTHDC1;SAFB2;SAFB
prerank,fibrinolysis (GO:0042730),0.4087194495942308,1.0018869511548723,0.4533898305084746,0.9177840890005153,1.0,3/13,10.54%,PLAT;PLG;HRG
prerank,cellular response to purine-containing compound (GO:0071415),0.4289966999001719,1.001861394612744,0.4477317554240631,0.9166551070505665,1.0,3/10,11.37%,GSTM2;RYR2;TRPM2
prerank,positive regulation of cell aging (GO:0090343),0.42083553380585526,1.001858111957202,0.46449136276391556,0.9154757719302623,1.0,3/11,4.52%,CDKN2A;LMNA;ARG2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4094832786096261,-1.0017720763940354,0.46586345381526106,0.7460366430713578,1.0,9/11,45.14%,LYN;JAK1;PLAUR;SYK;ANK3;CCL5;RDX;BLK;TNFSF11
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.30224291960829486,-1.0015061837610508,0.41501103752759383,0.7461569879490416,1.0,7/35,11.00%,GHR;CAV1;NOTCH1;CYP1B1;HES1;VHL;HGS
prerank,kidney development (GO:0001822),0.2885509303887888,1.001497701985612,0.4525043177892919,0.9153174880803515,1.0,12/65,13.54%,BMP7;WNT4;GREB1L;OSR1;CITED1;LRP4;CEP290;VANGL2;TGFBR1;CTSH;BAG6;FOXC1
prerank,dendritic spine organization (GO:0097061),-0.32445845438982424,-1.0014740009022791,0.4491869918699187,0.7456683359495478,1.0,3/26,2.03%,SHANK3;DOCK10;INSR
prerank,protein palmitoylation (GO:0018345),0.33531020255525884,1.0007650022819827,0.44545454545454544,0.9163537665697319,1.0,10/30,17.81%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29931140891514707,-1.0007467851075897,0.425764192139738,0.7469375888922303,1.0,6/36,10.74%,MECOM;FOXO1;PPIA;DUSP3;PER1;AIDA
prerank,regulation of secretion by cell (GO:1903530),0.2969269318139996,1.0006706049502654,0.4442446043165468,0.9154517537046748,1.0,19/54,20.05%,SNCAIP;RAB21;SYT1;RAB3C;LLGL2;STXBP5L;RIMS1;LLGL1;NSF;CPLANE2;RAB13;CPLX1;SYN1;STX4;HTR1A;CPLX2;RHBDF1;RAB15;SCG5
prerank,response to amino acid starvation (GO:1990928),0.28240932605542857,1.000324528060406,0.4725085910652921,0.9152891124107119,1.0,17/72,15.11%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;NPRL2;ATP6V0D2;LAMTOR3
prerank,positive regulation of protein acetylation (GO:1901985),0.4139421384735029,0.9997911094732735,0.4904580152671756,0.9157451323547603,1.0,4/12,13.17%,PRKAA2;CAMK1;KAT5;RAPGEF3
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3431429384743199,-0.999659516056922,0.4613733905579399,0.7491125634067906,1.0,10/21,32.06%,DUSP3;PIBF1;JAK3;SOX11;FCGR2B;FOXJ1;SAMSN1;IL4I1;LAPTM5;GPNMB
prerank,alanine transport (GO:0032328),-0.42376012898259063,-0.9995085282587777,0.4722222222222222,0.7489326468767857,1.0,1/10,0.33%,SLC6A6
prerank,retinal metabolic process (GO:0042574),0.42792326770403244,0.9994426438779784,0.48523206751054854,0.9155735546346921,1.0,2/12,2.50%,ALDH8A1;ABCA4
prerank,stress fiber assembly (GO:0043149),-0.3905202658795225,-0.9989835481934649,0.45625,0.7491359675451483,1.0,4/15,8.89%,RHOA;ITGB1;ITGB5;SRC
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3905202658795225,-0.9989835481934649,0.45625,0.7491359675451483,1.0,4/15,8.89%,RHOA;ITGB1;ITGB5;SRC
prerank,positive regulation of reproductive process (GO:2000243),-0.31501075161085784,-0.998949662399212,0.44798301486199577,0.7486566772905685,1.0,5/31,14.04%,PDE3A;LHFPL2;AGO2;VEGFA;PGAM4
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3892888893964176,-0.9989225737154143,0.46747967479674796,0.7481781007966062,1.0,3/13,12.66%,EPS8;EPS8L2;PFN1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.40729318712624263,-0.9989071355762389,0.48336594911937375,0.7476627051329213,1.0,7/11,38.70%,LANCL1;STK26;FYN;UBQLN1;PARK7;MMP3;GATA4
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3822507678580367,-0.998894983126269,0.47468354430379744,0.747142450341923,1.0,3/14,10.19%,GAS6;CARD16;CCDC3
prerank,epithelial cell morphogenesis (GO:0003382),0.37548347990364306,0.998733840563812,0.4392156862745098,0.9165062204945706,1.0,4/17,9.34%,COL22A1;RILPL2;RILPL1;DACT2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2980190107119154,-0.9987122576375669,0.47235023041474655,0.7470192727410134,1.0,18/42,30.97%,SHLD1;TERF2IP;SMCHD1;FUS;FANCB;TIMELESS;PPP4R2;MAD2L2;RPA2;SPIDR;CHEK1;SIRT6;SHLD3;RAD51AP1;CGAS;PARP1;HELB;MRNIP
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2803104778285441,-0.9971157887938901,0.43953488372093025,0.7505464973071556,1.0,15/52,15.33%,YWHAE;YWHAB;UBE2D3;ABLIM3;SAE1;YWHAQ;ARIH2;YWHAZ;SREBF2;MICALL2;UBE2L3;FBXW7;UBL5;UBE2J2;BBC3
prerank,microtubule anchoring (GO:0034453),0.4185608447898418,0.9970059002415047,0.4596153846153846,0.9205178084872171,1.0,3/12,10.65%,CLASP1;PCM1;BICD1
prerank,cellular response to acid chemical (GO:0071229),-0.32692496993425413,-0.9967523878444122,0.4722792607802875,0.7509261467752494,1.0,10/27,14.43%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;KLF2;VEGFA;GLRA2
prerank,cellular response to amyloid-beta (GO:1904646),0.31513984379583815,0.9963967592518145,0.45251396648044695,0.9210949675846264,1.0,3/35,1.57%,SNX6;IGF1;CACNB1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3266913068196178,-0.9963535292557545,0.480083857442348,0.7514061924014008,1.0,11/27,19.95%,TEK;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;PIK3R4;IRS1;FGFR3;NOD2;AGAP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.2859088515802909,-0.9962049448199572,0.48325358851674644,0.7512634074046776,1.0,18/46,29.04%,MTAP;PAK2;RPLP0;PPIA;CNN2;SOD1;CFL1;PDCD4;JAK1;BOLA2;CAPZA1;CDC42;HNRNPF;MSN;IL12RB2;STAT4;MIF;AIP
prerank,plasma membrane tubulation (GO:0097320),-0.3899100548586521,-0.9960465940198008,0.4446601941747573,0.7511385687999702,1.0,5/13,11.29%,CAVIN2;CHMP4A;WHAMM;EHD2;FNBP1L
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2405685228717947,-0.9960219088959658,0.46835443037974683,0.7506436204800583,1.0,33/133,17.23%,CAV1;STIM2;ATP2B1;TRPC3;YWHAE;SLC10A7;MICU3;SLC30A1;CAMK2D;SLC35G1;NPTN;TRPC6;TPT1;TRPC4;CXCL12;CCL13;ATP2A3;MCUB;TRPC1;TMCO1;CAV2;EDN1;TRPV4;EDN3;HTR2A;SMDT1;MICU2;CD40;VAPB;BAK1;PRKACA;PLN;GPER1
prerank,negative regulation of DNA binding (GO:0043392),-0.32455917841320464,-0.9959181723104281,0.47010309278350515,0.7503591132579277,1.0,9/28,16.97%,LEF1;NFKBIA;JUN;TNKS;HEY2;SMO;MAD2L2;HEY1;SP100
prerank,regulation of cholesterol esterification (GO:0010872),-0.42693511089742703,-0.9956830393433209,0.4686192468619247,0.7504317347548718,1.0,3/10,11.02%,AGTR1;APOE;STARD4
prerank,protein O-linked glycosylation (GO:0006493),0.26925476219525657,0.9956224940208934,0.4542372881355932,0.9222442522076131,1.0,20/96,15.56%,GXYLT2;TRAK1;CHST4;MUC19;ST3GAL3;TMTC4;GALNT11;GALNT14;TET1;LARGE1;GALNT12;GALNT3;B3GLCT;FKTN;GALNT2;DPM1;CRPPA;GALNT1;TET2;MUC1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.29197574079978195,-0.9955516282108532,0.4791666666666667,0.750230633149498,1.0,11/44,19.61%,GSN;CDC42EP3;CDC42EP5;NCK1;WHAMM;CDC42EP2;PTK2B;PFN1;NCKAP1L;FCHSD1;HCK
prerank,purine nucleotide metabolic process (GO:0006163),-0.3363535021795955,-0.9954057382289834,0.4901185770750988,0.7500939967765721,1.0,8/24,22.76%,XDH;HPRT1;GPX1;NT5C1A;NT5E;NT5C;FHIT;GDA
prerank,regulation of dendritic spine development (GO:0060998),-0.35334149204029347,-0.9952087059843577,0.48155737704918034,0.7500123901718557,1.0,2/19,0.55%,MEF2C;SHANK3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3681767185975311,0.9951961387850913,0.4657258064516129,0.9223865936866055,1.0,5/19,9.64%,TGFBR3;BMPR1A;RBPJ;FGFR2;TGFBR1
prerank,renal filtration (GO:0097205),-0.426991491473578,-0.9951190271862584,0.4869215291750503,0.7496903936592019,1.0,7/10,44.18%,CD34;MCAM;MYO1E;JCHAIN;SULF2;ITGA3;SULF1
prerank,endomembrane system organization (GO:0010256),-0.22615586180225616,-0.9951129474562239,0.4428969359331476,0.7491563757136249,1.0,41/178,18.55%,SPTBN1;SYNE1;ATP8B1;ATL3;LMAN2L;TMED10;USP6NL;WASHC4;CHMP2B;PRKD1;FBXW8;COG3;ALS2CL;CSNK1A1;SEC16B;RAB22A;EIF2AK3;GOLPH3;CAV2;DYSF;BAG5;LEMD3;SUN1;SQSTM1;SNX10;SEC61A1;SEC31A;UBXN2A;REEP3;REEP5;ZW10;SURF4;VAPB;SYNGR2;USP50;TLCD1;LYSMD3;SYNGR1;CTDNEP1;HACE1;TOR1AIP2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.31028219814888836,-0.9950419236461864,0.43383947939262474,0.7487826291940765,1.0,8/34,17.80%,SLC7A5;VAMP3;WNT5A;EPHB2;PHB2;CD86;PTPRC;NOD2
prerank,nitric oxide biosynthetic process (GO:0006809),0.39973172944475,0.9949975275469153,0.4625984251968504,0.9218020157158774,1.0,3/13,4.52%,GCHFR;NQO1;ARG2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25089710413831945,-0.9947895972811839,0.4675,0.7488995839909262,1.0,22/98,17.23%,SPTBN1;PRKCH;YWHAE;PIK3R1;EGFR;MFF;YWHAB;STX3;ITGB1;NKD2;ZDHHC8;YWHAQ;STAC;YWHAZ;EPHB2;SQSTM1;AKT2;KCNB1;BBC3;CEMIP;LRP1;GPER1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3495853844382846,0.9946097276971727,0.45864661654135336,0.921761667307252,1.0,9/25,17.00%,HSPA1A;ABCB10;MED1;STAT1;MAPK14;ARNT;PRKDC;HSPA1B;STAT5B
prerank,cellular response to ketone (GO:1901655),0.3196811743267223,0.9945831048366199,0.46904315196998125,0.9206669424028984,1.0,6/35,11.76%,ADCY5;ROCK2;ADCY1;ADCY8;NDOR1;SPHK2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3837207490396306,0.9945194657248371,0.46484375,0.9196805106648841,1.0,4/17,5.14%,NOTCH2;GALNT11;BMPR1A;RBPJ
prerank,regulation of muscle cell differentiation (GO:0051147),-0.31036882252082915,-0.9944169028746892,0.4444444444444444,0.7493024649588212,1.0,12/31,24.85%,MEF2C;BOC;CTNNA1;HDAC9;IGF2;MYOCD;CDH2;ID2;MAPK12;CDC42;MAPK11;BNIP2
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3824854421121944,-0.9936042180430569,0.4772234273318872,0.7507900189434951,1.0,4/14,14.53%,FOXO3;FASTKD1;EARS2;MRPL12
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.37868910652145404,0.9933440851982287,0.45351043643263755,0.9220400943352463,1.0,1/17,0.29%,FGF1
prerank,positive regulation of endocytosis (GO:0045807),-0.2892351272148544,-0.9932523716474366,0.47983014861995754,0.7510993951924033,1.0,17/45,22.25%,HIP1;NEDD4L;B2M;ANKFY1;RAB31;SGIP1;SERPINE1;APOE;NCKAP1L;CBL;LDLRAP1;LRP1;VTN;CD151;C3;CDC42;DLL1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2290933531938934,0.9931606437663014,0.47655068078668683,0.9214114643681665,1.0,53/327,12.94%,DENND4A;RORA;PPARGC1B;SUFU;CTR9;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;TULP3;POU1F1;CCAR2;CCAR1;ASCC2;PQBP1;ACTR8;MZF1;E2F1;RNF14;WWTR1;NFYC;CEBPA;SRSF10;PHF1;CHD3;HES6;MAFA;HINFP;PPARGC1A;GON4L;PRDM2;SSBP2;CLOCK;FZD7;TGFBR1;NSD1;CREBL2;LDB1;RNF20;MAGED1;RNF6;ZFPL1;DMTF1;PML;CHEK2;RBAK;MYBL1;TGFBRAP1;NIF3L1
prerank,T cell receptor signaling pathway (GO:0050852),-0.2334917280759134,-0.9928763141075966,0.47802197802197804,0.7515339615113661,1.0,36/138,22.88%,PDE4D;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;PAK2;INPP5D;TEC;PSMB7;PSMA6;NCK1;TNFRSF21;EIF2B2;PIK3CA;SPPL3;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;PTPRC;PSMC4;PSMB8;PSMD11;DENND1B;EIF2B1;PSMB4;PSMD14;ZC3H12A;PSMD10;PSME1;RIPK2;FYN;PSMB3;BCL10
prerank,response to reactive oxygen species (GO:0000302),-0.2745471576393851,-0.9927779019107578,0.48086124401913877,0.7512672040349324,1.0,12/54,10.49%,EGFR;PTPRK;JUN;PXN;MAPK1;RPS3;APOD;STK24;SOD1;CAT;GPX1;APOE
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.301674064226352,0.992678025848478,0.4486486486486487,0.92167049731659,1.0,16/46,18.69%,IGF1;IL18;OGN;IGFBP3;NOX1;NDRG4;STAT1;VIP;MFN2;PRKDC;TCF7L2;IL6;RBPMS2;CX3CL1;AKT1;IL12A
prerank,protein kinase B signaling (GO:0043491),0.3475438488200495,0.992463341341927,0.4555984555984556,0.9211204497770276,1.0,2/23,2.49%,IGF1;PIK3R3
prerank,regulation of protein processing (GO:0070613),-0.3409343235461709,-0.9924419181164515,0.4793926247288503,0.7515773972494709,1.0,5/21,15.26%,RUNX1;NKD2;TMEM59;CCBE1;RHBDD1
prerank,phospholipid biosynthetic process (GO:0008654),-0.29817117778550317,-0.9923538883719818,0.4520255863539446,0.7512344867659047,1.0,5/36,4.97%,SGMS1;SGMS2;MBOAT1;AGK;CPNE3
prerank,metanephros development (GO:0001656),0.3434932790681133,0.9918940441661994,0.43202979515828677,0.921699610327253,1.0,2/26,1.12%,BMP7;OSR1
prerank,presynaptic endocytosis (GO:0140238),0.3623944547016753,0.9916632345943028,0.4930139720558882,0.9212027804339485,1.0,6/24,11.20%,CEL;NLGN2;SYT1;NLGN3;SYNJ2;CANX
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2544265967730053,-0.9912700687167757,0.48157248157248156,0.7533653622070691,1.0,20/88,13.77%,STXBP6;MYO1B;CLINT1;RAB14;VPS13C;EXOC6;APP;EXOC4;SORT1;RP2;FTL;RABIF;EXOC1;HGS;SH3GL2;VPS13A;SCAMP1;STEAP2;SYS1;AP2A1
prerank,positive regulation of mRNA processing (GO:0050685),-0.35079092434277725,-0.9909962976185851,0.4731182795698925,0.7534800445803205,1.0,9/21,24.70%,RBM3;PRDX6;PAF1;NCBP2;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,negative regulation of nervous system development (GO:0051961),0.3759787142332559,0.9909955818865821,0.46421663442940037,0.9220706638834391,1.0,4/17,10.64%,APPL2;WNT7A;PAX6;PCM1
prerank,regulation of telomere capping (GO:1904353),-0.34083366259172554,-0.990734483951224,0.46284501061571126,0.7535734041365942,1.0,10/23,26.50%,NEK7;TNKS;MAPK1;USP7;NBN;MAPK3;MAP2K7;MAP3K4;HNRNPD;TERF2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.411592917146871,0.9906651119099044,0.46184738955823296,0.9218752752253496,1.0,3/12,16.88%,STRAP;SOX9;RBP4
prerank,error-free translesion synthesis (GO:0070987),-0.34131037337065645,-0.9905696222904062,0.4733606557377049,0.7534322482296086,1.0,4/22,5.65%,RPA1;UBC;RPS27A;UBB
prerank,negative regulation of cellular component movement (GO:0051271),0.3873367163057948,0.9904672187085052,0.4717741935483871,0.9213050270290809,1.0,2/15,1.93%,TGFBR3;FBLN1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.370197923595097,-0.9901281254127278,0.48523206751054854,0.7540747488840659,1.0,8/15,20.47%,DCN;CSGALNACT1;CSPG4;VCAN;BGN;B3GAT3;NCAN;BCAN
prerank,positive regulation of viral genome replication (GO:0045070),0.33067553271884537,0.9900085121763879,0.4849624060150376,0.9214996008222902,1.0,4/29,7.81%,HACD3;TOP2B;PPARA;IFIT1
prerank,endosome organization (GO:0007032),-0.289609290449695,-0.9890517711123437,0.44954128440366975,0.7562508707126526,1.0,8/41,12.65%,CORO1C;WASHC4;CHMP2B;ALS2CL;RAB22A;RAB27A;SQSTM1;SNX10
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.3043600940930017,-0.9887005454431373,0.4700854700854701,0.7565794800462585,1.0,13/33,22.53%,SLC39A8;GLS;GCLC;DDAH1;GCLM;GLUD1;ALDH5A1;CAD;ALDH18A1;PRODH;PYCR3;GGT1;DDAH2
prerank,intracellular protein transport (GO:0006886),0.23030285751317356,0.9886541133184192,0.4769874476987448,0.9243631797583067,1.0,73/304,20.36%,RANBP3L;SNX6;TRAK1;APPL2;CTSA;WLS;IPO13;RAB21;FAM53A;POM121;STAM;NUP155;NAPB;CLIP3;SGSM3;COX18;ARFGAP3;NUP62CL;VPS26C;GGA2;STX16;STRADB;TNPO3;RUNDC1;TBC1D9B;KIF13B;SNF8;NAPA;RAB6B;ARL5B;NSF;SEC23IP;LAMP2;NXT1;TMED9;AP4M1;SGSM2;TMED4;SNX8;USO1;RAB1A;IPO8;TBC1D14;TBC1D10B;FUT10;TBC1D16;DESI1;GGA1;VPS45;RAB23;STX4;TMED2;TNPO2;AKAP6;RPGR;RAB19;IPO4;NUP88;SEC31B;PICK1;SYNDIG1;OXA1L;AKT1;SNX9;HPS4;RAB38;VPS29;LTBP2;GRTP1;SCG5;MAIP1;STXBP3;PDCD6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2688341690421608,-0.9884944943510305,0.4967032967032967,0.7565300290421145,1.0,11/63,8.89%,CAV1;ITGA6;ACVR1;TNFSF10;THBS1;BMP4;FAS;PAK2;AR;FEM1B;SRC
prerank,pseudouridine synthesis (GO:0001522),-0.390491934254969,-0.9883277414797097,0.504149377593361,0.7563854069396131,1.0,6/13,26.58%,PUS3;PUS7L;NHP2;DKC1;PUSL1;NOP10
prerank,negative regulation of macrophage activation (GO:0043031),0.38827488410877176,0.9881327586197741,0.4648956356736243,0.9247710047863156,1.0,3/16,9.21%,SYT11;TAFA3;NR1H3
prerank,ncRNA metabolic process (GO:0034660),0.31384460092181415,0.9880096034013475,0.44565217391304346,0.9239671733874872,1.0,7/37,13.37%,DTD1;TDRD9;TRIM71;DDX17;BCDIN3D;TUT4;DICER1
prerank,regulation of stem cell differentiation (GO:2000736),-0.2525674823822101,-0.9878575656963764,0.4793187347931874,0.75699689438879,1.0,25/89,22.69%,PTN;JAG1;TCF12;NOTCH1;LMO2;RUNX1;HES1;PSMB7;PSMA6;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMC4;PSMB8;PSMD11;SP7;PSMB4;PSMD14;METTL3;PSMD10;PSME1;RBM24;PSMB3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4211270553580925,0.9878535600905575,0.4588910133843212,0.9232651406625791,1.0,3/10,11.22%,RUVBL2;PIH1D2;PIH1D1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.22823741139329395,-0.9874289586531868,0.48257372654155495,0.7575700017473793,1.0,19/158,6.90%,ROR1;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;MID2;FLNA;TFRC;BRD4;CARD16;PRKD1;S100A13;SLC44A2;TRIM14;PLK2;TRIM25
prerank,pre-miRNA processing (GO:0031054),-0.3821623450977615,-0.9871824651082731,0.487012987012987,0.7576497368287441,1.0,6/14,24.12%,AGO1;AGO2;DROSHA;AGO4;MRPL44;TARBP2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.37289550654804315,-0.9869900615241654,0.4820295983086681,0.757558598363707,1.0,5/15,14.25%,CDC27;HECW2;CDC16;TPR;PTTG1
prerank,positive regulation of lipid transport (GO:0032370),-0.4011449174874936,-0.9866366491186294,0.47884615384615387,0.7579119715141253,1.0,4/12,24.11%,ABCA3;APOE;LRP1;TRIAP1
prerank,regulation of mitotic nuclear division (GO:0007088),0.2885790901664191,0.9864521557539269,0.4564459930313589,0.9261490064025237,1.0,7/55,9.35%,BMP7;IGF1;OBSL1;CDC25C;TOM1L2;DRD3;PHIP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.26289185536450216,-0.9864413371112766,0.46258503401360546,0.7578763965131621,1.0,20/70,22.69%,B2M;VAMP3;TAP2;PSMB7;PSMA6;ITGB5;NCF2;PSMB6;PSMB5;LNPEP;PSMC4;PSMB8;SNAP23;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,regulation of interferon-alpha production (GO:0032647),0.3592348659197455,0.9858853406393456,0.48404255319148937,0.9266366560381349,1.0,8/23,23.19%,CHUK;NLRC3;STAT1;TLR8;HAVCR2;DDX3X;PTPRS;SETD2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3511823687253817,0.9854701486543602,0.4745098039215686,0.9266385444376787,1.0,9/22,20.74%,ANK2;GSTM2;HTT;RYR2;GSTO1;AKAP6;ATP2A1;STAC3;VMP1
prerank,cell part morphogenesis (GO:0032990),-0.38646098704277354,-0.985038290652143,0.48484848484848486,0.7609443023074483,1.0,3/13,7.75%,PID1;MFF;NUBPL
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.33868997540268514,0.9848952535892885,0.4672566371681416,0.9271995692359071,1.0,10/27,17.26%,DDX5;KMT5A;SPRED3;SMYD2;ATM;MSX1;SIRT1;MDM2;KDM1A;SPRED1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.27830720081905796,-0.9848086861286526,0.4671201814058957,0.7610094766205655,1.0,10/49,15.33%,SGMS1;CAV1;BCL2L1;RACK1;BCAP31;SRC;EIF2AK3;PTPMT1;PLAUR;BBC3
prerank,regulation of DNA binding (GO:0051101),-0.2812362833957818,-0.9847521517984459,0.49213483146067416,0.760602344427239,1.0,6/44,6.03%,LEF1;HJURP;NGF;NFKBIA;JUN;HES1
prerank,negative regulation of gene expression (GO:0010629),0.22846025816266957,0.9844503835857773,0.5056980056980057,0.9273509576310215,1.0,35/302,10.23%,ROBO1;NOTCH2;WNT4;LGR4;SYT11;IGF1;HSPA1A;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;TWSG1;CPNE1;OPRD1;BMPR1A;PICALM;TNRC6A;LRP3;DNMT3A;TRIM71;FLOT2;PTBP2;JARID2;PHF1;PPHLN1;PTBP1;LSM5;HINFP;PARP14;EIF2AK2;MPHOSPH8;PAIP2B;PAIP2;PPM1D
prerank,response to growth factor (GO:0070848),-0.2848104298193756,-0.9839966702599459,0.4684095860566449,0.7620560114796124,1.0,10/41,14.62%,BMPR2;ACVR1;ACVRL1;TGFBR2;CPNE3;RACK1;KLF4;HDAC6;TBC1D7;ACVR1C
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3138893918357499,-0.9835667558141779,0.43383947939262474,0.7625672454527835,1.0,6/28,12.48%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.32708108991947,0.9835058700191215,0.4666666666666667,0.9289598279586145,1.0,6/30,9.38%,ACSL1;HACD3;HACD4;HACD1;SLC27A6;ABCD1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3885560093849977,-0.9834199880469457,0.484251968503937,0.7623877503455027,1.0,4/13,17.14%,NFU1;GLRX3;BOLA2;ISCA2
prerank,ear morphogenesis (GO:0042471),0.3561360248740865,0.983291984173246,0.4943820224719101,0.9284488291193802,1.0,3/20,6.87%,OSR1;USH1C;FGFR2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2999372641741485,-0.9832549688999112,0.4824016563146998,0.7623046801306792,1.0,12/36,20.19%,ENG;RASSF2;RAP2A;CALM3;PPP2R5C;PDGFC;PDGFD;VEGFA;NBN;TNKS1BP1;ENPP1;PPP2R5B
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21707046990205392,0.983112531680223,0.5179282868525896,0.9278364516961882,1.0,133/572,20.72%,PRDM6;AEBP1;WWOX;BMP6;DAB2;HSPA1A;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;CXXC5;MSX2;FHL2;SUFU;CTR9;THRB;SCRT1;NR6A1;PCGF2;PPARA;ZNF431;GLIS3;ENO1;ZHX1;IFI27;DLG1;PLK1;PEG3;RBPJ;PAX6;MZF1;DNMT3A;E2F1;HNRNPU;HOXA7;ZKSCAN3;MOSPD1;NR2F2;ATN1;FGFR2;KAT5;CHD3;MIER3;IMPACT;MED1;E2F8;MAX;NR1H3;PRDM2;DMAP1;NKAP;CBX6;NSD1;ZFP90;FOXP4;STAT1;RXRA;MED25;C1QBP;LCOR;LDB2;LDB1;MXI1;RITA1;FST;TAF1;GATAD2A;CDC73;SOX9;BEND3;NOC2L;BHLHE41;JAZF1;DICER1;SMYD2;FOXC1;HDAC4;CTBP2;MEN1;GADD45A;TBL1XR1;BCL11A;NCOR2;PER2;HEXIM2;TCF7L2;ERF;SIRT1;MDFI;MDM2;USP9X;RARA;TENM2;RELA;ARID5B;KDM1A;FNIP1;MITF;DNAJA3;IRF8;MTF2;CITED2;PCGF1;NFKB1;GLI2;TCF25;HDGF;APBB1;POU6F1;NCOR1;CGGBP1;SOX2;MLX;IRF2BP2;DDIT3;MEF2A;BRMS1L;LIN37;SMAD2;SIN3A;TGIF2;REST;GLIS1;NFX1;CPEB3;DR1;SMAD4;DNAJB1;SUPT4H1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3521054074428439,0.9831112803854788,0.4806201550387597,0.9266957650229334,1.0,2/23,1.84%,IGF1;PRKAA2
prerank,odontogenesis (GO:0042476),-0.2968898172462453,-0.9831062055011944,0.46466809421841543,0.7621428568861996,1.0,7/35,12.31%,LRP6;TGFB2;BMP4;TBX1;AXIN2;TGFB3;BMP2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.26748997392427437,-0.9829947817102169,0.4954954954954955,0.7619087918402111,1.0,11/59,8.00%,NET1;MAP3K5;EGFR;CYP1B1;PTPRK;JUN;PXN;PRKCD;MAPK1;ANXA1;RPS3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3797993644631479,0.9823526103683575,0.46942800788954636,0.9277865211705852,1.0,1/17,0.51%,LPGAT1
prerank,axon extension (GO:0048675),-0.3335654386919682,-0.9821854439392753,0.5103305785123967,0.7634548403515105,1.0,11/23,21.03%,NRP1;NRP2;SLIT2;SEMA5B;CDK5;MAP1B;SEMA5A;ULK2;SLIT1;SLIT3;SEMA3F
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3032465933542341,-0.9815846764597129,0.47544204322200395,0.7644975062094483,1.0,6/32,6.45%,RAPGEF2;NEDD4L;HECW2;TNIK;RAP2A;FBXW8
prerank,negative regulation of histone methylation (GO:0031061),0.42538569227266393,0.981559060844983,0.4857142857142857,0.9289711190228842,1.0,4/10,17.68%,JARID2;PHF1;KDM1A;MTF2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.23822277125063018,-0.9812177650795092,0.4946808510638298,0.764847132052222,1.0,30/108,23.24%,RHOBTB1;TJP1;RHOA;CLIC4;PHLDB1;IQGAP1;F11R;PHLDB2;PAK2;CAPN2;PRKCD;MAPK1;ARHGAP35;EFNA5;FAM107A;HIP1R;RND3;BICD2;TRAF3IP1;LRP1;MAPK3;ARHGEF5;RHOBTB3;RHOB;RAC3;ROCK1;TAOK1;CYLD;RND2;MAP6D1
prerank,dendrite morphogenesis (GO:0048813),-0.3014521480931437,-0.9806402037386144,0.4891304347826087,0.7658267834620579,1.0,5/35,4.24%,SHANK3;FARP1;DOCK10;PTN;KLF7
prerank,establishment of protein localization to membrane (GO:0090150),0.2814825480232,0.9806252673037048,0.4753521126760563,0.9304954862391819,1.0,11/66,12.47%,AFDN;SYNE3;MICALL1;ZDHHC12;RAB3GAP1;COX18;PRKCI;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3
prerank,regulation of exit from mitosis (GO:0007096),-0.29220832691353815,-0.9805652692097909,0.47317073170731705,0.7654663484051006,1.0,6/38,7.23%,CDC27;UBC;ANAPC5;RPS27A;UBB;CDC16
prerank,pinocytosis (GO:0006907),-0.40843246069219474,-0.9799297086699664,0.4933837429111531,0.7665325553712382,1.0,7/10,34.90%,DOCK2;MAPKAPK2;SNX5;CARMIL1;AHSG;MAPKAPK3;RAB34
prerank,vacuolar acidification (GO:0007035),0.36328324192457956,0.9798872115481374,0.4873294346978557,0.9315127247699383,1.0,7/21,14.91%,ATP6V0A2;ATP6V1H;CCDC115;TMEM199;ATP6V0E2;CLN5;ATP6V0D2
prerank,neuron differentiation (GO:0030182),0.24623418829637891,0.9795153836347554,0.5024875621890548,0.9313933876442864,1.0,21/165,10.43%,WNT4;HS6ST1;IL1RAPL1;VXN;WNT5B;TENM1;PBX2;DTNB;WNT7A;PAX6;FZD3;FZD8;PBX4;CASP3;WNT6;NTRK2;PTPRD;TDP2;FZD7;TGFBR1;LDB1
prerank,regulation of phagocytosis (GO:0050764),-0.2759798482549785,-0.9792723444745534,0.5068181818181818,0.7676441106849748,1.0,12/53,13.88%,SCARB1;MERTK;GAS6;PLSCR1;RACK1;TGM2;DOCK2;GATA2;IL15;DYSF;RAB27A;PTPRC
prerank,ureteric bud morphogenesis (GO:0060675),-0.36972278952435744,-0.97911385335488,0.48125,0.7674687048287222,1.0,4/16,12.31%,BMP4;SIX1;FGF2;BMP2
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.360728575153861,-0.9787441906592877,0.49298597194388777,0.7678516170500442,1.0,6/18,20.59%,ADAM10;ADAM19;APOE;LDLRAP1;PSEN2;PSENEN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.30676948016861777,-0.978665880146222,0.5010940919037199,0.7675225045281476,1.0,9/32,23.15%,DEFA6;RPL39;RPL30;CCL13;ROMO1;HMGN2;GAPDH;RPS19;PGLYRP1
prerank,regulation of cation channel activity (GO:2001257),0.26835686346791415,0.9784885327267729,0.4904679376083189,0.9332791369641681,1.0,20/89,16.32%,CACNG7;ACTN2;CACNB1;ANK2;CACNB3;NLGN2;JPH1;DLG1;FGF12;SHANK1;SHISA7;DLG4;GSG1L;CNIH3;FGF14;OPRM1;SHISA8;GRIA2;LRRC7;NEFL
prerank,protein autophosphorylation (GO:0046777),-0.22719844088894708,-0.9782391928424473,0.5134408602150538,0.7680288705483541,1.0,43/157,21.76%,TEK;INSR;EGFR;PEAK1;EEF2K;KDR;BMX;TNIK;PRKD1;PAK2;ERN1;FLT1;CAMK2D;LYN;TEC;PRKX;STK24;FLT4;SRC;STK33;MAPKAPK2;EIF2AK3;GRK5;STK10;DYRK1A;PTK2B;STK16;ALK;CSF1R;MKNK2;CAD;TAOK3;FGFR3;STK26;MAPK3;MARK3;HCK;STK17B;RIPK1;ULK2;IGF1R;TAOK1;SLK
prerank,exit from mitosis (GO:0010458),-0.3950740706449138,-0.9782383789674775,0.5,0.7674836378099683,1.0,3/12,7.50%,PPP2R2D;EPS8;CHMP4B
prerank,regulation of sodium ion transport (GO:0002028),0.3196760400009161,0.977810933612624,0.47920433996383366,0.9340432149958345,1.0,5/34,7.03%,WNK3;SNTA1;DLG1;FGF12;WNK4
prerank,negative regulation of kinase activity (GO:0033673),0.2844810054964206,0.977766581637717,0.4906937394247039,0.9330322756126261,1.0,9/62,14.05%,PRKAG2;DEPTOR;HNRNPU;WWTR1;PDPK1;DTNBP1;QARS1;NPRL2;DUSP19
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.36138899489671916,-0.9774461063017652,0.5040816326530613,0.7689694315393323,1.0,8/17,28.53%,FAF2;HM13;RHBDD1;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,cellular response to lectin (GO:1990858),-0.24300301023131887,-0.9771742088188142,0.5024271844660194,0.7685422982500341,1.0,28/104,22.88%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMB7;PSMA6;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMC4;PSMB8;TAB1;PRKACA;PSMD11;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;PSMB3;BCL10
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.24300301023131887,-0.9771742088188142,0.5024271844660194,0.7685422982500341,1.0,28/104,22.88%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMB7;PSMA6;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMC4;PSMB8;TAB1;PRKACA;PSMD11;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;PSMB3;BCL10
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.38907270477897493,-0.9770654097160706,0.47890295358649787,0.7682705226090719,1.0,3/12,10.32%,SERINC5;SRR;SERINC3
prerank,regulation of sensory perception of pain (GO:0051930),-0.4077582029593872,-0.9769948563868236,0.5122950819672131,0.7679212678670457,1.0,6/11,25.35%,CCN3;MGLL;TMEM100;ATPSCKMT;ACP3;F2R
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2867745486753843,0.9769728681565804,0.4927797833935018,0.9341927631675088,1.0,12/58,15.05%,PAXX;POLM;ERCC1;ABRAXAS1;KAT5;KDM2A;MDC1;MRE11;PRPF19;PIAS4;PRKDC;ATM
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.375478061043174,0.976965035655575,0.4871287128712871,0.9330743245343571,1.0,6/15,15.90%,KIT;WHRN;ADGRV1;KCNK4;PDZD7;LHFPL5
prerank,smooth muscle contraction (GO:0006939),-0.37847224715134276,-0.9769017095222517,0.5064102564102564,0.767602916890278,1.0,5/14,8.04%,EDNRA;SMTN;PIK3C2A;ACTA2;MYH11
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4207082274854405,0.9766925049519759,0.5129224652087475,0.9327658529603107,1.0,2/10,8.09%,BMP6;PLG
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2922980457345195,0.9765920717228307,0.48936170212765956,0.9319388775463212,1.0,8/49,11.94%,PRKCZ;OPRD1;TFIP11;NLRP2B;NLRC3;IMPACT;CLU;PMEPA1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3896875617222983,0.9765620231646248,0.4618249534450652,0.9308960899440009,1.0,4/14,10.98%,LPIN1;ETNK2;PCYT2;CHKB
prerank,response to cholesterol (GO:0070723),-0.3613149477545954,-0.9764898146139418,0.4787018255578093,0.7681126110677969,1.0,5/17,12.98%,LRP6;TGFBR2;GRAMD1A;PTCH1;SMO
prerank,RNA splicing (GO:0008380),0.2601260644153373,0.9759143878481061,0.48408710217755446,0.9316688125646653,1.0,35/95,26.67%,RRAGC;NOVA1;CCAR2;HNRNPH3;SRSF10;PTBP1;ZMAT5;PPARGC1A;LSM4;MPHOSPH10;USP39;SRSF11;USB1;DHX8;RNPS1;PRPF3;PRPF6;NOL3;DDX39B;DDX47;SF3B2;SF3B1;SNRPB;CDK12;SF3B3;SCNM1;SRPK1;SRSF2;SNRPN;WDR83;HNRNPC;PRPF8;NONO;SNRNP40;DHX16
prerank,cellular response to alkaloid (GO:0071312),0.37427249796207274,0.9757777378584119,0.49304174950298213,0.9309468253188429,1.0,4/17,11.28%,TRPV1;CASP3;GSTM2;RYR2
prerank,protein autoprocessing (GO:0016540),0.37409438298638736,0.9755247492736507,0.49490835030549896,0.9305375696511228,1.0,3/17,7.50%,AFG3L2;SPRTN;HTRA2
prerank,negative regulation of lipid storage (GO:0010888),0.36205777314466014,0.9753171870423265,0.4781783681214421,0.930061739574399,1.0,4/19,9.21%,OSBPL8;PPARA;ABHD5;NR1H3
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.37521239923252003,-0.9753005441127249,0.48380566801619435,0.7706917820847559,1.0,2/15,2.36%,YWHAE;GAS6
prerank,regulation of presynapse organization (GO:0099174),0.3690969581732991,0.9745137613873859,0.49190283400809715,0.9300524586733542,1.0,4/18,8.72%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,regulation of presynapse assembly (GO:1905606),0.3690969581732991,0.9745137613873859,0.49190283400809715,0.9300524586733542,1.0,4/18,8.72%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,response to peptide hormone (GO:0043434),0.3003217696267641,0.9743609772795719,0.47680890538033394,0.9294125030915676,1.0,14/43,18.59%,TGFBR3;ROCK2;CYP11B1;CITED1;EIF2B4;STAT1;STAT2;TSC1;SIRT1;STAT5B;CREB1;STAT6;AKT1;KHK
prerank,actin filament network formation (GO:0051639),-0.408619798241825,-0.9743199523382561,0.5081967213114754,0.7726747057656868,1.0,2/11,4.41%,PLS3;ACTN1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3280408353424189,0.9742445310639202,0.48592870544090055,0.9286246678799965,1.0,8/30,18.84%,ACAT2;INSIG2;DHCR24;CYP51A1;SQLE;MSMO1;GGPS1;HMGCR
prerank,regulation of Golgi organization (GO:1903358),-0.3496310823399701,-0.9741161338042998,0.4896694214876033,0.7726419559639891,1.0,9/17,33.59%,USP6NL;ARMH3;MAPK1;MAPK3;STX5;AKAP9;CAMSAP2;CAMSAP3;RBSN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.39937247219152294,0.9741014139290668,0.4953271028037383,0.9279459929288815,1.0,5/13,17.26%,DDX5;SPRED3;ATM;MSX1;SPRED1
prerank,sensory perception of light stimulus (GO:0050953),0.265348409686886,0.974050243062577,0.4867109634551495,0.9269745518072511,1.0,11/87,9.38%,USH1C;GPR143;EYA4;WHRN;ARR3;EML2;PAX6;PCDH15;ADGRV1;CHRNB2;ZIC2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.34619937513057736,-0.9738278282070119,0.48060344827586204,0.7728044260143745,1.0,2/19,1.59%,PARD3;CLIC4
prerank,polyol biosynthetic process (GO:0046173),0.37460409327207383,0.9735247634103055,0.5059760956175299,0.927371435881651,1.0,4/16,17.02%,ISYNA1;CYP27A1;IPPK;IP6K2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.29699044487911713,0.9734189619770941,0.4897260273972603,0.9265814545199105,1.0,12/45,18.13%,HSPA1A;DDX5;RIOK2;SUPV3L1;ZC3H18;WDR75;GRSF1;IL6;ZPR1;RELA;UTP15;NFKB1
prerank,dendritic spine morphogenesis (GO:0060997),-0.36337470620396717,-0.9734042715816335,0.4931506849315068,0.773313099912674,1.0,2/15,0.85%,SHANK3;DOCK10
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4040451036887236,-0.9728405350229753,0.5,0.7741948330076557,1.0,6/11,30.02%,SCARB1;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.4078941014951727,-0.9725303231928658,0.48643006263048016,0.7744341241937349,1.0,4/10,16.96%,CSGALNACT1;XYLT1;B3GAT1;B3GAT3
prerank,mRNA catabolic process (GO:0006402),0.30710316481555416,0.9724134813908837,0.47377938517179025,0.9283740053816016,1.0,8/44,14.65%,HSPA1A;DDX5;DHX34;SUPV3L1;LSM5;TUT4;AGO3;HSPA1B
prerank,cGMP biosynthetic process (GO:0006182),-0.4095082530543094,-0.9723349441591278,0.5099206349206349,0.7744242445538552,1.0,3/10,18.98%,GUCY1B1;GUCY1A1;NPPC
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2604410570192644,-0.9723128118767037,0.5023809523809524,0.7739277189668492,1.0,18/70,20.92%,TCF12;LMO2;RUNX1;PSMB7;PSMA6;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;METTL3;PSMD10;PSME1
prerank,regulation of RNA splicing (GO:0043484),0.27621183630454765,0.9718964212485991,0.46983546617915906,0.9287186544294642,1.0,26/69,21.81%,HSPA1A;HNRNPH3;PQBP1;FASTK;PTBP2;SON;SRSF10;HNRNPL;PTBP1;TIA1;SRRM4;CLK3;YTHDC1;AFF2;GRSF1;MBNL3;FAM50A;CLK2;ZPR1;HNRNPH2;PTBP3;CLK1;POLR2A;LARP7;CELF1;HNRNPH1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.22439204740118968,-0.9717863649130101,0.5292479108635098,0.7747382046115554,1.0,31/159,17.80%,HIP1;STXBP6;RPL38;PIK3C2A;TBCD;FCHO2;SGIP1;VAMP3;SMAD1;CLTB;PXN;NCK1;CHMP4B;CHMP4A;PTGES3;SRP19;TIAM1;NUP107;SRC;IMMP2L;BBS12;HIP1R;TPR;HIGD2A;CCT2;RTN4;PSMD11;DNAI4;ADRM1;DMD;TMEM35A
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2640328603033854,0.9710883043055429,0.4896551724137931,0.9298922424386465,1.0,26/88,22.17%,BMP7;SMAD3;STX18;ERCC1;STAM;SMPD3;NRG1;SNF8;GNL3L;PIH1D1;CLU;CHGA;HYAL1;PRKCA;FNIP1;TIRAP;CX3CL1;BRK1;SLF1;TRABD2B;BAX;EMILIN1;SDCBP;PLEK;SLX4;ATP13A2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.38226860058515844,0.970844863857905,0.4854771784232365,0.9294387867081498,1.0,3/15,3.64%,FGF1;FGF4;SMOC2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.24146979341712974,-0.9704646446333106,0.5231143552311436,0.7774958859736618,1.0,28/105,22.88%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMB7;PSMA6;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMC4;PSMB8;TAB1;PRKACA;PSMD11;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;PSMB3;BCL10
prerank,negative regulation of T cell activation (GO:0050868),-0.2898773652023657,-0.9704171147107613,0.5011185682326622,0.7770620545160387,1.0,17/35,39.69%,TNFRSF21;CEACAM1;DUSP3;CD86;NCKAP1L;JAK3;GLMN;FCGR2B;CEBPB;IL4I1;LAPTM5;GPNMB;SDC4;VTCN1;ARG1;PDCD1LG2;CD80
prerank,regulation of spindle assembly (GO:0090169),0.3435813780493736,0.9702688031096937,0.4712430426716141,0.9300155997876904,1.0,8/25,16.72%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A;SPAG5
prerank,regulation of TOR signaling (GO:0032006),0.27662853683389804,0.9702644230350994,0.5062388591800356,0.928918059768261,1.0,25/67,24.63%,PRKAA2;NPRL3;RRAGC;RICTOR;DEPTOR;SLC38A9;PIH1D1;FBXO9;LAMTOR2;NPRL2;TSC1;LAMTOR3;SIRT1;TELO2;FNIP1;RRAGB;PDCD6;MLST8;ARAF;TMEM127;LAMTOR1;EPM2A;TTI1;GPAT3;UBR2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2778171893870925,0.9700507868063484,0.4982394366197183,0.928414841260282,1.0,16/68,18.49%,GTPBP1;ACSM2A;ACSM2B;ACAT1;GLYAT;LRRK2;AMPD3;RHOQ;CROT;ABHD14B;RAB23;ACOT1;ACOT6;TPST1;AK3;ACOT13
prerank,regulation of fibrinolysis (GO:0051917),-0.3760393029297423,-0.9698140028358615,0.4768611670020121,0.7780360044941647,1.0,3/13,9.37%,FAP;THBS1;SERPINE1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.36794948032927133,0.9691399061790069,0.5020080321285141,0.9298966673763868,1.0,4/16,9.38%,APPL2;PPARA;NLRC3;ABCD1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.35217706050225633,0.9690067354686116,0.4959349593495935,0.9291737238132037,1.0,5/22,8.17%,CACNB1;CACNB3;CRHR1;GNB5;DRD3
prerank,connective tissue development (GO:0061448),-0.2976651933451535,-0.9689631266591403,0.49888641425389757,0.77965283070469,1.0,5/35,6.88%,ZBTB16;LRP5;PKD1;CD44;SH3PXD2B
prerank,lysine catabolic process (GO:0006554),0.4151905189092414,0.9688840323131501,0.50293542074364,0.9273201717802119,1.0,2/12,12.05%,ALDH7A1;GCDH
prerank,lysine metabolic process (GO:0006553),0.4151905189092414,0.9688840323131501,0.50293542074364,0.9273201717802119,1.0,2/12,12.05%,ALDH7A1;GCDH
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.31709569519930425,0.968883905289607,0.4943820224719101,0.9262253427698456,1.0,7/33,11.57%,PLK5;APPL2;E2F1;CRNN;TAF1;STXBP4;CDC73
prerank,cellular response to interleukin-2 (GO:0071352),-0.3948495628240627,-0.9688138745678455,0.5300207039337475,0.7789109472784508,1.0,6/11,28.04%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3948495628240627,-0.9688138745678455,0.5300207039337475,0.7789109472784508,1.0,6/11,28.04%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,primary miRNA processing (GO:0031053),0.42414081612482435,0.9678329774879617,0.524390243902439,0.928178723234861,1.0,2/10,4.80%,SMAD3;HNRNPA2B1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4127878734894268,0.9675247253728373,0.5183673469387755,0.9279830832605804,1.0,4/11,18.34%,DERL1;BAG6;RNF5;UGGT2
prerank,cholesterol homeostasis (GO:0042632),-0.2582204320120074,-0.9675220196316487,0.5248756218905473,0.7815914202451212,1.0,13/64,12.06%,CAV1;CYP7B1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;INSIG1;APOE;LIMA1
prerank,mammary gland development (GO:0030879),-0.33735496817553223,-0.96745418962584,0.5,0.781212140074341,1.0,6/21,13.96%,CAV1;TBX3;ARHGAP35;NOTCH4;TGFB3;VEGFA
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2189099916129588,-0.9672908727714096,0.5674157303370787,0.7810714912677088,1.0,48/198,19.74%,PTPRB;PLCB4;PLCE1;PLA2G4A;PIP4K2A;INPP4A;LIMD1;LIMK2;PLCG1;ALPL;STAT3;AGK;PLCG2;PANK3;TNFAIP8L3;PAK2;INPP5D;ALDOA;PPP3CA;PRKCG;PIK3CA;PLPP1;CDK5;PPP1CA;PFKL;BCKDK;DUSP3;PIK3CD;EPHB2;GFPT2;DUSP23;AGPAT1;PTPRC;ALK;PLPP3;NT5C;IPMK;THNSL2;ACYP1;COQ8A;PPIP5K1;ENPP1;MAPK3;PTEN;TIGAR;NADK;IMPA2;INPP4B
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2656124184729784,0.9670608086097199,0.4927536231884058,0.9282170132130911,1.0,7/87,3.18%,NOTCH2;ROCK2;PDGFRA;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3413052465549194,0.9666609051254377,0.5028790786948176,0.9282433861213698,1.0,4/24,8.37%,ERRFI1;ROCK2;HOXA7;MED1
prerank,regulation of fibroblast proliferation (GO:0048145),0.297594859256849,0.9665806679302245,0.4982078853046595,0.9273679497279316,1.0,8/45,11.57%,IGF1;PDGFRA;SPHK1;E2F1;NLRC3;MED25;CD300A;CDC73
prerank,response to exogenous dsRNA (GO:0043330),-0.3394084541564051,-0.9665579940448366,0.4928131416837782,0.7823701022290771,1.0,4/18,4.50%,CAV1;RFTN1;IRAK3;RALB
prerank,negative regulation of dephosphorylation (GO:0035305),0.35950342721022643,0.9663957954651322,0.4789579158316633,0.9267984351746148,1.0,2/18,2.62%,SH3RF2;SH2D4A
prerank,protein import (GO:0017038),0.263764638348712,0.9663084686589235,0.5406779661016949,0.9260030736788097,1.0,19/84,18.18%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;ATAD1;TOMM22;ABCD1;LAMP2;NXT1;CLU;IPO8;SNX33;TNPO2;IPO4;NUP88;AKT1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.40058066099826883,-0.9657240557055393,0.48893360160965793,0.7839645502487754,1.0,3/10,16.22%,THBS1;AKT2;CTTNBP2NL
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.21836315377381535,-0.9656094997495908,0.5357142857142857,0.7837228341395982,1.0,55/190,20.58%,PDE4D;PDE3A;CAV1;DAB2IP;SLIT2;TMSB4X;THBS1;SH3BP4;BCL2L1;LIMD1;PTPRJ;ESR1;CCN3;PDE10A;PIK3IP1;CIT;XDH;RACK1;PDE2A;LYN;OTUD7B;HDAC7;IFI35;PPP2R5C;SRC;CD2AP;DUSP3;PER1;PHLPP1;TWIST1;TNFAIP8L1;PEBP1;TBC1D7;PLAUR;DDIT4;APLNR;GPER1;RNF157;PHLPP2;UBR1;CARD19;MCL1;MARK3;PTEN;ZC3H12A;USP10;NR1H4;AKT1S1;ARRB2;PSMD10;RIPK1;SPI1;PPP2R5B;AJUBA;NMI
prerank,regulation of mitochondrial fission (GO:0090140),-0.3235196445743259,-0.9655409388058674,0.4746450304259635,0.7833627367800884,1.0,4/24,9.44%,DCN;KDR;MFF;MYO19
prerank,neurotrophin signaling pathway (GO:0038179),-0.3304976964123775,-0.9654794993915313,0.494949494949495,0.78295217191182,1.0,5/21,9.67%,RAPGEF2;RAP1A;NGF;SORT1;BCAR1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3486581783687775,-0.9653825649354769,0.4891089108910891,0.7826449248166983,1.0,3/18,5.65%,UBC;RPS27A;UBB
prerank,mitotic cytokinetic process (GO:1902410),-0.3405385813771892,-0.9652114302937727,0.48812095032397407,0.7825364337798761,1.0,4/20,7.51%,RHOA;CHMP2B;CHMP4B;CHMP4A
prerank,negative regulation of cell communication (GO:0010648),-0.3361628547882899,-0.9651806107753368,0.49056603773584906,0.7820624058246672,1.0,5/21,9.76%,ACVR1;UBASH3B;HHIP;PTPN1;SOCS5
prerank,regulation of blood circulation (GO:1903522),-0.29741358036635446,-0.9650348935981319,0.5130434782608696,0.7819141587533813,1.0,10/34,18.83%,ECE1;AGTR1;CAMK2D;KCNMB2;KCNQ1;KCNJ12;ACE2;TBX2;PLN;CACNA1H
prerank,iron-sulfur cluster assembly (GO:0016226),-0.32515800037891074,-0.9648896027844173,0.5206611570247934,0.7817494786880137,1.0,8/24,18.07%,NUBPL;NFU1;HSCB;NFS1;GLRX3;BOLA2;ISCA2;NUBP1
prerank,DNA catabolic process (GO:0006308),-0.3955198676532911,-0.964887647736859,0.49901768172888017,0.7812122245859152,1.0,5/11,35.13%,REXO4;DFFB;XRN2;ISG20;MUS81
prerank,negative regulation of viral process (GO:0048525),0.2831543067824852,0.9648562227941523,0.4948453608247423,0.9290362670994963,1.0,28/57,29.40%,OAS2;TRIM62;UBP1;TRIM5;TRIM35;IFIT1;EIF2AK2;OAS3;STAT1;PML;TRIM13;ILF3;CHMP3;LARP7;TRIM32;PARP10;SLPI;BST2;SRPK1;BTBD17;ZFP36;RNASEL;TRIM8;TRIM11;TRIM28;MBL2;SHFL;MAVS
prerank,regulation of gluconeogenesis (GO:0006111),0.33005776918443597,0.964644312446853,0.4888888888888889,0.9285447671065502,1.0,6/27,16.21%,GCK;PDK2;C1QTNF3;PPARGC1A;SIRT1;CLK2
prerank,regulation of transferase activity (GO:0051338),0.36392521405098677,0.9634981793301035,0.49317738791423,0.930743873108616,1.0,7/17,15.10%,PPP1R3F;PARP4;LDB2;LDB1;SMG6;ATM;FEM1A
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25823529378665566,-0.9634871783089243,0.5154867256637168,0.7841851507235817,1.0,20/66,25.74%,FOXP1;STAT3;APP;CARD16;GBP5;AIM2;WNT5A;TRIM16;MALT1;HSPB1;GIT1;USP50;NOD2;ZC3H12A;MYD88;RIPK2;CASP1;TLR4;F2R;CASP8
prerank,double-strand break repair (GO:0006302),0.24136169458197965,0.9632828894589037,0.5215311004784688,0.930210826701612,1.0,29/158,16.11%,EYA1;PAXX;POLM;ERCC1;RECQL4;XRCC1;ACTR8;AUNIP;TENT4A;ABRAXAS1;EME2;MEIOB;KAT5;KDM2A;ZFYVE26;TDP2;MDC1;MRE11;PRPF19;KDM4A;CHEK2;PIAS4;RNF138;PRKDC;RAD51D;RPA3;ATM;AP5Z1;RAD52
prerank,cellular response to pH (GO:0071467),0.3640892568933366,0.9629329811839282,0.4968944099378882,0.9301406758368532,1.0,4/17,13.67%,TRPV1;IMPACT;KCNK4;HYAL1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.32161032609871726,-0.962758514784192,0.4936708860759494,0.7854629394622622,1.0,8/23,17.93%,ELOVL7;FAR2;ELOVL5;ACSL5;ACSL3;ELOVL6;ELOVL1;ACSL4
prerank,hyaluronan catabolic process (GO:0030214),-0.3498738993987564,-0.9626556792838155,0.5092783505154639,0.785176615136855,1.0,5/18,15.88%,CD44;FGF2;HEXA;CEMIP;CEMIP2
prerank,protein polyglutamylation (GO:0018095),0.41418845763399836,0.962486798562555,0.50199203187251,0.9303016981294815,1.0,4/11,20.68%,TTLL6;CFAP20;TTLL11;TTLL4
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2881434425101394,-0.9623596152156237,0.484304932735426,0.7853872539701497,1.0,8/39,11.29%,MYO1D;ACTN4;MYO1B;SYT4;MYO19;MYO1F;DYNC1I1;FNBP1L
prerank,regulation of protein modification process (GO:0031399),-0.271356104978953,-0.9622970013025018,0.5206971677559913,0.7850080635803682,1.0,10/50,11.11%,CORO1C;FN1;FNIP2;SPRED2;PPP1R16B;LYN;HPF1;IGF2;PARG;HSPB1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3850468149892796,-0.9617104786981933,0.4896694214876033,0.785943611404307,1.0,3/13,4.84%,CAV1;NEDD4L;CAB39
prerank,regulation of programmed necrotic cell death (GO:0062098),0.35177292881672606,0.961546770799103,0.5009633911368016,0.9319486474893416,1.0,3/20,9.37%,NUPR1;FLOT2;CFLAR
prerank,apical protein localization (GO:0045176),-0.4112128762582572,-0.961478681499342,0.51171875,0.7859529787693267,1.0,2/10,0.64%,ACTB;ATP8B1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4033053931496653,-0.9612967983171258,0.5238095238095238,0.7858909692711479,1.0,6/11,27.51%,ICMT;ATG12;ATG5;AGTPBP1;LCMT1;FOLH1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.3147042513623387,-0.9611525727060833,0.5329087048832272,0.7857151156940112,1.0,4/27,5.88%,PRKCH;NFKBIA;ABCA1;AGTR1
prerank,regulation of urine volume (GO:0035809),0.41868766929072937,0.9609380280706468,0.5021097046413502,0.9325258332335088,1.0,1/10,1.90%,NPR3
prerank,purine-containing compound catabolic process (GO:0072523),-0.3896601174096793,-0.9606687022201551,0.533203125,0.7863912149604148,1.0,5/13,15.44%,XDH;GPX1;NT5C1A;NT5E;NT5C
prerank,cellular response to interleukin-12 (GO:0071349),-0.2757267444568017,-0.960125923555007,0.5416666666666666,0.7872340022546763,1.0,21/48,32.39%,MTAP;PAK2;RPLP0;PPIA;CNN2;SOD1;CFL1;PDCD4;JAK1;BOLA2;CAPZA1;CDC42;HNRNPF;MSN;IL12RB2;STAT4;MIF;AIP;CD47;LMNB1;RAP1B
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.29639146091041235,-0.959753733135512,0.529045643153527,0.7876399456782371,1.0,6/33,8.00%,NET1;MAP3K5;CYP1B1;PRKCD;ANXA1;RPS3
prerank,vesicle transport along microtubule (GO:0047496),0.34272839106992276,0.9594841717354451,0.5140712945590994,0.9356150738370693,1.0,8/23,20.29%,TRAK1;FYCO1;HTT;KIF3A;RAB1A;KIF3B;KIF1A;NDE1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4012009044786401,0.9593514588851039,0.4979757085020243,0.9348932645008347,1.0,4/12,16.00%,PRKCZ;GKAP1;SORBS1;SIRT1
prerank,axonemal dynein complex assembly (GO:0070286),0.3281417202878622,0.9593205396784144,0.5180265654648957,0.9339057683849777,1.0,9/27,27.19%,DNAH1;DNAL1;DRC1;DNAAF2;DNAAF5;DNAAF3;DNAH5;DNAH17;ODAD4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.35824006479320475,0.959125639987498,0.5134615384615384,0.9333892292685085,1.0,3/21,8.83%,OSBPL8;PLA1A;OSBPL5
prerank,fatty acid elongation (GO:0030497),0.39211123405662973,0.9590986540667602,0.5,0.9323788929557715,1.0,4/13,9.38%,HACD3;HACD4;HACD1;ABCD1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4031036329066645,0.9590769871810322,0.5089463220675944,0.9313708846068888,1.0,3/12,9.69%,TET1;PPHLN1;MPHOSPH8
prerank,ion transport (GO:0006811),0.2526187518436018,0.9590601359348088,0.5382059800664452,0.9303428702567385,1.0,14/111,12.36%,TRPM3;SLC8A3;SLC24A3;SLC5A5;SLC26A1;GLRA1;WNK4;SLC15A2;CHRNB2;KCNN4;SLC12A5;SLC12A1;PLP2;SLC9A9
prerank,regulation of interleukin-13 production (GO:0032656),0.3938296009207902,0.9587406770223749,0.547244094488189,0.9301753334104176,1.0,2/13,1.64%,IL18;PRKCZ
prerank,T cell differentiation in thymus (GO:0033077),-0.3753874703821827,-0.9585389231979619,0.5275590551181102,0.7900227727246018,1.0,6/14,33.38%,GLI3;PTPRC;LIG4;ZFP36L2;FADD;RABL3
prerank,determination of bilateral symmetry (GO:0009855),-0.3237258795809021,-0.9585116718840261,0.5416666666666666,0.7895482712871706,1.0,14/24,36.70%,NOTCH1;TBX1;DNAH11;STIL;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1;ZIC3;NPHP3;LEFTY1;BBS7;DNAAF4
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.24069042693188317,-0.9583137322537142,0.5768321513002365,0.7895100738506612,1.0,35/87,33.04%,FBXL7;DCUN1D3;FHL1;PSMB7;PSMA6;APC;KLF4;PSMB6;FAM107A;PSMB5;FBXO5;USP47;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PTEN;PSMD10;CDK6;PSME1;PSMB3;E2F7;JADE1;RGCC;ZFP36L2;AVEN;CDKN2B;CUL1;PSMB9;PSMD5;AURKA;GPNMB;MYO16;RBL2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.24393341746817754,-0.9582275204691535,0.5646766169154229,0.7891949645803251,1.0,18/88,13.88%,PTPRB;CAV1;DAB2IP;LRP6;LRP5;CORO1C;ADARB1;PAK2;UBASH3B;PPIA;CEACAM1;CDKN1C;PTPN1;DUSP3;HSPB1;DBNDD2;GSKIP;PTPRC
prerank,gastrulation (GO:0007369),-0.3607365783003439,-0.9580641354612439,0.5168986083499006,0.7890653803751453,1.0,3/15,14.04%,LRP5;LMBRD1;TASOR
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.34561181863475465,-0.9580301471181218,0.516597510373444,0.7886109868949275,1.0,9/17,39.94%,NOS1AP;KCNE4;KCNAB1;KCNS2;RNF207;ANK3;VAMP2;KCNG1;KCNE5
prerank,response to calcium ion (GO:0051592),0.25477784859087915,0.9579528828285867,0.5463743676222597,0.9312163590055187,1.0,18/102,12.28%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SYT10;SLC25A12;RYR2;TRPM2;CPNE6
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.30332836029274945,-0.9574441320901762,0.5042016806722689,0.7895262356591218,1.0,6/30,6.84%,NEDD4L;GJC1;KCNJ2;CACNA2D1;CACNA1G;KCNQ1
prerank,smoothened signaling pathway (GO:0007224),-0.3029587070854428,-0.9573523311134319,0.5232067510548524,0.7891998940371703,1.0,12/32,20.20%,HIPK1;GLI3;ARL13B;TCTN3;PTCH1;SMO;PTCH2;EVC2;STIL;IFT27;DISP3;DYRK2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4041471407174343,-0.957034225079197,0.5173745173745173,0.7894820989248218,1.0,5/10,31.60%,EIF2AK3;ATF4;HERPUD1;QRICH1;HSPA5
prerank,icosanoid secretion (GO:0032309),-0.38742380319812464,-0.9566278052409438,0.49015748031496065,0.7899216573845402,1.0,2/12,7.14%,ABCC4;ANXA1
prerank,diacylglycerol metabolic process (GO:0046339),-0.31737207511458243,-0.9565342775089534,0.5298969072164949,0.7896224170220755,1.0,3/23,3.32%,PLCE1;DGKH;DGKZ
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.31580695969783834,0.9558332220195486,0.5245614035087719,0.9361005346613708,1.0,8/30,13.08%,LEPROT;PDCD5;HTRA2;CSNK2A2;RHOU;FZD5;ATG13;RNF31
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2579747968024959,-0.9557376077755823,0.5238095238095238,0.7910503238630441,1.0,19/67,22.69%,B2M;VAMP3;TAP2;PSMB7;PSMA6;ITGB5;NCF2;PSMB6;PSMB5;PSMC4;PSMB8;SNAP23;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.39102919870584835,0.9557143474355242,0.5334645669291339,0.9353864995204098,1.0,4/13,11.36%,NUPR1;NR1H3;USP19;CLU
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.31749578977511606,-0.9555351722837838,0.5223880597014925,0.7909967389927174,1.0,6/26,20.13%,CAV1;MFHAS1;IFI35;RSAD2;RTN4;HMGB1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3131550647328019,0.9553385217015591,0.527831094049904,0.9353933201924629,1.0,9/32,15.78%,MAP2;CLIP3;TTBK2;EML2;CLASP1;APC2;TUBB4A;NAV3;MAPRE1
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.33490678491442466,-0.9550795630383845,0.5104602510460251,0.7916197429591878,1.0,6/19,15.08%,PRKCD;ABCD2;TWIST1;PNPLA2;AKT2;IRS1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.34592576278033293,0.9548777713088944,0.5221579961464354,0.9355979069745778,1.0,5/20,11.57%,CTR9;MEIS1;LEO1;LDB1;CDC73
prerank,cellular response to cAMP (GO:0071320),-0.2979358488875434,-0.9547674369536934,0.5407239819004525,0.7918510404611576,1.0,7/30,15.91%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6;CFTR
prerank,protein methylation (GO:0006479),0.2985756942304056,0.9546425999962506,0.5290102389078498,0.9352075870956731,1.0,13/40,21.33%,EEF2KMT;PRMT2;N6AMT1;FAM98B;NSD1;PCMT1;PRMT3;NTMT1;ETF1;NSD3;SNRPB;VCPKMT;PRMT5
prerank,somite development (GO:0061053),-0.3925753346728639,-0.9541905012390001,0.5238095238095238,0.7927241385040867,1.0,4/11,12.98%,MEOX2;PPP2R3A;PTCH1;SMO
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3930491772126059,0.9538648977250809,0.5057692307692307,0.9363366300337026,1.0,2/14,4.99%,IL18;EBI3
prerank,endoplasmic reticulum organization (GO:0007029),-0.2515315950728803,-0.9538301473560938,0.5419664268585132,0.7931147896841992,1.0,27/72,26.64%,ATL3;APP;STX1A;LMAN2L;SEC16B;EIF2AK3;CAV2;SHTN1;SEC61A1;SEC31A;REEP3;REEP5;UBE2J2;VAPB;RTN4;RTN3;REEP1;TOR1AIP2;WDR83OS;STX5;DOP1B;GAK;TLE6;LPCAT3;REEP2;VAPA;HMOX1
prerank,positive regulation of viral transcription (GO:0050434),-0.3146307954093857,-0.9538153866650358,0.5138888888888888,0.7926142000118996,1.0,13/25,37.63%,MDFIC;GTF2F1;POLR2I;POLR2F;POLR2H;NELFCD;CCNT1;POLR2E;RSF1;POLR2J;NELFE;DHX9;NELFB
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2514818699753614,-0.9537344866793046,0.5586854460093896,0.7922470779911539,1.0,30/68,36.87%,STAT3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;CD74;TWIST1;IFIH1;NOD2;IL33;HMGB1;MYD88;SYK;BCL10;TLR4;PTPN11;F2R;AIF1;TLR6;TLR1;NOS2;TMEM106A;LGALS9;TYROBP;TLR3;TSLP;POU2AF1;DHX9;TLR2
prerank,sodium ion import across plasma membrane (GO:0098719),0.3670393491190287,0.9536949498150895,0.4972375690607735,0.9357298065614802,1.0,1/17,0.21%,SLC6A1
prerank,response to ionizing radiation (GO:0010212),0.27130808688514463,0.9534098293926919,0.5134680134680135,0.9354678031276411,1.0,17/70,18.80%,EYA1;FANCD2;ABRAXAS1;KAT5;CLOCK;INIP;MAPK14;BRAT1;AEN;MEN1;ATM;GADD45A;SIRT1;CLK2;FIGNL1;TRIM13;NHEJ1
prerank,cardiolipin metabolic process (GO:0032048),-0.38012172376648834,-0.9533920130655174,0.5122448979591837,0.7925833223637636,1.0,4/13,17.50%,PLA2G4A;PTPMT1;PLA2G6;TAMM41
prerank,protein polymerization (GO:0051258),-0.26797080782914834,-0.9533785599310041,0.5207373271889401,0.7920764123115395,1.0,12/55,12.88%,GSN;MSRB2;MAP7D3;CHMP4B;CHMP4A;TPPP3;WASHC3;FAM107A;FGF13;MICALL2;PSTPIP2;TRPV4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.35233044690194415,0.9532791077396563,0.499054820415879,0.9347284193545548,1.0,4/19,11.43%,RENBP;GNPNAT1;GNPDA1;PMM2
prerank,positive regulation of telomere capping (GO:1904355),-0.3511603049839461,-0.9531856827820454,0.5246913580246914,0.7920250235999697,1.0,6/17,21.29%,NEK7;TNKS;MAPK1;MAPK3;MAP2K7;MAP3K4
prerank,pyruvate metabolic process (GO:0006090),0.2864766985956023,0.9531172274069112,0.5245614035087719,0.9341113937174562,1.0,8/52,6.76%,GCK;ME2;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,response to interferon-beta (GO:0035456),-0.32108977613114875,-0.9531123485189578,0.5138004246284501,0.7916746743550962,1.0,4/22,7.53%,PLSCR1;IFITM3;AIM2;XAF1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4162182553850695,0.9528039362905555,0.5214592274678111,0.9338855516163616,1.0,6/10,20.04%,NLRC3;CACTIN;PPM1B;SIRPA;PTPRS;PYCARD
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.40145365732097194,-0.9526647426161551,0.5158562367864693,0.792189692282813,1.0,4/11,31.15%,AGTR1;PLA2G7;AGT;PLA2G5
prerank,positive regulation of autophagy (GO:0010508),0.2636187776384006,0.9524933229566676,0.534804753820034,0.9336909817788239,1.0,13/81,10.32%,RNF152;PRKAA2;PLEKHF1;OPTN;PIK3CB;TRIM5;IKBKG;LRRK2;KAT5;GPSM1;SESN1;HTT;PAFAH1B2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.35700391918594987,0.952265077615615,0.5292929292929293,0.9332528004504135,1.0,3/17,5.25%,NUPR1;PPARA;PPIF
prerank,negative regulation of metabolic process (GO:0009892),0.2850905735295344,0.9521530447690743,0.5212014134275619,0.9325025589780088,1.0,11/54,13.41%,LGR4;NPR3;NOVA1;ARRDC3;RBPJ;MAP2K6;ALDH1A1;NR1H3;DOCK7;LAMA4;NRDC
prerank,neuron remodeling (GO:0016322),-0.40358936873203927,-0.9520594052700511,0.5374015748031497,0.7931408597795137,1.0,3/10,3.60%,ANKS1A;SCARF1;APP
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.23942688461846673,-0.9518714308168779,0.5597189695550351,0.7930479636756956,1.0,23/88,22.69%,FBXL7;PSMB7;PSMA6;FBXO31;FBXO4;PSMB6;PSMB5;FBXO44;FBXW7;FBXL18;PSMC4;PSMB8;PSMD11;PSMB4;CCNF;AMN1;FBXL4;PSMD14;PSMD10;FBXW5;PSME1;FBXL6;PSMB3
prerank,regulation of translation (GO:0006417),-0.21900798799509452,-0.9517956429008989,0.5714285714285714,0.7927063907728339,1.0,59/173,29.33%,NIBAN1;THBS1;FOXO3;RBM3;RPL5;APP;RPL10;RPS6KA3;EIF3E;ALKBH1;EIF3H;RACK1;EEF2;MTRF1;EIF2B2;RPS3;EIF4E;EIF2AK3;HSPB1;NCBP2;SYNCRIP;EIF1B;NCBP1;DHFR;DDX25;FMR1;FXR1;EIF4G3;RIDA;GAPDH;NCL;METTL3;PIWIL2;MTG1;EIF4H;EIF4A3;PRR16;EIF3B;KLHL25;CAPRIN1;NANOS3;RPL13A;BTG2;SHMT2;DAPK1;BCL3;TYMS;HNRNPD;RPS4X;RPS6KA1;LTN1;MTIF2;METTL14;NSUN5;SHMT1;GEMIN5;CNOT1;IGF2BP1;PCIF1
prerank,body fluid secretion (GO:0007589),0.3761973342158318,0.9516906901039983,0.4869215291750503,0.9327341455172009,1.0,3/15,13.20%,PRLR;VIP;SLC22A2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.246993533619529,0.9516472087315134,0.5698051948051948,0.9318041981702854,1.0,14/129,8.56%,RNF220;LGR4;LRRK1;WLS;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2;LRRK2;LYPD6
prerank,nucleotide biosynthetic process (GO:0009165),-0.33696237657626776,-0.9512462578190118,0.5061224489795918,0.7935488467118699,1.0,10/18,39.32%,ME1;HPRT1;RRM2B;NMNAT1;PRPSAP1;RRM1;PRPS2;GART;RRM2;PPAT
prerank,neuromuscular synaptic transmission (GO:0007274),0.3553531876853331,0.9510053169884944,0.5372050816696915,0.9325079714150979,1.0,2/18,8.95%,DTNA;CHRNB2
prerank,proteasome assembly (GO:0043248),-0.3958636460765099,-0.9509076507580101,0.537109375,0.7938532396893344,1.0,4/11,21.67%,PSMD11;ADRM1;PSMD10;PSMG1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.26331408456013033,-0.9505113461666663,0.5532879818594104,0.7943051811653881,1.0,11/56,13.45%,SPTBN1;RHOA;STMN1;SNX18;CIT;APC;CHMP4B;KIF23;DCTN3;INCENP;IST1
prerank,positive regulation of proteolysis (GO:0045862),0.2833249581530738,0.9500280432158474,0.5496575342465754,0.9341058042848233,1.0,18/55,23.51%,SH3D19;FURIN;CAPN3;ADRA2A;PLK1;CYFIP2;CTSH;NRDC;NDUFA13;SNX33;SNX9;ASPH;NLRC4;RCN3;ATP5IF1;TRIM32;BTRC;PACSIN3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3214459508186682,-0.949973224474751,0.5387931034482759,0.7950981195375676,1.0,4/23,10.45%,MYO10;DYNC1I2;TUBA1A;DYNC1I1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.25561549080458634,0.9496888670620014,0.5477386934673367,0.933992738120561,1.0,24/95,16.31%,HS3ST3A1;UST;HS3ST3B1;OGN;CHST15;ST3GAL3;HS6ST1;OMD;NDST1;PXYLP1;B4GALT2;B4GALT1;B3GALT6;B4GALT3;HS3ST5;HS3ST6;HS6ST2;HYAL1;CSPG5;HS2ST1;FMOD;DSE;ABCC5;NDST2
prerank,protein localization to cilium (GO:0061512),0.3165370029667425,0.9495234321928845,0.5327272727272727,0.9334113348339766,1.0,7/32,15.62%,TTC21B;TULP3;WDR19;WDR35;IFT122;TCTN2;ARL3
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3497789863576547,-0.9495213836107559,0.5247933884297521,0.7957150560378395,1.0,4/17,9.58%,TMSB4X;ANXA1;OTUD7B;KLF4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.37297111477875405,0.9493817130168043,0.5337301587301587,0.9327511941859037,1.0,2/15,3.76%,TMEM33;ATL1
prerank,nuclear body organization (GO:0030575),-0.3854873965602398,-0.9491840371148159,0.539714867617108,0.7960587544070977,1.0,4/12,16.33%,ETS1;SERBP1;USPL1;USP50
prerank,mitochondrial protein processing (GO:0034982),0.4044961670156267,0.9480636947244054,0.524896265560166,0.9352775494651,1.0,2/11,5.71%,AFG3L2;IMMP1L
prerank,mesenchymal cell development (GO:0014031),-0.3447506719611192,-0.9480150764388334,0.5463917525773195,0.7984822614072241,1.0,12/18,37.05%,NOTCH1;HEYL;HEY2;CDH2;SOX8;SOX11;TAPT1;SNAI2;TBX20;KBTBD8;NOLC1;CYP26C1
prerank,regulation of protein polymerization (GO:0032271),0.30467606003574127,0.9479631665717585,0.5098039215686274,0.9345143665939543,1.0,10/35,21.12%,MAP2;ARHGAP28;PRUNE1;ARL2;ABL1;GBA2;ABITRAM;HSP90AA1;TTBK1;DBNL
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2486331750515705,-0.947884596541093,0.5776255707762558,0.7982473505071814,1.0,14/75,12.90%,ACTB;MEF2C;FARP1;PARD3;APP;KLF7;TBCD;BTBD3;CDK5;S100A6;DSCAML1;RAB3A;MFSD2A;SHTN1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3767404827158403,0.9478396866272462,0.5334608030592735,0.9338369972927786,1.0,6/15,18.18%,IGF1;PPIF;CLU;HGF;NOL3;AKT1
prerank,peroxisome organization (GO:0007031),-0.3169906541606735,-0.947745458910218,0.5265306122448979,0.7980652637194942,1.0,5/25,8.59%,TMEM135;MFF;SEC16B;ABCD2;PEX7
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3411129383355778,0.9477384011245827,0.5303030303030303,0.9330771257139484,1.0,4/20,6.63%,IGF1;IGFBP3;BMPR1A;NDRG4
prerank,phospholipid metabolic process (GO:0006644),0.27173723169528946,0.9476912324084875,0.5404929577464789,0.9321640845960721,1.0,16/71,17.56%,FITM2;AGPAT4;PLA2G4C;SMPD3;PCYT2;PLCD1;CLN8;PLPPR3;SMPD2;ACP6;ABCA2;PLA2G15;GDE1;PLBD2;PLAAT3;AGPAT2
prerank,macromolecule catabolic process (GO:0009057),0.32768301156351665,0.9474291448224299,0.5470249520153551,0.9318260398585404,1.0,6/26,15.00%,CAPN3;KIF16B;CTRL;CLN8;CLN5;UCHL3
prerank,regulation of cell motility (GO:2000145),-0.22946228861570694,-0.9473445133146018,0.5798969072164949,0.7985571113638619,1.0,37/121,22.35%,FRMD5;SPOCK2;DOCK10;TMSB4X;RHOA;NTN1;EGFR;MACF1;SPATA13;FLNA;ROBO4;PRKX;CEACAM1;ABI3;FGF2;TMSB10;FGF7;CCDC25;TWIST1;PLXNC1;SST;AKT2;AMOT;CAVIN1;CSF1R;PLXNA4;MEMO1;OSGIN1;HACE1;PRAG1;RHOB;CDK6;AMOTL1;ROCK1;PLXND1;SLK;NRG2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.39663849278859004,0.9466910057021745,0.5334685598377282,0.9328423014034533,1.0,6/12,18.89%,CHRNB2;EPHA4;TSKU;EPHB1;GLI2;MYCBP2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3393386829661308,-0.9460078440865648,0.5205761316872428,0.8013623440612118,1.0,11/18,40.18%,RAD51B;BRD4;FBXO5;CCND1;RAB11A;DTL;STOX1;CDK1;CCNB1;VPS4B;RCC2
prerank,glutathione derivative metabolic process (GO:1901685),0.3421716807748147,0.9459938871334416,0.5138888888888888,0.9326708297518196,1.0,7/20,18.67%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3421716807748147,0.9459938871334416,0.5138888888888888,0.9326708297518196,1.0,7/20,18.67%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,regulation of myotube differentiation (GO:0010830),-0.3156145585776934,-0.9458750915183832,0.5325842696629214,0.8011675478759058,1.0,5/24,9.00%,NOTCH1;PIEZO1;CCN3;HDAC9;TMEM119
prerank,N-glycan processing (GO:0006491),-0.33814245922253716,-0.9456683880698712,0.5564853556485355,0.8011698146004782,1.0,6/18,14.13%,ST8SIA4;FUT8;ST8SIA6;MGAT4A;MGAT4B;ST8SIA2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.36064426315968945,0.9456162058394929,0.5329341317365269,0.9327398146042681,1.0,4/17,11.28%,ANK2;SNTA1;KCNH2;RYR2
prerank,renal water homeostasis (GO:0003091),0.3325075907210051,0.9452609986380224,0.5200764818355641,0.932691766598807,1.0,3/23,6.40%,ADCY5;ADCY1;ADCY8
prerank,regulation of synapse assembly (GO:0051963),-0.2756625322485269,-0.9452086687910761,0.5464362850971922,0.8017696857019775,1.0,9/46,14.50%,GPC6;MEF2C;PDLIM5;APP;CLSTN2;IL1RAP;EPHB2;LHFPL4;SRPX2
prerank,protein localization to cell junction (GO:1902414),-0.3230436133436039,-0.9451833184163737,0.5244444444444445,0.8012907438380036,1.0,7/22,15.01%,HEG1;TJP1;TJP2;PAK2;JAK1;JAM3;FERMT2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.39107343787764226,-0.9450615889238323,0.545271629778672,0.8010670131156034,1.0,2/10,1.96%,ZBTB16;ACVRL1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.286621541625749,0.9447379007789068,0.5597147950089126,0.9330996679953647,1.0,13/52,17.87%,ADHFE1;ALDH1L1;ME2;HAAO;SLC19A1;MTHFS;MTHFR;IDH2;GOT1;MTHFD1;FPGS;GOT2;MTHFD2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3152193647069948,-0.9445181199221684,0.5450733752620545,0.8018662387828303,1.0,6/25,13.57%,RPL5;GABARAPL2;RPS7;PRKCG;RPL23;CSNK2A1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3632945545420224,0.9442824540791804,0.520242914979757,0.9333180150906788,1.0,3/16,12.01%,APPL2;WDTC1;SOX9
prerank,positive regulation of axonogenesis (GO:0050772),-0.27439345791959757,-0.9439595458239695,0.5692640692640693,0.802731743343819,1.0,13/43,15.86%,SLIT2;RHOA;NTN1;SEMA7A;NGF;MACF1;TIAM2;TIAM1;PLXNC1;SHTN1;ARHGDIA;LIMK1;PLXNA4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.36675342742543743,0.9439338608678164,0.5370018975332068,0.9333063203547811,1.0,7/16,21.38%,MRAP2;GRP;CHGA;MRAP;PRKCA;PRMT5;KLK6
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.24617518094949223,-0.9438328128646644,0.5544303797468354,0.8024881500299124,1.0,29/78,28.02%,ACTB;PKD1;EGFR;CCNY;APC;IPO7;CDKN1C;SERTAD1;MYOCD;IPO5;GTF2H1;HHEX;BLM;LATS1;CCNF;CCND1;PTEN;PSMD10;CCND2;CDKN1B;CCNH;CCNB2;RGCC;LATS2;CDKN3;MAPRE3;CCNJ;CDKN2B;CCNT1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3421527854523331,0.9433515272889599,0.5251396648044693,0.9339055656074787,1.0,3/21,4.60%,CEL;CYP26B1;LPIN1
prerank,negative regulation of bone remodeling (GO:0046851),-0.38470254473471044,-0.9432206647705601,0.5343811394891945,0.8034285898549156,1.0,4/11,27.88%,UBASH3B;TMEM119;GREM1;GPR137B
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24058790036528097,0.9431478694262806,0.5721153846153846,0.9334086460937732,1.0,15/138,9.80%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;RBPJ;WWTR1;MED1;TAF10;PPARGC1A;NR1H3;RXRA
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3007494760579897,0.9422105958287984,0.5677083333333334,0.9348943494615423,1.0,9/38,13.08%,LEPROT;LRRK2;HTRA2;BAG4;CSNK2A2;RHOU;FZD5;ATG13;RNF31
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3776694064901676,-0.9416669693738723,0.551440329218107,0.8067058913835973,1.0,6/13,21.57%,RPS15;NMD3;ABCE1;LTV1;SDAD1;RRS1
prerank,defense response to virus (GO:0051607),0.2530237610596464,0.941282426812092,0.5759599332220368,0.9362667761668727,1.0,16/100,9.76%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;AGBL4;NCBP3;IFIT1;EIF2AK2;ZDHHC1;RNF135;OAS3;BCL2;STAT1
prerank,response to UV (GO:0009411),-0.2367023652993803,-0.9412662178766242,0.6146341463414634,0.8072082067182849,1.0,33/95,25.20%,DCUN1D3;EGFR;PTPRK;PRKCD;ZBTB1;MFAP4;CAT;GPX1;ERCC2;USP47;COPS9;SCARA3;BAK1;RHBDD1;UBE2A;ATF4;FMR1;N4BP1;RHNO1;PRIMPOL;CCND1;PCLAF;METTL3;XPA;NEDD4;MAP2K7;NSMCE3;MAP3K4;MAP4K3;TRIAP1;DTL;USP1;BCL3
prerank,fatty acid beta-oxidation (GO:0006635),0.2820148497740737,0.9410730511330532,0.5499092558983666,0.9358140500224275,1.0,11/51,12.05%,ACAT2;IVD;ACAT1;ACAD10;ECHS1;ABCD1;AMACR;ACAD11;ECHDC2;CROT;GCDH
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.35573564508286415,0.9407525892282855,0.5512104283054003,0.9356584407627768,1.0,4/18,12.63%,C5AR2;SPG21;C3AR1;BAG6
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3384792212028236,0.9405462825959965,0.547486033519553,0.935167422692713,1.0,2/22,5.04%,ROCK2;PPP4R4
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.3910548802911134,0.9403838730832124,0.5220883534136547,0.9346044591070597,1.0,1/12,0.87%,IL18
prerank,regulation of DNA replication (GO:0006275),-0.26581553567315236,-0.9399591042194911,0.5648148148148148,0.809846008495032,1.0,5/49,2.77%,BCAR3;ACVRL1;KAT7;WAPL;EGFR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.31369735337168625,0.93972620992719,0.5480943738656987,0.9354353740260398,1.0,4/31,4.35%,HSPA1A;DNAJC18;OPTN;DNAJB14
prerank,positive regulation of histone acetylation (GO:0035066),0.3248626652004809,0.9394524588801662,0.5354477611940298,0.9351520809494639,1.0,8/23,15.56%,RUVBL2;ARRB1;PPARGC1A;BRD7;PIH1D1;SPHK2;WBP2;MUC1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2975651174644679,-0.9393066849811775,0.5134529147982063,0.8109886714676932,1.0,7/27,15.66%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.1953353377145333,0.9388540183825921,0.7549361207897793,0.9357495488641613,1.0,228/1646,13.19%,DENND4A;ZKSCAN2;MAF;BMP7;RORA;HLF;EPAS1;WNT4;CREB5;SNX6;PPARGC1B;IGF1;DDX5;TRAK1;SMAD3;KMT5A;VGLL3;KDM7A;OSR1;NR2E1;DNMT3L;HMX2;NPAS3;SCML4;SOX5;MSX2;OVOL2;SUFU;CTR9;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;FBXL19;MYBL2;ARID4A;NR6A1;CREBRF;CRABP2;ARNT2;ZNF23;TENM1;PPARA;ZNF431;PBX2;KIT;SALL4;ZFP3;NFYB;GLIS3;UBP1;SLTM;ESRRA;TULP3;POU1F1;KMT2A;HOXB9;CAPN3;PICALM;SIM1;TFDP2;CCAR2;ENO1;WNT7A;SMARCD3;MSANTD1;DKK3;CCNT2;HOXB3;CHUK;LOXL3;ZHX1;MEIS1;MAFG;CCAR1;ASCC2;TIAL1;MLXIP;PEG3;RUVBL2;RBPJ;PRMT2;PCID2;PQBP1;PAX6;ACTR8;IKZF1;PHF8;MZF1;IKZF2;E2F1;ARID3A;ZBTB26;ZFHX2;BICRAL;RNF14;WWTR1;HOXA7;RCOR3;ZKSCAN3;RFX8;DRGX;PBX4;DDX17;NFYC;NR2F2;CITED1;CEBPA;NRG1;DPF1;PCGF5;PBXIP1;JARID2;BCL11B;LBH;ARRB1;ZSCAN22;HOXB6;BCL7A;SRSF10;BEND5;KAT5;TEF;ZC3H8;PHF1;PHF2;SNF8;CHD3;ARHGEF11;KLF15;KDM5B;ZNF569;ZNF467;HOXA3;KCNH2;MED1;E2F8;KDM2A;HES6;ZFX;CEP290;MAFA;HINFP;MAX;MAP3K10;ZNF711;PPARGC1A;USF1;NR1H3;HIF3A;GON4L;PRDM2;ZBTB22;SSBP2;PHIP;HDX;ZIC2;CLOCK;DMAP1;FZD7;NKAP;COMMD7;MLLT11;TGFBR1;HOXB4;MPHOSPH8;NSD1;ZFP90;FOXP4;PSIP1;STAT1;RXRA;BATF;SALL3;CREBL2;LCOR;ZNF260;BRD7;LDB1;CSRNP3;PLCB1;PRKCB;MBD1;RNF20;MXI1;RNF10;MAGED1;RNF6;CAND2;E2F4;CSRNP1;MAPK14;ABCA2;ZFPL1;STAT2;GATAD2A;KDM5C;PCGF6;ZBTB49;QARS1;SRA1;SOX9;RCOR2;CIPC;DMTF1;KDM4A;PML;CHEK2;RBAK;RLIM;RING1;ZNF367;MED12L;PURB;GABPA;HBP1;MYBL1;CBFA2T2;BHLHE41;TGFBRAP1;ARNT;NIF3L1;PIAS4;MAP3K12;ZIC5;BRD2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3411331178182268,-0.9388146121109172,0.5482546201232033,0.8116304222339369,1.0,9/17,35.61%,CXCL12;SERPINE1;HMGB1;CCR2;ANO6;PLA2G7;AIF1;CXCL17;CCL5
prerank,protein modification by small protein conjugation (GO:0032446),0.21442394939813553,0.9378901782968563,0.6384180790960452,0.937301828097774,1.0,83/361,21.78%,RNF220;EYA1;RNF152;RNF43;EPAS1;CTR9;PDZRN3;ASB2;DTX1;DERL1;TRIM62;RNF41;POM121;NUP155;TRIM5;PLK1;KLHL13;LEO1;SHPRH;RNF14;UBA1;TRIM35;ARRB1;FBXO11;DTX2;DCUN1D4;DTX3;BRAP;HIF3A;RNF135;TRAF7;TOPORS;RNF20;UBE2W;RNF6;CAND2;HLTF;CDC73;FBXO9;NUP98;RLIM;NEDD8;PIAS4;RNF138;SPSB2;PRKDC;UBE2R2;RNF7;EIPR1;UCHL3;NUP37;BCL11A;RNF213;SIRT1;MDM2;KLHL20;USP9X;RANGAP1;UBE2S;NUP88;ANAPC7;SPSB1;RNF139;TRIM13;MYCBP2;RNF26;KCTD13;TRIM63;NDC1;FBXL5;ZSWIM8;KLHL7;NFX1;TRIM41;RNF103-CHMP3;RAE1;URM1;FBXL15;KLHL21;CUL7;TRIM33;HECW1;TRIM32
prerank,tRNA wobble uridine modification (GO:0002098),0.36414018013306326,0.9378410826792282,0.5038461538461538,0.9364068917149155,1.0,5/14,22.89%,TRMT9B;GTPBP3;KTI12;URM1;ELP1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.37155198749476365,0.937794574094017,0.519774011299435,0.9355273973550107,1.0,2/14,7.38%,HSPA1A;LRRK2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24348429788266568,-0.9373787681068084,0.597254004576659,0.8146485646066031,1.0,20/74,22.69%,NOTCH1;LIMD1;UBC;RPS27A;UBB;PSMB7;PSMA6;VHL;PSMB6;PSMB5;VEGFA;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;EGLN3;PSMB3
prerank,regulation of protein metabolic process (GO:0051246),-0.2734898758095697,-0.9371285404740991,0.5568181818181818,0.8146970932703468,1.0,11/44,15.93%,LTBP4;NEDD4L;APP;SPOPL;KLF4;APOE;HGS;GSAP;KLF2;PLAUR;ZDHHC2
prerank,spinal cord development (GO:0021510),-0.3742963569832197,-0.9370846249780691,0.5515789473684211,0.814258028489804,1.0,2/12,2.39%,VIT;PKD1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3844877876043027,-0.9369894637939241,0.5330578512396694,0.8139139783615833,1.0,7/11,37.73%,IL34;ID2;RIPK1;CASP8;FADD;LIF;PF4
prerank,regulation of fat cell differentiation (GO:0045598),0.2679477768921147,0.9365815787104327,0.5759599332220368,0.9377497968716343,1.0,11/74,12.29%,RORA;TMEM64;SMAD3;LMO3;LRP3;E2F1;WWTR1;CREBL2;AAMDC;ADIG;CDS1
prerank,ion homeostasis (GO:0050801),-0.292371401405302,-0.9364557705072285,0.5653104925053534,0.8146769369943042,1.0,4/30,6.13%,SLC4A10;NEDD4L;FHL1;CAMK2D
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3400727127244223,0.9362724015223245,0.5202952029520295,0.9375836754151115,1.0,7/21,24.26%,GCK;HKDC1;G6PC3;HK1;GPI;PGLS;SHPK
prerank,endocrine system development (GO:0035270),0.3392675548844873,0.93613416260893,0.523719165085389,0.9369546385675375,1.0,3/21,9.64%,WNT4;DKK3;TGFBR1
prerank,sterol transport (GO:0015918),-0.33521890836669666,-0.9360669485066454,0.5665961945031712,0.8151142334787708,1.0,3/19,6.14%,CAV1;NPC2;OSBP
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3389646859602719,-0.9359498934808704,0.5575757575757576,0.8148662131336473,1.0,4/17,13.88%,PPP1R12A;ITGA1;CALM3;PTPRC
prerank,positive regulation of cell cycle process (GO:0090068),-0.2339575358097885,-0.9359179702604001,0.6222760290556901,0.8144118179799996,1.0,31/91,25.64%,RHOA;SVIL;INSR;LRP5;PLSCR1;MAP3K20;CIT;IGF2;EDN1;KIF23;TPR;RAD21;EDN3;NUSAP1;RHNO1;CEP295;NUDT16;RANBP1;KIF20B;DYNC1H1;CDC42;E2F7;GPSM2;NUP62;GIPC1;EGF;CUL3;PRKCE;RGCC;XRCC3;KIF14
prerank,myeloid cell development (GO:0061515),-0.32980845969842176,-0.9351549721784504,0.5650406504065041,0.8158454378354192,1.0,5/18,16.25%,FOXP1;APP;SRC;NCKAP1L;NRROS
prerank,Golgi organization (GO:0007030),0.24741611077744946,0.9350137061905471,0.5824742268041238,0.9389524286657006,1.0,22/112,13.20%,PLK5;OBSL1;DYM;TANGO2;BET1;OPTN;CLASP1;FAM174B;STX16;LRRK2;GOLGA2;TRAPPC11;HTT;SEC23IP;MYO18A;VPS51;TMED9;GOLGA8B;GOLGA5;STK25;TMED4;RAB1A
prerank,negative regulation of telomere maintenance (GO:0032205),0.37265674306485147,0.9345698690581842,0.5401174168297456,0.9391429479901864,1.0,7/15,21.97%,ERCC1;TNKS2;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.21150067859960767,-0.9343517706419766,0.6763005780346821,0.8172438699965777,1.0,59/184,27.27%,YWHAE;PKD1;CDC27;HECW2;DYNC1I2;UBC;ANAPC5;CSNK1E;XPC;RPS27A;UBB;PSMB7;PSMA6;CDC16;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;ERCC2;ODF2;DYNLL1;ZW10;PSMC4;FZR1;PSMB8;CCP110;PRKAR2B;ID2;PRKACA;PAFAH1B1;PSMD11;PSMB4;PTPN6;PSMD14;CDC26;DYNC1H1;PSMD10;DCTN1;PSME1;CSNK1D;TUBA4A;CEP131;TPX2;PSMB3;CEP41;CDK5RAP2;CDC23;CEP152;CUL3;RGCC;HMMR;ZFP36L2;KIF14;ANAPC1;AKAP9;CDK2;ACTR1A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.33382509712918235,-0.9340319600921504,0.534020618556701,0.8174883739461729,1.0,7/18,17.93%,ELOVL7;ELOVL5;ACSL5;ACSL3;ELOVL6;ELOVL1;ACSL4
prerank,peptidyl-proline modification (GO:0018208),0.3225797921442627,0.9339770221295137,0.5559633027522936,0.9397252707926755,1.0,3/25,5.88%,PPIL6;PPIF;NKTR
prerank,regulation of mRNA stability (GO:0043488),-0.21878133362486615,-0.9338865717697032,0.6180048661800487,0.8172986269821315,1.0,42/145,23.38%,FTO;UBC;YWHAB;SERBP1;PABPC1;FASTKD1;RPS27A;UBB;EXOSC1;AXIN2;PRKCD;PSMB7;PSMA6;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;FUS;PSMC4;PSMB8;PUM1;TENT5C;FMR1;PSMD11;TBRG4;FXR1;PSMB4;CARHSP1;RIDA;PSMD14;METTL3;PSMD10;SET;TENT5A;PSME1;ROCK1;RBM24;PSMB3;EXOSC5;EXOSC4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2793092928882716,0.9335314542461736,0.5818505338078291,0.9399404973951064,1.0,11/51,13.37%,BMP7;GAS7;LRRK2;CNTNAP2;WASF1;KLK8;GPM6A;DTNBP1;NYAP2;BDNF;DICER1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2940367264353676,-0.9333639032706154,0.5844444444444444,0.8180179520842766,1.0,12/31,30.16%,HJURP;RBBP4;NASP;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;SMARCA5;RSF1
prerank,myotube cell development (GO:0014904),0.3913342876321614,0.9333350155563057,0.5304878048780488,0.9394971235339142,1.0,2/10,9.28%,IGF1;MYORG
prerank,response to amyloid-beta (GO:1904645),0.2847628354066702,0.9331457525607365,0.5444444444444444,0.938981192527178,1.0,3/44,1.57%,SNX6;IGF1;CACNB1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3349912541344028,0.9331133372986462,0.5504761904761905,0.9380466368733604,1.0,6/21,15.48%,HS3ST3B1;HS6ST1;HS6ST3;HS3ST5;HS6ST2;HS2ST1
prerank,maintenance of protein localization in organelle (GO:0072595),0.3522185436660857,0.9329426715713396,0.5426356589147286,0.937499196015414,1.0,6/19,18.18%,HNRNPU;ARL2;TOPORS;PML;HK1;AKT1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3180530140839094,-0.9329193375629425,0.550321199143469,0.8185362551945191,1.0,9/23,31.15%,PLA2G4A;MBOAT1;ABHD4;PLA2G6;LPCAT3;PLA2G4F;PLA2G4B;LPCAT4;PLA2G5
prerank,positive regulation of secretion by cell (GO:1903532),-0.24900944786926132,-0.9327370296114993,0.5990783410138248,0.8184225202232157,1.0,21/70,18.80%,SLC12A2;TGFB2;UNC13B;STX1A;TMED10;PPIA;CD2AP;TGFB3;GOLPH3;EDN1;EXOC1;RAB3A;RAB27A;BMP2;EDN3;KCNB1;APBB3;CFTR;GPER1;EXPH5;MYOM1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30860698179346563,-0.9327004800215548,0.5615866388308977,0.8179632023454229,1.0,7/27,12.43%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.33902467279759296,-0.9324658595903049,0.5566801619433198,0.8179966466717125,1.0,4/17,11.11%,PPIA;SOD1;BAG5;HSPB1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.29387378311642315,-0.932374422825895,0.5641025641025641,0.8176814566112157,1.0,17/30,33.91%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;TLR4;CASP8;CD300LF;FADD;TLR6;IRF3;IKBKB;CD14;TLR3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.26588487867534016,-0.9322020204286655,0.5533333333333333,0.8175793380615163,1.0,20/50,32.81%,ACTB;CDKN1C;SERTAD1;GTF2H1;BLM;CCNF;CCND1;CCND2;CDKN1B;CCNH;CCNB2;CDKN3;CCNJ;CDKN2B;CCNT1;STOX1;CDK5R2;CAMK2N1;CCNE1;CDC6
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.340301627057966,-0.9319260832774813,0.5560165975103735,0.8177246025035436,1.0,6/18,20.61%,PLCG2;DOCK2;IFI35;DYSF;NMI;SYK
prerank,lipoxygenase pathway (GO:0019372),-0.3596179603113392,-0.9318402663085815,0.5493827160493827,0.8173895509038368,1.0,3/14,9.66%,PTGS2;PON2;GPX1
prerank,lymphocyte proliferation (GO:0046651),-0.3137085362512958,-0.9316460994835879,0.5564853556485355,0.8173208576183493,1.0,5/22,14.49%,MEF2C;ELF4;CTPS1;PTPRC;CD40
prerank,cellular response to insulin stimulus (GO:0032869),0.24294596819536932,0.9313609979917771,0.5812101910828026,0.9408440010046919,1.0,27/124,15.14%,CPEB2;GCK;BAIAP2;PIK3R3;ATP6V0A2;INSIG2;LPIN1;ATP6V0B;ATP6V1H;SOS1;PDPK1;PDK2;PRKCI;ATP6V1B2;USF1;PHIP;RHOQ;ATP6V1E1;SORBS1;EPRS1;RAB13;SLC27A4;ATP6V0E2;ATP6V1C1;PRKDC;ATP6V0D2;GOT1
prerank,protein hydroxylation (GO:0018126),-0.36047935553697885,-0.9313315932322754,0.5511022044088176,0.8175510115490128,1.0,9/15,38.19%,PLOD2;PLOD3;JMJD4;EGLN3;JMJD7;P3H1;VIPAS39;P3H2;PLOD1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.23364703225668929,-0.9312951060858907,0.6240786240786241,0.817128481913024,1.0,24/91,23.71%,CDC27;ANAPC5;XPC;PSMB7;PSMA6;CDC16;PSMB6;PSMB5;FBXO5;ERCC2;TCIM;FBXW7;PSMC4;FZR1;PSMB8;PSMD11;PSMB4;PSMD14;CDC26;PSMD10;PSME1;PSMB3;CDKN1B;CDC23
prerank,triglyceride metabolic process (GO:0006641),0.2828968343056084,0.9312710201800092,0.5668449197860963,0.9400776412374223,1.0,7/48,16.47%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2;SIRT1;PLAAT3
prerank,cell proliferation in forebrain (GO:0021846),0.41342210525042916,0.9312609020164696,0.5447316103379721,0.9390985534266487,1.0,3/10,11.00%,WNT7A;PCM1;DOCK7
prerank,glial cell differentiation (GO:0010001),-0.3044312247601779,-0.9312116075979392,0.5651260504201681,0.8167790357521207,1.0,10/28,22.99%,ADGRG6;STAT3;CDK5;PTPRZ1;CDH2;GPC1;SOX8;METRN;MYRF;SOX11
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3583708803088058,0.930902124961602,0.5282651072124757,0.9390918290111154,1.0,5/15,12.87%,SOS1;CASP3;NTRK2;FRS2;BDNF
prerank,regulation of superoxide anion generation (GO:0032928),-0.35712244169861795,-0.930713432483937,0.5386138613861386,0.8174308163704967,1.0,10/14,47.30%,PRKCD;SOD1;SYK;AATF;MAPT;TYROBP;CRP;GSTP1;F2RL1;CD177
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.29684280070740915,0.9306143701941081,0.5369718309859155,0.9388894484210599,1.0,3/39,2.86%,NNAT;GCK;NLGN2
prerank,dendritic cell differentiation (GO:0097028),-0.3220543172420327,-0.9305659311748419,0.5711422845691383,0.8172791830427744,1.0,3/22,6.32%,GAS6;TGFBR2;LYN
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.34207406514901595,0.9305505628888835,0.5338645418326693,0.9380621879599754,1.0,3/21,3.46%,IGF1;FGF9;BMPR1A
prerank,regulation of lymphocyte activation (GO:0051249),-0.3781917842378397,-0.9304777123054441,0.5474747474747474,0.8169607587968519,1.0,7/12,37.71%,DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,inner dynein arm assembly (GO:0036159),0.40361777989475744,0.9303678985703135,0.533195020746888,0.9374981322865916,1.0,1/10,2.79%,DNAH1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2261993144956233,-0.9302879453632086,0.6551724137931034,0.8168795054059322,1.0,34/121,23.38%,PRR5L;UBC;YWHAB;SERBP1;PABPC1;RPS27A;UBB;EXOSC1;PRKCD;PSMB7;PSMA6;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;PSMC4;PSMB8;PUM1;FMR1;PSMD11;FXR1;PSMB4;CARHSP1;PSMD14;ZC3H12A;PSMD10;SET;PSME1;RBM24;PSMB3;EXOSC5;EXOSC4
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.39056334255064573,0.9302168442559321,0.5360824742268041,0.936867507998773,1.0,4/12,17.04%,DPYD;CRMP1;DPYSL2;UMPS
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2738594996370289,-0.9300061039146759,0.5897435897435898,0.8169766305114434,1.0,6/47,4.54%,SPTBN1;STXBP6;MACF1;EXOC6;RAB31;EXOC4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3481518169458811,0.9297594158339316,0.5519848771266541,0.937131507711851,1.0,6/20,13.49%,DAB2;PICALM;PKDCC;RHOQ;MRAP2;MRAP
prerank,regulation of intracellular protein transport (GO:0033157),-0.2884944844014391,-0.9297375082958353,0.589010989010989,0.8171113950599548,1.0,14/32,25.14%,PRR5L;BMP4;ICE1;PTPN1;RIPOR1;TPR;ZFAND1;B3GAT3;KIF20B;SIRT7;CEP131;OAZ1;PLK3;NDEL1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.33168976391613214,0.9297240256069657,0.5413669064748201,0.9362345835938108,1.0,2/23,2.82%,PLK5;ZWINT
prerank,cellular response to fatty acid (GO:0071398),-0.3859178520470607,-0.9294289707705038,0.5526838966202783,0.8173124418192792,1.0,4/12,19.29%,PID1;IRS1;ZC3H12A;NR1H4
prerank,positive regulation of protein import (GO:1904591),-0.29203724048411667,-0.9292971359716368,0.5521064301552107,0.8171311395814168,1.0,10/30,22.95%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR;ARHGEF5;ZC3H12A;JUP;HCLS1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.39551266987871214,0.9292371009160704,0.563953488372093,0.9365909638200935,1.0,3/11,8.26%,KCND3;KCNJ5;KCNH2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2643695797106024,-0.9290668434848359,0.5981308411214953,0.8171639357311564,1.0,26/54,26.31%,RPL5;RPL10;RPL7;MRPL20;RPLP0;RPL35A;RPF1;RPL7A;SURF6;RPL6;RPL24;RPL10A;RRP15;RPL14;GTF3A;MRPL1;MRTO4;EBNA1BP2;RPL3;SDAD1;RRS1;NHP2;NOP16;RPL23A;PPAN;MDN1
prerank,retrograde axonal transport (GO:0008090),-0.35360294473564063,-0.928979857849254,0.572938689217759,0.8168470337040867,1.0,5/16,19.47%,DST;SOD1;PAFAH1B1;KIF1C;DYNC1H1
prerank,neuronal action potential (GO:0019228),-0.3205398640037296,-0.9288993572536849,0.5796460176991151,0.8165125396196853,1.0,7/22,23.54%,CACNA1G;KCNMB2;CACNA1I;SCN3A;GPER1;CACNA1H;SCN7A
prerank,protein polyubiquitination (GO:0000209),-0.19906292530363107,-0.928831847545547,0.7407407407407407,0.8161253221551864,1.0,64/297,18.73%,FBXL7;NEDD4L;TRAF5;WWP1;ZNRF1;CDC27;SMURF1;HECW2;UBC;ANAPC5;LMO7;RNF166;RNF144A;UBE2V2;RNF144B;RPS27A;UBB;RNF125;UBE2D3;TNKS;TRIM14;FBXW8;PSMB7;TRIM56;PSMA6;UBE2J1;ZNRF2;CDC16;CBFB;FBXO31;FBXO30;ARIH2;FBXO4;PSMB6;FBXO32;ARIH1;PSMB5;FBXW2;FBXO44;UBE2Q1;LNPEP;UBE2L3;FBXW7;PPIL2;FBXO28;FBXL18;TPP2;UBE2J2;KLHL3;PSMC4;FZR1;PSMB8;KBTBD7;UBE2A;RNF19A;PSMD11;UBE2G1;PSMB4;CCNF;BARD1;FBXL4;HACE1;PSMD14;CDC26
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.29906868341107234,-0.9286872775949352,0.5535714285714286,0.8159674431576952,1.0,12/26,30.68%,ST3GAL4;ST8SIA6;GOLPH3;GCNT1;B4GALT5;ST3GAL2;ALG6;RRM2B;GK5;B3GNT6;ALG11;RRM1
prerank,membrane repolarization during action potential (GO:0086011),-0.3720650012751853,-0.9286850410081934,0.5443298969072164,0.8154495845080177,1.0,5/13,15.61%,YWHAE;KCNJ2;KCNQ1;ATP1A1;KCNE4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3756327139315345,-0.9280867512701761,0.5618448637316562,0.8163501625263931,1.0,6/12,28.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,regulation of mitochondrion organization (GO:0010821),-0.26551406575286673,-0.9279207401130259,0.5738758029978587,0.816227519022109,1.0,21/47,31.63%,PID1;MFF;PDE2A;IAPP;MYO19;GOLPH3;SREBF2;SQSTM1;HDAC6;FBXW7;PRMT6;SIRT7;RHOT2;SREBF1;MUL1;MAPT;STOX1;TREM2;VPS35;USP36;FLCN
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21210908992593341,0.9278533816784449,0.6980568011958147,0.9393199987016229,1.0,91/366,21.05%,DENND4A;RORA;PPARGC1B;SUFU;CTR9;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;TULP3;POU1F1;CCAR2;CCAR1;ASCC2;PQBP1;ACTR8;MZF1;E2F1;RNF14;WWTR1;NFYC;CEBPA;SRSF10;PHF1;CHD3;EIF2B4;HES6;MAFA;HINFP;PPARGC1A;GON4L;PRDM2;SSBP2;CLOCK;FZD7;TGFBR1;NSD1;CREBL2;LDB1;RNF20;MAGED1;RNF6;ZFPL1;OBI1;CYFIP1;DMTF1;PML;CHEK2;RBAK;MYBL1;TGFBRAP1;FOXC1;TSC1;ABL1;SMC3;ANKRD17;METTL18;RBBP6;RELA;MITF;NSD3;MYCBP;ELAVL2;MTF2;SOX6;SRRT;MYT1;PCGF1;NLK;APBB1;SOX2;MLX;MLXIPL;KAT6B;DDIT3;PUM3;SPTY2D1;TGIF2;REST;POLR2A;EIF2A;NFX1;BAZ2A;SUPT4H1;MLLT6;GCFC2;HOXB7
prerank,B cell differentiation (GO:0030183),-0.26464517386144437,-0.9273623229309391,0.6013513513513513,0.8170163832487933,1.0,9/46,13.88%,VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;HHEX;ITGA4;PTPRC
prerank,regulation of protein neddylation (GO:2000434),0.39376777723183554,0.9271493695010413,0.5285714285714286,0.9401952021921113,1.0,2/10,8.05%,EPAS1;DCUN1D4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3875688308638331,-0.9269981661046791,0.5705996131528046,0.8173162627003177,1.0,7/10,31.14%,MYD88;TICAM1;TLR4;CD68;TREM2;TLR6;CD36
prerank,cellular response to chemical stress (GO:0062197),-0.23455077401879837,-0.9267437026367555,0.6597402597402597,0.8173698944159031,1.0,21/96,16.00%,CAV1;LRRC8D;FOXO1;PRR5L;FOXO3;FAS;PRKD1;PPIA;ETV5;PIK3CA;SOD1;CAT;GPX1;NCF2;PRDX6;TRPV4;MT3;VKORC1L1;ZFAND1;SRXN1;ATF4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3944441359077064,0.9264747747201486,0.5530612244897959,0.9409913590809639,1.0,5/11,24.44%,PARP14;PARP4;PARP16;PARP10;TIPARP
prerank,response to insulin (GO:0032868),0.2571099895555684,0.926469251398033,0.5794701986754967,0.9400179826771479,1.0,25/80,21.55%,CPEB2;GCK;INSIG2;LPIN1;PDPK1;CITED1;PRKCI;USF1;RHOQ;SORBS1;EPRS1;RAB13;TSC1;PRKDC;GOT1;SIRT1;AKT1;KHK;INHBB;MYO5A;DENND4C;RAB15;EIF6;CAPN10;INPP5K
prerank,positive regulation of chromosome organization (GO:2001252),-0.3567080809330836,-0.9261893495307707,0.5685393258426966,0.8181174428305955,1.0,7/15,23.33%,GNL3;RAD21;SHCBP1L;NBN;LIG4;PPP1R10;SIRT6
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3177405312151649,0.9257729186764077,0.5580524344569289,0.9408306738740476,1.0,8/28,17.86%,HSPA1A;CLASP1;ARL2;DRG1;HSPA1B;NAV3;MAPRE1;CDK5R1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3718435328376032,0.9255970051841825,0.5488721804511278,0.940345779227154,1.0,3/13,9.58%,PCID2;MAD2L1;NDC80
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.3943060969022183,-0.9252233820584576,0.5702970297029702,0.8198559580245028,1.0,3/10,2.26%,BMP5;LRP6;NOTCH1
prerank,glutathione biosynthetic process (GO:0006750),-0.382891724159528,-0.9249758836935243,0.5807127882599581,0.8199411635671189,1.0,6/11,28.75%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.34030043813797517,0.9249138856007341,0.5719626168224299,0.9412471830586632,1.0,2/22,1.39%,IL18;SPHK1
prerank,protein sumoylation (GO:0016925),0.27988593340765755,0.9249110141673205,0.5616197183098591,0.9402661992778263,1.0,10/49,17.14%,EYA1;POM121;NUP155;TOPORS;NUP98;PIAS4;NUP37;BCL11A;RANGAP1;NUP88
prerank,myelin maintenance (GO:0043217),-0.3884341244742227,-0.9246564006128309,0.5463917525773195,0.8202040897665339,1.0,6/10,25.24%,ABCD2;SOD1;PRX;PTEN;MYRF;CXCR4
prerank,ceramide catabolic process (GO:0046514),-0.35167224240546424,-0.924374355713679,0.5295315682281059,0.8203327819985005,1.0,4/14,19.83%,ACER2;HEXA;ASAH2;ACER3
prerank,iron ion transport (GO:0006826),-0.26312241884198284,-0.9241906827646572,0.6108597285067874,0.8202423477514613,1.0,10/47,13.97%,SCARA5;STEAP3;ATP6V0A4;SLC40A1;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B
prerank,negative regulation of cilium assembly (GO:1902018),-0.3713806045292027,-0.9241070323401865,0.5533596837944664,0.8199113274819704,1.0,6/12,19.73%,LIMK2;MAP4;EVI5L;TBC1D7;CCP110;CEP97
prerank,regulation of tau-protein kinase activity (GO:1902947),0.400012553351745,0.9240963834355131,0.5588235294117647,0.9415003654371928,1.0,10/10,60.02%,CLU;HSP90AA1;SORL1;RB1;HSP90AB1;IFNG;DKK1;NAB2;C5AR1;EGR1
prerank,sensory organ development (GO:0007423),0.27872860223851065,0.9238221718479884,0.5582191780821918,0.9412670642918938,1.0,11/51,14.48%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;CPAMD8;ZDHHC16;SHROOM2;FOXC1;ADAMTS18
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2293311108465132,-0.923697214311001,0.6289473684210526,0.8203242433896566,1.0,34/100,23.83%,CBFA2T3;EIF3H;RNF144A;CSNK1E;COP1;RNF144B;NKD2;RACK1;ZYG11B;CSNK1A1;UBXN1;ARIH2;USP7;SOCS5;ARIH1;BAG5;PABIR1;FOXF2;RAD23B;GABARAP;GNA12;RNF19A;N4BP1;RYBP;PSMD10;TRIB2;UCHL5;GLMN;FHIT;CSNK1D;TAF9;TRIB3;SUMO2;GIPC1
prerank,positive regulation of lyase activity (GO:0051349),0.3726816348045747,0.9236792034712061,0.5562130177514792,0.9406254629029048,1.0,1/14,0.44%,CACNA1D
prerank,nucleotide-excision repair (GO:0006289),-0.23188783094620732,-0.9233974496150468,0.60880195599022,0.8205310403786218,1.0,30/101,23.39%,RPA1;UBC;RNF111;XPC;RPS27A;UBB;SLC30A9;CHD1L;USP7;GTF2H5;GTF2H1;RAD23B;ERCC2;AQR;BRCA2;PPIE;GPS1;RPA2;LIG4;POLA1;XPA;RFC4;POLR2I;COPS6;POLD4;ATXN3;POLR2F;CCNH;POLB;COPS4
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2367100948502214,-0.9227380918955703,0.6191646191646192,0.8215440311935076,1.0,31/96,23.05%,MEF2C;TGFB2;NDNF;FOXO3;NGF;SIX1;PRKCG;FOXQ1;MDK;SOD1;CDK5;TGFB3;NSMF;APOE;UNC5B;PTPRZ1;PTK2B;LANCL1;MT3;KCNB1;SIX4;ATF4;CRLF1;LIG4;AKT1S1;AGAP2;SET;EGLN3;RASA1;NFATC4;KDM2B
prerank,protein dephosphorylation (GO:0006470),0.2368340491749433,0.9224500493617048,0.6142857142857143,0.9429104405335887,1.0,28/135,16.57%,PPP2R2B;EYA1;DUSP29;PTPN9;EYA4;EYA2;PPM1M;PTPN13;PTPN4;DUSP11;PPEF2;TNS2;PPM1G;MTMR4;PTPRD;PTPN21;PPM1D;PPP1CB;MTMR2;CDC14B;PTPN14;PPP6C;PTPRO;PTPRU;PPP2CB;UBLCP1;DAPP1;PPM1B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3856687104369098,0.9223908127133937,0.5404858299595142,0.9421010628896377,1.0,4/12,12.39%,HNRNPU;PCGF5;YTHDC1;RLIM
prerank,protein deubiquitination (GO:0016579),-0.2042424774935803,-0.9219891833404562,0.7151162790697675,0.8228669446977576,1.0,64/242,23.11%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;USP46;AR;PSMB7;PSMA6;APC;OTUD7B;MINDY1;USP7;USP35;EIF3F;SPATA2;PSMB6;MINDY2;PSMB5;HGS;BABAM2;RAD23B;RNF123;USP47;BIRC3;IFIH1;PSMC4;PSMB8;CCP110;FOXO4;TAB1;ENY2;CFTR;USP50;PSMD11;ADRM1;RNF128;JOSD1;PSMB4;RUVBL1;BARD1;PSMD14;UCHL1;PTEN;ZC3H12A;USP10;IL33;ARRB2;PSMD10;RIPK1;UCHL5;PSME1;RCE1;TRRAP;CYLD;ATXN3;PSMB3;POLB;USP15
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2348424105483312,0.9218150909269405,0.627831715210356,0.9426327940888165,1.0,15/152,7.38%,RNF220;LGR4;LRRK1;RSPO2;WLS;WNT5B;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2;LRRK2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.29956689554242544,-0.9217087991098644,0.5766871165644172,0.8230022403132257,1.0,6/26,7.62%,ST3GAL4;ST3GAL6;B3GNT2;B4GALT4;ST3GAL1;LUM
prerank,cilium organization (GO:0044782),0.2239759724493784,0.9214349384098751,0.6320610687022901,0.942685782880904,1.0,55/209,21.20%,CFAP44;DCDC2;INTU;CC2D2A;DYNLT2B;GALNT11;TEKT2;WDR19;ATAT1;RILPL2;IFT74;WDR35;TTBK2;TEKT5;CEP78;RILPL1;SNAP29;CFAP61;TMEM138;CEP290;DYNC2I2;WDPCP;BBS5;ARMC9;IFT122;PCM1;TTC8;CPLANE2;B9D1;KIF3A;TMEM67;ASAP1;IFT80;CDC14B;RAB1A;CFAP20;TCTN2;ARL3;RAB23;GBF1;FUZ;RPGR;PTPN23;KIF3B;DYNC2H1;OCRL;ARMC2;TTC36;CFAP54;RFX2;PTPDC1;CNGB1;CEP126;TXNDC15;DZIP1
prerank,regulation of mast cell degranulation (GO:0043304),0.36920720971492027,0.9213962661941445,0.5424063116370809,0.9418005973154541,1.0,3/14,11.76%,UNC13D;CD300A;SPHK2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.39394977958081556,0.9212969476933507,0.5415821501014199,0.9410896232891695,1.0,2/10,8.28%,HSPA1A;IMPACT
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2205647014614562,-0.9212348659718643,0.6648793565683646,0.8236257986878667,1.0,35/116,24.27%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;PLK2;GNG2;ADCY7;IAPP;SRC;ADCY2;YES1;CYSLTR2;CYSLTR1;ADM;PRKAR2B;PRKACA;PTH1R;GPR27;ADCYAP1R1;HCK;NPSR1;PTHLH;SYK;FYN;GPR176;GGT1;FCGR1A;FCGR2B;PRKAR1B;LHCGR
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3202488447907717,0.9208175230091321,0.5430711610486891,0.9414035454361782,1.0,10/25,23.74%,LEO1;HNRNPU;EAF2;LDB1;CDC73;SUPT4H1;LARP7;CDK12;WDR43;RNF8
prerank,protein K48-linked ubiquitination (GO:0070936),0.2744301774024127,0.9205893612813019,0.5703971119133574,0.9410094061820046,1.0,4/54,4.61%,RNF152;UBE2E2;IFI27;RNF126
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2681180621354324,0.9204483106453527,0.5803571428571429,0.9404119902258569,1.0,18/59,18.70%,ROCK2;OXSR1;WNK3;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;MAP3K12;PRKDC;PRKCA;DYRK4;CDK5R1;AKT1;NLK;HIPK2
prerank,cellular response to nutrient levels (GO:0031669),-0.25106589097723303,-0.9204210508221692,0.6258503401360545,0.8250715111694613,1.0,18/62,18.03%,BMPR2;FOXO1;WIPI1;RALB;TFEB;MAP1LC3B;STK24;FAM107A;RPTOR;RIPOR1;SREBF2;MFSD2A;RRAGA;GAS2L1;KCNB1;CLEC16A;WDR45B;STK26
prerank,glycine metabolic process (GO:0006544),0.38430117738588343,0.9202473961056028,0.5489443378119002,0.9399769882741801,1.0,3/12,15.28%,GLDC;GLYAT;GCAT
prerank,striated muscle cell development (GO:0055002),-0.3467483661654624,-0.9199063236768915,0.5308641975308642,0.8257703538749349,1.0,2/14,8.47%,PGM5;TMOD3
prerank,"transcription, DNA-templated (GO:0006351)",0.224221700810995,0.9198003677452176,0.6533742331288344,0.9401796678349811,1.0,24/207,11.69%,MAF;DDX5;SOX5;CTR9;THRB;RRAGC;DTX1;GLIS3;CCNT2;POLRMT;TCEA1;LEO1;E2F1;TAF10;EAF2;DRG1;CREBL2;TOPORS;RNMT;MBD1;TAF1;TSC22D1;CDC73;MLLT1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.36897900456413796,-0.9195749242896455,0.5647773279352226,0.8260090062583562,1.0,3/13,6.84%,GJC1;CACNB2;KCNQ1
prerank,protein localization to organelle (GO:0033365),0.23850225355906082,0.9194173249854743,0.6217532467532467,0.9402339552453536,1.0,28/133,16.93%,BMP7;OBSL1;ANK2;MICALL1;TTC21B;TULP3;CSRP3;OPTN;LMNA;WDR35;LRRK2;TOR1B;TIA1;TOPORS;LAMP2;SCG3;IFT122;BICD1;CCDC47;CYB5A;FAM83H;BANP;ARL3;MSX1;GET1;MDM2;GBF1;MTCH2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.38095938738853075,0.9191902449208416,0.5529865125240848,0.9388920163547186,1.0,6/12,23.47%,IGF1;PTBP1;CHERP;AKAP6;CAMTA1;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.38095938738853075,0.9191902449208416,0.5529865125240848,0.9388920163547186,1.0,6/12,23.47%,IGF1;PTBP1;CHERP;AKAP6;CAMTA1;SLC9A1
prerank,positive regulation of vacuole organization (GO:0044090),-0.38829326997235564,-0.9188533170851496,0.5772811918063314,0.8271299298446069,1.0,2/10,4.50%,PIP4K2A;RALB
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.381951412238853,0.9185884118512433,0.545816733067729,0.939487814094176,1.0,2/12,1.66%,IGF1;GCK
prerank,granulocyte differentiation (GO:0030851),-0.3281296751547392,-0.9182698230455529,0.5541922290388548,0.8279661485951161,1.0,3/18,9.75%,LEF1;CBFA2T3;TAL1
prerank,renal absorption (GO:0070293),-0.38618202458448336,-0.9181602756666448,0.5787321063394683,0.8276809903269214,1.0,4/10,22.13%,GSN;KCNQ1;KLHL3;HAS2
prerank,hyaluronan metabolic process (GO:0030212),-0.3102293301225777,-0.9179022023487077,0.5849056603773585,0.8277578742090472,1.0,6/23,15.88%,CD44;FGF2;HEXA;HAS1;CEMIP;CEMIP2
prerank,response to glucose (GO:0009749),-0.2598088489993736,-0.9171223277908682,0.5990783410138248,0.8290619779034392,1.0,13/46,20.70%,THBS1;GAS6;UNC13B;ERN1;RACK1;EIF2B2;PFKL;KCNB1;PRKACA;GPER1;EIF2B1;NKX6-1;IGF1R
prerank,positive regulation of protein transport (GO:0051222),-0.24157334702851513,-0.9171066712288735,0.657074340527578,0.8285759898539927,1.0,21/67,19.04%,TGFB2;PRR5L;ICE1;UNC13B;TMED10;RACK1;PPIA;CD2AP;TGFB3;GOLPH3;ACSL3;RIPOR1;EXOC1;TPR;ZFAND1;APBB3;B3GAT3;KIF20B;EXPH5;MYOM1;ARHGEF5
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29391497674899614,-0.9170000351316283,0.5711206896551724,0.8283136307421467,1.0,4/29,5.71%,CAV1;TNFSF10;THBS1;PAK2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3309188054047658,0.9168724759894719,0.5667311411992263,0.9429911653530366,1.0,3/23,8.23%,IGF1;NLRP2B;NLRP3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3168369518041179,0.9167048639380372,0.576427255985267,0.942459037450179,1.0,9/26,23.47%,IGF1;FHL2;PTBP1;CHERP;AKAP6;PRNP;RCAN1;CAMTA1;SLC9A1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.23645472008323615,-0.9161915411175201,0.6225961538461539,0.8295972568573788,1.0,16/78,12.95%,CAV1;CBFA2T3;RNF144A;CSNK1E;COP1;RNF144B;NKD2;RACK1;ZYG11B;CSNK1A1;BCAP31;ARIH2;SOCS5;ARIH1;PABIR1;GABARAP
prerank,organelle assembly (GO:0070925),-0.18881523704923764,-0.9155905038480632,0.7857142857142857,0.8304570315463373,1.0,69/384,15.70%,ABCC4;PGM5;ABLIM1;NEK7;GSN;NOTCH1;PKD1;DISC1;CD34;STARD9;LIMD1;ATG3;EXOC6;WIPI1;RPS23;EXOC4;FLNA;FAM161A;GABARAPL2;CHMP2B;IFT140;ABLIM3;TNKS;SH3PXD2B;BBS9;ABCA3;MAP1LC3B;ARL13B;CHMP4B;CHMP4A;RB1CC1;RPS3;ATP6V0D1;G3BP1;VPS36;TMOD3;ATG16L1;PDE6D;RP2;WDR11;PARVA;EXOC1;EHD2;TCTN3;HGS;FNBP1L;EHD4;PIBF1;PIK3C3;SNX10;HDAC6;GABARAP;STX7;UBXN2A;ATP6V1D;DYNLL1;IST1;AVIL;CYS1;UBAP2L;DZIP1L;RAB1B;BBIP1;VPS37A;CFAP43;TMEM216;KIF24;ATG12;AUP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.21901119731265467,-0.9154821146848959,0.671957671957672,0.8301587484388335,1.0,32/117,22.22%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;PLK2;GNG2;ADCY7;IAPP;SRC;ADCY2;YES1;CYSLTR2;CYSLTR1;ADM;PRKAR2B;PRKACA;PTH1R;GPR27;ADCYAP1R1;HCK;NPSR1;PTHLH;SYK;FYN;GPR176;GGT1;FCGR1A
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31613061771827855,0.9153842351634177,0.5882352941176471,0.9449402915883571,1.0,4/25,8.85%,GPR143;ITPR1;LRRK2;HTT
prerank,tRNA methylation (GO:0030488),-0.2926022853273391,-0.9153568062711513,0.5929203539823009,0.8299096536528936,1.0,10/34,19.24%,METTL2A;METTL2B;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;METTL6;LCMT2;TRMT112
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.37997950659319707,-0.9152062670772774,0.5791583166332666,0.8297424393921049,1.0,4/10,17.78%,CRY1;FEM1B;WDR76;RPA2
prerank,positive regulation of cell cycle (GO:0045787),-0.24639149930996987,-0.9149084600931642,0.6205250596658711,0.8299062836487135,1.0,10/62,10.00%,LRP6;TGFB2;TBX3;PKD1;EGFR;APP;CCNY;EIF4E;TAL1;DUSP3
prerank,regulation of cellular response to heat (GO:1900034),-0.2371511779354731,-0.9148737374099759,0.6383495145631068,0.8294485782751718,1.0,21/77,19.93%,RPA1;YWHAE;CD34;CAMK2D;MAPK1;PTGES3;NUP107;MAPKAPK2;RPTOR;BAG5;TPR;HSBP1;HIKESHI;BAG1;SEC13;DNAJC2;RPA2;NUP50;MAPK3;AKT1S1;NUP85
prerank,activin receptor signaling pathway (GO:0032924),0.3513065540320087,0.9144457373380817,0.5665399239543726,0.9464479754845897,1.0,4/15,19.90%,SMAD3;TGFBR1;INHBB;SMAD2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3631016750919268,0.9140190263224565,0.562,0.9465966674690702,1.0,6/13,25.78%,SRSF10;PRPF19;PRPF3;PRPF6;SART3;PRPF8
prerank,negative regulation of cell projection organization (GO:0031345),-0.25702688235036664,-0.9139999591601048,0.6127659574468085,0.8310099350940775,1.0,17/48,23.30%,RAPGEF2;KANK1;GRIN2B;SPRY2;APOE;BAG5;TRPV4;PAQR3;MT3;RTN4RL1;HDAC2;PRAG1;PTEN;RTN4R;FYN;MYLIP;GAK
prerank,development of primary male sexual characteristics (GO:0046546),-0.28166561315369815,-0.9138175875367505,0.6079295154185022,0.8309174251664797,1.0,5/34,6.76%,KITLG;TGFB2;LHFPL2;WNT5A;AR
prerank,centromere complex assembly (GO:0034508),-0.2732959431023864,-0.9130439944403026,0.6026200873362445,0.8322486987712071,1.0,13/36,30.16%,HJURP;RBBP4;NASP;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;MIS12;SMARCA5;RSF1
prerank,calcium-mediated signaling (GO:0019722),0.24623808771014924,0.9129159752031295,0.6327868852459017,0.9485090922093661,1.0,14/93,11.84%,CCR9;ACKR2;SPHK1;GPR143;ANK2;DMPK;PDPK1;LRRK2;NUDT4;NMUR1;ADGRL1;RYR2;TRPM2;KSR2
prerank,protein-containing complex subunit organization (GO:0043933),0.23871458212751057,0.9128866892186803,0.6369426751592356,0.9476206328561547,1.0,30/109,19.46%,CD247;KMT2A;WDR19;CAPN3;PICALM;ADD2;AFG3L2;IKBKG;SHANK1;RIMS1;WASF1;PPARGC1A;TUBGCP4;LLGL1;DLG4;WASL;EPRS1;SOX9;NUP98;PML;WASF3;WAS;TAPBP;SKAP2;MDM2;MITF;HFE;SNX9;NDC1;TFAP4
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.28468573281437665,-0.9123284607674302,0.6105032822757112,0.8333345240228172,1.0,16/31,39.75%,LYN;TNFRSF21;CD86;GLMN;SOX11;FCGR2B;CEBPB;IL4I1;GPNMB;TYROBP;SDC4;VTCN1;ARG1;PDCD1LG2;CD80;CTLA4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.24607460013713958,-0.9117647845079601,0.6372315035799523,0.8340766469958464,1.0,22/60,28.34%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;FBXO4;HMBOX1;KLF4;FGF2;CCT2;PARM1;MAPK3;GREM1;RFC4;MAP2K7;MAP3K4;DKC1;POLG2;RGCC;RFC2;DSCC1;CCT7
prerank,regulation of catabolic process (GO:0009894),-0.32245895018112236,-0.9116424456769684,0.5760869565217391,0.8338495676606383,1.0,7/18,15.93%,NEDD4L;FAP;ITGB1;HGS;ZDHHC7;RARRES2;ZDHHC2
prerank,mitochondrial translational termination (GO:0070126),-0.23133405964931433,-0.9114954563810505,0.6650485436893204,0.8336720718312106,1.0,23/88,19.87%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL43;MRPL1;MRPS22;MRPL55;MRPL45;MRPL44;MRPL33;CHCHD1;MRPL36;MRPL35
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3560635683396459,-0.9112605001471652,0.5757575757575758,0.8337029886411211,1.0,6/13,19.24%,MDFIC;APOD;TPR;SP100;BARD1;CABP1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2714185696106983,-0.9111590050330889,0.6193415637860082,0.8334201915090096,1.0,15/39,31.20%,SHLD1;SMCHD1;FUS;FANCB;TIMELESS;MAD2L2;SLF2;SPIDR;DTX3L;SHLD3;RAD51AP1;PARP3;PARP1;MRNIP;SPIRE2
prerank,regulation of viral release from host cell (GO:1902186),0.3295413106356469,0.9110648978621666,0.5754716981132075,0.951383133556111,1.0,7/21,21.78%,TRIM62;TRIM5;TRIM35;PML;TRIM13;CHMP3;TRIM32
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.38681893615292695,-0.9110517126653257,0.5788461538461539,0.8331385439346018,1.0,2/10,1.99%,CAV1;ENG
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3870372315332445,-0.9102864835652247,0.5841995841995842,0.8343633761112792,1.0,2/11,6.32%,MFHAS1;LYN
prerank,protein heterooligomerization (GO:0051291),0.34715604449506937,0.9102438433581308,0.5657142857142857,0.9524904682121957,1.0,4/17,9.87%,TMEM120B;CPSF6;CPSF7;KCNC2
prerank,innate immune response (GO:0045087),-0.20247952493090537,-0.9100490668608305,0.7590361445783133,0.8343898175999096,1.0,59/217,25.04%,B2M;APP;ALPK1;MFHAS1;REL;DEFA6;SERINC5;MID2;PLCG2;IFITM3;GCH1;RPL39;TRIM14;LYN;NLRC5;TRIM56;TRIM25;RELB;MFAP4;CAPZA2;SRC;NCF2;MALT1;PIK3CD;SERINC3;YES1;ISG15;PHB2;CD74;PTK2B;ADAM15;RARRES2;IFIH1;CD40;NRROS;IFITM1;SP100;NOD2;IRF5;BTK;KYNU;HCK;HMGB1;C3;POLR3A;MYD88;SYK;CAPZA1;RIPK2;IFITM2;FYN;CYLD;BCL10;PGLYRP1;TLR4;FES;SHMT2;PIK3CG;LCN2
prerank,regulation of interleukin-4 production (GO:0032673),-0.31297018384451053,-0.9099021970547589,0.5895833333333333,0.834207898659598,1.0,2/21,3.12%,LEF1;SLC7A5
prerank,cAMP metabolic process (GO:0046058),0.368239812419455,0.909856356038266,0.5618661257606491,0.9525544579663054,1.0,3/13,6.40%,ADCY5;ADCY1;ADCY8
prerank,telomere maintenance (GO:0000723),-0.2569533196247797,-0.9098365168508185,0.6106194690265486,0.8338298860042161,1.0,23/50,33.78%,RPA1;XRCC5;PTGES3;SMC5;TERF2IP;BLM;TEP1;SP100;NBN;RPA2;ZBTB48;POLD4;TEN1;TINF2;CTC1;XRCC3;TERF2;PARP3;PARP1;HUS1B;NSMCE2;SMC6;LTO1
prerank,regulation of neurogenesis (GO:0050767),-0.2530200864410534,-0.9097524901988986,0.6492027334851936,0.8334974417567206,1.0,10/55,8.57%,B2M;NOTCH1;SERPINF1;BHLHE40;NUMB;HES1;TGM2;HEYL;HEY2;SPEN
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.378010834586947,-0.9096069971973295,0.5909090909090909,0.8333369808156414,1.0,8/11,36.68%,FGF2;IPMK;PPIP5K1;ITPKB;ITPKC;PPIP5K2;ITPKA;IP6K3
prerank,defense response to symbiont (GO:0140546),0.24707592289455546,0.9094352514449595,0.6224489795918368,0.9526864888418461,1.0,14/92,9.76%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;AGBL4;NCBP3;IFIT1;EIF2AK2;OAS3;BCL2;STAT1
prerank,RNA biosynthetic process (GO:0032774),-0.27978222599037356,-0.9094299089664548,0.5961538461538461,0.8332660060291205,1.0,16/31,37.43%,NCOA6;POLA1;SMN1;TBPL1;POLA2;NAT14;PRIM2;BRF2;SMARCA5;SETX;HELB;RSF1;TAF7;TAF5;TCEA2;TTF1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.29780835239829245,-0.9087497072815502,0.587991718426501,0.8342974556860449,1.0,6/24,9.77%,IL6ST;CYP1B1;PTGS2;FLT4;CCBE1;EIF2AK3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.27490283723284414,-0.9085295884854365,0.5995575221238938,0.83429067853078,1.0,10/35,21.29%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.19338116881756198,-0.9084130856808075,0.8035087719298246,0.834040216697437,1.0,106/341,27.06%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;HECW2;NTAN1;RNF111;SPOPL;ANAPC5;RNF166;RNF144A;COP1;RNF144B;UBR4;RNF125;UBE2D3;KCTD10;PSMB7;TRIM25;ZNRF3;PSMA6;CDC16;OTUD7B;FEM1B;PPP2R5C;UBXN1;ARIH2;MVB12B;PSMB6;ARIH1;PSMB5;MTA1;SQSTM1;RAD23B;UBXN2A;UBE2L3;FBXW7;PTTG1;KLHL3;PSMC4;FZR1;PSMB8;VPS37A;KBTBD7;RNF149;CBL;OS9;UBE2A;RNF19A;UBA6;PSMD11;KCTD5;ADRM1;KLHL22;PCBP2;UBE2G1;RNF128;KCTD6;RMND5B;PSMB4;ATE1;FBXL4;HACE1;PPP1R11;PSMD14;CDC26;UCHL1;ARRB2;PSMD10;FBXW5;TRPC4AP;NEDD4;PSME1;TGFB1I1;FAF1;DTX3L;AGAP3;ATXN3;KLHL25;PSMB3;MYLIP;RNF40;TSG101;KCTD17;CDC23;CUL3;FBXO45;NHLRC3;DTL;UFD1;CDC34;TOM1L1;CUL4A;KIF14;RNF150;AREL1;ANAPC1;SPSB3;PELI1;RNF168;RCHY1;ZFAND2B;HERPUD1
prerank,negative regulation of neuron projection development (GO:0010977),0.2661954075307982,0.9077888669069435,0.6127272727272727,0.9560689464517432,1.0,12/56,15.38%,EFNB2;PTPN9;CRMP1;RUFY3;NGEF;LRP4;LPAR1;EPHA4;CBFA2T2;PTPRO;BCL11A;TSKU
prerank,cellular response to UV (GO:0034644),-0.2378000700960152,-0.9073751374001392,0.674937965260546,0.835898390804333,1.0,21/76,21.47%,PTPRK;CARD16;CRIP1;XPC;PRKCD;ZBTB1;MFAP4;USP47;COPS9;BAK1;RHBDD1;ATF4;FMR1;N4BP1;RHNO1;METTL3;XPA;NEDD4;CHEK1;NSMCE3;MMP2
prerank,carboxylic acid metabolic process (GO:0019752),-0.2816599758544511,-0.9069968993173574,0.5995475113122172,0.8362387746673349,1.0,6/33,6.47%,SLC2A1;PLA2G4A;CSGALNACT1;PTGIS;ST3GAL1;SLC2A3
prerank,generation of neurons (GO:0048699),-0.20651449189637452,-0.9068383407178873,0.7275204359673024,0.8360906856322746,1.0,32/190,15.99%,NRP1;MEF2C;RAPGEF2;MARK1;TGFB2;NDNF;DISC1;RUNX2;SIX1;EML1;RUNX1;CEP85L;BHLHE40;CIT;LHX6;MET;HES1;WNT5A;HEYL;HEY2;CDK5;FGF13;ACSL3;FZD4;NGRN;WNT9A;NR4A2;FZD1;MAP1B;DDIT4;SIX4;PAFAH1B1
prerank,calcium ion homeostasis (GO:0055074),0.2447925970577916,0.9067724351117218,0.6397941680960549,0.9577231185050473,1.0,8/95,4.22%,SLC8A3;SLC24A3;ATP13A5;ANK2;DMPK;FAM20A;CSRP3;ATP13A3
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.36679786973729284,-0.9067708434344853,0.5864077669902913,0.8357295902558249,1.0,4/12,22.46%,DDC;MAOA;HNMT;ODC1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2930787772455926,-0.9067124867510719,0.5838926174496645,0.8353469317302398,1.0,9/29,17.93%,ELOVL7;ELOVL5;ACSL5;ACSL3;FASN;ELOVL6;SCD;ELOVL1;ACSL4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.326402614267812,-0.9064362774219769,0.6189473684210526,0.8354456001259017,1.0,4/18,12.31%,NOTCH1;CCN3;TMEM119;BMP2
prerank,ceramide transport (GO:0035627),-0.3679759205257134,-0.9062912677432882,0.5771428571428572,0.8352614687764551,1.0,8/12,28.78%,CERT1;PLEKHA8;PLTP;PSAP;SGPP1;GLTP;PLEKHA3;CPTP
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2586528483612456,0.9062594105124426,0.6122082585278277,0.9580794524202793,1.0,20/66,21.58%,UBE2E2;PLK5;APPL2;CDKN2A;DLG1;PRMT2;E2F1;BRD7;PLCB1;CDC73;LSM11;HYAL1;ANKRD17;AKT1;WEE1;FGF10;DDX3X;CDK2AP2;PSME2;KANK2
prerank,positive regulation of organelle organization (GO:0010638),0.29292237088452183,0.9059792458003292,0.5962264150943396,0.9578413797023992,1.0,6/32,11.82%,STX18;RAB3GAP1;FYCO1;HTRA2;PPARGC1A;TMED9
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.3452377608485241,-0.9059144856503889,0.5704989154013015,0.835588422503808,1.0,8/14,24.43%,SEC24D;SEC23A;SEC31A;SEC24B;SAR1A;SEC13;SEC24A;TBC1D20
prerank,activation of phospholipase C activity (GO:0007202),-0.29591807902197514,-0.905822153720313,0.6012396694214877,0.8352883642930866,1.0,7/29,13.93%,EDNRA;EGFR;PLCG1;PHB2;HTR2A;CD86;P2RY6
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3071305904668763,-0.9052460306785773,0.5967413441955194,0.8361368720581382,1.0,12/21,40.18%,RAD51B;BRD4;FBXO5;CCND1;RAB11A;DTL;STOX1;CDK1;DYRK3;CCNB1;VPS4B;RCC2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3428705307268593,0.9040749834932529,0.5778210116731517,0.9617939837399981,1.0,5/16,11.76%,PPARA;ANTKMT;ENO1;PPARGC1A;SPHK2
prerank,signal transduction by p53 class mediator (GO:0072331),0.30184408318356115,0.9039856182951412,0.5740402193784278,0.9610176614367893,1.0,5/30,9.85%,DDX5;MAGEA2;PDK2;NDRG1;BATF
prerank,membrane raft organization (GO:0031579),-0.3372387420245917,-0.903870225095997,0.6181434599156118,0.8387952291104878,1.0,5/15,18.94%,RFTN1;EMP2;S100A10;NAXE;YJEFN3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.25868017667368526,-0.9038063802905788,0.6152125279642058,0.8384185925552585,1.0,15/47,24.43%,AGK;TIMM22;ATP5MF;ATP5F1B;ATP5F1E;DNAJC11;ATP5MC3;GHITM;ROMO1;ATP5F1D;TIMM29;ATP5MG;ATP5PD;LETM1;TIMM10
prerank,zymogen activation (GO:0031638),0.2861680113355028,0.9036353409241862,0.5855018587360595,0.9609158571580606,1.0,12/39,23.71%,FURIN;CYFIP2;PLAT;PGK1;CTSH;KLK1;ASPH;NLRC4;OMA1;C1RL;MMP14;LGMN
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.28687759954373615,-0.9035749423940161,0.6217391304347826,0.8384163583402237,1.0,7/31,15.33%,YWHAE;YWHAB;YWHAQ;YWHAZ;HIP1R;BAK1;BBC3
prerank,nuclear transport (GO:0051169),0.35131452209268477,0.9030194195841551,0.5786290322580645,0.961520330341118,1.0,4/16,12.14%,CITED1;PSIP1;NXT1;NUP98
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.33140499948526286,0.9028500161609265,0.6022727272727273,0.9609547931364714,1.0,8/20,21.15%,CHRM2;CHRNB2;LY6G6D;PLCB1;CHRM1;RGS8;CDK5R1;GNAQ
prerank,lipid phosphorylation (GO:0046834),-0.38336417961237407,-0.9028221978918173,0.5711462450592886,0.8396337441097691,1.0,2/10,3.32%,DGKH;DGKZ
prerank,regulation of endocytosis (GO:0030100),0.2582459114750654,0.9027970099079198,0.6312056737588653,0.9601094838742369,1.0,6/61,4.80%,DAB2;SYT11;SPHK1;PICALM;CLIP3;RUFY2
prerank,regulation of phospholipase activity (GO:0010517),0.38425830923238935,0.9025413031518548,0.5678776290630975,0.9598106845741649,1.0,2/10,6.87%,PDPK1;FGFR2
prerank,membrane lipid catabolic process (GO:0046466),0.39877255823331714,0.9024035915426006,0.5666041275797373,0.9591679255555612,1.0,3/10,9.96%,NAGA;FUCA1;SMPD2
prerank,membrane protein proteolysis (GO:0033619),-0.2709331935942075,-0.902194771283407,0.6285097192224622,0.8405605323857169,1.0,11/37,23.93%,MYH9;ADAM10;SPPL3;ADAM19;RET;HM13;RHBDD1;PSEN2;PSENEN;ERAP1;MBTPS2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3152516440516333,-0.9020288814043973,0.6012396694214877,0.8404234527912606,1.0,6/20,23.93%,ADAM10;HM13;RHBDD1;PSEN2;PSENEN;MBTPS2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3292496817644129,0.9017411040221025,0.591254752851711,0.9598994124949591,1.0,6/20,16.18%,FITM2;ACSM2A;GCDH;DGAT2;ACACA;FAR1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22402031090065985,-0.9016365123304495,0.7035294117647058,0.84076646088834,1.0,33/104,28.02%,ACTB;DAB2IP;RHOA;LRP6;LRP5;RALB;CAB39;CALM3;SRC;RPTOR;SERTAD1;HGS;GTF2H1;BLM;INCENP;CSF1R;CCNF;CCND1;TRIB2;CCND2;PPP2CA;CDKN1B;CCNH;CCNB2;TSG101;TRIB3;CDKN3;SLC8A1;CALM1;CIB1;CCNJ;CDKN2B;CCNT1
prerank,peptidyl-lysine modification (GO:0018205),0.246092722932047,0.9015176711814262,0.6386138613861386,0.9594774657981466,1.0,24/99,20.89%,EYA1;NNAT;SENP3;POM121;NUP155;LOXL3;LOXL1;KAT5;TOPORS;NUP98;PIAS4;HDAC4;NUP37;BCL11A;SIRT1;ATP7A;RANGAP1;CTH;NUP88;LIPT1;NDC1;P3H3;RAE1;VCPKMT
prerank,regulation of cytoplasmic transport (GO:1903649),-0.3708145412369164,-0.9012856982527458,0.5882352941176471,0.8409990827894062,1.0,3/11,8.89%,MAPK1;USP7;SRC
prerank,regulation of intracellular pH (GO:0051453),-0.27851049099322844,-0.900853895039517,0.6268656716417911,0.8414309409732934,1.0,7/34,15.91%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2;CFTR
prerank,sister chromatid segregation (GO:0000819),0.2998040816351629,0.9005508514400115,0.5727788279773157,0.9609543316501703,1.0,6/31,9.58%,TOP2B;ZWINT;PLK1;DSN1;TUBG1;NDC80
prerank,zinc ion transmembrane transport (GO:0071577),-0.3064971459216313,-0.9001786615087523,0.6085192697768763,0.8424332056299384,1.0,5/22,12.68%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,positive regulation of neurogenesis (GO:0050769),0.25729942530571576,0.9000765110280725,0.6648250460405156,0.9612520658099037,1.0,10/68,8.72%,ROBO1;OBSL1;IL1RAPL1;PLXNA2;SMARCD3;FZD3;PLXNA1;NTRK2;PLXNA3;PTPRD
prerank,regulation of protein transport (GO:0051223),-0.2923268728893208,-0.8999957228235941,0.5950920245398773,0.8423514399462839,1.0,5/27,9.26%,DISP1;DNAJC1;DNAJA1;GAPVD1;PTPN1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.28451241907966424,-0.8997974720311503,0.6218487394957983,0.842271331040681,1.0,8/30,17.48%,MLLT3;BMP4;KDR;FLT1;FLT4;PTPRC;CSF1R;SP7
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.24683334263442708,0.8992104469217818,0.6417112299465241,0.9625153678701576,1.0,17/87,14.63%,FGF1;FGF4;FGF9;FLRT3;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;GALNT3;FRS2;DSTYK;FGFBP1;HYAL1;KLB
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.3652015347551618,-0.8988047093631635,0.6286836935166994,0.8439833844133765,1.0,3/11,11.40%,IL6ST;STAT3;JAK1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.30824638641909496,-0.8984734906117109,0.6303030303030303,0.8442582296137993,1.0,9/24,26.69%,PDE4D;CAMK2D;CALM3;JPH2;PRKACA;DMD;JPH3;CALM1;SELENON
prerank,positive regulation of nervous system development (GO:0051962),0.27622702360540674,0.8982987726317899,0.6,0.9638508606284939,1.0,12/42,19.52%,IL1RAPL1;NLGN2;WNT7A;GRID2;NLGN3;PTPRD;FAIM;BDNF;OPRM1;EPHB1;SYNDIG1;DLG5
prerank,synaptic membrane adhesion (GO:0099560),-0.34696027480943736,-0.8982614466296877,0.5782178217821782,0.8442213556551852,1.0,1/14,0.24%,GPC6
prerank,regulation of NMDA receptor activity (GO:2000310),0.2985803579871072,0.898132540307491,0.5918762088974855,0.963276213256921,1.0,8/32,16.32%,ACTN2;SLC6A9;DLG1;DLG4;OPRM1;GRIA2;LRRC7;NEFL
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2657766892987957,-0.8981124921404188,0.6276346604215457,0.8440440651846097,1.0,8/42,14.33%,DEFA6;RPL30;IL6R;SERPINE1;DROSHA;MPEG1;RARRES2;ROMO1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.31280374467245,0.8979167831571951,0.6184971098265896,0.9628231243757368,1.0,5/25,12.60%,LEPROT;CHMP6;VTA1;UBXN6;DENND10
prerank,chromosome organization (GO:0051276),0.2372494548477543,0.8976430617555959,0.646774193548387,0.9625796989264735,1.0,27/99,21.13%,DDB2;TOP2B;DOT1L;HMGN3;NUP155;PHF1;MSH6;NDC80;LDB1;SETD7;MSH3;MTHFR;BAHD1;ABL1;TCF7L2;SIRT1;FAM50A;SAFB;CETN2;MTF2;CENPV;COPS7A;SOX2;ACTL6B;SUPT4H1;RAE1;NUF2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.393258722890122,0.8972542333613241,0.5652173913043478,0.9625553871091712,1.0,3/10,9.85%,LMBR1L;HOXB4;BATF
prerank,calcium ion transport into cytosol (GO:0060402),0.3271536539030578,0.89710636013449,0.5830188679245283,0.9619626406192257,1.0,5/21,11.37%,CACNB3;JPH1;GRIN2D;RYR2;TRPM2
prerank,nuclear envelope organization (GO:0006998),0.32487950689028483,0.8970951652825018,0.5942307692307692,0.9610329569020926,1.0,3/20,8.34%,DMPK;NUP155;TOR1B
prerank,axon development (GO:0061564),-0.2342161704614732,-0.8970568919960638,0.6755447941888619,0.8459571143328563,1.0,17/78,16.99%,ACTB;PARD3;APP;KLF7;GRM7;ARHGAP35;CDK5;S100A6;DSCAML1;EPHB2;RAB3A;SHTN1;DHFR;MAP1B;SEMA5A;RTN4;RTN4RL1
prerank,regulation of neuron differentiation (GO:0045664),0.2489805607865878,0.8969589708328162,0.6638078902229846,0.9603810709514198,1.0,10/76,8.37%,BMP7;DTX1;CPNE1;GPRC5B;NREP;ZFHX2;BEND6;LRRK2;IMPACT;MED1
prerank,insulin secretion (GO:0030073),-0.31884470097290946,-0.8968432788536717,0.596,0.8458975619816116,1.0,4/19,13.97%,RAB11FIP5;SNX19;ANXA1;RAB11B
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.29029200781715697,0.896406246551539,0.6218181818181818,0.9608632825667921,1.0,9/35,16.50%,PPARGC1B;DDX5;RNF14;DDX17;MED1;PMEPA1;WBP2;TADA3;SAFB
prerank,phospholipid homeostasis (GO:0055091),-0.36963721198507227,-0.8961136055337715,0.6210526315789474,0.8470232246694205,1.0,3/11,25.59%,ABCA1;TLCD1;FABP3
prerank,negative regulation of transport (GO:0051051),0.2696708547490045,0.8960113847658232,0.6343283582089553,0.9608986543189169,1.0,10/51,18.15%,SYT11;NDFIP1;NRG1;NR1H3;SCAMP5;MTMR2;SNX3;SNX33;NDFIP2;SIRPA
prerank,mitochondrial translational elongation (GO:0070125),-0.22696855630558058,-0.8955426808898141,0.6938271604938272,0.8478634007091504,1.0,23/88,19.87%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL43;MRPL1;MRPS22;MRPL55;MRPL45;MRPL44;MRPL33;CHCHD1;MRPL36;MRPL35
prerank,calcium import into the mitochondrion (GO:0036444),-0.37770102062443867,-0.8955257069889858,0.6149068322981367,0.8473788271103467,1.0,4/10,14.09%,MICU3;MCUB;SMDT1;MICU2
prerank,quinone biosynthetic process (GO:1901663),0.3556190047388382,0.8954894173860444,0.5596707818930041,0.9612892276309942,1.0,5/14,20.34%,COQ10A;COQ8B;COQ3;COQ7;FDXR
prerank,cellular response to type I interferon (GO:0071357),0.28300910224816533,0.8953159207094534,0.6179577464788732,0.9598037414538202,1.0,8/41,11.44%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2
prerank,type I interferon signaling pathway (GO:0060337),0.28300910224816533,0.8953159207094534,0.6179577464788732,0.9598037414538202,1.0,8/41,11.44%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.29562822168311403,-0.8952759223786987,0.6213389121338913,0.8474383916814625,1.0,6/24,11.77%,BCL2L1;CD44;TPT1;CXCL12;ACKR3;CD74
prerank,positive regulation of protein polymerization (GO:0032273),-0.24127904042152654,-0.8952366576047842,0.6540284360189573,0.8470095343290243,1.0,22/65,27.79%,CDC42EP3;CDC42EP5;MET;OCLN;NCK1;RPS3;TPPP3;CDC42EP2;PTK2B;PFN1;CLIP1;NCKAP1L;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;PRKCE;FES;AKAP9;CARMIL1;MAPT
prerank,negative regulation of protein secretion (GO:0050709),-0.27185102921535065,-0.8951288486191642,0.649890590809628,0.8467557263803158,1.0,11/38,17.64%,CD200;CCN3;RAB11FIP5;MIDN;RAB11FIP1;APOE;RSAD2;KCNB1;IRS1;RAB11FIP3;DPH3
prerank,regulation of lipid storage (GO:0010883),-0.3042981977315451,-0.8950268988230565,0.5901639344262295,0.8464736740360044,1.0,6/22,20.17%,FTO;NFKBIA;FBXW7;ZC3H12A;MEST;C3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.29693745828995743,0.8947279573218937,0.6156716417910447,0.9604040025324078,1.0,3/30,8.27%,ROBO1;ARRB1;LPAR1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3555159855593336,-0.8944038236590027,0.6139240506329114,0.847318815839446,1.0,4/13,12.04%,NOS3;GCH1;QDPR;PRKG2
prerank,ether lipid metabolic process (GO:0046485),-0.34532751545281654,-0.8932196515107044,0.6263982102908278,0.849417810871587,1.0,4/14,15.99%,DHRS7B;PEX7;PLA2G6;PAFAH1B1
prerank,sterol homeostasis (GO:0055092),0.2571868631647605,0.8931127780803274,0.6243739565943238,0.9634855126944583,1.0,14/65,16.00%,RORA;IL18;ABCG5;SOAT2;GRAMD1B;SOAT1;NR1H3;ABCD1;ABCA2;DGAT2;EPHX2;TSKU;TMEM97;SIRT1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.32259284427315726,-0.8928850159436054,0.6491596638655462,0.8496762009710647,1.0,5/20,9.28%,PID1;BCL2L1;TMEM59;NUMB;ABI3
prerank,homocysteine metabolic process (GO:0050667),0.37658140677126006,0.8927234253431359,0.5909980430528375,0.9635510580217355,1.0,6/11,29.82%,MMUT;MTHFR;CTH;BLMH;DPEP1;MTRR
prerank,protein-DNA complex disassembly (GO:0032986),-0.3272171344304591,-0.8923585174445459,0.5873983739837398,0.8502514634917131,1.0,5/16,20.36%,SMARCC1;ARID1A;RPL23;SMARCA4;SET
prerank,positive regulation of organelle assembly (GO:1902117),-0.25839788663609187,-0.8919818167825858,0.6529284164859002,0.8505890476556369,1.0,14/44,23.87%,PIP4K2A;RALB;CNOT6L;ARHGAP35;G3BP1;CAPG;CCP110;RAB3GAP2;DYNC1H1;GPSM2;NUP62;KCTD17;TAPT1;ENTR1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.335961678805129,-0.891492925516196,0.5991561181434599,0.851171510304624,1.0,8/16,25.35%,BMP4;RUNX1;CREB3L1;TGFB3;HDAC2;AMELX;RGCC;F2R
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3790591222898562,0.8910994525425053,0.5846774193548387,0.9667237353889331,1.0,2/10,12.35%,TFIP11;RTEL1
prerank,glutamate receptor signaling pathway (GO:0007215),0.28554108786743043,0.8907589896380687,0.6333938294010889,0.9666451363578366,1.0,9/37,17.86%,DAGLA;GRIN3A;GRID2;GRIK2;CPEB4;PLCB1;GRIA2;GRM8;CDK5R1
prerank,male gonad development (GO:0008584),0.29275941362369157,0.8900548436775787,0.6324626865671642,0.9674597222998618,1.0,3/34,3.34%,WNT4;KIT;FGF9
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2984941769383339,-0.8899831960994091,0.6316916488222698,0.8539587608733273,1.0,12/26,27.79%,MET;OCLN;RPS3;TRPV4;CLIP1;KATNB1;TOGARAM1;DCTN1;CDK5RAP2;FES;AKAP9;MAPT
prerank,response to organic cyclic compound (GO:0014070),0.2668415977903812,0.8898269485329445,0.6144366197183099,0.9670337756719926,1.0,12/52,17.00%,IL18;TRPV1;GLDC;LRRK2;DRD3;CHRNB2;PAQR7;ABCA2;TRPM2;ABCB4;GGT5;STAT5B
prerank,TOR signaling (GO:0031929),0.3084954134084446,0.8893088657305471,0.6240875912408759,0.9674373682797287,1.0,2/26,2.10%,NPRL3;RICTOR
prerank,regulation of gastrulation (GO:0010470),-0.33461402633991766,-0.8891892708322015,0.5927342256214149,0.8551966362630212,1.0,3/14,6.00%,PHLDB1;PHLDB2;RACK1
prerank,gene silencing by miRNA (GO:0035195),-0.2793560923480509,-0.8891645938976203,0.6331877729257642,0.8547398320979017,1.0,10/32,20.54%,LIMD1;AGO1;ZC3H7A;PUM2;NOTCH4;AGO2;PUM1;AGO4;XPO5;AJUBA
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.27434002521472917,0.8891049457776499,0.6711635750421585,0.967023715351619,1.0,5/46,4.69%,LMO3;DUSP29;FBLN1;TIMP3;DLG1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.241486286033664,-0.889027525591226,0.6590909090909091,0.8545528230579873,1.0,11/64,11.18%,PLA2G4A;CYP1B1;PTGS2;MGLL;ACOX1;ELOVL5;ACSL5;GPX1;ACSL3;ELOVL6;HACL1
prerank,negative regulation of hemostasis (GO:1900047),-0.35344205189926453,-0.888758551388203,0.5926680244399185,0.8546427830909364,1.0,5/12,17.26%,CD34;SERPINE1;EDN1;APOE;VTN
prerank,positive regulation of protein metabolic process (GO:0051247),-0.21686641249319477,-0.8885415962425041,0.7472826086956522,0.8545794074583085,1.0,20/110,14.90%,DAB2IP;NEDD4L;WWP1;FOXO1;NFKBIA;SMURF1;HECW2;APP;AGTR1;WNT5A;PLK2;APC;KLF4;APOE;RANBP9;KLF2;CD86;CSNK2A1;RAB1B;FZR1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3479531482949516,0.8884767173618121,0.6193181818181818,0.9676953631783038,1.0,2/16,0.77%,IGF1;ROCK2
prerank,regulation of cholesterol transport (GO:0032374),0.3318229363960101,0.8882393803633979,0.6088631984585742,0.9673263966901272,1.0,7/20,18.58%,ABCA13;NR1H3;ABCA2;ABCB4;NFKB1;NUS1;ABCA5
prerank,regulation of isotype switching (GO:0045191),-0.3421684171637215,-0.8877404458798613,0.5934959349593496,0.8559747037005473,1.0,8/14,38.44%,TFRC;SHLD1;MAD2L2;SHLD3;PARP3;PAXIP1;IL4;SHLD2
prerank,regulation of aerobic respiration (GO:1903715),0.3510448285872906,0.8876043466991878,0.601980198019802,0.967956147760293,1.0,4/15,16.35%,COX7A1;COX7A2L;ABCD1;ATP7A
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3844477023627177,0.8874894931186627,0.6058823529411764,0.9672823919776584,1.0,1/11,0.42%,WNT4
prerank,signal peptide processing (GO:0006465),-0.36154256999394785,-0.8870851882371567,0.5909980430528375,0.8569221938450063,1.0,3/11,14.77%,PCSK5;SPPL3;HM13
prerank,maintenance of protein location in nucleus (GO:0051457),-0.31180523110138036,-0.8869270005504724,0.6174636174636174,0.8567451347289461,1.0,6/20,18.10%,SYNE1;SUN1;ARL2BP;MORC3;SP100;BARD1
prerank,ncRNA 3'-end processing (GO:0043628),-0.3429995847953885,-0.8867264517068325,0.5943204868154158,0.8566898098757249,1.0,6/14,34.42%,ELAC2;TOE1;INTS6L;ERI1;PTCD1;INTS12
prerank,phosphatidylserine metabolic process (GO:0006658),0.2950928978620127,0.8864092023002381,0.6233269598470363,0.9689555490596222,1.0,7/32,17.22%,OSBPL8;PLA1A;PTDSS2;OSBPL5;PLA2G15;PLAAT3;OSBPL10
prerank,urogenital system development (GO:0001655),0.36976571533191405,0.8862503652649227,0.6016949152542372,0.9684450732611075,1.0,2/11,12.01%,OSR1;SOX9
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.32695334636282725,0.8861929653311842,0.6307129798903108,0.9657491136234081,1.0,5/20,15.05%,ZWINT;PLK1;MAD2L1;IK;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.32695334636282725,0.8861929653311842,0.6307129798903108,0.9657491136234081,1.0,5/20,15.05%,ZWINT;PLK1;MAD2L1;IK;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.32695334636282725,0.8861929653311842,0.6307129798903108,0.9657491136234081,1.0,5/20,15.05%,ZWINT;PLK1;MAD2L1;IK;ATM
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.29633385650522603,-0.8858342425727703,0.6266375545851528,0.8582240439513732,1.0,9/24,24.85%,MEF2C;BOC;CTNNA1;MYOCD;CDH2;MAPK12;CDC42;MAPK11;BNIP2
prerank,regulation of innate immune response (GO:0045088),-0.2388729461171694,-0.8852681492087462,0.6339285714285714,0.8589999415142037,1.0,20/57,25.74%,POLR3F;PLSCR1;IRAK3;GBP5;IFI35;XIAP;PTPN1;ABCE1;BIRC3;POLR3B;N4BP1;PTPN6;NMI;POLR3D;ERAP1;FCGR2B;MUL1;LRP8;PTPN11;CASP8
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3759773789873952,-0.8850801307192256,0.6159554730983302,0.8588876622169875,1.0,3/10,6.13%,NEDD4L;HECW2;CAMK2D
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2831067323359473,-0.8849868299851373,0.6100217864923747,0.8585711884663608,1.0,2/27,1.51%,PLA2G4A;GPCPD1
prerank,cilium assembly (GO:0060271),0.2061367720515036,0.8848882861076461,0.7569141193595342,0.9680452206915237,1.0,58/296,16.82%,CFAP44;DCDC2;INTU;TTC21B;CC2D2A;DYNLT2B;GALNT11;TEKT2;WDR19;RSPH4A;ATAT1;RILPL2;IFT74;PLK1;WDR35;DYNC2LI1;TTBK2;TEKT5;CEP78;CLASP1;KIF3C;RILPL1;SNAP29;BBOF1;TMEM138;CEP290;VANGL2;DYNC2I2;WDPCP;TUBG1;BBS5;ARMC9;IFT122;PCM1;TTC8;CPLANE2;B9D1;KIF3A;E2F4;TMEM67;ASAP1;IFT80;CDC14B;SFI1;RAB1A;TUBB4A;CFAP20;TCTN2;ARL3;NINL;MAPRE1;RAB23;NEDD1;GBF1;FUZ;RPGR;CETN2;PTPN23
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2125665797593217,-0.8848021313955912,0.7564766839378239,0.8584638757124717,1.0,35/124,23.97%,PTPRM;FRY;RAPGEF2;APP;STMN1;FAM161A;STX3;MAP4;LYN;MYOC;CDK5;FRYL;APOE;SH3GL2;LIMA1;MICALL2;ODF2;CSF1R;ATCAY;MANF;FAM161B;MNS1;RAB11A;STMN4;CDK16;HMGB1;NEDD4;RAB35;ROCK1;TTC17;RYK;PRMT1;IQCG;BTG2;NPY
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2886730359886538,0.8847206321449008,0.6355311355311355,0.9675132221343945,1.0,11/35,17.55%,HSPA1A;ABCB10;MED1;STAT1;LDB1;MAPK14;ARNT;PRKDC;HSPA1B;STAT5B;HSPA9
prerank,negative regulation of response to external stimulus (GO:0032102),-0.21741456192765643,-0.884680167029227,0.7268041237113402,0.8582104835283003,1.0,16/105,10.49%,TEK;PPARD;PTGIS;IRAK3;MFHAS1;CCN3;CD109;CARD16;CASK;AJAP1;PRKCD;SERPINE1;KLF4;FGF2;DUSP3;APOE
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.28318120095603977,-0.8844022464462359,0.6371681415929203,0.8583440084663214,1.0,11/29,25.24%,NLRC5;WNT5A;PTPN1;ISG15;ABCE1;PTPN6;METTL3;TTLL12;MUL1;ZBP1;PTPN11
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.35823849078757397,-0.8832388102718381,0.6233009708737864,0.8604016569606575,1.0,3/12,15.91%,ANO1;PLA2G6;CFTR
prerank,negative regulation of protein binding (GO:0032091),0.2522669678725499,0.8830419413342743,0.6589698046181173,0.9706756483620143,1.0,10/71,8.74%,DAB2;IFIT2;MAP2;TFIP11;CAMK1;TTBK2;LRRK2;IFIT1;GNL3L;GOLGA2
prerank,regulation of interleukin-6 production (GO:0032675),-0.21881267751791483,-0.8826603762239658,0.7669683257918553,0.8611706877032763,1.0,22/96,20.61%,CD200;GAS6;AFAP1L2;STAT3;APP;IRAK3;PLCG2;ARHGEF2;WNT5A;IL6R;MAPKAPK2;CD74;TWIST1;IFIH1;NCKAP1L;NOD2;PTPN6;ZC3H12A;IL33;HMGB1;MYD88;SYK
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.2842814023897097,-0.8822472544611928,0.6440677966101694,0.8615847854786423,1.0,6/26,9.77%,IL6ST;CYP1B1;PTGS2;FLT4;CCBE1;EIF2AK3
prerank,positive regulation of insulin secretion (GO:0032024),0.2871694170873982,0.8818594623625866,0.609375,0.9725944762816154,1.0,4/36,6.40%,NNAT;GCK;NLGN2;ADCY8
prerank,negative regulation of protein catabolic process (GO:0042177),-0.26450775453479264,-0.8816831903819076,0.6823266219239373,0.8623605292809827,1.0,6/40,7.74%,DAB2IP;EGFR;IRAK3;FLNA;CST3;PRKCG
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3581728757464497,0.8815645076138522,0.6286836935166994,0.9723965056449534,1.0,2/12,7.75%,SOAT2;SOAT1
prerank,protein targeting (GO:0006605),0.23111734683099494,0.8813164822094571,0.6983333333333334,0.9720494180055343,1.0,19/118,12.47%,TRAK1;MICALL1;ZDHHC12;PITRM1;TOMM40;ZFAND6;TIMM17A;KIF13B;PRKCI;TOMM22;LONP2;ZDHHC24;ZDHHC1;LAMP2;PEX1;MFN2;ZDHHC6;AP4M1;ZDHHC3
prerank,cell chemotaxis (GO:0060326),-0.2422150156394776,-0.8812416642786621,0.6763990267639902,0.8627772066156197,1.0,10/60,10.85%,NRP1;LEF1;ABCC1;CCN3;AGTR1;PRKCD;CXCL12;BCAR1;ACKR3;PARVA
prerank,negative regulation of defense response (GO:0031348),0.24659447482188815,0.8807760042970759,0.6643835616438356,0.9725060701110695,1.0,10/77,10.07%,RORA;ENPP3;PPARA;METRNL;C1QTNF3;NLRC3;NLRP3;CACTIN;NR1H3;C1QBP
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.34461920512114924,0.8805445441139718,0.607421875,0.972109310307004,1.0,3/15,8.26%,KCND3;KCNJ5;KCNH2
prerank,glycerolipid metabolic process (GO:0046486),-0.36467218992803474,-0.8805346816883184,0.6125,0.8637590746472793,1.0,8/11,43.72%,DGKZ;DGKB;DGKG;DGKA;DGKQ;PIP5K1A;PDXP;PNPLA3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.2856594958206019,-0.8804896051174728,0.651685393258427,0.8633339613590262,1.0,14/27,29.39%,PDE4D;CAV1;CAMK2D;CTNNA3;FGF13;DSG2;PLN;DSP;JUP;GJA5;STC1;AKAP9;HCN4;RANGRF
prerank,RNA metabolic process (GO:0016070),0.2271692583662547,0.8804092888100371,0.709731543624161,0.9714796027681459,1.0,31/127,20.19%,CELF2;RNASEH2A;PABPN1;NOVA1;TFIP11;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;DDX17;HNRNPA3;SUPV3L1;HNRNPL;PTBP1;BICD1;MPHOSPH10;AGO3;DICER1;SND1;RBM5;LSM8;POLR2D;DHX8;HNRNPH2;MTREX;DDX39B;THOC1;DDX3X;ADAR;POLR2A
prerank,negative regulation of inflammatory response (GO:0050728),0.21870797781800583,0.8803658551844159,0.7235023041474654,0.970645310721368,1.0,17/182,7.31%,RORA;ADCY5;IGF1;PTH2R;CD247;ENPP3;PPARA;FURIN;METRNL;ADCY1;CRHR1;GPR45;ADCY8;C1QTNF3;NLRC3;HRH2;HTR7
prerank,regulation of axon extension (GO:0030516),-0.26450376855014146,-0.8803137286974176,0.6757990867579908,0.8632259473802126,1.0,9/37,16.13%,NTN1;SEMA7A;MACF1;APOE;SEMA3G;SHTN1;LIMK1;MT3;RTN4
prerank,megakaryocyte differentiation (GO:0030219),0.3753332803575252,0.8800065093556111,0.6227180527383367,0.9705976471135666,1.0,2/11,8.37%,KIT;MED1
prerank,sphingoid biosynthetic process (GO:0046520),0.3833704544460015,0.8799189582222147,0.5988483685220729,0.9689534811412769,1.0,3/11,11.76%,SPHK1;ABCA2;SPHK2
prerank,sphingosine biosynthetic process (GO:0046512),0.3833704544460015,0.8799189582222147,0.5988483685220729,0.9689534811412769,1.0,3/11,11.76%,SPHK1;ABCA2;SPHK2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3168366457798353,0.8795626952739989,0.5910931174089069,0.9688740332905986,1.0,3/21,6.40%,ADCY5;ADCY1;ADCY8
prerank,axonal fasciculation (GO:0007413),-0.35598341291532376,-0.8795287174293488,0.6377649325626205,0.8644237751346955,1.0,4/12,16.13%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,regulation of lipid catabolic process (GO:0050994),0.33203955373281757,0.879406726884801,0.6337760910815939,0.9683009561005614,1.0,3/19,9.38%,ADRA2A;LONP2;ABCD1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.240724117121383,0.8791693197160664,0.6786941580756014,0.9679321048027836,1.0,22/84,21.77%,IGF1;SPHK1;RTN1;TRIM71;NTRK2;ORMDL2;EIF2AK2;PAIP2B;PAIP2;CLU;EPRS1;EIF4E2;TSC1;FXR2;RNF139;GIGYF2;ILF3;PRNP;DDX3X;CPEB3;LARP1;CNOT8
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.27123262873571985,-0.8790789558741631,0.6651480637813212,0.864921177837949,1.0,14/37,26.30%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4;CUL4A;RFC2
prerank,regulation of cellular response to stress (GO:0080135),0.23138129735538554,0.8788222512748978,0.6947723440134908,0.9678546069225675,1.0,21/115,16.00%,HSPA1A;ROCK2;NUPR1;POM121;CCAR2;NUP155;ADCY8;ARMT1;BAG4;USP19;ABCD1;NUP98;AIFM2;OPRM1;HSPA1B;ABL1;RPA3;ATM;NUP37;VASH1;SIRT1
prerank,peptide hormone secretion (GO:0030072),-0.29114213469498834,-0.8785768122133225,0.6461864406779662,0.8654890506669616,1.0,5/26,12.97%,LTBP4;SNX19;ANXA1;EDN1;EDN3
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2206089214796791,-0.878247362879625,0.7292161520190024,0.8656905452080742,1.0,15/91,14.59%,HIP1;NRP1;STON2;SCARB1;CDH13;MAPK1;USP7;SRC;ZFYVE16;PTPN1;RAB3A;HIP1R;PTPRC;RAB11B;RAB5C
prerank,response to retinoic acid (GO:0032526),0.2596577901835249,0.8779796197434336,0.6714031971580817,0.9689877457017437,1.0,15/59,18.54%,WNT5B;HSD17B2;PTK7;WNT6;HTRA2;FZD7;RXRA;CTSH;SOX9;ATM;NDUFA13;RARA;RBP4;CREB1;FZD10
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23618054439507166,-0.8776947050182783,0.6728110599078341,0.8663705454778518,1.0,25/69,25.64%,MEF2C;NDNF;NGF;SIX1;PRKCG;FOXQ1;MDK;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;SIX4;CRLF1;LIG4;AGAP2;SET;RASA1;NFATC4;KDM2B;WFS1;F2R;KIF14
prerank,regulation of biosynthetic process (GO:0009889),0.3728972188160132,0.8774306975135375,0.5979591836734693,0.9694220541329903,1.0,4/11,25.01%,SPHK2;MID1IP1;ALOX5;PIKFYVE
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.2780424006888365,-0.877256058539125,0.625,0.8668255949876241,1.0,4/31,5.40%,PARD3;RHOA;WDR1;RAP2A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.34051842390923504,-0.8771887417290195,0.613588110403397,0.8664368841673611,1.0,6/14,15.08%,ABCD2;TWIST1;MFSD2A;AKT2;TYSND1;IRS1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3645443256754207,-0.8770918354954148,0.6182902584493042,0.8661194921736451,1.0,2/11,9.66%,CAT;GPX1
prerank,cellular response to interleukin-15 (GO:0071350),-0.3458692772172655,-0.8768577238324374,0.6285714285714286,0.8655837178772701,1.0,6/13,28.04%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3458692772172655,-0.8768577238324374,0.6285714285714286,0.8655837178772701,1.0,6/13,28.04%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3558864033702133,0.876796747947217,0.6276803118908382,0.9699867275157893,1.0,2/13,7.38%,NUPR1;LRRK2
prerank,regulation of peptidase activity (GO:0052547),-0.3113225308705156,-0.8766234648662841,0.6232179226069247,0.8655758945246598,1.0,5/19,17.98%,CAV1;CST3;ECM1;PSMB8;MAPK12
prerank,ovarian follicle development (GO:0001541),0.3520536924476088,0.8763609911152392,0.6138211382113821,0.9701245328850902,1.0,3/13,8.44%,KIT;INHA;EIF2B4
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.3687138893307533,-0.8762505214116144,0.657314629258517,0.8659057148280388,1.0,3/11,3.58%,ACVR1;TGFB2;TGFBR2
prerank,lipoprotein localization (GO:0044872),0.3754120234931915,0.8759189897245464,0.624,0.9702502387319032,1.0,5/11,24.97%,PRKCB;ZDHHC3;MIA3;VMP1;PPARG
prerank,positive regulation of cyclase activity (GO:0031281),0.3525475144163124,0.8758312497298351,0.6055226824457594,0.969533137358016,1.0,1/14,0.44%,CACNA1D
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3650232990878977,-0.8754754345839204,0.61875,0.8670610640507107,1.0,3/10,17.26%,ITGA5;MT3;VTN
prerank,protein targeting to membrane (GO:0006612),-0.22502513022768686,-0.8753986822852678,0.7597087378640777,0.86670988512276,1.0,26/83,25.26%,PARD3;ATG3;ZDHHC20;AQP11;CHMP4B;CHMP4A;ABCD2;SRP19;SEC61A1;ZDHHC7;VPS37A;ICMT;SRP14;ZDHHC2;ACBD5;PEX14;SRPRA;PEX2;GDAP1;GOLGA7;CHM;MYO1C;SEC62;PEX12;ARL6IP1;ZDHHC14
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.294659088037484,0.8752454951916347,0.6431159420289855,0.970026885565697,1.0,11/29,19.90%,SMAD3;HNRNPA2B1;TRIM71;TUT4;ZC3H7B;AGO3;DICER1;SNIP1;SRRT;ADAR;SMAD2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.32461723848831675,0.8751983250933665,0.6324626865671642,0.9692184109481278,1.0,7/18,23.27%,GINS1;POLD2;POLE;MCM7;MCMDC2;LIG3;LIG1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.30631990323279945,0.8751893698838983,0.6425992779783394,0.9683193482871011,1.0,6/24,10.23%,DNMT3A;JARID2;PHF1;PPHLN1;MPHOSPH8;PPM1D
prerank,response to amino acid (GO:0043200),-0.2805618724212425,-0.8749533167172066,0.6559139784946236,0.8671600429991904,1.0,11/31,19.67%,SH3BP4;CAPN2;GLRB;SPAAR;RPTOR;NSMF;IPO5;RRAGA;GLRA2;GRIN1;RRAGD
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3707568144484661,0.8748397452557208,0.625,0.9682525263320512,1.0,2/10,10.57%,APPL2;PRKCB
prerank,neuron projection regeneration (GO:0031102),-0.37065730848583,-0.8747607993885297,0.6244813278008299,0.8670680351829886,1.0,3/10,16.99%,PTN;DHFR;RTN4RL1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3356993271832115,-0.8746677884311921,0.6365591397849463,0.8667392207619019,1.0,5/14,26.04%,RAPGEF2;PRKAR2B;PKIA;PRKAR1B;PRKAR2A
prerank,negative regulation of hippo signaling (GO:0035331),-0.3495530910275562,-0.8742077888752916,0.6385068762278978,0.8671795673225883,1.0,4/12,20.54%,LIMD1;CIT;MARK3;AJUBA
prerank,vitamin transport (GO:0051180),-0.277507933979691,-0.8736740954983687,0.6673553719008265,0.8678095972267609,1.0,3/29,8.29%,ABCG2;SLC5A6;CUBN
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2747912456019854,0.8735185591978776,0.6607142857142857,0.9705411957634899,1.0,15/39,20.49%,TANGO2;ARFGAP3;RAB3C;COPG1;CANX;TVP23B;RAB13;MIA3;COPG2;SCG2;NECAB3;TANGO6;LTBP2;RAB15;RCN3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2987755592565437,-0.8732815517650132,0.6350515463917525,0.8681372743774979,1.0,9/24,22.95%,RPA1;UBC;RPS27A;UBB;RPA2;LIG4;RFC4;POLD4;POLB
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.350648993989033,-0.8729692304532862,0.6504237288135594,0.8682970207986787,1.0,6/13,15.89%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECRL;ELOVL4
prerank,negative regulation of immune effector process (GO:0002698),0.3570003218893271,0.8728645741737862,0.5916334661354582,0.9712433013489004,1.0,3/13,14.85%,ENPP3;CD300A;HAVCR2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2826067622783977,0.8728522248647068,0.6326923076923077,0.9703538015092878,1.0,6/33,11.57%,PLK5;CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3508466275726462,-0.8727918079711022,0.6414342629482072,0.8681650481122618,1.0,6/12,23.72%,PROM1;STAT3;VEGFA;AGTPBP1;RORB;MYO7A
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3453224133813247,-0.8726775430008551,0.6673427991886409,0.867904735877187,1.0,11/13,51.93%,PRKCD;SOD1;SYK;MAPT;TYROBP;CRP;GSTP1;F2RL1;CD177;ITGB2;FPR2
prerank,gonad development (GO:0008406),0.2737163717806999,0.8720084267762552,0.6581818181818182,0.9714420481142462,1.0,6/41,12.01%,WNT4;KIT;FGF9;NR2F2;COL9A3;SOX9
prerank,modification-dependent protein catabolic process (GO:0019941),-0.19701532404198097,-0.8715879571821555,0.8371428571428572,0.8697285677183468,1.0,63/193,27.06%,FBXL7;NEDD4L;CDC27;SMURF1;NTAN1;UBC;RNF111;ANAPC5;RNF166;RNF144A;RNF144B;UBR4;RPS27A;UBB;RNF125;KCTD10;TRIM25;ZNRF3;CDC16;ARIH2;ARIH1;ISG15;SQSTM1;UBE2L3;PTTG1;KLHL3;FZR1;RNF149;CBL;OS9;UBE2A;RNF19A;UBA6;PSMD11;ADRM1;UBE2G1;RNF128;KCTD6;FBXL4;HACE1;PPP1R11;PCYOX1L;PSMD14;CDC26;TRPC4AP;NEDD4;DTX3L;ATXN3;KLHL25;MYLIP;RNF40;CDC23;CUL3;FBXO45;DTL;UFD1;CDC34;RNF150;AREL1;ANAPC1;RNF168;RCHY1;HERPUD1
prerank,mRNA 3'-end processing (GO:0031124),0.24183811955488335,0.871443881206412,0.6888888888888889,0.9718694403389331,1.0,20/78,18.57%,PABPN1;CPSF3;SRSF5;CPSF6;LEO1;CPSF7;SLBP;CDC73;UPF3B;RPRD2;LSM11;SRSF11;PAPOLB;GRSF1;POLR2D;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.36366216775306087,-0.8713061028403843,0.5992217898832685,0.869854908485739,1.0,4/10,24.12%,AGO2;DROSHA;MRPL44;TARBP2
prerank,female gamete generation (GO:0007292),-0.2798604822641583,-0.8712121379079029,0.6721991701244814,0.8695426024152669,1.0,17/29,46.64%,PTN;MDK;DMC1;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;BMP15;IHO1;MARF1;NANOS2;M1AP;FSHR;BCL2L10;FMN2;HORMAD1
prerank,regulation of neuroblast proliferation (GO:1902692),0.3444283586274628,0.8707269285695597,0.6245136186770428,0.9727235853847319,1.0,4/15,7.38%,TAFA3;SMARCD3;FZD3;LRRK2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3165477030168057,0.8707028334406562,0.6666666666666666,0.9718594496280842,1.0,3/20,11.36%,HSPA1A;PTGES3L;CLU
prerank,oligodendrocyte development (GO:0014003),-0.33242100492069904,-0.8704474055356157,0.6512096774193549,0.8706765536091204,1.0,7/15,31.99%,EIF2B2;B4GALT5;EIF2B1;MYRF;NSUN5;B4GALT6;PRDM8
prerank,histone methylation (GO:0016571),0.30217697087149276,0.8699396092050251,0.6433962264150943,0.9726813043077783,1.0,7/26,17.39%,PRMT2;N6AMT1;NSD1;SMYD3;SMYD2;NTMT1;NSD3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3592795638078705,0.8694168539326019,0.6446601941747573,0.9730102851686646,1.0,3/12,11.28%,DSC2;DLG1;RYR2
prerank,autophagosome maturation (GO:0097352),0.2817425394003781,0.8691577200541669,0.6361974405850092,0.9727288946450724,1.0,11/32,23.10%,SNX14;VAMP7;SNAP29;VPS16;LAMP2;LIX1L;RUBCNL;CHMP3;VMP1;UVRAG;ATP2A2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3295399624345483,-0.8691376052990637,0.6666666666666666,0.8728676154393625,1.0,2/16,6.60%,CLDN5;CLDN14
prerank,phasic smooth muscle contraction (GO:0014821),-0.36382277981232647,-0.8690046422389056,0.6242299794661191,0.8726181043883777,1.0,6/10,41.14%,EDN1;EDN3;PTGER3;DRD2;TIFAB;HTR1D
prerank,histone H3 deacetylation (GO:0070932),-0.32703350813935805,-0.8689102006628123,0.632016632016632,0.8722892814547224,1.0,6/15,25.85%,HDAC9;PER1;HDAC2;SIRT7;SIRT6;ELK4
prerank,negative regulation of macroautophagy (GO:0016242),0.3032101337764877,0.868865536951768,0.6511627906976745,0.9725449476277886,1.0,10/26,25.81%,NUPR1;QSOX1;LRRK2;TSC1;SEC22B;AKT1;NRBP2;LZTS1;FEZ1;MTM1
prerank,negative regulation of reproductive process (GO:2000242),0.3295312142212953,0.8679007346893173,0.6743295019157088,0.9739185402791448,1.0,1/17,0.69%,IGF1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.34390337436740864,0.8676232196659,0.6199186991869918,0.9736880020193743,1.0,4/14,18.12%,ENPP3;AK5;AK1;AK3
prerank,regulation of complement activation (GO:0030449),0.27427539245946303,0.8674275076970418,0.6818181818181818,0.9732406307485568,1.0,7/40,11.36%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,cellular defense response (GO:0006968),0.27629569835850204,0.866880505276574,0.6308243727598566,0.9735970061918048,1.0,2/40,1.12%,CCR9;DCDC2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3202286952856277,0.866519274393082,0.6615969581749049,0.9735110201794324,1.0,5/19,22.22%,NQO1;CHRNB2;RAPSN;ACHE;RIC3
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.24590202643179437,-0.8664801016984737,0.7245370370370371,0.876914345459751,1.0,3/48,3.12%,PDE4D;IL1R1;SLC7A5
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3280171842557652,0.8660785467770721,0.6259398496240601,0.9736469231019306,1.0,4/17,16.56%,PRKCZ;NLRP3;HAVCR2;RARA
prerank,regulation of cellular catabolic process (GO:0031329),0.25204121296904847,0.8657672381326827,0.6759581881533101,0.9735053086018467,1.0,9/62,9.38%,NUPR1;RRAGC;WDR91;ITPR1;RMC1;LRRK2;MTMR4;LONP2;ABCD1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32982578409666885,0.8653731165819712,0.6516007532956686,0.9735187339649508,1.0,5/18,14.52%,NAGA;FUCA1;FBXO6;FBXO17;ADAMTS9
prerank,transferrin transport (GO:0033572),-0.2686954697144076,-0.8651306166217967,0.7101123595505618,0.8792236382925909,1.0,8/33,13.97%,STEAP3;ATP6V0A4;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B
prerank,respiratory chain complex IV assembly (GO:0008535),0.3150183545129989,0.8651271729790532,0.6490196078431373,0.9731845740854652,1.0,9/21,26.01%,COX18;COX10;COX14;TIMM21;COX20;OXA1L;COA6;COX19;FASTKD3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.37397171613468605,0.8650584206893881,0.6471774193548387,0.9724510998088535,1.0,3/10,12.05%,IVD;ACAD11;GCDH
prerank,regulation of feeding behavior (GO:0060259),0.376115639667435,0.8649519076063477,0.6245136186770428,0.9717867849933179,1.0,1/11,0.66%,LEPR
prerank,protein localization to chromatin (GO:0071168),0.3241394166732065,0.8646969005001193,0.630057803468208,0.971468854793291,1.0,5/18,11.22%,SGF29;PLK1;RUVBL2;PPHLN1;PIH1D1
prerank,RNA transport (GO:0050658),0.24459050943903368,0.8640713313359134,0.6881533101045296,0.9719693177596402,1.0,18/71,20.79%,SIDT1;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;NUP62CL;SLBP;UPF3B;SRSF11;RNPS1;ALYREF;RBFOX1;DDX39B;THOC1;SRSF6;SARNP;RAE1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3478299423504871,0.864020214193351,0.6132264529058116,0.9711756773738789,1.0,5/13,28.15%,SPHK2;STX4;ITGAM;LAMP1;AP1G1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.22563680877229644,-0.8639854797015389,0.7471783295711061,0.881198237813181,1.0,17/75,18.00%,PLCE1;RGS3;RGS12;RGS5;CRY1;YWHAB;MGLL;RGS6;EDN1;GRK5;ZDHHC7;RGS4;GIT1;GIT2;GPER1;RNF157;PDE6H
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.31079144303753203,-0.8639226013379382,0.6987179487179487,0.8807975957752991,1.0,3/18,4.08%,EGFR;BMP4;ESR1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.2900048990659715,-0.8637674467716964,0.6701680672268907,0.8806199638328801,1.0,5/24,9.28%,PID1;BCL2L1;TMEM59;NUMB;ABI3
prerank,excitatory postsynaptic potential (GO:0060079),0.32356183857765775,0.863739481496831,0.6357012750455373,0.9709303340036151,1.0,4/19,7.38%,RAB3GAP1;GRID2;GRIN2D;LRRK2
prerank,translational termination (GO:0006415),-0.21674264919625968,-0.863684198662478,0.7975,0.880277217523078,1.0,25/95,19.87%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;MRPL10;ABCE1;MRPL12;GFM2;PTCD3;MRPS12;MRPL43;MRPL1;MRPS22;MRPL55;MRPL45;MRPL44;TRMT112;MRPL33;CHCHD1;MRPL36;MRPL35
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.34900388249292347,-0.8633770069071706,0.6508264462809917,0.8804268476153871,1.0,6/12,30.69%,CEACAM1;PIBF1;ACADVL;TRIB3;APOC1;ERLIN1
prerank,neuromuscular process (GO:0050905),-0.3247028101673409,-0.8632648041356642,0.6552462526766595,0.8801579256441913,1.0,5/16,20.89%,GCH1;STRA6;PAFAH1B1;AGTPBP1;DCTN1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3277713838247212,-0.8632299487857222,0.6567460317460317,0.8797013454572623,1.0,9/15,30.02%,SCARB1;MFSD2A;FBXW7;CTDNEP1;C3;SREBF1;LDLR;SIK1;NR1H2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.37903359628859923,0.8630597890795512,0.6403162055335968,0.9716014842113062,1.0,3/10,15.02%,GABRG1;GABRG3;GABRB2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22956117416161187,-0.8630394727273597,0.7540603248259861,0.8795699942412947,1.0,17/72,20.92%,REL;CARD14;PSMB7;PSMA6;RELB;PSMB6;MALT1;PSMB5;BIRC3;PSMC4;PSMB8;PSMD11;NFKB2;PSMB4;PSMD14;PSMD10;PSME1
prerank,muscle tissue morphogenesis (GO:0060415),-0.3250660334246078,-0.8628335600778385,0.6503067484662577,0.879458755060187,1.0,5/16,12.31%,NOTCH1;BMP4;TBX1;HEY2;BMP2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.31790326407354785,-0.8627797056529627,0.6561844863731656,0.8790647034638357,1.0,8/17,25.35%,BMP4;RUNX1;CREB3L1;TGFB3;HDAC2;AMELX;RGCC;F2R
prerank,protein secretion (GO:0009306),0.2551939221519232,0.8625705706203094,0.7007042253521126,0.9718123628529403,1.0,19/56,20.49%,WLS;TANGO2;ARFGAP3;RAB3C;MAFA;VIP;COPG1;CANX;TVP23B;RAB13;MIA3;COPG2;SCG2;NECAB3;PTPRN;TANGO6;LTBP2;RAB15;RCN3
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3699162241730617,-0.8622916895041248,0.6203522504892368,0.8796095197678828,1.0,4/10,17.01%,ABCA3;PHB2;MFSD2A;MTMR1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.2996471447406981,-0.8621829084199927,0.6735966735966736,0.8793213592815955,1.0,7/20,17.23%,BMP5;ASXL3;CEACAM1;BMP2;FBXW7;ACADVL;GPER1
prerank,RNA catabolic process (GO:0006401),0.26111536205484787,0.862172228061018,0.6774744027303754,0.9718508743823352,1.0,9/46,17.60%,HSPA1A;RNASEH2A;SUPV3L1;LSM5;AGO3;SND1;HSPA1B;ZPR1;MTREX
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3107565698293447,0.8621615244061717,0.6415841584158416,0.9709793899267416,1.0,4/23,11.12%,IGF1;EFNB2;NRG1;MAPK14
prerank,cardiocyte differentiation (GO:0035051),-0.36210614520997914,-0.8618081268238316,0.6485943775100401,0.8795984285399503,1.0,3/10,12.31%,TGFB2;MYOCD;BMP2
prerank,inositol phosphate metabolic process (GO:0043647),-0.24741566230306375,-0.8613038377659308,0.7043879907621247,0.880093333875444,1.0,6/46,6.53%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.18189427082578935,-0.8610495485304638,0.9351851851851852,0.8801140296063993,1.0,123/336,31.19%,FOXP1;ACER2;RPA1;FOXO1;RAD51B;BCL2L1;TNFRSF1B;CRY1;HERC2;FNIP2;ALKBH1;SMC1A;CSNK1E;CRIP1;XPC;NIPBL;XRCC5;LYN;REXO4;APC;ZBTB1;FBXO31;RPS3;CHD1L;HPF1;SMC5;RPAIN;XIAP;STK33;MAPKAPK2;WDR76;CDKN2AIP;RNF169;NFATC2;OARD1;BABAM2;GTF2H1;DCUN1D5;BLM;KIN;SUSD6;NCOA6;USP47;SUV39H1;TIMELESS;BAK1;UBE2A;UBA6;FMR1;FANCG;TAOK3;TOP2A;GNL1;MASTL;BOD1L1;NBN;MAPK12;SLF2;BARD1;CCND1;MAPK3;MCL1;ZC3H12A;USP10;TIGAR;PCLAF;METTL3;POLA1;SPIDR;SIRT7;DYRK2;XPA;NSMCE4A;RFC4;CHEK1;MUTYH;NSMCE3;TAOK1;TRRAP;DTX3L;RBM24;WDHD1;POLB;TAF9;BOK;BTG2;PLK3;FBXO45;TRAIP;ZBTB40;AATF;ASH2L;DTL;XRCC3;CUL4A;BCL3;NUDT1;OTUB1;RFC2;FANCL;RNF168;POLE3;CIB1;RAD51AP1;RECQL5;GRB2;PARP3;FAM111A;VCP;VAV3;FAAP20;CGAS;PARP1;YAP1;SETX;HELB;PARK7;ERCC8;IRF3;MRNIP;MYC;PIDD1;OGG1
prerank,glycosphingolipid metabolic process (GO:0006687),0.26759090982622746,0.8607494301235569,0.6788321167883211,0.973363196814083,1.0,10/42,15.83%,CTSA;ST3GAL5;SUMF1;LARGE1;SMPD3;SMPD2;ABCA2;ST6GALNAC6;GBA2;CERK
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.263140459375623,-0.8606324091639979,0.7214912280701754,0.8804534611961342,1.0,9/38,16.03%,CAV1;GAS6;APP;IL34;NEDD9;PTPN1;PTPRC;CSF1R;RAP2B
prerank,actin filament bundle assembly (GO:0051017),0.28493839943041793,0.8605624266827291,0.6391941391941391,0.9729206812439948,1.0,5/33,6.98%,USH1C;BAIAP2;PAWR;ADD2;CORO1B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3275453621776623,-0.8603693107100401,0.6446280991735537,0.8804834872475522,1.0,4/15,17.22%,LRP6;TBX1;BMP2;HDAC2
prerank,chromatin remodeling (GO:0006338),-0.21345871313367829,-0.860203832934935,0.7974683544303798,0.880327445402336,1.0,12/100,8.67%,ACTB;ESR1;BPTF;ARID1B;SMARCC1;BAZ2B;EZH1;ZBTB1;CHD1L;ARID1A;GATAD2B;RBBP4
prerank,heart process (GO:0003015),-0.3316364554567263,-0.8601471074872696,0.6387755102040816,0.879943772832298,1.0,3/14,9.66%,SGCD;SOD1;GPX1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2539930962192791,-0.8601067578574442,0.7029914529914529,0.8795150111904156,1.0,10/40,15.04%,SNRPD1;BACH2;MALT1;RSRC1;SNRPD2;NCBP2;GEMIN8;ATXN1;SNRPE;NCBP1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.37105453409936,0.8600862728847991,0.6391752577319587,0.9731443689421795,1.0,2/11,5.92%,NUPR1;FZD9
prerank,regulation of chemotaxis (GO:0050920),0.28746783269188947,0.8600337951227459,0.6679245283018868,0.9723790385646828,1.0,2/30,1.52%,PDGFRA;EFNB2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.26213567930380266,-0.8600033439678327,0.6892778993435449,0.8792041925006071,1.0,9/35,18.32%,PPP1R12A;ITGA1;NUAK1;CALM3;PPP1R2;PPP6R1;MASTL;BOD1L1;PPP1R11
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3033177967593712,-0.8599749980552878,0.6811594202898551,0.878764622398444,1.0,6/20,20.54%,LIMD1;AGO1;AGO2;HELZ;AGO4;AJUBA
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2744142371679581,-0.8598706574212799,0.6479166666666667,0.8784897935729875,1.0,20/29,41.37%,RPS16;RPS8;BMS1;DCAF13;PWP2;RRS1;RPS21;RPS19;WDR46;DHX37;HELB;TSR1;RPP40;HEATR1;NOP14;NOL10;UTP4;UTP20;MRPS11;UTP6
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.1979752499704505,-0.8596862939740817,0.84,0.8783501090800627,1.0,55/166,27.04%,NIBAN1;BCAR3;SCARB1;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;RPL5;PTGS2;NOS1AP;EIF3E;ELOVL5;EEF2;NNMT;IGF2;KLF4;FGF2;EDN1;STARD4;DDAH1;MFSD2A;NMD3;AKT2;KLF2;IRS1;FMR1;FXR1;BRPF3;CTDNEP1;ASS1;PTH1R;METTL3;DYRK2;PIWIL2;FAF1;EIF4A3;PRR16;DDAH2;SREBF1;PRMT1;GIPC1;EGF;RGCC;TLR4;PPP1R3E;CTC1;BCL3;FABP3;HNRNPD;LDLR;RPS4X;METTL14;SLC25A37
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33388712581938396,-0.859537365211327,0.6553911205073996,0.8781498043641496,1.0,4/14,11.77%,SEMA7A;PLCG2;WNT5A;CD74
prerank,regulation of ion transmembrane transport (GO:0034765),0.280791578422984,0.8593984412305558,0.6672897196261682,0.9729313332249052,1.0,6/33,10.01%,KCNJ13;WNK3;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,I-kappaB phosphorylation (GO:0007252),-0.35597315191551293,-0.8593690008465135,0.650103519668737,0.8779921819925309,1.0,1/10,0.90%,DAB2IP
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2388301075403631,0.8593242149002206,0.7240204429301533,0.972208184962064,1.0,16/85,16.22%,DAB2;HSPA1A;NUPR1;SH3RF2;PLK1;RNF14;CEBPA;LRRK2;TAF1;CLU;RNFT1;BAG6;PSMC5;HSPA1B;DNAJB2;MDM2
prerank,receptor recycling (GO:0001881),-0.3624895703630576,-0.8590258284164577,0.6701902748414377,0.8782333931998912,1.0,5/10,29.51%,RAB11B;PHETA1;PHETA2;NSG1;LMTK2
prerank,photoperiodism (GO:0009648),-0.2697374770531138,-0.8588519068356422,0.6651480637813212,0.8780912570702332,1.0,7/28,15.66%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,regulation of phosphorylation (GO:0042325),0.22404948706835187,0.8584675989460814,0.7774193548387097,0.9733656677469404,1.0,15/120,12.24%,PRKAG2;BMP7;GCK;CDKN2A;POM121;NUP155;INHA;PHIP;FZD7;ROPN1L;LDB2;LDB1;STAT2;NUP98;PML
prerank,synaptic vesicle localization (GO:0097479),0.3544083641646937,0.8584249409930215,0.6193415637860082,0.9725702474025891,1.0,6/13,25.17%,KIF5C;SNAPIN;SPG11;SYNDIG1;SYNJ1;KIF5A
prerank,protein acylation (GO:0043543),0.27240636467173746,0.8582833486370386,0.6730769230769231,0.9719978080404357,1.0,10/38,17.81%,SPHK1;ZDHHC12;ZDHHC1;CLOCK;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,diterpenoid metabolic process (GO:0016101),0.25346802732721374,0.8582327286065836,0.7229129662522202,0.9712185701792312,1.0,4/55,2.50%,ADH7;ADH4;RBP1;ABCA4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3156547515573508,-0.8580486428920274,0.65,0.8791482357297259,1.0,10/16,29.24%,CAV1;VHL;HGS;PIBF1;SOCS3;PPP2CA;SOCS1;BCL3;INPP5F;PPP2R1A
prerank,positive regulation of signaling (GO:0023056),0.28054042057326434,0.857918429064107,0.6660447761194029,0.9710304112860616,1.0,6/37,9.33%,WLS;SYT1;GRIK2;RIMS1;DLG4;NSF
prerank,negative regulation of organelle assembly (GO:1902116),0.2761985909225217,0.8577706944365276,0.6535008976660682,0.9704715648922314,1.0,4/35,7.38%,NUPR1;ODF2L;TCHP;LRRK2
prerank,regulation of DNA repair (GO:0006282),0.26793392957197687,0.857550637993418,0.6950998185117967,0.9700891796763732,1.0,3/44,2.72%,EYA1;EYA4;EYA2
prerank,proteoglycan biosynthetic process (GO:0030166),0.28617147653573904,0.8575159280279114,0.662431941923775,0.9692756457039218,1.0,5/31,8.17%,IGF1;HS3ST3B1;CHST10;PXYLP1;B3GALT6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.3739213812826619,-0.8574778992414755,0.6756756756756757,0.8798104132976311,1.0,2/10,11.35%,PFKL;GFPT2
prerank,snRNA metabolic process (GO:0016073),-0.30735528519305644,-0.8574191680844152,0.6376811594202898,0.8794355425368316,1.0,5/17,19.78%,INTS11;RBM7;INTS10;INTS9;MEPCE
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28019605861046226,-0.8566664782681168,0.689727463312369,0.880492827147894,1.0,12/27,30.26%,ERN1;TRIR;NUDT16;ZC3H12A;TOE1;NYNRIN;NHP2;RNASE4;PCF11;POP7;CSTF3;XRN1
prerank,negative regulation of peptidase activity (GO:0010466),-0.2453586560886748,-0.8566564679111239,0.7158590308370044,0.8800071975909739,1.0,20/47,32.16%,SPOCK2;SERPINF1;CST3;UBXN1;SERPINE1;SERPINB8;SERPINB9;ECM1;LRP1;VTN;GAPDH;SERPINH1;SERPINI1;TIMP1;AGT;AHSG;PARK7;SERPINC1;CRB2;TIMP2
prerank,negative regulation of insulin secretion (GO:0046676),-0.3135632638583082,-0.8564193451219974,0.6714876033057852,0.8799920188701412,1.0,5/17,15.08%,CCN3;KLF7;MIDN;KCNB1;IRS1
prerank,negative regulation of DNA replication (GO:0008156),0.35119389957650404,0.8560582714854529,0.6431226765799256,0.9717358509436954,1.0,2/13,5.02%,GMNC;TSPYL2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.29637796625613066,-0.8556294165320242,0.6756756756756757,0.8811236003791294,1.0,11/23,30.83%,FAF2;SURF4;AUP1;OS9;SEC13;UFD1;HERPUD1;VCP;TECPR2;RANGRF;LMAN1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3030494564642508,-0.855571849430902,0.6877637130801688,0.8807330446802576,1.0,5/19,10.34%,POLR3F;ICE1;AR;MAF1;RPTOR
prerank,protein modification by small protein removal (GO:0070646),-0.18906107143035697,-0.8554598053039957,0.8764367816091954,0.8804527543236178,1.0,65/252,23.39%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;USP46;AR;PSMB7;PSMA6;APC;OTUD7B;USP7;USP35;EIF3F;USPL1;SENP6;PSMB6;PSMB5;HGS;BABAM2;RAD23B;RNF123;USP47;BIRC3;IFIH1;PSMC4;PSMB8;CCP110;FOXO4;TAB1;CFTR;GPS1;USP50;PSMD11;ADRM1;RNF128;JOSD1;PSMB4;RUVBL1;BARD1;PSMD14;UCHL1;PTEN;ZC3H12A;USP10;IL33;ARRB2;PSMD10;RIPK1;UCHL5;PSME1;COPS6;RCE1;TRRAP;CYLD;ATXN3;PSMB3;POLB;USP15;COPS4
prerank,regulation of pH (GO:0006885),0.37328990753921365,0.8554268781202331,0.6173076923076923,0.972264864390543,1.0,5/11,23.59%,LACC1;PDK2;CLCN3;SLC9A1;PDK4
prerank,mitotic sister chromatid segregation (GO:0000070),0.2282191614880843,0.8553697715567407,0.7382113821138211,0.9715009111322066,1.0,12/98,9.72%,KMT5A;NCAPD2;EML4;CHMP6;ZWINT;PLK1;PHF8;TENT4A;DSN1;TUBG1;NDC80;CSNK2A2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3066143251765646,0.855313405528576,0.6495238095238095,0.9707439781104333,1.0,3/24,11.61%,LPGAT1;PNPLA8;PLA2G15
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3575238268049028,-0.8536889839897054,0.6517311608961304,0.8836266911090972,1.0,5/10,33.32%,APC;NUP62;MARK4;PARD6A;CEP250
prerank,mitotic cytokinesis (GO:0000281),-0.24501789759474202,-0.853579930977374,0.7472766884531591,0.8833254436702255,1.0,8/47,12.65%,SPTBN1;STMN1;SNX18;CIT;APC;CHMP4B;KIF23;INCENP
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.28427367644956747,-0.8533824975189086,0.6801705756929638,0.8832176577014507,1.0,5/24,8.17%,BCL2L1;AQP11;CREB3L1;RACK1;UBXN1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.37349810605816763,0.853339266658277,0.650103519668737,0.9743991636308162,1.0,1/10,1.01%,ACTN2
prerank,regulation of cell development (GO:0060284),0.27895334535505895,0.8531850740415073,0.6654545454545454,0.9738595919651355,1.0,10/36,18.34%,NOTCH2;PRUNE1;HES6;CLOCK;DOCK7;BHLHE41;PER2;CX3CL1;AKT1;FBXO22
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2536776957730167,0.8527905578552432,0.7225130890052356,0.9738877586757516,1.0,16/54,19.40%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;FUCA1;HS3ST5;HS3ST6;HS6ST2;HS2ST1;NDST2;CHST9;HGSNAT;B3GAT2;IDUA
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2597309964456949,-0.8527538259911132,0.7186046511627907,0.8839277211118955,1.0,12/39,22.24%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,histone H4 acetylation (GO:0043967),0.2618954173313699,0.852587465592198,0.708838821490468,0.9734780311014418,1.0,18/47,22.21%,KMT2A;BRD8;KANSL2;RUVBL2;MEAF6;DMAP1;EP400;BEND3;YEATS4;CHD5;TADA3;MCRS1;MSL1;APBB1;ACTL6B;KAT8;ATF2;ACTL6A
prerank,regulation of humoral immune response (GO:0002920),0.262862342952932,0.8523391783743922,0.6762075134168157,0.9731650860071756,1.0,7/44,11.36%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,negative regulation of cell activation (GO:0050866),-0.33095028167822627,-0.8515069658653514,0.6843177189409368,0.8859197756101478,1.0,2/14,1.49%,NOS3;CD200
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19446764084077633,-0.851467898943221,0.8575581395348837,0.8855142645716444,1.0,44/171,23.94%,TTC28;NEK7;CDC27;IQGAP1;AFAP1L2;BTG1;APP;ANAPC5;XPC;PSMB7;PSMA6;CDC16;CDKN1C;EIF4E;TAL1;DUSP3;CAV2;PSMB6;BTG3;PSMB5;FBXO5;ERCC2;PSMC4;FZR1;PSMB8;PSMD11;PSMB4;KIF20B;PSMD14;CDC26;ASAH2;PSMD10;L3MBTL1;THAP1;PSME1;TTLL12;CYLD;PSMB3;CDKN1B;MKI67;RNF40;CDK11B;CDC23;BTG2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24688742396840077,0.851407749166962,0.7026548672566372,0.9743592779834754,1.0,11/63,13.63%,LEPR;NUPR1;TIMP3;ZKSCAN3;GOLGA2;IL10RA;BCL2;ATRAID;KDM4A;MTMR2;TBC1D14
prerank,positive regulation of intracellular transport (GO:0032388),0.2759912077793948,0.8511535251605648,0.693950177935943,0.9740551996915914,1.0,6/38,10.64%,ACTN2;STX18;TENM1;RUFY3;CEP290;PCM1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.21939896966167838,-0.8507752727130719,0.7815533980582524,0.8864151805579114,1.0,16/76,13.50%,SMURF1;CBFA2T3;RNF144A;CSNK1E;COP1;RNF144B;NKD2;RACK1;ZYG11B;CSNK1A1;ARIH2;SOCS5;ARIH1;PABIR1;GABARAP;FBXW7
prerank,regulation of cellular metabolic process (GO:0031323),0.26425154844281745,0.8506621821450141,0.7142857142857143,0.9742312817214663,1.0,11/45,15.91%,PPARA;RNF41;KIF16B;PANK2;PDK2;MPV17;RSPO1;ABCA2;TBC1D16;NCOR2;ACACA
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3572437127520181,0.850433248491272,0.6929133858267716,0.9738433458156649,1.0,1/11,0.82%,DDX5
prerank,aminoglycan biosynthetic process (GO:0006023),0.2561945630476968,0.8502948906074141,0.7010869565217391,0.9732613974322853,1.0,9/49,13.04%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;HS3ST5;HS3ST6;HS6ST2
prerank,positive regulation of cell death (GO:0010942),-0.23166992421193072,-0.8502537941213052,0.740174672489083,0.8869581740842667,1.0,20/59,23.35%,SLC6A6;ACER2;MAP3K5;BMP4;AXIN2;WNT5A;APC;GRIN2B;RARG;MT3;DDIT4;LRP1;PRODH;ZC3H12A;RIPK1;RIPK2;FAF1;FYN;CDKN1B;FCGR2B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.334031812843858,-0.8496530719736847,0.697196261682243,0.8876843124508397,1.0,5/13,29.54%,BPNT2;TPST2;ENPP1;SULT1A1;SULT2B1
prerank,cellular response to ionizing radiation (GO:0071479),-0.24530877371220974,-0.8493366437972953,0.7419354838709677,0.8877949994039965,1.0,11/47,20.94%,NET1;MAP3K20;NIPBL;XRCC5;BLM;RHNO1;TNKS1BP1;LIG4;RHOB;SPIDR;TMEM109
prerank,response to purine-containing compound (GO:0014074),-0.31081486316351764,-0.8489384983425757,0.6706349206349206,0.8881028474318041,1.0,2/17,2.25%,TRPC3;ABCC9
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3081530609077804,-0.8481382056818595,0.6568421052631579,0.8892199879198218,1.0,7/16,32.86%,TIPIN;ORC1;TIMELESS;CDC45;HUS1B;CDC6;TICRR
prerank,regulation of primary metabolic process (GO:0080090),0.2181395910597103,0.8481320482475377,0.7714748784440842,0.9773270287839897,1.0,28/126,19.94%,ROCK2;NQO1;PPARA;NFYB;PSMD3;SMARCD3;NFYC;CHD9;MED1;SC5D;RXRA;PSMD1;PSMC5;CYP51A1;SQLE;PSMA1;TBL1XR1;RUBCNL;NCOR2;PSMD12;ACACA;TM6SF2;GGPS1;HMGCR;NCOR1;PSMD7;OPA3;SIN3A
prerank,protein stabilization (GO:0050821),-0.1949720435098659,-0.8474949343604647,0.8732782369146006,0.8900297897002372,1.0,37/168,19.68%,HIP1;STK3;RASSF2;PIK3R1;RPL5;NAA16;FLNA;SOX17;PRKCD;COG3;RPS7;PTGES3;USP7;VHL;CRTAP;MFSD1;RPL23;PARVA;BAG5;PHB2;HIP1R;MORC3;PFN1;FBXW7;CCT2;MT3;PLPP3;BAG1;RTN4;NCLN;SUGT1;GAPDH;ATF7IP;DNLZ;PTEN;GOLGA7;HYPK
prerank,regulation of protein ubiquitination (GO:0031396),-0.20708667374338627,-0.84722041171425,0.8269230769230769,0.8900927102847362,1.0,23/108,14.87%,CAV1;CRY1;SPOPL;DNAJA1;UBB;PRKCG;RPS3;SPRY2;UBXN1;XIAP;FBXO4;FAM107A;MALT1;AMER1;BAG5;ISG15;FOXF2;SQSTM1;UBE2L3;FBXW7;BIRC3;TBC1D7;PHF23
prerank,neuron maturation (GO:0042551),-0.2978240162512583,-0.8471724758857149,0.6863905325443787,0.8896804109033656,1.0,5/18,11.55%,ANKS1A;SCARF1;APP;LGI4;B4GALT5
prerank,stress-activated MAPK cascade (GO:0051403),-0.23031783723499655,-0.847071591913588,0.7775061124694377,0.8893723493621689,1.0,17/61,22.04%,MAP3K5;UBC;NOD1;MAP3K20;RPS27A;UBB;MAPK1;TNFRSF19;TAB1;IRAK2;GPS1;MAP3K8;NOD2;MAPK3;MAP2K7;RIPK2;MAP4K3
prerank,regulation of endocytic recycling (GO:2001135),0.3624588102930365,0.8469010730559691,0.6500956022944551,0.9791582249604887,1.0,1/11,1.01%,ACTN2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.22618338969814222,0.8467946511325473,0.7743589743589744,0.9785292271258728,1.0,29/94,20.04%,DDX5;ITPR1;AIFM1;E2F1;PDK2;HTRA2;TMEM117;MSH6;IKBKE;DNAJC10;MLLT11;BCL2;C1QBP;TOPORS;PML;CHEK2;BAG6;PDK1;PRKDC;ABL1;ATM;ERO1A;ATP2A1;HIPK2;RRP8;DDIT3;BAX;DDX3X;PYCARD
prerank,diol biosynthetic process (GO:0034312),-0.3217378446433513,-0.8464656993188304,0.6724511930585684,0.8900765068307022,1.0,6/15,19.83%,ACER2;GCH1;QDPR;DHFR;ASAH2;ACER3
prerank,necroptotic process (GO:0070266),-0.3089422483596247,-0.8461579388093907,0.6686390532544378,0.8901752460492766,1.0,8/16,33.91%,IPMK;RIPK1;MLKL;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,negative regulation of cartilage development (GO:0061037),-0.33416813028578357,-0.8459697824841667,0.6720321931589537,0.8900220936517549,1.0,7/13,27.48%,WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2
prerank,second-messenger-mediated signaling (GO:0019932),-0.2143238063171818,-0.845775763624261,0.7702020202020202,0.8898964363032839,1.0,15/82,13.12%,PLCE1;NOS3;NDNF;GUCY1B1;PLCG1;PLCG2;AGTR1;MCTP2;EIF2AK3;EDN1;ACKR3;APOE;DDAH1;EDN3;GUCY1A1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.254975477611952,0.8457271358086383,0.698943661971831,0.9800139351012049,1.0,17/48,20.04%,E2F1;HTRA2;MSH6;IKBKE;BCL2;TOPORS;PML;CHEK2;BAG6;AEN;PRKDC;ABL1;ATM;SIRT1;HIPK2;BAX;PYCARD
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3528339235014698,-0.8455084612937394,0.6783505154639176,0.8899290028629144,1.0,1/10,0.84%,RAPGEF2
prerank,negative regulation of histone modification (GO:0031057),0.3355001522584082,0.8454342712784164,0.6548856548856549,0.9797604689518087,1.0,3/14,12.74%,JARID2;SPHK2;NOC2L
prerank,response to UV-B (GO:0010224),-0.3406787104304202,-0.8446631853739331,0.6708595387840671,0.8910768029436652,1.0,2/12,7.87%,CRIP1;MFAP4
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3672629934810521,0.8445005773725262,0.6160164271047228,0.9809630692206694,1.0,3/10,16.52%,NDFIP1;SNX3;NDFIP2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.30062310500973644,-0.8444022600663039,0.686,0.8910512421646792,1.0,3/18,5.59%,CD200;RPS6KA5;PRKD1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23200943708328903,0.8437895435824015,0.7543859649122807,0.9816870715892814,1.0,11/80,10.34%,MAGEA2;SPHK1;NDFIP1;DERL1;PLK1;ARRDC3;LRRK2;SPRTN;DCUN1D4;TOPORS;FANCI
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2732696005889967,-0.8430916020776205,0.710239651416122,0.8930858606399398,1.0,9/28,22.20%,UBC;NOD1;RPS27A;UBB;TAB1;IRAK2;NOD2;RIPK2;CYLD
prerank,muscle cell migration (GO:0014812),-0.3646676046835087,-0.8427932550902849,0.6646586345381527,0.8931208414275347,1.0,2/10,4.15%,SIX1;CCN3
prerank,positive regulation of cell killing (GO:0031343),0.33683005897845386,0.842320403939153,0.6495238095238095,0.984036020061971,1.0,3/13,14.03%,NOX1;FZD7;CYBA
prerank,DNA repair (GO:0006281),0.19578888159155683,0.8420457209304937,0.8859649122807017,0.9837674093030665,1.0,48/284,16.11%,EYA1;DDB2;RNASEH2A;DOT1L;ERCC1;RECQL4;PMS2;FANCD2;XRCC1;ASCC2;ACTR8;TENT4A;POLD2;ABRAXAS1;EME2;SPRTN;KAT5;MBD4;MSH6;HINFP;EXO5;TDP2;MDC1;RFC5;PARP4;KMT5C;INIP;MRE11;FANCI;FBXO6;MLH3;KDM4A;CHEK2;PIAS4;MSH3;POLI;PRKDC;MEN1;RAD51D;NEIL1;POLE;ABL1;RPA3;ATM;GADD45A;FAAP100;SIRT1;RAD52
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.3226271958894076,0.8420079378981904,0.667910447761194,0.9829680778495524,1.0,5/16,16.34%,ANK2;LRRK2;RYR2;MIA3;GBF1
prerank,axonal transport (GO:0098930),0.2714358127428856,0.8418442341619244,0.6815742397137746,0.9824486631542834,1.0,11/36,19.63%,RAB21;AP3S2;SNAPIN;DTNBP1;KIF3A;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2359827309470982,0.8413332087995503,0.7483333333333333,0.9826855088975567,1.0,29/80,22.92%,STX18;ARFGAP3;KIF3C;ARFGAP2;NAPA;RAB6B;HTT;NSF;RINT1;COPG1;KIF3A;TMED9;RAB1A;COPG2;RER1;TAPBP;COPE;GBF1;TMED2;COPB1;PICK1;SEC22B;KIF3B;KLC1;KLC2;UVRAG;ATP9B;KDELR2;LMAN2
prerank,positive regulation of viral life cycle (GO:1903902),-0.286177444411012,-0.8410763272640229,0.7085828343313373,0.8959759553745353,1.0,4/22,16.38%,CHMP2B;CD74;KPNA2;FMR1
prerank,positive regulation of receptor internalization (GO:0002092),-0.2862567438263941,-0.8409020020229534,0.7045454545454546,0.895787264121361,1.0,7/22,19.78%,INSR;SFRP4;TBC1D5;VEGFA;FMR1;GREM1;ARRB2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.30371105894263434,0.8407585710401,0.6561338289962825,0.9830985279049513,1.0,6/22,18.96%,PPARA;SORBS1;CREBL2;CREB1;AKT1;MLXIPL
prerank,positive regulation of T cell cytokine production (GO:0002726),0.30548101505778236,0.8406457939605773,0.6731141199226306,0.9824707970105596,1.0,4/20,11.81%,IL18;PRKCZ;NLRP3;FZD5
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.22594812490868468,-0.8404854741730579,0.7759815242494227,0.896114086767286,1.0,22/62,26.23%,LIMD1;H3-3A;STAT3;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;SEC13;FMR1;FXR1;NUP50;NUP85;AJUBA;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205
prerank,T cell differentiation (GO:0030217),0.2676133099717358,0.8404719951979824,0.7380073800738007,0.9820011803094216,1.0,3/40,3.32%,LEPR;KIT;LMBR1L
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2220414983156718,-0.8403273860635712,0.8,0.8959291076614458,1.0,32/72,37.40%,RPA1;UBC;DCP1B;RPS27A;UBB;REXO4;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;ENPP1;ZC3H12A;XPA;RFC4;RNASE4;POLD4;PNRC2;CUL4A;RFC2;XRN2;PARP1;OGG1;ISG20;EDC3;FEN1;GTF2H2;MUS81;ANKLE1;IHO1;DDX1;POLK
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20925578828841024,0.840197549657144,0.847926267281106,0.9817181527366818,1.0,16/166,9.80%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;POLRMT;RBPJ;WWTR1;MED1;TAF10;PPARGC1A;NR1H3;RXRA
prerank,neuron projection development (GO:0031175),0.20971039439520722,0.8401128104830989,0.8121212121212121,0.9810183883588599,1.0,28/168,13.37%,BMP7;MAP2;USH1C;MICALL1;EPHA8;WHRN;GAS7;FLRT3;WNT7A;NRTN;PQBP1;SNAPIN;LRRK2;SHANK1;CNTNAP2;ADGRV1;DLG4;KLK8;GPM6A;DTNBP1;DOCK7;WASL;EPHA4;NYAP2;RAB13;BDNF;L1CAM;DICER1
prerank,primary neural tube formation (GO:0014020),0.28331609418140896,0.8400600667333689,0.7051039697542533,0.980275909268958,1.0,8/30,16.41%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFR;MTHFD1;FUZ
prerank,ubiquinone biosynthetic process (GO:0006744),0.32714410059528987,0.8396707060920477,0.6450304259634888,0.9803053031150398,1.0,5/15,20.34%,COQ10A;COQ8B;COQ3;COQ7;FDXR
prerank,regulation of immune effector process (GO:0002697),0.2646384609696213,0.8395274490893673,0.7262773722627737,0.9797471236274053,1.0,7/41,11.36%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,positive regulation of biosynthetic process (GO:0009891),0.26519958384184866,0.8391585823363527,0.7093862815884476,0.979693368300292,1.0,3/40,2.88%,WNT4;SLC5A3;PPARA
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3417883576273406,-0.8388261969277975,0.6796714579055442,0.898341506811472,1.0,5/12,28.50%,IAPP;APOE;PFDN6;LDLR;TREM2
prerank,NAD biosynthetic process (GO:0009435),-0.29661688172340517,-0.8388001989165634,0.7021276595744681,0.8978796869737354,1.0,7/20,23.21%,PTGIS;PTGS2;NNMT;NUDT12;NAXE;KYNU;NMNAT1
prerank,regulation of organelle assembly (GO:1902115),0.2371428492664004,0.8387249635832601,0.75,0.9797793145270894,1.0,10/72,8.66%,DCDC2;NPRL3;STX18;DYNLT2B;STAM;SGSM3;DYNC2LI1;ATXN2L;TBC1D9B;RABEP2
prerank,response to acidic pH (GO:0010447),0.3356244682565206,0.8386657866841173,0.6484848484848484,0.9790405142213368,1.0,2/13,8.28%,TRPV1;IMPACT
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.25440410246602957,0.8382939284662712,0.7209737827715356,0.9789718106038465,1.0,3/47,1.66%,WNT4;ROCK2;GCK
prerank,response to glucocorticoid (GO:0051384),-0.272036303162758,-0.8382297599100337,0.7261410788381742,0.8985287736715233,1.0,4/26,13.36%,SLIT2;ANXA1;FAM107A;UBE2L3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3256335955240519,-0.8380806392284565,0.6903765690376569,0.8982793302300768,1.0,6/14,26.50%,TNKS;XRCC5;TERF2IP;BRCA2;TINF2;TERF2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.30456369223955315,0.838023715834683,0.6827458256029685,0.9786834495911603,1.0,2/22,0.77%,IGF1;ROCK2
prerank,nucleus organization (GO:0006997),-0.24161668173648085,-0.8378299491285485,0.7328605200945626,0.8982755322037311,1.0,12/47,18.54%,SYNE1;CHMP2B;ATXN7;CHMP4B;CHMP4A;LEMD3;SUN1;TPR;REEP3;PITPNB;CTDNEP1;CHMP1B
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3416019739700865,0.8375452145939103,0.6608527131782945,0.978844994722807,1.0,3/12,9.38%,PPARA;PPARGC1A;ABCD1
prerank,regulation of necroptotic process (GO:0060544),-0.28744271322729764,-0.8369610668379959,0.6890243902439024,0.8994629309200016,1.0,10/23,26.55%,ARHGEF2;YBX3;SPATA2;BIRC3;RIPK1;MLKL;CYLD;ZBP1;CASP8;PELI1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.31078784392226405,-0.8366998892951425,0.6845493562231759,0.8994926665297444,1.0,7/16,21.30%,GSN;KANK1;RACK1;PTK2B;SHTN1;KIF20B;ROCK1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3269222645453292,0.8364182201570614,0.666023166023166,0.9804568346830332,1.0,4/15,17.85%,CAMK1;MAPK14;RAPGEF3;RIPOR2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.35694216199493395,0.8360555195077146,0.6540880503144654,0.9803755570799159,1.0,2/10,11.27%,APPL2;CD300A
prerank,myeloid dendritic cell activation (GO:0001773),-0.33708092940713763,-0.8357832776316098,0.693609022556391,0.9007421221809132,1.0,2/12,7.79%,TGFBR2;DOCK2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.30776829342207035,-0.8357448869761601,0.6931106471816284,0.9002992749727513,1.0,5/16,15.39%,SCARB1;NOS1AP;GCH1;APOE;DHFR
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.32784051418287263,-0.8354511880568183,0.6828282828282828,0.9003647624992532,1.0,4/13,20.45%,PIK3C3;PIK3R4;IRAK2;MYD88
prerank,myelin assembly (GO:0032288),-0.3572971459732769,-0.8348298482955971,0.6918367346938775,0.9010948235951113,1.0,3/10,17.90%,CD9;GPC1;PMP22
prerank,peptidyl-methionine modification (GO:0018206),0.35232660752881034,0.8347211417719677,0.6673511293634496,0.9824164848087356,1.0,1/12,0.85%,METAP2
prerank,determination of left/right symmetry (GO:0007368),-0.25143455257332714,-0.834645939139986,0.7416666666666667,0.9009452325257027,1.0,19/36,39.74%,NOTCH1;TBX1;SMO;DNAH11;STIL;CFAP53;DLL1;ODAD2;ENKUR;ODAD3;FOXJ1;ZIC3;NPHP3;CCDC40;LEFTY1;BBS7;DNAAF4;PKD1L1;RFX3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.22205317434222455,-0.8345519581394372,0.7747747747747747,0.9005877645837822,1.0,23/72,26.30%,RPA1;UBC;RPS27A;UBB;USP7;GTF2H5;GTF2H1;ERCC2;AQR;PPIE;GPS1;RPA2;XPA;RFC4;POLR2I;COPS6;POLD4;POLR2F;CCNH;COPS4;CUL4A;POLR2H;RFC2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.31853640157170815,-0.8344267066275844,0.6962524654832347,0.9003300503535758,1.0,4/14,15.72%,AR;PELP1;SERPINB9;ARID5A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.27397837031369504,-0.8336952043512744,0.72,0.9012648813423624,1.0,9/23,20.73%,GLI3;RACK1;HHIP;HERC4;PTCH1;PTCH2;KCTD6;ENPP1;MOSMO
prerank,nuclear pore complex assembly (GO:0051292),-0.34789482407237365,-0.8336255908195627,0.6726546906187625,0.9008879885960815,1.0,3/10,16.13%,NUP107;TPR;RTN4
prerank,endoderm development (GO:0007492),-0.3289485641968783,-0.8335733230984388,0.6745562130177515,0.9004867233402697,1.0,8/13,41.31%,SOX17;SOX7;DUSP1;LHX1;TBX20;GATA4;DUSP5;DUSP2
prerank,positive regulation of filopodium assembly (GO:0051491),0.29600538210248156,0.8331728167459687,0.6771037181996086,0.9848805973776049,1.0,8/24,17.85%,DOCK11;TENM1;RHOQ;GPM6A;WASL;MIEN1;TENM2;RIPOR2
prerank,response to ATP (GO:0033198),-0.3047650700526844,-0.8330663978580473,0.7037773359840954,0.9009426599781296,1.0,2/18,2.25%,TRPC3;ABCC9
prerank,regulation of actin filament-based movement (GO:1903115),0.3581622332486908,0.8328026126189985,0.6680244399185336,0.9847854784193127,1.0,2/10,6.42%,ANK2;PDPN
prerank,cell differentiation in hindbrain (GO:0021533),0.34955756069205407,0.8326158956742891,0.68389662027833,0.9843323491658444,1.0,4/11,19.76%,GRID2;ATP7A;FAIM2;KNDC1
prerank,embryonic digit morphogenesis (GO:0042733),-0.3025087470199034,-0.8320655297845226,0.7151639344262295,0.9023456437520575,1.0,6/18,13.29%,ECE1;TBX3;GLI3;MAP3K20;TWIST1;TBX2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.32724902175395754,0.8316733801309246,0.667953667953668,0.9854361765821935,1.0,4/14,15.89%,RFLNA;TGFBR1;SOX9;ADAMTS7
prerank,DNA metabolic process (GO:0006259),-0.18106853546646498,-0.8311061658977307,0.9613095238095238,0.9036551093834694,1.0,83/270,27.72%,RPA1;RAD51B;UBC;ALKBH1;UBE2V2;SMC1A;CSNK1E;XPC;RPS27A;UBB;XRCC5;AXIN2;REXO4;ZBTB1;PTGES3;CHD1L;USP7;RPAIN;PARG;TERF2IP;GTF2H1;BLM;DMC1;RAD21;ORC1;NT5E;DDX23;TIMELESS;KPNA2;ZNF445;UBE2A;DFFB;FANCG;SP100;TOP2A;TDG;NEIL3;ORC2;NBN;RPA2;PRIMPOL;BARD1;CDC45;ORC5;LIG4;POLA1;HMGB1;SIRT7;XPA;NSMCE4A;RFC4;CHEK1;DNMT1;MUTYH;NSMCE3;PURA;TOP1;MCM3;POLA2;TRRAP;SMUG1;POLD4;WDHD1;POLB;BTG2;UHRF2;CDC34;TINF2;PRIM2;CTC1;XRCC3;NUDT1;TYMS;MCM5;MCM6;RFC2;FANCL;TERF2;POLE3;CDK2;CBS;RAD51AP1;RECQL5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.30579961280026074,0.8310046751490346,0.6924603174603174,0.9859502846068329,1.0,1/20,0.87%,IL18
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24327555643658919,0.8305977978730578,0.7538726333907056,0.9859709383280368,1.0,15/62,18.18%,HSPA1A;CCAR2;ENO1;PPIF;DDIAS;LRRK2;HTRA2;BCL2;CLU;NOC2L;NDUFA13;SIRT1;MDM2;NOL3;AKT1
prerank,RNA 3'-end processing (GO:0031123),0.2370024233516714,0.8305142729997108,0.7709790209790209,0.9852824309048726,1.0,15/69,18.57%,PABPN1;CPSF3;SRSF5;TENT4A;SUPV3L1;CPSF7;TUT4;UPF3B;RPRD2;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,regulation of receptor internalization (GO:0002090),-0.2546467459997398,-0.8304117880682678,0.7671517671517671,0.9044690061093349,1.0,12/35,23.91%,INSR;SFRP4;MKLN1;TBC1D5;ANKRD13A;VEGFA;FMR1;ANKRD13B;GREM1;ARRB2;ANKRD13D;EGF
prerank,synaptic vesicle transport (GO:0048489),0.35592103235867406,0.8303219856316933,0.6845238095238095,0.9848146310780835,1.0,3/11,13.77%,KIF5C;SNAPIN;SPG11
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.20172314047597095,0.830317124191366,0.8656488549618321,0.9839704173874899,1.0,41/208,18.03%,RORA;CXXC5;WLS;NDFIP1;CPNE1;TRIM62;S100A4;CAPN3;GPRC5B;CHUK;OPTN;TRIM5;TNIP3;PDPK1;IKBKG;ZFAND6;NLRC3;NLRX1;LPAR1;TNIP2;IKBKE;CACTIN;CFLAR;STAT1;PRKCB;SPHK2;TMED4;RNF31;OTUD7A;MAPKBP1;RBCK1;GOLT1B;ANKRD17;SIRT1;NDFIP2;PPM1B;RELA;CANT1;TIRAP;TFG;CX3CL1
prerank,polyol metabolic process (GO:0019751),-0.23786158431973173,-0.8301829640121787,0.7385321100917431,0.9044243336210385,1.0,6/46,6.53%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2577512841238341,-0.8301413905901229,0.7387580299785867,0.9039800717643686,1.0,8/33,17.81%,H3-3A;RUNX1;ESR1;AR;CBFB;HDAC6;LATS1;KCTD6
prerank,potassium ion export across plasma membrane (GO:0097623),-0.3418289305927641,-0.8301284267127428,0.6858846918489065,0.9035010230455526,1.0,3/13,8.45%,KCNT2;KCNQ1;KCNK5
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.31720297841517886,0.8300472137126168,0.7104247104247104,0.9836407666190051,1.0,3/17,8.26%,ANK2;SNTA1;KCNH2
prerank,regulation of double-strand break repair (GO:2000779),-0.24900339564878324,-0.8297124023868401,0.765625,0.9037595349567922,1.0,16/39,31.20%,RNF169;TERF2IP;TWIST1;TIMELESS;PPP4R2;RPA2;SLF2;SPIDR;SIRT7;CHEK1;SIRT6;OTUB2;OTUB1;RAD51AP1;MRNIP;SPIRE2
prerank,protein import into nucleus (GO:0006606),0.23603424623610864,0.8296664575798326,0.787052810902896,0.9836249372159728,1.0,7/66,6.89%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3273895376588255,0.8294762578507107,0.7142857142857143,0.9831810629923295,1.0,4/15,11.44%,USP18;CACTIN;OAS3;STAT2
prerank,phagosome-lysosome fusion (GO:0090385),-0.3559826275965194,-0.829185595640237,0.7136752136752137,0.9042482577587123,1.0,6/10,34.90%,ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23365235592674033,-0.8289671659628973,0.7935779816513762,0.9041657904395299,1.0,8/51,9.38%,NEK7;TNKS;XRCC5;MAPK1;SRC;FBXO4;HMBOX1;TENT4B
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3144238078317826,-0.8289124060724061,0.6857142857142857,0.9037757211132998,1.0,4/14,15.04%,ERN1;CPSF4;NCBP2;NCBP1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.28046590981663505,-0.8285290178511123,0.7276507276507277,0.9039849465302865,1.0,12/25,29.98%,ARHGEF2;ATXN7;APC;FGF13;TRPV4;KATNB1;MAP1B;TAOK1;TPX2;CIB1;CAMSAP2;CAMSAP3
prerank,isotype switching (GO:0045190),0.3694550902142648,0.8285020193747571,0.6584362139917695,0.9843586502018625,1.0,2/10,9.85%,MSH6;BATF
prerank,mitochondrion localization (GO:0051646),0.30718699126705695,0.8282745843863795,0.6996197718631179,0.983968661672781,1.0,4/19,11.47%,TRAK1;LRRK2;MFN2;BRAT1
prerank,diol metabolic process (GO:0034311),-0.30045349062307614,-0.8281788745885341,0.6872427983539094,0.9041503327212103,1.0,8/19,18.95%,NOS3;DEGS2;GCH1;PLPP1;PRKG2;PLPP3;SGPP1;ASAH2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.24438383196775418,0.8280611971549803,0.7285974499089253,0.9835961309368284,1.0,14/54,17.07%,TFDP2;E2F1;ARID3A;CDC25C;E2F8;E2F4;PML;CHEK2;PCBP4;ATM;GADD45A;MUC1;MDM2;CNOT3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3591482751281311,-0.8279907178867427,0.6807228915662651,0.9039844554220708,1.0,4/10,21.45%,ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,tube closure (GO:0060606),0.2779549129566918,0.8278677511732506,0.7250470809792844,0.9831336938998876,1.0,8/31,16.41%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFR;MTHFD1;FUZ
prerank,cholesterol transport (GO:0030301),0.25499702888273706,0.8277943150080134,0.75,0.9824468806269309,1.0,11/45,18.67%,CEL;ABCG5;SOAT2;STARD5;SOAT1;OSBPL5;CLU;TSKU;STAR;ABCA5;RELCH
prerank,zinc ion transport (GO:0006829),0.2983324346786774,0.8276748347845327,0.6827852998065764,0.9818382548369954,1.0,4/21,11.37%,SLC30A6;SLC30A10;SLC39A13;TRPM2
prerank,response to axon injury (GO:0048678),0.3120402096595914,0.8276545989480408,0.7100591715976331,0.9810279689799689,1.0,5/18,14.81%,FLRT3;NREP;GAP43;SARM1;MORN4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3224288678086151,-0.8275129910613427,0.7018255578093306,0.9043147536779853,1.0,2/13,3.07%,PPARD;BMP4
prerank,cellular response to leucine starvation (GO:1990253),0.35504794409353196,0.8270032215742513,0.6937984496124031,0.9815592846406046,1.0,3/10,17.38%,IMPACT;SESN1;RRAGB
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.23930860223818734,0.8268932797850758,0.7614035087719299,0.9809362976127665,1.0,3/59,2.75%,ALDH1A2;ACSM2A;ACSM2B
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.1934809227964316,-0.826784996113281,0.8973684210526316,0.9052064003444701,1.0,24/132,15.04%,RPS15;RPL38;RPL5;RPL10;MRPL20;COIL;RPLP0;XRCC5;SNRNP200;RPS5;SNRPD1;PTGES3;RPS28;RPL6;PRMT7;RPL24;RPS27;SNRPD2;RRP7A;CLP1;GEMIN8;SNRPE;DDX23;NCBP1
prerank,tRNA modification (GO:0006400),-0.22464071711389985,-0.8265580364345838,0.8091954022988506,0.9051258263404965,1.0,15/62,19.24%,ALKBH1;METTL2A;METTL2B;THUMPD2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRIT1;TRMT44;CDKAL1;TYW3;METTL6;LCMT2;TRMT112
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3134002686802901,-0.8265437117343551,0.7203219315895373,0.9046434602456582,1.0,4/15,5.93%,SIX1;TGFBR2;TBX1;NIPBL
prerank,defense response to tumor cell (GO:0002357),0.3604953742232214,0.8265219299548797,0.6470588235294118,0.9808909138050781,1.0,1/10,0.99%,PLK5
prerank,response to UV-A (GO:0070141),-0.3230744283987551,-0.8261984911026692,0.7172995780590717,0.9047770859253729,1.0,4/14,26.08%,EGFR;CCND1;MMP2;TIMP1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.24942054620755602,-0.8261838084585312,0.7678571428571429,0.9042996530472952,1.0,15/38,27.86%,DAB2IP;APAF1;RBBP4;SUZ12;FOXO4;YAF2;EPC1;RHNO1;RYBP;CHEK1;MGA;BMI1;PHC3;TFDP1;CDKN2B
prerank,positive regulation of RNA splicing (GO:0033120),-0.26768689710269467,-0.8261433704936999,0.7242888402625821,0.9038857679922153,1.0,10/29,24.70%,PIK3R1;RBM3;ERN1;PRDX6;DYRK1A;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,snRNA transcription (GO:0009301),-0.21818791800079934,-0.8256891434053317,0.835990888382688,0.9042071400646876,1.0,22/70,29.41%,ICE1;INTS11;USPL1;GTF2F1;NCBP2;ELL2;POU2F1;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;GTF2E2;POLR2F;TAF9;GTF2E1;RPRD1A;POLR2H;CCNT1;POLR2E;SNAPC5
prerank,histone exchange (GO:0043486),-0.24813106405128774,-0.825461312877134,0.7532751091703057,0.9041448738962594,1.0,14/37,30.90%,HJURP;RBBP4;NASP;ACTR6;CENPL;CENPQ;RUVBL1;CENPX;MIS18A;CENPN;CENPK;SMARCA5;RSF1;ANP32E
prerank,cellular response to oxidative stress (GO:0034599),0.21424125792713328,0.8254036430801726,0.8192,0.9823470366366363,1.0,21/118,16.11%,CPEB2;HSPA1A;PDGFRA;PRKAA2;RBM11;CHUK;PDK2;LRRK2;PRDX5;HTRA2;PPARGC1A;CYCS;MPV17;ALDH3B1;MAPK9;ARNT;CYBA;HSPA1B;ABL1;STX4;RAD52
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.31882954626964444,-0.8253178727619109,0.7057613168724279,0.9039149091855739,1.0,2/15,5.88%,PRKCH;AGTR1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.20070131551148046,-0.8249757306690986,0.8602941176470589,0.9040401105782265,1.0,25/112,20.61%,FOXP1;THBS1;GAS6;CD34;STAT3;PTPRJ;APP;IRAK3;PLCG2;ARHGEF2;WNT5A;MAPKAPK2;EPHB2;HSPB1;TWIST1;PTPRC;IFIH1;NOD2;PTPN6;ZC3H12A;IL33;NR1H4;RIPK1;HMGB1;SYK
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2565800882747584,-0.8249296403379762,0.7543478260869565,0.9036303081252809,1.0,8/33,11.76%,KMT2E;EGFR;PLCG2;ANXA1;ADAMTS1;RPTOR;PAF1;PHB2
prerank,pyroptosis (GO:0070269),0.31737114703987035,0.824922995709855,0.680373831775701,0.982491034906522,1.0,2/15,5.56%,GSDME;GSDMD
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23039055074782003,0.8244773707533568,0.798941798941799,0.9825003419675943,1.0,12/76,11.25%,ACTN2;C5AR2;OPRD1;ADRA2A;CHRM2;DRD3;LPAR1;NMUR1;C3AR1;VIP;GRPR;CHRM1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.2228889734719568,-0.8244077650833016,0.8228155339805825,0.9041295873083849,1.0,13/59,18.84%,LEF1;RUNX2;AGO1;JUN;CBFB;MED27;TWIST1;MED31;CSF1R;AGO4;CCND1;MED14;PTEN
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.306856575536786,0.8240993094121057,0.6936758893280632,0.9823952539224963,1.0,7/19,22.17%,HTRA2;HTT;CSNK2A2;FZD5;VDAC1;DNM1L;ATP13A2
prerank,DNA conformation change (GO:0071103),-0.3003510303175815,-0.8240921127520587,0.7107942973523421,0.9042237728763114,1.0,6/17,21.45%,KAT6A;HHEX;NAA10;TOP2A;HMGB1;TOP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.34165746199025326,-0.8239079173499568,0.6882352941176471,0.904027860937924,1.0,5/11,27.07%,TENT4B;DKC1;EXOSC5;EXOSC4;EXOSC3
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2564846623587427,-0.8234370609760303,0.755741127348643,0.9043811763645335,1.0,13/33,21.77%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;SESN3;GLRA2;KLHL22;UBR1;RRAGD;FYN
prerank,endocytic recycling (GO:0032456),-0.2359551587653055,-0.8231353801910865,0.7822222222222223,0.9044764596464825,1.0,19/50,24.38%,RAB14;VPS53;CMTM6;VPS26A;EHD2;EHD4;MICALL2;RAB11B;ANKRD27;RAB11FIP3;DENND1B;STX6;DENND1A;RAB35;CCDC22;EPS15;VPS52;ENTR1;VPS50
prerank,lung epithelium development (GO:0060428),0.36200993530456277,0.8229986500433122,0.6794354838709677,0.9838298202774286,1.0,1/10,0.48%,ERRFI1
prerank,regulation of cytokinesis (GO:0032465),-0.21593101349499094,-0.8225514832200789,0.8216867469879519,0.905084549463149,1.0,26/78,24.12%,RHOA;SVIL;BCL2L1;CIT;PLK2;CALM3;MYO19;MAP9;KIF23;PIK3C3;PIK3R4;CCP110;GIT1;RAB11FIP3;KIF13A;KIF20B;RAB11A;PRC1;CDC42;E2F7;GIPC1;ENTR1;FSD1;PLK3;CUL3;PRKCE
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2014754221531903,-0.8224381564824251,0.8542713567839196,0.9047891296938475,1.0,35/101,30.02%,NIBAN1;THBS1;NFKBIA;RBM3;RPL5;EIF3E;AGTR1;PERP;EEF2;KLF4;AMER1;IST1;TBC1D10A;BAK1;FMR1;FXR1;HDAC2;METTL3;PIWIL2;FAF1;EIF4A3;PRR16;MSN;BCL3;CASP8;HNRNPD;RPS4X;METTL14;NSUN5;AGT;FBXW11;PTTG1IP;PCIF1;FADD;NR1H2
prerank,negative regulation of cell cycle process (GO:0010948),0.2396840812450418,0.8218203746097246,0.7820738137082601,0.9854776859314877,1.0,9/61,12.40%,BMP7;PCGF2;TFDP2;E2F1;TOM1L2;E2F8;MAX;PCGF6;RING1
prerank,peptidyl-arginine modification (GO:0018195),-0.3082299740897894,-0.8215657047311905,0.7045908183632734,0.9059038566589701,1.0,10/15,46.83%,ART3;PRMT7;KRTCAP2;PRMT1;PARK7;ART1;PADI1;PADI4;PRMT8;ART5
prerank,aerobic electron transport chain (GO:0019646),-0.22063965690813703,-0.821517899641128,0.8316831683168316,0.9054985334019651,1.0,19/68,21.08%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA5;NDUFA7;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;COX15;NDUFS8;NDUFS7;UQCR10
prerank,glycerophospholipid metabolic process (GO:0006650),-0.21320011301585978,-0.8214759725233532,0.8249400479616307,0.9050679632772296,1.0,14/75,15.99%,PLA2G4A;GPCPD1;DGKH;PLCG1;AGK;SERINC5;CPNE3;ABCA3;PIGC;PRDX6;ABHD6;PLA2G6;CSF1R;PAFAH1B1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.32851105540815906,-0.820596826708826,0.7227926078028748,0.9061230917792535,1.0,2/12,3.91%,NFKBIA;ABCA1
prerank,multivesicular body organization (GO:0036257),-0.2612585735286033,-0.8203478217640582,0.7615894039735099,0.9060727711518067,1.0,10/31,18.85%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;RAB27A;IST1;VPS37A;CHMP1B;RAB11A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.2982769450864872,0.8203263765395755,0.72,0.9876838780409102,1.0,4/21,9.80%,ZWINT;PLK1;MAD2L1;IK
prerank,protein deacylation (GO:0035601),-0.2833896425665547,-0.8201566503450366,0.712742980561555,0.9059067302397994,1.0,7/23,23.33%,HDAC7;SIRT5;HDAC6;ABHD17C;SIRT7;ABHD17B;SIRT6
prerank,mRNA stabilization (GO:0048255),0.26038574456943786,0.819637767447667,0.7314487632508834,0.9882308186852686,1.0,9/40,14.70%,ANGEL2;ELAVL4;E2F1;HNRNPU;ELAVL1;VIP;MAPK14;BOLL;PAIP1
prerank,cristae formation (GO:0042407),-0.2691521139254939,-0.8194600614555252,0.7149122807017544,0.9067129911623659,1.0,9/27,24.31%,ATP5MF;ATP5F1B;ATP5F1E;DNAJC11;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD;LETM1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2915124188184839,0.8193762468343382,0.6936758893280632,0.9879093988965517,1.0,4/21,12.84%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,regulation of interleukin-17 production (GO:0032660),0.2773689421086758,0.8192566961369177,0.7156308851224106,0.9872835324967533,1.0,2/31,1.39%,IL18;SPHK1
prerank,androgen metabolic process (GO:0008209),0.30917849101347467,0.8191109800108575,0.6872586872586872,0.9867314456137485,1.0,4/18,22.02%,MED1;HSD17B11;HSD17B4;SHH
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.33952074812536037,-0.8186723890060256,0.7105263157894737,0.9076201649122132,1.0,1/10,6.08%,GNB1
prerank,regulation of synapse organization (GO:0050807),-0.26710474837321085,-0.8186265074696195,0.766,0.9072016143752952,1.0,4/26,10.31%,MEF2C;PDLIM5;WNT5A;YWHAZ
prerank,regulation of calcium ion transport (GO:0051924),0.23880538604351798,0.8185352089612158,0.7435897435897436,0.9870177711993555,1.0,4/54,4.52%,CACNA1D;ANK2;WNK3;ADRA2A
prerank,regulation of autophagosome assembly (GO:2000785),0.265622723812258,0.8184577316529017,0.7071823204419889,0.9863355279642608,1.0,4/33,7.38%,NUPR1;NPRL3;RAB3GAP1;LRRK2
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.20513361305664138,-0.8184108220859199,0.8393285371702638,0.9070996509414392,1.0,34/95,32.40%,RPA1;RAD51B;REV3L;HELQ;NIPBL;MMS22L;SMC5;RAD54B;BLM;RAD21;FANCB;BRCA2;PALB2;NBN;RPA2;CDC45;PSMD14;RMI1;RAD51AP2;SPIDR;MCM3;NUCKS1;REC8;XRCC3;MCM5;MCM6;RAD51AP1;RECQL5;PARP1;HUS1B;GINS2;NSMCE2;RECQL;FEN1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.34881530094731483,0.8183925903531938,0.7130434782608696,0.9856194987266647,1.0,3/10,19.14%,ADRA2A;HBEGF;NCF1
prerank,protein deneddylation (GO:0000338),-0.35231726869056257,-0.8177572166960904,0.7017208413001912,0.9077928710565654,1.0,3/10,23.39%,GPS1;COPS6;COPS4
prerank,regulation of cell cycle process (GO:0010564),-0.20672938940164093,-0.8172470728236121,0.8734177215189873,0.9081916616186161,1.0,32/104,24.01%,DCUN1D3;BCL2L1;PLK2;CALM3;APC;TIPIN;MYO19;CAV2;MAP9;FBXO5;PIK3C3;CSNK2A1;PIK3R4;CCP110;GIT1;RAB11FIP3;GPER1;KIF13A;NUDT16;KIF20B;RAB11A;PRC1;DYNC1H1;CHEK1;L3MBTL1;CDC42;RPRD1B;KNSTRN;MKI67;ENTR1;FSD1;PLK3
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.34504885469639773,-0.8170609748829759,0.7128099173553719,0.9080147376847065,1.0,1/10,0.89%,PLA2G4A
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.2983592573824935,0.8170392831390025,0.6870229007633588,0.987517428293052,1.0,4/20,13.59%,SLC8A3;AFG3L2;SLC25A23;MICU1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.294871792613713,-0.8162748074114462,0.7217573221757322,0.9089258122518389,1.0,6/17,23.72%,BCL2L1;MFF;BAK1;BBC3;TIMM50;BOK
prerank,regulation of viral life cycle (GO:1903900),0.2948745103006648,0.8160829361140403,0.7223264540337712,0.9886097599615093,1.0,5/21,16.46%,TRIM62;TRIM5;HS3ST5;TYRO3;AXL
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.30601269087706273,-0.8159116970662351,0.7006109979633401,0.9090922275165426,1.0,6/15,24.53%,STAT3;GBP5;NOD2;MYD88;TICAM1;TLR4
prerank,cortical cytoskeleton organization (GO:0030865),-0.2417511803348616,-0.8158825336579929,0.7457627118644068,0.9086475844301366,1.0,3/41,1.42%,FMNL2;RHOBTB1;RHOA
prerank,positive regulation of cellular protein localization (GO:1903829),0.22887451071102294,0.8154246227648474,0.7969018932874354,0.9890603284054245,1.0,9/69,10.65%,SYT11;PRKAA2;SLC5A3;PLK1;WWTR1;GNL3L;NDC80;PDZK1;BICD1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.33227775390731396,-0.815350929348724,0.7361111111111112,0.9090200107454284,1.0,5/12,20.62%,ARHGAP35;EPHB2;B4GALT5;PTEN;EPHB6
prerank,triglyceride catabolic process (GO:0019433),-0.28670278799216165,-0.8151575510664556,0.710691823899371,0.9089085462864739,1.0,10/19,52.73%,PNPLA2;FABP3;FABP5;FABP4;FABP12;LPL;PNPLA3;FABP7;LIPG;CPS1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.31281996020570285,-0.8148894558170309,0.7156673114119922,0.9089107808787935,1.0,4/15,13.11%,ERN1;TSEN2;CPSF4;CLP1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.32801035124870703,0.813700529101384,0.6962524654832347,0.9917022594525494,1.0,2/13,7.58%,CPSF6;CPSF7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.23027041066938142,-0.8136275553166816,0.8257918552036199,0.9106473907906527,1.0,16/53,22.86%,PSMB7;PSMA6;BCKDK;PSMB6;PSMB5;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.35984299968879796,0.8135977401753284,0.6974459724950884,0.9910805759073448,1.0,4/10,19.46%,KAT5;MUC1;HIPK2;TFAP4
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3498489730844273,-0.8131954327568994,0.7355212355212355,0.9109161500694818,1.0,2/10,6.27%,GNL3;SAE1
prerank,positive regulation of hormone secretion (GO:0046887),0.3110010352933036,0.8130027166133631,0.7139959432048681,0.9914544410209661,1.0,4/17,17.41%,VAMP7;C1QTNF3;GRP;HFE
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2988023956785293,-0.8129617876986268,0.735357917570499,0.9108265736024157,1.0,6/17,19.25%,COX6C;COX7C;NDUFA4;COX8A;COX4I1;COX15
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2873974545448238,0.8127811526615087,0.706766917293233,0.9910470372045714,1.0,6/24,19.94%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,response to muscle stretch (GO:0035994),-0.30432284837120305,-0.8127558915482049,0.7172131147540983,0.9107048128572165,1.0,8/15,34.22%,GSN;PIK3CA;CDH2;DMD;SLC8A1;TTN;CTNNB1;TCAP
prerank,cholesterol efflux (GO:0033344),0.3009080123798142,0.812514838985265,0.7246653919694073,0.9907411746502153,1.0,3/20,7.75%,ABCG5;SOAT2;SOAT1
prerank,homologous chromosome segregation (GO:0045143),0.297654878339307,0.8125060120228178,0.7308411214953271,0.9899241326645194,1.0,3/20,14.40%,FANCD2;MEIOB;CENPC
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.290400444532862,0.8123348852851698,0.7312252964426877,0.9894412466715802,1.0,8/22,21.48%,CCNT2;LEO1;CDC73;ALYREF;DDX39B;THOC1;SUPT4H1;CDK12
prerank,regulation of cilium assembly (GO:1902017),0.23519758618008263,0.8121216341733178,0.7697715289982425,0.9890401753938849,1.0,9/62,8.85%,DCDC2;ODF2L;DYNLT2B;SGSM3;DYNC2LI1;TCHP;TBC1D9B;RABEP2;HTT
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.33846298925742413,-0.8120308212996286,0.7300970873786408,0.9115064923454432,1.0,4/11,15.08%,GHR;PIK3R1;EIF2AK3;IRS1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2584073001436106,-0.8116604348440577,0.7668845315904139,0.9116486429058942,1.0,9/29,27.08%,GAS6;CXCL12;SERPINE1;HMGB1;JAM2;CCR2;ANO6;PLA2G7;AIF1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.3216935409603157,-0.8116046182426954,0.7172557172557172,0.9112447997570969,1.0,3/14,15.24%,DAB2IP;PTPN1;BAK1
prerank,positive regulation of sodium ion transport (GO:0010765),0.33388600203637997,0.8114449286648855,0.6875,0.9895072047259442,1.0,1/12,2.35%,WNK3
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.33905175200855187,0.8113346251192459,0.6955684007707129,0.9889032837101376,1.0,4/12,19.98%,ACSL1;ABCD1;FADS2;HSD17B4
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.22872617550903085,-0.8110897300315789,0.7967289719626168,0.9111727309483854,1.0,13/56,19.88%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA5;NDUFA7;NDUFAF6;NDUFA1;NDUFAF8;NDUFS8;NDUFS7
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.22872617550903085,-0.8110897300315789,0.7967289719626168,0.9111727309483854,1.0,13/56,19.88%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA5;NDUFA7;NDUFAF6;NDUFA1;NDUFAF8;NDUFS8;NDUFS7
prerank,regulation of actin filament depolymerization (GO:0030834),-0.3281639971225778,-0.810982416342864,0.7257142857142858,0.9108649647802114,1.0,4/12,15.71%,WDR1;PIK3CA;LIMA1;SEMA5A
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2315917234395206,-0.8103473295065055,0.830316742081448,0.9115387316723659,1.0,15/50,22.86%,PSMB7;PSMA6;PSMB6;PSMB5;PSMC4;PSMB8;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.32720058479394987,-0.8100360968158044,0.7125256673511293,0.9115682478386855,1.0,6/12,25.48%,BMP4;TPR;SIRT7;NEDD4;AAAS;NUP214
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.31401465646520543,-0.8098482589825806,0.751984126984127,0.9113913157576345,1.0,6/14,30.97%,FUS;FANCB;TIMELESS;RAD51AP1;PARP1;MRNIP
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.2988822853180283,-0.809789385620119,0.7355371900826446,0.9110021227902076,1.0,2/16,1.99%,PTN;TGFB2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.21894797269046498,-0.8095266997352898,0.8431372549019608,0.9109595092597662,1.0,13/60,18.84%,LEF1;RUNX2;AGO1;CBFB;HEY2;MED27;MED31;CSF1R;AGO4;CCND1;MED14;ATF7IP;PTEN
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2280071857248199,0.8090569353306619,0.8091993185689949,0.9925272715686174,1.0,23/80,20.43%,ROCK2;PICALM;PASK;SMPD3;CASP3;ELAVL1;SMPD2;ABCA2;CLU;SPHK2;UPF3B;EPHA4;PRKDC;FXR2;METTL5;IL6;PYM1;UPF3A;RELA;LARP4B;DDX3X;EIF6;CPEB3
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3008444894015498,-0.8089430448895449,0.7439516129032258,0.9114826414565165,1.0,9/16,43.04%,NAA16;NAA10;NAA15;NAA50;AANAT;NAA60;NAA40;NAA35;NAA11
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2765947458589087,0.8089126887327737,0.7650375939849624,0.9919895392268657,1.0,10/26,21.45%,NLRC3;CACTIN;C1QBP;MAPKBP1;TYRO3;PPM1B;RNF26;NFKBIL1;ILRUN;DHX58
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.27353101501810084,0.8088570161706532,0.7292490118577075,0.9912614606811958,1.0,7/29,15.10%,MAGEA2;PLK1;ARRDC3;DCUN1D4;TOPORS;ABL1;FEM1A
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2962632158206199,-0.8087687799540982,0.7609561752988048,0.9112952261347237,1.0,11/17,41.31%,TERF2IP;TDG;NEIL3;MUTYH;SMUG1;TINF2;TERF2;OGG1;UNG;NTHL1;TERF1
prerank,negative regulation of viral transcription (GO:0032897),0.33220951363558165,0.808202869124289,0.6882352941176471,0.9917025753506131,1.0,2/13,3.12%,TRIM62;UBP1
prerank,spermatid development (GO:0007286),0.2699028191858597,0.8078267496649851,0.7624521072796935,0.9915987431419999,1.0,2/32,5.07%,CCDC42;TDRD5
prerank,RNA methylation (GO:0001510),-0.221152065074646,-0.8077903141915027,0.8640552995391705,0.9124147369169376,1.0,15/60,19.85%,METTL2A;METTL2B;THUMPD2;TRMT10A;FTSJ1;TRMT44;WTAP;TYW3;METTL6;LCMT2;TRMT112;DIMT1;MEPCE;METTL3;NSUN4
prerank,response to cAMP (GO:0051591),-0.2401808041285799,-0.8076212136185701,0.7878103837471784,0.9122127136122755,1.0,6/37,12.50%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6
prerank,brain morphogenesis (GO:0048854),-0.3245833852490763,-0.8075843798288205,0.7352380952380952,0.9117800785928349,1.0,1/12,0.55%,SHANK3
prerank,establishment of mitotic spindle localization (GO:0040001),0.2713833950186785,0.8070619851821367,0.7522935779816514,0.9922419346595157,1.0,5/28,9.58%,PLK1;CLASP1;MAD2L1;HTT;NDC80
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.3378842864070212,-0.8070240840420565,0.7151767151767152,0.9122326211641234,1.0,5/11,18.10%,PAPOLA;PAF1;NCBP2;NCBP1;BARD1
prerank,neural tube closure (GO:0001843),0.2626579808372429,0.8069230820460043,0.7703703703703704,0.9916852920192202,1.0,8/34,16.41%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFR;MTHFD1;FUZ
prerank,histone deubiquitination (GO:0016578),-0.2895030585438961,-0.8069043908153217,0.7478448275862069,0.9119480410787316,1.0,8/18,34.78%,ATXN7;USP7;ENY2;TRRAP;USP15;USP36;BRCC3;ATXN7L3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2159686921297896,-0.8063745838356412,0.8641975308641975,0.9123653347298449,1.0,19/69,21.08%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA5;NDUFA7;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;COX15;NDUFS8;NDUFS7;UQCR10
prerank,transcription by RNA polymerase III (GO:0006383),-0.2632166137454992,-0.8063055781548676,0.7567567567567568,0.9120123656902187,1.0,6/27,19.81%,ICE1;GTF3C5;POLR3H;GTF3A;ELL;GTF3C3
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.20819035913152395,-0.806193196020506,0.8629807692307693,0.9117100287748275,1.0,30/80,28.37%,VPS53;RAB6A;ANKFY1;TBC1D5;VAMP3;SNX1;VPS26A;TMEM87B;GOSR1;TBC1D10A;SURF4;SNX2;RHOBTB3;STX6;PREPL;DCTN1;EVI5;VPS52;RIC1;VPS26B;STX5;RAB9B;SNX5;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B;GOSR2
prerank,organophosphate biosynthetic process (GO:0090407),0.2541578166905409,0.8054240192734494,0.7696526508226691,0.993734979476694,1.0,4/37,6.90%,GK;FITM2;AGPAT4;PCYT2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3164205143630041,-0.8051128285523569,0.7314285714285714,0.9130898736828241,1.0,4/13,17.40%,PHF23;TBC1D25;CLEC16A;TMEM39A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.23958628004953236,-0.8049863689298467,0.799554565701559,0.9128211999262316,1.0,14/37,20.84%,STAT3;GBP5;ADCY7;APOD;ABCD2;CHID1;PER1;PDCD4;NOD2;ZC3H12A;PLD3;CUEDC2;MYD88;TICAM1
prerank,replicative senescence (GO:0090399),0.34180677970644,0.8048467216823866,0.6921606118546845,0.9940265610532549,1.0,4/12,15.05%,CDKN2A;CHEK2;TERT;ATM
prerank,telomere organization (GO:0032200),0.2502185976673741,0.8048204227640375,0.7404718693284936,0.9932577026965614,1.0,10/43,15.05%,DOT1L;RECQL4;POLD2;MRE11;RTEL1;TERT;PRKDC;RAD51D;RPA3;ATM
prerank,cellular response to nitrogen compound (GO:1901699),0.29546436290402023,0.8048111532179201,0.7318982387475538,0.9924474775328432,1.0,1/20,0.77%,ROCK2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2070833233318311,-0.8047110718222744,0.8759305210918115,0.912834857011198,1.0,34/88,31.89%,DAB2IP;DNAJC1;CST3;RACK1;RPS3;CDK5;EIF2AK3;EDN1;APOE;HDAC6;SYNCRIP;DHFR;FMR1;FXR1;RIDA;GAPDH;NCL;EIF4A3;RIC1;CAPRIN1;NANOS3;RPL13A;BTG2;DAPK1;TYMS;SHMT1;CNOT1;IGF2BP1;PCIF1;CAMK2N1;CNOT10;PATL2;CLN3;NANOS1
prerank,lysosome localization (GO:0032418),-0.2418408873594746,-0.8046546256631479,0.797752808988764,0.9124371833916592,1.0,16/37,32.19%,MYH9;TFEB;S100A13;PIK3CD;RAB3A;HDAC6;ARL8B;PIK3CG;BORCS6;NDEL1;MILR1;HPS6;TMEM106B;PLEKHM1;FLCN;SYTL4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2611879499305299,-0.804542179837034,0.7517084282460137,0.9121225622986395,1.0,8/28,21.82%,DAB2IP;SMURF1;ECSCR;FBXW7;FMR1;PTEN;TMTC3;CCDC22
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2559494868335323,-0.8044788635310539,0.757700205338809,0.9117358513392524,1.0,11/29,27.02%,RPA1;PPIA;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.29279409354532526,-0.8043579558496516,0.7348178137651822,0.9114523879479333,1.0,6/16,28.13%,SHLD1;SMCHD1;MAD2L2;DTX3L;SHLD3;PARP3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.33252756716123655,0.804315081936088,0.7056603773584905,0.9925631450544685,1.0,1/13,1.88%,GTPBP1
prerank,snRNA processing (GO:0016180),-0.30069911816167266,-0.804186559661623,0.7520491803278688,0.9112388738211191,1.0,5/16,22.31%,INTS11;INTS10;INTS9;TOE1;INTS6L
prerank,response to nutrient levels (GO:0031667),-0.2942281645566087,-0.8041470129886344,0.7416173570019724,0.9108275775509685,1.0,10/17,36.55%,FAM107A;RPTOR;KCNB1;ATF4;CD68;ULK1;MEAK7;PRKAA1;EIF4G1;RPS6KB1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24725769663774197,-0.8041319267192957,0.7714884696016772,0.9103640372873556,1.0,12/33,27.02%,RPA1;PTGES3;TERF2IP;TNKS1BP1;ZBTB48;NHP2;DKC1;TINF2;CTC1;TERF2;NOP10;CDK2
prerank,positive regulation of catalytic activity (GO:0043085),0.25877558633114234,0.803854059088091,0.7436399217221135,0.9926050794488723,1.0,13/37,18.80%,SLC5A3;PHACTR4;MSH6;SSBP1;AZIN2;MAPK14;MSH3;APH1A;ABL1;STX4;ATP7A;MID1IP1;NHEJ1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.30139053786192327,0.8037623222505218,0.7151162790697675,0.9919778917393812,1.0,5/18,18.08%,COX18;COX14;TIMM21;COX20;OXA1L
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.2894340585095212,-0.8037539423226241,0.7300613496932515,0.9104883145437315,1.0,3/17,9.26%,PCSK5;HDAC9;SORT1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3453133392347741,0.8035437004973992,0.7131474103585658,0.9915649170460227,1.0,1/12,0.99%,PLK5
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.33080095789910435,-0.8034800448574504,0.7396449704142012,0.910443778645289,1.0,6/11,24.60%,TPR;TASOR;ATF7IP;DNMT1;SIRT6;SETDB2
prerank,DNA double-strand break processing (GO:0000729),0.30703808178305525,0.8034043695253037,0.7192660550458716,0.9910046244561753,1.0,5/18,16.11%,KAT5;MRE11;RNF138;ATM;RAD52
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3408389816716666,-0.8034029542589363,0.7137176938369781,0.9100958284444297,1.0,6/10,29.24%,PIBF1;SOCS3;PPP2CA;SOCS1;INPP5F;PPP2R1A
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3086448837775674,-0.8032078661457118,0.7189922480620154,0.9099228160354412,1.0,2/14,10.19%,CARD14;MALT1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3002191025677835,-0.8030480618207311,0.7424547283702213,0.9097284320084733,1.0,7/16,30.02%,SCARB1;PNPLA2;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,negative regulation of coagulation (GO:0050819),-0.31254965365285503,-0.8023886850916097,0.75625,0.9103475774552464,1.0,4/14,10.49%,CD34;SERPINE1;EDN1;APOE
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.26440454997010804,0.8023150347718625,0.7404718693284936,0.992202462144259,1.0,9/33,17.00%,HSPA1A;ABCB10;MED1;STAT1;MAPK14;ARNT;PRKDC;HSPA1B;STAT5B
prerank,protein import into peroxisome matrix (GO:0016558),-0.31998908896622535,-0.8022105190791229,0.7261904761904762,0.9101558659033818,1.0,4/12,23.97%,PEX7;PEX14;PEX2;PEX12
prerank,regulation of hormone secretion (GO:0046883),0.31631421084340616,0.8014525408042468,0.7445972495088409,0.9929807404762551,1.0,1/15,0.62%,SNX6
prerank,protein insertion into ER membrane (GO:0045048),0.2558440992910851,0.8011546815511636,0.7467652495378928,0.9927082354200555,1.0,12/37,19.23%,EMC2;EMC4;CCDC47;CYB5A;BAG6;MMGT1;GET1;UBL4A;EMC1;EMC10;PRNP;TRAM1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2708668433639328,0.8010849414347848,0.7596153846153846,0.9920263498062741,1.0,2/29,6.87%,TGFBR3;FGFR2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3212649484618888,-0.8009880702312571,0.7302231237322515,0.9117042756028294,1.0,2/12,4.08%,STAT3;ESR1
prerank,positive regulation of transport (GO:0051050),-0.20572266649439502,-0.8009206317319362,0.9014423076923077,0.9113292060172288,1.0,29/85,28.93%,ACTB;NEDD4L;MERTK;GAS6;ANXA1;DOCK2;GATA2;IL15;APOE;ACSL3;HIP1R;RAB27A;AKT2;BAK1;FMR1;LRP1;CD151;DYNC1H1;DLL1;FCGR2B;BOK;SMPD1;SGK2;CBLL1;DOC2B;IL2RG;LYAR;TREM2;AHSG
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.22568382821500593,0.800760919116223,0.8164665523156089,0.9918198070764584,1.0,23/72,22.00%,TFDP2;E2F1;ARID3A;CDC25C;KAT5;E2F8;NDRG1;BATF;E2F4;PML;CHEK2;PCBP4;ATM;GADD45A;MUC1;MDM2;CNOT3;HIPK2;TFAP4;BAX;MYO6;CNOT8;ATRX
prerank,protein neddylation (GO:0045116),-0.3236729909425788,-0.8007367238814167,0.7254509018036072,0.9111272002257172,1.0,3/13,12.16%,DCUN1D3;UBE2F;DCUN1D5
prerank,negative regulation of signaling (GO:0023057),0.28450266743027974,0.800315498744326,0.7290076335877863,0.9918588418686085,1.0,4/25,8.89%,IGFBP3;GLRA1;OPTN;BRAP
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2592500075412311,-0.8002228417772068,0.7857142857142857,0.9115122893597142,1.0,10/27,25.60%,DTYMK;CTPS1;NME2;AK4;CTPS2;DUT;RRM2B;AK2;DCTD;TYMS
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.1714105035650909,-0.8000827075993276,0.976271186440678,0.9112694622268886,1.0,90/314,27.06%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;HECW2;UBC;FAF2;SPOPL;ANAPC5;COP1;RPS27A;UBB;UBE2D3;KCTD10;PSMB7;TRIM25;PSMA6;UBE2J1;CDC16;FEM1B;FBXO31;PPP2R5C;STT3B;UBXN1;FBXO4;PSMB6;PSMB5;FBXO5;MTA1;RAD23B;FBXO44;UBXN2A;FBXW7;PTTG1;FBXL18;UBE2J2;PSMC4;FZR1;PSMB8;KBTBD7;AUP1;OS9;UBE2A;PSMD11;KCTD5;KLHL22;ECRG4;PCBP2;UBE2G1;RMND5B;PSMB4;CCNF;AMN1;FBXL4;HACE1;UBR1;PSMD14;CDC26;UCHL1;ARRB2;PSMD10;FBXW5;NEDD4;PSME1;FAF1;FBXL6;AGAP3;ATXN3;PSMB3;KCTD17;CDC23;CUL3;FBXO45;NHLRC3;UFD1;CDC34;CUL4A;WFS1;KIF14;AREL1;ANAPC1;SPSB3;PELI1;LTN1;ZFAND2B;CDK2;HERPUD1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2692124882363414,0.799822916352504,0.7790476190476191,0.9919266022565165,1.0,6/30,14.46%,SH3BP5L;PRKCZ;SH3BP5;PARP14;CD300A;MVP
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2823604520641752,-0.7997495836844152,0.7470119521912351,0.9113267288774676,1.0,8/20,27.06%,CAMK2D;TGM2;BCAP31;TMCO1;BAK1;KCTD17;WFS1;HERPUD1
prerank,glutamate metabolic process (GO:0006536),-0.284185057425923,-0.7988270919611247,0.7550607287449392,0.9124036377232773,1.0,8/19,22.19%,GLS;GCLC;GCLM;GLUD1;ALDH5A1;ALDH18A1;PRODH;GGT1
prerank,mesenchymal to epithelial transition (GO:0060231),0.34756278382948647,0.7987084515449989,0.7137254901960784,0.9931947621600556,1.0,2/10,9.47%,CITED1;FZD7
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.27089554947067873,-0.7986993100028402,0.7545045045045045,0.9121252108709429,1.0,4/22,10.00%,DGKZ;PTPRJ;CEACAM1;DUSP3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3140983273230873,-0.797503980849144,0.7494780793319415,0.913617107832068,1.0,7/14,36.87%,PUM2;PUM1;ZCCHC3;USP15;OASL;TLR3;TLR2
prerank,cellular response to retinoic acid (GO:0071300),0.2469648945036143,0.7972551528481072,0.7653239929947461,0.9950388794885514,1.0,10/42,18.54%,WNT5B;PTK7;WNT6;HTRA2;FZD7;SOX9;ATM;NDUFA13;CREB1;FZD10
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.34535592411439847,0.7971600979898066,0.6992031872509961,0.9943814169367807,1.0,4/10,18.03%,SMARCD3;FZD3;KDM1A;CX3CL1
prerank,GPI anchor metabolic process (GO:0006505),0.2717227989916531,0.7970451058313932,0.7574626865671642,0.9937888022504991,1.0,11/26,28.88%,PIGH;PIGG;DPM1;PGAP4;PGAP2;DPM2;PIGO;PIGW;MPPE1;PIGB;PGAP3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.29571554739028866,0.7966421059268239,0.7238095238095238,0.9936731120597275,1.0,8/20,20.36%,CDKN2A;PLK1;NR2F2;CEBPA;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2711136792966845,-0.796566278949006,0.7605042016806722,0.9147392792602973,1.0,9/22,23.29%,MFHAS1;XDH;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;PRMT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.29800081290393576,0.7963929986495449,0.7321772639691715,0.993323969282877,1.0,4/18,9.10%,ROCK2;RUFY3;LLGL2;LLGL1
prerank,negative regulation of proteolysis (GO:0045861),0.26277014955551486,0.7960910115284923,0.7644927536231884,0.9930561843282344,1.0,7/34,12.63%,TIMP3;PLAT;LRRK2;CLN8;GAS1;EPHA4;BAG6
prerank,sulfur compound catabolic process (GO:0044273),0.25820962638949324,0.795495513413065,0.7815275310834814,0.9933049330171181,1.0,10/38,17.07%,OGN;OMD;FITM2;ACAT1;GALNS;HYAL1;CSPG5;FMOD;GGT5;CTH
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2852662962087466,-0.794770284041307,0.7521008403361344,0.9171681425347612,1.0,12/18,38.98%,EGFR;ESR1;NRIP1;GPER1;NCOA3;CCDC62;SSTR2;POU4F1;RAMP3;CRHBP;FAM210B;SSTR1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2749530035815245,0.7944876231713855,0.734,0.9943852095692567,1.0,3/26,6.40%,ADCY5;ADRA2A;ADCY8
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.32524198728763914,0.7941054996743377,0.7269155206286837,0.9942320665057043,1.0,5/13,16.00%,OAS2;EBI3;STAT1;CANX;TYK2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24410919975025083,0.7939019452776612,0.7988929889298892,0.9937932274163924,1.0,10/46,18.18%,PITRM1;AIFM1;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;TIMM21;HK1;AKT1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.25721534982516586,0.7936236732997394,0.7902350813743219,0.9934805397017973,1.0,7/34,14.37%,LGR4;NLRP2B;OTUD4;CACTIN;CD300A;TYRO3;SARM1
prerank,DNA packaging (GO:0006323),-0.2928907913602068,-0.7935902831224839,0.7551440329218106,0.9185814422294187,1.0,9/16,38.93%,KAT6A;RBBP4;NAA10;CHAF1A;BANF2;BANF1;TP53;H1-0;CHAF1B
prerank,non-motile cilium assembly (GO:1905515),-0.25265565602545687,-0.7931710520788935,0.778021978021978,0.9187742929898355,1.0,12/30,26.45%,DISC1;ARL13B;IFT57;PIBF1;GORAB;TMEM216;TOGARAM1;TMEM107;DCTN1;CSNK1D;BBS10;TBC1D32
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3319140892553456,-0.792871861924191,0.7359223300970874,0.9187772471756259,1.0,2/10,5.65%,SEC14L1;RNF125
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.24098151243031532,-0.7920982479338137,0.8275058275058275,0.9195459090370768,1.0,6/33,11.96%,DGKZ;PTPRJ;CEACAM1;RPS3;DUSP3;NECTIN2
prerank,regulation of RNA export from nucleus (GO:0046831),0.3419958860535427,0.7917025896180651,0.701010101010101,0.9961554554862533,1.0,3/11,16.22%,CPSF6;NSUN2;AKAP8L
prerank,cell-cell junction maintenance (GO:0045217),-0.3255450746134442,-0.7916858802628398,0.7428571428571429,0.9196945738401557,1.0,7/11,35.75%,TJP1;FERMT2;CSF1R;F2R;PRTN3;PARD6A;MYADM
prerank,nucleotide metabolic process (GO:0009117),0.2779845759318415,0.7916000841101912,0.7609561752988048,0.9955440880565277,1.0,5/23,14.50%,ENPP3;AK5;DCK;AK1;GUK1
prerank,positive regulation of nuclear division (GO:0051785),-0.2581945633260813,-0.7912172508056237,0.7975460122699386,0.9199671194020317,1.0,9/25,24.36%,INSR;LRP5;IGF2;EDN1;EDN3;NUSAP1;NUP62;EGF;RGCC
prerank,motile cilium assembly (GO:0044458),0.33370207423285503,0.7912155706235368,0.7335907335907336,0.9954266466585556,1.0,3/12,11.07%,BBOF1;BBS5;E2F4
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.23970223529837573,-0.7909752950130786,0.8285077951002228,0.919865460004405,1.0,16/37,32.78%,ENTPD1;ENTPD6;SIDT2;ENTPD2;ADPRM;NCBP1;DFFB;NUDT16;PPP1R8;NUDT1;HNRNPD;RNASEH2B;XRN2;PABPC4;ISG20;ENTPD3
prerank,cellular response to radiation (GO:0071478),-0.24093319487931641,-0.7904743095218225,0.8111888111888111,0.9201982484818133,1.0,16/40,34.00%,NET1;BLM;RHNO1;TNKS1BP1;LIG4;RHOB;SPIDR;GPR88;NSMCE3;RAD51AP1;GRB2;GPR52;RRH;TP53;OPN1MW3;OPN1MW
prerank,regulation of interferon-beta production (GO:0032648),0.24669235073056484,0.7904497442871001,0.8032490974729242,0.9959698907132054,1.0,15/46,21.45%,OAS2;NLRC3;CACTIN;RNF135;OAS3;POLR3C;TLR8;PPM1B;TIRAP;SIRPA;HSP90AA1;DDX3X;PTPRS;PYCARD;DHX58
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.34407467183514673,0.7901946172145105,0.7351778656126482,0.9956213721173468,1.0,3/10,12.61%,FURIN;ATRAID;EPHA4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.19479504252297264,0.7894522108128361,0.913312693498452,0.9961484452572157,1.0,40/173,17.95%,F5;ANK1;ANK2;BET1;PROZ;F10;VAMP7;ARFGAP3;ARFGAP2;NAPA;GOLGA2;TRAPPC11;NSF;COPG1;IER3IP1;TMED9;CNIH3;TMED4;TRAPPC1;USO1;MIA3;SPTBN2;RAB1A;COPG2;TRAPPC4;ACTR10;SPTA1;CAPZB;CNIH4;GOLT1A;TRAPPC3;DYNC1LI2;COPE;GBF1;TMED2;COPB1;MCFD2;F8;TFG;SEC22B
prerank,recombinational repair (GO:0000725),-0.20599570769149078,-0.7892161457109813,0.8746928746928747,0.9216552464720902,1.0,17/77,20.02%,RPA1;RAD51B;REV3L;HELQ;MMS22L;SMC5;RAD54B;BLM;BRCA2;PALB2;RHNO1;NBN;RPA2;PSMD14;RMI1;RAD51AP2;SPIDR
prerank,erythrocyte development (GO:0048821),0.34059987267833547,0.7891588644414752,0.7237113402061855,0.9958501104074066,1.0,2/10,8.37%,ABCB10;MED1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.22638916710052742,0.7891500975434678,0.8268551236749117,0.995055034069233,1.0,18/68,17.91%,ALDH1L1;SLC23A2;SLC23A1;PCCA;PANK2;GSTO2;SLC19A1;MMUT;AMN;MTHFS;GSTO1;CYB5A;THTPA;MTHFR;MTHFD1;FPGS;MTHFD2;AASDHPPT
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3250811417343401,-0.7884057480119847,0.7237113402061855,0.9224552253966996,1.0,6/11,25.20%,CAV1;VHL;HGS;SOCS3;SOCS1;BCL3
prerank,positive regulation of TOR signaling (GO:0032008),0.24649240964757962,0.7880370739899221,0.8028673835125448,0.9962485362173551,1.0,10/40,17.38%,RRAGC;RICTOR;GPR137C;SLC38A9;PIH1D1;LAMTOR2;LAMTOR3;TELO2;FNIP1;RRAGB
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3314784018698884,-0.7878241738334453,0.7449392712550608,0.9228599488657289,1.0,3/10,21.84%,APC;CDC42;KNSTRN
prerank,regulation of cellular senescence (GO:2000772),-0.2554951839359261,-0.7878029794246111,0.8116883116883117,0.92240670305524,1.0,7/28,13.83%,B2M;AKT3;NUAK1;ABI3;FBXO5;TWIST1;EEF1E1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.25513211311060596,-0.7869176682879412,0.7987551867219918,0.9233219580187639,1.0,7/28,16.00%,DAB2IP;MAP3K5;ERN1;ATP2A3;BAK1;BBC3;ATF4
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24809447375102844,-0.7868969277733566,0.7877551020408163,0.9228596494075826,1.0,13/30,31.19%,SHLD1;RNF169;TWIST1;SMCHD1;FANCB;MAD2L2;NUDT16L1;OTUB2;OTUB1;SHLD3;CGAS;HELB;OGG1
prerank,negative regulation of biosynthetic process (GO:0009890),0.29813718454022564,0.7864173462286023,0.7461832061068703,0.9982551143990348,1.0,7/16,22.28%,PPARA;SLC30A10;ABCD1;TRAP1;IL6;EMILIN1;CIITA
prerank,inflammatory response (GO:0006954),0.19407870903281504,0.7862924307904773,0.9231950844854071,0.997684800087064,1.0,35/195,18.13%,IL18;TAC1;C5AR2;KIT;IL17D;ADCY1;CHUK;LOXL3;PLA2G4C;BDKRB2;NOX1;ADCY8;IKBKG;PRDX5;NLRP3;LTB4R2;KLRG1;PTGER1;C3AR1;PARP4;CDO1;HYAL1;HDAC4;CYBA;SCG2;TLR5;GGT5;HRH1;IL6;TAC4;RELA;IL1A;TPST1;CX3CL1;NFKB1
prerank,defense response to bacterium (GO:0042742),0.20956654812855469,0.7862218855871,0.8762376237623762,0.9969911897951212,1.0,20/105,20.78%,COLEC12;OAS2;PGLYRP3;CFP;OPTN;GSDMD;OAS3;CHGA;GBP6;RAB1A;TNFRSF14;ANKRD17;IL6;STAB2;TIRAP;IL12A;NLRC4;SHC1;PYCARD;RNASE7
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.1987697407927747,-0.7858898135746162,0.919047619047619,0.9239024626930175,1.0,23/86,22.69%,LIMD1;UBC;RPS27A;UBB;PSMB7;PSMA6;VHL;PSMB6;PSMB5;KLF2;VEGFA;PSMC4;PSMB8;ATF4;PSMD11;PSMB4;PSMD14;PSMD10;ATF3;CHEK1;PSME1;EGLN3;PSMB3
prerank,histone acetylation (GO:0016573),0.22265542198647575,0.7855848093259602,0.8397976391231029,0.9973211042068623,1.0,22/69,22.21%,BRD8;SGF29;RUVBL2;MEAF6;KAT5;TAF10;DMAP1;EP400;KAT14;BEND3;YEATS4;TADA1;CHD5;TADA3;APBB1;KAT6B;ACTL6B;MAP3K7;KAT8;DR1;ATF2;ACTL6A
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2656586969013376,-0.7851628652561493,0.8029350104821803,0.9240335489668506,1.0,5/23,15.33%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2656586969013376,-0.7851628652561493,0.8029350104821803,0.9240335489668506,1.0,5/23,15.33%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.34239431566367706,0.7846124764116628,0.7213740458015268,0.9981860164383832,1.0,2/10,10.87%,ALDH7A1;COMT
prerank,DNA recombination (GO:0006310),-0.23846470034660294,-0.7841223180329334,0.8165938864628821,0.9251867546107917,1.0,10/37,20.13%,RPA1;RAD51B;RPAIN;RAD54B;BLM;DMC1;RAD21;RHNO1;LIG4;HMGB1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.27588094397955526,0.78381575382018,0.7597042513863216,0.9987860524054196,1.0,12/23,27.84%,MTMR4;INPP5J;SYNJ2;MTMR2;MTMR10;OCRL;PIP4P2;INPP5K;SYNJ1;MTM1;TPTE;PIP4P1
prerank,regulation of interferon-gamma production (GO:0032649),-0.20594340887028761,-0.7837543315249861,0.8788598574821853,0.9252896376453617,1.0,4/71,3.12%,PDE4D;IL1R1;GAS6;SLC7A5
prerank,positive regulation of cellular senescence (GO:2000774),0.3363899260851593,0.7836723877850773,0.7153846153846154,0.9982357429785743,1.0,2/10,4.52%,CDKN2A;ARG2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3095487183701573,-0.783641407683421,0.7470817120622568,0.9249892729115131,1.0,7/12,39.32%,HPRT1;AMPD2;ADA;PRPSAP1;PRPS2;GART;PPAT
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3221933183286439,0.7834719201011441,0.7283236994219653,0.997761925162648,1.0,1/12,0.36%,UST
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.26241052859000263,0.7831047717907871,0.7574074074074074,0.997606032258862,1.0,10/30,21.16%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2;ST6GAL1
prerank,inner ear morphogenesis (GO:0042472),0.28152262436620007,0.7828395846900682,0.7806691449814126,0.9972308004821465,1.0,4/22,12.01%,USH1C;FGFR2;MYO3A;SOX9
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2985357342151753,0.7827536909695331,0.7545638945233266,0.9965893850710148,1.0,3/18,9.67%,SLC25A5;PPIF;BCL2
prerank,snRNA 3'-end processing (GO:0034472),0.29054619688811456,0.782465399850276,0.7603960396039604,0.996309619225927,1.0,4/19,15.41%,EXOSC8;EXOSC2;USB1;INTS8
prerank,regulation of neuron death (GO:1901214),0.21573815364628962,0.7819253690621718,0.8576388888888888,0.996475892523115,1.0,23/82,20.20%,EFNB2;PM20D1;PICALM;GRID2;DHCR24;RILPL1;IKBKG;LRRK2;HTRA2;PPARGC1A;CLU;CHGA;TSC1;SARM1;ITGAM;EPHB1;FAIM2;AKT1;C1QA;PRNP;TRIM2;REST;EIF2S1
prerank,regulation of centrosome cycle (GO:0046605),-0.2745387501255604,-0.7816272843822988,0.8275862068965517,0.9275930855269277,1.0,10/21,35.33%,CHMP2B;CHMP4B;CHMP1B;FBXW5;CEP131;XRCC3;MARK4;AURKA;PKHD1;ATF5
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2677632455932133,0.7796422047417044,0.7869822485207101,0.999534672764687,1.0,9/25,24.35%,DERL1;UBE2W;BAG6;RNF5;UGGT2;LONP1;OMA1;NGLY1;KLHL15
prerank,chromatin assembly (GO:0031497),-0.23152353486210792,-0.7795008231896449,0.8482142857142857,0.9303217935748287,1.0,6/38,13.01%,CTCF;H3-3A;EZH1;RBBP4;PAF1;LIN54
prerank,negative regulation of locomotion (GO:0040013),-0.3132248571207937,-0.7794072820491285,0.7645875251509054,0.9299670503069182,1.0,2/12,10.00%,FRMD5;DUSP3
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2605216904511947,-0.7792044094283894,0.7773109243697479,0.9297679156950934,1.0,6/23,15.74%,SLIT2;MPP1;MDK;JAM3;CD74;NCKAP1L
prerank,positive regulation of isotype switching (GO:0045830),-0.2953807265324544,-0.779121232754326,0.7470119521912351,0.9294019496060953,1.0,4/15,15.57%,TFRC;SHLD1;CD40;MAD2L2
prerank,establishment of spindle localization (GO:0051293),0.31250376345638997,0.7781278952669366,0.7551401869158878,1.0,1.0,3/14,9.10%,CLASP1;LLGL2;LLGL1
prerank,peptidyl-asparagine modification (GO:0018196),0.25916506445612203,0.7771900143082525,0.7796296296296297,1.0,1.0,10/31,21.16%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2;ST6GAL1
prerank,regulation of cellular protein localization (GO:1903827),-0.22633574083669117,-0.77679002025625,0.8523206751054853,0.9324163315161388,1.0,20/45,33.00%,GPC6;RAB11FIP5;RALB;CSNK1E;PTPN1;RAB11B;GPC1;SPIDR;GPC4;SUMO3;EGF;NDEL1;TRIM67;MAPT;VCP;PARP1;GPC3;GPC2;PRKAA1;CTNNB1
prerank,nucleosome disassembly (GO:0006337),-0.2960962793303361,-0.7765815441355111,0.7738589211618258,0.9317572681022226,1.0,4/14,20.36%,SMARCC1;ARID1A;SMARCA4;SET
prerank,chromatin disassembly (GO:0031498),-0.2960962793303361,-0.7765815441355111,0.7738589211618258,0.9317572681022226,1.0,4/14,20.36%,SMARCC1;ARID1A;SMARCA4;SET
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2790389966038832,0.7762470655216354,0.7622641509433963,1.0,1.0,4/22,6.78%,CDKN2A;PLK1;NR2F2;CEBPA
prerank,regulation of macrophage activation (GO:0043030),-0.2434904640925144,-0.775207136728551,0.793859649122807,0.9333162085783889,1.0,4/30,6.47%,CD200;THBS1;MFHAS1;WNT5A
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.23713201721280858,-0.7750351478331344,0.8475336322869955,0.9330514146780614,1.0,10/35,24.35%,FAR2;GGTA1;HMGCLL1;FASN;AACS;SCD;GGT7;GGT1;AWAT2;HMGCS2
prerank,integrated stress response signaling (GO:0140467),0.3071612900414551,0.7750236868130534,0.7484909456740443,1.0,1.0,5/14,21.05%,IMPACT;EIF2AK1;DDIT3;EIF2S1;OMA1
prerank,cellular response to UV-A (GO:0071492),-0.31222640869710894,-0.7743409785013341,0.7644710578842315,0.933594471262955,1.0,8/11,48.74%,MMP2;TIMP1;MMP3;MME;OPN5;MMP9;CERS1;OPN1SW
prerank,mitotic cell cycle phase transition (GO:0044772),-0.17201133317474826,-0.7743099511369751,0.9762532981530343,0.9331587736401443,1.0,67/203,29.47%,FBXL7;ACVR1;YWHAE;CDC27;PPP1R12A;DYNC1I2;CDK14;CACUL1;PPP2R2D;CSNK1E;EPS8;CCNY;PLK2;CDC16;TUBA1A;CHMP4B;EIF4E;CEP76;NASP;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PRKACA;PAFAH1B1;LATS1;MASTL;CCNF;CCND1;DYNC1H1;CDK6;LCMT1;AJUBA;CCND2;DCTN1;CSNK1D;TUBA4A;FBXL6;CEP131;CDKN1B;CCNH;CEP41;CDK5RAP2;CCNB2;CDC23;CEP152;PLK3;CUL3;CDC34;KDM8;LATS2;PIM2;CDKN3;CUL4A;ANAPC1;AKAP9;PPP2R2A;CDK2;ACTR1A;CCNJ;CDKN2B;FBXW11;CUL1;DNM2;PPP2R1A;CNTRL
prerank,regulation of cell aging (GO:0090342),0.33184201156124615,0.7737434906287062,0.7565392354124748,1.0,1.0,3/11,19.39%,LMNA;VASH1;NEK4
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.28328564882228985,0.7735761718797776,0.77431906614786,1.0,1.0,6/21,18.03%,SMARCD3;FZD9;FZD3;NES;KDM1A;CX3CL1
prerank,positive regulation of type I interferon production (GO:0032481),-0.20111390677896135,-0.7721319822668853,0.9142156862745098,0.9358505208128595,1.0,22/73,25.50%,LRRFIP1;POLR3F;DHX33;XRCC5;TRIM56;G3BP1;POLR3H;ISG15;IFIH1;POLR3B;NFKB2;GAPDH;IRF5;POLR3A;MYD88;RIPK2;POLR3D;POLR2F;TLR4;ZBP1;PTPN11;POLR2H
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.29354123771781687,-0.7719681998136078,0.8,0.9355935010404228,1.0,4/15,17.23%,ANXA1;FAM107A;UBE2L3;GPER1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3347897837344273,0.7717387223786184,0.7350597609561753,1.0,1.0,4/10,22.00%,JARID2;SIRT1;KDM1A;ATRX
prerank,positive regulation of translational initiation (GO:0045948),0.2885210443618217,0.771234381874655,0.7777777777777778,1.0,1.0,7/18,23.99%,BOLL;POLR2D;DDX3X;UHMK1;LARP1;YTHDF3;YTHDF2
prerank,mitochondrial gene expression (GO:0140053),-0.22498412532580087,-0.7710422347858715,0.8482758620689655,0.9364290047355704,1.0,9/42,16.90%,GATB;FOXO3;LARS2;MRPL23;NDUFA7;MRPL12;GFM2;PTCD3;MRPS12
prerank,embryonic axis specification (GO:0000578),0.3018242492617612,0.7705886423170861,0.7593688362919132,1.0,1.0,2/15,3.81%,CXXC4;WNT7A
prerank,placenta development (GO:0001890),0.32230543229032993,0.77057025551853,0.7571428571428571,1.0,1.0,6/12,24.97%,CITED1;E2F8;PLAC1;CUL7;PTK2;PPARG
prerank,regulation of mRNA metabolic process (GO:1903311),0.32708525005987205,0.7705176307352297,0.7542533081285444,1.0,1.0,3/11,16.50%,SLTM;SAFB2;SAFB
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.32062245222643226,-0.7704407158450743,0.7677543186180422,0.9368198739766355,1.0,1/10,0.87%,PDE8A
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.231400611199293,0.7702929676699094,0.8358714043993232,1.0,1.0,13/57,17.93%,FANCD2;PLK1;ABRAXAS1;EME2;MDC1;RINT1;MRE11;CHEK2;CDC14B;PRKDC;ATM;CLSPN;RAD17
prerank,defense response to fungus (GO:0050832),-0.27952677612019516,-0.7702482769915542,0.7910447761194029,0.9366093351948319,1.0,4/17,22.88%,PLCG2;RARRES2;GAPDH;BCL10
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.2572202327536029,0.7702345482954976,0.791814946619217,1.0,1.0,9/29,16.69%,NAPA;RAB6B;NSF;COPG1;GOLGA5;COPG2;TRAPPC3;COPE;COPB1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2666377125870603,-0.7701740269707371,0.7917620137299771,0.9362376950388372,1.0,7/21,18.84%,RPL5;RPS7;RPL23;FBXO5;FZR1;MAD2L2;PTEN
prerank,neurogenesis (GO:0022008),0.23831716036689843,0.7696348842004291,0.8163992869875223,1.0,1.0,6/43,10.89%,TRAK1;VXN;DAGLA;LPAR1;WDR62;RITA1
prerank,dermatan sulfate metabolic process (GO:0030205),0.3102827766958187,0.7690560932979527,0.7416829745596869,1.0,1.0,1/13,0.36%,UST
prerank,negative regulation of developmental growth (GO:0048640),-0.24569474122315088,-0.7687620983124894,0.8405172413793104,0.9377704738196008,1.0,12/30,26.19%,FGF13;SEMA3G;PTCH1;MT3;RTN4;FGFR3;PTEN;ULK2;RTN4R;CDKN1B;ULK1;DCC
prerank,import into nucleus (GO:0051170),0.21203113522458183,0.7682595153159405,0.8777969018932874,1.0,1.0,7/73,6.89%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.27748377229864185,-0.7681483622436033,0.8085106382978723,0.9381611441826431,1.0,10/18,37.85%,AMER1;APOE;RNF128;FAF1;MSN;PTTG1IP;VPS35;DACT1;EZR;RDX
prerank,regulation of telomere maintenance (GO:0032204),-0.257135984380735,-0.7680119030064666,0.8100436681222707,0.9378881447865202,1.0,11/26,26.50%,GNL3;XRCC5;USP7;TERF2IP;YLPM1;NBN;PPP1R10;SIRT6;TINF2;HNRNPD;TERF2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3105496333393313,0.7679435137345851,0.7535641547861507,1.0,1.0,3/12,18.18%,PPARA;MIA3;AKT1
prerank,positive regulation of macrophage activation (GO:0043032),0.28845242553413275,0.767609840354425,0.7585513078470825,1.0,1.0,3/17,8.31%,TAFA3;CEBPA;TNIP2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.288622364696677,-0.7673538474680764,0.7489711934156379,0.9383647310679436,1.0,8/15,33.33%,CD200;GPER1;ZC3H12A;FCGR2B;CD300LF;MILR1;GRN;CD84
prerank,cellular response to unfolded protein (GO:0034620),0.2673294895288127,0.7672442573015735,0.7871559633027523,1.0,1.0,3/26,5.73%,HSPA1A;OPTN;ABCB10
prerank,dendritic cell migration (GO:0036336),-0.2801596297822534,-0.7669933602783395,0.7995991983967936,0.9383927828951076,1.0,11/16,44.84%,EPS8;HMGB1;CCR2;PIK3CG;CXCR4;GPR183;CCL5;CCL19;CCR1;CCR6;CXCR2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.32237326627837415,0.7669546006397029,0.7754716981132076,1.0,1.0,1/11,2.03%,LRRC38
prerank,negative regulation by host of viral process (GO:0044793),-0.31832476646045527,-0.7668553675144089,0.7631578947368421,0.9381109357117856,1.0,7/10,50.03%,ZC3H12A;VAPA;CRP;CCL8;PTX3;PSMC3;LTF
prerank,estrogen metabolic process (GO:0008210),0.2922609973041784,0.7665770809584272,0.7794970986460348,1.0,1.0,1/15,2.64%,HSD17B2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.27615257781845454,0.7665273214421084,0.7813765182186235,1.0,1.0,3/22,7.73%,STAM;RNF126;SNF8
prerank,proteasomal protein catabolic process (GO:0010498),0.18591463721678467,0.7664232595634008,0.9614791987673343,1.0,1.0,51/201,21.23%,DERL1;FBXL19;SIAH2;HECTD3;PSMD3;RNF41;IFI27;RNF126;MAEA;TRIM71;SOCS6;UBE4B;ARRB1;KAT5;CLOCK;TOPORS;UBE2W;PRPF19;CCDC47;PML;UBXN6;BAG6;PSMD1;PSMC5;SPSB2;RBCK1;RNF5;PSMA1;FEM1C;TBL1XR1;PSMD12;SIRT1;MDM2;KLHL20;TRIM3;KCTD2;SPSB1;FBXL22;RNF139;TRIM13;PSMD7;KCTD13;DDIT3;TRIM2;BFAR;ZSWIM8;RCN3;PSME2;RMND5A;KLHL42;TRIM9
prerank,negative regulation of translation (GO:0017148),0.21110177077825193,0.7661731480667854,0.8951048951048951,1.0,1.0,22/87,21.77%,CPEB2;ROCK2;TRIM71;CPEB4;UNK;EIF2AK2;PAIP2B;PAIP2;EPRS1;EIF4E2;TSC1;FXR2;EIF4EBP3;RNF139;GIGYF2;ILF3;DDX3X;CPEB3;LARP1;YTHDF3;CELF1;CNOT8
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2513545358304009,-0.7661296051604143,0.8355855855855856,0.9386108413758737,1.0,8/27,18.73%,CDC27;ANAPC5;UBE2D3;CDC16;UBE2L3;FZR1;UBE2A;CDC26
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.22757833828194565,0.7659535126591914,0.8353765323992994,1.0,1.0,20/51,27.34%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LEMD2;CHMP3;CHMP7;LBR;CHMP4C;SPAST;VRK1;RCC1;NUP160;SUMO1;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.22757833828194565,0.7659535126591914,0.8353765323992994,1.0,1.0,20/51,27.34%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LEMD2;CHMP3;CHMP7;LBR;CHMP4C;SPAST;VRK1;RCC1;NUP160;SUMO1;NUP133
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.28585525129259776,-0.7656652408551652,0.8062015503875969,0.9388346392477926,1.0,4/16,22.99%,TNFRSF1B;AHR;TNFSF8;SOX11
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2769066815574376,0.7654566068408473,0.7877629063097514,1.0,1.0,2/21,3.40%,DDB2;ERCC1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2769066815574376,0.7654566068408473,0.7877629063097514,1.0,1.0,2/21,3.40%,DDB2;ERCC1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.29030504376219046,-0.7653085113745867,0.7588235294117647,0.9388636952107571,1.0,6/15,28.53%,FAF2;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.202156584644881,-0.7653044741248167,0.9327354260089686,0.938381906603594,1.0,21/69,29.41%,ICE1;INTS11;GTF2F1;NCBP2;ELL2;POU2F1;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;GTF2E2;POLR2F;TAF9;GTF2E1;RPRD1A;POLR2H;CCNT1;POLR2E;SNAPC5
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2724927503809487,-0.7652911431702368,0.7963709677419355,0.93792278571967,1.0,9/18,37.69%,NCKAP1L;METTL3;PRDM1;CCR2;ZFP36L2;IL4I1;IKZF3;CRTAM;PRELID1
prerank,inositol phosphate catabolic process (GO:0071545),0.3158748156655,0.7651777285288427,0.7644859813084112,1.0,1.0,7/12,28.06%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A;NUDT3
prerank,negative regulation of B cell proliferation (GO:0030889),-0.31666334261153406,-0.7649722236535373,0.7830578512396694,0.9378701528024229,1.0,2/11,7.72%,LYN;TNFRSF21
prerank,regulation of B cell activation (GO:0050864),-0.25657108261107087,-0.7646423528800473,0.8131634819532909,0.9378657756612397,1.0,10/25,33.68%,AHR;NOD2;FCGR2B;ZFP36L2;FOXJ1;SAMSN1;IL4I1;LAPTM5;IKZF3;THEMIS2
prerank,negative regulation of type I interferon production (GO:0032480),-0.23063380724585486,-0.7645201290822528,0.8672566371681416,0.9375430473960495,1.0,9/40,17.03%,REL;RNF125;NLRC5;TRIM25;RELB;ISG15;IFIH1;TRAF3IP1;PCBP2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.28772188590365977,-0.7643484176043176,0.7854330708661418,0.9373169555032954,1.0,4/16,16.38%,MEF2C;MCTP2;MCTP1;FMR1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.284986615637239,0.7642503041853574,0.7658349328214972,1.0,1.0,1/19,0.42%,WNT4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.23854812711873363,-0.7640363609522751,0.8512396694214877,0.9372849048463029,1.0,12/32,26.26%,PLCG1;CALM3;TRPC1;JPH2;P2RY6;CEMIP;APLNR;GPER1;NPSR1;F2R;CASQ1;CALM1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.33329148882751686,0.763100550388624,0.7312252964426877,1.0,1.0,10/10,66.69%,CNGB1;CACNA2D4;RPE65;GRM6;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.33329148882751686,0.763100550388624,0.7312252964426877,1.0,1.0,10/10,66.69%,CNGB1;CACNA2D4;RPE65;GRM6;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,proteoglycan metabolic process (GO:0006029),-0.24914795981980217,-0.7628478638449843,0.8268398268398268,0.9384671381942805,1.0,3/26,4.70%,BMPR2;CSGALNACT1;CHST8
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2719817639732375,-0.7618242022471263,0.8167330677290837,0.9394422008855489,1.0,5/17,17.04%,STX1A;STX3;SYNGR2;SNAP23;SYNGR1
prerank,peptide catabolic process (GO:0043171),0.2768553032106067,0.761800983656018,0.7909604519774012,1.0,1.0,5/23,15.71%,ADAMTS13;CPQ;CTSH;TRHDE;GGT5
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.2598758983572152,0.7612829978259449,0.8071833648393195,1.0,1.0,5/29,10.45%,DHX34;E2F1;HNRNPU;ELAVL1;VIP
prerank,"base-excision repair, gap-filling (GO:0006287)",0.23971240160396645,0.761160058474674,0.826007326007326,1.0,1.0,8/35,15.66%,XRCC1;POLD2;MBD4;RFC5;NEIL1;POLE;RPA3;POLG
prerank,fatty acid biosynthetic process (GO:0006633),-0.20678137248706221,-0.7608523930037183,0.8951048951048951,0.9402506731433147,1.0,14/63,19.52%,ELOVL7;ABHD2;PTGS2;ELOVL5;FADS3;ELOVL6;LIAS;SCD;ELOVL1;TECRL;ELOVL4;MCAT;ASAH2;MLYCD
prerank,establishment of melanosome localization (GO:0032401),0.27907751005880804,0.7605401074814182,0.8125,1.0,1.0,5/19,22.43%,GPR143;BBS5;SHROOM2;MYO5A;BBS2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.28617086112799484,-0.7601838559062728,0.8115384615384615,0.9406825285253919,1.0,9/15,31.14%,DHX33;GBP5;USP50;MYD88;TLR4;TREM2;CPTP;TLR6;CD36
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2610829006785292,-0.760128182081057,0.8295218295218295,0.940272588970451,1.0,4/21,9.77%,BCL2L1;CREB3L1;NCK1;EIF2AK3
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.27359183504553425,0.7601004194563054,0.803960396039604,1.0,1.0,7/23,21.37%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.27359183504553425,0.7601004194563054,0.803960396039604,1.0,1.0,7/23,21.37%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,T cell proliferation (GO:0042098),-0.29730909139340383,-0.7595563708409043,0.7938144329896907,0.940584043109261,1.0,8/13,37.94%,DOCK8;CTPS1;CADM1;MSN;PIK3CG;RASGRP1;CRTAM;TNFRSF4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.3164927527696072,-0.7594010451914158,0.7858627858627859,0.9403164925345976,1.0,2/11,7.55%,RUNX1;CBFB
prerank,regulation of viral genome replication (GO:0045069),-0.20963005604147789,-0.7593923841752488,0.9113082039911308,0.9398471374338992,1.0,13/56,17.40%,PLSCR1;ADARB1;IFITM3;PABPC1;PPIA;ISG15;RSAD2;IFIH1;VAPB;PPIE;IFITM1;N4BP1;TMEM39A
prerank,central nervous system neuron development (GO:0021954),-0.29044881423558166,-0.7590049144513226,0.7846790890269151,0.9398935609986978,1.0,4/15,11.55%,RAPGEF2;LHX6;ARHGAP35;B4GALT5
prerank,tRNA metabolic process (GO:0006399),0.29046391562924384,0.7588715205553428,0.795131845841785,1.0,1.0,3/17,12.22%,DTD1;TRPT1;DARS2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3351623857102257,0.7584461091492684,0.7766798418972332,1.0,1.0,2/10,10.35%,NPTX1;NPTXR
prerank,regulation of actin filament-based process (GO:0032970),0.2165652391330325,0.7583424532804168,0.8831385642737897,1.0,1.0,5/70,3.18%,ROCK2;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.30040320967118744,-0.7582103013296444,0.7897838899803536,0.9405248480828463,1.0,3/13,16.72%,NECTIN2;STX7;PVR
prerank,fluid transport (GO:0042044),-0.30712865367236486,-0.758099495758302,0.8012295081967213,0.9401957940806434,1.0,2/12,12.50%,AQP11;SLC26A6
prerank,rRNA 3'-end processing (GO:0031125),0.33283370667833434,0.7575858915748088,0.7690721649484537,1.0,1.0,2/10,10.75%,EXOSC8;EXOSC2
prerank,long-chain fatty acid import into cell (GO:0044539),0.3311134994547268,0.757482159162319,0.7520491803278688,1.0,1.0,1/10,0.70%,ACSL1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.21712140572122623,-0.7574138275047482,0.8857142857142857,0.940635602220238,1.0,12/48,21.53%,EGFR;IRAK3;FLNA;PRKCG;IAPP;EDN1;APOE;MAD2L2;PFDN6;AGAP2;ROCK1;AZIN1
prerank,cellular lipid catabolic process (GO:0044242),-0.24697942980769813,-0.7570354750136076,0.8307692307692308,0.9406479331050833,1.0,6/27,16.35%,PPARD;CYP1B1;ACOX1;LPIN3;MT3;ACBD5
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23964751711636778,-0.7567602085827262,0.8533916849015317,0.9405420881847681,1.0,13/28,39.69%,TNFRSF21;CD86;GLMN;CEBPB;IL4I1;GPNMB;LGALS9;SDC4;VTCN1;ARG1;CRTAM;PDCD1LG2;CD80
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3103182910149442,0.7562110783122499,0.7596899224806202,1.0,1.0,1/13,0.87%,IL18
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.19316436156018313,-0.7556972638326549,0.9236276849642004,0.9415386435151126,1.0,37/82,36.15%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PRKACA;PAFAH1B1;DYNC1H1;DCTN1;CSNK1D;TUBA4A;CEP131;TPX2;CEP41;CDK5RAP2;CEP152;HMMR;KIF14;AKAP9;CDK2;ACTR1A;PPP2R1A;CNTRL;AURKA;CDK1;TP53;CEP250;CKAP5;DYRK3;ATF5;CEP135;HAUS7
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26047164710353043,-0.7555365471150097,0.8526315789473684,0.9412853821814932,1.0,6/22,18.07%,NUBPL;NFU1;HSCB;NFS1;ISCA2;NUBP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.26078132411575106,0.7554653883527604,0.8164435946462715,1.0,1.0,3/26,4.49%,NPR3;CDH3;PIK3CB
prerank,positive regulation of neuron death (GO:1901216),0.23264576745458648,0.7554419548011098,0.8455882352941176,1.0,1.0,13/46,20.20%,NUPR1;EFNB2;PICALM;CLU;SARM1;ITGAM;CDK5R1;C1QA;PRNP;DDIT3;BAX;REST;EIF2S1
prerank,oligodendrocyte differentiation (GO:0048709),0.2766009268610192,0.7554342581546946,0.8115079365079365,1.0,1.0,3/19,12.01%,SLC8A3;EIF2B4;SOX9
prerank,heme biosynthetic process (GO:0006783),-0.2575316714655597,-0.7546597899703814,0.84,0.9419394868966862,1.0,7/22,24.66%,ABCG2;NFE2L1;UROS;HMBS;COX15;FXN;FECH
prerank,protein targeting to mitochondrion (GO:0006626),0.22498001530248704,0.754216805897586,0.864963503649635,1.0,1.0,10/52,15.68%,PITRM1;AIFM1;IMMP1L;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;NDUFA13;TIMM21
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2466749256591365,-0.7541019828901178,0.8348214285714286,0.9422101610302295,1.0,5/26,10.00%,APP;HES1;EIF4E;TAL1;DUSP3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2140367010556487,-0.7540206538960806,0.8857808857808858,0.941813965333285,1.0,9/48,17.15%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;PLA2G6;ABHD8;AGPAT5;DGKB
prerank,phosphatidylcholine metabolic process (GO:0046470),0.21618021391978415,0.753748228572195,0.8881469115191987,1.0,1.0,11/70,12.23%,PON1;STARD7;PLA2G4C;LPIN1;PNPLA8;NR1H3;CSNK2A2;CHPT1;CHKB;PLA2G15;ABHD3
prerank,regulation of osteoblast proliferation (GO:0033688),0.28021788158170446,0.7535963099906691,0.7910750507099391,1.0,1.0,4/17,11.55%,NPR3;FGFR2;EIF2AK2;ATRAID
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.17830693361032987,-0.753499816493003,0.9761273209549072,0.9420509536174527,1.0,39/125,26.78%,EML1;STMN1;DYNC1I2;TNKS;MAP4;PLK2;NUP107;DYNC1I1;RPS27;RMDN1;INCENP;DYNLL1;ZWILCH;CLIP1;PPP1CC;ZW10;DCTN6;STIL;PAFAH1B1;SEC13;PMF1;NUSAP1;CENPL;CENPQ;DYNC1H1;NUP85;TAOK1;B9D2;GPSM2;NSL1;KIF4A;CENPN;CENPK;NDEL1;SPDL1;MIS12;CDCA8;SPC25;SGO1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.31679995042549824,0.7529757758426655,0.757201646090535,1.0,1.0,3/11,10.21%,EFNB2;FZD7;FRS2
prerank,regulation of cell death (GO:0010941),0.20376320486225746,0.7528216980505346,0.9075342465753424,1.0,1.0,14/94,14.65%,BMP7;HSPA1A;CCN2;OLFM4;DHCR24;RILPL1;LRRK2;IMPACT;PRR7;CLU;PARP16;TSC1;SARM1;HSPA1B
prerank,response to tumor necrosis factor (GO:0034612),-0.18972780074037982,-0.7527043967222501,0.9406175771971497,0.9426151878013466,1.0,22/91,22.19%,DAB2IP;PID1;TNFRSF11A;GCH1;ARHGEF2;ADAM10;YBX3;TNFRSF21;CCL13;RPS3;CD40;GPER1;ADAMTS12;CCL25;ZC3H12A;ERBIN;RIPK1;GGT7;MAP2K7;MAP4K3;HAS2;GGT1
prerank,negative regulation of immune response (GO:0050777),0.1903880580440767,0.7524316542573766,0.9463722397476341,1.0,1.0,29/154,18.90%,ADCY5;PTH2R;CD247;ENPP3;FURIN;ADCY1;CRHR1;GPR45;ADCY8;NLRC3;HRH2;HTR7;CACTIN;C1QBP;VIP;MAPK14;CD300A;MAPKBP1;COL3A1;TYRO3;HAVCR2;GGT5;IL6;GIPR;PPM1B;CREB1;VIPR2;ADCY6;RNF26
prerank,regulation of endopeptidase activity (GO:0052548),0.22416233613455006,0.7508302061802488,0.8904593639575972,1.0,1.0,14/59,20.74%,TIMP3;SERPINA10;FURIN;PICALM;SERPIND1;HRG;NRDC;APH1A;SERPINA9;SERPINE3;AKT1;SERPING1;SPOCK1;PSME2
prerank,regulation of cell division (GO:0051302),-0.19832572740059692,-0.7506729598199128,0.9270588235294117,0.9448083764215425,1.0,34/72,33.23%,MLLT3;BCL2L1;RACK1;PLK2;CALM3;TXNIP;MYO19;TAL1;PIK3C3;BLM;PIK3R4;CCP110;GIT1;RAB11FIP3;KIF13A;RAB11A;PRC1;NCOA3;DLL1;TLE6;ENTR1;FSD1;PLK3;SUSD2;CALM1;CIB1;MYC;FLCN;AURKA;SH3GLB1;KIF20A;CSPP1;ESRRB;BIRC6
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29579187026423526,-0.7504103601081711,0.8016032064128257,0.9446462637449276,1.0,5/13,23.91%,MGAT5;HES1;PTPRC;JAK3;EGF
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2473303089651788,0.7501427230519733,0.8407871198568873,1.0,1.0,7/30,14.95%,VAMP5;OPTN;GGA2;NSF;AMN;GOLGA4;GGA1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.23350898885632718,0.7499490313942551,0.8583916083916084,1.0,1.0,3/44,4.34%,ROCK2;GTPBP1;TNRC6A
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.23021774433957154,-0.7496457714200825,0.8501118568232662,0.9451742657241194,1.0,10/36,20.88%,DAB2IP;APAF1;RBBP4;SUZ12;FOXO4;YAF2;EPC1;RYBP;CHEK1;MGA
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3223700728094401,0.7487349531340394,0.7683168316831683,1.0,1.0,10/10,67.78%,PRNP;PRKAR1A;SCRIB;CD274;RC3H1;BTN2A2;FOXP3;PDCD1LG2;CRTAM;LGALS9
prerank,intracellular protein transmembrane transport (GO:0065002),-0.22434296108665933,-0.7486494919548909,0.8653421633554084,0.94596177403306,1.0,13/42,23.97%,PEX7;SEC61A1;AKT2;ROMO1;GRPEL1;PEX14;TIMM23;DNLZ;PEX2;TOMM40L;SEC62;TIMM50;PEX12
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.30397095037549426,-0.7483728312940968,0.8117408906882592,0.9458179328451535,1.0,8/12,50.83%,ZBTB1;CCR2;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,skeletal muscle contraction (GO:0003009),0.2764482894417408,0.7483106777365126,0.8247011952191236,1.0,1.0,5/19,21.19%,TNNI1;MYH14;STAC3;TNNI3;TNNC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3274244123440508,0.7478812519130843,0.7587628865979381,1.0,1.0,1/10,3.40%,ERCC1
prerank,t-circle formation (GO:0090656),0.3274244123440508,0.7478812519130843,0.7587628865979381,1.0,1.0,1/10,3.40%,ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3274244123440508,0.7478812519130843,0.7587628865979381,1.0,1.0,1/10,3.40%,ERCC1
prerank,peptidyl-lysine acetylation (GO:0018394),0.32780861295689157,0.7477590289975318,0.7702702702702703,1.0,1.0,3/10,16.00%,KAT5;BAG6;SIRT1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.24295951771015825,0.7476488118248849,0.845724907063197,1.0,1.0,5/33,13.34%,PABPN1;CPSF3;CPSF7;SLBP;LSM11
prerank,negative regulation of DNA recombination (GO:0045910),-0.21832439570667658,-0.7476289240342172,0.8741721854304636,0.9462996330034128,1.0,16/43,29.98%,SHLD1;TERF2IP;BLM;SMCHD1;FANCB;MAD2L2;POLR2I;POLR2F;TINF2;POLR2H;TERF2;SHLD3;PARP3;CGAS;POLR2E;HELB
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3168834573512298,0.74758599736491,0.7615230460921844,1.0,1.0,4/11,11.22%,HTRA2;CAAP1;PRR7;PIH1D1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2856596215565597,-0.7472565980482413,0.8104166666666667,0.946283987244525,1.0,8/14,35.20%,RFK;ADSS1;IMPDH1;ADSS2;ADK;PAICS;IMPDH2;GART
prerank,positive regulation of histone modification (GO:0031058),-0.23873815577169274,-0.7472372597717813,0.8562231759656652,0.9458242975897275,1.0,8/33,18.74%,RPS6KA5;GLYR1;NIPBL;SAP30BP;PAF1;APLNR;FMR1;MAPK3
prerank,positive regulation of bone resorption (GO:0045780),-0.3079982375195546,-0.7470457505082031,0.7909836065573771,0.9455937167588918,1.0,5/11,33.53%,TNFRSF11A;SYK;PLEKHM1;MC4R;ATP6AP1
prerank,protein targeting to peroxisome (GO:0006625),0.25871791190262977,0.7469967783369956,0.8023255813953488,1.0,1.0,5/29,10.39%,ZFAND6;ATAD1;LONP2;ABCD1;PEX1
prerank,regulation of mitotic spindle organization (GO:0060236),0.2453428971784499,0.7464915036882875,0.842756183745583,1.0,1.0,9/35,20.79%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A;CHMP3;RAE1
prerank,regulation of T cell activation (GO:0050863),-0.2189808236128842,-0.7462334343449979,0.8866213151927438,0.9461155208779658,1.0,25/42,49.39%,TNFRSF1B;DUSP3;JAK3;METTL3;TNFSF8;CCR2;IL4I1;LAPTM5;CD47;LAT;GPNMB;CCL5;VTCN1;CRTAM;PRELID1;LCK;CCDC88B;TNFSF9;FGL1;TNFAIP8L2;TNFSF11;TBX21;LGALS3;TNFSF18;CD2
prerank,tRNA processing (GO:0008033),-0.20698450727464518,-0.7460719527305733,0.916289592760181,0.9458357613880565,1.0,25/61,33.02%,TSEN2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRMT10B;CPSF4;TRIT1;ELAC2;CLP1;CDKAL1;RPP21;ADAT1;LCMT2;RTCB;WDR4;AARS2;ADAT2;POP7;RTRAF;CTU2;TRMT61A;CTU1;PTCD1;RPP40
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.28076735734691677,-0.7454222055874296,0.8104166666666667,0.9461976832394922,1.0,2/15,5.56%,FAP;CST3
prerank,regulation of secretion (GO:0051046),0.29967003840724593,0.7450952776986531,0.7829614604462475,1.0,1.0,2/13,6.81%,OAS2;NRG1
prerank,cellular respiration (GO:0045333),0.23635636602344293,0.7450237775050704,0.835820895522388,1.0,1.0,13/41,21.86%,COQ10A;NDUFS1;PPARGC1A;CYCS;UQCRH;SDHC;COX10;LYRM7;OXA1L;SDHB;ETFDH;SLC25A13;NR4A3
prerank,regulation of protein kinase C signaling (GO:0090036),-0.28571241205943637,-0.7448321014852339,0.8098290598290598,0.9464882920049466,1.0,4/14,14.49%,WNT5A;FLT4;VEGFA;CD40
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.29014935423988164,-0.744661989151129,0.802547770700637,0.9457481925199598,1.0,6/15,31.89%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.29014935423988164,-0.744661989151129,0.802547770700637,0.9457481925199598,1.0,6/15,31.89%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,microtubule polymerization (GO:0046785),0.25575630107963576,0.7441508755115369,0.8370786516853933,1.0,1.0,5/28,9.15%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2810677682368824,-0.7437323444989683,0.8444924406047516,0.9464540457794128,1.0,4/16,14.68%,SNRNP200;SFSWAP;NCBP2;DDX23
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2428507391838005,-0.7436633189984937,0.8426501035196687,0.9460773712334339,1.0,4/26,11.11%,PDE8A;PPIA;BAG5;HSPB1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.25870991524358566,0.7434890147477152,0.8382066276803118,1.0,1.0,3/25,6.52%,ANK2;CAPN3;PDPK1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2150406596299282,0.7432603703731897,0.8644366197183099,1.0,1.0,15/63,17.07%,TFDP2;E2F1;ARID3A;CDC25C;E2F8;E2F4;PML;CHEK2;PRKDC;PCBP4;ATM;GADD45A;MUC1;MDM2;CNOT3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.25501459785231506,0.7431896440616034,0.830078125,1.0,1.0,7/28,20.04%,TNIP2;PRKDC;IL6;SIRPA;IL12A;FGF10;PYCARD
prerank,regulation of macrophage differentiation (GO:0045649),-0.27757673515818604,-0.7431164611754347,0.8232848232848233,0.9463035522817205,1.0,8/15,37.73%,IL34;C1QC;ID2;RIPK1;CASP8;FADD;LIF;PF4
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2621734675008418,0.743040238519294,0.8181818181818182,0.9998904330945707,1.0,7/23,19.35%,INHA;C1QBP;HAVCR2;AXL;RARA;PRNP;DDIT3
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.26057529311456157,-0.742818096345881,0.8151950718685832,0.9461975145643392,1.0,10/21,29.98%,ARHGEF2;ATXN7;APC;FGF13;KATNB1;TAOK1;TPX2;CIB1;CAMSAP2;CAMSAP3
prerank,mitotic metaphase plate congression (GO:0007080),-0.20148590495458446,-0.7424075798559556,0.929384965831435,0.9462266057843505,1.0,19/51,26.34%,CHMP2B;CHMP4B;CHMP4A;PIBF1;RMDN1;ZW10;CHMP1B;RAB11A;RRS1;NUP62;CDC23;CUL3;KIFC1;KIF22;KIF14;SPDL1;MIS12;CDCA8;CEP55
prerank,RNA modification (GO:0009451),-0.20714410501680308,-0.7423416178154719,0.9095238095238095,0.9458361654235556,1.0,21/54,31.38%,ADARB1;ALKBH1;PUS3;THUMPD1;FTSJ1;TRIT1;CDKAL1;LCMT2;PUS7L;MEPCE;METTL3;NSUN4;WDR4;AARS2;NOP10;ADAT2;NSUN5;CTU2;TRMT61A;TSR3;CTU1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.31734810813635295,-0.7416880346256912,0.7971014492753623,0.9461701746652174,1.0,5/10,31.05%,NHP2;DKC1;NOP10;TSR3;RPUSD3
prerank,sphingosine metabolic process (GO:0006670),-0.2734658113186859,-0.7415568032487663,0.838074398249453,0.9458520168523971,1.0,7/17,22.29%,ACER2;PLPP1;PLPP3;SGPP1;ASAH2;ACER3;PLPP2
prerank,N-terminal protein amino acid modification (GO:0031365),0.3005429867489115,0.7411629542524638,0.7605633802816901,1.0,1.0,1/14,0.85%,METAP2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.23712142272065256,-0.7411244447614148,0.8678414096916299,0.9459072836282824,1.0,9/31,24.53%,PLCG2;MDK;CD40;IRF5;HMGB1;SYK;RIPK2;MAPK11;TLR4
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.2478751156385141,-0.7405848908277547,0.84375,0.9460851059111857,1.0,5/26,14.41%,SHANK3;ACTG1;SYNPO2;PFN1;LIMK1
prerank,"phototransduction, visible light (GO:0007603)",-0.2809586909578146,-0.7399487599968041,0.8298319327731093,0.9463618046352289,1.0,2/14,6.08%,GNA11;GNB1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2087364468819371,-0.7393720292565739,0.884090909090909,0.9465937992312583,1.0,22/49,33.91%,F3;AFAP1L2;STAT3;NOD1;SERPINE1;CD74;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL10;TLR4;F2R;FADD;PARK7;LAMTOR5;TLR1;NOS2;LGALS9;CD14;TLR3
prerank,digestive tract morphogenesis (GO:0048546),0.2992113046460846,0.7383690277237261,0.7883817427385892,1.0,1.0,2/14,6.87%,PDGFRA;FGFR2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.2821337389699376,-0.7381115000153566,0.8604166666666667,0.9476286253247013,1.0,1/14,0.48%,ACTN4
prerank,negative regulation of catabolic process (GO:0009895),0.22166108002912524,0.7377937566927605,0.8677839851024208,1.0,1.0,11/47,18.87%,NUPR1;PPARA;ADRA2A;MAD2L1;AZIN2;HDAC4;CYP51A1;SNX3;BANP;HMGCR;NCOR1
prerank,negative regulation of immune system process (GO:0002683),0.2863752584563668,0.7377913957020292,0.8032454361054767,1.0,1.0,4/16,13.69%,IL17D;HOXA7;SOX9;COL3A1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2458257997540273,0.7374210677139676,0.8442776735459663,1.0,1.0,9/29,22.32%,EXOSC8;PATL1;LSM5;EXOSC2;LSM4;EDC4;CNOT8;DCPS;DCP2
prerank,histone deacetylation (GO:0016575),-0.21413681410548543,-0.736952209517041,0.918552036199095,0.9486072516912121,1.0,12/43,23.33%,MIER1;HDAC9;PRDM5;PER1;MTA1;HDAC6;HDAC2;MTA3;MIER2;SIRT7;MSL3;SIRT6
prerank,response to unfolded protein (GO:0006986),0.2238609251094016,0.7369331935186931,0.8858131487889274,1.0,1.0,13/48,21.65%,HSPA1A;DERL1;OPTN;DNAJB4;TOR1B;HSPA1B;DNAJB2;HSPA9;HSP90AA1;DDIT3;BAX;DNAJB1;PACRG
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.2948635286211736,-0.7366889476870232,0.8075396825396826,0.948443609929619,1.0,2/13,8.69%,BMP4;SOD1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.29873122423595344,0.7366538653683081,0.8011811023622047,1.0,1.0,2/13,8.59%,KRI1;NOP9
prerank,phagosome maturation (GO:0090382),0.24366830631268524,0.7365291684394208,0.8589743589743589,1.0,1.0,8/35,14.91%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,mRNA destabilization (GO:0061157),0.23368674357415903,0.7363340379275065,0.8692449355432781,1.0,1.0,12/38,25.89%,ROCK2;TRIM71;TUT4;POLR2D;GIGYF2;CPEB3;YTHDF3;CELF1;DCPS;YTHDF2;ZFP36;ZFP36L1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.1827819845156743,-0.7362320096355481,0.9675,0.9485062480166417,1.0,25/101,25.71%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;LYN;WNT5A;SERPINE1;PDCD4;PAF1;CD86;GIT1;NOD2;ZC3H12A;HCK;HMGB1;MYD88;TICAM1;BCL10;CASP1;PRKCE;TLR4;CD68;SBNO2
prerank,regulation of neutrophil migration (GO:1902622),-0.3169066517570193,-0.7361536538214818,0.7966101694915254,0.948128847418576,1.0,3/10,15.74%,MPP1;JAM3;NCKAP1L
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.22753733568915857,0.7361120792260591,0.889090909090909,1.0,1.0,9/53,16.30%,OPRD1;CHRM2;HRH2;HTR7;HTR1F;CHRM1;OPRM1;HRH1;HTR1A
prerank,regulation of response to biotic stimulus (GO:0002831),0.2474496346809142,0.735071559565747,0.8288973384030418,1.0,1.0,4/28,9.42%,APPL2;TKFC;TRIM5;RNF135
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3123803953389888,0.7348425003501066,0.7638095238095238,1.0,1.0,6/11,26.83%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3123803953389888,0.7348425003501066,0.7638095238095238,1.0,1.0,6/11,26.83%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,positive regulation of translation (GO:0045727),-0.18572777976309196,-0.7347865773389183,0.9708029197080292,0.9492874880929256,1.0,11/94,11.95%,NIBAN1;THBS1;RBM3;RPL5;EIF3E;EEF2;YBX3;CDC123;AGO2;NGRN;RPS9
prerank,melanosome localization (GO:0032400),0.2661270334736905,0.7346171865717068,0.8192534381139489,1.0,1.0,3/21,13.32%,GPR143;BBS5;SHROOM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3037348005861378,0.7334014312855712,0.7901234567901234,1.0,1.0,2/11,11.74%,GSTM2;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3037348005861378,0.7334014312855712,0.7901234567901234,1.0,1.0,2/11,11.74%,GSTM2;GSTO1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.20193943680101928,-0.7333010510308495,0.9372093023255814,0.9506068671163516,1.0,20/54,29.98%,RHOA;DST;LIMK2;CLIP4;CLIP2;TRPV4;CLIP1;KATNAL1;CRIPT;RAB11A;DYNC1H1;DCTN1;SLK;FSD1;PLK3;KATNA1;CIB1;MAPT;CAMSAP2;CAMSAP3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.28815814163471776,-0.7328720497710732,0.7937743190661478,0.9506335294036049,1.0,1/13,0.30%,SLC4A10
prerank,nucleosome organization (GO:0034728),-0.20291590287007688,-0.7326859990687495,0.9105504587155964,0.9503739640853105,1.0,9/55,13.52%,CTCF;H3-3A;BPTF;SMARCC1;ARID1A;PAF1;NASP;LIN54;ACTR6
prerank,membrane depolarization (GO:0051899),-0.22725972012123058,-0.7326682966653266,0.8766233766233766,0.9499163759885696,1.0,7/32,18.83%,CAV1;CACNA1G;CACNA1B;CACNB4;CACNA1I;SCN3A;CACNA1H
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.25600674206158525,-0.7323373971236561,0.8551587301587301,0.9498272108311933,1.0,8/20,24.83%,ENTPD1;APP;TXNIP;NT5E;SUGT1;C3;CASP1;ANO6
prerank,natural killer cell mediated immunity (GO:0002228),0.29112929773650664,0.7323120954075159,0.7935871743486974,1.0,1.0,1/15,3.01%,KLRD1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.24749385101647092,0.7308604323590863,0.8623326959847036,1.0,1.0,6/31,15.68%,AIFM1;TOMM40;TIMM17A;PEX1;PAM16;TIMM21
prerank,response to hexose (GO:0009746),-0.24122764815350167,-0.7304455190031839,0.8580645161290322,0.9515410809898444,1.0,3/25,9.35%,THBS1;EIF2B2;PFKL
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.2766984824320466,0.7304019882821619,0.8081395348837209,1.0,1.0,7/18,21.15%,CHRM2;PLCB1;CHRM1;OPRM1;RGS8;CDK5R1;GNAQ
prerank,covalent chromatin modification (GO:0016569),-0.2892328519121916,-0.7302944062717677,0.8272357723577236,0.9512342915416171,1.0,10/14,44.60%,CHD1;MT3;SIRT7;PARK7;HDAC1;PARP2;MBD2;AURKB;HLCS;AURKC
prerank,chromatin organization (GO:0006325),-0.17286037951425123,-0.7302767877953554,0.9892761394101877,0.9507715163127345,1.0,14/132,11.03%,MECOM;PRDM16;ESR1;BPTF;SMARCC1;BAZ2B;EZH1;ZBTB1;CHD1L;ARID1A;RBBP4;BRWD1;CHD1;PBRM1
prerank,cell junction maintenance (GO:0034331),0.2863936619344525,0.7302664705997052,0.8111332007952287,1.0,1.0,1/14,2.86%,NLGN2
prerank,regulation of nuclear division (GO:0051783),0.2728252600784703,0.7297769547293843,0.8405511811023622,1.0,1.0,2/20,5.90%,OBSL1;CDC25C
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3161886081153169,-0.7295447720891438,0.8093385214007782,0.9511230297614842,1.0,5/10,29.61%,AKT2;IRS1;PTH1R;PRKCE;PMAIP1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2612988325746023,0.7294973084676801,0.8249534450651769,1.0,1.0,6/24,20.68%,TTLL6;AGBL4;GGCX;CFAP20;TTLL11;TTLL4
prerank,actin filament polymerization (GO:0030041),-0.23869510024962232,-0.7292367539661567,0.8619246861924686,0.9510013760732631,1.0,8/29,17.55%,GSN;MSRB2;WASHC3;FAM107A;MICALL2;PSTPIP2;PREX1;DIAPH3
prerank,sensory perception of chemical stimulus (GO:0007606),0.28322973566898996,0.7286117586924623,0.8020408163265306,1.0,1.0,15/15,71.70%,SYT10;SLC24A4;UBR3;GNAL;MKKS;GFY;OBP2B;OMP;BEST2;C5AR1;GNAS;BBS4;ADCY3;CD36;DRD2
prerank,fatty acid transport (GO:0015908),0.278269433874655,0.7284999966612977,0.8156862745098039,1.0,1.0,4/17,16.08%,ACSL1;SLC27A6;SLC27A4;GOT2
prerank,microtubule bundle formation (GO:0001578),-0.21668680024525738,-0.7275629153426366,0.9047619047619048,0.9524838477439459,1.0,18/42,36.77%,NCKAP5;TPPP3;GAS2L1;NCKAP5L;CLIP1;TOGARAM1;RP1;AAAS;CDK5RAP2;CFAP46;FOXJ1;MARK4;KIF20A;CFAP206;PSRC1;CCDC40;NAV1;SPAG16
prerank,pigment granule transport (GO:0051904),0.26928198838515943,0.7269253734468315,0.8436293436293436,1.0,1.0,2/18,9.27%,GPR143;BBS5
prerank,melanosome transport (GO:0032402),0.26928198838515943,0.7269253734468315,0.8436293436293436,1.0,1.0,2/18,9.27%,GPR143;BBS5
prerank,establishment of mitotic spindle orientation (GO:0000132),0.25403606902675296,0.726420448221511,0.8423005565862709,1.0,1.0,8/23,23.79%,PLK1;MAD2L1;HTT;NDC80;INSC;NDE1;CENPA;MISP
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18244835918255428,-0.7263284452905162,0.9624060150375939,0.953411990004903,1.0,23/95,25.71%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;SERPINE1;PDCD4;PAF1;CD86;GIT1;NOD2;ZC3H12A;HMGB1;MYD88;TICAM1;BCL10;FCGR2B;CASP1;TLR4;CD68;SBNO2
prerank,heterochromatin assembly (GO:0031507),0.2670937909763256,0.726301489278224,0.8,1.0,1.0,8/20,22.07%,CDKN2A;BEND3;BAHD1;SIRT1;CENPV;RRP8;BAZ2A;HELLS
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.25539499952208555,-0.7259690528043719,0.8469184890656064,0.9528690594204119,1.0,8/19,32.03%,TERF2IP;POLR2I;POLR2F;TINF2;POLR2H;TERF2;POLR2E;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.25539499952208555,-0.7259690528043719,0.8469184890656064,0.9528690594204119,1.0,8/19,32.03%,TERF2IP;POLR2I;POLR2F;TINF2;POLR2H;TERF2;POLR2E;POLR2J
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.21693675380208277,-0.7250259273539281,0.9063231850117096,0.9534571234112933,1.0,11/38,23.11%,POLR3F;PLSCR1;GBP5;PUM2;IFI35;PUM1;POLR3B;ZCCHC3;NMI;POLR3D;USP15
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.24128954277411627,-0.7250164296163574,0.8719646799116998,0.952994456851915,1.0,8/24,24.66%,ABCG2;NFE2L1;UROS;RSAD1;HMBS;COX15;FXN;FECH
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.23658769643960242,-0.724832355717161,0.8813229571984436,0.9527072923322654,1.0,9/26,21.77%,STAT3;AIM2;LYN;GRIN2B;USP50;GRIN1;PSENEN;PSME1;FYN
prerank,regulation of calcium ion import (GO:0090279),-0.252471216947307,-0.724630729620996,0.8611111111111112,0.9524555297484547,1.0,7/21,25.38%,SLC30A1;CXCL12;PLN;PSEN2;FYN;EGF;STC1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.26340673569188305,-0.7244506592039047,0.8625,0.9521745594298434,1.0,3/18,11.96%,THBS1;WNT5A;NECTIN2
prerank,protein N-linked glycosylation (GO:0006487),0.20893947116967043,0.7242607613372732,0.9050966608084359,1.0,1.0,19/66,22.85%,MAN1C1;ASGR1;B4GALT1;TUSC3;MGAT4C;MAGT1;PMM2;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2;DPAGT1;ALG2;ALG12;ST6GAL1;PGM3;DOLPP1
prerank,sphingolipid catabolic process (GO:0030149),0.2885243203361395,0.723675034816981,0.8166666666666667,1.0,1.0,2/15,9.96%,SPHK1;SMPD2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2762311269713182,-0.7236594008813343,0.8131021194605009,0.9526142909528185,1.0,5/15,16.36%,PPARD;ADM;AKT2;IRS1;LDLRAP1
prerank,histone mRNA catabolic process (GO:0071044),-0.280883039197104,-0.7232614005925563,0.8336633663366336,0.9525733337675816,1.0,6/15,30.26%,TENT2;TENT4B;MTPAP;EXOSC4;ERI1;XRN1
prerank,histone H4-K16 acetylation (GO:0043984),0.2677489873584512,0.7232334203888567,0.8426294820717132,1.0,1.0,3/19,6.45%,KMT2A;KANSL2;MEAF6
prerank,cellular response to interferon-beta (GO:0035458),0.2820909634241071,0.7231860200710031,0.8259109311740891,1.0,1.0,3/14,15.64%,HTRA2;STAT1;NDUFA13
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3068231678258643,-0.721630155964092,0.7975708502024291,0.9538435367794715,1.0,6/10,41.45%,EFHB;STIM1;CASQ1;CD84;GRAMD2A;HOMER2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.24080815375920647,0.7214325344186027,0.8805147058823529,1.0,1.0,9/32,20.04%,DDX5;PDK2;PML;BAG6;AEN;SIRT1;HIPK2;RRP8;PYCARD
prerank,receptor catabolic process (GO:0032801),0.2594453439933248,0.7211508150723382,0.85,1.0,1.0,2/24,6.35%,RNF43;KIF16B
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.22490653724351894,0.7207675212880142,0.8690265486725663,1.0,1.0,12/42,18.82%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;PPA1;IARS2;FARSA;YARS1;IARS1
prerank,interstrand cross-link repair (GO:0036297),-0.20467401888447165,-0.7207211793698146,0.9174107142857143,0.9543962566525409,1.0,19/53,28.89%,RPA1;UBC;RPS27A;UBB;FANCB;FANCG;NEIL3;RPA2;RAD51AP2;XPA;CENPX;NUCKS1;USP1;XRCC3;FANCL;RNF168;RAD51AP1;VCP;FAAP20
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2753607165626511,0.7206674282639729,0.8272552783109405,1.0,1.0,6/17,20.37%,MOSPD2;C1QBP;CAMK1D;TIRAP;RIPOR2;DNM1L
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.28905465837351263,0.7203826436697373,0.8199608610567515,1.0,1.0,5/13,19.94%,MSX2;TAF1;PER2;DDIT3;SIN3A
prerank,protein acetylation (GO:0006473),-0.22903519620609278,-0.7202133127449192,0.8886363636363637,0.954473892434574,1.0,3/30,4.37%,FOXO1;NAA16;KAT6A
prerank,tRNA aminoacylation (GO:0043039),0.22912805669807174,0.7197301347184182,0.8734177215189873,1.0,1.0,12/37,18.82%,HARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;QRSL1;PPA1;IARS2;FARSA;YARS1;IARS1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.23686827722463816,0.7195599670599864,0.852670349907919,1.0,1.0,5/35,12.18%,PCDHB11;CDH17;CDH10;CDH18;PCDHB3
prerank,protein localization to kinetochore (GO:0034501),-0.2778527747076208,-0.7194052856195207,0.8361702127659575,0.9548857740266065,1.0,9/14,42.30%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;RCC2;AURKB;MTBP
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2632129305204983,-0.7191834056538928,0.8539094650205762,0.9546489202537086,1.0,10/18,37.85%,DAB2IP;AMER1;FAF1;MSN;RIC1;PTTG1IP;VPS35;DACT1;EZR;RDX
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.24582863550506218,0.7191781787134252,0.8728971962616823,1.0,1.0,4/25,12.31%,PICALM;DLG4;ABCA2;MTMR2
prerank,positive regulation of neutrophil migration (GO:1902624),0.2707326286916548,0.7188456434518312,0.8365019011406845,1.0,1.0,6/18,20.37%,MOSPD2;C1QBP;CAMK1D;TIRAP;RIPOR2;DNM1L
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22865538694697946,-0.7182999164039259,0.8865546218487395,0.9551321000119019,1.0,10/31,24.89%,OTUD7B;USP7;SPATA2;BABAM2;USP50;PSMD14;CYLD;ATXN3;OTUB2;SHMT2
prerank,positive regulation of dendritic spine development (GO:0060999),0.258478948067442,0.7181799774222356,0.8712273641851107,1.0,1.0,7/20,21.12%,CAMK1;LLPH;SHANK1;CAPRIN2;DLG5;CPEB3;DBNL
prerank,regulation of gene silencing by RNA (GO:0060966),-0.20336311677911778,-0.7178425235830284,0.9399538106235565,0.9546738196376807,1.0,26/50,35.35%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;SEC13;FMR1;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP43;NUP210;POLR2J;EIF4G1;NUP42;NUP54;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.20336311677911778,-0.7178425235830284,0.9399538106235565,0.9546738196376807,1.0,26/50,35.35%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;SEC13;FMR1;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP43;NUP210;POLR2J;EIF4G1;NUP42;NUP54;NUP35
prerank,mRNA methylation (GO:0080009),0.2804473331338272,0.7176409557575096,0.8380566801619433,1.0,1.0,6/15,23.25%,NSUN2;TRMT6;TRMT61B;TRMT10C;ZC3H13;METTL8
prerank,nuclear membrane reassembly (GO:0031468),0.2121219898072385,0.7167751085992049,0.9125,1.0,1.0,20/54,27.34%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LEMD2;CHMP3;CHMP7;LBR;CHMP4C;SPAST;VRK1;RCC1;NUP160;SUMO1;NUP133
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2933119658863255,0.7163564891576497,0.8106995884773662,1.0,1.0,4/12,15.98%,SNAP29;SNAP47;SNAP25;STX4
prerank,histone H2A ubiquitination (GO:0033522),0.2710869756200347,0.7159498326462569,0.8122529644268774,1.0,1.0,1/17,1.02%,DDB2
prerank,multivesicular body assembly (GO:0036258),0.23869866717544608,0.7159053868572579,0.8805147058823529,1.0,1.0,4/30,7.73%,CHMP6;STAM;VTA1;SNF8
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.29474945128370056,0.7156296653753482,0.8102766798418972,1.0,1.0,1/12,0.53%,DAB2
prerank,nuclear membrane organization (GO:0071763),0.2627506357288962,0.7155648577923991,0.8408644400785854,0.9994160785141034,1.0,7/19,24.10%,PLK1;TOR1B;TMEM43;AKAP8L;CHMP7;SPAST;TOR1AIP1
prerank,sphingoid metabolic process (GO:0046519),-0.29262190236470814,-0.714924099762745,0.861328125,0.9573604639102202,1.0,6/12,22.29%,DEGS2;PLPP1;PLPP3;SGPP1;ASAH2;PLPP2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.23662692491945705,0.7140429668268464,0.8758992805755396,1.0,1.0,7/32,16.74%,PLK1;ABRAXAS1;RINT1;MRE11;CDC14B;ATM;CLSPN
prerank,telomere capping (GO:0016233),0.2738356861040389,0.7137042522346394,0.8407258064516129,1.0,1.0,3/16,14.22%,TFIP11;MRE11;PRKDC
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.17885474918809857,-0.7133331915658597,0.9851851851851852,0.95862016140385,1.0,34/94,29.64%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;TCTN3;DCTN3;ODF2;DYNLL1;CCP110;TMEM216;PRKAR2B;KIF24;PRKACA;NPHP1;PAFAH1B1;RAB11A;DYNC1H1;CEP97;DCTN1;CSNK1D;B9D2;TUBA4A;CEP131;CEP41;CDK5RAP2;CEP152;AKAP9;ACTR1A;TCTN1;MARK4;PPP2R1A;CNTRL;CEP83
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.2512841075736814,-0.7127437650468808,0.8725868725868726,0.9587309009023534,1.0,10/18,40.89%,ANXA1;FAM107A;UBE2L3;ZFP36L2;SSTR2;AQP1;KLF9;PCK2;ISL1;BCL2L11
prerank,glycogen catabolic process (GO:0005980),-0.26820387056693756,-0.7122414385549796,0.8261802575107297,0.95881040934194,1.0,5/15,16.02%,RB1CC1;PYGB;GAA;PGM2;PHKA2
prerank,regulation of viral transcription (GO:0046782),-0.2104261715732132,-0.7121173626549598,0.9277899343544858,0.9584630597030583,1.0,5/39,10.16%,MDFIC;MID2;IFITM3;TRIM14;GTF2F1
prerank,negative regulation of axonogenesis (GO:0050771),0.24333771800144952,0.7113954755740811,0.8532110091743119,1.0,1.0,4/27,10.92%,MAP2;RUFY3;LRP4;RNF6
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.256065069894176,-0.7111382404753134,0.8763326226012793,0.9590002820375486,1.0,3/18,13.88%,CD34;HDAC7;PTPRC
prerank,membrane fusion (GO:0061025),-0.21904118062190275,-0.7111240483584409,0.8982683982683982,0.9585400655646604,1.0,7/33,18.25%,DNM3;VAMP3;RABIF;DYSF;UBXN2A;SNAP23;HACE1
prerank,response to gamma radiation (GO:0010332),-0.24303742631733777,-0.7110994472912383,0.8717391304347826,0.9580939690904657,1.0,3/24,6.17%,DCUN1D3;MAP3K20;XRCC5
prerank,tetrahydrofolate metabolic process (GO:0046653),0.30357097344156175,0.7102580737850247,0.7857142857142857,1.0,1.0,4/10,17.87%,MTHFS;MTHFR;MTHFD1;MTHFD2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2819663828775605,-0.7101299046245794,0.834051724137931,0.9586343050345933,1.0,6/12,33.60%,SLC37A3;SLC25A14;SLC37A4;SLC20A1;XPR1;SLC20A2
prerank,dendritic cell chemotaxis (GO:0002407),-0.27497337006496164,-0.7099618706475617,0.8436213991769548,0.9583443710792217,1.0,10/14,44.84%,HMGB1;CCR2;PIK3CG;CXCR4;GPR183;CCL5;CCL19;CCR1;CCR6;CXCR2
prerank,C4-dicarboxylate transport (GO:0015740),-0.2643739524757839,-0.7093852172666277,0.8580375782881002,0.958469077174708,1.0,1/14,0.88%,LRRC8D
prerank,negative regulation of protein depolymerization (GO:1901880),-0.24071034158434307,-0.7088347760121534,0.8539553752535497,0.9585298020195995,1.0,7/24,15.41%,ARHGEF2;ATXN7;APC;PIK3CA;FGF13;LIMA1;KATNB1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.31357413958082786,0.7088083902166524,0.8307086614173228,1.0,1.0,3/10,11.76%,SMPD3;SMPD2;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.31357413958082786,0.7088083902166524,0.8307086614173228,1.0,1.0,3/10,11.76%,SMPD3;SMPD2;SPHK2
prerank,visual perception (GO:0007601),0.19308022396594368,0.7087820358379525,0.9459901800327333,1.0,1.0,17/84,20.53%,GPR143;EYA4;ARR3;EML2;PAX6;ADGRV1;CHRNB2;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;RDH12;MYO9A;CABP4;CNGB1
prerank,negative regulation of cellular senescence (GO:2000773),0.28236366425235726,0.7086087305042797,0.8217821782178217,1.0,1.0,4/13,16.00%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,tyrosine metabolic process (GO:0006570),-0.29362463583848053,-0.70741590319518,0.8646464646464647,0.9594598810696066,1.0,5/11,46.10%,FAH;IL4I1;HGD;DCT;IYD
prerank,RNA destabilization (GO:0050779),0.26417748265290936,0.7065996943923657,0.8496993987975952,1.0,1.0,1/18,0.77%,ROCK2
prerank,regulation of response to stress (GO:0080134),0.30910686001255283,0.7064356806726815,0.8381147540983607,1.0,1.0,2/10,13.81%,ADCY8;OPRM1
prerank,glucan catabolic process (GO:0009251),0.2725515915053089,0.7064302846814641,0.8506375227686703,1.0,1.0,4/15,14.00%,PHKG2;PHKB;PYGL;PYGM
prerank,protein import into mitochondrial matrix (GO:0030150),0.2646076872788008,0.7062553766832563,0.8413001912045889,1.0,1.0,4/18,15.68%,TOMM40;TIMM17A;PAM16;TIMM21
prerank,macrophage chemotaxis (GO:0048246),-0.29935300598137293,-0.7061564026099743,0.8404669260700389,0.9603035723681024,1.0,6/10,49.13%,TAFA4;CXCL17;CCL5;CCL3;LGALS3;CKLF
prerank,acyl-CoA biosynthetic process (GO:0071616),0.2741643582332495,0.7057901115831807,0.8401559454191033,1.0,1.0,6/16,24.63%,ACAT1;GCDH;ACACA;CBR4;DIP2A;ACSS1
prerank,apoptotic DNA fragmentation (GO:0006309),0.2731807059697333,0.7057718586828082,0.8365758754863813,1.0,1.0,4/16,17.39%,CASP3;DFFA;DICER1;EXOG
prerank,cell cycle G1/S phase transition (GO:0044843),0.20176838247715004,0.7055710735937304,0.9343065693430657,1.0,1.0,7/61,8.75%,CDKN2A;PHF8;E2F1;TRIM71;USP26;HINFP;MAX
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23303371657269284,0.705260496421416,0.9009345794392524,0.9999098111623774,1.0,9/31,22.32%,EXOSC8;PATL1;LSM5;EXOSC2;LSM4;EDC4;CNOT8;DCPS;DCP2
prerank,regulation of cilium movement (GO:0003352),-0.3038780883233234,-0.7050878984396275,0.854122621564482,0.9608919960496387,1.0,5/10,34.53%,DNAH11;CFAP43;ODAD2;CFAP206;CCDC40
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2738051488546115,-0.7049186292181573,0.8333333333333334,0.9605863386347642,1.0,6/13,29.41%,PERP;TBC1D10A;BAK1;RIPK2;CASP8;FADD
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.21213683775193695,-0.7048147385467292,0.9029345372460497,0.9602123312639758,1.0,7/40,14.33%,DEFA6;GBP4;RPL39;DROSHA;MPEG1;RARRES2;ROMO1
prerank,tRNA wobble base modification (GO:0002097),0.2788015113622421,0.7042881417217635,0.8534653465346534,1.0,1.0,2/14,5.97%,TRMT9B;GTPBP3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.24518728596802147,-0.7041541940141359,0.876,0.9603987464260005,1.0,8/21,34.04%,JUN;TWIST1;MED14;MED13;MED24;SETX;MED30;PAXIP1
prerank,regulation of myoblast fusion (GO:1901739),0.2981576433813007,0.7039370418847413,0.8075471698113208,1.0,1.0,3/11,17.85%,CFLAR;MAPK14;RIPOR2
prerank,positive regulation of interferon-beta production (GO:0032728),-0.21570232668678416,-0.7038594783108748,0.9295454545454546,0.9602142627214179,1.0,11/33,25.24%,POLR3F;TRIM56;ISG15;IFIH1;POLR3B;IRF5;POLR3A;RIPK2;POLR3D;TLR4;PTPN11
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.29782186779554176,-0.7036733831798909,0.8433734939759037,0.9599447367364392,1.0,4/10,23.35%,CEACAM1;PTPRC;ARRB2;FCGR2B
prerank,protein insertion into membrane (GO:0051205),-0.22350759669976508,-0.7034804674306231,0.9013452914798207,0.9596767091155453,1.0,3/32,3.99%,EGFR;APP;STX1A
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.21458160701116333,-0.7033763878873012,0.9117647058823529,0.9593170176830386,1.0,9/38,19.88%,NDUFA10;NDUFA8;NDUFS6;NDUFA5;NDUFA7;NDUFA4;NDUFA1;NDUFS8;NDUFS7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2400204789050127,0.7030511607870223,0.8938223938223938,1.0,1.0,5/28,15.37%,TFIP11;AUNIP;KMT5C;PRKDC;WAS
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17980806302594451,-0.7018295394022345,0.973621103117506,0.9603192451974749,1.0,14/87,14.01%,SDHAF2;TIMMDC1;NUBPL;NDUFA10;NDUFA8;IMMP2L;TMEM126A;NDUFS6;SDHAF4;NDUFA5;NDUFA7;NDUFAF6;SCO1;UQCRFS1
prerank,outer dynein arm assembly (GO:0036158),0.27832576184022384,0.7014273456276651,0.8349705304518664,1.0,1.0,5/14,27.19%,DNAL1;DNAAF5;DNAH5;DNAH17;ODAD4
prerank,epithelial structure maintenance (GO:0010669),0.3009284422889445,0.7012852210560874,0.8279352226720648,1.0,1.0,1/11,3.14%,STRAP
prerank,detection of calcium ion (GO:0005513),-0.27351421000143084,-0.7012570792871159,0.8597194388777555,0.960421854127779,1.0,8/13,36.23%,KCNMB2;CALM3;STIM1;CALM1;KCNMB4;KCNIP2;KCNMB1;CALM2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.19936682245545745,-0.7012075319878845,0.944954128440367,0.9599988727479183,1.0,8/46,17.15%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;AGPAT5;DGKB
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23231377411965984,0.7004862196965503,0.8953068592057761,1.0,1.0,6/32,12.23%,STARD7;LPIN1;CSNK2A2;CHPT1;CHKB;ABHD3
prerank,ERK1 and ERK2 cascade (GO:0070371),0.24691708498920242,0.699434778163329,0.8579439252336448,1.0,1.0,3/21,12.01%,IGF1;CTSH;SOX9
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.23604153765806396,-0.6989825248254774,0.9030172413793104,0.9616833958017591,1.0,6/24,18.75%,TGFB2;FOXO3;CDK5;FBXW7;ATF4;MCL1
prerank,lipoprotein transport (GO:0042953),0.3075057528376276,0.6979352876105586,0.8289738430583501,1.0,1.0,4/10,24.97%,PRKCB;MIA3;VMP1;PPARG
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.1654556523459752,-0.6978622068746572,0.9922480620155039,0.9623353992365403,1.0,48/128,31.93%,FBXL7;YWHAE;PPP1R12A;DYNC1I2;CDK14;CSNK1E;CCNY;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PRKACA;PAFAH1B1;LATS1;MASTL;DYNC1H1;LCMT1;AJUBA;DCTN1;CSNK1D;TUBA4A;FBXL6;CEP131;CCNH;CEP41;CDK5RAP2;CCNB2;CEP152;PLK3;KDM8;AKAP9;PPP2R2A;CDK2;ACTR1A;CDKN2B;FBXW11;CUL1;DNM2;PPP2R1A;CNTRL;CCDC57;MELK;AURKA;FBXL3;CDK1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.26067219315276446,0.697204974701359,0.8596837944664032,1.0,1.0,6/19,20.37%,MOSPD2;C1QBP;CAMK1D;TIRAP;RIPOR2;DNM1L
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.30093237648102467,-0.6965755826015432,0.83991683991684,0.9630298269142711,1.0,4/10,21.58%,LYN;CD24;CD40;BTLA
prerank,lytic vacuole organization (GO:0080171),0.22799201969461028,0.6965135642189305,0.9012797074954296,1.0,1.0,10/32,23.05%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;HOOK2;LAMTOR1
prerank,water transport (GO:0006833),-0.27937099291755835,-0.6961446603044582,0.8485477178423236,0.9629654700406595,1.0,2/12,15.91%,AQP11;CFTR
prerank,regulation of osteoclast differentiation (GO:0045670),-0.21543467847857062,-0.6955004717990253,0.9357601713062098,0.9630861549043217,1.0,19/33,47.64%,FBN1;UBASH3B;TLR4;CEBPB;GPR137B;LRRC17;POU4F1;TLR3;BGLAP;IL4;CCR1;OCSTAMP;IL23A;TNF;TNFSF11;CCL3;IL12B;CSF1;IL23R
prerank,synaptonemal complex assembly (GO:0007130),-0.26854189838000364,-0.6950857345941953,0.8518518518518519,0.9625192141342745,1.0,7/15,35.49%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),-0.26854189838000364,-0.6950857345941953,0.8518518518518519,0.9625192141342745,1.0,7/15,35.49%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,negative regulation of phagocytosis (GO:0050765),0.2640019696018538,0.6942655429548155,0.8544303797468354,1.0,1.0,1/17,0.56%,SYT11
prerank,protein mannosylation (GO:0035268),0.25008760542941616,0.6937423419731377,0.8904109589041096,1.0,1.0,8/22,19.16%,TMTC4;LARGE1;FKTN;DPM1;DPY19L1;CRPPA;POMT1;DPM2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2480826866535999,0.693742159585152,0.8936170212765957,1.0,1.0,4/19,12.67%,POLD2;DCK;AMPD3;TERT
prerank,negative regulation of bone mineralization (GO:0030502),0.280901673372164,0.6936288125605042,0.8490945674044266,1.0,1.0,1/13,1.70%,RFLNA
prerank,respiratory electron transport chain (GO:0022904),0.2772243487240344,0.6935005080442446,0.8683693516699411,1.0,1.0,6/14,23.68%,PPARGC1A;SLC25A12;SDHB;ETFDH;SLC25A13;SLC25A18
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.23163607786960083,-0.6934950285293836,0.9227557411273486,0.9634935285956434,1.0,5/26,10.34%,KMT2E;EGFR;ANXA1;ADAMTS1;RPTOR
prerank,neuropeptide signaling pathway (GO:0007218),0.20235167565089862,0.6933348262934677,0.9314586994727593,1.0,1.0,10/58,17.19%,OPRD1;GLRA1;NTS;LTB4R2;NMUR1;GPR37;GRP;OPRM1;GPR149;PENK
prerank,phosphate ion homeostasis (GO:0055062),-0.29538634568305855,-0.6933146969531152,0.8373983739837398,0.9632174960521602,1.0,1/10,3.61%,SFRP4
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18950567950304537,-0.693278806315025,0.9565217391304348,0.9627866291258197,1.0,21/57,31.66%,DCN;TNFSF10;KDR;MFF;HIP1R;BAK1;PLAUR;BBC3;GPER1;MIEF1;BIK;CAMKK2;BOK;MUL1;TREM2;HRK;PMAIP1;PARK7;BMF;VPS35;AURKA
prerank,protein K48-linked deubiquitination (GO:0071108),-0.23295213600844844,-0.6931336818058491,0.8711656441717791,0.9624376775411666,1.0,7/23,25.89%,OTUD7B;MINDY1;MINDY2;USP50;ATXN3;OTUB2;OTUB1
prerank,organelle transport along microtubule (GO:0072384),0.2301241265708947,0.6928877282906915,0.9053030303030303,1.0,1.0,6/31,13.29%,TRAK1;HTT;BICD1;COPG1;RAB1A;COPG2
prerank,actin crosslink formation (GO:0051764),-0.27980194819347887,-0.6925615939169761,0.8562992125984252,0.9624718517373663,1.0,3/12,13.46%,FLNA;EPS8;GAS2L1
prerank,DNA biosynthetic process (GO:0071897),0.2638682267967388,0.6923425303233662,0.8704061895551257,1.0,1.0,4/16,16.00%,POLD2;TERT;POLE;SIRT1
prerank,organelle disassembly (GO:1903008),0.22568418461710432,0.6921695432873293,0.9072727272727272,1.0,1.0,6/33,16.34%,PLK5;RETREG1;GOLGA2;ATG2B;MRRF;GBF1
prerank,regulation of receptor recycling (GO:0001919),-0.25931169039057766,-0.6917682827500388,0.8717391304347826,0.9627631006331305,1.0,2/16,5.51%,ECE1;VAMP3
prerank,negative regulation of B cell activation (GO:0050869),-0.2469519171041854,-0.691733000394084,0.896774193548387,0.9623302310859687,1.0,9/21,32.55%,LYN;TNFRSF21;ID2;FCGR2B;FOXJ1;SAMSN1;PARP3;LAPTM5;TYROBP
prerank,transition metal ion homeostasis (GO:0055076),0.2328996248209792,0.6911807971272012,0.9099264705882353,1.0,1.0,4/28,10.24%,HEPHL1;PICALM;CP;CUTC
prerank,negative regulation of cell division (GO:0051782),-0.2826353495599714,-0.6901865470761278,0.8512720156555773,0.9632811478922532,1.0,5/11,30.97%,TXNIP;BLM;E2F7;SUSD2;MYC
prerank,positive regulation of telomere maintenance (GO:0032206),0.23149991271136966,0.6898816441844977,0.891500904159132,1.0,1.0,8/31,16.94%,ERCC1;HNRNPA2B1;TNKS2;MRE11;PML;RTEL1;ATM;PKIB
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.2117994184368424,-0.688808189737455,0.9316770186335404,0.9640355359683527,1.0,12/33,25.16%,PIK3R1;PIK3C2A;PIK3CA;EDN1;PIK3CD;HTR2A;IRS1;PTEN;IGF1R;NYAP1;PIK3CG;PIK3C2B
prerank,protein localization to condensed chromosome (GO:1903083),-0.28159265590446314,-0.68822890652695,0.8622881355932204,0.9641049007620847,1.0,8/12,42.30%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;MTBP
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.23307832329129366,0.6881903531163732,0.8988970588235294,1.0,1.0,5/26,11.99%,ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.27754262100476257,0.6875813143207312,0.859344894026975,1.0,1.0,6/13,28.25%,HNRNPU;SUPT4H1;LARP7;RNF8;NELFA;EAPP
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2625259615571013,0.6872156903296087,0.8754578754578755,1.0,1.0,4/16,14.00%,PHKG2;PHKB;PYGL;PYGM
prerank,oxoacid metabolic process (GO:0043436),0.22943892185741627,0.6861910279135666,0.9273743016759777,1.0,1.0,6/27,19.26%,DDO;ABHD14B;PPA1;MINPP1;TPST1;LIPT1
prerank,negative regulation of histone acetylation (GO:0035067),0.28381025647213365,0.6860556542171721,0.8503937007874016,1.0,1.0,3/11,19.94%,NOC2L;SIRT1;SIN3A
prerank,mitotic recombination (GO:0006312),0.2695067274630554,0.6851923776726172,0.851063829787234,1.0,1.0,4/15,16.11%,ERCC1;MSH3;RAD51D;RAD52
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2565176743255206,0.685124757264058,0.8718446601941747,1.0,1.0,6/18,18.87%,PTBP2;PTBP1;TERT;NCOR2;PTBP3;NCOR1
prerank,protein O-linked mannosylation (GO:0035269),0.2568837245771148,0.6843398661408486,0.8636363636363636,1.0,1.0,7/18,19.16%,TMTC4;LARGE1;FKTN;DPM1;CRPPA;POMT1;DPM2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2606026335681322,0.6838834358743215,0.8545454545454545,1.0,1.0,6/19,26.19%,CHUK;STAT1;TLR8;DDX3X;SETD2;TLR7
prerank,positive regulation of glucose metabolic process (GO:0010907),0.27420545594989204,0.6834379317286059,0.8716904276985743,1.0,1.0,4/14,18.18%,SLC45A3;PPARGC1A;SIRT1;AKT1
prerank,neuron fate commitment (GO:0048663),0.2664464214021152,0.6828888069392535,0.8549323017408124,1.0,1.0,2/14,9.64%,PAX6;TGFBR1
prerank,cellular senescence (GO:0090398),0.23589944295158793,0.6827301962887837,0.8845470692717584,0.999996637843566,1.0,2/27,2.01%,MAGEA2;CDKN2A
prerank,negative regulation of catalytic activity (GO:0043086),0.2343226753343432,0.6818734360411142,0.8966202783300199,1.0,1.0,4/24,10.61%,APBA3;CCAR2;IFIT1;NES
prerank,aerobic respiration (GO:0009060),-0.2383700255950714,-0.6818646948558953,0.8784067085953878,0.9691402431227839,1.0,8/20,25.52%,ATP5F1D;UQCRB;MTFR2;NDUFS8;NDUFS7;SLC25A14;UQCR10;UQCRC1
prerank,telomere maintenance via telomerase (GO:0007004),-0.2198235168703669,-0.6818228102666581,0.9291666666666667,0.9687114383067547,1.0,10/28,27.02%,RPA1;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,sensory perception of smell (GO:0007608),0.283158621555458,0.6813192385435853,0.8326612903225806,0.9999643357965027,1.0,11/11,71.70%,SYT10;SLC24A4;UBR3;MKKS;GFY;OBP2B;OMP;BEST2;BBS4;ADCY3;DRD2
prerank,negative regulation of defense response to virus (GO:0050687),-0.2852602276199148,-0.6810015737072599,0.875,0.9689212009661302,1.0,5/10,24.16%,TRAF3IP1;PCBP2;TSPAN6;TARBP2;MUL1
prerank,transport along microtubule (GO:0010970),0.2755974851642801,0.6806676418197711,0.8619329388560157,0.9998739975381492,1.0,5/13,17.83%,CLIP3;COPG1;COPG2;SPG11;BORCS5
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.23321409809888644,-0.6786419164999966,0.8916666666666667,0.9704564517970646,1.0,4/21,18.01%,CNOT6L;CNOT11;PAN3;TNKS1BP1
prerank,chromatin assembly or disassembly (GO:0006333),-0.2737201354902431,-0.6782048684738466,0.87279843444227,0.9703457909316691,1.0,2/11,19.03%,RBBP4;CHAF1A
prerank,rRNA modification (GO:0000154),-0.23046881187962195,-0.6770753002691607,0.9087048832271762,0.9708017969958316,1.0,8/21,30.55%,THUMPD1;TRMT112;DIMT1;NSUN4;NHP2;DKC1;NOP10;TSR3
prerank,midbody abscission (GO:0061952),-0.24598154223671004,-0.6751851624384814,0.9166666666666666,0.9718498322662728,1.0,3/17,7.51%,CHMP2B;CHMP4B;CHMP4A
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2909604868986739,0.675028872067891,0.8497109826589595,1.0,1.0,4/11,19.46%,KAT5;MUC1;HIPK2;TFAP4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25075310455620986,0.6743911909740565,0.8814531548757171,1.0,1.0,5/17,19.48%,HNRNPU;CITED1;TERT;KDM1A;LTBP3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.1951817586595363,0.6743041510341907,0.9567567567567568,1.0,1.0,8/62,11.69%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;CDC73;MLLT1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2551567834055961,-0.6739958704315671,0.8953722334004024,0.9723198876884087,1.0,5/15,28.75%,HOGA1;PRODH;GGT7;GGT1;CHAC2
prerank,negative regulation of translational initiation (GO:0045947),-0.2646437905383302,-0.6733344278036412,0.8939096267190569,0.9724001630891453,1.0,4/13,16.38%,EIF3E;AGO2;TPR;FMR1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2460585107008294,-0.6728104715733982,0.9108527131782945,0.9723672676146206,1.0,5/16,19.21%,CD24;PGAM1;SRPX2;BARD1;TIGAR
prerank,detection of visible light (GO:0009584),0.26022666596272054,0.6727131270605329,0.8809073724007561,1.0,1.0,1/16,2.50%,ABCA4
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.2726874228203825,-0.6717441080613922,0.8715415019762845,0.9727622502373571,1.0,1/12,2.03%,INSR
prerank,L-glutamate transmembrane transport (GO:0015813),-0.27574181029218364,-0.6716864110514883,0.8937007874015748,0.972345307678874,1.0,2/10,11.97%,SLC1A3;SLC1A1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.2807499915846339,-0.6713755293091856,0.8571428571428571,0.9721072690422801,1.0,3/11,13.88%,CEACAM1;AHR;PTPRC
prerank,cellular response to gamma radiation (GO:0071480),-0.24961838819788326,-0.6701198796194352,0.9029535864978903,0.9726419909705637,1.0,2/17,6.17%,MAP3K20;XRCC5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.21990371806424097,0.6700024310902265,0.9066666666666666,1.0,1.0,5/31,11.57%,CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.23282420592638878,-0.6699760523998555,0.9039665970772442,0.9723027419227676,1.0,8/20,33.04%,BCL2L1;FAS;BAK1;MCL1;BOK;DCC;ITGAV;APPL1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.22086149497629087,-0.6697469264270582,0.9201680672268907,0.9720135336625388,1.0,11/28,31.76%,MFF;AKT2;KCNB1;CEMIP;MIEF1;FYN;MYO1C;DMTN;CIB1;GDI1;ITGB1BP1
prerank,Rac protein signal transduction (GO:0016601),0.25354572925110963,0.6696328636153657,0.8851485148514852,1.0,1.0,3/18,11.99%,HACD3;WASF1;CYFIP1
prerank,protein lipidation (GO:0006497),0.19510294954974364,0.6695832993941774,0.9634146341463414,1.0,1.0,16/59,20.07%,ZDHHC12;ZDHHC1;ZDHHC16;PIGH;PIGG;ZDHHC6;ZDHHC3;DPM1;PGAP4;ZDHHC21;GLUL;WDR45;PGAP2;ZDHHC23;DPM2;PIGO
prerank,regulation of interleukin-8 production (GO:0032677),0.19224814295278442,0.6686712964655858,0.9625212947189097,1.0,1.0,14/69,17.32%,HSPA1A;C5AR2;IL17D;SSC5D;ARRB1;CACTIN;RAB1A;MAPKBP1;HSPA1B;TLR8;TLR5;IL6;RELA;TIRAP
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2697017782478515,0.6683868470775955,0.8884540117416829,1.0,1.0,4/15,17.21%,RUVBL2;CCT3;CCT8;CCT5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.26640180048706275,-0.6681310275147012,0.8884462151394422,0.9727826516049574,1.0,5/11,28.05%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.29812284882018364,0.6680745651732906,0.8605108055009824,1.0,1.0,5/10,25.77%,CCT3;CCT8;CCT5;WRAP53;CCT6A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2137734831158349,0.6678684019451856,0.9376114081996435,1.0,1.0,2/36,2.66%,HSPA1A;CPNE1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.19841605005815766,-0.6677681234992325,0.952914798206278,0.9725922186252278,1.0,9/40,24.13%,TIPIN;MMS22L;BLM;TIMELESS;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,miRNA mediated inhibition of translation (GO:0035278),0.2865953593259917,0.6676131501897674,0.865546218487395,1.0,1.0,7/11,26.94%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2865953593259917,0.6676131501897674,0.865546218487395,1.0,1.0,7/11,26.94%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.22912505096182806,-0.6674874075112149,0.9022403258655805,0.9723408228611945,1.0,7/24,22.27%,MFF;AKT2;KCNB1;CEMIP;MIEF1;FYN;MYO1C
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.21034338515423567,0.6670140596152923,0.9306569343065694,1.0,1.0,11/40,20.37%,IGF1;PPIF;PDCD5;MLLT11;CLU;HGF;NOL3;AKT1;BAX;PYCARD;DNM1L
prerank,regulation of actin nucleation (GO:0051125),-0.26860719926770554,-0.6669379368946097,0.8940936863543788,0.9722778581201651,1.0,2/12,10.43%,GSN;WHAMM
prerank,anterior/posterior axis specification (GO:0009948),0.2554258261027971,0.6661184730201983,0.8641975308641975,1.0,1.0,1/15,1.63%,WLS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.27749629204028226,0.6656704667121278,0.871031746031746,1.0,1.0,1/12,2.52%,CYP26B1
prerank,aminoglycan metabolic process (GO:0006022),-0.2787954909889643,-0.6642038490731362,0.8722986247544204,0.9739241794713326,1.0,3/10,16.96%,XYLT1;B3GAT1;B3GAT3
prerank,glycogen biosynthetic process (GO:0005978),0.27654658653326086,0.6638892143559934,0.8448979591836735,1.0,1.0,3/12,15.46%,PGM1;GYG1;PER2
prerank,glucan biosynthetic process (GO:0009250),0.27654658653326086,0.6638892143559934,0.8448979591836735,1.0,1.0,3/12,15.46%,PGM1;GYG1;PER2
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.26621011748515855,-0.6628500957000635,0.8813229571984436,0.9744330074892158,1.0,7/12,32.14%,IDH3B;GLUD1;ASS1;IDH3G;ACLY;SIRT4;IDH1
prerank,histone H4-K5 acetylation (GO:0043981),-0.24761266223232758,-0.6623093977723283,0.888,0.9738680535958812,1.0,6/15,26.26%,KAT7;JADE2;ING4;PHF20;JADE1;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),-0.24761266223232758,-0.6623093977723283,0.888,0.9738680535958812,1.0,6/15,26.26%,KAT7;JADE2;ING4;PHF20;JADE1;KANSL3
prerank,positive regulation of DNA binding (GO:0043388),0.21565991883672422,0.6609237855709125,0.9174147217235189,1.0,1.0,1/31,0.69%,IGF1
prerank,T cell activation (GO:0042110),0.1894154218365507,0.6607423809616585,0.9656946826758147,1.0,1.0,5/69,7.43%,LEPR;KIT;LMBR1L;NLRC3;KIF13B
prerank,superoxide anion generation (GO:0042554),0.2665385211228388,0.6604381475904756,0.879245283018868,1.0,1.0,3/13,19.14%,NOX1;CYBA;NCF1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.20161714162321986,0.6603641511934204,0.9452296819787986,1.0,1.0,10/47,19.82%,TIMP3;SERPINA10;PCID2;SERPIND1;HRG;SERPINA9;SERPINE3;AKT1;SERPING1;SPOCK1
prerank,tRNA 5'-end processing (GO:0099116),0.2659743361155286,0.6596899374236306,0.9004065040650406,1.0,1.0,4/15,21.52%,POP4;RPP25L;TRMT10C;RPP30
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.18803273770408319,0.65787638053871,0.9681978798586572,1.0,1.0,8/64,11.69%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;CDC73;MLLT1
prerank,nuclear pore organization (GO:0006999),-0.2519754026382109,-0.6578358645963539,0.8953722334004024,0.9766272387262515,1.0,3/14,16.13%,NUP107;TPR;RTN4
prerank,purine-containing compound salvage (GO:0043101),-0.26557388627097167,-0.6573451811686595,0.8919449901768173,0.976499652869497,1.0,6/12,28.56%,GMPR;HPRT1;DGUOK;AMPD2;ADA;ADK
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.27050347109205775,0.6565622276901053,0.9044715447154471,1.0,1.0,1/12,2.11%,SLC5A3
prerank,regulation of stem cell population maintenance (GO:2000036),-0.23615600595019587,-0.6563594280372764,0.9006085192697769,0.9767135357495216,1.0,1/18,1.11%,PTN
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.2546541149846755,-0.6550475617822195,0.8910133843212237,0.9771659220681116,1.0,4/14,23.21%,ME1;NME2;AK4;NMNAT1
prerank,Golgi localization (GO:0051645),0.27804832565712256,0.6548481073321236,0.8752475247524752,1.0,1.0,3/11,12.51%,TBCCD1;COPG1;STK25
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.24654431453043518,0.654342406588442,0.9227642276422764,1.0,1.0,5/18,18.18%,HTRA2;TRAP1;SIRT1;NOL3;AKT1
prerank,phospholipid dephosphorylation (GO:0046839),-0.19474768401406528,-0.6542311056575191,0.9577167019027484,0.9772798681263614,1.0,13/37,26.46%,PLPP1;MTMR11;MTMR7;MTMR12;PLPP3;MTMR1;SGPP1;PTEN;INPP5B;PLPP2;PLPP6;PLPP5;INPP5F
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.27442510390577357,0.6533301131209208,0.873046875,1.0,1.0,4/12,18.87%,ELAVL1;TERT;NCOR2;NCOR1
prerank,mitotic DNA replication (GO:1902969),-0.2734887529272745,-0.6533052892406245,0.8950495049504951,0.977473800883381,1.0,5/10,26.19%,CDC45;POLA1;MCM3;GINS3;MCM6
prerank,B cell activation involved in immune response (GO:0002312),0.2698227764182093,0.6531285970618378,0.8971774193548387,1.0,1.0,2/13,9.85%,MSH6;BATF
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.2715364741689301,-0.6528507899854423,0.8807692307692307,0.9773412999639571,1.0,8/11,34.93%,NOVA2;ZNF445;PCBP2;PCBP1;RASA1;IGF2BP1;IGF2BP2;PCBP3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.229692585265161,0.6526061649679646,0.9147286821705426,1.0,1.0,3/23,9.76%,PARP14;NR1H3;STAT1
prerank,protein prenylation (GO:0018342),-0.280135761917757,-0.6505816408870699,0.893491124260355,0.9783707065848914,1.0,4/10,25.33%,PTAR1;RCE1;CHM;CHML
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22424569761544796,-0.6498898155926476,0.9346534653465347,0.9783635886687856,1.0,8/22,34.04%,ESR1;PSMC4;MED14;MED13;MED24;MED30;TP53;PAXIP1
prerank,phosphate ion transport (GO:0006817),0.24964786176116094,0.6484789511695843,0.9035250463821892,1.0,1.0,2/16,9.43%,SLC25A11;SLC34A3
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24383473014285295,-0.6477853055690359,0.9020833333333333,0.9792905462936546,1.0,3/15,11.76%,PLCG2;PAF1;PHB2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.27882400265731794,0.6474811595891273,0.8823529411764706,1.0,1.0,3/10,14.76%,GALNT3;GALNT2;GALNT1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20886200423800572,0.6472965925292317,0.9292364990689013,1.0,1.0,4/38,8.17%,MAGI2;PPARA;PIK3CB;DRD3
prerank,mitochondrial transcription (GO:0006390),-0.2712762399214443,-0.6472891765724774,0.8955823293172691,0.9791406102986239,1.0,2/10,14.53%,FOXO3;MRPL12
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.22418962551353788,0.6472573136046337,0.9178082191780822,1.0,1.0,3/26,7.53%,TCTA;HOXA7;INHA
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2583521277943094,0.6468921107438022,0.9163568773234201,1.0,1.0,8/15,27.18%,TNRC6A;TENT4A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22037960892671038,0.6466589065300095,0.9432234432234432,1.0,1.0,4/29,15.76%,FANCD2;MEIOB;BAG6;SYCE2
prerank,defense response to protozoan (GO:0042832),-0.26209245808073045,-0.6462084620740178,0.8961538461538462,0.9793955550393254,1.0,5/12,30.40%,GBP4;CD40;MYD88;BATF2;LYST
prerank,regulation of protein export from nucleus (GO:0046825),0.23229180679748385,0.6458926402175199,0.9058380414312618,1.0,1.0,7/23,19.84%,IFI27;CAMK1;RAPGEF3;PTPN14;TCF7L2;RANGAP1;UHMK1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22120002047340187,-0.6453153809409582,0.92152466367713,0.9795146083706662,1.0,8/22,28.19%,DHX33;EIF2AK3;ATF4;UBTF;NCL;SMARCA4;RASL11A;LYAR
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2676613859545909,-0.6449101315467447,0.8933601609657947,0.9793071864883283,1.0,2/11,16.00%,RACK1;ATF4
prerank,base-excision repair (GO:0006284),-0.1849799343909416,-0.6438029560153533,0.9652173913043478,0.9795323057397987,1.0,13/48,22.95%,RPA1;PARG;USP47;TDG;NEIL3;PRMT6;RPA2;XPA;RFC4;MUTYH;SMUG1;POLD4;POLB
prerank,negative regulation of transferase activity (GO:0051348),-0.20653561271802745,-0.6436955774399481,0.9418103448275862,0.9791416685298089,1.0,12/28,32.89%,CDKN1C;SRC;BAG5;FBXO5;LIMK1;DTX3L;CDKN1B;MAPT;SMAD7;PARK7;PIF1;TP53
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.23884765627484503,-0.6436880443020007,0.9280898876404494,0.9786795134685771,1.0,5/17,26.21%,CTCF;ZWILCH;ZW10;SPDL1;MIS12
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.2334325842178775,0.6435991655154077,0.9117647058823529,1.0,1.0,6/22,18.64%,MAN1C1;RNF5;MAN1A2;UGGT2;RNF139;TRIM13
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19568008072676252,0.6424928064575245,0.9566787003610109,1.0,1.0,2/42,4.19%,OXSR1;STK39
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2658505963590711,0.642385542224485,0.912109375,1.0,1.0,12/12,73.43%,HNRNPU;LARP7;RNF8;NELFA;EAPP;TCERG1;HEXIM1;NELFB;NELFE;RECQL5;RNF168;NELFCD
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2692355779022476,0.6423243898248017,0.9027237354085603,1.0,1.0,4/12,21.13%,NDC80;CENPC;BOD1;NUF2
prerank,GPI anchor biosynthetic process (GO:0006506),0.21368136067572027,0.6421223053231802,0.9253731343283582,1.0,1.0,11/30,27.09%,PIGH;PIGG;DPM1;PGAP4;PGAP2;DPM2;PIGO;PIGS;PIGW;MPPE1;PIGB
prerank,muscle filament sliding (GO:0030049),-0.19084861330928865,-0.6420410196797864,0.9663677130044843,0.9787673966658552,1.0,15/38,35.15%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;MYBPC1;TTN;TMOD1;NEB;TCAP;MYBPC2;MYL3;ACTA1;TNNT3
prerank,actin-myosin filament sliding (GO:0033275),-0.19084861330928865,-0.6420410196797864,0.9663677130044843,0.9787673966658552,1.0,15/38,35.15%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;MYBPC1;TTN;TMOD1;NEB;TCAP;MYBPC2;MYL3;ACTA1;TNNT3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24352813579176738,-0.6418577789285048,0.920997920997921,0.9784245249142376,1.0,7/15,29.95%,SEC61A1;SRP14;RAB3GAP2;SRPRA;ZFAND2B;ZFAND2A;EDEM1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.18400613431757312,-0.6414201030401175,0.9672131147540983,0.9782452156058042,1.0,17/43,32.86%,FOXN3;BABAM2;PABIR1;BLM;ORC1;FZR1;TAOK3;NBN;CHEK1;TAOK1;DTL;HUS1B;MRNIP;CDK1;CDC6;BRCC3;TICRR
prerank,glycolipid biosynthetic process (GO:0009247),0.20289764421015413,0.6413724686626885,0.9476534296028881,1.0,1.0,10/38,20.07%,ST3GAL5;LARGE1;PIGH;PIGG;DPM1;SCCPDH;PGAP4;PGAP2;DPM2;PIGO
prerank,reticulophagy (GO:0061709),0.26502114798179693,0.640925065775406,0.8810916179337231,1.0,1.0,2/12,11.89%,RETREG1;ATG2B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.19923811034108566,0.640319445465509,0.975925925925926,1.0,1.0,7/41,13.26%,GPRC5B;ADRA2A;NTRK2;DLG4;EPHA4;BDNF;HBEGF
prerank,negative regulation of chemokine production (GO:0032682),0.2525093700753603,0.6400687664859466,0.9096153846153846,1.0,1.0,4/14,18.15%,C1QTNF3;OAS3;IL6;SIRPA
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.24768662122045634,-0.6397097154049302,0.9174852652259332,0.9788639462389142,1.0,5/12,28.05%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2557235059837255,0.6396648114670981,0.9076620825147348,1.0,1.0,5/14,26.01%,C1QBP;TRMT10C;MPV17L2;RCC1L;FASTKD3
prerank,regulation of ERAD pathway (GO:1904292),0.2729138364368372,0.6390502208637389,0.900390625,1.0,1.0,3/11,12.63%,USP19;RNFT1;BAG6
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.24365153432257852,-0.638036099317895,0.9135021097046413,0.9793811347564427,1.0,9/14,35.86%,ACOX1;ECI2;ACOX3;SCP2;DECR2;CRAT;ACOX2;ACOT8;ACOXL
prerank,positive regulation of rRNA processing (GO:2000234),0.2777948658382457,0.6373445199528339,0.8816568047337278,1.0,1.0,4/10,23.04%,RIOK2;WDR75;UTP15;WDR43
prerank,maturation of SSU-rRNA (GO:0030490),-0.20077910944061358,-0.6371465896140289,0.9565217391304348,0.9794959923094092,1.0,15/34,34.01%,RPS16;RPS8;RPS28;BMS1;DCAF13;PWP2;RPS19;RIOK1;WDR46;DHX37;HELB;TSR3;TSR1;HEATR1;NOP14
prerank,ESCRT complex disassembly (GO:1904896),-0.26764186903715736,-0.6370794411246352,0.9132149901380671,0.9786122665885729,1.0,3/10,18.54%,CHMP2B;IST1;CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),-0.26764186903715736,-0.6370794411246352,0.9132149901380671,0.9786122665885729,1.0,3/10,18.54%,CHMP2B;IST1;CHMP1B
prerank,positive regulation of cytokinesis (GO:0032467),0.2088811833980066,0.6362170077787173,0.9612546125461254,1.0,1.0,3/32,8.17%,TAS1R2;PKP4;DRD3
prerank,negative regulation of cell aging (GO:0090344),0.24243601042946927,0.636210867405674,0.9347826086956522,1.0,1.0,4/16,16.00%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,modulation by host of viral genome replication (GO:0044827),-0.24651332827593384,-0.6360844189378266,0.9035639412997903,0.9787714467004683,1.0,6/13,26.09%,FMR1;ZC3H12A;PPIB;NUCKS1;TBC1D20;VAPA
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2493446160573219,0.635825904458709,0.9168278529980658,1.0,1.0,1/15,3.34%,DAGLA
prerank,negative regulation of intracellular protein transport (GO:0090317),0.22524225807725967,0.6354461762292745,0.9398496240601504,0.999825578679117,1.0,5/22,16.82%,SUFU;LRRK2;BAG4;RAB23;RANGAP1
prerank,cellular component maintenance (GO:0043954),0.2606389797591023,0.6350923005682241,0.9030927835051547,0.9994042442731333,1.0,4/12,19.21%,SUPV3L1;MTMR2;PICK1;PRNP
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.18794160859103706,-0.6348772832323117,0.9799107142857143,0.9790454967815312,1.0,7/40,16.42%,PID1;BCL2L1;UBB;SOD1;AKT2;BAK1;SLC25A36
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.26534460990420417,-0.6342799647615045,0.9006211180124224,0.978964263138043,1.0,5/11,25.52%,UQCR11;UQCRFS1;UQCRB;UQCR10;UQCRC1
prerank,telomere maintenance via recombination (GO:0000722),0.2702387169816555,0.6332286331529294,0.8838582677165354,1.0,1.0,2/11,14.36%,ERCC1;RAD51D
prerank,negative regulation of secretion (GO:0051048),-0.26612831998577396,-0.632886639252997,0.9018789144050104,0.9793022663822579,1.0,4/10,23.91%,VAMP3;CD74;PTGER3;EGF
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.24319805682139417,0.6326119854131265,0.9072847682119205,0.9997425867407818,1.0,4/16,17.08%,RECQL4;SSBP1;MCM7;MCMDC2
prerank,negative regulation of viral genome replication (GO:0045071),0.19944204152616482,0.6323662607340566,0.9707495429616088,0.9992277148947728,1.0,12/40,23.01%,OAS2;IFIT1;EIF2AK2;OAS3;MPHOSPH8;ILF3;INPP5K;SETDB1;PARP10;SLPI;BST2;SRPK1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.26388588144569136,-0.6315088353190438,0.9190283400809717,0.9796554236470597,1.0,7/11,48.79%,MALT1;NFKBID;CARD9;IL23A;IL12B;IL23R;CLEC6A
prerank,regulation of rRNA processing (GO:2000232),0.24570918718029186,0.630638676968149,0.9168278529980658,0.9996851734843348,1.0,6/16,23.99%,RIOK2;WDR75;METTL18;UTP15;WDR43;YTHDF2
prerank,lysosome organization (GO:0007040),0.2015360577359257,0.6297675632451386,0.9655172413793104,0.9995839505129089,1.0,10/36,23.05%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;HOOK2;LAMTOR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.1638250244706552,0.6287136142414476,0.9950819672131147,0.9995776447912597,1.0,27/129,19.24%,USH1C;OPTN;FBXL12;PLK1;CEP78;CLASP1;CDC25C;CEP290;TUBG1;PLCB1;NES;PCM1;PPP1CB;CHEK2;SFI1;ENSA;TUBB4A;AKAP8;NINL;MAPRE1;AKAP8L;NEDD1;CETN2;FBXL22;PKMYT1;WEE1;HSP90AA1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.26593156838468834,-0.6281110355149474,0.9212121212121213,0.9806574225081907,1.0,1/10,9.58%,KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.26593156838468834,-0.6281110355149474,0.9212121212121213,0.9806574225081907,1.0,1/10,9.58%,KLF4
prerank,protein import into peroxisome membrane (GO:0045046),-0.21235019453344783,-0.6265126756805519,0.9376299376299376,0.9811288912765178,1.0,11/22,39.17%,ABCD2;ACBD5;PEX14;PEX2;GDAP1;PEX12;SLC25A17;PEX3;FIS1;PXMP4;RAB8B
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2712440896591377,0.6261248925079624,0.912109375,1.0,1.0,5/11,25.77%,CCT3;CCT8;CCT5;WRAP53;CCT6A
prerank,Golgi to lysosome transport (GO:0090160),0.2647845742902598,0.6240718656249529,0.8975903614457831,1.0,1.0,2/11,12.44%,CCDC91;AP4M1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.25537581466369286,-0.623032347684986,0.9212765957446809,0.9826180245667367,1.0,3/11,20.25%,NCL;SIRT7;SMARCA4
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.2374620857391801,0.6223787964679435,0.9447731755424064,1.0,1.0,5/18,20.12%,ADRA2A;BMP8A;CHGA;INHBB;REST
prerank,peroxisomal membrane transport (GO:0015919),-0.20406193525487842,-0.6217570184738168,0.9455337690631809,0.9828167980773411,1.0,6/27,19.38%,ABCD2;PEX7;ACBD5;PEX14;PEX2;GDAP1
prerank,methylguanosine-cap decapping (GO:0110156),0.2734993572358165,0.6207479648045567,0.900990099009901,1.0,1.0,4/10,22.32%,PATL1;EDC4;DCPS;DCP2
prerank,T cell homeostasis (GO:0043029),-0.2661586071343157,-0.6197823423048233,0.9098039215686274,0.9834195148804246,1.0,5/10,29.61%,FAS;NCKAP1L;JAK3;FADD;PMAIP1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.2416083859732307,0.6192566927358055,0.9127906976744186,1.0,1.0,1/15,1.61%,MAGI2
prerank,ruffle organization (GO:0031529),0.23768321607835727,0.6177947782849054,0.900375939849624,1.0,1.0,4/16,21.95%,CORO1B;CYFIP1;INPP5K;PLEK
prerank,regulation of response to interferon-gamma (GO:0060330),-0.23834559372936232,-0.6167884482128133,0.9305555555555556,0.9845578791024808,1.0,3/14,23.56%,JAK1;SOCS3;SOCS1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2639092497873128,0.616474481675237,0.9076305220883534,1.0,1.0,6/12,25.77%,GNL3L;CCT3;CCT8;CCT5;WRAP53;CCT6A
prerank,polyamine metabolic process (GO:0006595),0.2480005007897888,0.6144404847729132,0.9109311740890689,1.0,1.0,1/13,4.10%,SAT1
prerank,positive regulation of peptidase activity (GO:0010952),0.2274514708639323,0.6136858094733282,0.9384615384615385,1.0,1.0,5/20,20.74%,CTSH;APH1A;NDUFA13;RCN3;PSME2
prerank,stem cell development (GO:0048864),0.23844964253311732,0.6130407436384172,0.9302788844621513,1.0,1.0,2/16,6.81%,WNT7A;NRG1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.2115803100157208,0.6120616861804405,0.9444444444444444,1.0,1.0,10/25,27.91%,SRSF10;MPHOSPH10;PRPF3;PRPF6;SF3B1;SF3B3;WDR83;PRPF8;SNRNP40;BCAS2
prerank,serine family amino acid catabolic process (GO:0009071),-0.25823332478204036,-0.6119772116061017,0.935672514619883,0.9865797479033772,1.0,5/10,28.16%,THNSL2;SHMT2;CBS;DLD;SHMT1
prerank,regulation of DNA recombination (GO:0000018),0.20418026775378056,0.6110483862745767,0.9515828677839852,1.0,1.0,8/32,18.55%,MSH6;MRE11;RTEL1;MSH3;ALYREF;KDM1A;THOC1;FIGNL1
prerank,glutathione metabolic process (GO:0006749),0.19468202379754723,0.6104549147561349,0.969258589511754,1.0,1.0,9/38,18.67%,ETHE1;GSTM2;CNDP2;GGT5;GSTM1;OPLAH;GSTA3;GSTZ1;MGST2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.235288492424224,0.6100198143091512,0.9388145315487572,1.0,1.0,4/18,17.21%,RUVBL2;CCT3;CCT8;CCT5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.23997469667182136,0.6097221900372832,0.9298245614035088,1.0,1.0,5/15,17.25%,BCL2;MUC1;SIRT1;MDM2;KDM1A
prerank,protein targeting to lysosome (GO:0006622),0.2239044551366846,0.6097216718086739,0.9442307692307692,1.0,1.0,4/20,12.44%,SNX16;LAMP2;CLU;AP4M1
prerank,negative regulation of innate immune response (GO:0045824),0.200819190723539,0.6092405230396724,0.9616858237547893,0.999744050904061,1.0,9/34,21.63%,USP18;NLRC3;CACTIN;OAS3;STAT2;TYRO3;SERPING1;DHX58;YTHDF3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2360772703312564,0.6086995118650088,0.9293893129770993,0.9993553805094888,1.0,6/16,28.15%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,regulation of defense response to virus (GO:0050688),0.24062169851550907,0.6063838183562286,0.9377510040160643,0.9999464667184428,1.0,4/14,20.25%,C1QBP;PPM1B;RNF26;ILRUN
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.22947353335913132,0.6059748060424301,0.9419475655430711,0.9994915277279259,1.0,7/18,27.91%,PPARA;MIA3;AKT1;PAG1;WNK1;PTPN22;LAX1
prerank,protein localization to centrosome (GO:0071539),-0.22313262104084647,-0.6057937226330217,0.9551282051282052,0.989088018900961,1.0,11/17,39.95%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;GOLGB1;CCDC14;BBS4;HOOK3;DCTN2
prerank,stress granule assembly (GO:0034063),0.2180909428011485,0.6057190009026019,0.9363817097415507,0.9989633584194382,1.0,9/20,26.97%,ATXN2L;BICD1;OGFOD1;DDX3X;EIF2S1;YTHDF3;YTHDF2;CSDE1;PRRC2C
prerank,regulation of defense response to virus by host (GO:0050691),0.20234407277382194,0.6051792655377565,0.9566787003610109,0.9985844966434926,1.0,6/30,19.94%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,cell cycle checkpoint signaling (GO:0000075),0.25444069541647985,0.6046759542738893,0.9226519337016574,0.9981808716178628,1.0,3/12,18.98%,ZWINT;PRCC;WEE1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.25205764197527636,0.6037772237201537,0.9251968503937008,0.9979653536208168,1.0,3/12,15.33%,INSIG2;ANKRD13C;RER1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.22648879346348597,-0.6023264822572912,0.9505154639175257,0.9902274474159529,1.0,10/15,39.95%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;CCDC14;BBS4;HOOK3;DCTN2
prerank,RNA stabilization (GO:0043489),0.19785699062941728,0.6014185616112889,0.9575289575289575,0.9985447095870339,1.0,6/33,14.70%,E2F1;HNRNPU;ELAVL1;VIP;NSUN2;PAIP1
prerank,protein heterotetramerization (GO:0051290),0.24858840510823166,0.6013076634234843,0.9206349206349206,0.9979309190843666,1.0,2/13,7.58%,CPSF6;CPSF7
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.23351556578139565,-0.6002181638945313,0.9299242424242424,0.9907702101553746,1.0,3/13,16.30%,SAE1;SENP6;UBA6
prerank,secretory granule organization (GO:0033363),-0.25182651766624753,-0.5982827637536743,0.923728813559322,0.9911532784964193,1.0,1/10,3.91%,ABCA1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.24585737766273918,0.5982789858370325,0.9328358208955224,0.9988011270451557,1.0,7/13,27.18%,TNRC6A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B
prerank,positive regulation of chemokine production (GO:0032722),-0.17439672259762048,-0.5975727173822524,1.0,0.9909864949114747,1.0,12/44,27.08%,APP;WNT5A;IL6R;CD74;TWIST1;CSF1R;IL33;HMGB1;SYK;TLR4;HMOX1;AIF1
prerank,transcription preinitiation complex assembly (GO:0070897),0.2498430634023855,0.5969946728203755,0.9158878504672897,0.9987856918185437,1.0,12/12,75.03%,TAF1;DR1;GTF2A2;TAF12;GTF2B;TBP;TAF11;TAF7L;TAF1B;BDP1;TAF7;POLR1E
prerank,regulation of B cell differentiation (GO:0045577),-0.2213425506741109,-0.5959094913766245,0.9526881720430107,0.9912549989597764,1.0,7/17,33.18%,ID2;NCKAP1L;BTK;SYK;ZFP36L2;IL4I1;IKZF3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.21025583374229875,-0.5949915656428377,0.9618473895582329,0.9911911465163825,1.0,6/19,25.20%,HIPK1;DDIT4;DYRK2;TMEM109;SNW1;BCL3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.24199230338372657,-0.5949410133817399,0.9513618677042801,0.9907505146524849,1.0,1/12,4.05%,JUN
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19919650623128843,-0.5945147294314007,0.9635193133047211,0.9904549386083126,1.0,5/25,17.23%,TNFSF10;MFF;PLAUR;BBC3;GPER1
prerank,positive regulation of immune effector process (GO:0002699),0.208746806745978,0.5944916736966372,0.9694656488549618,0.9993136655927216,1.0,1/27,1.06%,APPL2
prerank,protein kinase A signaling (GO:0010737),0.239292954888075,0.5927766733836494,0.9507874015748031,0.9994919241205467,1.0,2/12,12.85%,TCP11;RAB13
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.25563155007106547,-0.5918198040013982,0.9405737704918032,0.9910961347437496,1.0,3/10,15.04%,PAF1;NCBP2;NCBP1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.22588554721636478,-0.5916433971827596,0.9640591966173362,0.9906950942739449,1.0,3/14,17.73%,RPL7;RPL35;ZNHIT6
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.22770674961021176,0.5914312250424912,0.9404990403071017,0.9994632399030594,1.0,2/17,10.14%,KLRD1;SLAMF6
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.23891163840598678,0.5867465731251803,0.9583333333333334,1.0,1.0,3/13,14.48%,MBD4;UPP2;NEIL1
prerank,B cell mediated immunity (GO:0019724),-0.24413600372942984,-0.5855147930975011,0.9291666666666667,0.9926396688700673,1.0,5/10,43.88%,CD74;FCGR2B;FCER1G;CARD9;SLA2
prerank,regulation of lymphocyte migration (GO:2000401),0.2581130173657516,0.5846369849208412,0.9582504970178927,1.0,1.0,4/10,24.67%,WASL;MIA3;AKT1;SLC8B1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2196304167524081,0.5835064689298024,0.9617590822179732,1.0,1.0,4/18,11.57%,NLRC3;MED25;CD300A;CDC73
prerank,toxin transport (GO:1901998),-0.24509152010857774,-0.5834002983971447,0.9570552147239264,0.9929925565749577,1.0,1/10,5.93%,ADAM10
prerank,tRNA export from nucleus (GO:0006409),0.18909976022206412,0.5826816985597213,0.9649737302977233,0.999992654994252,1.0,7/32,20.79%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1;RAE1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.18909976022206412,0.5826816985597213,0.9649737302977233,0.999992654994252,1.0,7/32,20.79%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1;RAE1
prerank,histone H4 deacetylation (GO:0070933),-0.24971304470860267,-0.5824887254878728,0.9441117764471058,0.9928715571574679,1.0,2/10,17.22%,HDAC9;HDAC2
prerank,macrophage migration (GO:1905517),0.2367380249858748,0.5818423474147248,0.934,0.9997011544822556,1.0,13/13,76.35%,P2RX4;P2RY12;EDNRB;CCL2;SAA1;EDN2;CKLF;LGALS3;CCL3;CCL5;CXCL17;CCR2;TAFA4
prerank,regulation of protein localization to Cajal body (GO:1904869),0.24751038702521683,0.5799549115293515,0.9272030651340997,0.9991738972289216,1.0,5/11,25.77%,CCT3;CCT8;CCT5;LARP7;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.24751038702521683,0.5799549115293515,0.9272030651340997,0.9991738972289216,1.0,5/11,25.77%,CCT3;CCT8;CCT5;LARP7;CCT6A
prerank,inhibitory synapse assembly (GO:1904862),0.2519449274863732,0.5798240361239775,0.9214145383104125,0.9985683985626718,1.0,3/11,18.33%,CBLN4;GABRB2;GABRB3
prerank,piRNA metabolic process (GO:0034587),0.21826691532581657,0.5796789884593331,0.9443413729128015,0.9979657332479782,1.0,2/19,12.71%,TDRD9;MYBL1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.1996593319367602,0.5794881244202877,0.9758812615955473,0.9973918658601794,1.0,5/29,17.05%,PLA2G4C;PNPLA8;NR1H3;PLAAT3;TMEM86B
prerank,sulfur amino acid catabolic process (GO:0000098),0.24736379613356763,0.5788920860377277,0.932,0.9969724342854359,1.0,10/10,75.28%,CTH;BLMH;MTRR;MAT1A;GADL1;TST;ADO;TXN2;CBS;MPST
prerank,vitamin D metabolic process (GO:0042359),-0.2274829371582031,-0.5782248250341736,0.9529411764705882,0.9939952392933377,1.0,8/13,46.88%,CUBN;CYP2R1;LRP2;VDR;CYP1A1;CYP24A1;FGF23;CYP27B1
prerank,amyloid-beta metabolic process (GO:0050435),-0.21805737655258733,-0.577492208196592,0.9622266401590457,0.9937991514924324,1.0,4/16,24.98%,DYRK1A;PSEN2;PSENEN;MGAT3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2261666826679692,-0.5769684097530654,0.9539347408829175,0.9935197253799205,1.0,3/14,13.11%,TSEN2;CPSF4;CLP1
prerank,regulation of lamellipodium organization (GO:1902743),0.2270099978493751,0.576408611036541,0.9601518026565465,0.9973102767472815,1.0,4/14,19.54%,PDPN;CAPZB;WAS;CARMIL2
prerank,cell differentiation in spinal cord (GO:0021515),0.24795417066568376,0.5744357850508305,0.9448979591836735,0.9974733578566659,1.0,2/10,17.70%,MDGA2;SOX6
prerank,histone mRNA metabolic process (GO:0008334),0.19460022916252184,0.5729169679782575,0.9683426443202979,0.9974345949063715,1.0,5/27,15.05%,CPSF3;SLBP;TUT4;LSM11;ATM
prerank,nucleic acid metabolic process (GO:0090304),0.16362534036029613,0.5725995649802257,0.9964664310954063,0.9969116766391675,1.0,16/69,22.95%,HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;HNRNPL;PTBP1;LSM8;POLG;POLR2D;HNRNPH2;POLR2A;DNASE1L2;HNRNPH1;MMS19;POLR2B;DDX24
prerank,spliceosomal snRNP assembly (GO:0000387),0.18232792741900788,0.5717668123901467,0.9884393063583815,0.9965933450672998,1.0,13/38,26.55%,STRAP;SRSF10;PRPF19;LSM4;SNUPN;PRPF3;PRPF6;SNRPB;PRMT5;SART3;SNRPC;PRPF8;GEMIN7
prerank,ncRNA catabolic process (GO:0034661),0.1954072775387177,0.5713868374907989,0.9806949806949807,0.9960888936594167,1.0,6/28,19.43%,EXOSC8;EXOSC2;TUT4;SND1;MTREX;DIS3L
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.1862611426298239,-0.5713330425550296,0.9794238683127572,0.9949907484128659,1.0,14/25,39.32%,GMPR;HPRT1;DGUOK;AMPD2;ADA;SHMT2;SHMT1;PRPSAP1;ADK;PAICS;PRPS2;GART;AMPD1;PPAT
prerank,protein ADP-ribosylation (GO:0006471),-0.18564414378754124,-0.5712839168510199,0.976890756302521,0.9945476664483016,1.0,4/28,10.75%,TNKS;ART3;HPF1;SIRT5
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.21289481319168188,-0.5712217181441068,0.9764453961456103,0.9941091087196111,1.0,8/16,31.63%,RRAGA;KLHL22;CLEC16A;RRAGD;SIK3;GPR137B;LAMTOR5;FLCN
prerank,replication fork processing (GO:0031297),-0.17328808220426736,-0.570263082782028,0.9886621315192744,0.9939668488451348,1.0,8/38,24.13%,MMS22L;BLM;BRCA2;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,mitochondrion transport along microtubule (GO:0047497),-0.22377660531084656,-0.569799367306219,0.950592885375494,0.9936662828884614,1.0,4/13,27.79%,UBB;RHOT2;SYBU;MAPT
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.2020562731909056,0.5696331032367551,0.97265625,0.9961002718940957,1.0,6/23,20.17%,COX18;TOMM22;NDUFA13;HSP90AA1;BAX;MAIP1
prerank,ncRNA export from nucleus (GO:0097064),0.18184555217670229,0.5695956955527973,0.962432915921288,0.9954656869014439,1.0,12/36,27.34%,POM121;NUP155;NUP98;TSC1;NUP37;NUP88;NDC1;RAE1;PHAX;NPM1;NUP160;NUP133
prerank,P-body assembly (GO:0033962),-0.2314537423927049,-0.5682389917807033,0.943579766536965,0.9937237836376528,1.0,5/12,31.97%,LIMD1;DYNC1H1;LSM3;PATL2;EDC3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2300834955113314,0.5674061860716529,0.9476744186046512,0.9956438973791251,1.0,13/13,77.01%,VDAC2;BAX;RHOT1;BLOC1S2;BAD;RTL10;MOAP1;BNIP3L;BCL2L11;BNIP3;BMF;PMAIP1;RHOT2
prerank,positive regulation of viral process (GO:0048524),-0.15575787203892916,-0.5670162278792891,0.9954954954954955,0.9936510804113098,1.0,18/60,30.16%,MDFIC;ADARB1;PABPC1;PPIA;GTF2F1;VAPB;KPNA2;PPIE;TMEM39A;POLR2I;POLR2F;TARBP2;TBC1D20;POLR2H;NELFCD;CCNT1;POLR2E;RSF1
prerank,regulation of leukocyte migration (GO:0002685),-0.21103334814679808,-0.5652902376026113,0.9698189134808853,0.9937753377751383,1.0,3/16,15.74%,ANXA1;VEGFA;NCKAP1L
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.22155371810499702,0.5651662996034723,0.9554655870445344,0.9957890136394557,1.0,5/15,24.12%,EBI3;NKAP;IL12A;SHH;PNP
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.21066600079936698,-0.5648514840160647,0.9579158316633266,0.9934537475809285,1.0,7/16,31.77%,PIGC;PIGL;PIGX;PIGQ;PIGF;PIGV;PIGN
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.21275764948758108,-0.5635186070777474,0.9780439121756487,0.9934076160943569,1.0,3/16,13.88%,CEACAM1;STX7;PTPRC
prerank,protein localization to phagophore assembly site (GO:0034497),0.23619175736970122,0.5621308678727253,0.946058091286307,0.996186055911629,1.0,6/11,27.14%,MFN2;ATG13;WDR45;TRAPPC8;PACS2;STX17
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.21014154542237898,-0.5600924720026799,0.979757085020243,0.9940040499800478,1.0,8/16,38.42%,APOE;MYOCD;LRP1;ROCK1;TREM2;ABCA7;HDAC1;IL4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.19922428183205954,-0.5598955590543229,0.9769874476987448,0.9936009146321022,1.0,8/19,32.08%,SRC;TENT4B;TEN1;TINF2;CTC1;TERF2;XRN1;PIF1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.19731002904876116,-0.5592819847683541,0.9593147751605996,0.9933314493528338,1.0,9/18,38.69%,PTP4A3;CCT2;CEP295;DKC1;CCT7;TREM2;CORO2B;CEP135;CCT4
prerank,positive regulation of lipid storage (GO:0010884),-0.19272128485151127,-0.558784179123693,0.9853249475890985,0.9930318469921637,1.0,5/21,20.42%,SCARB1;SREBF2;ZC3H12A;C3;PLIN2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.21609792836602285,-0.5587349373711276,0.9696969696969697,0.992584747092863,1.0,9/15,45.04%,NUDT16;ZC3H12A;NYNRIN;POP7;RPP40;ZC3H12D;RNASEH1;LACTB2;ZC3H12C
prerank,negative regulation of interleukin-17 production (GO:0032700),0.24131560272509073,0.5570896393373049,0.9564315352697096,0.997203622920285,1.0,3/10,19.35%,IL12A;PRNP;DDIT3
prerank,tRNA transport (GO:0051031),0.17734836010099458,0.5534122159164765,0.9858657243816255,0.9977617049660265,1.0,7/35,20.79%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1;RAE1
prerank,axoneme assembly (GO:0035082),0.1851051053748341,0.552967893871874,0.9679245283018868,0.9972576038528466,1.0,5/30,21.77%,RSPH4A;DRC1;DNAAF2;DNAAF3;DCX
prerank,V(D)J recombination (GO:0033151),-0.22249582524302897,-0.552228614927143,0.9585062240663901,0.9939986980636216,1.0,4/11,31.62%,LIG4;HMGB1;DCAF1;XRCC4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.19587124526009847,0.5516340300265096,0.969639468690702,0.9970459317855724,1.0,3/24,8.73%,HNRNPU;TNKS2;GNL3L
prerank,negative regulation of receptor internalization (GO:0002091),-0.222949077025096,-0.5495553129298659,0.9692622950819673,0.9942915067532301,1.0,5/12,29.69%,ANKRD13A;ANKRD13B;ANKRD13D;NECAB2;WDR54
prerank,programmed necrotic cell death (GO:0097300),-0.19707396618734285,-0.5481217205813113,0.9776422764227642,0.9942078285068844,1.0,6/18,24.53%,IPMK;RIPK1;MLKL;TICAM1;CYLD;TLR4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.16195239552565865,0.5472804530673921,0.9964850615114236,0.9977138219330856,1.0,14/52,23.37%,EXOSC8;PATL1;LSM5;EXOSC2;LSM4;TUT4;EDC4;POLR2D;CNOT3;CNOT8;PNLDC1;DCPS;DCP2;PAN2
prerank,positive regulation of lipid localization (GO:1905954),-0.2237646588407818,-0.5460570863666411,0.9623015873015873,0.9943230344051184,1.0,4/11,26.13%,LRP1;ZC3H12A;C3;HILPDA
prerank,glycoprotein catabolic process (GO:0006516),-0.20013654330410138,-0.5457223955050565,0.9827956989247312,0.9939503790685994,1.0,8/17,35.84%,STT3B;FBXO44;ADAMTS12;EDEM2;FBXO2;EDEM1;OGA;NEU4
prerank,positive regulation of cilium assembly (GO:0045724),0.20424638880020674,0.5440526565079065,0.9638095238095238,0.9980325798649725,1.0,2/18,8.85%,SEPTIN9;HTT
prerank,microtubule-based transport (GO:0099111),-0.22148775915787688,-0.5425958561198999,0.9645833333333333,0.9942665504622537,1.0,5/12,27.10%,DYNC1I2;DYNC1I1;CABYR;ADCY10;SPEF2
prerank,apoptotic nuclear changes (GO:0030262),0.19086189343772528,0.5425668496549789,0.9772727272727273,0.9978293672130016,1.0,5/24,17.39%,CASP3;DFFA;DICER1;ACIN1;EXOG
prerank,photoreceptor cell development (GO:0042461),-0.21005414057420618,-0.5424013718510694,0.9727095516569201,0.9938529288453897,1.0,6/14,28.95%,MFSD2A;VEGFA;RP1;RORB;MYO7A;CDHR1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.2135111484719833,-0.5399202355978872,0.9643605870020965,0.9940099851759445,1.0,3/13,17.80%,HDAC6;MT3;NOD2
prerank,negative regulation of centrosome duplication (GO:0010826),0.2226349739529708,0.538910428654059,0.9497991967871486,0.9982335858731026,1.0,2/11,11.21%,CENATAC;TMEM67
prerank,mRNA modification (GO:0016556),0.19102211439002303,0.538076157636346,0.9755639097744361,0.9978290849759781,1.0,8/22,25.48%,NSUN2;TRMT6;TRMT61B;TRMT10C;ZC3H13;RPUSD2;METTL8;TRUB1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.22228774062563533,0.5374351728537716,0.9703557312252964,0.9973447917879606,1.0,2/12,11.26%,CLCN2;ABCA2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.21782915918746382,0.5357596238031735,0.9823529411764705,0.9971475656462707,1.0,3/14,17.09%,IKBKG;KCNN4;RELA
prerank,mitochondrial genome maintenance (GO:0000002),-0.2213450028129923,-0.534571124364219,0.9642058165548099,0.994809056413859,1.0,1/11,3.56%,AKT3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.1841339607057393,-0.5318807101782997,0.9854469854469855,0.9949475037628656,1.0,8/22,27.58%,PPP1CA;DUSP6;PPP2CA;DUSP1;PDP1;DUSP7;PPP5C;DUSP18
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.21739066024977632,-0.5259942115868471,0.9803921568627451,0.9957698139693916,1.0,6/12,35.13%,CDC45;MCM3;MCM5;MCM6;GINS2;MUS81
prerank,extracellular transport (GO:0006858),0.21536539175066655,0.5236178927527464,0.9693251533742331,0.999508348443763,1.0,3/12,19.31%,ROPN1L;DNAAF2;SPA17
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.1989449886963074,0.5231166718282272,0.9838709677419355,0.9989768150908207,1.0,18/18,80.13%,ROPN1L;DNAAF2;SPA17;ODAD4;OFD1;CCDC39;SPAG17;AQP4;DNAAF1;NEK10;RFX3;DNAAF4;CCDC40;NPHP3;SPEF2;ADCY10;CFAP53;CABYR
prerank,tRNA 5'-leader removal (GO:0001682),0.21860809562021596,0.5221424871484814,0.9608247422680413,0.9985536131315421,1.0,3/13,21.52%,POP4;RPP25L;RPP30
prerank,eosinophil chemotaxis (GO:0048245),-0.1980887388580314,-0.522050851052419,0.9723320158102767,0.995675602353436,1.0,9/14,47.93%,CCL13;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,eosinophil migration (GO:0072677),-0.1980887388580314,-0.522050851052419,0.9723320158102767,0.995675602353436,1.0,9/14,47.93%,CCL13;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.20490691905599917,-0.5129035836137958,0.9859484777517564,0.9969903014287985,1.0,5/12,32.86%,STK33;ORC1;HUS1B;CDC6;TICRR
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.1720367160248845,-0.5114582598617974,0.9912280701754386,0.9968083933997861,1.0,5/23,19.78%,PIK3R6;NECTIN2;PVR;CADM1;ARRB2
prerank,intermediate filament organization (GO:0045109),-0.18486894039525023,-0.5105548311775939,0.9939516129032258,0.9964927201247209,1.0,3/17,20.97%,GFAP;DSP;BFSP2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.18524332810047095,-0.509762846366268,0.9897119341563786,0.996166325958539,1.0,17/17,81.50%,DHDDS;ALG6;ALG3;DOLK;ALG13;MVD;ALG1;SRD5A3;ALG8;ALG14;ALG9;MPDU1;DOLPP1;ALG12;ALG2;DPAGT1;NUS1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.19960115810593332,-0.5086687339426057,0.9860557768924303,0.9958819384984221,1.0,7/12,39.32%,ADSS1;IMPDH1;ADSS2;PAICS;IMPDH2;GART;PPAT
prerank,rRNA catabolic process (GO:0016075),0.197303974533472,0.5068403421149587,0.9838056680161943,1.0,1.0,2/16,10.75%,EXOSC8;EXOSC2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.16160479228223207,0.5052192524328559,0.9981203007518797,1.0,1.0,8/37,21.37%,OPTN;DLG4;ABCA2;MTMR2;TRAP1;NFKB1;NCOR1;SDCBP
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.18245318183670495,-0.5038200402192355,0.9839357429718876,0.996246287518367,1.0,6/19,24.53%,TRIL;NR1H4;NMI;RAB11FIP2;PRKCE;TLR4
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.20718243759729163,-0.5026131792129512,0.9862204724409449,0.9959736989898275,1.0,6/11,44.02%,HDAC2;TAF7;TMEM106A;PF4;IL4;XBP1
prerank,regulation of response to oxidative stress (GO:1902882),0.20958053629179843,0.5019854953037209,0.9855670103092784,1.0,1.0,2/11,13.02%,ABCD1;AIFM2
prerank,central nervous system myelination (GO:0022010),0.21495643713662027,0.49670618342764034,0.9885496183206107,1.0,1.0,2/11,11.36%,ABCA2;CLU
prerank,nucleosome assembly (GO:0006334),0.1615812044610502,0.4921037788670935,0.9923954372623575,1.0,1.0,9/31,22.00%,SOX9;BRD2;CABIN1;NAP1L2;IPO4;KAT6B;SPTY2D1;SART3;ATRX
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.1905688810749718,0.49149437489034653,0.9822834645669292,1.0,1.0,16/16,80.96%,TRIM71;CPEB3;ZFP36;ZFP36L1;PLEKHN1;UPF1;TARDBP;KHSRP;MOV10;DHX36;RC3H1;DND1;ZC3H12D;ZFP36L2;RBM24;ZC3H12A
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.1755812419995731,0.48777302670130546,0.998015873015873,1.0,1.0,6/23,22.98%,GSTM2;EPHX2;GSTM1;ACSBG1;ALOX5;GPX4
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.18862656086894827,0.4864396751291816,0.9860834990059643,1.0,1.0,1/16,5.44%,VAMP7
prerank,negative regulation of lipid catabolic process (GO:0050995),0.18418825273088857,0.4860984486708499,0.9806201550387597,0.999537524268078,1.0,1/17,4.52%,ADRA2A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.1955552765396447,-0.48577396890266533,0.9939879759519038,0.9979220863168992,1.0,13/13,80.47%,ALG6;ALG3;ALG11;ALG13;ALG1;SRD5A3;ALG8;ALG14;ALG9;MPDU1;ALG12;ALG2;DPAGT1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.21196460747945853,0.4850196912763425,0.974308300395257,0.9990619542898885,1.0,1/10,7.06%,PDK2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.15704806581495317,-0.484984719940035,0.9978260869565218,0.9975749698670185,1.0,12/27,35.92%,AGTR1;LPAR6;GPR4;GPR35;F2R;GPR20;DRD2;GNA15;GPR157;GPR17;GPR18;CALCA
prerank,cranial nerve development (GO:0021545),-0.20110539766738444,-0.4827188927449406,0.9818181818181818,0.9973784345326359,1.0,6/11,39.76%,TMEM126A;SALL1;POU4F1;TIFAB;ERBB3;ISL1
prerank,serine family amino acid metabolic process (GO:0009069),0.18954619711878634,0.4806502469644239,0.9867172675521821,0.999065747917631,1.0,4/16,17.07%,GLYAT;CDO1;MTHFD1;CTH
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.1682831298314105,0.4805651742260074,0.9887429643527205,0.9984400524193578,1.0,5/23,21.36%,CASP3;DFFA;DICER1;EXOG;DNASE1L2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.16853322164225693,-0.4795511192609075,0.9918200408997955,0.9973057005711924,1.0,11/20,39.32%,HPRT1;ADSS1;IMPDH1;AK4;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.193498747858597,0.47708530971918167,0.9898580121703854,0.9982749282690292,1.0,5/13,24.02%,SNX33;STX4;GPD1L;RIC3;MAP1A
prerank,cytoplasmic translational initiation (GO:0002183),0.18166460661900766,0.47549976337455296,0.9885931558935361,0.9978400850933495,1.0,9/17,31.38%,EIF4A2;EIF3A;EIF2D;DENR;RBM4;EIF3D;DHX29;EIF2S2;EIF2B3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.2008034649425648,0.474999071609352,0.9803149606299213,0.9972614970922445,1.0,11/11,79.93%,STX4;ITGAM;MAVS;CAMK4;ITGB2;CD177;F2RL1;STAP1;TYROBP;TICAM1;SPI1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.20462177581110053,0.4744393740707917,0.9898167006109979,0.9967000015572806,1.0,2/10,17.32%,NR1H3;TIRAP
prerank,acetyl-CoA metabolic process (GO:0006084),-0.17801936356120118,-0.4685122981097925,0.98989898989899,0.9980206138903603,1.0,6/15,31.29%,ACACB;MLYCD;PMVK;HMGCS2;NUDT7;ACLY
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.1685630804135731,-0.46729666519088364,0.98989898989899,0.997666584969162,1.0,6/18,33.91%,FBN1;FBXW7;TLR4;GPR137B;LRRC17;TLR3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.17760443132903753,0.4619548358103703,0.9824561403508771,0.9975070899918382,1.0,3/16,14.67%,AMPD3;PFAS;GMPS
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.19648164070220078,-0.45840501084689284,0.9958932238193019,0.9980074397544577,1.0,4/10,35.75%,QDPR;KYNU;IL4I1;PCBD1
prerank,regulation of mitochondrial translation (GO:0070129),-0.15961213788408743,-0.45454339887704354,0.9938398357289527,0.997859591504064,1.0,8/21,34.83%,ALKBH1;NGRN;MTG1;SHMT2;RPUSD3;MTG2;MRPS27;MALSU1
prerank,microglial cell activation (GO:0001774),-0.1526579353461687,-0.44656327222539893,1.0,0.9980271416301657,1.0,1/21,3.60%,APP
prerank,protein auto-ADP-ribosylation (GO:0070213),0.18369936420800256,0.43864189638503676,0.9899598393574297,0.9989436890103343,1.0,4/12,24.44%,TNKS2;PARP16;PARP10;TIPARP
prerank,immunoglobulin mediated immune response (GO:0016064),-0.18473409257695994,-0.4346396000468855,0.9958847736625515,0.9983333754726877,1.0,2/10,23.35%,CD74;FCGR2B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.1471801906279969,0.43045719335341404,1.0,0.9988649381433917,1.0,9/29,28.15%,KLRD1;SLAMF6;ITGAM;IL12A;IL12RB1;LAMP1;CD226;CYRIB;AP1G1
prerank,regulation of protein kinase A signaling (GO:0010738),0.15694389169709458,0.41776386384916525,1.0,0.9989162882065519,1.0,2/20,8.36%,LRRK2;ADGRV1
prerank,positive regulation of calcium ion import (GO:0090280),-0.16694963252307046,-0.4119322361846738,0.9980276134122288,0.9988915402350741,1.0,1/12,7.69%,CXCL12
prerank,long-term memory (GO:0007616),0.14298634080978959,0.3758131005001449,1.0,0.9995746795524107,1.0,7/19,30.56%,SHANK1;PRNP;CPEB3;SGK1;RASGRF1;EIF2AK4;CAMK4
